id	sid	tid	token	lemma	pos
fnp-5343	1	1	hiv	hiv	PROPN
fnp-5343	1	2	and	and	CCONJ
fnp-5343	1	3	covid-19	covid-19	PROPN
fnp-5343	1	4	:	:	PUNCT
fnp-5343	1	5	two	two	NUM
fnp-5343	1	6	pandemics	pandemic	NOUN
fnp-5343	1	7	with	with	ADP
fnp-5343	1	8	significant	significant	ADJ
fnp-5343	1	9	(	(	PUNCT
fnp-5343	1	10	but	but	CCONJ
fnp-5343	1	11	different	different	ADJ
fnp-5343	1	12	)	)	PUNCT
fnp-5343	1	13	central	central	ADJ
fnp-5343	1	14	nervous	nervous	ADJ
fnp-5343	1	15	system	system	NOUN
fnp-5343	1	16	complications	complication	NOUN
fnp-5343	1	17	feel	feel	VERB
fnp-5343	1	18	free	free	ADJ
fnp-5343	1	19	to	to	PART
fnp-5343	1	20	add	add	VERB
fnp-5343	1	21	comments	comment	NOUN
fnp-5343	1	22	by	by	ADP
fnp-5343	1	23	clicking	click	VERB
fnp-5343	1	24	these	these	DET
fnp-5343	1	25	icons	icon	NOUN
fnp-5343	1	26	on	on	ADP
fnp-5343	1	27	the	the	DET
fnp-5343	1	28	sidebar	sidebar	NOUN
fnp-5343	1	29	free	free	ADJ
fnp-5343	1	30	neuropathology	neuropathology	NOUN
fnp-5343	1	31	5:5	5:5	NUM
fnp-5343	1	32	(	(	PUNCT
fnp-5343	1	33	2024	2024	NUM
fnp-5343	1	34	)	)	PUNCT
fnp-5343	1	35	review	review	VERB
fnp-5343	1	36	hiv	hiv	PROPN
fnp-5343	1	37	and	and	CCONJ
fnp-5343	1	38	covid-19	covid-19	PROPN
fnp-5343	1	39	:	:	PUNCT
fnp-5343	1	40	two	two	NUM
fnp-5343	1	41	pandemics	pandemic	NOUN
fnp-5343	1	42	with	with	ADP
fnp-5343	1	43	significant	significant	ADJ
fnp-5343	1	44	(	(	PUNCT
fnp-5343	1	45	but	but	CCONJ
fnp-5343	1	46	different	different	ADJ
fnp-5343	1	47	)	)	PUNCT
fnp-5343	1	48	central	central	ADJ
fnp-5343	1	49	nervous	nervous	ADJ
fnp-5343	1	50	system	system	NOUN
fnp-5343	1	51	complications	complication	NOUN
fnp-5343	1	52	shino	shino	NOUN
fnp-5343	1	53	magaki1	magaki1	PROPN
fnp-5343	1	54	,	,	PUNCT
fnp-5343	1	55	ting	ting	PROPN
fnp-5343	1	56	zhang1	zhang1	PROPN
fnp-5343	1	57	,	,	PUNCT
fnp-5343	1	58	karam	karam	PROPN
fnp-5343	1	59	han1a	han1a	PROPN
fnp-5343	1	60	,	,	PUNCT
fnp-5343	1	61	hilda	hilda	VERB
fnp-5343	1	62	mirbaha1	mirbaha1	PROPN
fnp-5343	1	63	,	,	PUNCT
fnp-5343	1	64	william	william	PROPN
fnp-5343	1	65	h.	h.	PROPN
fnp-5343	1	66	yong2	yong2	PROPN
fnp-5343	1	67	,	,	PUNCT
fnp-5343	1	68	cristian	cristian	PROPN
fnp-5343	1	69	achim3	achim3	PROPN
fnp-5343	1	70	,	,	PUNCT
fnp-5343	1	71	gregory	gregory	PROPN
fnp-5343	1	72	fishbein4	fishbein4	PROPN
fnp-5343	1	73	,	,	PUNCT
fnp-5343	1	74	michael	michael	PROPN
fnp-5343	1	75	c.	c.	PROPN
fnp-5343	1	76	fishbein4	fishbein4	PROPN
fnp-5343	1	77	,	,	PUNCT
fnp-5343	1	78	omai	omai	PROPN
fnp-5343	1	79	garner4	garner4	PROPN
fnp-5343	1	80	,	,	PUNCT
fnp-5343	1	81	noriko	noriko	NOUN
fnp-5343	1	82	salamon5	salamon5	NOUN
fnp-5343	1	83	,	,	PUNCT
fnp-5343	1	84	christopher	christopher	PROPN
fnp-5343	1	85	k.	k.	PROPN
fnp-5343	1	86	williams1	williams1	PROPN
fnp-5343	1	87	,	,	PUNCT
fnp-5343	1	88	miguel	miguel	PROPN
fnp-5343	1	89	a.	a.	PROPN
fnp-5343	1	90	valdes	valdes	PROPN
fnp-5343	1	91	-	-	PUNCT
fnp-5343	1	92	sueiras6	sueiras6	PROPN
fnp-5343	1	93	,	,	PUNCT
fnp-5343	1	94	jeffrey	jeffrey	PROPN
fnp-5343	1	95	j.	j.	PROPN
fnp-5343	1	96	hsu7	hsu7	PROPN
fnp-5343	1	97	,	,	PUNCT
fnp-5343	1	98	theodoros	theodoros	PROPN
fnp-5343	1	99	kelesidis8b	kelesidis8b	PROPN
fnp-5343	1	100	,	,	PUNCT
fnp-5343	1	101	glenn	glenn	PROPN
fnp-5343	1	102	e.	e.	PROPN
fnp-5343	1	103	mathisen9	mathisen9	PROPN
fnp-5343	1	104	,	,	PUNCT
fnp-5343	1	105	helen	helen	PROPN
fnp-5343	1	106	lavretsky10	lavretsky10	PROPN
fnp-5343	1	107	,	,	PUNCT
fnp-5343	1	108	elyse	elyse	PROPN
fnp-5343	1	109	j.	j.	PROPN
fnp-5343	1	110	singer6	singer6	PROPN
fnp-5343	1	111	,	,	PUNCT
fnp-5343	1	112	harry	harry	PROPN
fnp-5343	1	113	v.	v.	PROPN
fnp-5343	1	114	vinters1,6,11	vinters1,6,11	PROPN
fnp-5343	1	115	section	section	NOUN
fnp-5343	1	116	of	of	ADP
fnp-5343	1	117	neuropathology	neuropathology	NOUN
fnp-5343	1	118	,	,	PUNCT
fnp-5343	1	119	department	department	NOUN
fnp-5343	1	120	of	of	ADP
fnp-5343	1	121	pathology	pathology	PROPN
fnp-5343	1	122	and	and	CCONJ
fnp-5343	1	123	laboratory	laboratory	NOUN
fnp-5343	1	124	medicine	medicine	NOUN
fnp-5343	1	125	,	,	PUNCT
fnp-5343	1	126	david	david	PROPN
fnp-5343	1	127	geffen	geffen	PROPN
fnp-5343	1	128	school	school	PROPN
fnp-5343	1	129	of	of	ADP
fnp-5343	1	130	medicine	medicine	NOUN
fnp-5343	1	131	,	,	PUNCT
fnp-5343	1	132	university	university	PROPN
fnp-5343	1	133	of	of	ADP
fnp-5343	1	134	california	california	PROPN
fnp-5343	1	135	los	los	PROPN
fnp-5343	1	136	angeles	angeles	PROPN
fnp-5343	1	137	,	,	PUNCT
fnp-5343	1	138	los	los	PROPN
fnp-5343	1	139	angeles	angeles	PROPN
fnp-5343	1	140	ca	ca	PROPN
fnp-5343	1	141	,	,	PUNCT
fnp-5343	1	142	usa	usa	PROPN
fnp-5343	1	143	department	department	PROPN
fnp-5343	1	144	of	of	ADP
fnp-5343	1	145	pathology	pathology	PROPN
fnp-5343	1	146	and	and	CCONJ
fnp-5343	1	147	laboratory	laboratory	NOUN
fnp-5343	1	148	medicine	medicine	NOUN
fnp-5343	1	149	,	,	PUNCT
fnp-5343	1	150	university	university	PROPN
fnp-5343	1	151	of	of	ADP
fnp-5343	1	152	california	california	PROPN
fnp-5343	1	153	-	-	PUNCT
fnp-5343	1	154	irvine	irvine	PROPN
fnp-5343	1	155	school	school	NOUN
fnp-5343	1	156	of	of	ADP
fnp-5343	1	157	medicine	medicine	NOUN
fnp-5343	1	158	,	,	PUNCT
fnp-5343	1	159	irvine	irvine	PROPN
fnp-5343	1	160	,	,	PUNCT
fnp-5343	1	161	ca	ca	PROPN
fnp-5343	1	162	,	,	PUNCT
fnp-5343	1	163	usa	usa	PROPN
fnp-5343	1	164	department	department	PROPN
fnp-5343	1	165	of	of	ADP
fnp-5343	1	166	psychiatry	psychiatry	NOUN
fnp-5343	1	167	,	,	PUNCT
fnp-5343	1	168	university	university	PROPN
fnp-5343	1	169	of	of	ADP
fnp-5343	1	170	california	california	PROPN
fnp-5343	1	171	san	san	PROPN
fnp-5343	1	172	diego	diego	PROPN
fnp-5343	1	173	,	,	PUNCT
fnp-5343	1	174	la	la	PROPN
fnp-5343	1	175	jolla	jolla	PROPN
fnp-5343	1	176	,	,	PUNCT
fnp-5343	1	177	san	san	PROPN
fnp-5343	1	178	diego	diego	PROPN
fnp-5343	1	179	,	,	PUNCT
fnp-5343	1	180	ca	ca	PROPN
fnp-5343	1	181	,	,	PUNCT
fnp-5343	1	182	usa	usa	PROPN
fnp-5343	1	183	department	department	PROPN
fnp-5343	1	184	of	of	ADP
fnp-5343	1	185	pathology	pathology	PROPN
fnp-5343	1	186	and	and	CCONJ
fnp-5343	1	187	laboratory	laboratory	NOUN
fnp-5343	1	188	medicine	medicine	NOUN
fnp-5343	1	189	,	,	PUNCT
fnp-5343	1	190	david	david	PROPN
fnp-5343	1	191	geffen	geffen	PROPN
fnp-5343	1	192	school	school	PROPN
fnp-5343	1	193	of	of	ADP
fnp-5343	1	194	medicine	medicine	NOUN
fnp-5343	1	195	,	,	PUNCT
fnp-5343	1	196	university	university	PROPN
fnp-5343	1	197	of	of	ADP
fnp-5343	1	198	california	california	PROPN
fnp-5343	1	199	los	los	PROPN
fnp-5343	1	200	angeles	angeles	PROPN
fnp-5343	1	201	,	,	PUNCT
fnp-5343	1	202	los	los	PROPN
fnp-5343	1	203	angeles	angeles	PROPN
fnp-5343	1	204	,	,	PUNCT
fnp-5343	1	205	ca	ca	PROPN
fnp-5343	1	206	,	,	PUNCT
fnp-5343	1	207	usa	usa	PROPN
fnp-5343	1	208	department	department	PROPN
fnp-5343	1	209	of	of	ADP
fnp-5343	1	210	radiological	radiological	ADJ
fnp-5343	1	211	sciences	science	NOUN
fnp-5343	1	212	,	,	PUNCT
fnp-5343	1	213	david	david	PROPN
fnp-5343	1	214	geffen	geffen	PROPN
fnp-5343	1	215	school	school	PROPN
fnp-5343	1	216	of	of	ADP
fnp-5343	1	217	medicine	medicine	NOUN
fnp-5343	1	218	,	,	PUNCT
fnp-5343	1	219	university	university	PROPN
fnp-5343	1	220	of	of	ADP
fnp-5343	1	221	california	california	PROPN
fnp-5343	1	222	los	los	PROPN
fnp-5343	1	223	angeles	angeles	PROPN
fnp-5343	1	224	,	,	PUNCT
fnp-5343	1	225	los	los	PROPN
fnp-5343	1	226	angeles	angeles	PROPN
fnp-5343	1	227	,	,	PUNCT
fnp-5343	1	228	ca	ca	PROPN
fnp-5343	1	229	,	,	PUNCT
fnp-5343	1	230	usa	usa	PROPN
fnp-5343	1	231	department	department	PROPN
fnp-5343	1	232	of	of	ADP
fnp-5343	1	233	neurology	neurology	NOUN
fnp-5343	1	234	,	,	PUNCT
fnp-5343	1	235	david	david	PROPN
fnp-5343	1	236	geffen	geffen	PROPN
fnp-5343	1	237	school	school	PROPN
fnp-5343	1	238	of	of	ADP
fnp-5343	1	239	medicine	medicine	NOUN
fnp-5343	1	240	,	,	PUNCT
fnp-5343	1	241	university	university	PROPN
fnp-5343	1	242	of	of	ADP
fnp-5343	1	243	california	california	PROPN
fnp-5343	1	244	los	los	PROPN
fnp-5343	1	245	angeles	angeles	PROPN
fnp-5343	1	246	,	,	PUNCT
fnp-5343	1	247	los	los	PROPN
fnp-5343	1	248	angeles	angeles	PROPN
fnp-5343	1	249	,	,	PUNCT
fnp-5343	1	250	ca	ca	PROPN
fnp-5343	1	251	,	,	PUNCT
fnp-5343	1	252	usa	usa	PROPN
fnp-5343	1	253	division	division	NOUN
fnp-5343	1	254	of	of	ADP
fnp-5343	1	255	cardiology	cardiology	NOUN
fnp-5343	1	256	,	,	PUNCT
fnp-5343	1	257	david	david	PROPN
fnp-5343	1	258	geffen	geffen	PROPN
fnp-5343	1	259	school	school	PROPN
fnp-5343	1	260	of	of	ADP
fnp-5343	1	261	medicine	medicine	NOUN
fnp-5343	1	262	,	,	PUNCT
fnp-5343	1	263	university	university	PROPN
fnp-5343	1	264	of	of	ADP
fnp-5343	1	265	california	california	PROPN
fnp-5343	1	266	los	los	PROPN
fnp-5343	1	267	angeles	angeles	PROPN
fnp-5343	1	268	,	,	PUNCT
fnp-5343	1	269	los	los	PROPN
fnp-5343	1	270	angeles	angeles	PROPN
fnp-5343	1	271	,	,	PUNCT
fnp-5343	1	272	ca	ca	PROPN
fnp-5343	1	273	,	,	PUNCT
fnp-5343	1	274	usa	usa	PROPN
fnp-5343	1	275	department	department	PROPN
fnp-5343	1	276	of	of	ADP
fnp-5343	1	277	medicine	medicine	NOUN
fnp-5343	1	278	,	,	PUNCT
fnp-5343	1	279	division	division	NOUN
fnp-5343	1	280	of	of	ADP
fnp-5343	1	281	infectious	infectious	ADJ
fnp-5343	1	282	diseases	disease	NOUN
fnp-5343	1	283	,	,	PUNCT
fnp-5343	1	284	david	david	PROPN
fnp-5343	1	285	geffen	geffen	PROPN
fnp-5343	1	286	school	school	PROPN
fnp-5343	1	287	of	of	ADP
fnp-5343	1	288	medicine	medicine	NOUN
fnp-5343	1	289	,	,	PUNCT
fnp-5343	1	290	university	university	PROPN
fnp-5343	1	291	of	of	ADP
fnp-5343	1	292	california	california	PROPN
fnp-5343	1	293	los	los	PROPN
fnp-5343	1	294	angeles	angeles	PROPN
fnp-5343	1	295	,	,	PUNCT
fnp-5343	1	296	los	los	PROPN
fnp-5343	1	297	angeles	angeles	PROPN
fnp-5343	1	298	,	,	PUNCT
fnp-5343	1	299	ca	ca	PROPN
fnp-5343	1	300	,	,	PUNCT
fnp-5343	1	301	usa	usa	PROPN
fnp-5343	1	302	department	department	PROPN
fnp-5343	1	303	of	of	ADP
fnp-5343	1	304	infectious	infectious	ADJ
fnp-5343	1	305	diseases	disease	NOUN
fnp-5343	1	306	,	,	PUNCT
fnp-5343	1	307	olive	olive	ADJ
fnp-5343	1	308	view	view	NOUN
fnp-5343	1	309	-	-	PUNCT
fnp-5343	1	310	university	university	NOUN
fnp-5343	1	311	of	of	ADP
fnp-5343	1	312	california	california	PROPN
fnp-5343	1	313	los	los	PROPN
fnp-5343	1	314	angeles	angeles	PROPN
fnp-5343	1	315	medical	medical	ADJ
fnp-5343	1	316	center	center	PROPN
fnp-5343	1	317	,	,	PUNCT
fnp-5343	1	318	sylmar	sylmar	PROPN
fnp-5343	1	319	,	,	PUNCT
fnp-5343	1	320	ca	ca	PROPN
fnp-5343	1	321	,	,	PUNCT
fnp-5343	1	322	usa	usa	PROPN
fnp-5343	1	323	department	department	PROPN
fnp-5343	1	324	of	of	ADP
fnp-5343	1	325	psychiatry	psychiatry	NOUN
fnp-5343	1	326	and	and	CCONJ
fnp-5343	1	327	biobehavioral	biobehavioral	ADJ
fnp-5343	1	328	sciences	science	NOUN
fnp-5343	1	329	,	,	PUNCT
fnp-5343	1	330	david	david	PROPN
fnp-5343	1	331	geffen	geffen	PROPN
fnp-5343	1	332	school	school	PROPN
fnp-5343	1	333	of	of	ADP
fnp-5343	1	334	medicine	medicine	NOUN
fnp-5343	1	335	,	,	PUNCT
fnp-5343	1	336	university	university	PROPN
fnp-5343	1	337	of	of	ADP
fnp-5343	1	338	california	california	PROPN
fnp-5343	1	339	los	los	PROPN
fnp-5343	1	340	angeles	angeles	PROPN
fnp-5343	1	341	,	,	PUNCT
fnp-5343	1	342	los	los	PROPN
fnp-5343	1	343	angeles	angeles	PROPN
fnp-5343	1	344	,	,	PUNCT
fnp-5343	1	345	ca	ca	PROPN
fnp-5343	1	346	,	,	PUNCT
fnp-5343	1	347	usa	usa	PROPN
fnp-5343	1	348	brain	brain	PROPN
fnp-5343	1	349	research	research	PROPN
fnp-5343	1	350	institute	institute	PROPN
fnp-5343	1	351	,	,	PUNCT
fnp-5343	1	352	david	david	PROPN
fnp-5343	1	353	geffen	geffen	PROPN
fnp-5343	1	354	school	school	PROPN
fnp-5343	1	355	of	of	ADP
fnp-5343	1	356	medicine	medicine	NOUN
fnp-5343	1	357	,	,	PUNCT
fnp-5343	1	358	university	university	PROPN
fnp-5343	1	359	of	of	ADP
fnp-5343	1	360	california	california	PROPN
fnp-5343	1	361	los	los	PROPN
fnp-5343	1	362	angeles	angeles	PROPN
fnp-5343	1	363	,	,	PUNCT
fnp-5343	1	364	los	los	PROPN
fnp-5343	1	365	angeles	angeles	PROPN
fnp-5343	1	366	,	,	PUNCT
fnp-5343	1	367	ca	ca	PROPN
fnp-5343	1	368	,	,	PUNCT
fnp-5343	1	369	usa	usa	PROPN
fnp-5343	1	370	a	a	DET
fnp-5343	1	371	current	current	ADJ
fnp-5343	1	372	affiliation	affiliation	NOUN
fnp-5343	1	373	:	:	PUNCT
fnp-5343	1	374	department	department	NOUN
fnp-5343	1	375	of	of	ADP
fnp-5343	1	376	pathology	pathology	PROPN
fnp-5343	1	377	and	and	CCONJ
fnp-5343	1	378	laboratory	laboratory	NOUN
fnp-5343	1	379	medicine	medicine	NOUN
fnp-5343	1	380	,	,	PUNCT
fnp-5343	1	381	school	school	NOUN
fnp-5343	1	382	of	of	ADP
fnp-5343	1	383	medicine	medicine	NOUN
fnp-5343	1	384	and	and	CCONJ
fnp-5343	1	385	public	public	ADJ
fnp-5343	1	386	health	health	NOUN
fnp-5343	1	387	,	,	PUNCT
fnp-5343	1	388	university	university	PROPN
fnp-5343	1	389	of	of	ADP
fnp-5343	1	390	wisconsin	wisconsin	PROPN
fnp-5343	1	391	-	-	PUNCT
fnp-5343	1	392	madison	madison	PROPN
fnp-5343	1	393	,	,	PUNCT
fnp-5343	1	394	madison	madison	PROPN
fnp-5343	1	395	,	,	PUNCT
fnp-5343	1	396	wi	wi	PROPN
fnp-5343	1	397	,	,	PUNCT
fnp-5343	1	398	usa	usa	PROPN
fnp-5343	1	399	b	b	PROPN
fnp-5343	1	400	current	current	ADJ
fnp-5343	1	401	affiliation	affiliation	NOUN
fnp-5343	1	402	:	:	PUNCT
fnp-5343	1	403	division	division	NOUN
fnp-5343	1	404	of	of	ADP
fnp-5343	1	405	infectious	infectious	ADJ
fnp-5343	1	406	diseases	disease	NOUN
fnp-5343	1	407	and	and	CCONJ
fnp-5343	1	408	geographic	geographic	ADJ
fnp-5343	1	409	medicine	medicine	NOUN
fnp-5343	1	410	,	,	PUNCT
fnp-5343	1	411	department	department	NOUN
fnp-5343	1	412	of	of	ADP
fnp-5343	1	413	internal	internal	ADJ
fnp-5343	1	414	medicine	medicine	NOUN
fnp-5343	1	415	,	,	PUNCT
fnp-5343	1	416	university	university	PROPN
fnp-5343	1	417	of	of	ADP
fnp-5343	1	418	texas	texas	PROPN
fnp-5343	1	419	southwestern	southwestern	PROPN
fnp-5343	1	420	medical	medical	ADJ
fnp-5343	1	421	center	center	NOUN
fnp-5343	1	422	,	,	PUNCT
fnp-5343	1	423	dallas	dallas	PROPN
fnp-5343	1	424	,	,	PUNCT
fnp-5343	1	425	tx	tx	PROPN
fnp-5343	1	426	,	,	PUNCT
fnp-5343	1	427	usa	usa	PROPN
fnp-5343	1	428	corresponding	corresponding	PROPN
fnp-5343	1	429	author	author	NOUN
fnp-5343	1	430	:	:	PUNCT
fnp-5343	1	431	shino	shino	PROPN
fnp-5343	1	432	magaki	magaki	PROPN
fnp-5343	1	433	·	·	PUNCT
fnp-5343	1	434	department	department	PROPN
fnp-5343	1	435	of	of	ADP
fnp-5343	1	436	pathology	pathology	PROPN
fnp-5343	1	437	&	&	CCONJ
fnp-5343	1	438	laboratory	laboratory	PROPN
fnp-5343	1	439	medicine	medicine	PROPN
fnp-5343	1	440	·	·	PUNCT
fnp-5343	1	441	ronald	ronald	PROPN
fnp-5343	1	442	reagan	reagan	PROPN
fnp-5343	1	443	ucla	ucla	PROPN
fnp-5343	1	444	medical	medical	PROPN
fnp-5343	1	445	center	center	PROPN
fnp-5343	1	446	and	and	CCONJ
fnp-5343	1	447	david	david	PROPN
fnp-5343	1	448	geffen	geffen	PROPN
fnp-5343	1	449	school	school	PROPN
fnp-5343	1	450	of	of	ADP
fnp-5343	1	451	medicine	medicine	NOUN
fnp-5343	1	452	·	·	PUNCT
fnp-5343	1	453	center	center	NOUN
fnp-5343	1	454	for	for	ADP
fnp-5343	1	455	health	health	NOUN
fnp-5343	1	456	sciences	sciences	PROPN
fnp-5343	1	457	,	,	PUNCT
fnp-5343	1	458	rm	rm	PROPN
fnp-5343	1	459	1p-250	1p-250	NUM
fnp-5343	1	460	·	·	SYM
fnp-5343	1	461	10833	10833	NUM
fnp-5343	1	462	le	le	PROPN
fnp-5343	1	463	conte	conte	PROPN
fnp-5343	1	464	ave	ave	PROPN
fnp-5343	1	465	,	,	PUNCT
fnp-5343	1	466	los	los	PROPN
fnp-5343	1	467	angeles	angeles	PROPN
fnp-5343	1	468	,	,	PUNCT
fnp-5343	1	469	ca	ca	NOUN
fnp-5343	1	470	90095	90095	NUM
fnp-5343	1	471	-	-	SYM
fnp-5343	1	472	1732	1732	NUM
fnp-5343	1	473	·	·	PUNCT
fnp-5343	1	474	usa	usa	PROPN
fnp-5343	1	475	smagaki@mednet.ucla.edu	smagaki@mednet.ucla.edu	PROPN
fnp-5343	1	476	submitted	submit	VERB
fnp-5343	1	477	:	:	PUNCT
fnp-5343	1	478	05	05	NUM
fnp-5343	1	479	february	february	PROPN
fnp-5343	1	480	2024	2024	NUM
fnp-5343	1	481	accepted	accept	VERB
fnp-5343	1	482	:	:	PUNCT
fnp-5343	1	483	02	02	NUM
fnp-5343	1	484	march	march	PROPN
fnp-5343	1	485	2024	2024	NUM
fnp-5343	1	486	copyedited	copyedit	VERB
fnp-5343	1	487	by	by	ADP
fnp-5343	1	488	:	:	PUNCT
fnp-5343	1	489	shafiq	shafiq	PROPN
fnp-5343	1	490	qaadri	qaadri	PROPN
fnp-5343	1	491	published	publish	VERB
fnp-5343	1	492	:	:	PUNCT
fnp-5343	1	493	05	05	NUM
fnp-5343	1	494	march	march	PROPN
fnp-5343	1	495	2024	2024	NUM
fnp-5343	1	496	https://doi.org/10.17879/freeneuropathology-2024-5343	https://doi.org/10.17879/freeneuropathology-2024-5343	NOUN
fnp-5343	1	497	keywords	keyword	NOUN
fnp-5343	1	498	:	:	PUNCT
fnp-5343	1	499	hiv	hiv	PROPN
fnp-5343	1	500	,	,	PUNCT
fnp-5343	1	501	covid-19	covid-19	PROPN
fnp-5343	1	502	,	,	PUNCT
fnp-5343	1	503	hiv	hiv	PROPN
fnp-5343	1	504	-	-	PUNCT
fnp-5343	1	505	associated	associate	VERB
fnp-5343	1	506	neurocognitive	neurocognitive	ADJ
fnp-5343	1	507	disorders	disorder	NOUN
fnp-5343	1	508	,	,	PUNCT
fnp-5343	1	509	long	long	ADJ
fnp-5343	1	510	covid	covid	PROPN
fnp-5343	1	511	,	,	PUNCT
fnp-5343	1	512	post	post	ADJ
fnp-5343	1	513	-	-	ADJ
fnp-5343	1	514	covid	covid	ADJ
fnp-5343	1	515	conditions	condition	NOUN
fnp-5343	1	516	,	,	PUNCT
fnp-5343	1	517	neuropathology	neuropathology	NOUN
fnp-5343	1	518	abstract	abstract	ADJ
fnp-5343	1	519	human	human	ADJ
fnp-5343	1	520	immunodeficiency	immunodeficiency	NOUN
fnp-5343	1	521	virus	virus	NOUN
fnp-5343	1	522	(	(	PUNCT
fnp-5343	1	523	hiv	hiv	PROPN
fnp-5343	1	524	)	)	PUNCT
fnp-5343	1	525	and	and	CCONJ
fnp-5343	1	526	severe	severe	ADJ
fnp-5343	1	527	acute	acute	ADJ
fnp-5343	1	528	respiratory	respiratory	ADJ
fnp-5343	1	529	syndrome	syndrome	NOUN
fnp-5343	1	530	coronavirus	coronavirus	NOUN
fnp-5343	1	531	2	2	NUM
fnp-5343	1	532	(	(	PUNCT
fnp-5343	1	533	sars	sar	NOUN
fnp-5343	1	534	-	-	PUNCT
fnp-5343	1	535	cov-2	cov-2	NOUN
fnp-5343	1	536	)	)	PUNCT
fnp-5343	1	537	cause	cause	VERB
fnp-5343	1	538	significant	significant	ADJ
fnp-5343	1	539	neurologic	neurologic	ADJ
fnp-5343	1	540	disease	disease	NOUN
fnp-5343	1	541	.	.	PUNCT
fnp-5343	2	1	central	central	ADJ
fnp-5343	2	2	nervous	nervous	ADJ
fnp-5343	2	3	system	system	NOUN
fnp-5343	2	4	(	(	PUNCT
fnp-5343	2	5	cns	cns	NOUN
fnp-5343	2	6	)	)	PUNCT
fnp-5343	2	7	involvement	involvement	NOUN
fnp-5343	2	8	of	of	ADP
fnp-5343	2	9	hiv	hiv	PROPN
fnp-5343	2	10	has	have	AUX
fnp-5343	2	11	been	be	AUX
fnp-5343	2	12	extensively	extensively	ADV
fnp-5343	2	13	studied	study	VERB
fnp-5343	2	14	,	,	PUNCT
fnp-5343	2	15	with	with	ADP
fnp-5343	2	16	well	well	ADV
fnp-5343	2	17	-	-	PUNCT
fnp-5343	2	18	documented	document	VERB
fnp-5343	2	19	invasion	invasion	NOUN
fnp-5343	2	20	of	of	ADP
fnp-5343	2	21	hiv	hiv	PROPN
fnp-5343	2	22	into	into	ADP
fnp-5343	2	23	the	the	DET
fnp-5343	2	24	brain	brain	NOUN
fnp-5343	2	25	in	in	ADP
fnp-5343	2	26	the	the	DET
fnp-5343	2	27	initial	initial	ADJ
fnp-5343	2	28	stage	stage	NOUN
fnp-5343	2	29	of	of	ADP
fnp-5343	2	30	infection	infection	NOUN
fnp-5343	2	31	,	,	PUNCT
fnp-5343	2	32	while	while	SCONJ
fnp-5343	2	33	the	the	DET
fnp-5343	2	34	acute	acute	ADJ
fnp-5343	2	35	effects	effect	NOUN
fnp-5343	2	36	of	of	ADP
fnp-5343	2	37	sars	sar	NOUN
fnp-5343	2	38	-	-	PUNCT
fnp-5343	2	39	cov-2	cov-2	NOUN
fnp-5343	2	40	in	in	ADP
fnp-5343	2	41	the	the	DET
fnp-5343	2	42	brain	brain	NOUN
fnp-5343	2	43	are	be	AUX
fnp-5343	2	44	unclear	unclear	ADJ
fnp-5343	2	45	.	.	PUNCT
fnp-5343	3	1	neuropathologic	neuropathologic	ADJ
fnp-5343	3	2	features	feature	NOUN
fnp-5343	3	3	of	of	ADP
fnp-5343	3	4	active	active	ADJ
fnp-5343	3	5	hiv	hiv	PROPN
fnp-5343	3	6	infection	infection	NOUN
fnp-5343	3	7	in	in	ADP
fnp-5343	3	8	the	the	DET
fnp-5343	3	9	brain	brain	NOUN
fnp-5343	3	10	are	be	AUX
fnp-5343	3	11	well	well	ADV
fnp-5343	3	12	characterized	characterized	ADJ
fnp-5343	3	13	whereas	whereas	SCONJ
fnp-5343	3	14	neuropathologic	neuropathologic	ADJ
fnp-5343	3	15	findings	finding	NOUN
fnp-5343	3	16	in	in	ADP
fnp-5343	3	17	acute	acute	PROPN
fnp-5343	3	18	covid-19	covid-19	PROPN
fnp-5343	3	19	are	be	AUX
fnp-5343	3	20	largely	largely	ADV
fnp-5343	3	21	non	non	ADJ
fnp-5343	3	22	-	-	ADJ
fnp-5343	3	23	specific	specific	ADJ
fnp-5343	3	24	.	.	PUNCT
fnp-5343	4	1	on	on	ADP
fnp-5343	4	2	the	the	DET
fnp-5343	4	3	other	other	ADJ
fnp-5343	4	4	hand	hand	NOUN
fnp-5343	4	5	,	,	PUNCT
fnp-5343	4	6	neuropathologic	neuropathologic	ADJ
fnp-5343	4	7	substrates	substrate	NOUN
fnp-5343	4	8	of	of	ADP
fnp-5343	4	9	chronic	chronic	ADJ
fnp-5343	4	10	dysfunction	dysfunction	NOUN
fnp-5343	4	11	in	in	ADP
fnp-5343	4	12	both	both	DET
fnp-5343	4	13	infections	infection	NOUN
fnp-5343	4	14	,	,	PUNCT
fnp-5343	4	15	as	as	ADP
fnp-5343	4	16	hiv	hiv	NOUN
fnp-5343	4	17	-	-	PUNCT
fnp-5343	4	18	associated	associate	VERB
fnp-5343	4	19	neurocognitive	neurocognitive	ADJ
fnp-5343	4	20	disorders	disorder	NOUN
fnp-5343	4	21	(	(	PUNCT
fnp-5343	4	22	hand	hand	NOUN
fnp-5343	4	23	)	)	PUNCT
fnp-5343	4	24	and	and	CCONJ
fnp-5343	4	25	post	post	ADJ
fnp-5343	4	26	-	-	ADJ
fnp-5343	4	27	covid	covid	ADJ
fnp-5343	4	28	conditions	condition	NOUN
fnp-5343	4	29	(	(	PUNCT
fnp-5343	4	30	pcc)/long	pcc)/long	X
fnp-5343	4	31	covid	covid	PROPN
fnp-5343	4	32	are	be	AUX
fnp-5343	4	33	unknown	unknown	ADJ
fnp-5343	4	34	.	.	PUNCT
fnp-5343	5	1	thus	thus	ADV
fnp-5343	5	2	far	far	ADV
fnp-5343	5	3	,	,	PUNCT
fnp-5343	5	4	neuropathologic	neuropathologic	ADJ
fnp-5343	5	5	studies	study	NOUN
fnp-5343	5	6	on	on	ADP
fnp-5343	5	7	patients	patient	NOUN
fnp-5343	5	8	with	with	ADP
fnp-5343	5	9	hand	hand	NOUN
fnp-5343	5	10	in	in	ADP
fnp-5343	5	11	the	the	DET
fnp-5343	5	12	era	era	NOUN
fnp-5343	5	13	of	of	ADP
fnp-5343	5	14	combined	combine	VERB
fnp-5343	5	15	antiretroviral	antiretroviral	ADJ
fnp-5343	5	16	therapy	therapy	NOUN
fnp-5343	5	17	have	have	AUX
fnp-5343	5	18	been	be	AUX
fnp-5343	5	19	inconclusive	inconclusive	ADJ
fnp-5343	5	20	,	,	PUNCT
fnp-5343	5	21	and	and	CCONJ
fnp-5343	5	22	autopsy	autopsy	ADJ
fnp-5343	5	23	studies	study	NOUN
fnp-5343	5	24	on	on	ADP
fnp-5343	5	25	patients	patient	NOUN
fnp-5343	5	26	diagnosed	diagnose	VERB
fnp-5343	5	27	with	with	ADP
fnp-5343	5	28	pcc	pcc	NOUN
fnp-5343	5	29	have	have	VERB
fnp-5343	5	30	yet	yet	ADV
fnp-5343	5	31	to	to	PART
fnp-5343	5	32	be	be	AUX
fnp-5343	5	33	published	publish	VERB
fnp-5343	5	34	.	.	PUNCT
fnp-5343	6	1	further	far	ADV
fnp-5343	6	2	longitudinal	longitudinal	ADJ
fnp-5343	6	3	,	,	PUNCT
fnp-5343	6	4	multidisciplinary	multidisciplinary	ADJ
fnp-5343	6	5	studies	study	NOUN
fnp-5343	6	6	on	on	ADP
fnp-5343	6	7	patients	patient	NOUN
fnp-5343	6	8	with	with	ADP
fnp-5343	6	9	hand	hand	NOUN
fnp-5343	6	10	and	and	CCONJ
fnp-5343	6	11	pcc	pcc	NOUN
fnp-5343	6	12	and	and	CCONJ
fnp-5343	6	13	neuropathologic	neuropathologic	ADJ
fnp-5343	6	14	studies	study	NOUN
fnp-5343	6	15	in	in	ADP
fnp-5343	6	16	comparison	comparison	NOUN
fnp-5343	6	17	to	to	ADP
fnp-5343	6	18	controls	control	NOUN
fnp-5343	6	19	are	be	AUX
fnp-5343	6	20	warranted	warrant	VERB
fnp-5343	6	21	to	to	PART
fnp-5343	6	22	help	help	VERB
fnp-5343	6	23	elucidate	elucidate	VERB
fnp-5343	6	24	the	the	DET
fnp-5343	6	25	mechanisms	mechanism	NOUN
fnp-5343	6	26	of	of	ADP
fnp-5343	6	27	cns	cns	NOUN
fnp-5343	6	28	dysfunction	dysfunction	NOUN
fnp-5343	6	29	in	in	ADP
fnp-5343	6	30	both	both	DET
fnp-5343	6	31	conditions	condition	NOUN
fnp-5343	6	32	.	.	PUNCT
fnp-5343	7	1	introduction	introduction	NOUN
fnp-5343	7	2	human	human	ADJ
fnp-5343	7	3	immunodeficiency	immunodeficiency	NOUN
fnp-5343	7	4	virus	virus	NOUN
fnp-5343	7	5	(	(	PUNCT
fnp-5343	7	6	hiv	hiv	PROPN
fnp-5343	7	7	)	)	PUNCT
fnp-5343	7	8	and	and	CCONJ
fnp-5343	7	9	severe	severe	ADJ
fnp-5343	7	10	acute	acute	ADJ
fnp-5343	7	11	respiratory	respiratory	ADJ
fnp-5343	7	12	syndrome	syndrome	NOUN
fnp-5343	7	13	coronavirus	coronavirus	NOUN
fnp-5343	7	14	2	2	NUM
fnp-5343	7	15	(	(	PUNCT
fnp-5343	7	16	sars	sar	NOUN
fnp-5343	7	17	-	-	PUNCT
fnp-5343	7	18	cov-2	cov-2	NOUN
fnp-5343	7	19	)	)	PUNCT
fnp-5343	7	20	are	be	AUX
fnp-5343	7	21	both	both	PRON
fnp-5343	7	22	human	human	ADJ
fnp-5343	7	23	viruses	virus	NOUN
fnp-5343	7	24	that	that	PRON
fnp-5343	7	25	cause	cause	VERB
fnp-5343	7	26	neurologic	neurologic	ADJ
fnp-5343	7	27	disease	disease	NOUN
fnp-5343	7	28	.	.	PUNCT
fnp-5343	8	1	hiv	hiv	PROPN
fnp-5343	8	2	is	be	AUX
fnp-5343	8	3	a	a	DET
fnp-5343	8	4	retrovirus	retrovirus	NOUN
fnp-5343	8	5	and	and	CCONJ
fnp-5343	8	6	is	be	AUX
fnp-5343	8	7	clearly	clearly	ADV
fnp-5343	8	8	neurotropic	neurotropic	ADJ
fnp-5343	8	9	,	,	PUNCT
fnp-5343	8	10	with	with	ADP
fnp-5343	8	11	tropism	tropism	NOUN
fnp-5343	8	12	for	for	ADP
fnp-5343	8	13	microglial	microglial	ADJ
fnp-5343	8	14	cells	cell	NOUN
fnp-5343	8	15	in	in	ADP
fnp-5343	8	16	the	the	DET
fnp-5343	8	17	central	central	ADJ
fnp-5343	8	18	nervous	nervous	ADJ
fnp-5343	8	19	system	system	NOUN
fnp-5343	8	20	(	(	PUNCT
fnp-5343	8	21	cns	cns	NOUN
fnp-5343	8	22	)	)	PUNCT
fnp-5343	8	23	,	,	PUNCT
fnp-5343	8	24	infection	infection	NOUN
fnp-5343	8	25	of	of	ADP
fnp-5343	8	26	which	which	PRON
fnp-5343	8	27	generates	generate	VERB
fnp-5343	8	28	downstream	downstream	ADJ
fnp-5343	8	29	effects	effect	NOUN
fnp-5343	8	30	that	that	PRON
fnp-5343	8	31	injure	injure	VERB
fnp-5343	8	32	brain	brain	NOUN
fnp-5343	8	33	parenchyma	parenchyma	NOUN
fnp-5343	8	34	.	.	PUNCT
fnp-5343	9	1	its	its	PRON
fnp-5343	9	2	clinical	clinical	ADJ
fnp-5343	9	3	and	and	CCONJ
fnp-5343	9	4	pathologic	pathologic	ADJ
fnp-5343	9	5	manifestations	manifestation	NOUN
fnp-5343	9	6	are	be	AUX
fnp-5343	9	7	fairly	fairly	ADV
fnp-5343	9	8	well	well	ADV
fnp-5343	9	9	characterized	characterized	ADJ
fnp-5343	9	10	.	.	PUNCT
fnp-5343	10	1	by	by	ADP
fnp-5343	10	2	contrast	contrast	NOUN
fnp-5343	10	3	,	,	PUNCT
fnp-5343	10	4	coronavirus	coronavirus	NOUN
fnp-5343	10	5	disease	disease	NOUN
fnp-5343	10	6	2019	2019	NUM
fnp-5343	10	7	(	(	PUNCT
fnp-5343	10	8	covid-19	covid-19	PROPN
fnp-5343	10	9	)	)	PUNCT
fnp-5343	10	10	caused	cause	VERB
fnp-5343	10	11	by	by	ADP
fnp-5343	10	12	the	the	DET
fnp-5343	10	13	novel	novel	ADJ
fnp-5343	10	14	coronavirus	coronavirus	NOUN
fnp-5343	10	15	sars	sar	NOUN
fnp-5343	10	16	-	-	PUNCT
fnp-5343	10	17	cov-2	cov-2	NOUN
fnp-5343	10	18	leads	lead	VERB
fnp-5343	10	19	to	to	ADP
fnp-5343	10	20	neuropsychiatric	neuropsychiatric	ADJ
fnp-5343	10	21	morbidity	morbidity	NOUN
fnp-5343	10	22	in	in	ADP
fnp-5343	10	23	a	a	DET
fnp-5343	10	24	significant	significant	ADJ
fnp-5343	10	25	percentage	percentage	NOUN
fnp-5343	10	26	of	of	ADP
fnp-5343	10	27	infected	infected	ADJ
fnp-5343	10	28	patients	patient	NOUN
fnp-5343	10	29	,	,	PUNCT
fnp-5343	10	30	but	but	CCONJ
fnp-5343	10	31	the	the	DET
fnp-5343	10	32	mechanisms	mechanism	NOUN
fnp-5343	10	33	for	for	ADP
fnp-5343	10	34	this	this	PRON
fnp-5343	10	35	are	be	AUX
fnp-5343	10	36	heterogeneous	heterogeneous	ADJ
fnp-5343	10	37	and	and	CCONJ
fnp-5343	10	38	may	may	AUX
fnp-5343	10	39	include	include	VERB
fnp-5343	10	40	indirect	indirect	ADJ
fnp-5343	10	41	effects	effect	NOUN
fnp-5343	10	42	on	on	ADP
fnp-5343	10	43	the	the	DET
fnp-5343	10	44	brain	brain	NOUN
fnp-5343	10	45	through	through	ADP
fnp-5343	10	46	activation	activation	NOUN
fnp-5343	10	47	of	of	ADP
fnp-5343	10	48	inflammatory	inflammatory	ADJ
fnp-5343	10	49	cascades	cascade	NOUN
fnp-5343	10	50	,	,	PUNCT
fnp-5343	10	51	possible	possible	ADJ
fnp-5343	10	52	microangiopathic	microangiopathic	ADJ
fnp-5343	10	53	changes	change	NOUN
fnp-5343	10	54	and	and	CCONJ
fnp-5343	10	55	disruption	disruption	NOUN
fnp-5343	10	56	of	of	ADP
fnp-5343	10	57	the	the	DET
fnp-5343	10	58	neurovascular	neurovascular	ADJ
fnp-5343	10	59	unit	unit	NOUN
fnp-5343	10	60	.	.	PUNCT
fnp-5343	11	1	however	however	ADV
fnp-5343	11	2	,	,	PUNCT
fnp-5343	11	3	knowledge	knowledge	NOUN
fnp-5343	11	4	of	of	ADP
fnp-5343	11	5	hiv	hiv	PROPN
fnp-5343	11	6	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	11	7	may	may	AUX
fnp-5343	11	8	be	be	AUX
fnp-5343	11	9	instructive	instructive	ADJ
fnp-5343	11	10	for	for	ADP
fnp-5343	11	11	understanding	understand	VERB
fnp-5343	11	12	many	many	ADJ
fnp-5343	11	13	aspects	aspect	NOUN
fnp-5343	11	14	of	of	ADP
fnp-5343	11	15	covid-19	covid-19	PROPN
fnp-5343	11	16	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	11	17	.	.	PUNCT
fnp-5343	12	1	the	the	DET
fnp-5343	12	2	brain	brain	NOUN
fnp-5343	12	3	research	research	PROPN
fnp-5343	12	4	institute	institute	PROPN
fnp-5343	12	5	at	at	ADP
fnp-5343	12	6	ucla	ucla	PROPN
fnp-5343	12	7	sponsored	sponsor	VERB
fnp-5343	12	8	two	two	NUM
fnp-5343	12	9	half	half	ADJ
fnp-5343	12	10	-	-	PUNCT
fnp-5343	12	11	day	day	NOUN
fnp-5343	12	12	"	"	PUNCT
fnp-5343	12	13	neurovirology	neurovirology	ADJ
fnp-5343	12	14	affinity	affinity	NOUN
fnp-5343	12	15	group	group	NOUN
fnp-5343	12	16	"	"	PUNCT
fnp-5343	12	17	meetings	meeting	NOUN
fnp-5343	12	18	in	in	ADP
fnp-5343	12	19	the	the	DET
fnp-5343	12	20	spring	spring	NOUN
fnp-5343	12	21	of	of	ADP
fnp-5343	12	22	2022	2022	NUM
fnp-5343	12	23	and	and	CCONJ
fnp-5343	12	24	2023	2023	NUM
fnp-5343	12	25	at	at	ADP
fnp-5343	12	26	which	which	PRON
fnp-5343	12	27	a	a	DET
fnp-5343	12	28	multidisciplinary	multidisciplinary	ADJ
fnp-5343	12	29	team	team	NOUN
fnp-5343	12	30	of	of	ADP
fnp-5343	12	31	representatives	representative	NOUN
fnp-5343	12	32	from	from	ADP
fnp-5343	12	33	neuropathology	neuropathology	NOUN
fnp-5343	12	34	,	,	PUNCT
fnp-5343	12	35	cardiovascular	cardiovascular	ADJ
fnp-5343	12	36	pathology	pathology	NOUN
fnp-5343	12	37	,	,	PUNCT
fnp-5343	12	38	microbiology	microbiology	NOUN
fnp-5343	12	39	,	,	PUNCT
fnp-5343	12	40	radiology	radiology	NOUN
fnp-5343	12	41	,	,	PUNCT
fnp-5343	12	42	infectious	infectious	ADJ
fnp-5343	12	43	disease	disease	NOUN
fnp-5343	12	44	,	,	PUNCT
fnp-5343	12	45	cardiology	cardiology	NOUN
fnp-5343	12	46	,	,	PUNCT
fnp-5343	12	47	neurology	neurology	NOUN
fnp-5343	12	48	,	,	PUNCT
fnp-5343	12	49	and	and	CCONJ
fnp-5343	12	50	psychiatry	psychiatry	NOUN
fnp-5343	12	51	convened	convene	VERB
fnp-5343	12	52	to	to	PART
fnp-5343	12	53	address	address	VERB
fnp-5343	12	54	the	the	DET
fnp-5343	12	55	cns	cns	PROPN
fnp-5343	12	56	complications	complication	NOUN
fnp-5343	12	57	of	of	ADP
fnp-5343	12	58	covid-19	covid-19	PROPN
fnp-5343	12	59	,	,	PUNCT
fnp-5343	12	60	considering	consider	VERB
fnp-5343	12	61	what	what	PRON
fnp-5343	12	62	we	we	PRON
fnp-5343	12	63	have	have	AUX
fnp-5343	12	64	learned	learn	VERB
fnp-5343	12	65	from	from	ADP
fnp-5343	12	66	the	the	DET
fnp-5343	12	67	hiv	hiv	PROPN
fnp-5343	12	68	pandemic	pandemic	ADJ
fnp-5343	12	69	over	over	ADP
fnp-5343	12	70	the	the	DET
fnp-5343	12	71	past	past	ADJ
fnp-5343	12	72	several	several	ADJ
fnp-5343	12	73	decades	decade	NOUN
fnp-5343	12	74	.	.	PUNCT
fnp-5343	13	1	the	the	DET
fnp-5343	13	2	meeting	meeting	NOUN
fnp-5343	13	3	aims	aim	VERB
fnp-5343	13	4	were	be	AUX
fnp-5343	13	5	to	to	PART
fnp-5343	13	6	identify	identify	VERB
fnp-5343	13	7	gaps	gap	NOUN
fnp-5343	13	8	in	in	ADP
fnp-5343	13	9	current	current	ADJ
fnp-5343	13	10	knowledge	knowledge	NOUN
fnp-5343	13	11	on	on	ADP
fnp-5343	13	12	cns	cns	NOUN
fnp-5343	13	13	disease	disease	NOUN
fnp-5343	13	14	in	in	ADP
fnp-5343	13	15	covid-19	covid-19	PROPN
fnp-5343	13	16	and	and	CCONJ
fnp-5343	13	17	hiv	hiv	PROPN
fnp-5343	13	18	and	and	CCONJ
fnp-5343	13	19	potential	potential	ADJ
fnp-5343	13	20	directions	direction	NOUN
fnp-5343	13	21	for	for	ADP
fnp-5343	13	22	future	future	ADJ
fnp-5343	13	23	study	study	NOUN
fnp-5343	13	24	.	.	PUNCT
fnp-5343	14	1	this	this	DET
fnp-5343	14	2	selective	selective	ADJ
fnp-5343	14	3	review	review	NOUN
fnp-5343	14	4	summarizes	summarize	VERB
fnp-5343	14	5	the	the	DET
fnp-5343	14	6	main	main	ADJ
fnp-5343	14	7	topics	topic	NOUN
fnp-5343	14	8	discussed	discuss	VERB
fnp-5343	14	9	and	and	CCONJ
fnp-5343	14	10	conclusions	conclusion	NOUN
fnp-5343	14	11	reached	reach	VERB
fnp-5343	14	12	.	.	PUNCT
fnp-5343	15	1	human	human	ADJ
fnp-5343	15	2	immunodeficiency	immunodeficiency	NOUN
fnp-5343	15	3	virus	virus	NOUN
fnp-5343	15	4	(	(	PUNCT
fnp-5343	15	5	hiv	hiv	PROPN
fnp-5343	15	6	)	)	PUNCT
fnp-5343	15	7	an	an	DET
fnp-5343	15	8	immunodeficiency	immunodeficiency	NOUN
fnp-5343	15	9	disease	disease	NOUN
fnp-5343	15	10	,	,	PUNCT
fnp-5343	15	11	later	later	ADV
fnp-5343	15	12	named	name	VERB
fnp-5343	15	13	acquired	acquire	VERB
fnp-5343	15	14	immunodeficiency	immunodeficiency	NOUN
fnp-5343	15	15	syndrome	syndrome	NOUN
fnp-5343	15	16	(	(	PUNCT
fnp-5343	15	17	aids	aids	PROPN
fnp-5343	15	18	)	)	PUNCT
fnp-5343	15	19	,	,	PUNCT
fnp-5343	15	20	started	start	VERB
fnp-5343	15	21	to	to	PART
fnp-5343	15	22	become	become	AUX
fnp-5343	15	23	recognized	recognize	VERB
fnp-5343	15	24	in	in	ADP
fnp-5343	15	25	the	the	DET
fnp-5343	15	26	summer	summer	NOUN
fnp-5343	15	27	of	of	ADP
fnp-5343	15	28	1981	1981	NUM
fnp-5343	15	29	in	in	ADP
fnp-5343	15	30	the	the	DET
fnp-5343	15	31	united	united	PROPN
fnp-5343	15	32	states	states	PROPN
fnp-5343	15	33	[	[	X
fnp-5343	15	34	1,2	1,2	NUM
fnp-5343	15	35	]	]	PUNCT
fnp-5343	15	36	.	.	PUNCT
fnp-5343	16	1	this	this	DET
fnp-5343	16	2	discovery	discovery	NOUN
fnp-5343	16	3	was	be	AUX
fnp-5343	16	4	followed	follow	VERB
fnp-5343	16	5	soon	soon	ADV
fnp-5343	16	6	after	after	ADP
fnp-5343	16	7	by	by	ADP
fnp-5343	16	8	the	the	DET
fnp-5343	16	9	identification	identification	NOUN
fnp-5343	16	10	of	of	ADP
fnp-5343	16	11	human	human	ADJ
fnp-5343	16	12	immunodeficiency	immunodeficiency	NOUN
fnp-5343	16	13	virus-1	virus-1	NOUN
fnp-5343	16	14	(	(	PUNCT
fnp-5343	16	15	hiv-1	hiv-1	X
fnp-5343	16	16	)	)	PUNCT
fnp-5343	16	17	as	as	ADP
fnp-5343	16	18	the	the	DET
fnp-5343	16	19	causative	causative	ADJ
fnp-5343	16	20	agent	agent	NOUN
fnp-5343	16	21	[	[	X
fnp-5343	16	22	3–5	3–5	NOUN
fnp-5343	16	23	]	]	PUNCT
fnp-5343	16	24	.	.	PUNCT
fnp-5343	17	1	at	at	ADP
fnp-5343	17	2	the	the	DET
fnp-5343	17	3	time	time	NOUN
fnp-5343	17	4	,	,	PUNCT
fnp-5343	17	5	nearly	nearly	ADV
fnp-5343	17	6	all	all	PRON
fnp-5343	17	7	patients	patient	NOUN
fnp-5343	17	8	infected	infect	VERB
fnp-5343	17	9	with	with	ADP
fnp-5343	17	10	hiv	hiv	PROPN
fnp-5343	17	11	progressed	progress	VERB
fnp-5343	17	12	to	to	PART
fnp-5343	17	13	end	end	VERB
fnp-5343	17	14	stage	stage	NOUN
fnp-5343	17	15	aids	aid	NOUN
fnp-5343	17	16	with	with	ADP
fnp-5343	17	17	fatal	fatal	ADJ
fnp-5343	17	18	opportunistic	opportunistic	ADJ
fnp-5343	17	19	infections	infection	NOUN
fnp-5343	17	20	and	and	CCONJ
fnp-5343	17	21	malignancies	malignancy	NOUN
fnp-5343	17	22	,	,	PUNCT
fnp-5343	17	23	many	many	ADJ
fnp-5343	17	24	involving	involve	VERB
fnp-5343	17	25	the	the	DET
fnp-5343	17	26	cns	cns	NOUN
fnp-5343	18	1	[	[	X
fnp-5343	18	2	6	6	NUM
fnp-5343	18	3	]	]	PUNCT
fnp-5343	18	4	.	.	PUNCT
fnp-5343	19	1	a	a	DET
fnp-5343	19	2	few	few	ADJ
fnp-5343	19	3	years	year	NOUN
fnp-5343	19	4	later	later	ADV
fnp-5343	19	5	,	,	PUNCT
fnp-5343	19	6	hiv-2	hiv-2	ADV
fnp-5343	19	7	,	,	PUNCT
fnp-5343	19	8	primarily	primarily	ADV
fnp-5343	19	9	restricted	restrict	VERB
fnp-5343	19	10	to	to	ADP
fnp-5343	19	11	west	west	PROPN
fnp-5343	19	12	africa	africa	PROPN
fnp-5343	19	13	,	,	PUNCT
fnp-5343	19	14	was	be	AUX
fnp-5343	19	15	discovered	discover	VERB
fnp-5343	19	16	[	[	PUNCT
fnp-5343	19	17	7–9	7–9	X
fnp-5343	19	18	]	]	X
fnp-5343	19	19	.	.	PUNCT
fnp-5343	20	1	with	with	ADP
fnp-5343	20	2	the	the	DET
fnp-5343	20	3	advent	advent	NOUN
fnp-5343	20	4	of	of	ADP
fnp-5343	20	5	combined	combine	VERB
fnp-5343	20	6	antiretroviral	antiretroviral	ADJ
fnp-5343	20	7	therapy	therapy	NOUN
fnp-5343	20	8	(	(	PUNCT
fnp-5343	20	9	cart	cart	NOUN
fnp-5343	20	10	)	)	PUNCT
fnp-5343	20	11	in	in	ADP
fnp-5343	20	12	the	the	DET
fnp-5343	20	13	mid	mid	ADJ
fnp-5343	20	14	1990s	1990	NOUN
fnp-5343	20	15	,	,	PUNCT
fnp-5343	20	16	hiv	hiv	PROPN
fnp-5343	20	17	has	have	AUX
fnp-5343	20	18	become	become	VERB
fnp-5343	20	19	a	a	DET
fnp-5343	20	20	chronic	chronic	ADJ
fnp-5343	20	21	disease	disease	NOUN
fnp-5343	20	22	with	with	ADP
fnp-5343	20	23	near	near	ADP
fnp-5343	20	24	normal	normal	ADJ
fnp-5343	20	25	life	life	NOUN
fnp-5343	20	26	expectancies	expectancy	NOUN
fnp-5343	20	27	,	,	PUNCT
fnp-5343	20	28	at	at	ADP
fnp-5343	20	29	least	least	ADJ
fnp-5343	20	30	in	in	ADP
fnp-5343	20	31	industrialized	industrialized	ADJ
fnp-5343	20	32	countries	country	NOUN
fnp-5343	21	1	[	[	X
fnp-5343	21	2	6,10	6,10	X
fnp-5343	21	3	]	]	PUNCT
fnp-5343	21	4	.	.	PUNCT
fnp-5343	22	1	there	there	PRON
fnp-5343	22	2	have	have	AUX
fnp-5343	22	3	been	be	AUX
fnp-5343	22	4	approximately	approximately	ADV
fnp-5343	22	5	40	40	NUM
fnp-5343	22	6	million	million	NUM
fnp-5343	22	7	deaths	death	NOUN
fnp-5343	22	8	since	since	SCONJ
fnp-5343	22	9	the	the	DET
fnp-5343	22	10	beginning	beginning	NOUN
fnp-5343	22	11	of	of	ADP
fnp-5343	22	12	the	the	DET
fnp-5343	22	13	pandemic	pandemic	ADJ
fnp-5343	22	14	and	and	CCONJ
fnp-5343	22	15	currently	currently	ADV
fnp-5343	22	16	38	38	NUM
fnp-5343	22	17	million	million	NUM
fnp-5343	22	18	infected	infect	VERB
fnp-5343	22	19	worldwide	worldwide	ADV
fnp-5343	22	20	according	accord	VERB
fnp-5343	22	21	to	to	ADP
fnp-5343	22	22	the	the	DET
fnp-5343	22	23	joint	joint	ADJ
fnp-5343	22	24	united	united	PROPN
fnp-5343	22	25	nations	nations	PROPN
fnp-5343	22	26	programme	programme	PROPN
fnp-5343	22	27	on	on	ADP
fnp-5343	22	28	hiv	hiv	PROPN
fnp-5343	22	29	/	/	SYM
fnp-5343	22	30	aids	aids	PROPN
fnp-5343	22	31	(	(	PUNCT
fnp-5343	22	32	unaids	unaid	NOUN
fnp-5343	22	33	)	)	PUNCT
fnp-5343	23	1	[	[	X
fnp-5343	23	2	11	11	NUM
fnp-5343	23	3	]	]	PUNCT
fnp-5343	23	4	.	.	PUNCT
fnp-5343	23	5	hiv-1	hiv-1	PUNCT
fnp-5343	23	6	and	and	CCONJ
fnp-5343	23	7	hiv-2	hiv-2	NUM
fnp-5343	23	8	are	be	AUX
fnp-5343	23	9	lentiviruses	lentiviruse	NOUN
fnp-5343	23	10	of	of	ADP
fnp-5343	23	11	the	the	DET
fnp-5343	23	12	retrovirus	retrovirus	NOUN
fnp-5343	23	13	family	family	NOUN
fnp-5343	23	14	and	and	CCONJ
fnp-5343	23	15	predominantly	predominantly	ADV
fnp-5343	23	16	infect	infect	VERB
fnp-5343	23	17	monocytes	monocyte	NOUN
fnp-5343	23	18	/	/	SYM
fnp-5343	23	19	macrophages	macrophage	NOUN
fnp-5343	23	20	,	,	PUNCT
fnp-5343	23	21	as	as	ADP
fnp-5343	23	22	with	with	ADP
fnp-5343	23	23	all	all	DET
fnp-5343	23	24	lentiviruses	lentiviruse	NOUN
fnp-5343	23	25	,	,	PUNCT
fnp-5343	23	26	but	but	CCONJ
fnp-5343	23	27	also	also	ADV
fnp-5343	23	28	cd4	cd4	PROPN
fnp-5343	23	29	t	t	PROPN
fnp-5343	23	30	-	-	PUNCT
fnp-5343	23	31	cells	cell	NOUN
fnp-5343	23	32	by	by	ADP
fnp-5343	23	33	binding	bind	VERB
fnp-5343	23	34	to	to	ADP
fnp-5343	23	35	cd4	cd4	PROPN
fnp-5343	23	36	and	and	CCONJ
fnp-5343	23	37	the	the	DET
fnp-5343	23	38	chemokine	chemokine	ADJ
fnp-5343	23	39	co	co	NOUN
fnp-5343	23	40	-	-	NOUN
fnp-5343	23	41	receptors	receptor	NOUN
fnp-5343	23	42	cxcr4	cxcr4	NOUN
fnp-5343	23	43	and	and	CCONJ
fnp-5343	23	44	ccr5	ccr5	NOUN
fnp-5343	24	1	[	[	X
fnp-5343	24	2	12,13	12,13	NUM
fnp-5343	24	3	]	]	PUNCT
fnp-5343	24	4	.	.	PUNCT
fnp-5343	25	1	other	other	ADJ
fnp-5343	25	2	co	co	NOUN
fnp-5343	25	3	-	-	NOUN
fnp-5343	25	4	receptors	receptor	NOUN
fnp-5343	25	5	such	such	ADJ
fnp-5343	25	6	as	as	ADP
fnp-5343	25	7	ccr2	ccr2	PROPN
fnp-5343	25	8	and	and	CCONJ
fnp-5343	25	9	ccr3	ccr3	PROPN
fnp-5343	25	10	have	have	AUX
fnp-5343	25	11	also	also	ADV
fnp-5343	25	12	been	be	AUX
fnp-5343	25	13	reported	report	VERB
fnp-5343	25	14	to	to	PART
fnp-5343	25	15	mediate	mediate	VERB
fnp-5343	25	16	infection	infection	NOUN
fnp-5343	25	17	in	in	ADP
fnp-5343	25	18	vitro	vitro	X
fnp-5343	25	19	[	[	X
fnp-5343	25	20	12,13	12,13	NUM
fnp-5343	25	21	]	]	PUNCT
fnp-5343	25	22	.	.	PUNCT
fnp-5343	26	1	infection	infection	NOUN
fnp-5343	26	2	of	of	ADP
fnp-5343	26	3	macrophages	macrophage	NOUN
fnp-5343	26	4	(	(	PUNCT
fnp-5343	26	5	and	and	CCONJ
fnp-5343	26	6	microglia	microglia	ADJ
fnp-5343	26	7	)	)	PUNCT
fnp-5343	26	8	is	be	AUX
fnp-5343	26	9	primarily	primarily	ADV
fnp-5343	26	10	through	through	ADP
fnp-5343	26	11	ccr5	ccr5	NOUN
fnp-5343	27	1	[	[	X
fnp-5343	27	2	14,15	14,15	NUM
fnp-5343	27	3	]	]	PUNCT
fnp-5343	27	4	.	.	PUNCT
fnp-5343	28	1	the	the	DET
fnp-5343	28	2	entrance	entrance	NOUN
fnp-5343	28	3	of	of	ADP
fnp-5343	28	4	virus	virus	NOUN
fnp-5343	28	5	into	into	ADP
fnp-5343	28	6	the	the	DET
fnp-5343	28	7	cell	cell	NOUN
fnp-5343	28	8	may	may	AUX
fnp-5343	28	9	result	result	VERB
fnp-5343	28	10	in	in	ADP
fnp-5343	28	11	productive	productive	ADJ
fnp-5343	28	12	infection	infection	NOUN
fnp-5343	28	13	or	or	CCONJ
fnp-5343	28	14	latent	latent	NOUN
fnp-5343	28	15	infection	infection	NOUN
fnp-5343	28	16	[	[	X
fnp-5343	28	17	7,12,16,17	7,12,16,17	NUM
fnp-5343	28	18	]	]	PUNCT
fnp-5343	28	19	.	.	PUNCT
fnp-5343	29	1	hiv	hiv	PROPN
fnp-5343	29	2	is	be	AUX
fnp-5343	29	3	neuroinvasive	neuroinvasive	ADJ
fnp-5343	29	4	,	,	PUNCT
fnp-5343	29	5	characteristic	characteristic	ADJ
fnp-5343	29	6	of	of	ADP
fnp-5343	29	7	lentiviruses	lentiviruse	NOUN
fnp-5343	29	8	,	,	PUNCT
fnp-5343	29	9	and	and	CCONJ
fnp-5343	29	10	enters	enter	VERB
fnp-5343	29	11	the	the	DET
fnp-5343	29	12	cns	cns	NOUN
fnp-5343	29	13	at	at	ADP
fnp-5343	29	14	the	the	DET
fnp-5343	29	15	initial	initial	ADJ
fnp-5343	29	16	stage	stage	NOUN
fnp-5343	29	17	of	of	ADP
fnp-5343	29	18	infection	infection	NOUN
fnp-5343	29	19	[	[	X
fnp-5343	29	20	13,18–20	13,18–20	NUM
fnp-5343	29	21	]	]	X
fnp-5343	29	22	.	.	PUNCT
fnp-5343	30	1	neurologic	neurologic	ADJ
fnp-5343	30	2	manifestations	manifestation	NOUN
fnp-5343	30	3	hiv	hiv	PROPN
fnp-5343	30	4	causes	cause	VERB
fnp-5343	30	5	neurologic	neurologic	ADJ
fnp-5343	30	6	complications	complication	NOUN
fnp-5343	30	7	,	,	PUNCT
fnp-5343	30	8	due	due	ADP
fnp-5343	30	9	to	to	ADP
fnp-5343	30	10	opportunistic	opportunistic	ADJ
fnp-5343	30	11	infections	infection	NOUN
fnp-5343	30	12	and	and	CCONJ
fnp-5343	30	13	hiv	hiv	PROPN
fnp-5343	30	14	infection	infection	NOUN
fnp-5343	30	15	itself	itself	PRON
fnp-5343	30	16	,	,	PUNCT
fnp-5343	30	17	in	in	ADP
fnp-5343	30	18	over	over	ADP
fnp-5343	30	19	half	half	NOUN
fnp-5343	30	20	of	of	ADP
fnp-5343	30	21	patients	patient	NOUN
fnp-5343	30	22	not	not	PART
fnp-5343	30	23	receiving	receive	VERB
fnp-5343	30	24	cart	cart	NOUN
fnp-5343	31	1	[	[	X
fnp-5343	31	2	21,22	21,22	X
fnp-5343	31	3	]	]	X
fnp-5343	31	4	.	.	PUNCT
fnp-5343	32	1	with	with	ADP
fnp-5343	32	2	the	the	DET
fnp-5343	32	3	advent	advent	NOUN
fnp-5343	32	4	of	of	ADP
fnp-5343	32	5	cart	cart	NOUN
fnp-5343	32	6	,	,	PUNCT
fnp-5343	32	7	the	the	DET
fnp-5343	32	8	rates	rate	NOUN
fnp-5343	32	9	of	of	ADP
fnp-5343	32	10	opportunistic	opportunistic	ADJ
fnp-5343	32	11	infections	infection	NOUN
fnp-5343	32	12	of	of	ADP
fnp-5343	32	13	the	the	DET
fnp-5343	32	14	cns	cns	NOUN
fnp-5343	32	15	such	such	ADJ
fnp-5343	32	16	as	as	ADP
fnp-5343	32	17	by	by	ADP
fnp-5343	32	18	cytomegalovirus	cytomegalovirus	NOUN
fnp-5343	32	19	,	,	PUNCT
fnp-5343	32	20	toxoplasma	toxoplasma	NOUN
fnp-5343	32	21	,	,	PUNCT
fnp-5343	32	22	cryptococcus	cryptococcus	NOUN
fnp-5343	32	23	and	and	CCONJ
fnp-5343	32	24	progressive	progressive	ADJ
fnp-5343	32	25	multifocal	multifocal	ADJ
fnp-5343	32	26	leukoencephalopathy	leukoencephalopathy	NOUN
fnp-5343	32	27	caused	cause	VERB
fnp-5343	32	28	by	by	ADP
fnp-5343	32	29	jc	jc	PROPN
fnp-5343	32	30	virus	virus	PROPN
fnp-5343	32	31	,	,	PUNCT
fnp-5343	32	32	as	as	ADV
fnp-5343	32	33	well	well	ADV
fnp-5343	32	34	as	as	ADP
fnp-5343	32	35	primary	primary	ADJ
fnp-5343	32	36	cns	cns	NOUN
fnp-5343	32	37	lymphoma	lymphoma	NOUN
fnp-5343	32	38	,	,	PUNCT
fnp-5343	32	39	have	have	AUX
fnp-5343	32	40	decreased	decrease	VERB
fnp-5343	32	41	in	in	ADP
fnp-5343	32	42	some	some	DET
fnp-5343	32	43	series	series	NOUN
fnp-5343	32	44	[	[	X
fnp-5343	32	45	21,23	21,23	NUM
fnp-5343	32	46	]	]	PUNCT
fnp-5343	32	47	.	.	PUNCT
fnp-5343	33	1	hiv	hiv	PROPN
fnp-5343	33	2	-	-	PUNCT
fnp-5343	33	3	associated	associate	VERB
fnp-5343	33	4	neurocognitive	neurocognitive	ADJ
fnp-5343	33	5	disorders	disorder	NOUN
fnp-5343	33	6	(	(	PUNCT
fnp-5343	33	7	hand	hand	NOUN
fnp-5343	33	8	)	)	PUNCT
fnp-5343	33	9	,	,	PUNCT
fnp-5343	33	10	with	with	ADP
fnp-5343	33	11	revised	revise	VERB
fnp-5343	33	12	consensus	consensus	NOUN
fnp-5343	33	13	nomenclature	nomenclature	NOUN
fnp-5343	33	14	and	and	CCONJ
fnp-5343	33	15	criteria	criterion	NOUN
fnp-5343	33	16	in	in	ADP
fnp-5343	33	17	2007	2007	NUM
fnp-5343	33	18	[	[	X
fnp-5343	33	19	24	24	NUM
fnp-5343	33	20	]	]	PUNCT
fnp-5343	33	21	,	,	PUNCT
fnp-5343	33	22	previously	previously	ADV
fnp-5343	33	23	referred	refer	VERB
fnp-5343	33	24	to	to	ADP
fnp-5343	33	25	as	as	SCONJ
fnp-5343	33	26	aids	aids	PROPN
fnp-5343	33	27	dementia	dementia	NOUN
fnp-5343	33	28	complex	complex	NOUN
fnp-5343	33	29	and	and	CCONJ
fnp-5343	33	30	hiv-1	hiv-1	PUNCT
fnp-5343	33	31	associated	associated	ADJ
fnp-5343	33	32	cognitive	cognitive	ADJ
fnp-5343	33	33	/	/	SYM
fnp-5343	33	34	motor	motor	NOUN
fnp-5343	33	35	complex	complex	NOUN
fnp-5343	34	1	[	[	X
fnp-5343	34	2	25–28	25–28	NUM
fnp-5343	34	3	]	]	PUNCT
fnp-5343	34	4	,	,	PUNCT
fnp-5343	34	5	comprise	comprise	VERB
fnp-5343	34	6	a	a	DET
fnp-5343	34	7	spectrum	spectrum	NOUN
fnp-5343	34	8	of	of	ADP
fnp-5343	34	9	cognitive	cognitive	ADJ
fnp-5343	34	10	dysfunction	dysfunction	NOUN
fnp-5343	34	11	associated	associate	VERB
fnp-5343	34	12	with	with	ADP
fnp-5343	34	13	hiv	hiv	PROPN
fnp-5343	34	14	infection	infection	NOUN
fnp-5343	34	15	[	[	X
fnp-5343	34	16	24,25	24,25	NUM
fnp-5343	34	17	]	]	PUNCT
fnp-5343	34	18	.	.	PUNCT
fnp-5343	35	1	hand	hand	NOUN
fnp-5343	35	2	includes	include	VERB
fnp-5343	35	3	,	,	PUNCT
fnp-5343	35	4	with	with	ADP
fnp-5343	35	5	increasing	increase	VERB
fnp-5343	35	6	severity	severity	NOUN
fnp-5343	35	7	,	,	PUNCT
fnp-5343	35	8	asymptomatic	asymptomatic	ADJ
fnp-5343	35	9	neurocognitive	neurocognitive	ADJ
fnp-5343	35	10	impairment	impairment	NOUN
fnp-5343	35	11	(	(	PUNCT
fnp-5343	35	12	ani	ani	NOUN
fnp-5343	35	13	)	)	PUNCT
fnp-5343	35	14	,	,	PUNCT
fnp-5343	35	15	mild	mild	ADJ
fnp-5343	35	16	neurocognitive	neurocognitive	ADJ
fnp-5343	35	17	disorder	disorder	NOUN
fnp-5343	35	18	(	(	PUNCT
fnp-5343	35	19	mnd	mnd	PROPN
fnp-5343	35	20	)	)	PUNCT
fnp-5343	35	21	and	and	CCONJ
fnp-5343	35	22	hiv	hiv	PROPN
fnp-5343	35	23	-	-	PUNCT
fnp-5343	35	24	associated	associate	VERB
fnp-5343	35	25	dementia	dementia	NOUN
fnp-5343	35	26	(	(	PUNCT
fnp-5343	35	27	had	have	VERB
fnp-5343	35	28	)	)	PUNCT
fnp-5343	35	29	,	,	PUNCT
fnp-5343	35	30	and	and	CCONJ
fnp-5343	35	31	continues	continue	VERB
fnp-5343	35	32	to	to	PART
fnp-5343	35	33	affect	affect	VERB
fnp-5343	35	34	approximately	approximately	ADV
fnp-5343	35	35	33	33	NUM
fnp-5343	35	36	-	-	SYM
fnp-5343	35	37	50	50	NUM
fnp-5343	35	38	%	%	NOUN
fnp-5343	35	39	of	of	ADP
fnp-5343	35	40	treated	treat	VERB
fnp-5343	35	41	hiv	hiv	PROPN
fnp-5343	35	42	-	-	PUNCT
fnp-5343	35	43	positive	positive	ADJ
fnp-5343	35	44	individuals	individual	NOUN
fnp-5343	35	45	[	[	X
fnp-5343	35	46	24,29–31	24,29–31	NOUN
fnp-5343	35	47	]	]	PUNCT
fnp-5343	35	48	.	.	PUNCT
fnp-5343	36	1	had	have	AUX
fnp-5343	36	2	is	be	AUX
fnp-5343	36	3	the	the	DET
fnp-5343	36	4	most	most	ADV
fnp-5343	36	5	severe	severe	ADJ
fnp-5343	36	6	and	and	CCONJ
fnp-5343	36	7	was	be	AUX
fnp-5343	36	8	the	the	DET
fnp-5343	36	9	most	most	ADV
fnp-5343	36	10	common	common	ADJ
fnp-5343	36	11	form	form	NOUN
fnp-5343	36	12	of	of	ADP
fnp-5343	36	13	hand	hand	NOUN
fnp-5343	36	14	in	in	ADP
fnp-5343	36	15	the	the	DET
fnp-5343	36	16	pre	pre	ADJ
fnp-5343	36	17	-	-	ADJ
fnp-5343	36	18	cart	cart	ADJ
fnp-5343	36	19	era	era	NOUN
fnp-5343	36	20	but	but	CCONJ
fnp-5343	36	21	has	have	AUX
fnp-5343	36	22	decreased	decrease	VERB
fnp-5343	36	23	with	with	ADP
fnp-5343	36	24	the	the	DET
fnp-5343	36	25	advent	advent	NOUN
fnp-5343	36	26	of	of	ADP
fnp-5343	36	27	cart	cart	NOUN
fnp-5343	36	28	,	,	PUNCT
fnp-5343	36	29	now	now	ADV
fnp-5343	36	30	comprising	comprise	VERB
fnp-5343	36	31	less	less	ADJ
fnp-5343	36	32	than	than	ADP
fnp-5343	36	33	10	10	NUM
fnp-5343	36	34	%	%	NOUN
fnp-5343	36	35	of	of	ADP
fnp-5343	36	36	those	those	PRON
fnp-5343	36	37	with	with	ADP
fnp-5343	36	38	hand	hand	NOUN
fnp-5343	36	39	[	[	X
fnp-5343	36	40	6	6	NUM
fnp-5343	36	41	]	]	PUNCT
fnp-5343	36	42	.	.	PUNCT
fnp-5343	37	1	however	however	ADV
fnp-5343	37	2	,	,	PUNCT
fnp-5343	37	3	the	the	DET
fnp-5343	37	4	overall	overall	ADJ
fnp-5343	37	5	proportion	proportion	NOUN
fnp-5343	37	6	of	of	ADP
fnp-5343	37	7	individuals	individual	NOUN
fnp-5343	37	8	with	with	ADP
fnp-5343	37	9	hand	hand	NOUN
fnp-5343	37	10	has	have	AUX
fnp-5343	37	11	not	not	PART
fnp-5343	37	12	changed	change	VERB
fnp-5343	37	13	in	in	ADP
fnp-5343	37	14	the	the	DET
fnp-5343	37	15	cart	cart	NOUN
fnp-5343	37	16	era	era	NOUN
fnp-5343	37	17	due	due	ADP
fnp-5343	37	18	to	to	ADP
fnp-5343	37	19	a	a	DET
fnp-5343	37	20	relative	relative	ADJ
fnp-5343	37	21	increase	increase	NOUN
fnp-5343	37	22	in	in	ADP
fnp-5343	37	23	the	the	DET
fnp-5343	37	24	milder	mild	ADJ
fnp-5343	37	25	forms	form	NOUN
fnp-5343	37	26	of	of	ADP
fnp-5343	37	27	hand	hand	NOUN
fnp-5343	37	28	,	,	PUNCT
fnp-5343	37	29	the	the	DET
fnp-5343	37	30	pathogenesis	pathogenesis	NOUN
fnp-5343	37	31	and	and	CCONJ
fnp-5343	37	32	neuropathologic	neuropathologic	ADJ
fnp-5343	37	33	substrates	substrate	NOUN
fnp-5343	37	34	of	of	ADP
fnp-5343	37	35	which	which	PRON
fnp-5343	37	36	are	be	AUX
fnp-5343	37	37	unclear	unclear	ADJ
fnp-5343	37	38	[	[	X
fnp-5343	37	39	6,31	6,31	NUM
fnp-5343	37	40	]	]	PUNCT
fnp-5343	37	41	.	.	PUNCT
fnp-5343	38	1	the	the	DET
fnp-5343	38	2	clinical	clinical	ADJ
fnp-5343	38	3	features	feature	NOUN
fnp-5343	38	4	of	of	ADP
fnp-5343	38	5	hand	hand	NOUN
fnp-5343	38	6	have	have	AUX
fnp-5343	38	7	also	also	ADV
fnp-5343	38	8	changed	change	VERB
fnp-5343	38	9	before	before	ADV
fnp-5343	38	10	and	and	CCONJ
fnp-5343	38	11	after	after	ADP
fnp-5343	38	12	cart	cart	NOUN
fnp-5343	38	13	[	[	X
fnp-5343	38	14	32	32	NUM
fnp-5343	38	15	]	]	PUNCT
fnp-5343	38	16	.	.	PUNCT
fnp-5343	39	1	in	in	ADP
fnp-5343	39	2	the	the	DET
fnp-5343	39	3	pre	pre	ADJ
fnp-5343	39	4	-	-	ADJ
fnp-5343	39	5	cart	cart	ADJ
fnp-5343	39	6	era	era	NOUN
fnp-5343	39	7	,	,	PUNCT
fnp-5343	39	8	patients	patient	NOUN
fnp-5343	39	9	commonly	commonly	ADV
fnp-5343	39	10	presented	present	VERB
fnp-5343	39	11	with	with	ADP
fnp-5343	39	12	extrapyramidal	extrapyramidal	ADJ
fnp-5343	39	13	signs	sign	NOUN
fnp-5343	39	14	(	(	PUNCT
fnp-5343	39	15	bradykinesia	bradykinesia	NOUN
fnp-5343	39	16	,	,	PUNCT
fnp-5343	39	17	rigidity	rigidity	NOUN
fnp-5343	39	18	and	and	CCONJ
fnp-5343	39	19	tremor	tremor	NOUN
fnp-5343	39	20	)	)	PUNCT
fnp-5343	39	21	and	and	CCONJ
fnp-5343	39	22	more	more	ADV
fnp-5343	39	23	frequent	frequent	ADJ
fnp-5343	39	24	subcortical	subcortical	ADJ
fnp-5343	39	25	features	feature	NOUN
fnp-5343	39	26	with	with	ADP
fnp-5343	39	27	motor	motor	NOUN
fnp-5343	39	28	dysfunction	dysfunction	NOUN
fnp-5343	39	29	and	and	CCONJ
fnp-5343	39	30	speed	speed	NOUN
fnp-5343	39	31	of	of	ADP
fnp-5343	39	32	processing	processing	NOUN
fnp-5343	39	33	deficits	deficit	NOUN
fnp-5343	39	34	[	[	X
fnp-5343	39	35	26,32–35	26,32–35	NOUN
fnp-5343	39	36	]	]	PUNCT
fnp-5343	39	37	.	.	PUNCT
fnp-5343	40	1	in	in	ADP
fnp-5343	40	2	the	the	DET
fnp-5343	40	3	cart	cart	NOUN
fnp-5343	40	4	era	era	NOUN
fnp-5343	40	5	,	,	PUNCT
fnp-5343	40	6	extrapyramidal	extrapyramidal	ADJ
fnp-5343	40	7	signs	sign	NOUN
fnp-5343	40	8	are	be	AUX
fnp-5343	40	9	less	less	ADV
fnp-5343	40	10	common	common	ADJ
fnp-5343	40	11	with	with	ADP
fnp-5343	40	12	more	more	ADV
fnp-5343	40	13	cortical	cortical	ADJ
fnp-5343	40	14	features	feature	NOUN
fnp-5343	40	15	with	with	ADP
fnp-5343	40	16	deficits	deficit	NOUN
fnp-5343	40	17	in	in	ADP
fnp-5343	40	18	learning	learning	NOUN
fnp-5343	40	19	,	,	PUNCT
fnp-5343	40	20	memory	memory	NOUN
fnp-5343	40	21	and	and	CCONJ
fnp-5343	40	22	executive	executive	NOUN
fnp-5343	40	23	functioning	functioning	NOUN
fnp-5343	40	24	[	[	X
fnp-5343	40	25	32–34,36	32–34,36	NUM
fnp-5343	40	26	]	]	PUNCT
fnp-5343	40	27	.	.	PUNCT
fnp-5343	41	1	risk	risk	NOUN
fnp-5343	41	2	factors	factor	NOUN
fnp-5343	41	3	for	for	ADP
fnp-5343	41	4	hand	hand	NOUN
fnp-5343	41	5	include	include	VERB
fnp-5343	41	6	older	old	ADJ
fnp-5343	41	7	age	age	NOUN
fnp-5343	41	8	[	[	X
fnp-5343	41	9	37	37	NUM
fnp-5343	41	10	]	]	PUNCT
fnp-5343	41	11	,	,	PUNCT
fnp-5343	41	12	cerebrovascular	cerebrovascular	ADJ
fnp-5343	41	13	disease	disease	NOUN
fnp-5343	41	14	risk	risk	NOUN
fnp-5343	41	15	factors	factor	NOUN
fnp-5343	42	1	[	[	X
fnp-5343	42	2	38,39	38,39	NOUN
fnp-5343	42	3	]	]	X
fnp-5343	42	4	,	,	PUNCT
fnp-5343	42	5	duration	duration	NOUN
fnp-5343	42	6	of	of	ADP
fnp-5343	42	7	hiv	hiv	PROPN
fnp-5343	42	8	infection	infection	NOUN
fnp-5343	42	9	and	and	CCONJ
fnp-5343	42	10	history	history	NOUN
fnp-5343	42	11	of	of	ADP
fnp-5343	42	12	aids	aid	NOUN
fnp-5343	42	13	defining	define	VERB
fnp-5343	42	14	illness	illness	NOUN
fnp-5343	43	1	[	[	X
fnp-5343	43	2	40	40	NUM
fnp-5343	43	3	]	]	PUNCT
fnp-5343	43	4	,	,	PUNCT
fnp-5343	43	5	lower	lower	ADV
fnp-5343	43	6	cd4	cd4	PROPN
fnp-5343	43	7	nadir	nadir	NOUN
fnp-5343	43	8	[	[	X
fnp-5343	43	9	40,41	40,41	NOUN
fnp-5343	43	10	]	]	X
fnp-5343	43	11	,	,	PUNCT
fnp-5343	43	12	and	and	CCONJ
fnp-5343	43	13	in	in	ADP
fnp-5343	43	14	treatment	treatment	NOUN
fnp-5343	43	15	naïve	naïve	ADJ
fnp-5343	43	16	patients	patient	NOUN
fnp-5343	43	17	,	,	PUNCT
fnp-5343	43	18	burden	burden	NOUN
fnp-5343	43	19	of	of	ADP
fnp-5343	43	20	hiv	hiv	PROPN
fnp-5343	43	21	dna	dna	PROPN
fnp-5343	43	22	in	in	ADP
fnp-5343	43	23	monocyte	monocyte	NOUN
fnp-5343	43	24	-	-	PUNCT
fnp-5343	43	25	enriched	enrich	VERB
fnp-5343	43	26	peripheral	peripheral	ADJ
fnp-5343	43	27	blood	blood	NOUN
fnp-5343	43	28	cells	cell	NOUN
fnp-5343	43	29	[	[	X
fnp-5343	43	30	42	42	NUM
fnp-5343	43	31	]	]	PUNCT
fnp-5343	43	32	.	.	PUNCT
fnp-5343	44	1	currently	currently	ADV
fnp-5343	44	2	,	,	PUNCT
fnp-5343	44	3	the	the	DET
fnp-5343	44	4	only	only	ADJ
fnp-5343	44	5	treatment	treatment	NOUN
fnp-5343	44	6	for	for	ADP
fnp-5343	44	7	hand	hand	NOUN
fnp-5343	44	8	is	be	AUX
fnp-5343	44	9	cart	cart	NOUN
fnp-5343	44	10	,	,	PUNCT
fnp-5343	44	11	but	but	CCONJ
fnp-5343	44	12	cart	cart	NOUN
fnp-5343	44	13	is	be	AUX
fnp-5343	44	14	effective	effective	ADJ
fnp-5343	44	15	in	in	ADP
fnp-5343	44	16	only	only	ADV
fnp-5343	44	17	a	a	DET
fnp-5343	44	18	subset	subset	NOUN
fnp-5343	44	19	of	of	ADP
fnp-5343	44	20	patients	patient	NOUN
fnp-5343	44	21	with	with	ADP
fnp-5343	44	22	hand	hand	NOUN
fnp-5343	44	23	[	[	X
fnp-5343	44	24	32,43	32,43	NOUN
fnp-5343	44	25	]	]	PUNCT
fnp-5343	44	26	.	.	PUNCT
fnp-5343	45	1	after	after	ADP
fnp-5343	45	2	the	the	DET
fnp-5343	45	3	advent	advent	NOUN
fnp-5343	45	4	of	of	ADP
fnp-5343	45	5	cart	cart	NOUN
fnp-5343	45	6	,	,	PUNCT
fnp-5343	45	7	the	the	DET
fnp-5343	45	8	median	median	ADJ
fnp-5343	45	9	survival	survival	NOUN
fnp-5343	45	10	of	of	ADP
fnp-5343	45	11	had	have	AUX
fnp-5343	45	12	patients	patient	NOUN
fnp-5343	45	13	increased	increase	VERB
fnp-5343	45	14	to	to	ADP
fnp-5343	45	15	38	38	NUM
fnp-5343	45	16	months	month	NOUN
fnp-5343	45	17	compared	compare	VERB
fnp-5343	45	18	to	to	ADP
fnp-5343	45	19	5	5	NUM
fnp-5343	45	20	months	month	NOUN
fnp-5343	45	21	pre	pre	ADJ
fnp-5343	45	22	-	-	NOUN
fnp-5343	45	23	cart	cart	ADJ
fnp-5343	45	24	[	[	X
fnp-5343	45	25	44	44	NUM
fnp-5343	45	26	]	]	PUNCT
fnp-5343	45	27	,	,	PUNCT
fnp-5343	45	28	and	and	CCONJ
fnp-5343	45	29	most	most	ADJ
fnp-5343	45	30	individuals	individual	NOUN
fnp-5343	45	31	with	with	ADP
fnp-5343	45	32	hand	hand	NOUN
fnp-5343	45	33	on	on	ADP
fnp-5343	45	34	cart	cart	NOUN
fnp-5343	45	35	remained	remain	VERB
fnp-5343	45	36	stable	stable	ADJ
fnp-5343	46	1	[	[	X
fnp-5343	46	2	29,32	29,32	NUM
fnp-5343	46	3	]	]	X
fnp-5343	46	4	.	.	PUNCT
fnp-5343	47	1	however	however	ADV
fnp-5343	47	2	,	,	PUNCT
fnp-5343	47	3	even	even	ADV
fnp-5343	47	4	in	in	ADP
fnp-5343	47	5	patients	patient	NOUN
fnp-5343	47	6	on	on	ADP
fnp-5343	47	7	cart	cart	NOUN
fnp-5343	47	8	,	,	PUNCT
fnp-5343	47	9	hand	hand	NOUN
fnp-5343	47	10	is	be	AUX
fnp-5343	47	11	associated	associate	VERB
fnp-5343	47	12	with	with	ADP
fnp-5343	47	13	shorter	short	ADJ
fnp-5343	47	14	survival	survival	NOUN
fnp-5343	47	15	and	and	CCONJ
fnp-5343	47	16	is	be	AUX
fnp-5343	47	17	an	an	DET
fnp-5343	47	18	important	important	ADJ
fnp-5343	47	19	cause	cause	NOUN
fnp-5343	47	20	of	of	ADP
fnp-5343	47	21	morbidity	morbidity	NOUN
fnp-5343	47	22	and	and	CCONJ
fnp-5343	47	23	mortality	mortality	NOUN
fnp-5343	47	24	in	in	ADP
fnp-5343	47	25	the	the	DET
fnp-5343	47	26	aging	age	VERB
fnp-5343	47	27	hiv	hiv	NOUN
fnp-5343	47	28	-	-	PUNCT
fnp-5343	47	29	positive	positive	ADJ
fnp-5343	47	30	population	population	NOUN
fnp-5343	48	1	[	[	X
fnp-5343	48	2	45–47	45–47	NUM
fnp-5343	48	3	]	]	X
fnp-5343	48	4	.	.	PUNCT
fnp-5343	49	1	a	a	DET
fnp-5343	49	2	recent	recent	ADJ
fnp-5343	49	3	study	study	NOUN
fnp-5343	49	4	showed	show	VERB
fnp-5343	49	5	that	that	SCONJ
fnp-5343	49	6	cognitive	cognitive	ADJ
fnp-5343	49	7	decline	decline	NOUN
fnp-5343	49	8	in	in	ADP
fnp-5343	49	9	hiv	hiv	PROPN
fnp-5343	49	10	positive	positive	ADJ
fnp-5343	49	11	individuals	individual	NOUN
fnp-5343	49	12	was	be	AUX
fnp-5343	49	13	not	not	PART
fnp-5343	49	14	associated	associate	VERB
fnp-5343	49	15	with	with	ADP
fnp-5343	49	16	age	age	NOUN
fnp-5343	49	17	or	or	CCONJ
fnp-5343	49	18	markers	marker	NOUN
fnp-5343	49	19	of	of	ADP
fnp-5343	49	20	hiv	hiv	PROPN
fnp-5343	49	21	disease	disease	NOUN
fnp-5343	49	22	but	but	CCONJ
fnp-5343	49	23	rather	rather	ADV
fnp-5343	49	24	comorbidities	comorbiditie	NOUN
fnp-5343	49	25	such	such	ADJ
fnp-5343	49	26	as	as	ADP
fnp-5343	49	27	hypertension	hypertension	NOUN
fnp-5343	49	28	and	and	CCONJ
fnp-5343	49	29	diabetes	diabetes	NOUN
fnp-5343	49	30	[	[	X
fnp-5343	49	31	48	48	NUM
fnp-5343	49	32	]	]	PUNCT
fnp-5343	49	33	.	.	PUNCT
fnp-5343	50	1	before	before	ADP
fnp-5343	50	2	cart	cart	NOUN
fnp-5343	50	3	,	,	PUNCT
fnp-5343	50	4	brain	brain	NOUN
fnp-5343	50	5	magnetic	magnetic	ADJ
fnp-5343	50	6	resonance	resonance	NOUN
fnp-5343	50	7	imaging	imaging	NOUN
fnp-5343	50	8	(	(	PUNCT
fnp-5343	50	9	mri	mri	NOUN
fnp-5343	50	10	)	)	PUNCT
fnp-5343	50	11	studies	study	NOUN
fnp-5343	50	12	showed	showed	AUX
fnp-5343	50	13	accelerated	accelerate	VERB
fnp-5343	50	14	global	global	ADJ
fnp-5343	50	15	white	white	ADJ
fnp-5343	50	16	matter	matter	NOUN
fnp-5343	50	17	atrophy	atrophy	NOUN
fnp-5343	50	18	and	and	CCONJ
fnp-5343	50	19	cerebrospinal	cerebrospinal	ADJ
fnp-5343	50	20	fluid	fluid	NOUN
fnp-5343	50	21	(	(	PUNCT
fnp-5343	50	22	csf	csf	NOUN
fnp-5343	50	23	)	)	PUNCT
fnp-5343	50	24	volume	volume	NOUN
fnp-5343	50	25	increase	increase	NOUN
fnp-5343	50	26	(	(	PUNCT
fnp-5343	50	27	corresponding	correspond	VERB
fnp-5343	50	28	to	to	ADP
fnp-5343	50	29	tissue	tissue	NOUN
fnp-5343	50	30	loss	loss	NOUN
fnp-5343	50	31	)	)	PUNCT
fnp-5343	50	32	as	as	ADV
fnp-5343	50	33	well	well	ADV
fnp-5343	50	34	as	as	ADP
fnp-5343	50	35	atrophy	atrophy	NOUN
fnp-5343	50	36	of	of	ADP
fnp-5343	50	37	the	the	DET
fnp-5343	50	38	caudate	caudate	NOUN
fnp-5343	50	39	in	in	ADP
fnp-5343	50	40	hiv	hiv	PROPN
fnp-5343	50	41	-	-	PUNCT
fnp-5343	50	42	positive	positive	ADJ
fnp-5343	50	43	individuals	individual	NOUN
fnp-5343	51	1	[	[	X
fnp-5343	51	2	49,50	49,50	X
fnp-5343	51	3	]	]	PUNCT
fnp-5343	51	4	.	.	PUNCT
fnp-5343	52	1	postmortem	postmortem	PROPN
fnp-5343	52	2	mri	mri	NOUN
fnp-5343	52	3	studies	study	NOUN
fnp-5343	52	4	demonstrated	demonstrate	VERB
fnp-5343	52	5	that	that	SCONJ
fnp-5343	52	6	increase	increase	NOUN
fnp-5343	52	7	in	in	ADP
fnp-5343	52	8	volume	volume	NOUN
fnp-5343	52	9	of	of	ADP
fnp-5343	52	10	abnormal	abnormal	ADJ
fnp-5343	52	11	white	white	ADJ
fnp-5343	52	12	matter	matter	NOUN
fnp-5343	52	13	and	and	CCONJ
fnp-5343	52	14	decrease	decrease	NOUN
fnp-5343	52	15	in	in	ADP
fnp-5343	52	16	volume	volume	NOUN
fnp-5343	52	17	of	of	ADP
fnp-5343	52	18	deep	deep	ADJ
fnp-5343	52	19	gray	gray	ADJ
fnp-5343	52	20	matter	matter	NOUN
fnp-5343	52	21	correlated	correlate	VERB
fnp-5343	52	22	with	with	ADP
fnp-5343	52	23	increasing	increase	VERB
fnp-5343	52	24	viral	viral	ADJ
fnp-5343	52	25	burden	burden	NOUN
fnp-5343	52	26	as	as	SCONJ
fnp-5343	52	27	assessed	assess	VERB
fnp-5343	52	28	by	by	ADP
fnp-5343	52	29	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	52	30	for	for	ADP
fnp-5343	52	31	hiv	hiv	PROPN
fnp-5343	52	32	protein	protein	NOUN
fnp-5343	52	33	[	[	X
fnp-5343	52	34	51	51	NUM
fnp-5343	52	35	]	]	PUNCT
fnp-5343	52	36	.	.	PUNCT
fnp-5343	53	1	even	even	ADV
fnp-5343	53	2	after	after	ADP
fnp-5343	53	3	cart	cart	NOUN
fnp-5343	53	4	,	,	PUNCT
fnp-5343	53	5	compared	compare	VERB
fnp-5343	53	6	to	to	ADP
fnp-5343	53	7	hiv	hiv	PROPN
fnp-5343	53	8	-	-	PUNCT
fnp-5343	53	9	negative	negative	ADJ
fnp-5343	53	10	individuals	individual	NOUN
fnp-5343	53	11	,	,	PUNCT
fnp-5343	53	12	hiv	hiv	PROPN
fnp-5343	53	13	-	-	PUNCT
fnp-5343	53	14	positive	positive	ADJ
fnp-5343	53	15	individuals	individual	NOUN
fnp-5343	53	16	show	show	VERB
fnp-5343	53	17	higher	high	ADJ
fnp-5343	53	18	rates	rate	NOUN
fnp-5343	53	19	of	of	ADP
fnp-5343	53	20	white	white	ADJ
fnp-5343	53	21	matter	matter	NOUN
fnp-5343	53	22	atrophy	atrophy	NOUN
fnp-5343	53	23	,	,	PUNCT
fnp-5343	53	24	which	which	PRON
fnp-5343	53	25	correlate	correlate	VERB
fnp-5343	53	26	with	with	ADP
fnp-5343	53	27	lower	low	ADJ
fnp-5343	53	28	cd4	cd4	PROPN
fnp-5343	53	29	counts	count	NOUN
fnp-5343	53	30	[	[	X
fnp-5343	53	31	52	52	NUM
fnp-5343	53	32	]	]	PUNCT
fnp-5343	53	33	.	.	PUNCT
fnp-5343	54	1	mri	mri	NOUN
fnp-5343	54	2	changes	change	NOUN
fnp-5343	54	3	can	can	AUX
fnp-5343	54	4	be	be	AUX
fnp-5343	54	5	seen	see	VERB
fnp-5343	54	6	in	in	ADP
fnp-5343	54	7	all	all	DET
fnp-5343	54	8	degrees	degree	NOUN
fnp-5343	54	9	of	of	ADP
fnp-5343	54	10	hand	hand	NOUN
fnp-5343	54	11	,	,	PUNCT
fnp-5343	54	12	with	with	ADP
fnp-5343	54	13	individuals	individual	NOUN
fnp-5343	54	14	with	with	ADP
fnp-5343	54	15	hand	hand	NOUN
fnp-5343	54	16	showing	show	VERB
fnp-5343	54	17	greater	great	ADJ
fnp-5343	54	18	abnormality	abnormality	NOUN
fnp-5343	54	19	in	in	ADP
fnp-5343	54	20	cerebral	cerebral	ADJ
fnp-5343	54	21	white	white	ADJ
fnp-5343	54	22	matter	matter	NOUN
fnp-5343	54	23	compared	compare	VERB
fnp-5343	54	24	to	to	ADP
fnp-5343	54	25	neurocognitively	neurocognitively	ADV
fnp-5343	54	26	intact	intact	ADJ
fnp-5343	54	27	hiv	hiv	NOUN
fnp-5343	54	28	-	-	PUNCT
fnp-5343	54	29	positive	positive	ADJ
fnp-5343	54	30	individuals	individual	NOUN
fnp-5343	54	31	[	[	X
fnp-5343	54	32	53	53	NUM
fnp-5343	54	33	]	]	PUNCT
fnp-5343	54	34	.	.	PUNCT
fnp-5343	55	1	utilizing	utilize	VERB
fnp-5343	55	2	dynamic	dynamic	ADJ
fnp-5343	55	3	contrast	contrast	NOUN
fnp-5343	55	4	enhanced	enhance	VERB
fnp-5343	55	5	perfusion	perfusion	NOUN
fnp-5343	55	6	(	(	PUNCT
fnp-5343	55	7	dce	dce	PROPN
fnp-5343	55	8	p	p	X
fnp-5343	55	9	)	)	PUNCT
fnp-5343	55	10	mri	mri	NOUN
fnp-5343	55	11	,	,	PUNCT
fnp-5343	55	12	a	a	DET
fnp-5343	55	13	marker	marker	NOUN
fnp-5343	55	14	of	of	ADP
fnp-5343	55	15	capillary	capillary	ADJ
fnp-5343	55	16	permeability	permeability	NOUN
fnp-5343	55	17	,	,	PUNCT
fnp-5343	55	18	to	to	PART
fnp-5343	55	19	assess	assess	VERB
fnp-5343	55	20	for	for	ADP
fnp-5343	55	21	blood	blood	NOUN
fnp-5343	55	22	-	-	PUNCT
fnp-5343	55	23	brain	brain	NOUN
fnp-5343	55	24	barrier	barrier	NOUN
fnp-5343	55	25	(	(	PUNCT
fnp-5343	55	26	bbb	bbb	NOUN
fnp-5343	55	27	)	)	PUNCT
fnp-5343	55	28	disruption	disruption	NOUN
fnp-5343	55	29	,	,	PUNCT
fnp-5343	55	30	chaganti	chaganti	PROPN
fnp-5343	55	31	et	et	PROPN
fnp-5343	55	32	al	al	PROPN
fnp-5343	55	33	.	.	PROPN
fnp-5343	55	34	showed	show	VERB
fnp-5343	55	35	impaired	impaired	ADJ
fnp-5343	55	36	bbb	bbb	NOUN
fnp-5343	55	37	in	in	ADP
fnp-5343	55	38	the	the	DET
fnp-5343	55	39	frontal	frontal	ADJ
fnp-5343	55	40	white	white	ADJ
fnp-5343	55	41	matter	matter	NOUN
fnp-5343	55	42	and	and	CCONJ
fnp-5343	55	43	basal	basal	VERB
fnp-5343	55	44	ganglia	ganglia	NOUN
fnp-5343	55	45	in	in	ADP
fnp-5343	55	46	virally	virally	ADV
fnp-5343	55	47	suppressed	suppress	VERB
fnp-5343	55	48	patients	patient	NOUN
fnp-5343	55	49	with	with	ADP
fnp-5343	55	50	hand	hand	NOUN
fnp-5343	55	51	compared	compare	VERB
fnp-5343	55	52	to	to	ADP
fnp-5343	55	53	controls	control	NOUN
fnp-5343	55	54	[	[	X
fnp-5343	55	55	54	54	NUM
fnp-5343	55	56	]	]	PUNCT
fnp-5343	55	57	.	.	PUNCT
fnp-5343	56	1	neuropathologic	neuropathologic	PROPN
fnp-5343	56	2	findings	findings	PROPN
fnp-5343	56	3	neuropathologic	neuropathologic	PROPN
fnp-5343	56	4	studies	study	NOUN
fnp-5343	56	5	have	have	AUX
fnp-5343	56	6	made	make	VERB
fnp-5343	56	7	important	important	ADJ
fnp-5343	56	8	contributions	contribution	NOUN
fnp-5343	56	9	to	to	ADP
fnp-5343	56	10	understanding	understand	VERB
fnp-5343	56	11	hiv	hiv	PROPN
fnp-5343	56	12	infection	infection	NOUN
fnp-5343	56	13	in	in	ADP
fnp-5343	56	14	the	the	DET
fnp-5343	56	15	cns	cns	NOUN
fnp-5343	57	1	[	[	X
fnp-5343	57	2	7,12,55–57	7,12,55–57	NUM
fnp-5343	57	3	]	]	PUNCT
fnp-5343	57	4	.	.	PUNCT
fnp-5343	58	1	hiv	hiv	PROPN
fnp-5343	58	2	has	have	AUX
fnp-5343	58	3	been	be	AUX
fnp-5343	58	4	isolated	isolate	VERB
fnp-5343	58	5	from	from	ADP
fnp-5343	58	6	the	the	DET
fnp-5343	58	7	csf	csf	PROPN
fnp-5343	58	8	,	,	PUNCT
fnp-5343	58	9	brain	brain	NOUN
fnp-5343	58	10	including	include	VERB
fnp-5343	58	11	frontal	frontal	ADJ
fnp-5343	58	12	and	and	CCONJ
fnp-5343	58	13	temporal	temporal	ADJ
fnp-5343	58	14	lobes	lobe	NOUN
fnp-5343	58	15	,	,	PUNCT
fnp-5343	58	16	caudate	caudate	NOUN
fnp-5343	58	17	,	,	PUNCT
fnp-5343	58	18	and	and	CCONJ
fnp-5343	58	19	cerebellum	cerebellum	ADJ
fnp-5343	58	20	,	,	PUNCT
fnp-5343	58	21	spinal	spinal	ADJ
fnp-5343	58	22	cord	cord	NOUN
fnp-5343	58	23	,	,	PUNCT
fnp-5343	58	24	and	and	CCONJ
fnp-5343	58	25	sural	sural	ADJ
fnp-5343	58	26	nerve	nerve	NOUN
fnp-5343	58	27	from	from	ADP
fnp-5343	58	28	aids	aid	NOUN
fnp-5343	58	29	patients	patient	NOUN
fnp-5343	58	30	with	with	ADP
fnp-5343	58	31	meningitis	meningitis	NOUN
fnp-5343	58	32	,	,	PUNCT
fnp-5343	58	33	encephalopathy	encephalopathy	ADJ
fnp-5343	58	34	,	,	PUNCT
fnp-5343	58	35	myelopathy	myelopathy	ADJ
fnp-5343	58	36	,	,	PUNCT
fnp-5343	58	37	and	and	CCONJ
fnp-5343	58	38	peripheral	peripheral	ADJ
fnp-5343	58	39	neuropathy	neuropathy	ADJ
fnp-5343	58	40	[	[	X
fnp-5343	58	41	58	58	NUM
fnp-5343	58	42	-	-	SYM
fnp-5343	58	43	60	60	NUM
fnp-5343	58	44	]	]	PUNCT
fnp-5343	58	45	.	.	PUNCT
fnp-5343	59	1	even	even	ADV
fnp-5343	59	2	in	in	ADP
fnp-5343	59	3	asymptomatic	asymptomatic	ADJ
fnp-5343	59	4	patients	patient	NOUN
fnp-5343	59	5	,	,	PUNCT
fnp-5343	59	6	hiv	hiv	PROPN
fnp-5343	59	7	specific	specific	ADJ
fnp-5343	59	8	antibodies	antibody	NOUN
fnp-5343	59	9	can	can	AUX
fnp-5343	59	10	be	be	AUX
fnp-5343	59	11	detected	detect	VERB
fnp-5343	59	12	and	and	CCONJ
fnp-5343	59	13	hiv	hiv	PROPN
fnp-5343	59	14	isolated	isolate	VERB
fnp-5343	59	15	from	from	ADP
fnp-5343	59	16	the	the	DET
fnp-5343	59	17	csf	csf	NOUN
fnp-5343	59	18	[	[	X
fnp-5343	59	19	19,61	19,61	NUM
fnp-5343	59	20	]	]	X
fnp-5343	59	21	.	.	PUNCT
fnp-5343	60	1	hiv-1	hiv-1	PUNCT
fnp-5343	60	2	has	have	AUX
fnp-5343	60	3	also	also	ADV
fnp-5343	60	4	been	be	AUX
fnp-5343	60	5	isolated	isolate	VERB
fnp-5343	60	6	from	from	ADP
fnp-5343	60	7	the	the	DET
fnp-5343	60	8	brain	brain	NOUN
fnp-5343	60	9	15	15	NUM
fnp-5343	60	10	days	day	NOUN
fnp-5343	60	11	after	after	SCONJ
fnp-5343	60	12	a	a	DET
fnp-5343	60	13	patient	patient	NOUN
fnp-5343	60	14	accidentally	accidentally	ADV
fnp-5343	60	15	inoculated	inoculate	VERB
fnp-5343	60	16	himself	himself	PRON
fnp-5343	60	17	with	with	ADP
fnp-5343	60	18	hiv-1	hiv-1	PUNCT
fnp-5343	60	19	infected	infect	VERB
fnp-5343	60	20	white	white	ADJ
fnp-5343	60	21	blood	blood	NOUN
fnp-5343	60	22	cells	cell	NOUN
fnp-5343	60	23	[	[	X
fnp-5343	60	24	62	62	NUM
fnp-5343	60	25	]	]	PUNCT
fnp-5343	60	26	.	.	PUNCT
fnp-5343	61	1	hiv	hiv	PROPN
fnp-5343	61	2	is	be	AUX
fnp-5343	61	3	thought	think	VERB
fnp-5343	61	4	to	to	PART
fnp-5343	61	5	enter	enter	VERB
fnp-5343	61	6	the	the	DET
fnp-5343	61	7	cns	cns	NOUN
fnp-5343	61	8	predominantly	predominantly	ADV
fnp-5343	61	9	through	through	ADP
fnp-5343	61	10	a	a	DET
fnp-5343	61	11	trojan	trojan	NOUN
fnp-5343	61	12	horse	horse	NOUN
fnp-5343	61	13	-	-	PUNCT
fnp-5343	61	14	like	like	ADJ
fnp-5343	61	15	mechanism	mechanism	NOUN
fnp-5343	61	16	in	in	ADP
fnp-5343	61	17	which	which	PRON
fnp-5343	61	18	hiv-1	hiv-1	PRON
fnp-5343	61	19	infected	infected	ADJ
fnp-5343	61	20	monocytes	monocyte	NOUN
fnp-5343	61	21	cross	cross	VERB
fnp-5343	61	22	the	the	DET
fnp-5343	61	23	blood	blood	NOUN
fnp-5343	61	24	-	-	PUNCT
fnp-5343	61	25	brain	brain	NOUN
fnp-5343	61	26	barrier	barrier	NOUN
fnp-5343	61	27	(	(	PUNCT
fnp-5343	61	28	bbb	bbb	NOUN
fnp-5343	61	29	)	)	PUNCT
fnp-5343	61	30	and	and	CCONJ
fnp-5343	61	31	release	release	VERB
fnp-5343	61	32	viral	viral	ADJ
fnp-5343	61	33	particles	particle	NOUN
fnp-5343	61	34	in	in	ADP
fnp-5343	61	35	the	the	DET
fnp-5343	61	36	brain	brain	NOUN
fnp-5343	61	37	parenchyma	parenchyma	NOUN
fnp-5343	61	38	[	[	X
fnp-5343	61	39	16,19,63	16,19,63	X
fnp-5343	61	40	]	]	X
fnp-5343	61	41	although	although	SCONJ
fnp-5343	61	42	entry	entry	NOUN
fnp-5343	61	43	may	may	AUX
fnp-5343	61	44	also	also	ADV
fnp-5343	61	45	be	be	AUX
fnp-5343	61	46	facilitated	facilitate	VERB
fnp-5343	61	47	through	through	ADP
fnp-5343	61	48	a	a	DET
fnp-5343	61	49	disrupted	disrupt	VERB
fnp-5343	61	50	bbb	bbb	NOUN
fnp-5343	62	1	[	[	X
fnp-5343	62	2	64	64	NUM
fnp-5343	62	3	]	]	PUNCT
fnp-5343	62	4	.	.	PUNCT
fnp-5343	62	5	hiv-1	hiv-1	PUNCT
fnp-5343	62	6	has	have	AUX
fnp-5343	62	7	been	be	AUX
fnp-5343	62	8	shown	show	VERB
fnp-5343	62	9	to	to	PART
fnp-5343	62	10	productively	productively	ADV
fnp-5343	62	11	infect	infect	VERB
fnp-5343	62	12	brain	brain	NOUN
fnp-5343	62	13	microglia	microglia	NOUN
fnp-5343	62	14	/	/	SYM
fnp-5343	62	15	macrophages	macrophage	NOUN
fnp-5343	62	16	[	[	X
fnp-5343	62	17	65–69	65–69	NUM
fnp-5343	62	18	]	]	X
fnp-5343	62	19	.	.	PUNCT
fnp-5343	63	1	although	although	SCONJ
fnp-5343	63	2	hiv-1	hiv-1	PUNCT
fnp-5343	63	3	dna	dna	NOUN
fnp-5343	63	4	and	and	CCONJ
fnp-5343	63	5	proteins	protein	NOUN
fnp-5343	63	6	have	have	AUX
fnp-5343	63	7	been	be	AUX
fnp-5343	63	8	detected	detect	VERB
fnp-5343	63	9	in	in	ADP
fnp-5343	63	10	other	other	ADJ
fnp-5343	63	11	cns	cns	NOUN
fnp-5343	63	12	cell	cell	NOUN
fnp-5343	63	13	types	type	NOUN
fnp-5343	63	14	,	,	PUNCT
fnp-5343	63	15	such	such	ADJ
fnp-5343	63	16	as	as	ADP
fnp-5343	63	17	astrocytes	astrocyte	NOUN
fnp-5343	63	18	and	and	CCONJ
fnp-5343	63	19	endothelial	endothelial	ADJ
fnp-5343	63	20	cells	cell	NOUN
fnp-5343	63	21	in	in	ADP
fnp-5343	63	22	postmortem	postmortem	NOUN
fnp-5343	63	23	brain	brain	NOUN
fnp-5343	64	1	[	[	X
fnp-5343	64	2	17,18,70,71	17,18,70,71	NUM
fnp-5343	64	3	]	]	PUNCT
fnp-5343	64	4	and	and	CCONJ
fnp-5343	64	5	shown	show	VERB
fnp-5343	64	6	to	to	PART
fnp-5343	64	7	infect	infect	VERB
fnp-5343	64	8	other	other	ADJ
fnp-5343	64	9	cell	cell	NOUN
fnp-5343	64	10	types	type	NOUN
fnp-5343	64	11	in	in	ADP
fnp-5343	64	12	vitro	vitro	X
fnp-5343	64	13	,	,	PUNCT
fnp-5343	64	14	their	their	PRON
fnp-5343	64	15	role	role	NOUN
fnp-5343	64	16	in	in	ADP
fnp-5343	64	17	propagation	propagation	NOUN
fnp-5343	64	18	of	of	ADP
fnp-5343	64	19	cns	cns	NOUN
fnp-5343	64	20	infection	infection	NOUN
fnp-5343	64	21	is	be	AUX
fnp-5343	64	22	unclear	unclear	ADJ
fnp-5343	64	23	[	[	X
fnp-5343	64	24	12	12	NUM
fnp-5343	64	25	]	]	PUNCT
fnp-5343	64	26	.	.	PUNCT
fnp-5343	65	1	neuropathologic	neuropathologic	ADJ
fnp-5343	65	2	changes	change	NOUN
fnp-5343	65	3	can	can	AUX
fnp-5343	65	4	be	be	AUX
fnp-5343	65	5	seen	see	VERB
fnp-5343	65	6	early	early	ADV
fnp-5343	65	7	in	in	ADP
fnp-5343	65	8	hiv	hiv	PROPN
fnp-5343	65	9	infection	infection	NOUN
fnp-5343	65	10	[	[	X
fnp-5343	65	11	20,72	20,72	NUM
fnp-5343	65	12	]	]	PUNCT
fnp-5343	65	13	.	.	PUNCT
fnp-5343	66	1	in	in	ADP
fnp-5343	66	2	asymptomatic	asymptomatic	ADJ
fnp-5343	66	3	hiv	hiv	PROPN
fnp-5343	66	4	-	-	PUNCT
fnp-5343	66	5	positive	positive	ADJ
fnp-5343	66	6	patients	patient	NOUN
fnp-5343	66	7	who	who	PRON
fnp-5343	66	8	died	die	VERB
fnp-5343	66	9	from	from	ADP
fnp-5343	66	10	other	other	ADJ
fnp-5343	66	11	causes	cause	NOUN
fnp-5343	66	12	,	,	PUNCT
fnp-5343	66	13	lymphocytic	lymphocytic	ADJ
fnp-5343	66	14	leptomeningitis	leptomeningitis	NOUN
fnp-5343	66	15	,	,	PUNCT
fnp-5343	66	16	perivascular	perivascular	ADJ
fnp-5343	66	17	mononuclear	mononuclear	ADJ
fnp-5343	66	18	cell	cell	NOUN
fnp-5343	66	19	infiltrates	infiltrate	NOUN
fnp-5343	66	20	,	,	PUNCT
fnp-5343	66	21	microgliosis	microgliosis	NOUN
fnp-5343	66	22	and	and	CCONJ
fnp-5343	66	23	astrocytic	astrocytic	ADJ
fnp-5343	66	24	gliosis	gliosis	NOUN
fnp-5343	66	25	,	,	PUNCT
fnp-5343	66	26	which	which	PRON
fnp-5343	66	27	is	be	AUX
fnp-5343	66	28	more	more	ADV
fnp-5343	66	29	prominent	prominent	ADJ
fnp-5343	66	30	in	in	ADP
fnp-5343	66	31	white	white	ADJ
fnp-5343	66	32	matter	matter	NOUN
fnp-5343	66	33	compared	compare	VERB
fnp-5343	66	34	to	to	PART
fnp-5343	66	35	gray	gray	VERB
fnp-5343	66	36	matter	matter	NOUN
fnp-5343	66	37	,	,	PUNCT
fnp-5343	66	38	myelin	myelin	NOUN
fnp-5343	66	39	pallor	pallor	NOUN
fnp-5343	66	40	,	,	PUNCT
fnp-5343	66	41	and	and	CCONJ
fnp-5343	66	42	elevated	elevated	ADJ
fnp-5343	66	43	cytokines	cytokine	NOUN
fnp-5343	66	44	,	,	PUNCT
fnp-5343	66	45	have	have	AUX
fnp-5343	66	46	been	be	AUX
fnp-5343	66	47	seen	see	VERB
fnp-5343	66	48	along	along	ADP
fnp-5343	66	49	with	with	ADP
fnp-5343	66	50	hiv-1	hiv-1	PUNCT
fnp-5343	66	51	proviral	proviral	ADJ
fnp-5343	66	52	dna	dna	NOUN
fnp-5343	66	53	(	(	PUNCT
fnp-5343	66	54	but	but	CCONJ
fnp-5343	66	55	no	no	DET
fnp-5343	66	56	hiv-1	hiv-1	ADJ
fnp-5343	66	57	protein	protein	NOUN
fnp-5343	66	58	)	)	PUNCT
fnp-5343	66	59	in	in	ADP
fnp-5343	66	60	a	a	DET
fnp-5343	66	61	subset	subset	NOUN
fnp-5343	66	62	[	[	X
fnp-5343	66	63	20,72,73	20,72,73	NUM
fnp-5343	66	64	]	]	PUNCT
fnp-5343	66	65	.	.	PUNCT
fnp-5343	67	1	before	before	ADP
fnp-5343	67	2	the	the	DET
fnp-5343	67	3	advent	advent	NOUN
fnp-5343	67	4	of	of	ADP
fnp-5343	67	5	cart	cart	NOUN
fnp-5343	67	6	,	,	PUNCT
fnp-5343	67	7	most	most	ADJ
fnp-5343	67	8	hiv	hiv	NOUN
fnp-5343	67	9	-	-	PUNCT
fnp-5343	67	10	positive	positive	ADJ
fnp-5343	67	11	individuals	individual	NOUN
fnp-5343	67	12	progressed	progress	VERB
fnp-5343	67	13	to	to	ADP
fnp-5343	67	14	aids	aids	VERB
fnp-5343	67	15	[	[	X
fnp-5343	67	16	6	6	NUM
fnp-5343	67	17	]	]	PUNCT
fnp-5343	67	18	,	,	PUNCT
fnp-5343	67	19	and	and	CCONJ
fnp-5343	67	20	the	the	DET
fnp-5343	67	21	majority	majority	NOUN
fnp-5343	67	22	70	70	NUM
fnp-5343	67	23	-	-	SYM
fnp-5343	67	24	90	90	NUM
fnp-5343	67	25	%	%	NOUN
fnp-5343	67	26	demonstrated	demonstrate	VERB
fnp-5343	67	27	neuropathologic	neuropathologic	ADJ
fnp-5343	67	28	abnormalities	abnormality	NOUN
fnp-5343	67	29	at	at	ADP
fnp-5343	67	30	autopsy	autopsy	ADJ
fnp-5343	68	1	[	[	X
fnp-5343	68	2	27,55,56,68,74–77	27,55,56,68,74–77	NOUN
fnp-5343	68	3	]	]	PUNCT
fnp-5343	68	4	.	.	PUNCT
fnp-5343	69	1	in	in	ADP
fnp-5343	69	2	addition	addition	NOUN
fnp-5343	69	3	to	to	ADP
fnp-5343	69	4	frequent	frequent	ADJ
fnp-5343	69	5	opportunistic	opportunistic	ADJ
fnp-5343	69	6	infections	infection	NOUN
fnp-5343	69	7	and	and	CCONJ
fnp-5343	69	8	lymphomas	lymphoma	NOUN
fnp-5343	69	9	seen	see	VERB
fnp-5343	69	10	in	in	ADP
fnp-5343	69	11	the	the	DET
fnp-5343	69	12	context	context	NOUN
fnp-5343	69	13	of	of	ADP
fnp-5343	69	14	immunodeficiency	immunodeficiency	NOUN
fnp-5343	69	15	,	,	PUNCT
fnp-5343	69	16	there	there	PRON
fnp-5343	69	17	are	be	VERB
fnp-5343	69	18	characteristic	characteristic	ADJ
fnp-5343	69	19	neuropathologic	neuropathologic	ADJ
fnp-5343	69	20	findings	finding	NOUN
fnp-5343	69	21	attributed	attribute	VERB
fnp-5343	69	22	to	to	ADP
fnp-5343	69	23	hiv	hiv	PROPN
fnp-5343	69	24	infection	infection	NOUN
fnp-5343	69	25	itself	itself	PRON
fnp-5343	69	26	[	[	X
fnp-5343	69	27	19,27,68,74	19,27,68,74	NUM
fnp-5343	69	28	]	]	PUNCT
fnp-5343	69	29	.	.	PUNCT
fnp-5343	70	1	these	these	PRON
fnp-5343	70	2	were	be	AUX
fnp-5343	70	3	summarized	summarize	VERB
fnp-5343	70	4	in	in	ADP
fnp-5343	70	5	consensus	consensus	NOUN
fnp-5343	70	6	guidelines	guideline	NOUN
fnp-5343	70	7	in	in	ADP
fnp-5343	70	8	1991	1991	NUM
fnp-5343	70	9	[	[	X
fnp-5343	70	10	28	28	NUM
fnp-5343	70	11	]	]	PUNCT
fnp-5343	70	12	and	and	CCONJ
fnp-5343	70	13	include	include	VERB
fnp-5343	70	14	hiv	hiv	PROPN
fnp-5343	70	15	encephalitis	encephalitis	NOUN
fnp-5343	70	16	(	(	PUNCT
fnp-5343	70	17	hive	hive	NOUN
fnp-5343	70	18	)	)	PUNCT
fnp-5343	70	19	,	,	PUNCT
fnp-5343	70	20	hiv	hiv	PROPN
fnp-5343	70	21	leukoencephalopathy	leukoencephalopathy	NOUN
fnp-5343	70	22	,	,	PUNCT
fnp-5343	70	23	lymphocytic	lymphocytic	ADJ
fnp-5343	70	24	(	(	PUNCT
fnp-5343	70	25	aseptic	aseptic	ADJ
fnp-5343	70	26	)	)	PUNCT
fnp-5343	70	27	leptomeningitis	leptomeningitis	NOUN
fnp-5343	70	28	,	,	PUNCT
fnp-5343	70	29	and	and	CCONJ
fnp-5343	70	30	diffuse	diffuse	PROPN
fnp-5343	70	31	microgliosis	microgliosis	NOUN
fnp-5343	70	32	and	and	CCONJ
fnp-5343	70	33	astrogliosis	astrogliosis	NOUN
fnp-5343	70	34	in	in	ADP
fnp-5343	70	35	cerebral	cerebral	ADJ
fnp-5343	70	36	gray	gray	ADJ
fnp-5343	70	37	matter	matter	NOUN
fnp-5343	70	38	(	(	PUNCT
fnp-5343	70	39	"	"	PUNCT
fnp-5343	70	40	diffuse	diffuse	VERB
fnp-5343	70	41	poliodystrophy	poliodystrophy	NOUN
fnp-5343	70	42	"	"	PUNCT
fnp-5343	70	43	)	)	PUNCT
fnp-5343	71	1	[	[	X
fnp-5343	71	2	7,56,78	7,56,78	NUM
fnp-5343	71	3	]	]	PUNCT
fnp-5343	71	4	.	.	PUNCT
fnp-5343	72	1	hiv	hiv	PROPN
fnp-5343	72	2	encephalitis	encephalitis	NOUN
fnp-5343	72	3	,	,	PUNCT
fnp-5343	72	4	seen	see	VERB
fnp-5343	72	5	in	in	ADP
fnp-5343	72	6	10	10	NUM
fnp-5343	72	7	-	-	SYM
fnp-5343	72	8	63	63	NUM
fnp-5343	72	9	%	%	NOUN
fnp-5343	72	10	of	of	ADP
fnp-5343	72	11	autopsies	autopsy	NOUN
fnp-5343	72	12	,	,	PUNCT
fnp-5343	72	13	is	be	AUX
fnp-5343	72	14	characterized	characterize	VERB
fnp-5343	72	15	by	by	ADP
fnp-5343	72	16	microglial	microglial	ADJ
fnp-5343	72	17	nodules	nodule	NOUN
fnp-5343	72	18	and	and	CCONJ
fnp-5343	72	19	multinucleated	multinucleate	VERB
fnp-5343	72	20	giant	giant	ADJ
fnp-5343	72	21	cells	cell	NOUN
fnp-5343	72	22	(	(	PUNCT
fnp-5343	72	23	figure	figure	NOUN
fnp-5343	72	24	1	1	NUM
fnp-5343	72	25	)	)	PUNCT
fnp-5343	72	26	and/or	and/or	CCONJ
fnp-5343	72	27	evidence	evidence	NOUN
fnp-5343	72	28	of	of	ADP
fnp-5343	72	29	hiv	hiv	PROPN
fnp-5343	72	30	in	in	ADP
fnp-5343	72	31	the	the	DET
fnp-5343	72	32	brain	brain	NOUN
fnp-5343	73	1	[	[	X
fnp-5343	73	2	57,79,80	57,79,80	NOUN
fnp-5343	73	3	]	]	PUNCT
fnp-5343	73	4	typically	typically	ADV
fnp-5343	73	5	affecting	affect	VERB
fnp-5343	73	6	the	the	DET
fnp-5343	73	7	white	white	ADJ
fnp-5343	73	8	matter	matter	NOUN
fnp-5343	73	9	most	most	ADV
fnp-5343	73	10	severely	severely	ADV
fnp-5343	73	11	,	,	PUNCT
fnp-5343	73	12	followed	follow	VERB
fnp-5343	73	13	by	by	ADP
fnp-5343	73	14	the	the	DET
fnp-5343	73	15	deep	deep	ADJ
fnp-5343	73	16	gray	gray	ADJ
fnp-5343	73	17	matter	matter	NOUN
fnp-5343	73	18	and	and	CCONJ
fnp-5343	73	19	then	then	ADV
fnp-5343	73	20	cortex	cortex	VERB
fnp-5343	73	21	[	[	X
fnp-5343	73	22	27,28,65,80	27,28,65,80	NUM
fnp-5343	73	23	]	]	PUNCT
fnp-5343	73	24	.	.	PUNCT
fnp-5343	74	1	multinucleated	multinucleate	VERB
fnp-5343	74	2	giant	giant	ADJ
fnp-5343	74	3	cells	cell	NOUN
fnp-5343	74	4	,	,	PUNCT
fnp-5343	74	5	often	often	ADV
fnp-5343	74	6	seen	see	VERB
fnp-5343	74	7	in	in	ADP
fnp-5343	74	8	a	a	DET
fnp-5343	74	9	perivascular	perivascular	ADJ
fnp-5343	74	10	distribution	distribution	NOUN
fnp-5343	74	11	and	and	CCONJ
fnp-5343	74	12	more	more	ADV
fnp-5343	74	13	commonly	commonly	ADV
fnp-5343	74	14	in	in	ADP
fnp-5343	74	15	the	the	DET
fnp-5343	74	16	subcortical	subcortical	ADJ
fnp-5343	74	17	white	white	ADJ
fnp-5343	74	18	matter	matter	NOUN
fnp-5343	74	19	or	or	CCONJ
fnp-5343	74	20	deep	deep	ADJ
fnp-5343	74	21	gray	gray	ADJ
fnp-5343	74	22	matter	matter	NOUN
fnp-5343	74	23	,	,	PUNCT
fnp-5343	74	24	are	be	AUX
fnp-5343	74	25	the	the	DET
fnp-5343	74	26	hallmark	hallmark	ADJ
fnp-5343	74	27	finding	finding	NOUN
fnp-5343	74	28	in	in	ADP
fnp-5343	74	29	hive	hive	NOUN
fnp-5343	74	30	and	and	CCONJ
fnp-5343	74	31	result	result	VERB
fnp-5343	74	32	from	from	ADP
fnp-5343	74	33	virus	virus	NOUN
fnp-5343	74	34	-	-	PUNCT
fnp-5343	74	35	induced	induce	VERB
fnp-5343	74	36	fusion	fusion	NOUN
fnp-5343	74	37	of	of	ADP
fnp-5343	74	38	macrophages	macrophage	NOUN
fnp-5343	74	39	which	which	PRON
fnp-5343	74	40	have	have	AUX
fnp-5343	74	41	been	be	AUX
fnp-5343	74	42	shown	show	VERB
fnp-5343	74	43	to	to	PART
fnp-5343	74	44	contain	contain	VERB
fnp-5343	74	45	hiv	hiv	NOUN
fnp-5343	74	46	protein	protein	NOUN
fnp-5343	75	1	[	[	X
fnp-5343	75	2	65,81–83	65,81–83	NOUN
fnp-5343	75	3	]	]	PUNCT
fnp-5343	75	4	.	.	PUNCT
fnp-5343	76	1	figure	figure	NOUN
fnp-5343	76	2	1	1	NUM
fnp-5343	76	3	.	.	PUNCT
fnp-5343	76	4	neuropathologic	neuropathologic	PROPN
fnp-5343	76	5	findings	finding	NOUN
fnp-5343	76	6	in	in	ADP
fnp-5343	76	7	covid-19	covid-19	PROPN
fnp-5343	76	8	and	and	CCONJ
fnp-5343	76	9	hiv	hiv	PROPN
fnp-5343	76	10	infection	infection	NOUN
fnp-5343	76	11	.	.	PUNCT
fnp-5343	77	1	a	a	DET
fnp-5343	77	2	)	)	PUNCT
fnp-5343	77	3	acute	acute	ADJ
fnp-5343	77	4	/	/	SYM
fnp-5343	77	5	subacute	subacute	NOUN
fnp-5343	77	6	microinfarct	microinfarct	NOUN
fnp-5343	77	7	(	(	PUNCT
fnp-5343	77	8	arrows	arrow	NOUN
fnp-5343	77	9	)	)	PUNCT
fnp-5343	77	10	in	in	ADP
fnp-5343	77	11	the	the	DET
fnp-5343	77	12	internal	internal	ADJ
fnp-5343	77	13	capsule	capsule	NOUN
fnp-5343	77	14	and	and	CCONJ
fnp-5343	77	15	b	b	X
fnp-5343	77	16	)	)	PUNCT
fnp-5343	77	17	sparse	sparse	ADJ
fnp-5343	77	18	leptomeningeal	leptomeningeal	NOUN
fnp-5343	77	19	(	(	PUNCT
fnp-5343	77	20	arrow	arrow	NOUN
fnp-5343	77	21	)	)	PUNCT
fnp-5343	77	22	and	and	CCONJ
fnp-5343	77	23	parenchymal	parenchymal	ADJ
fnp-5343	77	24	(	(	PUNCT
fnp-5343	77	25	arrowhead	arrowhead	NOUN
fnp-5343	77	26	)	)	PUNCT
fnp-5343	77	27	t	t	PROPN
fnp-5343	77	28	lymphocytes	lymphocyte	NOUN
fnp-5343	77	29	highlighted	highlight	VERB
fnp-5343	77	30	by	by	ADP
fnp-5343	77	31	cd3	cd3	PROPN
fnp-5343	77	32	immunohistochemistry	immunohistochemistry	PROPN
fnp-5343	77	33	in	in	ADP
fnp-5343	77	34	patients	patient	NOUN
fnp-5343	77	35	with	with	ADP
fnp-5343	77	36	covid-19	covid-19	PROPN
fnp-5343	77	37	.	.	PUNCT
fnp-5343	78	1	c	c	X
fnp-5343	78	2	)	)	PUNCT
fnp-5343	78	3	hiv	hiv	PROPN
fnp-5343	78	4	encephalitis	encephalitis	ADV
fnp-5343	78	5	with	with	ADP
fnp-5343	78	6	multinucleated	multinucleate	VERB
fnp-5343	78	7	giant	giant	ADJ
fnp-5343	78	8	cells	cell	NOUN
fnp-5343	78	9	(	(	PUNCT
fnp-5343	78	10	arrows	arrow	NOUN
fnp-5343	78	11	)	)	PUNCT
fnp-5343	78	12	and	and	CCONJ
fnp-5343	78	13	d	d	X
fnp-5343	78	14	)	)	PUNCT
fnp-5343	78	15	microglial	microglial	ADJ
fnp-5343	78	16	activation	activation	NOUN
fnp-5343	78	17	(	(	PUNCT
fnp-5343	78	18	arrowheads	arrowhead	NOUN
fnp-5343	78	19	)	)	PUNCT
fnp-5343	78	20	highlighted	highlight	VERB
fnp-5343	78	21	by	by	ADP
fnp-5343	78	22	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	78	23	for	for	ADP
fnp-5343	78	24	iba-1	iba-1	VERB
fnp-5343	78	25	in	in	ADP
fnp-5343	78	26	patients	patient	NOUN
fnp-5343	78	27	with	with	ADP
fnp-5343	78	28	hiv	hiv	PROPN
fnp-5343	78	29	infection	infection	NOUN
fnp-5343	78	30	.	.	PUNCT
fnp-5343	79	1	scale	scale	NOUN
fnp-5343	79	2	bars	bar	NOUN
fnp-5343	79	3	:	:	PUNCT
fnp-5343	79	4	a	a	DET
fnp-5343	79	5	=	=	SYM
fnp-5343	79	6	50	50	NUM
fnp-5343	79	7	μm	μm	NOUN
fnp-5343	79	8	,	,	PUNCT
fnp-5343	79	9	b	b	NOUN
fnp-5343	79	10	,	,	PUNCT
fnp-5343	79	11	d	d	NOUN
fnp-5343	79	12	=	=	SYM
fnp-5343	79	13	100	100	NUM
fnp-5343	79	14	μm	μm	NUM
fnp-5343	79	15	,	,	PUNCT
fnp-5343	79	16	c	c	NOUN
fnp-5343	79	17	=	=	SYM
fnp-5343	79	18	20	20	NUM
fnp-5343	79	19	μm	μm	NOUN
fnp-5343	79	20	in	in	ADP
fnp-5343	79	21	the	the	DET
fnp-5343	79	22	post	post	NOUN
fnp-5343	79	23	cart	cart	NOUN
fnp-5343	79	24	era	era	NOUN
fnp-5343	79	25	,	,	PUNCT
fnp-5343	79	26	the	the	DET
fnp-5343	79	27	majority	majority	NOUN
fnp-5343	79	28	of	of	ADP
fnp-5343	79	29	hiv	hiv	PROPN
fnp-5343	79	30	positive	positive	ADJ
fnp-5343	79	31	individuals	individual	NOUN
fnp-5343	79	32	show	show	VERB
fnp-5343	79	33	no	no	DET
fnp-5343	79	34	hiv	hiv	NOUN
fnp-5343	79	35	related	relate	VERB
fnp-5343	79	36	neuropathology	neuropathology	NOUN
fnp-5343	79	37	at	at	ADP
fnp-5343	79	38	autopsy	autopsy	ADJ
fnp-5343	79	39	,	,	PUNCT
fnp-5343	79	40	although	although	SCONJ
fnp-5343	79	41	hive	hive	NOUN
fnp-5343	79	42	has	have	AUX
fnp-5343	79	43	been	be	AUX
fnp-5343	79	44	reported	report	VERB
fnp-5343	79	45	in	in	ADP
fnp-5343	79	46	8	8	NUM
fnp-5343	79	47	-	-	SYM
fnp-5343	79	48	25	25	NUM
fnp-5343	79	49	%	%	NOUN
fnp-5343	79	50	of	of	ADP
fnp-5343	79	51	case	case	NOUN
fnp-5343	79	52	series	series	NOUN
fnp-5343	79	53	with	with	ADP
fnp-5343	79	54	equal	equal	ADJ
fnp-5343	79	55	or	or	CCONJ
fnp-5343	79	56	even	even	ADV
fnp-5343	79	57	increased	increase	VERB
fnp-5343	79	58	frequency	frequency	NOUN
fnp-5343	79	59	post	post	NOUN
fnp-5343	79	60	cart	cart	NOUN
fnp-5343	79	61	in	in	ADP
fnp-5343	79	62	some	some	DET
fnp-5343	79	63	series	series	NOUN
fnp-5343	79	64	[	[	X
fnp-5343	79	65	84–87	84–87	NUM
fnp-5343	79	66	]	]	PUNCT
fnp-5343	79	67	.	.	PUNCT
fnp-5343	80	1	opportunistic	opportunistic	ADJ
fnp-5343	80	2	infections	infection	NOUN
fnp-5343	80	3	,	,	PUNCT
fnp-5343	80	4	albeit	albeit	SCONJ
fnp-5343	80	5	decreased	decrease	VERB
fnp-5343	80	6	in	in	ADP
fnp-5343	80	7	frequency	frequency	NOUN
fnp-5343	80	8	after	after	ADP
fnp-5343	80	9	cart	cart	NOUN
fnp-5343	80	10	,	,	PUNCT
fnp-5343	80	11	are	be	AUX
fnp-5343	80	12	still	still	ADV
fnp-5343	80	13	seen	see	VERB
fnp-5343	80	14	[	[	X
fnp-5343	80	15	84–92	84–92	NUM
fnp-5343	80	16	]	]	PUNCT
fnp-5343	80	17	.	.	PUNCT
fnp-5343	81	1	hive	hive	PROPN
fnp-5343	81	2	indicates	indicate	VERB
fnp-5343	81	3	active	active	ADJ
fnp-5343	81	4	viral	viral	ADJ
fnp-5343	81	5	replication	replication	NOUN
fnp-5343	81	6	and	and	CCONJ
fnp-5343	81	7	is	be	AUX
fnp-5343	81	8	an	an	DET
fnp-5343	81	9	important	important	ADJ
fnp-5343	81	10	pathologic	pathologic	ADJ
fnp-5343	81	11	substrate	substrate	NOUN
fnp-5343	81	12	of	of	ADP
fnp-5343	81	13	had	have	AUX
fnp-5343	81	14	[	[	X
fnp-5343	81	15	93	93	NUM
fnp-5343	81	16	]	]	PUNCT
fnp-5343	81	17	,	,	PUNCT
fnp-5343	81	18	but	but	CCONJ
fnp-5343	81	19	not	not	PART
fnp-5343	81	20	all	all	DET
fnp-5343	81	21	subjects	subject	NOUN
fnp-5343	81	22	with	with	ADP
fnp-5343	81	23	cognitive	cognitive	ADJ
fnp-5343	81	24	impairment	impairment	NOUN
fnp-5343	81	25	have	have	VERB
fnp-5343	81	26	hive	hive	NOUN
fnp-5343	81	27	and	and	CCONJ
fnp-5343	81	28	not	not	PART
fnp-5343	81	29	all	all	DET
fnp-5343	81	30	patients	patient	NOUN
fnp-5343	81	31	with	with	ADP
fnp-5343	81	32	hive	hive	NOUN
fnp-5343	81	33	have	have	VERB
fnp-5343	81	34	cognitive	cognitive	ADJ
fnp-5343	81	35	impairment	impairment	NOUN
fnp-5343	81	36	,	,	PUNCT
fnp-5343	81	37	which	which	PRON
fnp-5343	81	38	was	be	AUX
fnp-5343	81	39	seen	see	VERB
fnp-5343	81	40	before	before	ADV
fnp-5343	81	41	but	but	CCONJ
fnp-5343	81	42	especially	especially	ADV
fnp-5343	81	43	after	after	ADP
fnp-5343	81	44	the	the	DET
fnp-5343	81	45	advent	advent	NOUN
fnp-5343	81	46	of	of	ADP
fnp-5343	81	47	cart	cart	NOUN
fnp-5343	81	48	[	[	X
fnp-5343	81	49	56,68,81,84,88,94	56,68,81,84,88,94	NUM
fnp-5343	81	50	]	]	PUNCT
fnp-5343	81	51	.	.	PUNCT
fnp-5343	82	1	in	in	ADP
fnp-5343	82	2	the	the	DET
fnp-5343	82	3	post	post	NOUN
fnp-5343	82	4	cart	cart	NOUN
fnp-5343	82	5	era	era	NOUN
fnp-5343	82	6	,	,	PUNCT
fnp-5343	82	7	hiv	hiv	PROPN
fnp-5343	82	8	associated	associate	VERB
fnp-5343	82	9	neuropathologic	neuropathologic	ADJ
fnp-5343	82	10	findings	finding	NOUN
fnp-5343	82	11	have	have	AUX
fnp-5343	82	12	not	not	PART
fnp-5343	82	13	correlated	correlate	VERB
fnp-5343	82	14	with	with	ADP
fnp-5343	82	15	cognitive	cognitive	ADJ
fnp-5343	82	16	impairment	impairment	NOUN
fnp-5343	83	1	[	[	X
fnp-5343	83	2	84	84	NUM
fnp-5343	83	3	]	]	PUNCT
fnp-5343	83	4	.	.	PUNCT
fnp-5343	84	1	aids	aids	PROPN
fnp-5343	84	2	patients	patient	NOUN
fnp-5343	84	3	demonstrate	demonstrate	VERB
fnp-5343	84	4	cortical	cortical	ADJ
fnp-5343	84	5	atrophy	atrophy	NOUN
fnp-5343	84	6	and	and	CCONJ
fnp-5343	84	7	neuronal	neuronal	ADJ
fnp-5343	84	8	apoptosis	apoptosis	NOUN
fnp-5343	84	9	[	[	X
fnp-5343	84	10	95,96	95,96	NOUN
fnp-5343	84	11	]	]	X
fnp-5343	84	12	,	,	PUNCT
fnp-5343	84	13	but	but	CCONJ
fnp-5343	84	14	neither	neither	CCONJ
fnp-5343	84	15	neuronal	neuronal	ADJ
fnp-5343	84	16	apoptosis	apoptosis	NOUN
fnp-5343	84	17	[	[	X
fnp-5343	84	18	97	97	NUM
fnp-5343	84	19	]	]	PUNCT
fnp-5343	84	20	nor	nor	CCONJ
fnp-5343	84	21	neuronal	neuronal	ADJ
fnp-5343	84	22	loss	loss	NOUN
fnp-5343	84	23	in	in	ADP
fnp-5343	84	24	the	the	DET
fnp-5343	84	25	frontal	frontal	ADJ
fnp-5343	84	26	and	and	CCONJ
fnp-5343	84	27	temporal	temporal	ADJ
fnp-5343	84	28	cortices	cortex	NOUN
fnp-5343	84	29	of	of	ADP
fnp-5343	84	30	patients	patient	NOUN
fnp-5343	84	31	with	with	ADP
fnp-5343	84	32	aids	aids	PROPN
fnp-5343	84	33	[	[	X
fnp-5343	84	34	98	98	NUM
fnp-5343	84	35	]	]	PUNCT
fnp-5343	84	36	correlate	correlate	VERB
fnp-5343	84	37	with	with	ADP
fnp-5343	84	38	dementia	dementia	NOUN
fnp-5343	84	39	.	.	PUNCT
fnp-5343	85	1	on	on	ADP
fnp-5343	85	2	the	the	DET
fnp-5343	85	3	other	other	ADJ
fnp-5343	85	4	hand	hand	NOUN
fnp-5343	85	5	,	,	PUNCT
fnp-5343	85	6	decreased	decrease	VERB
fnp-5343	85	7	cortical	cortical	ADJ
fnp-5343	85	8	synaptic	synaptic	ADJ
fnp-5343	85	9	density	density	NOUN
fnp-5343	85	10	and	and	CCONJ
fnp-5343	85	11	dendritic	dendritic	ADJ
fnp-5343	85	12	complexity	complexity	NOUN
fnp-5343	85	13	were	be	AUX
fnp-5343	85	14	demonstrated	demonstrate	VERB
fnp-5343	85	15	even	even	ADV
fnp-5343	85	16	with	with	ADP
fnp-5343	85	17	mild	mild	ADJ
fnp-5343	85	18	cognitive	cognitive	ADJ
fnp-5343	85	19	impairment	impairment	NOUN
fnp-5343	85	20	and	and	CCONJ
fnp-5343	85	21	have	have	AUX
fnp-5343	85	22	been	be	AUX
fnp-5343	85	23	shown	show	VERB
fnp-5343	85	24	to	to	PART
fnp-5343	85	25	correlate	correlate	VERB
fnp-5343	85	26	with	with	ADP
fnp-5343	85	27	severity	severity	NOUN
fnp-5343	85	28	of	of	ADP
fnp-5343	85	29	cognitive	cognitive	ADJ
fnp-5343	85	30	impairment	impairment	NOUN
fnp-5343	86	1	[	[	X
fnp-5343	86	2	99–101	99–101	PROPN
fnp-5343	86	3	]	]	PUNCT
fnp-5343	86	4	.	.	PUNCT
fnp-5343	87	1	disruption	disruption	NOUN
fnp-5343	87	2	of	of	ADP
fnp-5343	87	3	the	the	DET
fnp-5343	87	4	bbb	bbb	PROPN
fnp-5343	87	5	has	have	AUX
fnp-5343	87	6	been	be	AUX
fnp-5343	87	7	seen	see	VERB
fnp-5343	87	8	in	in	ADP
fnp-5343	87	9	patients	patient	NOUN
fnp-5343	87	10	both	both	CCONJ
fnp-5343	87	11	with	with	ADP
fnp-5343	87	12	aids	aid	NOUN
fnp-5343	87	13	with	with	ADP
fnp-5343	87	14	and	and	CCONJ
fnp-5343	87	15	without	without	ADP
fnp-5343	87	16	dementia	dementia	NOUN
fnp-5343	87	17	as	as	ADV
fnp-5343	87	18	well	well	ADV
fnp-5343	87	19	as	as	ADP
fnp-5343	87	20	with	with	ADP
fnp-5343	87	21	and	and	CCONJ
fnp-5343	87	22	without	without	ADP
fnp-5343	87	23	hive	hive	NOUN
fnp-5343	87	24	[	[	PUNCT
fnp-5343	87	25	64,102	64,102	NUM
fnp-5343	87	26	]	]	PUNCT
fnp-5343	87	27	.	.	PUNCT
fnp-5343	88	1	several	several	ADJ
fnp-5343	88	2	gene	gene	NOUN
fnp-5343	88	3	expression	expression	NOUN
fnp-5343	88	4	profiling	profiling	NOUN
fnp-5343	88	5	studies	study	NOUN
fnp-5343	88	6	performed	perform	VERB
fnp-5343	88	7	on	on	ADP
fnp-5343	88	8	the	the	DET
fnp-5343	88	9	brains	brain	NOUN
fnp-5343	88	10	of	of	ADP
fnp-5343	88	11	hiv	hiv	PROPN
fnp-5343	88	12	positive	positive	ADJ
fnp-5343	88	13	individuals	individual	NOUN
fnp-5343	88	14	have	have	AUX
fnp-5343	88	15	found	find	VERB
fnp-5343	88	16	upregulation	upregulation	NOUN
fnp-5343	88	17	of	of	ADP
fnp-5343	88	18	endothelial	endothelial	ADJ
fnp-5343	88	19	cell	cell	NOUN
fnp-5343	88	20	type	type	NOUN
fnp-5343	88	21	transcripts	transcript	NOUN
fnp-5343	88	22	[	[	X
fnp-5343	88	23	103	103	NUM
fnp-5343	88	24	]	]	PUNCT
fnp-5343	88	25	and	and	CCONJ
fnp-5343	88	26	dysregulation	dysregulation	NOUN
fnp-5343	88	27	of	of	ADP
fnp-5343	88	28	microglial	microglial	ADJ
fnp-5343	88	29	transcripts	transcript	NOUN
fnp-5343	88	30	[	[	X
fnp-5343	88	31	104	104	X
fnp-5343	88	32	]	]	PUNCT
fnp-5343	88	33	in	in	ADP
fnp-5343	88	34	patients	patient	NOUN
fnp-5343	88	35	with	with	ADP
fnp-5343	88	36	hand	hand	NOUN
fnp-5343	88	37	but	but	CCONJ
fnp-5343	88	38	without	without	ADP
fnp-5343	88	39	hive	hive	NOUN
fnp-5343	88	40	and	and	CCONJ
fnp-5343	88	41	increased	increase	VERB
fnp-5343	88	42	expression	expression	NOUN
fnp-5343	88	43	of	of	ADP
fnp-5343	88	44	a	a	DET
fnp-5343	88	45	subset	subset	NOUN
fnp-5343	88	46	of	of	ADP
fnp-5343	88	47	cytokines	cytokine	NOUN
fnp-5343	88	48	in	in	ADP
fnp-5343	88	49	white	white	ADJ
fnp-5343	88	50	matter	matter	NOUN
fnp-5343	89	1	[	[	X
fnp-5343	89	2	103–107	103–107	NUM
fnp-5343	89	3	]	]	PUNCT
fnp-5343	89	4	.	.	PUNCT
fnp-5343	90	1	although	although	SCONJ
fnp-5343	90	2	hiv	hiv	PROPN
fnp-5343	90	3	antigen	antigen	NOUN
fnp-5343	90	4	can	can	AUX
fnp-5343	90	5	be	be	AUX
fnp-5343	90	6	detected	detect	VERB
fnp-5343	90	7	throughout	throughout	ADP
fnp-5343	90	8	the	the	DET
fnp-5343	90	9	cns	cns	NOUN
fnp-5343	90	10	including	include	VERB
fnp-5343	90	11	the	the	DET
fnp-5343	90	12	cerebral	cerebral	ADJ
fnp-5343	90	13	hemispheres	hemisphere	NOUN
fnp-5343	90	14	,	,	PUNCT
fnp-5343	90	15	cerebellum	cerebellum	NOUN
fnp-5343	90	16	,	,	PUNCT
fnp-5343	90	17	brainstem	brainstem	NOUN
fnp-5343	90	18	,	,	PUNCT
fnp-5343	90	19	and	and	CCONJ
fnp-5343	90	20	spinal	spinal	ADJ
fnp-5343	90	21	cord	cord	NOUN
fnp-5343	90	22	using	use	VERB
fnp-5343	90	23	various	various	ADJ
fnp-5343	90	24	methods	method	NOUN
fnp-5343	90	25	such	such	ADJ
fnp-5343	90	26	as	as	ADP
fnp-5343	90	27	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	90	28	,	,	PUNCT
fnp-5343	90	29	in	in	ADP
fnp-5343	90	30	situ	situ	ADJ
fnp-5343	90	31	hybridization	hybridization	NOUN
fnp-5343	90	32	(	(	PUNCT
fnp-5343	90	33	ish	ish	PROPN
fnp-5343	90	34	)	)	PUNCT
fnp-5343	90	35	,	,	PUNCT
fnp-5343	90	36	pcr	pcr	NOUN
fnp-5343	90	37	,	,	PUNCT
fnp-5343	90	38	and	and	CCONJ
fnp-5343	90	39	electron	electron	NOUN
fnp-5343	90	40	microscopy	microscopy	NOUN
fnp-5343	90	41	,	,	PUNCT
fnp-5343	90	42	the	the	DET
fnp-5343	90	43	highest	high	ADJ
fnp-5343	90	44	levels	level	NOUN
fnp-5343	90	45	of	of	ADP
fnp-5343	90	46	hiv	hiv	PROPN
fnp-5343	90	47	proteins	protein	NOUN
fnp-5343	90	48	,	,	PUNCT
fnp-5343	90	49	rna	rna	NOUN
fnp-5343	90	50	and	and	CCONJ
fnp-5343	90	51	dna	dna	PROPN
fnp-5343	90	52	,	,	PUNCT
fnp-5343	90	53	primarily	primarily	ADV
fnp-5343	90	54	in	in	ADP
fnp-5343	90	55	macrophages	macrophage	NOUN
fnp-5343	90	56	,	,	PUNCT
fnp-5343	90	57	microglia	microglia	ADJ
fnp-5343	90	58	and	and	CCONJ
fnp-5343	90	59	multinucleated	multinucleate	VERB
fnp-5343	90	60	giant	giant	ADJ
fnp-5343	90	61	cells	cell	NOUN
fnp-5343	90	62	,	,	PUNCT
fnp-5343	90	63	have	have	AUX
fnp-5343	90	64	been	be	AUX
fnp-5343	90	65	seen	see	VERB
fnp-5343	90	66	in	in	ADP
fnp-5343	90	67	deep	deep	ADJ
fnp-5343	90	68	gray	gray	ADJ
fnp-5343	90	69	matter	matter	NOUN
fnp-5343	90	70	and	and	CCONJ
fnp-5343	90	71	hippocampus	hippocampus	NOUN
fnp-5343	90	72	[	[	X
fnp-5343	90	73	67,81,108,109	67,81,108,109	NUM
fnp-5343	90	74	]	]	PUNCT
fnp-5343	90	75	.	.	PUNCT
fnp-5343	91	1	even	even	ADV
fnp-5343	91	2	with	with	ADP
fnp-5343	91	3	viral	viral	ADJ
fnp-5343	91	4	suppression	suppression	NOUN
fnp-5343	91	5	on	on	ADP
fnp-5343	91	6	cart	cart	NOUN
fnp-5343	91	7	,	,	PUNCT
fnp-5343	91	8	low	low	ADJ
fnp-5343	91	9	levels	level	NOUN
fnp-5343	91	10	of	of	ADP
fnp-5343	91	11	hiv-1	hiv-1	X
fnp-5343	91	12	rna	rna	NOUN
fnp-5343	91	13	and	and	CCONJ
fnp-5343	91	14	anti	anti	ADJ
fnp-5343	91	15	-	-	ADJ
fnp-5343	91	16	hiv	hiv	ADJ
fnp-5343	91	17	antibodies	antibody	NOUN
fnp-5343	91	18	can	can	AUX
fnp-5343	91	19	be	be	AUX
fnp-5343	91	20	detected	detect	VERB
fnp-5343	91	21	in	in	ADP
fnp-5343	91	22	the	the	DET
fnp-5343	91	23	csf	csf	NOUN
fnp-5343	91	24	[	[	X
fnp-5343	91	25	110,111	110,111	NUM
fnp-5343	91	26	]	]	PUNCT
fnp-5343	91	27	.	.	PUNCT
fnp-5343	92	1	hiv-1	hiv-1	X
fnp-5343	92	2	dna	dna	PROPN
fnp-5343	92	3	,	,	PUNCT
fnp-5343	92	4	including	include	VERB
fnp-5343	92	5	intact	intact	ADJ
fnp-5343	92	6	proviruses	provirus	NOUN
fnp-5343	92	7	,	,	PUNCT
fnp-5343	92	8	and	and	CCONJ
fnp-5343	92	9	rna	rna	NOUN
fnp-5343	92	10	have	have	AUX
fnp-5343	92	11	been	be	AUX
fnp-5343	92	12	found	find	VERB
fnp-5343	92	13	in	in	ADP
fnp-5343	92	14	the	the	DET
fnp-5343	92	15	brains	brain	NOUN
fnp-5343	92	16	of	of	ADP
fnp-5343	92	17	virally	virally	ADV
fnp-5343	92	18	suppressed	suppress	VERB
fnp-5343	92	19	hiv	hiv	PROPN
fnp-5343	92	20	-	-	PUNCT
fnp-5343	92	21	positive	positive	ADJ
fnp-5343	92	22	individuals	individual	NOUN
fnp-5343	92	23	in	in	ADP
fnp-5343	92	24	microglia	microglia	ADJ
fnp-5343	92	25	/	/	SYM
fnp-5343	92	26	macrophages	macrophage	NOUN
fnp-5343	92	27	[	[	X
fnp-5343	92	28	112–114	112–114	NUM
fnp-5343	92	29	]	]	PUNCT
fnp-5343	92	30	.	.	PUNCT
fnp-5343	93	1	these	these	DET
fnp-5343	93	2	reservoirs	reservoir	NOUN
fnp-5343	93	3	have	have	AUX
fnp-5343	93	4	been	be	AUX
fnp-5343	93	5	postulated	postulate	VERB
fnp-5343	93	6	to	to	PART
fnp-5343	93	7	cause	cause	VERB
fnp-5343	93	8	chronic	chronic	ADJ
fnp-5343	93	9	inflammation	inflammation	NOUN
fnp-5343	93	10	and	and	CCONJ
fnp-5343	93	11	neuronal	neuronal	ADJ
fnp-5343	93	12	dysfunction	dysfunction	NOUN
fnp-5343	93	13	[	[	X
fnp-5343	93	14	114,115	114,115	NUM
fnp-5343	93	15	]	]	PUNCT
fnp-5343	93	16	,	,	PUNCT
fnp-5343	93	17	and	and	CCONJ
fnp-5343	93	18	microglial	microglial	ADJ
fnp-5343	93	19	activation	activation	NOUN
fnp-5343	93	20	and	and	CCONJ
fnp-5343	93	21	increased	increase	VERB
fnp-5343	93	22	cytokine	cytokine	NOUN
fnp-5343	93	23	levels	level	NOUN
fnp-5343	93	24	in	in	ADP
fnp-5343	93	25	the	the	DET
fnp-5343	93	26	brain	brain	NOUN
fnp-5343	93	27	have	have	AUX
fnp-5343	93	28	been	be	AUX
fnp-5343	93	29	shown	show	VERB
fnp-5343	93	30	to	to	PART
fnp-5343	93	31	correlate	correlate	VERB
fnp-5343	93	32	with	with	ADP
fnp-5343	93	33	hand	hand	NOUN
fnp-5343	93	34	[	[	X
fnp-5343	93	35	94,116–119	94,116–119	NUM
fnp-5343	93	36	]	]	X
fnp-5343	93	37	.	.	PUNCT
fnp-5343	94	1	however	however	ADV
fnp-5343	94	2	,	,	PUNCT
fnp-5343	94	3	although	although	SCONJ
fnp-5343	94	4	levels	level	NOUN
fnp-5343	94	5	of	of	ADP
fnp-5343	94	6	hiv-1	hiv-1	X
fnp-5343	94	7	dna	dna	PROPN
fnp-5343	94	8	are	be	AUX
fnp-5343	94	9	on	on	ADP
fnp-5343	94	10	average	average	ADJ
fnp-5343	94	11	higher	higher	ADV
fnp-5343	94	12	in	in	ADP
fnp-5343	94	13	brains	brain	NOUN
fnp-5343	94	14	from	from	ADP
fnp-5343	94	15	patients	patient	NOUN
fnp-5343	94	16	with	with	ADP
fnp-5343	94	17	aids	aid	NOUN
fnp-5343	94	18	compared	compare	VERB
fnp-5343	94	19	to	to	ADP
fnp-5343	94	20	patients	patient	NOUN
fnp-5343	94	21	without	without	ADP
fnp-5343	94	22	aids	aid	NOUN
fnp-5343	94	23	,	,	PUNCT
fnp-5343	94	24	there	there	PRON
fnp-5343	94	25	is	be	VERB
fnp-5343	94	26	overlap	overlap	NOUN
fnp-5343	94	27	[	[	X
fnp-5343	94	28	18,117	18,117	NUM
fnp-5343	94	29	]	]	PUNCT
fnp-5343	94	30	.	.	PUNCT
fnp-5343	95	1	brain	brain	NOUN
fnp-5343	95	2	viral	viral	ADJ
fnp-5343	95	3	load	load	NOUN
fnp-5343	95	4	correlates	correlate	VERB
fnp-5343	95	5	poorly	poorly	ADV
fnp-5343	95	6	with	with	ADP
fnp-5343	95	7	neuropathologic	neuropathologic	ADJ
fnp-5343	95	8	changes	change	NOUN
fnp-5343	95	9	or	or	CCONJ
fnp-5343	95	10	cognitive	cognitive	ADJ
fnp-5343	95	11	impairment	impairment	NOUN
fnp-5343	95	12	[	[	X
fnp-5343	95	13	94,117	94,117	NUM
fnp-5343	95	14	]	]	PUNCT
fnp-5343	95	15	.	.	PUNCT
fnp-5343	96	1	furthermore	furthermore	ADV
fnp-5343	96	2	,	,	PUNCT
fnp-5343	96	3	gelman	gelman	PROPN
fnp-5343	96	4	et	et	PROPN
fnp-5343	96	5	al	al	PROPN
fnp-5343	96	6	.	.	PROPN
fnp-5343	96	7	have	have	AUX
fnp-5343	96	8	shown	show	VERB
fnp-5343	96	9	that	that	SCONJ
fnp-5343	96	10	subjects	subject	NOUN
fnp-5343	96	11	with	with	ADP
fnp-5343	96	12	hand	hand	NOUN
fnp-5343	96	13	and	and	CCONJ
fnp-5343	96	14	hive	hive	NOUN
fnp-5343	96	15	have	have	VERB
fnp-5343	96	16	higher	high	ADJ
fnp-5343	96	17	brain	brain	NOUN
fnp-5343	96	18	hiv	hiv	PROPN
fnp-5343	96	19	rna	rna	PROPN
fnp-5343	96	20	and	and	CCONJ
fnp-5343	96	21	dna	dna	PROPN
fnp-5343	96	22	levels	level	NOUN
fnp-5343	96	23	than	than	ADP
fnp-5343	96	24	patients	patient	NOUN
fnp-5343	96	25	without	without	ADP
fnp-5343	96	26	hand	hand	NOUN
fnp-5343	96	27	,	,	PUNCT
fnp-5343	96	28	but	but	CCONJ
fnp-5343	96	29	individuals	individual	NOUN
fnp-5343	96	30	with	with	ADP
fnp-5343	96	31	hand	hand	NOUN
fnp-5343	96	32	without	without	ADP
fnp-5343	96	33	hive	hive	NOUN
fnp-5343	96	34	show	show	NOUN
fnp-5343	96	35	no	no	DET
fnp-5343	96	36	difference	difference	NOUN
fnp-5343	96	37	compared	compare	VERB
fnp-5343	96	38	to	to	ADP
fnp-5343	96	39	patients	patient	NOUN
fnp-5343	96	40	without	without	ADP
fnp-5343	96	41	hand	hand	NOUN
fnp-5343	96	42	[	[	X
fnp-5343	96	43	88	88	NUM
fnp-5343	96	44	]	]	PUNCT
fnp-5343	96	45	.	.	PUNCT
fnp-5343	97	1	thus	thus	ADV
fnp-5343	97	2	,	,	PUNCT
fnp-5343	97	3	complex	complex	ADJ
fnp-5343	97	4	mechanisms	mechanism	NOUN
fnp-5343	97	5	beyond	beyond	ADP
fnp-5343	97	6	viral	viral	ADJ
fnp-5343	97	7	replication	replication	NOUN
fnp-5343	97	8	in	in	ADP
fnp-5343	97	9	the	the	DET
fnp-5343	97	10	brain	brain	NOUN
fnp-5343	97	11	likely	likely	ADV
fnp-5343	97	12	underlie	underlie	ADJ
fnp-5343	97	13	hand	hand	NOUN
fnp-5343	97	14	,	,	PUNCT
fnp-5343	97	15	especially	especially	ADV
fnp-5343	97	16	in	in	ADP
fnp-5343	97	17	the	the	DET
fnp-5343	97	18	post	post	NOUN
fnp-5343	97	19	cart	cart	NOUN
fnp-5343	97	20	era	era	NOUN
fnp-5343	97	21	(	(	PUNCT
fnp-5343	97	22	figure	figure	NOUN
fnp-5343	97	23	2	2	NUM
fnp-5343	97	24	)	)	PUNCT
fnp-5343	98	1	[	[	X
fnp-5343	98	2	56,84,120,121	56,84,120,121	NUM
fnp-5343	98	3	]	]	PUNCT
fnp-5343	98	4	.	.	PUNCT
fnp-5343	99	1	figure	figure	NOUN
fnp-5343	99	2	2	2	NUM
fnp-5343	99	3	.	.	PUNCT
fnp-5343	99	4	potential	potential	ADJ
fnp-5343	99	5	mechanisms	mechanism	NOUN
fnp-5343	99	6	of	of	ADP
fnp-5343	99	7	neurologic	neurologic	ADJ
fnp-5343	99	8	disease	disease	NOUN
fnp-5343	99	9	in	in	ADP
fnp-5343	99	10	acute	acute	NOUN
fnp-5343	99	11	/	/	SYM
fnp-5343	99	12	chronic	chronic	ADJ
fnp-5343	99	13	hiv	hiv	PROPN
fnp-5343	99	14	infection	infection	NOUN
fnp-5343	99	15	and	and	CCONJ
fnp-5343	99	16	covid-19	covid-19	PROPN
fnp-5343	99	17	/	/	SYM
fnp-5343	99	18	pcc	pcc	PROPN
fnp-5343	99	19	.	.	PROPN
fnp-5343	99	20	hand	hand	PROPN
fnp-5343	99	21	,	,	PUNCT
fnp-5343	99	22	hiv	hiv	PROPN
fnp-5343	99	23	-	-	PUNCT
fnp-5343	99	24	associated	associate	VERB
fnp-5343	99	25	neurocognitive	neurocognitive	ADJ
fnp-5343	99	26	disorders	disorder	NOUN
fnp-5343	99	27	;	;	PUNCT
fnp-5343	99	28	pcc	pcc	NOUN
fnp-5343	99	29	,	,	PUNCT
fnp-5343	99	30	post	post	ADJ
fnp-5343	99	31	-	-	ADJ
fnp-5343	99	32	covid	covid	ADJ
fnp-5343	99	33	conditions	condition	NOUN
fnp-5343	99	34	.	.	PUNCT
fnp-5343	100	1	figure	figure	NOUN
fnp-5343	100	2	was	be	AUX
fnp-5343	100	3	created	create	VERB
fnp-5343	100	4	using	use	VERB
fnp-5343	100	5	biorender	biorender	NOUN
fnp-5343	100	6	.	.	PUNCT
fnp-5343	101	1	severe	severe	ADJ
fnp-5343	101	2	acute	acute	ADJ
fnp-5343	101	3	respiratory	respiratory	ADJ
fnp-5343	101	4	syndrome	syndrome	NOUN
fnp-5343	101	5	coronavirus	coronavirus	NOUN
fnp-5343	101	6	2	2	NUM
fnp-5343	101	7	(	(	PUNCT
fnp-5343	101	8	sars	sar	NOUN
fnp-5343	101	9	-	-	PUNCT
fnp-5343	101	10	cov-2	cov-2	NOUN
fnp-5343	101	11	)	)	PUNCT
fnp-5343	101	12	a	a	DET
fnp-5343	101	13	few	few	ADJ
fnp-5343	101	14	weeks	week	NOUN
fnp-5343	101	15	after	after	ADP
fnp-5343	101	16	a	a	DET
fnp-5343	101	17	cluster	cluster	NOUN
fnp-5343	101	18	of	of	ADP
fnp-5343	101	19	viral	viral	ADJ
fnp-5343	101	20	pneumonia	pneumonia	NOUN
fnp-5343	101	21	cases	case	NOUN
fnp-5343	101	22	,	,	PUNCT
fnp-5343	101	23	later	later	ADV
fnp-5343	101	24	called	call	VERB
fnp-5343	101	25	covid-19	covid-19	PROPN
fnp-5343	101	26	,	,	PUNCT
fnp-5343	101	27	was	be	AUX
fnp-5343	101	28	first	first	ADV
fnp-5343	101	29	described	describe	VERB
fnp-5343	101	30	in	in	ADP
fnp-5343	101	31	december	december	PROPN
fnp-5343	101	32	of	of	ADP
fnp-5343	101	33	2019	2019	NUM
fnp-5343	101	34	in	in	ADP
fnp-5343	101	35	china	china	PROPN
fnp-5343	102	1	[	[	X
fnp-5343	102	2	122–124	122–124	NUM
fnp-5343	102	3	]	]	PUNCT
fnp-5343	102	4	,	,	PUNCT
fnp-5343	102	5	the	the	DET
fnp-5343	102	6	causative	causative	ADJ
fnp-5343	102	7	agent	agent	NOUN
fnp-5343	102	8	was	be	AUX
fnp-5343	102	9	determined	determine	VERB
fnp-5343	102	10	to	to	PART
fnp-5343	102	11	be	be	AUX
fnp-5343	102	12	a	a	DET
fnp-5343	102	13	new	new	ADJ
fnp-5343	102	14	human	human	ADJ
fnp-5343	102	15	pathogen	pathogen	NOUN
fnp-5343	102	16	,	,	PUNCT
fnp-5343	102	17	the	the	DET
fnp-5343	102	18	coronavirus	coronavirus	NOUN
fnp-5343	102	19	later	later	ADV
fnp-5343	102	20	named	name	VERB
fnp-5343	102	21	severe	severe	ADJ
fnp-5343	102	22	acute	acute	ADJ
fnp-5343	102	23	respiratory	respiratory	ADJ
fnp-5343	102	24	syndrome	syndrome	NOUN
fnp-5343	102	25	coronavirus	coronavirus	NOUN
fnp-5343	102	26	2	2	NUM
fnp-5343	102	27	(	(	PUNCT
fnp-5343	102	28	sars	sar	NOUN
fnp-5343	102	29	-	-	PUNCT
fnp-5343	102	30	cov-2	cov-2	NOUN
fnp-5343	102	31	)	)	PUNCT
fnp-5343	103	1	[	[	X
fnp-5343	103	2	123	123	NUM
fnp-5343	103	3	]	]	PUNCT
fnp-5343	103	4	.	.	PUNCT
fnp-5343	104	1	several	several	ADJ
fnp-5343	104	2	vaccines	vaccine	NOUN
fnp-5343	104	3	were	be	AUX
fnp-5343	104	4	rapidly	rapidly	ADV
fnp-5343	104	5	developed	develop	VERB
fnp-5343	104	6	within	within	ADP
fnp-5343	104	7	a	a	DET
fnp-5343	104	8	year	year	NOUN
fnp-5343	104	9	and	and	CCONJ
fnp-5343	104	10	a	a	DET
fnp-5343	104	11	significant	significant	ADJ
fnp-5343	104	12	proportion	proportion	NOUN
fnp-5343	104	13	of	of	ADP
fnp-5343	104	14	the	the	DET
fnp-5343	104	15	population	population	NOUN
fnp-5343	104	16	of	of	ADP
fnp-5343	104	17	many	many	ADJ
fnp-5343	104	18	countries	country	NOUN
fnp-5343	104	19	,	,	PUNCT
fnp-5343	104	20	mostly	mostly	ADV
fnp-5343	104	21	high	high	ADJ
fnp-5343	104	22	-	-	PUNCT
fnp-5343	104	23	income	income	NOUN
fnp-5343	104	24	,	,	PUNCT
fnp-5343	104	25	have	have	AUX
fnp-5343	104	26	been	be	AUX
fnp-5343	104	27	vaccinated	vaccinate	VERB
fnp-5343	104	28	,	,	PUNCT
fnp-5343	104	29	albeit	albeit	SCONJ
fnp-5343	104	30	with	with	ADP
fnp-5343	104	31	large	large	ADJ
fnp-5343	104	32	differences	difference	NOUN
fnp-5343	104	33	among	among	ADP
fnp-5343	104	34	countries	country	NOUN
fnp-5343	104	35	[	[	X
fnp-5343	104	36	122,125,126	122,125,126	NUM
fnp-5343	104	37	]	]	X
fnp-5343	104	38	.	.	PUNCT
fnp-5343	105	1	however	however	ADV
fnp-5343	105	2	,	,	PUNCT
fnp-5343	105	3	there	there	PRON
fnp-5343	105	4	have	have	AUX
fnp-5343	105	5	been	be	AUX
fnp-5343	105	6	approximately	approximately	ADV
fnp-5343	105	7	6.9	6.9	NUM
fnp-5343	105	8	million	million	NUM
fnp-5343	105	9	deaths	death	NOUN
fnp-5343	105	10	and	and	CCONJ
fnp-5343	105	11	over	over	ADP
fnp-5343	105	12	750	750	NUM
fnp-5343	105	13	million	million	NUM
fnp-5343	105	14	infected	infect	VERB
fnp-5343	105	15	worldwide	worldwide	ADV
fnp-5343	105	16	according	accord	VERB
fnp-5343	105	17	to	to	ADP
fnp-5343	105	18	the	the	DET
fnp-5343	105	19	world	world	PROPN
fnp-5343	105	20	health	health	NOUN
fnp-5343	105	21	organization	organization	NOUN
fnp-5343	105	22	(	(	PUNCT
fnp-5343	105	23	who	who	PRON
fnp-5343	105	24	)	)	PUNCT
fnp-5343	106	1	[	[	X
fnp-5343	106	2	127	127	NUM
fnp-5343	106	3	]	]	PUNCT
fnp-5343	106	4	.	.	PUNCT
fnp-5343	106	5	coronaviruses	coronaviruse	NOUN
fnp-5343	106	6	are	be	AUX
fnp-5343	106	7	classified	classify	VERB
fnp-5343	106	8	into	into	ADP
fnp-5343	106	9	four	four	NUM
fnp-5343	106	10	distinct	distinct	ADJ
fnp-5343	106	11	genera	genera	NOUN
fnp-5343	106	12	:	:	PUNCT
fnp-5343	106	13	alpha	alpha	NOUN
fnp-5343	106	14	,	,	PUNCT
fnp-5343	106	15	beta	beta	NOUN
fnp-5343	106	16	,	,	PUNCT
fnp-5343	106	17	gamma	gamma	NOUN
fnp-5343	106	18	and	and	CCONJ
fnp-5343	106	19	deltacoronavirus	deltacoronavirus	NOUN
fnp-5343	106	20	[	[	X
fnp-5343	106	21	128	128	NUM
fnp-5343	106	22	]	]	PUNCT
fnp-5343	106	23	.	.	PUNCT
fnp-5343	107	1	sars	sar	NOUN
fnp-5343	107	2	-	-	PUNCT
fnp-5343	107	3	cov-2	cov-2	PART
fnp-5343	107	4	and	and	CCONJ
fnp-5343	107	5	sars	sar	NOUN
fnp-5343	107	6	-	-	PUNCT
fnp-5343	107	7	cov	cov	NOUN
fnp-5343	107	8	belong	belong	VERB
fnp-5343	107	9	to	to	ADP
fnp-5343	107	10	the	the	DET
fnp-5343	107	11	same	same	ADJ
fnp-5343	107	12	species	specie	NOUN
fnp-5343	107	13	,	,	PUNCT
fnp-5343	107	14	severe	severe	ADJ
fnp-5343	107	15	acute	acute	ADJ
fnp-5343	107	16	respiratory	respiratory	ADJ
fnp-5343	107	17	syndrome	syndrome	NOUN
fnp-5343	107	18	-	-	PUNCT
fnp-5343	107	19	related	relate	VERB
fnp-5343	107	20	coronavirus	coronavirus	NOUN
fnp-5343	107	21	(	(	PUNCT
fnp-5343	107	22	sarsr	sarsr	NOUN
fnp-5343	107	23	-	-	PUNCT
fnp-5343	107	24	cov	cov	NOUN
fnp-5343	107	25	)	)	PUNCT
fnp-5343	107	26	,	,	PUNCT
fnp-5343	107	27	which	which	PRON
fnp-5343	107	28	is	be	AUX
fnp-5343	107	29	of	of	ADP
fnp-5343	107	30	the	the	DET
fnp-5343	107	31	subgenus	subgenu	NOUN
fnp-5343	107	32	sarbecovirus	sarbecovirus	PROPN
fnp-5343	107	33	,	,	PUNCT
fnp-5343	107	34	genus	genus	ADJ
fnp-5343	107	35	betacoronavirus	betacoronavirus	NOUN
fnp-5343	107	36	which	which	PRON
fnp-5343	107	37	also	also	ADV
fnp-5343	107	38	includes	include	VERB
fnp-5343	107	39	middle	middle	PROPN
fnp-5343	107	40	east	east	PROPN
fnp-5343	107	41	respiratory	respiratory	ADJ
fnp-5343	107	42	syndrome	syndrome	NOUN
fnp-5343	107	43	coronavirus	coronavirus	NOUN
fnp-5343	107	44	(	(	PUNCT
fnp-5343	107	45	mers	mer	NOUN
fnp-5343	107	46	-	-	PUNCT
fnp-5343	107	47	cov	cov	NOUN
fnp-5343	107	48	)	)	PUNCT
fnp-5343	107	49	,	,	PUNCT
fnp-5343	107	50	of	of	ADP
fnp-5343	107	51	the	the	DET
fnp-5343	107	52	subfamily	subfamily	ADV
fnp-5343	107	53	orthocoronaviridae	orthocoronaviridae	NOUN
fnp-5343	107	54	[	[	X
fnp-5343	107	55	128,129	128,129	NUM
fnp-5343	107	56	]	]	PUNCT
fnp-5343	107	57	.	.	PUNCT
fnp-5343	108	1	during	during	ADP
fnp-5343	108	2	its	its	PRON
fnp-5343	108	3	spread	spread	ADJ
fnp-5343	108	4	several	several	ADJ
fnp-5343	108	5	sars	sar	NOUN
fnp-5343	108	6	-	-	PUNCT
fnp-5343	108	7	cov-2	cov-2	PART
fnp-5343	108	8	variants	variant	NOUN
fnp-5343	108	9	have	have	AUX
fnp-5343	108	10	emerged	emerge	VERB
fnp-5343	108	11	,	,	PUNCT
fnp-5343	108	12	termed	term	VERB
fnp-5343	108	13	"	"	PUNCT
fnp-5343	108	14	variants	variant	NOUN
fnp-5343	108	15	of	of	ADP
fnp-5343	108	16	concern	concern	NOUN
fnp-5343	108	17	"	"	PUNCT
fnp-5343	108	18	,	,	PUNCT
fnp-5343	108	19	including	include	VERB
fnp-5343	108	20	alpha	alpha	NOUN
fnp-5343	108	21	,	,	PUNCT
fnp-5343	108	22	gamma	gamma	NOUN
fnp-5343	108	23	,	,	PUNCT
fnp-5343	108	24	delta	delta	NOUN
fnp-5343	108	25	,	,	PUNCT
fnp-5343	108	26	and	and	CCONJ
fnp-5343	108	27	omicron	omicron	PROPN
fnp-5343	108	28	,	,	PUNCT
fnp-5343	108	29	that	that	PRON
fnp-5343	108	30	have	have	AUX
fnp-5343	108	31	caused	cause	VERB
fnp-5343	108	32	disease	disease	NOUN
fnp-5343	108	33	of	of	ADP
fnp-5343	108	34	similar	similar	ADJ
fnp-5343	108	35	severity	severity	NOUN
fnp-5343	108	36	except	except	SCONJ
fnp-5343	108	37	for	for	ADP
fnp-5343	108	38	omicron	omicron	PROPN
fnp-5343	108	39	which	which	PRON
fnp-5343	108	40	has	have	AUX
fnp-5343	108	41	been	be	AUX
fnp-5343	108	42	associated	associate	VERB
fnp-5343	108	43	with	with	ADP
fnp-5343	108	44	lower	low	ADJ
fnp-5343	108	45	rates	rate	NOUN
fnp-5343	108	46	of	of	ADP
fnp-5343	108	47	hospitalization	hospitalization	NOUN
fnp-5343	108	48	[	[	X
fnp-5343	108	49	128,130	128,130	NUM
fnp-5343	108	50	]	]	PUNCT
fnp-5343	108	51	.	.	PUNCT
fnp-5343	109	1	sars	sar	NOUN
fnp-5343	109	2	-	-	PUNCT
fnp-5343	109	3	cov-2	cov-2	PART
fnp-5343	109	4	predominantly	predominantly	ADV
fnp-5343	109	5	infects	infect	VERB
fnp-5343	109	6	nasal	nasal	ADJ
fnp-5343	109	7	or	or	CCONJ
fnp-5343	109	8	upper	upper	ADJ
fnp-5343	109	9	respiratory	respiratory	ADJ
fnp-5343	109	10	epithelium	epithelium	NOUN
fnp-5343	109	11	and	and	CCONJ
fnp-5343	109	12	sustentacular	sustentacular	ADJ
fnp-5343	109	13	cells	cell	NOUN
fnp-5343	109	14	of	of	ADP
fnp-5343	109	15	the	the	DET
fnp-5343	109	16	olfactory	olfactory	ADJ
fnp-5343	109	17	mucosa	mucosa	NOUN
fnp-5343	109	18	[	[	X
fnp-5343	109	19	131–134	131–134	NUM
fnp-5343	109	20	]	]	PUNCT
fnp-5343	109	21	with	with	ADP
fnp-5343	109	22	a	a	DET
fnp-5343	109	23	decreasing	decrease	VERB
fnp-5343	109	24	gradient	gradient	NOUN
fnp-5343	109	25	of	of	ADP
fnp-5343	109	26	infection	infection	NOUN
fnp-5343	109	27	from	from	ADP
fnp-5343	109	28	the	the	DET
fnp-5343	109	29	proximal	proximal	NOUN
fnp-5343	109	30	to	to	PART
fnp-5343	109	31	distal	distal	ADJ
fnp-5343	109	32	respiratory	respiratory	ADJ
fnp-5343	109	33	tract	tract	NOUN
fnp-5343	110	1	[	[	X
fnp-5343	110	2	135	135	NUM
fnp-5343	110	3	]	]	PUNCT
fnp-5343	110	4	.	.	PUNCT
fnp-5343	111	1	as	as	ADP
fnp-5343	111	2	with	with	ADP
fnp-5343	111	3	sars	sar	NOUN
fnp-5343	111	4	-	-	PUNCT
fnp-5343	111	5	cov	cov	PROPN
fnp-5343	111	6	,	,	PUNCT
fnp-5343	111	7	sars	sar	NOUN
fnp-5343	111	8	-	-	PUNCT
fnp-5343	111	9	cov-2	cov-2	NOUN
fnp-5343	111	10	uses	uses	AUX
fnp-5343	111	11	angiotensin	angiotensin	NOUN
fnp-5343	111	12	converting	convert	VERB
fnp-5343	111	13	enzyme	enzyme	NOUN
fnp-5343	111	14	2	2	NUM
fnp-5343	111	15	(	(	PUNCT
fnp-5343	111	16	ace2	ace2	PROPN
fnp-5343	111	17	)	)	PUNCT
fnp-5343	111	18	as	as	ADP
fnp-5343	111	19	the	the	DET
fnp-5343	111	20	obligate	obligate	NOUN
fnp-5343	111	21	receptor	receptor	NOUN
fnp-5343	111	22	for	for	ADP
fnp-5343	111	23	host	host	NOUN
fnp-5343	111	24	cell	cell	NOUN
fnp-5343	111	25	entry	entry	NOUN
fnp-5343	111	26	through	through	ADP
fnp-5343	111	27	binding	bind	VERB
fnp-5343	111	28	of	of	ADP
fnp-5343	111	29	the	the	DET
fnp-5343	111	30	viral	viral	ADJ
fnp-5343	111	31	spike	spike	NOUN
fnp-5343	111	32	(	(	PUNCT
fnp-5343	111	33	s	s	NOUN
fnp-5343	111	34	)	)	PUNCT
fnp-5343	111	35	protein	protein	NOUN
fnp-5343	111	36	,	,	PUNCT
fnp-5343	111	37	proteolytically	proteolytically	ADV
fnp-5343	111	38	activated	activate	VERB
fnp-5343	111	39	by	by	ADP
fnp-5343	111	40	transmembrane	transmembrane	ADJ
fnp-5343	111	41	protease	protease	NOUN
fnp-5343	111	42	/	/	SYM
fnp-5343	111	43	serine	serine	NOUN
fnp-5343	111	44	subfamily	subfamily	ADV
fnp-5343	111	45	member	member	NOUN
fnp-5343	111	46	2	2	NUM
fnp-5343	111	47	(	(	PUNCT
fnp-5343	111	48	tmprss2	tmprss2	ADV
fnp-5343	111	49	)	)	PUNCT
fnp-5343	111	50	,	,	PUNCT
fnp-5343	111	51	although	although	SCONJ
fnp-5343	111	52	ace2	ace2	NOUN
fnp-5343	111	53	-	-	PUNCT
fnp-5343	111	54	bound	bind	VERB
fnp-5343	111	55	virus	virus	NOUN
fnp-5343	111	56	can	can	AUX
fnp-5343	111	57	also	also	ADV
fnp-5343	111	58	enter	enter	VERB
fnp-5343	111	59	the	the	DET
fnp-5343	111	60	cell	cell	NOUN
fnp-5343	111	61	via	via	ADP
fnp-5343	111	62	clathrin	clathrin	NOUN
fnp-5343	111	63	-	-	PUNCT
fnp-5343	111	64	mediated	mediate	VERB
fnp-5343	111	65	endocytosis	endocytosis	NOUN
fnp-5343	111	66	without	without	ADP
fnp-5343	112	1	tmprss2	tmprss2	ADP
fnp-5343	113	1	[	[	X
fnp-5343	113	2	129,136–140	129,136–140	NOUN
fnp-5343	113	3	]	]	PUNCT
fnp-5343	113	4	.	.	PUNCT
fnp-5343	114	1	ace2	ace2	PROPN
fnp-5343	114	2	is	be	AUX
fnp-5343	114	3	a	a	DET
fnp-5343	114	4	human	human	ADJ
fnp-5343	114	5	homologue	homologue	NOUN
fnp-5343	114	6	of	of	ADP
fnp-5343	114	7	ace	ace	NOUN
fnp-5343	114	8	,	,	PUNCT
fnp-5343	114	9	and	and	CCONJ
fnp-5343	114	10	both	both	PRON
fnp-5343	114	11	ace	ace	VERB
fnp-5343	114	12	and	and	CCONJ
fnp-5343	114	13	ace2	ace2	NOUN
fnp-5343	114	14	play	play	VERB
fnp-5343	114	15	important	important	ADJ
fnp-5343	114	16	roles	role	NOUN
fnp-5343	114	17	in	in	ADP
fnp-5343	114	18	the	the	DET
fnp-5343	114	19	renin	renin	ADJ
fnp-5343	114	20	-	-	PUNCT
fnp-5343	114	21	angiotensin	angiotensin	NOUN
fnp-5343	114	22	system	system	NOUN
fnp-5343	114	23	[	[	X
fnp-5343	114	24	141	141	NUM
fnp-5343	114	25	]	]	PUNCT
fnp-5343	114	26	.	.	PUNCT
fnp-5343	115	1	ace2	ace2	PROPN
fnp-5343	115	2	mrna	mrna	PROPN
fnp-5343	115	3	has	have	AUX
fnp-5343	115	4	been	be	AUX
fnp-5343	115	5	reported	report	VERB
fnp-5343	115	6	in	in	ADP
fnp-5343	115	7	many	many	ADJ
fnp-5343	115	8	different	different	ADJ
fnp-5343	115	9	organs	organ	NOUN
fnp-5343	115	10	including	include	VERB
fnp-5343	115	11	,	,	PUNCT
fnp-5343	115	12	at	at	ADP
fnp-5343	115	13	least	least	ADJ
fnp-5343	115	14	in	in	ADP
fnp-5343	115	15	some	some	DET
fnp-5343	115	16	studies	study	NOUN
fnp-5343	115	17	,	,	PUNCT
fnp-5343	115	18	the	the	DET
fnp-5343	115	19	brain	brain	NOUN
fnp-5343	115	20	[	[	X
fnp-5343	115	21	142–145	142–145	NUM
fnp-5343	115	22	]	]	X
fnp-5343	115	23	.	.	PUNCT
fnp-5343	116	1	however	however	ADV
fnp-5343	116	2	,	,	PUNCT
fnp-5343	116	3	mrna	mrna	PROPN
fnp-5343	116	4	and	and	CCONJ
fnp-5343	116	5	protein	protein	NOUN
fnp-5343	116	6	levels	level	NOUN
fnp-5343	116	7	of	of	ADP
fnp-5343	116	8	ace2	ace2	PROPN
fnp-5343	116	9	have	have	AUX
fnp-5343	116	10	been	be	AUX
fnp-5343	116	11	shown	show	VERB
fnp-5343	116	12	to	to	PART
fnp-5343	116	13	be	be	AUX
fnp-5343	116	14	discordant	discordant	ADJ
fnp-5343	116	15	[	[	X
fnp-5343	116	16	146	146	NUM
fnp-5343	116	17	]	]	PUNCT
fnp-5343	116	18	.	.	PUNCT
fnp-5343	117	1	ace2	ace2	PROPN
fnp-5343	117	2	protein	protein	NOUN
fnp-5343	117	3	has	have	AUX
fnp-5343	117	4	been	be	AUX
fnp-5343	117	5	detected	detect	VERB
fnp-5343	117	6	in	in	ADP
fnp-5343	117	7	several	several	ADJ
fnp-5343	117	8	cell	cell	NOUN
fnp-5343	117	9	types	type	NOUN
fnp-5343	117	10	including	include	VERB
fnp-5343	117	11	ciliated	ciliated	ADJ
fnp-5343	117	12	cells	cell	NOUN
fnp-5343	117	13	of	of	ADP
fnp-5343	117	14	the	the	DET
fnp-5343	117	15	nasal	nasal	ADJ
fnp-5343	117	16	mucosa	mucosa	NOUN
fnp-5343	117	17	and	and	CCONJ
fnp-5343	117	18	bronchus	bronchu	NOUN
fnp-5343	117	19	,	,	PUNCT
fnp-5343	117	20	cardiomyocytes	cardiomyocyte	NOUN
fnp-5343	117	21	,	,	PUNCT
fnp-5343	117	22	enterocytes	enterocyte	NOUN
fnp-5343	117	23	of	of	ADP
fnp-5343	117	24	the	the	DET
fnp-5343	117	25	gastrointestinal	gastrointestinal	ADJ
fnp-5343	117	26	tract	tract	NOUN
fnp-5343	117	27	,	,	PUNCT
fnp-5343	117	28	gallbladder	gallbladder	NOUN
fnp-5343	117	29	epithelium	epithelium	NOUN
fnp-5343	117	30	,	,	PUNCT
fnp-5343	117	31	kidney	kidney	NOUN
fnp-5343	117	32	proximal	proximal	ADJ
fnp-5343	117	33	tubule	tubule	NOUN
fnp-5343	117	34	epithelium	epithelium	NOUN
fnp-5343	117	35	,	,	PUNCT
fnp-5343	117	36	and	and	CCONJ
fnp-5343	117	37	sertoli	sertoli	PROPN
fnp-5343	117	38	and	and	CCONJ
fnp-5343	117	39	leydig	leydig	NOUN
fnp-5343	117	40	cells	cell	NOUN
fnp-5343	117	41	of	of	ADP
fnp-5343	117	42	the	the	DET
fnp-5343	117	43	testis	testis	NOUN
fnp-5343	117	44	[	[	X
fnp-5343	117	45	143,146,147	143,146,147	NUM
fnp-5343	117	46	]	]	PUNCT
fnp-5343	117	47	.	.	PUNCT
fnp-5343	118	1	in	in	ADP
fnp-5343	118	2	the	the	DET
fnp-5343	118	3	brain	brain	NOUN
fnp-5343	118	4	,	,	PUNCT
fnp-5343	118	5	ace2	ace2	NOUN
fnp-5343	118	6	protein	protein	NOUN
fnp-5343	118	7	expression	expression	NOUN
fnp-5343	118	8	has	have	AUX
fnp-5343	118	9	been	be	AUX
fnp-5343	118	10	seen	see	VERB
fnp-5343	118	11	by	by	ADP
fnp-5343	118	12	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	118	13	in	in	ADP
fnp-5343	118	14	vascular	vascular	ADJ
fnp-5343	118	15	smooth	smooth	ADJ
fnp-5343	118	16	muscle	muscle	NOUN
fnp-5343	118	17	cells	cell	NOUN
fnp-5343	118	18	and/or	and/or	CCONJ
fnp-5343	118	19	endothelial	endothelial	ADJ
fnp-5343	118	20	cells	cell	NOUN
fnp-5343	118	21	/	/	SYM
fnp-5343	118	22	pericytes	pericyte	NOUN
fnp-5343	118	23	in	in	ADP
fnp-5343	118	24	some	some	DET
fnp-5343	118	25	studies	study	NOUN
fnp-5343	118	26	but	but	CCONJ
fnp-5343	118	27	not	not	PART
fnp-5343	118	28	others	other	NOUN
fnp-5343	118	29	[	[	X
fnp-5343	118	30	143,147–151	143,147–151	NOUN
fnp-5343	118	31	]	]	X
fnp-5343	118	32	.	.	PUNCT
fnp-5343	119	1	few	few	ADJ
fnp-5343	119	2	studies	study	NOUN
fnp-5343	119	3	have	have	AUX
fnp-5343	119	4	reported	report	VERB
fnp-5343	119	5	ace2	ace2	NOUN
fnp-5343	119	6	immunopositivity	immunopositivity	NOUN
fnp-5343	119	7	in	in	ADP
fnp-5343	119	8	choroid	choroid	NOUN
fnp-5343	119	9	plexus	plexus	NOUN
fnp-5343	119	10	,	,	PUNCT
fnp-5343	119	11	ependymal	ependymal	ADJ
fnp-5343	119	12	cells	cell	NOUN
fnp-5343	119	13	,	,	PUNCT
fnp-5343	119	14	meningothelial	meningothelial	ADJ
fnp-5343	119	15	cells	cell	NOUN
fnp-5343	119	16	,	,	PUNCT
fnp-5343	119	17	and	and	CCONJ
fnp-5343	119	18	neurons	neuron	NOUN
fnp-5343	119	19	in	in	ADP
fnp-5343	119	20	the	the	DET
fnp-5343	119	21	medulla	medulla	NOUN
fnp-5343	119	22	[	[	X
fnp-5343	119	23	151,152	151,152	NUM
fnp-5343	119	24	]	]	PUNCT
fnp-5343	119	25	.	.	PUNCT
fnp-5343	120	1	neurologic	neurologic	ADJ
fnp-5343	120	2	manifestations	manifestation	NOUN
fnp-5343	120	3	approximately	approximately	ADV
fnp-5343	120	4	a	a	DET
fnp-5343	120	5	third	third	NOUN
fnp-5343	120	6	of	of	ADP
fnp-5343	120	7	patients	patient	NOUN
fnp-5343	120	8	with	with	ADP
fnp-5343	120	9	acute	acute	ADJ
fnp-5343	120	10	covid-19	covid-19	PROPN
fnp-5343	120	11	exhibit	exhibit	VERB
fnp-5343	120	12	neurologic	neurologic	ADJ
fnp-5343	120	13	and	and	CCONJ
fnp-5343	120	14	psychiatric	psychiatric	ADJ
fnp-5343	120	15	manifestations	manifestation	NOUN
fnp-5343	120	16	,	,	PUNCT
fnp-5343	120	17	most	most	ADV
fnp-5343	120	18	commonly	commonly	ADV
fnp-5343	120	19	fatigue	fatigue	NOUN
fnp-5343	120	20	,	,	PUNCT
fnp-5343	120	21	alterations	alteration	NOUN
fnp-5343	120	22	in	in	ADP
fnp-5343	120	23	consciousness	consciousness	NOUN
fnp-5343	120	24	,	,	PUNCT
fnp-5343	120	25	impairment	impairment	ADJ
fnp-5343	120	26	in	in	ADP
fnp-5343	120	27	smell	smell	NOUN
fnp-5343	120	28	and	and	CCONJ
fnp-5343	120	29	taste	taste	NOUN
fnp-5343	120	30	,	,	PUNCT
fnp-5343	120	31	seizures	seizure	NOUN
fnp-5343	120	32	,	,	PUNCT
fnp-5343	120	33	myalgia	myalgia	NOUN
fnp-5343	120	34	,	,	PUNCT
fnp-5343	120	35	anxiety	anxiety	NOUN
fnp-5343	120	36	,	,	PUNCT
fnp-5343	120	37	and	and	CCONJ
fnp-5343	120	38	stroke	stroke	VERB
fnp-5343	121	1	[	[	X
fnp-5343	121	2	153–156	153–156	NUM
fnp-5343	121	3	]	]	PUNCT
fnp-5343	121	4	.	.	PUNCT
fnp-5343	122	1	ischemic	ischemic	ADJ
fnp-5343	122	2	stroke	stroke	NOUN
fnp-5343	122	3	is	be	AUX
fnp-5343	122	4	seen	see	VERB
fnp-5343	122	5	in	in	ADP
fnp-5343	122	6	approximately	approximately	ADV
fnp-5343	122	7	2	2	NUM
fnp-5343	122	8	%	%	NOUN
fnp-5343	122	9	of	of	ADP
fnp-5343	122	10	covid-19	covid-19	PROPN
fnp-5343	122	11	patients	patient	NOUN
fnp-5343	122	12	[	[	X
fnp-5343	122	13	153–156	153–156	NUM
fnp-5343	122	14	]	]	PUNCT
fnp-5343	122	15	,	,	PUNCT
fnp-5343	122	16	and	and	CCONJ
fnp-5343	122	17	occurs	occur	VERB
fnp-5343	122	18	in	in	ADP
fnp-5343	122	19	younger	young	ADJ
fnp-5343	122	20	individuals	individual	NOUN
fnp-5343	122	21	compared	compare	VERB
fnp-5343	122	22	to	to	ADP
fnp-5343	122	23	ischemic	ischemic	ADJ
fnp-5343	122	24	stroke	stroke	NOUN
fnp-5343	122	25	in	in	ADP
fnp-5343	122	26	non	non	ADJ
fnp-5343	122	27	-	-	ADJ
fnp-5343	122	28	covid-19	covid-19	ADJ
fnp-5343	122	29	patients	patient	NOUN
fnp-5343	122	30	[	[	X
fnp-5343	122	31	157	157	NUM
fnp-5343	122	32	]	]	PUNCT
fnp-5343	122	33	.	.	PUNCT
fnp-5343	123	1	moreover	moreover	ADV
fnp-5343	123	2	,	,	PUNCT
fnp-5343	123	3	patients	patient	NOUN
fnp-5343	123	4	with	with	ADP
fnp-5343	123	5	covid-19	covid-19	PROPN
fnp-5343	123	6	have	have	AUX
fnp-5343	123	7	increased	increase	VERB
fnp-5343	123	8	risk	risk	NOUN
fnp-5343	123	9	for	for	ADP
fnp-5343	123	10	ischemic	ischemic	ADJ
fnp-5343	123	11	and	and	CCONJ
fnp-5343	123	12	hemorrhagic	hemorrhagic	NOUN
fnp-5343	123	13	stroke	stroke	NOUN
fnp-5343	123	14	compared	compare	VERB
fnp-5343	123	15	to	to	ADP
fnp-5343	123	16	patients	patient	NOUN
fnp-5343	123	17	with	with	ADP
fnp-5343	123	18	influenza	influenza	NOUN
fnp-5343	123	19	or	or	CCONJ
fnp-5343	123	20	other	other	ADJ
fnp-5343	123	21	upper	upper	ADJ
fnp-5343	123	22	respiratory	respiratory	ADJ
fnp-5343	123	23	tract	tract	NOUN
fnp-5343	123	24	infections	infection	NOUN
fnp-5343	123	25	[	[	X
fnp-5343	123	26	155,158	155,158	NUM
fnp-5343	123	27	]	]	PUNCT
fnp-5343	123	28	,	,	PUNCT
fnp-5343	123	29	and	and	CCONJ
fnp-5343	123	30	increased	increase	VERB
fnp-5343	123	31	risk	risk	NOUN
fnp-5343	123	32	for	for	ADP
fnp-5343	123	33	ischemic	ischemic	ADJ
fnp-5343	123	34	stroke	stroke	NOUN
fnp-5343	123	35	and	and	CCONJ
fnp-5343	123	36	myocardial	myocardial	ADJ
fnp-5343	123	37	infarct	infarct	NOUN
fnp-5343	123	38	compared	compare	VERB
fnp-5343	123	39	to	to	ADP
fnp-5343	123	40	the	the	DET
fnp-5343	123	41	background	background	NOUN
fnp-5343	123	42	population	population	NOUN
fnp-5343	123	43	in	in	ADP
fnp-5343	123	44	sweden	sweden	PROPN
fnp-5343	124	1	[	[	X
fnp-5343	124	2	159	159	NUM
fnp-5343	124	3	]	]	PUNCT
fnp-5343	124	4	.	.	PUNCT
fnp-5343	125	1	neurologic	neurologic	ADJ
fnp-5343	125	2	manifestations	manifestation	NOUN
fnp-5343	125	3	have	have	AUX
fnp-5343	125	4	been	be	AUX
fnp-5343	125	5	associated	associate	VERB
fnp-5343	125	6	with	with	ADP
fnp-5343	125	7	increased	increase	VERB
fnp-5343	125	8	mortality	mortality	NOUN
fnp-5343	125	9	,	,	PUNCT
fnp-5343	125	10	especially	especially	ADV
fnp-5343	125	11	in	in	ADP
fnp-5343	125	12	older	old	ADJ
fnp-5343	125	13	individuals	individual	NOUN
fnp-5343	125	14	[	[	X
fnp-5343	125	15	154,156	154,156	NUM
fnp-5343	125	16	]	]	PUNCT
fnp-5343	125	17	.	.	PUNCT
fnp-5343	126	1	neurologic	neurologic	ADJ
fnp-5343	126	2	and	and	CCONJ
fnp-5343	126	3	psychiatric	psychiatric	ADJ
fnp-5343	126	4	complications	complication	NOUN
fnp-5343	126	5	are	be	AUX
fnp-5343	126	6	also	also	ADV
fnp-5343	126	7	seen	see	VERB
fnp-5343	126	8	as	as	ADP
fnp-5343	126	9	part	part	NOUN
fnp-5343	126	10	of	of	ADP
fnp-5343	126	11	the	the	DET
fnp-5343	126	12	constellation	constellation	NOUN
fnp-5343	126	13	of	of	ADP
fnp-5343	126	14	post	post	ADJ
fnp-5343	126	15	-	-	ADJ
fnp-5343	126	16	covid	covid	ADJ
fnp-5343	126	17	conditions	condition	NOUN
fnp-5343	126	18	(	(	PUNCT
fnp-5343	126	19	pcc	pcc	NOUN
fnp-5343	126	20	)	)	PUNCT
fnp-5343	126	21	,	,	PUNCT
fnp-5343	126	22	also	also	ADV
fnp-5343	126	23	known	know	VERB
fnp-5343	126	24	as	as	ADP
fnp-5343	126	25	post	post	ADJ
fnp-5343	126	26	-	-	ADJ
fnp-5343	126	27	acute	acute	ADJ
fnp-5343	126	28	sequelae	sequelae	NOUN
fnp-5343	126	29	of	of	ADP
fnp-5343	126	30	covid-19	covid-19	PROPN
fnp-5343	126	31	(	(	PUNCT
fnp-5343	126	32	pasc	pasc	PROPN
fnp-5343	126	33	)	)	PUNCT
fnp-5343	126	34	or	or	CCONJ
fnp-5343	126	35	long	long	ADJ
fnp-5343	126	36	covid	covid	NOUN
fnp-5343	126	37	,	,	PUNCT
fnp-5343	126	38	defined	define	VERB
fnp-5343	126	39	by	by	ADP
fnp-5343	126	40	the	the	DET
fnp-5343	126	41	who	who	PRON
fnp-5343	126	42	as	as	ADP
fnp-5343	126	43	persistent	persistent	ADJ
fnp-5343	126	44	symptoms	symptom	NOUN
fnp-5343	126	45	usually	usually	ADV
fnp-5343	126	46	3	3	NUM
fnp-5343	126	47	months	month	NOUN
fnp-5343	126	48	from	from	ADP
fnp-5343	126	49	onset	onset	NOUN
fnp-5343	126	50	of	of	ADP
fnp-5343	126	51	covid-19	covid-19	PROPN
fnp-5343	126	52	with	with	ADP
fnp-5343	126	53	symptoms	symptom	NOUN
fnp-5343	126	54	lasting	last	VERB
fnp-5343	126	55	at	at	ADP
fnp-5343	126	56	least	least	ADV
fnp-5343	126	57	2	2	NUM
fnp-5343	126	58	months	month	NOUN
fnp-5343	126	59	with	with	ADP
fnp-5343	126	60	no	no	DET
fnp-5343	126	61	alternative	alternative	ADJ
fnp-5343	126	62	diagnosis	diagnosis	NOUN
fnp-5343	126	63	[	[	X
fnp-5343	126	64	160–162	160–162	NUM
fnp-5343	126	65	]	]	X
fnp-5343	126	66	.	.	PUNCT
fnp-5343	127	1	most	most	ADJ
fnp-5343	127	2	frequent	frequent	ADJ
fnp-5343	127	3	neurologic	neurologic	ADJ
fnp-5343	127	4	manifestations	manifestation	NOUN
fnp-5343	127	5	of	of	ADP
fnp-5343	127	6	pcc	pcc	NOUN
fnp-5343	127	7	include	include	VERB
fnp-5343	127	8	fatigue	fatigue	NOUN
fnp-5343	127	9	and	and	CCONJ
fnp-5343	127	10	cognitive	cognitive	ADJ
fnp-5343	127	11	impairment	impairment	NOUN
fnp-5343	127	12	,	,	PUNCT
fnp-5343	127	13	impaired	impaired	ADJ
fnp-5343	127	14	concentration	concentration	NOUN
fnp-5343	127	15	or	or	CCONJ
fnp-5343	127	16	"	"	PUNCT
fnp-5343	127	17	brain	brain	NOUN
fnp-5343	127	18	fog	fog	NOUN
fnp-5343	127	19	"	"	PUNCT
fnp-5343	127	20	,	,	PUNCT
fnp-5343	127	21	which	which	PRON
fnp-5343	127	22	has	have	AUX
fnp-5343	127	23	been	be	AUX
fnp-5343	127	24	shown	show	VERB
fnp-5343	127	25	to	to	PART
fnp-5343	127	26	correlate	correlate	VERB
fnp-5343	127	27	with	with	ADP
fnp-5343	127	28	abnormal	abnormal	ADJ
fnp-5343	127	29	brain	brain	NOUN
fnp-5343	127	30	activation	activation	NOUN
fnp-5343	127	31	on	on	ADP
fnp-5343	127	32	task	task	NOUN
fnp-5343	127	33	-	-	PUNCT
fnp-5343	127	34	activated	activate	VERB
fnp-5343	127	35	blood	blood	NOUN
fnp-5343	127	36	oxygenation	oxygenation	NOUN
fnp-5343	127	37	level	level	NOUN
fnp-5343	127	38	-	-	PUNCT
fnp-5343	127	39	dependent	dependent	ADJ
fnp-5343	127	40	functional	functional	ADJ
fnp-5343	127	41	mri	mri	NOUN
fnp-5343	127	42	(	(	PUNCT
fnp-5343	127	43	bold	bold	ADJ
fnp-5343	127	44	-	-	PUNCT
fnp-5343	127	45	fmri	fmri	NOUN
fnp-5343	127	46	)	)	PUNCT
fnp-5343	128	1	[	[	X
fnp-5343	128	2	163	163	NUM
fnp-5343	128	3	]	]	PUNCT
fnp-5343	128	4	,	,	PUNCT
fnp-5343	128	5	as	as	ADV
fnp-5343	128	6	well	well	ADV
fnp-5343	128	7	as	as	ADP
fnp-5343	128	8	psychiatric	psychiatric	ADJ
fnp-5343	128	9	disorders	disorder	NOUN
fnp-5343	128	10	such	such	ADJ
fnp-5343	128	11	as	as	ADP
fnp-5343	128	12	post	post	ADJ
fnp-5343	128	13	-	-	ADJ
fnp-5343	128	14	traumatic	traumatic	ADJ
fnp-5343	128	15	stress	stress	NOUN
fnp-5343	128	16	disorder	disorder	NOUN
fnp-5343	128	17	,	,	PUNCT
fnp-5343	128	18	anxiety	anxiety	NOUN
fnp-5343	128	19	and	and	CCONJ
fnp-5343	128	20	depression	depression	NOUN
fnp-5343	128	21	[	[	X
fnp-5343	128	22	164,165	164,165	NUM
fnp-5343	128	23	]	]	PUNCT
fnp-5343	128	24	.	.	PUNCT
fnp-5343	129	1	similar	similar	ADJ
fnp-5343	129	2	complications	complication	NOUN
fnp-5343	129	3	were	be	AUX
fnp-5343	129	4	seen	see	VERB
fnp-5343	129	5	in	in	ADP
fnp-5343	129	6	the	the	DET
fnp-5343	129	7	sars	sar	NOUN
fnp-5343	129	8	2003	2003	NUM
fnp-5343	129	9	pandemic	pandemic	ADJ
fnp-5343	130	1	[	[	X
fnp-5343	130	2	166	166	NUM
fnp-5343	130	3	]	]	PUNCT
fnp-5343	130	4	,	,	PUNCT
fnp-5343	130	5	and	and	CCONJ
fnp-5343	130	6	post	post	ADJ
fnp-5343	130	7	-	-	ADJ
fnp-5343	130	8	viral	viral	ADJ
fnp-5343	130	9	syndromes	syndrome	NOUN
fnp-5343	130	10	occur	occur	VERB
fnp-5343	130	11	in	in	ADP
fnp-5343	130	12	other	other	ADJ
fnp-5343	130	13	viruses	virus	NOUN
fnp-5343	131	1	[	[	X
fnp-5343	131	2	167	167	NUM
fnp-5343	131	3	]	]	PUNCT
fnp-5343	131	4	.	.	PUNCT
fnp-5343	131	5	cognitive	cognitive	ADJ
fnp-5343	131	6	decline	decline	NOUN
fnp-5343	131	7	and	and	CCONJ
fnp-5343	131	8	psychiatric	psychiatric	ADJ
fnp-5343	131	9	symptoms	symptom	NOUN
fnp-5343	131	10	have	have	AUX
fnp-5343	131	11	also	also	ADV
fnp-5343	131	12	been	be	AUX
fnp-5343	131	13	described	describe	VERB
fnp-5343	131	14	after	after	ADP
fnp-5343	131	15	serious	serious	ADJ
fnp-5343	131	16	illness	illness	NOUN
fnp-5343	131	17	requiring	require	VERB
fnp-5343	131	18	admission	admission	NOUN
fnp-5343	131	19	to	to	ADP
fnp-5343	131	20	the	the	DET
fnp-5343	131	21	intensive	intensive	ADJ
fnp-5343	131	22	care	care	NOUN
fnp-5343	131	23	unit	unit	NOUN
fnp-5343	131	24	such	such	ADJ
fnp-5343	131	25	as	as	ADP
fnp-5343	131	26	sepsis	sepsis	NOUN
fnp-5343	131	27	[	[	X
fnp-5343	131	28	168,169	168,169	NUM
fnp-5343	131	29	]	]	PUNCT
fnp-5343	131	30	.	.	PUNCT
fnp-5343	132	1	however	however	ADV
fnp-5343	132	2	,	,	PUNCT
fnp-5343	132	3	examining	examine	VERB
fnp-5343	132	4	the	the	DET
fnp-5343	132	5	electronic	electronic	ADJ
fnp-5343	132	6	health	health	NOUN
fnp-5343	132	7	records	record	NOUN
fnp-5343	132	8	of	of	ADP
fnp-5343	132	9	the	the	DET
fnp-5343	132	10	us	us	PROPN
fnp-5343	132	11	department	department	PROPN
fnp-5343	132	12	of	of	ADP
fnp-5343	132	13	veterans	veterans	PROPN
fnp-5343	132	14	affairs	affairs	PROPN
fnp-5343	132	15	,	,	PUNCT
fnp-5343	132	16	al	al	PROPN
fnp-5343	132	17	-	-	PUNCT
fnp-5343	132	18	aly	aly	PROPN
fnp-5343	132	19	et	et	PROPN
fnp-5343	132	20	al	al	PROPN
fnp-5343	132	21	.	.	PROPN
fnp-5343	132	22	found	find	VERB
fnp-5343	132	23	a	a	DET
fnp-5343	132	24	higher	high	ADJ
fnp-5343	132	25	burden	burden	NOUN
fnp-5343	132	26	of	of	ADP
fnp-5343	132	27	both	both	CCONJ
fnp-5343	132	28	pulmonary	pulmonary	ADJ
fnp-5343	132	29	and	and	CCONJ
fnp-5343	132	30	extrapulmonary	extrapulmonary	NOUN
fnp-5343	132	31	disease	disease	NOUN
fnp-5343	132	32	,	,	PUNCT
fnp-5343	132	33	including	include	VERB
fnp-5343	132	34	neuropsychiatric	neuropsychiatric	ADJ
fnp-5343	132	35	and	and	CCONJ
fnp-5343	132	36	cardiovascular	cardiovascular	ADJ
fnp-5343	132	37	disorders	disorder	NOUN
fnp-5343	132	38	,	,	PUNCT
fnp-5343	132	39	in	in	ADP
fnp-5343	132	40	patients	patient	NOUN
fnp-5343	132	41	who	who	PRON
fnp-5343	132	42	had	have	AUX
fnp-5343	132	43	been	be	AUX
fnp-5343	132	44	hospitalized	hospitalize	VERB
fnp-5343	132	45	for	for	ADP
fnp-5343	132	46	covid-19	covid-19	PROPN
fnp-5343	132	47	and	and	CCONJ
fnp-5343	132	48	survived	survive	VERB
fnp-5343	132	49	for	for	ADP
fnp-5343	132	50	at	at	ADV
fnp-5343	132	51	least	least	ADV
fnp-5343	132	52	30	30	NUM
fnp-5343	132	53	days	day	NOUN
fnp-5343	132	54	after	after	ADP
fnp-5343	132	55	admission	admission	NOUN
fnp-5343	132	56	compared	compare	VERB
fnp-5343	132	57	to	to	ADP
fnp-5343	132	58	individuals	individual	NOUN
fnp-5343	132	59	hospitalized	hospitalize	VERB
fnp-5343	132	60	for	for	ADP
fnp-5343	132	61	influenza	influenza	NOUN
fnp-5343	132	62	[	[	X
fnp-5343	132	63	170	170	NUM
fnp-5343	132	64	]	]	PUNCT
fnp-5343	132	65	.	.	PUNCT
fnp-5343	133	1	a	a	DET
fnp-5343	133	2	different	different	ADJ
fnp-5343	133	3	study	study	NOUN
fnp-5343	133	4	using	use	VERB
fnp-5343	133	5	electronic	electronic	ADJ
fnp-5343	133	6	health	health	NOUN
fnp-5343	133	7	records	record	NOUN
fnp-5343	133	8	of	of	ADP
fnp-5343	133	9	health	health	NOUN
fnp-5343	133	10	care	care	NOUN
fnp-5343	133	11	organizations	organization	NOUN
fnp-5343	133	12	mostly	mostly	ADV
fnp-5343	133	13	in	in	ADP
fnp-5343	133	14	the	the	DET
fnp-5343	133	15	us	us	PROPN
fnp-5343	133	16	found	find	VERB
fnp-5343	133	17	that	that	SCONJ
fnp-5343	133	18	neurologic	neurologic	ADJ
fnp-5343	133	19	and	and	CCONJ
fnp-5343	133	20	psychiatric	psychiatric	ADJ
fnp-5343	133	21	diagnoses	diagnosis	NOUN
fnp-5343	133	22	are	be	AUX
fnp-5343	133	23	more	more	ADV
fnp-5343	133	24	common	common	ADJ
fnp-5343	133	25	in	in	ADP
fnp-5343	133	26	the	the	DET
fnp-5343	133	27	6	6	NUM
fnp-5343	133	28	months	month	NOUN
fnp-5343	133	29	following	follow	VERB
fnp-5343	133	30	the	the	DET
fnp-5343	133	31	diagnosis	diagnosis	NOUN
fnp-5343	133	32	of	of	ADP
fnp-5343	133	33	covid-19	covid-19	PROPN
fnp-5343	133	34	compared	compare	VERB
fnp-5343	133	35	to	to	ADP
fnp-5343	133	36	other	other	ADJ
fnp-5343	133	37	respiratory	respiratory	ADJ
fnp-5343	133	38	infections	infection	NOUN
fnp-5343	133	39	such	such	ADJ
fnp-5343	133	40	as	as	ADP
fnp-5343	133	41	influenza	influenza	NOUN
fnp-5343	133	42	[	[	X
fnp-5343	133	43	155	155	NUM
fnp-5343	133	44	]	]	PUNCT
fnp-5343	133	45	.	.	PUNCT
fnp-5343	134	1	pcc	pcc	PROPN
fnp-5343	134	2	can	can	AUX
fnp-5343	134	3	occur	occur	VERB
fnp-5343	134	4	regardless	regardless	ADV
fnp-5343	134	5	of	of	ADP
fnp-5343	134	6	the	the	DET
fnp-5343	134	7	severity	severity	NOUN
fnp-5343	134	8	of	of	ADP
fnp-5343	134	9	acute	acute	ADJ
fnp-5343	134	10	disease	disease	NOUN
fnp-5343	134	11	but	but	CCONJ
fnp-5343	134	12	is	be	AUX
fnp-5343	134	13	more	more	ADV
fnp-5343	134	14	severe	severe	ADJ
fnp-5343	134	15	in	in	ADP
fnp-5343	134	16	hospitalized	hospitalize	VERB
fnp-5343	134	17	patients	patient	NOUN
fnp-5343	134	18	,	,	PUNCT
fnp-5343	134	19	and	and	CCONJ
fnp-5343	134	20	those	those	PRON
fnp-5343	134	21	with	with	ADP
fnp-5343	134	22	comorbidities	comorbiditie	NOUN
fnp-5343	134	23	appear	appear	VERB
fnp-5343	134	24	to	to	PART
fnp-5343	134	25	be	be	AUX
fnp-5343	134	26	at	at	ADP
fnp-5343	134	27	increased	increase	VERB
fnp-5343	134	28	risk	risk	NOUN
fnp-5343	134	29	not	not	PART
fnp-5343	134	30	only	only	ADV
fnp-5343	134	31	for	for	ADP
fnp-5343	134	32	acute	acute	ADJ
fnp-5343	134	33	disease	disease	NOUN
fnp-5343	134	34	but	but	CCONJ
fnp-5343	134	35	also	also	ADV
fnp-5343	134	36	for	for	ADP
fnp-5343	134	37	pcc	pcc	NOUN
fnp-5343	134	38	[	[	X
fnp-5343	134	39	160,164,171	160,164,171	NUM
fnp-5343	134	40	]	]	PUNCT
fnp-5343	134	41	.	.	PUNCT
fnp-5343	135	1	vaccination	vaccination	NOUN
fnp-5343	135	2	may	may	AUX
fnp-5343	135	3	be	be	AUX
fnp-5343	135	4	less	less	ADV
fnp-5343	135	5	effective	effective	ADJ
fnp-5343	135	6	at	at	ADP
fnp-5343	135	7	preventing	prevent	VERB
fnp-5343	135	8	pcc	pcc	NOUN
fnp-5343	135	9	than	than	ADP
fnp-5343	135	10	severe	severe	ADJ
fnp-5343	135	11	acute	acute	NOUN
fnp-5343	135	12	covid-19	covid-19	PROPN
fnp-5343	136	1	[	[	X
fnp-5343	136	2	172	172	NUM
fnp-5343	136	3	]	]	PUNCT
fnp-5343	136	4	.	.	PUNCT
fnp-5343	137	1	further	further	ADJ
fnp-5343	137	2	clinical	clinical	ADJ
fnp-5343	137	3	phenotyping	phenotyping	NOUN
fnp-5343	137	4	of	of	ADP
fnp-5343	137	5	pcc	pcc	PROPN
fnp-5343	137	6	,	,	PUNCT
fnp-5343	137	7	as	as	ADP
fnp-5343	137	8	with	with	ADP
fnp-5343	137	9	hand	hand	NOUN
fnp-5343	137	10	in	in	ADP
fnp-5343	137	11	hiv	hiv	PROPN
fnp-5343	137	12	,	,	PUNCT
fnp-5343	137	13	may	may	AUX
fnp-5343	137	14	be	be	AUX
fnp-5343	137	15	helpful	helpful	ADJ
fnp-5343	137	16	in	in	ADP
fnp-5343	137	17	further	far	ADV
fnp-5343	137	18	defining	define	VERB
fnp-5343	137	19	research	research	NOUN
fnp-5343	137	20	nosology	nosology	NOUN
fnp-5343	138	1	[	[	X
fnp-5343	138	2	24	24	NUM
fnp-5343	138	3	]	]	PUNCT
fnp-5343	138	4	.	.	PUNCT
fnp-5343	139	1	brain	brain	NOUN
fnp-5343	139	2	mri	mri	NOUN
fnp-5343	139	3	findings	finding	NOUN
fnp-5343	139	4	in	in	ADP
fnp-5343	139	5	patients	patient	NOUN
fnp-5343	139	6	with	with	ADP
fnp-5343	139	7	acute	acute	NOUN
fnp-5343	139	8	covid-19	covid-19	PROPN
fnp-5343	139	9	presenting	present	VERB
fnp-5343	139	10	with	with	ADP
fnp-5343	139	11	neurologic	neurologic	ADJ
fnp-5343	139	12	symptoms	symptom	NOUN
fnp-5343	139	13	include	include	VERB
fnp-5343	139	14	acute	acute	ADJ
fnp-5343	139	15	/	/	SYM
fnp-5343	139	16	subacute	subacute	NOUN
fnp-5343	139	17	infarct	infarct	NOUN
fnp-5343	139	18	,	,	PUNCT
fnp-5343	139	19	which	which	PRON
fnp-5343	139	20	is	be	AUX
fnp-5343	139	21	the	the	DET
fnp-5343	139	22	most	most	ADV
fnp-5343	139	23	common	common	ADJ
fnp-5343	139	24	finding	finding	NOUN
fnp-5343	139	25	,	,	PUNCT
fnp-5343	139	26	abnormalities	abnormality	NOUN
fnp-5343	139	27	of	of	ADP
fnp-5343	139	28	the	the	DET
fnp-5343	139	29	olfactory	olfactory	NOUN
fnp-5343	139	30	bulb	bulb	NOUN
fnp-5343	139	31	,	,	PUNCT
fnp-5343	139	32	white	white	ADJ
fnp-5343	139	33	matter	matter	NOUN
fnp-5343	139	34	abnormalities	abnormality	NOUN
fnp-5343	139	35	,	,	PUNCT
fnp-5343	139	36	cerebral	cerebral	ADJ
fnp-5343	139	37	microbleeds	microbleed	NOUN
fnp-5343	139	38	,	,	PUNCT
fnp-5343	139	39	gray	gray	ADJ
fnp-5343	139	40	matter	matter	NOUN
fnp-5343	139	41	abnormalities	abnormality	NOUN
fnp-5343	139	42	,	,	PUNCT
fnp-5343	139	43	leptomeningeal	leptomeningeal	NOUN
fnp-5343	139	44	enhancement	enhancement	NOUN
fnp-5343	139	45	,	,	PUNCT
fnp-5343	139	46	acute	acute	NOUN
fnp-5343	139	47	disseminated	disseminate	VERB
fnp-5343	139	48	encephalomyelitis	encephalomyelitis	NOUN
fnp-5343	139	49	(	(	PUNCT
fnp-5343	139	50	adem	adem	PROPN
fnp-5343	139	51	)	)	PUNCT
fnp-5343	139	52	and	and	CCONJ
fnp-5343	139	53	adem	adem	PROPN
fnp-5343	139	54	-	-	PUNCT
fnp-5343	139	55	like	like	ADJ
fnp-5343	139	56	lesions	lesion	NOUN
fnp-5343	139	57	,	,	PUNCT
fnp-5343	139	58	intracerebral	intracerebral	ADJ
fnp-5343	139	59	hemorrhage	hemorrhage	NOUN
fnp-5343	139	60	,	,	PUNCT
fnp-5343	139	61	and	and	CCONJ
fnp-5343	139	62	posterior	posterior	ADJ
fnp-5343	139	63	reversible	reversible	ADJ
fnp-5343	139	64	encephalopathy	encephalopathy	ADJ
fnp-5343	139	65	syndrome	syndrome	NOUN
fnp-5343	139	66	(	(	PUNCT
fnp-5343	139	67	pres	pre	NOUN
fnp-5343	139	68	)	)	PUNCT
fnp-5343	140	1	[	[	X
fnp-5343	140	2	173,174	173,174	NUM
fnp-5343	140	3	]	]	PUNCT
fnp-5343	140	4	.	.	PUNCT
fnp-5343	141	1	in	in	ADP
fnp-5343	141	2	18f	18f	PROPN
fnp-5343	141	3	-	-	PUNCT
fnp-5343	141	4	fdg	fdg	PROPN
fnp-5343	141	5	pet	pet	PROPN
fnp-5343	141	6	studies	study	NOUN
fnp-5343	141	7	,	,	PUNCT
fnp-5343	141	8	subacute	subacute	VERB
fnp-5343	141	9	covid-19	covid-19	PROPN
fnp-5343	141	10	patients	patient	NOUN
fnp-5343	141	11	have	have	AUX
fnp-5343	141	12	shown	show	VERB
fnp-5343	141	13	hypometabolism	hypometabolism	NOUN
fnp-5343	141	14	in	in	ADP
fnp-5343	141	15	the	the	DET
fnp-5343	141	16	frontoparietal	frontoparietal	ADJ
fnp-5343	141	17	cortex	cortex	NOUN
fnp-5343	141	18	,	,	PUNCT
fnp-5343	141	19	which	which	PRON
fnp-5343	141	20	correlated	correlate	VERB
fnp-5343	141	21	with	with	ADP
fnp-5343	141	22	cognitive	cognitive	ADJ
fnp-5343	141	23	performance	performance	NOUN
fnp-5343	141	24	,	,	PUNCT
fnp-5343	141	25	with	with	ADP
fnp-5343	141	26	reduction	reduction	NOUN
fnp-5343	141	27	in	in	ADP
fnp-5343	141	28	hypometabolism	hypometabolism	NOUN
fnp-5343	141	29	along	along	ADP
fnp-5343	141	30	with	with	ADP
fnp-5343	141	31	improvement	improvement	NOUN
fnp-5343	141	32	in	in	ADP
fnp-5343	141	33	cognitive	cognitive	ADJ
fnp-5343	141	34	performance	performance	NOUN
fnp-5343	141	35	approximately	approximately	ADV
fnp-5343	141	36	6	6	NUM
fnp-5343	141	37	months	month	NOUN
fnp-5343	141	38	after	after	ADP
fnp-5343	141	39	onset	onset	NOUN
fnp-5343	141	40	of	of	ADP
fnp-5343	141	41	symptoms	symptom	NOUN
fnp-5343	141	42	[	[	X
fnp-5343	141	43	175,176	175,176	NUM
fnp-5343	141	44	]	]	PUNCT
fnp-5343	141	45	.	.	PUNCT
fnp-5343	142	1	in	in	ADP
fnp-5343	142	2	a	a	DET
fnp-5343	142	3	large	large	ADJ
fnp-5343	142	4	longitudinal	longitudinal	ADJ
fnp-5343	142	5	study	study	NOUN
fnp-5343	142	6	examining	examine	VERB
fnp-5343	142	7	participants	participant	NOUN
fnp-5343	142	8	in	in	ADP
fnp-5343	142	9	the	the	DET
fnp-5343	142	10	uk	uk	PROPN
fnp-5343	142	11	biobank	biobank	PROPN
fnp-5343	142	12	who	who	PRON
fnp-5343	142	13	had	have	AUX
fnp-5343	142	14	undergone	undergo	VERB
fnp-5343	142	15	repeat	repeat	NOUN
fnp-5343	142	16	imaging	imaging	NOUN
fnp-5343	142	17	,	,	PUNCT
fnp-5343	142	18	a	a	DET
fnp-5343	142	19	decrease	decrease	NOUN
fnp-5343	142	20	in	in	ADP
fnp-5343	142	21	gray	gray	ADJ
fnp-5343	142	22	matter	matter	NOUN
fnp-5343	142	23	thickness	thickness	NOUN
fnp-5343	142	24	in	in	ADP
fnp-5343	142	25	the	the	DET
fnp-5343	142	26	orbitofrontal	orbitofrontal	ADJ
fnp-5343	142	27	cortex	cortex	NOUN
fnp-5343	142	28	and	and	CCONJ
fnp-5343	142	29	parahippocampal	parahippocampal	ADJ
fnp-5343	142	30	gyrus	gyrus	NOUN
fnp-5343	142	31	as	as	ADV
fnp-5343	142	32	well	well	ADV
fnp-5343	142	33	as	as	ADP
fnp-5343	142	34	decrease	decrease	NOUN
fnp-5343	142	35	in	in	ADP
fnp-5343	142	36	global	global	ADJ
fnp-5343	142	37	brain	brain	NOUN
fnp-5343	142	38	size	size	NOUN
fnp-5343	142	39	were	be	AUX
fnp-5343	142	40	seen	see	VERB
fnp-5343	142	41	between	between	ADP
fnp-5343	142	42	two	two	NUM
fnp-5343	142	43	scans	scan	NOUN
fnp-5343	142	44	in	in	ADP
fnp-5343	142	45	those	those	PRON
fnp-5343	142	46	who	who	PRON
fnp-5343	142	47	had	have	AUX
fnp-5343	142	48	been	be	AUX
fnp-5343	142	49	infected	infect	VERB
fnp-5343	142	50	by	by	ADP
fnp-5343	142	51	sars	sar	NOUN
fnp-5343	142	52	-	-	PUNCT
fnp-5343	142	53	cov-2	cov-2	NOUN
fnp-5343	142	54	,	,	PUNCT
fnp-5343	142	55	likely	likely	ADJ
fnp-5343	142	56	with	with	ADP
fnp-5343	142	57	different	different	ADJ
fnp-5343	142	58	variants	variant	NOUN
fnp-5343	142	59	and	and	CCONJ
fnp-5343	142	60	averaging	average	VERB
fnp-5343	142	61	4	4	NUM
fnp-5343	142	62	-	-	SYM
fnp-5343	142	63	5	5	NUM
fnp-5343	142	64	months	month	NOUN
fnp-5343	142	65	after	after	ADP
fnp-5343	142	66	infection	infection	NOUN
fnp-5343	142	67	,	,	PUNCT
fnp-5343	142	68	compared	compare	VERB
fnp-5343	142	69	to	to	ADP
fnp-5343	142	70	those	those	PRON
fnp-5343	142	71	who	who	PRON
fnp-5343	142	72	had	have	AUX
fnp-5343	142	73	not	not	PART
fnp-5343	142	74	been	be	AUX
fnp-5343	142	75	infected	infect	VERB
fnp-5343	142	76	by	by	ADP
fnp-5343	142	77	sars	sar	NOUN
fnp-5343	142	78	-	-	PUNCT
fnp-5343	142	79	cov-2	cov-2	NOUN
fnp-5343	142	80	[	[	NOUN
fnp-5343	142	81	177	177	NUM
fnp-5343	142	82	]	]	PUNCT
fnp-5343	142	83	.	.	PUNCT
fnp-5343	143	1	greater	great	ADJ
fnp-5343	143	2	cognitive	cognitive	ADJ
fnp-5343	143	3	decline	decline	NOUN
fnp-5343	143	4	was	be	AUX
fnp-5343	143	5	also	also	ADV
fnp-5343	143	6	seen	see	VERB
fnp-5343	143	7	in	in	ADP
fnp-5343	143	8	the	the	DET
fnp-5343	143	9	sars	sar	NOUN
fnp-5343	143	10	-	-	PUNCT
fnp-5343	143	11	cov-2	cov-2	NOUN
fnp-5343	143	12	positive	positive	ADJ
fnp-5343	143	13	group	group	NOUN
fnp-5343	143	14	[	[	X
fnp-5343	143	15	177	177	NUM
fnp-5343	143	16	]	]	PUNCT
fnp-5343	143	17	.	.	PUNCT
fnp-5343	144	1	subsequently	subsequently	ADV
fnp-5343	144	2	,	,	PUNCT
fnp-5343	144	3	du	du	PROPN
fnp-5343	144	4	et	et	PROPN
fnp-5343	144	5	al	al	PROPN
fnp-5343	144	6	.	.	PROPN
fnp-5343	144	7	found	find	VERB
fnp-5343	144	8	that	that	SCONJ
fnp-5343	144	9	male	male	ADJ
fnp-5343	144	10	patients	patient	NOUN
fnp-5343	144	11	demonstrated	demonstrate	VERB
fnp-5343	144	12	reduced	reduce	VERB
fnp-5343	144	13	gray	gray	ADJ
fnp-5343	144	14	matter	matter	NOUN
fnp-5343	144	15	thickness	thickness	NOUN
fnp-5343	144	16	in	in	ADP
fnp-5343	144	17	the	the	DET
fnp-5343	144	18	parietal	parietal	ADJ
fnp-5343	144	19	and	and	CCONJ
fnp-5343	144	20	occipital	occipital	ADJ
fnp-5343	144	21	cortices	cortex	NOUN
fnp-5343	144	22	and	and	CCONJ
fnp-5343	144	23	hippocampal	hippocampal	ADJ
fnp-5343	144	24	volume	volume	NOUN
fnp-5343	144	25	after	after	ADP
fnp-5343	144	26	omicron	omicron	PROPN
fnp-5343	144	27	infection	infection	NOUN
fnp-5343	144	28	compared	compare	VERB
fnp-5343	144	29	to	to	ADP
fnp-5343	144	30	before	before	ADP
fnp-5343	144	31	infection	infection	NOUN
fnp-5343	144	32	[	[	X
fnp-5343	144	33	178	178	NUM
fnp-5343	144	34	]	]	PUNCT
fnp-5343	144	35	.	.	PUNCT
fnp-5343	145	1	in	in	ADP
fnp-5343	145	2	patients	patient	NOUN
fnp-5343	145	3	diagnosed	diagnose	VERB
fnp-5343	145	4	with	with	ADP
fnp-5343	145	5	pcc	pcc	PROPN
fnp-5343	145	6	,	,	PUNCT
fnp-5343	145	7	gray	gray	ADJ
fnp-5343	145	8	matter	matter	NOUN
fnp-5343	145	9	volume	volume	NOUN
fnp-5343	145	10	loss	loss	NOUN
fnp-5343	145	11	has	have	AUX
fnp-5343	145	12	been	be	AUX
fnp-5343	145	13	associated	associate	VERB
fnp-5343	145	14	with	with	ADP
fnp-5343	145	15	cognitive	cognitive	ADJ
fnp-5343	145	16	dysfunction	dysfunction	NOUN
fnp-5343	145	17	[	[	X
fnp-5343	145	18	179	179	NUM
fnp-5343	145	19	]	]	PUNCT
fnp-5343	145	20	.	.	PUNCT
fnp-5343	146	1	neuropathologic	neuropathologic	PROPN
fnp-5343	146	2	findings	finding	NOUN
fnp-5343	146	3	brain	brain	VERB
fnp-5343	146	4	autopsy	autopsy	ADJ
fnp-5343	146	5	examination	examination	NOUN
fnp-5343	146	6	of	of	ADP
fnp-5343	146	7	patients	patient	NOUN
fnp-5343	146	8	who	who	PRON
fnp-5343	146	9	died	die	VERB
fnp-5343	146	10	from	from	ADP
fnp-5343	146	11	covid-19	covid-19	PROPN
fnp-5343	146	12	have	have	AUX
fnp-5343	146	13	shown	show	VERB
fnp-5343	146	14	a	a	DET
fnp-5343	146	15	variety	variety	NOUN
fnp-5343	146	16	of	of	ADP
fnp-5343	146	17	neuropathologic	neuropathologic	ADJ
fnp-5343	146	18	findings	finding	NOUN
fnp-5343	146	19	,	,	PUNCT
fnp-5343	146	20	although	although	SCONJ
fnp-5343	146	21	many	many	ADJ
fnp-5343	146	22	are	be	AUX
fnp-5343	146	23	non	non	ADJ
fnp-5343	146	24	-	-	ADJ
fnp-5343	146	25	specific	specific	ADJ
fnp-5343	146	26	[	[	X
fnp-5343	146	27	180–184	180–184	NUM
fnp-5343	146	28	]	]	X
fnp-5343	146	29	.	.	PUNCT
fnp-5343	147	1	most	most	ADV
fnp-5343	147	2	commonly	commonly	ADV
fnp-5343	147	3	seen	see	VERB
fnp-5343	147	4	are	be	AUX
fnp-5343	147	5	acute	acute	ADJ
fnp-5343	147	6	hypoxic	hypoxic	ADV
fnp-5343	147	7	-	-	PUNCT
fnp-5343	147	8	ischemic	ischemic	ADJ
fnp-5343	147	9	changes	change	NOUN
fnp-5343	147	10	with	with	ADP
fnp-5343	147	11	neuronal	neuronal	ADJ
fnp-5343	147	12	eosinophilia	eosinophilia	NOUN
fnp-5343	147	13	,	,	PUNCT
fnp-5343	147	14	acute	acute	ADJ
fnp-5343	147	15	/	/	SYM
fnp-5343	147	16	subacute	subacute	NOUN
fnp-5343	147	17	infarcts	infarct	NOUN
fnp-5343	147	18	(	(	PUNCT
fnp-5343	147	19	figure	figure	NOUN
fnp-5343	147	20	1	1	NUM
fnp-5343	147	21	)	)	PUNCT
fnp-5343	147	22	with	with	ADP
fnp-5343	147	23	macrophage	macrophage	ADJ
fnp-5343	147	24	infiltration	infiltration	NOUN
fnp-5343	147	25	and	and	CCONJ
fnp-5343	147	26	neovascularization	neovascularization	NOUN
fnp-5343	147	27	,	,	PUNCT
fnp-5343	147	28	hemorrhage	hemorrhage	NOUN
fnp-5343	147	29	[	[	X
fnp-5343	147	30	149,185–191	149,185–191	NUM
fnp-5343	147	31	]	]	PUNCT
fnp-5343	147	32	,	,	PUNCT
fnp-5343	147	33	microthrombi	microthrombi	NOUN
fnp-5343	148	1	[	[	X
fnp-5343	149	1	192–194	192–194	NUM
fnp-5343	149	2	]	]	PUNCT
fnp-5343	149	3	,	,	PUNCT
fnp-5343	149	4	astrogliosis	astrogliosis	NOUN
fnp-5343	149	5	and	and	CCONJ
fnp-5343	149	6	microglial	microglial	ADJ
fnp-5343	149	7	activation	activation	NOUN
fnp-5343	149	8	occasionally	occasionally	ADV
fnp-5343	149	9	with	with	ADP
fnp-5343	149	10	microglial	microglial	ADJ
fnp-5343	149	11	nodules	nodule	NOUN
fnp-5343	149	12	and	and	CCONJ
fnp-5343	149	13	neuronophagia	neuronophagia	NOUN
fnp-5343	149	14	especially	especially	ADV
fnp-5343	149	15	in	in	ADP
fnp-5343	149	16	the	the	DET
fnp-5343	149	17	cerebellum	cerebellum	NOUN
fnp-5343	149	18	and	and	CCONJ
fnp-5343	149	19	brainstem	brainstem	NOUN
fnp-5343	149	20	[	[	X
fnp-5343	149	21	185,195–199	185,195–199	NOUN
fnp-5343	149	22	]	]	PUNCT
fnp-5343	149	23	,	,	PUNCT
fnp-5343	149	24	and	and	CCONJ
fnp-5343	149	25	t	t	NOUN
fnp-5343	149	26	-	-	PUNCT
fnp-5343	149	27	lymphocytic	lymphocytic	ADJ
fnp-5343	149	28	infiltration	infiltration	NOUN
fnp-5343	149	29	,	,	PUNCT
fnp-5343	149	30	predominantly	predominantly	ADV
fnp-5343	149	31	sparse	sparse	ADJ
fnp-5343	149	32	in	in	ADP
fnp-5343	149	33	a	a	DET
fnp-5343	149	34	perivascular	perivascular	ADJ
fnp-5343	149	35	distribution	distribution	NOUN
fnp-5343	149	36	[	[	X
fnp-5343	149	37	180,182,185,186,193	180,182,185,186,193	NUM
fnp-5343	149	38	,	,	PUNCT
fnp-5343	149	39	195,200,201	195,200,201	NUM
fnp-5343	149	40	]	]	PUNCT
fnp-5343	149	41	.	.	PUNCT
fnp-5343	150	1	similar	similar	ADJ
fnp-5343	150	2	features	feature	NOUN
fnp-5343	150	3	including	include	VERB
fnp-5343	150	4	hypoxic	hypoxic	ADJ
fnp-5343	150	5	-	-	PUNCT
fnp-5343	150	6	ischemic	ischemic	ADJ
fnp-5343	150	7	injury	injury	NOUN
fnp-5343	150	8	,	,	PUNCT
fnp-5343	150	9	microinfarcts	microinfarct	NOUN
fnp-5343	150	10	,	,	PUNCT
fnp-5343	150	11	hemorrhage	hemorrhage	NOUN
fnp-5343	150	12	,	,	PUNCT
fnp-5343	150	13	and	and	CCONJ
fnp-5343	150	14	sparse	sparse	VERB
fnp-5343	150	15	lymphocytic	lymphocytic	ADJ
fnp-5343	150	16	infiltrate	infiltrate	NOUN
fnp-5343	150	17	as	as	ADV
fnp-5343	150	18	well	well	ADV
fnp-5343	150	19	as	as	ADP
fnp-5343	150	20	fibrinogen	fibrinogen	NOUN
fnp-5343	150	21	leakage	leakage	NOUN
fnp-5343	150	22	were	be	AUX
fnp-5343	150	23	seen	see	VERB
fnp-5343	150	24	between	between	ADP
fnp-5343	150	25	delta	delta	PROPN
fnp-5343	150	26	,	,	PUNCT
fnp-5343	150	27	omicron	omicron	PROPN
fnp-5343	150	28	and	and	CCONJ
fnp-5343	150	29	non	non	ADJ
fnp-5343	150	30	-	-	ADJ
fnp-5343	150	31	delta	delta	ADJ
fnp-5343	150	32	/	/	SYM
fnp-5343	150	33	non	non	ADJ
fnp-5343	150	34	-	-	ADJ
fnp-5343	150	35	omicron	omicron	ADJ
fnp-5343	150	36	variants	variant	NOUN
fnp-5343	151	1	[	[	X
fnp-5343	151	2	202	202	NUM
fnp-5343	151	3	]	]	PUNCT
fnp-5343	151	4	.	.	PUNCT
fnp-5343	152	1	other	other	ADJ
fnp-5343	152	2	findings	finding	NOUN
fnp-5343	152	3	described	describe	VERB
fnp-5343	152	4	in	in	ADP
fnp-5343	152	5	patients	patient	NOUN
fnp-5343	152	6	who	who	PRON
fnp-5343	152	7	died	die	VERB
fnp-5343	152	8	from	from	ADP
fnp-5343	152	9	acute	acute	ADJ
fnp-5343	152	10	covid-19	covid-19	PROPN
fnp-5343	152	11	infection	infection	NOUN
fnp-5343	152	12	include	include	VERB
fnp-5343	152	13	perivascular	perivascular	ADJ
fnp-5343	152	14	hemosiderin	hemosiderin	ADJ
fnp-5343	152	15	deposition	deposition	NOUN
fnp-5343	152	16	/	/	SYM
fnp-5343	152	17	leakage	leakage	NOUN
fnp-5343	152	18	[	[	X
fnp-5343	152	19	182,193	182,193	NUM
fnp-5343	152	20	]	]	PUNCT
fnp-5343	152	21	,	,	PUNCT
fnp-5343	152	22	though	though	SCONJ
fnp-5343	152	23	perivascular	perivascular	ADJ
fnp-5343	152	24	hemosiderin	hemosiderin	ADJ
fnp-5343	152	25	deposition	deposition	NOUN
fnp-5343	152	26	is	be	AUX
fnp-5343	152	27	a	a	DET
fnp-5343	152	28	common	common	ADJ
fnp-5343	152	29	finding	finding	NOUN
fnp-5343	152	30	in	in	ADP
fnp-5343	152	31	autopsy	autopsy	ADJ
fnp-5343	152	32	brains	brain	NOUN
fnp-5343	152	33	,	,	PUNCT
fnp-5343	152	34	especially	especially	ADV
fnp-5343	152	35	in	in	ADP
fnp-5343	152	36	older	old	ADJ
fnp-5343	152	37	individuals	individual	NOUN
fnp-5343	152	38	,	,	PUNCT
fnp-5343	152	39	and	and	CCONJ
fnp-5343	152	40	can	can	AUX
fnp-5343	152	41	be	be	AUX
fnp-5343	152	42	seen	see	VERB
fnp-5343	152	43	in	in	ADP
fnp-5343	152	44	both	both	DET
fnp-5343	152	45	brains	brain	NOUN
fnp-5343	152	46	with	with	ADP
fnp-5343	152	47	and	and	CCONJ
fnp-5343	152	48	without	without	ADP
fnp-5343	152	49	significant	significant	ADJ
fnp-5343	152	50	vascular	vascular	ADJ
fnp-5343	152	51	disease	disease	NOUN
fnp-5343	152	52	[	[	X
fnp-5343	152	53	182,203–206	182,203–206	NOUN
fnp-5343	152	54	]	]	PUNCT
fnp-5343	152	55	.	.	PUNCT
fnp-5343	153	1	they	they	PRON
fnp-5343	153	2	have	have	AUX
fnp-5343	153	3	also	also	ADV
fnp-5343	153	4	been	be	AUX
fnp-5343	153	5	shown	show	VERB
fnp-5343	153	6	to	to	PART
fnp-5343	153	7	correspond	correspond	VERB
fnp-5343	153	8	to	to	ADP
fnp-5343	153	9	a	a	DET
fnp-5343	153	10	subset	subset	NOUN
fnp-5343	153	11	of	of	ADP
fnp-5343	153	12	cerebral	cerebral	ADJ
fnp-5343	153	13	microbleeds	microbleed	NOUN
fnp-5343	153	14	on	on	ADP
fnp-5343	153	15	mri	mri	NOUN
fnp-5343	153	16	[	[	X
fnp-5343	153	17	207	207	NUM
fnp-5343	153	18	]	]	PUNCT
fnp-5343	153	19	.	.	PUNCT
fnp-5343	154	1	megakaryocytes	megakaryocyte	NOUN
fnp-5343	154	2	in	in	ADP
fnp-5343	154	3	cortical	cortical	ADJ
fnp-5343	154	4	capillaries	capillary	NOUN
fnp-5343	154	5	and	and	CCONJ
fnp-5343	154	6	in	in	ADP
fnp-5343	154	7	an	an	DET
fnp-5343	154	8	infarct	infarct	NOUN
fnp-5343	154	9	were	be	AUX
fnp-5343	154	10	also	also	ADV
fnp-5343	154	11	reported	report	VERB
fnp-5343	154	12	in	in	ADP
fnp-5343	154	13	acute	acute	NOUN
fnp-5343	154	14	covid-19	covid-19	PROPN
fnp-5343	154	15	,	,	PUNCT
fnp-5343	154	16	but	but	CCONJ
fnp-5343	154	17	capillary	capillary	ADJ
fnp-5343	154	18	megakaryocytes	megakaryocyte	NOUN
fnp-5343	154	19	can	can	AUX
fnp-5343	154	20	been	be	AUX
fnp-5343	154	21	seen	see	VERB
fnp-5343	154	22	in	in	ADP
fnp-5343	154	23	the	the	DET
fnp-5343	154	24	setting	setting	NOUN
fnp-5343	154	25	of	of	ADP
fnp-5343	154	26	lung	lung	NOUN
fnp-5343	154	27	injury	injury	NOUN
fnp-5343	154	28	due	due	ADP
fnp-5343	154	29	to	to	ADP
fnp-5343	154	30	a	a	DET
fnp-5343	154	31	variety	variety	NOUN
fnp-5343	154	32	of	of	ADP
fnp-5343	154	33	causes	cause	NOUN
fnp-5343	155	1	[	[	X
fnp-5343	155	2	208–210	208–210	NUM
fnp-5343	155	3	]	]	X
fnp-5343	155	4	.	.	PUNCT
fnp-5343	156	1	uncommon	uncommon	ADJ
fnp-5343	156	2	findings	finding	NOUN
fnp-5343	156	3	include	include	VERB
fnp-5343	156	4	multifocal	multifocal	ADJ
fnp-5343	156	5	necrotizing	necrotizing	NOUN
fnp-5343	156	6	leukoencephalopathy	leukoencephalopathy	NOUN
fnp-5343	157	1	[	[	X
fnp-5343	157	2	185	185	NUM
fnp-5343	157	3	]	]	PUNCT
fnp-5343	157	4	,	,	PUNCT
fnp-5343	157	5	acute	acute	NOUN
fnp-5343	157	6	encephalitis	encephalitis	NOUN
fnp-5343	157	7	with	with	ADP
fnp-5343	157	8	lymphohistiocytic	lymphohistiocytic	ADJ
fnp-5343	157	9	infiltrate	infiltrate	NOUN
fnp-5343	157	10	and	and	CCONJ
fnp-5343	157	11	hemorrhage	hemorrhage	NOUN
fnp-5343	157	12	[	[	X
fnp-5343	157	13	200	200	NUM
fnp-5343	157	14	]	]	PUNCT
fnp-5343	157	15	,	,	PUNCT
fnp-5343	157	16	and	and	CCONJ
fnp-5343	157	17	adem	adem	PROPN
fnp-5343	157	18	/	/	SYM
fnp-5343	157	19	acute	acute	ADJ
fnp-5343	157	20	hemorrhagic	hemorrhagic	NOUN
fnp-5343	157	21	leukoencephalopathy	leukoencephalopathy	ADV
fnp-5343	157	22	(	(	PUNCT
fnp-5343	157	23	ahle	ahle	X
fnp-5343	157	24	)	)	PUNCT
fnp-5343	157	25	and	and	CCONJ
fnp-5343	157	26	adem	adem	PROPN
fnp-5343	157	27	/	/	SYM
fnp-5343	157	28	ahle	ahle	ADJ
fnp-5343	157	29	-	-	PUNCT
fnp-5343	157	30	like	like	ADJ
fnp-5343	157	31	pathology	pathology	NOUN
fnp-5343	157	32	[	[	X
fnp-5343	157	33	149,195,211–213	149,195,211–213	NUM
fnp-5343	157	34	]	]	X
fnp-5343	157	35	.	.	PUNCT
fnp-5343	158	1	some	some	DET
fnp-5343	158	2	comorbid	comorbid	NOUN
fnp-5343	158	3	neuropathologic	neuropathologic	PROPN
fnp-5343	158	4	findings	finding	NOUN
fnp-5343	158	5	described	describe	VERB
fnp-5343	158	6	include	include	VERB
fnp-5343	158	7	other	other	ADJ
fnp-5343	158	8	infections	infection	NOUN
fnp-5343	158	9	such	such	ADJ
fnp-5343	158	10	as	as	ADP
fnp-5343	158	11	hsv-1	hsv-1	PRON
fnp-5343	158	12	encephalitis	encephalitis	NOUN
fnp-5343	158	13	[	[	X
fnp-5343	158	14	185	185	NUM
fnp-5343	158	15	]	]	PUNCT
fnp-5343	158	16	and	and	CCONJ
fnp-5343	158	17	bacterial	bacterial	ADJ
fnp-5343	158	18	infection	infection	NOUN
fnp-5343	158	19	[	[	X
fnp-5343	158	20	193	193	NUM
fnp-5343	158	21	]	]	PUNCT
fnp-5343	158	22	,	,	PUNCT
fnp-5343	158	23	neurodegenerative	neurodegenerative	ADJ
fnp-5343	158	24	diseases	disease	NOUN
fnp-5343	158	25	including	include	VERB
fnp-5343	158	26	alzheimer	alzheimer	NOUN
fnp-5343	158	27	disease	disease	NOUN
fnp-5343	158	28	and	and	CCONJ
fnp-5343	158	29	lewy	lewy	ADJ
fnp-5343	158	30	body	body	NOUN
fnp-5343	158	31	disease	disease	NOUN
fnp-5343	158	32	[	[	X
fnp-5343	158	33	185,195	185,195	NUM
fnp-5343	158	34	]	]	X
fnp-5343	158	35	,	,	PUNCT
fnp-5343	158	36	and	and	CCONJ
fnp-5343	158	37	cerebrovascular	cerebrovascular	ADJ
fnp-5343	158	38	disease	disease	NOUN
fnp-5343	158	39	such	such	ADJ
fnp-5343	158	40	as	as	ADP
fnp-5343	158	41	cerebral	cerebral	ADJ
fnp-5343	158	42	amyloid	amyloid	NOUN
fnp-5343	158	43	angiopathy	angiopathy	NOUN
fnp-5343	158	44	[	[	X
fnp-5343	158	45	210	210	NUM
fnp-5343	158	46	]	]	PUNCT
fnp-5343	158	47	,	,	PUNCT
fnp-5343	158	48	not	not	PART
fnp-5343	158	49	surprising	surprising	ADJ
fnp-5343	158	50	given	give	VERB
fnp-5343	158	51	the	the	DET
fnp-5343	158	52	older	old	ADJ
fnp-5343	158	53	patient	patient	ADJ
fnp-5343	158	54	age	age	NOUN
fnp-5343	158	55	in	in	ADP
fnp-5343	158	56	some	some	DET
fnp-5343	158	57	series	series	NOUN
fnp-5343	158	58	[	[	X
fnp-5343	158	59	185,195,200,214	185,195,200,214	NUM
fnp-5343	158	60	]	]	PUNCT
fnp-5343	158	61	.	.	PUNCT
fnp-5343	159	1	few	few	ADJ
fnp-5343	159	2	studies	study	NOUN
fnp-5343	159	3	have	have	AUX
fnp-5343	159	4	compared	compare	VERB
fnp-5343	159	5	brains	brain	NOUN
fnp-5343	159	6	from	from	ADP
fnp-5343	159	7	covid-19	covid-19	PROPN
fnp-5343	159	8	patients	patient	NOUN
fnp-5343	159	9	to	to	PART
fnp-5343	159	10	controls	control	VERB
fnp-5343	159	11	[	[	X
fnp-5343	159	12	152,197,198,200	152,197,198,200	NUM
fnp-5343	159	13	]	]	PUNCT
fnp-5343	159	14	.	.	PUNCT
fnp-5343	160	1	no	no	DET
fnp-5343	160	2	differences	difference	NOUN
fnp-5343	160	3	in	in	ADP
fnp-5343	160	4	frequencies	frequency	NOUN
fnp-5343	160	5	of	of	ADP
fnp-5343	160	6	hypoxic	hypoxic	ADJ
fnp-5343	160	7	-	-	PUNCT
fnp-5343	160	8	ischemic	ischemic	ADJ
fnp-5343	160	9	changes	change	NOUN
fnp-5343	160	10	,	,	PUNCT
fnp-5343	160	11	infarcts	infarct	NOUN
fnp-5343	160	12	or	or	CCONJ
fnp-5343	160	13	hemorrhages	hemorrhage	NOUN
fnp-5343	160	14	were	be	AUX
fnp-5343	160	15	seen	see	VERB
fnp-5343	160	16	between	between	ADP
fnp-5343	160	17	covid-19	covid-19	PROPN
fnp-5343	160	18	and	and	CCONJ
fnp-5343	160	19	non	non	ADJ
fnp-5343	160	20	-	-	ADJ
fnp-5343	160	21	covid-19	covid-19	ADJ
fnp-5343	160	22	patients	patient	NOUN
fnp-5343	160	23	in	in	ADP
fnp-5343	160	24	one	one	NUM
fnp-5343	160	25	study	study	NOUN
fnp-5343	160	26	[	[	X
fnp-5343	160	27	200	200	NUM
fnp-5343	160	28	]	]	PUNCT
fnp-5343	160	29	.	.	PUNCT
fnp-5343	161	1	in	in	ADP
fnp-5343	161	2	another	another	DET
fnp-5343	161	3	study	study	NOUN
fnp-5343	161	4	,	,	PUNCT
fnp-5343	161	5	perivascular	perivascular	ADJ
fnp-5343	161	6	and	and	CCONJ
fnp-5343	161	7	leptomeningeal	leptomeningeal	ADJ
fnp-5343	161	8	t	t	PROPN
fnp-5343	161	9	-	-	PUNCT
fnp-5343	161	10	lymphocytic	lymphocytic	ADJ
fnp-5343	161	11	infiltrates	infiltrate	NOUN
fnp-5343	161	12	were	be	AUX
fnp-5343	161	13	seen	see	VERB
fnp-5343	161	14	in	in	ADP
fnp-5343	161	15	both	both	DET
fnp-5343	161	16	covid-19	covid-19	PROPN
fnp-5343	161	17	patients	patient	NOUN
fnp-5343	161	18	and	and	CCONJ
fnp-5343	161	19	in	in	ADP
fnp-5343	161	20	controls	control	NOUN
fnp-5343	161	21	with	with	ADP
fnp-5343	161	22	sepsis	sepsis	NOUN
fnp-5343	161	23	/systemic	/systemic	ADJ
fnp-5343	161	24	inflammation	inflammation	NOUN
fnp-5343	161	25	,	,	PUNCT
fnp-5343	161	26	and	and	CCONJ
fnp-5343	161	27	microglial	microglial	ADJ
fnp-5343	161	28	,	,	PUNCT
fnp-5343	161	29	activation	activation	NOUN
fnp-5343	161	30	in	in	ADP
fnp-5343	161	31	the	the	DET
fnp-5343	161	32	pons	pon	NOUN
fnp-5343	161	33	in	in	ADP
fnp-5343	161	34	covid-19	covid-19	PROPN
fnp-5343	161	35	patients	patient	NOUN
fnp-5343	161	36	was	be	AUX
fnp-5343	161	37	greater	great	ADJ
fnp-5343	161	38	as	as	SCONJ
fnp-5343	161	39	compared	compare	VERB
fnp-5343	161	40	to	to	ADP
fnp-5343	161	41	controls	control	NOUN
fnp-5343	161	42	without	without	ADP
fnp-5343	161	43	sepsis	sepsis	NOUN
fnp-5343	161	44	but	but	CCONJ
fnp-5343	161	45	similar	similar	ADJ
fnp-5343	161	46	to	to	ADP
fnp-5343	161	47	controls	control	NOUN
fnp-5343	161	48	with	with	ADP
fnp-5343	161	49	sepsis	sepsis	NOUN
fnp-5343	161	50	[	[	X
fnp-5343	161	51	152	152	NUM
fnp-5343	161	52	]	]	PUNCT
fnp-5343	161	53	.	.	PUNCT
fnp-5343	162	1	however	however	ADV
fnp-5343	162	2	,	,	PUNCT
fnp-5343	162	3	lee	lee	PROPN
fnp-5343	162	4	et	et	PROPN
fnp-5343	162	5	al	al	PROPN
fnp-5343	162	6	.	.	PROPN
fnp-5343	162	7	showed	show	VERB
fnp-5343	162	8	that	that	SCONJ
fnp-5343	162	9	the	the	DET
fnp-5343	162	10	brains	brain	NOUN
fnp-5343	162	11	of	of	ADP
fnp-5343	162	12	covid-19	covid-19	PROPN
fnp-5343	162	13	patients	patient	NOUN
fnp-5343	162	14	demonstrate	demonstrate	VERB
fnp-5343	162	15	increased	increase	VERB
fnp-5343	162	16	leakage	leakage	NOUN
fnp-5343	162	17	of	of	ADP
fnp-5343	162	18	fibrinogen	fibrinogen	NOUN
fnp-5343	162	19	,	,	PUNCT
fnp-5343	162	20	consistent	consistent	ADJ
fnp-5343	162	21	with	with	ADP
fnp-5343	162	22	bbb	bbb	PROPN
fnp-5343	162	23	disruption	disruption	NOUN
fnp-5343	162	24	,	,	PUNCT
fnp-5343	162	25	complement	complement	NOUN
fnp-5343	162	26	activation	activation	NOUN
fnp-5343	162	27	and	and	CCONJ
fnp-5343	162	28	microthrombi	microthrombi	NOUN
fnp-5343	162	29	compared	compare	VERB
fnp-5343	162	30	to	to	ADP
fnp-5343	162	31	controls	control	NOUN
fnp-5343	162	32	,	,	PUNCT
fnp-5343	162	33	supportive	supportive	ADJ
fnp-5343	162	34	of	of	ADP
fnp-5343	162	35	neurovascular	neurovascular	ADJ
fnp-5343	162	36	injury	injury	NOUN
fnp-5343	162	37	[	[	X
fnp-5343	162	38	198,215	198,215	NUM
fnp-5343	162	39	]	]	PUNCT
fnp-5343	162	40	.	.	PUNCT
fnp-5343	163	1	leakage	leakage	NOUN
fnp-5343	163	2	of	of	ADP
fnp-5343	163	3	fibrinogen	fibrinogen	NOUN
fnp-5343	163	4	and	and	CCONJ
fnp-5343	163	5	other	other	ADJ
fnp-5343	163	6	serum	serum	NOUN
fnp-5343	163	7	proteins	protein	NOUN
fnp-5343	163	8	in	in	ADP
fnp-5343	163	9	the	the	DET
fnp-5343	163	10	brain	brain	NOUN
fnp-5343	163	11	in	in	ADP
fnp-5343	163	12	covid-19	covid-19	PROPN
fnp-5343	163	13	have	have	AUX
fnp-5343	163	14	also	also	ADV
fnp-5343	163	15	been	be	AUX
fnp-5343	163	16	reported	report	VERB
fnp-5343	163	17	[	[	X
fnp-5343	163	18	150,202	150,202	NUM
fnp-5343	163	19	]	]	PUNCT
fnp-5343	163	20	.	.	PUNCT
fnp-5343	164	1	several	several	ADJ
fnp-5343	164	2	gene	gene	NOUN
fnp-5343	164	3	expression	expression	NOUN
fnp-5343	164	4	profiling	profiling	NOUN
fnp-5343	164	5	studies	study	NOUN
fnp-5343	164	6	on	on	ADP
fnp-5343	164	7	various	various	ADJ
fnp-5343	164	8	regions	region	NOUN
fnp-5343	164	9	of	of	ADP
fnp-5343	164	10	the	the	DET
fnp-5343	164	11	brain	brain	NOUN
fnp-5343	164	12	from	from	ADP
fnp-5343	164	13	covid-19	covid-19	PROPN
fnp-5343	164	14	patients	patient	NOUN
fnp-5343	164	15	have	have	AUX
fnp-5343	164	16	shown	show	VERB
fnp-5343	164	17	downregulation	downregulation	NOUN
fnp-5343	164	18	of	of	ADP
fnp-5343	164	19	neuronal	neuronal	ADJ
fnp-5343	164	20	and	and	CCONJ
fnp-5343	164	21	synaptic	synaptic	ADJ
fnp-5343	164	22	pathways	pathway	NOUN
fnp-5343	164	23	in	in	ADP
fnp-5343	164	24	the	the	DET
fnp-5343	164	25	olfactory	olfactory	NOUN
fnp-5343	164	26	bulb	bulb	NOUN
fnp-5343	164	27	and	and	CCONJ
fnp-5343	164	28	amygdala	amygdala	NOUN
fnp-5343	164	29	[	[	X
fnp-5343	164	30	200	200	NUM
fnp-5343	164	31	]	]	PUNCT
fnp-5343	164	32	,	,	PUNCT
fnp-5343	164	33	dysregulation	dysregulation	NOUN
fnp-5343	164	34	that	that	PRON
fnp-5343	164	35	overlap	overlap	VERB
fnp-5343	164	36	with	with	ADP
fnp-5343	164	37	aging	age	VERB
fnp-5343	164	38	and	and	CCONJ
fnp-5343	164	39	neurodegenerative	neurodegenerative	ADJ
fnp-5343	164	40	diseases	disease	NOUN
fnp-5343	164	41	in	in	ADP
fnp-5343	164	42	the	the	DET
fnp-5343	164	43	frontal	frontal	ADJ
fnp-5343	164	44	cortex	cortex	NOUN
fnp-5343	164	45	[	[	X
fnp-5343	164	46	145,216	145,216	NUM
fnp-5343	164	47	]	]	PUNCT
fnp-5343	164	48	,	,	PUNCT
fnp-5343	164	49	metabolic	metabolic	NOUN
fnp-5343	164	50	dysregulation	dysregulation	NOUN
fnp-5343	164	51	in	in	ADP
fnp-5343	164	52	the	the	DET
fnp-5343	164	53	brainstem	brainstem	NOUN
fnp-5343	164	54	[	[	X
fnp-5343	164	55	198	198	NUM
fnp-5343	164	56	]	]	PUNCT
fnp-5343	164	57	,	,	PUNCT
fnp-5343	164	58	and	and	CCONJ
fnp-5343	164	59	inflammation	inflammation	NOUN
fnp-5343	164	60	in	in	ADP
fnp-5343	164	61	the	the	DET
fnp-5343	164	62	choroid	choroid	NOUN
fnp-5343	164	63	plexus	plexus	NOUN
fnp-5343	165	1	[	[	X
fnp-5343	165	2	145,217	145,217	NUM
fnp-5343	165	3	]	]	PUNCT
fnp-5343	165	4	.	.	PUNCT
fnp-5343	166	1	very	very	ADV
fnp-5343	166	2	few	few	ADJ
fnp-5343	166	3	autopsy	autopsy	ADJ
fnp-5343	166	4	studies	study	NOUN
fnp-5343	166	5	have	have	AUX
fnp-5343	166	6	examined	examine	VERB
fnp-5343	166	7	patients	patient	NOUN
fnp-5343	166	8	who	who	PRON
fnp-5343	166	9	recovered	recover	VERB
fnp-5343	166	10	from	from	ADP
fnp-5343	166	11	covid-19	covid-19	PROPN
fnp-5343	166	12	prior	prior	ADV
fnp-5343	166	13	to	to	ADP
fnp-5343	166	14	death	death	NOUN
fnp-5343	166	15	;	;	PUNCT
fnp-5343	166	16	these	these	PRON
fnp-5343	166	17	have	have	AUX
fnp-5343	166	18	also	also	ADV
fnp-5343	166	19	shown	show	VERB
fnp-5343	166	20	microglial	microglial	ADJ
fnp-5343	166	21	activation	activation	NOUN
fnp-5343	166	22	/	/	SYM
fnp-5343	166	23	macrophages	macrophage	NOUN
fnp-5343	166	24	[	[	X
fnp-5343	166	25	195,197	195,197	NUM
fnp-5343	166	26	]	]	PUNCT
fnp-5343	166	27	.	.	PUNCT
fnp-5343	167	1	one	one	NUM
fnp-5343	167	2	of	of	ADP
fnp-5343	167	3	the	the	DET
fnp-5343	167	4	studies	study	NOUN
fnp-5343	167	5	included	include	VERB
fnp-5343	167	6	two	two	NUM
fnp-5343	167	7	patients	patient	NOUN
fnp-5343	167	8	with	with	ADP
fnp-5343	167	9	mild	mild	ADJ
fnp-5343	167	10	covid-19	covid-19	PROPN
fnp-5343	167	11	symptoms	symptom	NOUN
fnp-5343	167	12	who	who	PRON
fnp-5343	167	13	died	die	VERB
fnp-5343	167	14	4	4	NUM
fnp-5343	167	15	-	-	SYM
fnp-5343	167	16	5	5	NUM
fnp-5343	167	17	and	and	CCONJ
fnp-5343	167	18	10	10	NUM
fnp-5343	167	19	weeks	week	NOUN
fnp-5343	167	20	after	after	ADP
fnp-5343	167	21	testing	test	VERB
fnp-5343	167	22	positive	positive	ADJ
fnp-5343	167	23	for	for	ADP
fnp-5343	167	24	covid-19	covid-19	PROPN
fnp-5343	167	25	from	from	ADP
fnp-5343	167	26	causes	cause	NOUN
fnp-5343	167	27	unrelated	unrelated	ADJ
fnp-5343	167	28	to	to	ADP
fnp-5343	167	29	the	the	DET
fnp-5343	167	30	infection	infection	NOUN
fnp-5343	167	31	[	[	X
fnp-5343	167	32	197	197	NUM
fnp-5343	167	33	]	]	PUNCT
fnp-5343	167	34	.	.	PUNCT
fnp-5343	168	1	in	in	ADP
fnp-5343	168	2	these	these	DET
fnp-5343	168	3	subjects	subject	NOUN
fnp-5343	168	4	microglial	microglial	ADJ
fnp-5343	168	5	activation	activation	NOUN
fnp-5343	168	6	/	/	SYM
fnp-5343	168	7	macrophages	macrophage	NOUN
fnp-5343	168	8	were	be	AUX
fnp-5343	168	9	also	also	ADV
fnp-5343	168	10	seen	see	VERB
fnp-5343	168	11	,	,	PUNCT
fnp-5343	168	12	similar	similar	ADJ
fnp-5343	168	13	to	to	ADP
fnp-5343	168	14	findings	finding	NOUN
fnp-5343	168	15	in	in	ADP
fnp-5343	168	16	patients	patient	NOUN
fnp-5343	168	17	with	with	ADP
fnp-5343	168	18	acute	acute	NOUN
fnp-5343	168	19	covid-19	covid-19	PROPN
fnp-5343	168	20	in	in	ADP
fnp-5343	168	21	the	the	DET
fnp-5343	168	22	brainstem	brainstem	NOUN
fnp-5343	168	23	and	and	CCONJ
fnp-5343	168	24	cerebellum	cerebellum	NOUN
fnp-5343	168	25	but	but	CCONJ
fnp-5343	168	26	to	to	ADP
fnp-5343	168	27	a	a	DET
fnp-5343	168	28	milder	mild	ADJ
fnp-5343	168	29	degree	degree	NOUN
fnp-5343	168	30	in	in	ADP
fnp-5343	168	31	the	the	DET
fnp-5343	168	32	cerebral	cerebral	ADJ
fnp-5343	168	33	white	white	ADJ
fnp-5343	168	34	matter	matter	NOUN
fnp-5343	168	35	[	[	X
fnp-5343	168	36	197	197	NUM
fnp-5343	168	37	]	]	PUNCT
fnp-5343	168	38	.	.	PUNCT
fnp-5343	169	1	so	so	ADV
fnp-5343	169	2	far	far	ADV
fnp-5343	169	3	there	there	PRON
fnp-5343	169	4	have	have	AUX
fnp-5343	169	5	been	be	AUX
fnp-5343	169	6	no	no	DET
fnp-5343	169	7	autopsy	autopsy	ADJ
fnp-5343	169	8	studies	study	NOUN
fnp-5343	169	9	of	of	ADP
fnp-5343	169	10	patients	patient	NOUN
fnp-5343	169	11	diagnosed	diagnose	VERB
fnp-5343	169	12	with	with	ADP
fnp-5343	169	13	pcc	pcc	PROPN
fnp-5343	169	14	(	(	PUNCT
fnp-5343	169	15	long	long	ADJ
fnp-5343	169	16	covid	covid	NOUN
fnp-5343	169	17	)	)	PUNCT
fnp-5343	169	18	.	.	PUNCT
fnp-5343	170	1	in	in	ADP
fnp-5343	170	2	a	a	DET
fnp-5343	170	3	brief	brief	ADJ
fnp-5343	170	4	look	look	NOUN
fnp-5343	170	5	at	at	ADP
fnp-5343	170	6	other	other	ADJ
fnp-5343	170	7	pandemics	pandemic	NOUN
fnp-5343	170	8	,	,	PUNCT
fnp-5343	170	9	hypoxicischemic	hypoxicischemic	ADJ
fnp-5343	170	10	changes	change	NOUN
fnp-5343	170	11	,	,	PUNCT
fnp-5343	170	12	infarcts	infarct	VERB
fnp-5343	170	13	,	,	PUNCT
fnp-5343	170	14	hemorrhage	hemorrhage	NOUN
fnp-5343	170	15	,	,	PUNCT
fnp-5343	170	16	microglial	microglial	ADJ
fnp-5343	170	17	activation	activation	NOUN
fnp-5343	170	18	,	,	PUNCT
fnp-5343	170	19	and	and	CCONJ
fnp-5343	170	20	adem	adem	PROPN
fnp-5343	170	21	-	-	PUNCT
fnp-5343	170	22	like	like	ADJ
fnp-5343	170	23	lesions	lesion	NOUN
fnp-5343	170	24	were	be	AUX
fnp-5343	170	25	also	also	ADV
fnp-5343	170	26	seen	see	VERB
fnp-5343	170	27	in	in	ADP
fnp-5343	170	28	autopsies	autopsy	NOUN
fnp-5343	170	29	of	of	ADP
fnp-5343	170	30	patients	patient	NOUN
fnp-5343	170	31	who	who	PRON
fnp-5343	170	32	died	die	VERB
fnp-5343	170	33	from	from	ADP
fnp-5343	170	34	the	the	DET
fnp-5343	170	35	novel	novel	ADJ
fnp-5343	170	36	influenza	influenza	NOUN
fnp-5343	170	37	a	a	DET
fnp-5343	170	38	h1n1	h1n1	NOUN
fnp-5343	170	39	virus	virus	NOUN
fnp-5343	170	40	in	in	ADP
fnp-5343	170	41	2009	2009	NUM
fnp-5343	170	42	[	[	X
fnp-5343	170	43	218	218	NUM
fnp-5343	170	44	]	]	PUNCT
fnp-5343	170	45	.	.	PUNCT
fnp-5343	171	1	the	the	DET
fnp-5343	171	2	few	few	ADJ
fnp-5343	171	3	autopsies	autopsy	NOUN
fnp-5343	171	4	reported	report	VERB
fnp-5343	171	5	on	on	ADP
fnp-5343	171	6	sars	sar	NOUN
fnp-5343	171	7	-	-	PUNCT
fnp-5343	171	8	cov	cov	PROPN
fnp-5343	171	9	,	,	PUNCT
fnp-5343	171	10	the	the	DET
fnp-5343	171	11	etiologic	etiologic	ADJ
fnp-5343	171	12	agent	agent	NOUN
fnp-5343	171	13	responsible	responsible	ADJ
fnp-5343	171	14	for	for	ADP
fnp-5343	171	15	the	the	DET
fnp-5343	171	16	sars	sar	NOUN
fnp-5343	171	17	pandemic	pandemic	ADJ
fnp-5343	171	18	which	which	PRON
fnp-5343	171	19	emerged	emerge	VERB
fnp-5343	171	20	in	in	ADP
fnp-5343	171	21	2002	2002	NUM
fnp-5343	171	22	[	[	X
fnp-5343	171	23	219	219	NUM
fnp-5343	171	24	]	]	PUNCT
fnp-5343	171	25	,	,	PUNCT
fnp-5343	171	26	described	describe	VERB
fnp-5343	171	27	hypoxic	hypoxic	ADJ
fnp-5343	171	28	-	-	PUNCT
fnp-5343	171	29	ischemic	ischemic	ADJ
fnp-5343	171	30	changes	change	NOUN
fnp-5343	171	31	and	and	CCONJ
fnp-5343	171	32	gliosis	gliosis	NOUN
fnp-5343	171	33	in	in	ADP
fnp-5343	171	34	the	the	DET
fnp-5343	171	35	brain	brain	NOUN
fnp-5343	172	1	[	[	X
fnp-5343	172	2	220,221	220,221	NUM
fnp-5343	172	3	]	]	PUNCT
fnp-5343	172	4	.	.	PUNCT
fnp-5343	173	1	there	there	PRON
fnp-5343	173	2	are	be	VERB
fnp-5343	173	3	only	only	ADV
fnp-5343	173	4	rare	rare	ADJ
fnp-5343	173	5	reports	report	NOUN
fnp-5343	173	6	of	of	ADP
fnp-5343	173	7	sars	sars	PROPN
fnp-5343	173	8	-	-	PUNCT
fnp-5343	173	9	cov	cov	NOUN
fnp-5343	173	10	detected	detect	VERB
fnp-5343	173	11	in	in	ADP
fnp-5343	173	12	the	the	DET
fnp-5343	173	13	csf	csf	NOUN
fnp-5343	173	14	[	[	X
fnp-5343	173	15	222,223	222,223	NUM
fnp-5343	173	16	]	]	PUNCT
fnp-5343	173	17	and	and	CCONJ
fnp-5343	173	18	in	in	ADP
fnp-5343	173	19	brain	brain	NOUN
fnp-5343	173	20	using	use	VERB
fnp-5343	173	21	pcr	pcr	NOUN
fnp-5343	173	22	,	,	PUNCT
fnp-5343	173	23	ish	ish	NOUN
fnp-5343	173	24	,	,	PUNCT
fnp-5343	173	25	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	173	26	,	,	PUNCT
fnp-5343	173	27	and	and	CCONJ
fnp-5343	173	28	electron	electron	NOUN
fnp-5343	173	29	microscopy	microscopy	NOUN
fnp-5343	173	30	[	[	X
fnp-5343	173	31	220–222,224	220–222,224	NUM
fnp-5343	173	32	]	]	PUNCT
fnp-5343	173	33	with	with	ADP
fnp-5343	173	34	isolation	isolation	NOUN
fnp-5343	173	35	of	of	ADP
fnp-5343	173	36	sars	sars	PROPN
fnp-5343	173	37	-	-	PUNCT
fnp-5343	173	38	cov	cov	PROPN
fnp-5343	173	39	reported	report	VERB
fnp-5343	173	40	from	from	ADP
fnp-5343	173	41	the	the	DET
fnp-5343	173	42	brain	brain	NOUN
fnp-5343	173	43	of	of	ADP
fnp-5343	173	44	one	one	NUM
fnp-5343	173	45	patient	patient	NOUN
fnp-5343	173	46	[	[	X
fnp-5343	173	47	221	221	NUM
fnp-5343	173	48	]	]	PUNCT
fnp-5343	173	49	.	.	PUNCT
fnp-5343	174	1	the	the	DET
fnp-5343	174	2	"	"	PUNCT
fnp-5343	174	3	brain	brain	NOUN
fnp-5343	174	4	isolation	isolation	NOUN
fnp-5343	174	5	"	"	PUNCT
fnp-5343	174	6	may	may	AUX
fnp-5343	174	7	have	have	AUX
fnp-5343	174	8	reflected	reflect	VERB
fnp-5343	174	9	isolation	isolation	NOUN
fnp-5343	174	10	of	of	ADP
fnp-5343	174	11	virus	virus	NOUN
fnp-5343	174	12	from	from	ADP
fnp-5343	174	13	brain	brain	NOUN
fnp-5343	174	14	vasculature	vasculature	NOUN
fnp-5343	174	15	.	.	PUNCT
fnp-5343	175	1	although	although	SCONJ
fnp-5343	175	2	several	several	ADJ
fnp-5343	175	3	studies	study	NOUN
fnp-5343	175	4	have	have	AUX
fnp-5343	175	5	detected	detect	VERB
fnp-5343	175	6	sars	sar	NOUN
fnp-5343	175	7	-	-	PUNCT
fnp-5343	175	8	cov-2	cov-2	NOUN
fnp-5343	175	9	rna	rna	NOUN
fnp-5343	175	10	in	in	ADP
fnp-5343	175	11	the	the	DET
fnp-5343	175	12	brain	brain	NOUN
fnp-5343	175	13	using	use	VERB
fnp-5343	175	14	pcr	pcr	ADJ
fnp-5343	175	15	or	or	CCONJ
fnp-5343	175	16	transcriptomic	transcriptomic	ADJ
fnp-5343	175	17	analysis	analysis	NOUN
fnp-5343	175	18	[	[	X
fnp-5343	175	19	152,185,193,200,225–227	152,185,193,200,225–227	NUM
fnp-5343	175	20	]	]	PUNCT
fnp-5343	175	21	,	,	PUNCT
fnp-5343	175	22	including	include	VERB
fnp-5343	175	23	in	in	ADP
fnp-5343	175	24	the	the	DET
fnp-5343	175	25	affected	affected	ADJ
fnp-5343	175	26	area	area	NOUN
fnp-5343	175	27	of	of	ADP
fnp-5343	175	28	a	a	DET
fnp-5343	175	29	case	case	NOUN
fnp-5343	175	30	of	of	ADP
fnp-5343	175	31	hemorrhagic	hemorrhagic	NOUN
fnp-5343	175	32	encephalitis	encephalitis	NOUN
fnp-5343	175	33	possibly	possibly	ADV
fnp-5343	175	34	attributed	attribute	VERB
fnp-5343	175	35	to	to	ADP
fnp-5343	175	36	covid-19	covid-19	PROPN
fnp-5343	176	1	[	[	X
fnp-5343	176	2	200	200	NUM
fnp-5343	176	3	]	]	PUNCT
fnp-5343	176	4	,	,	PUNCT
fnp-5343	176	5	other	other	ADJ
fnp-5343	176	6	studies	study	NOUN
fnp-5343	176	7	have	have	AUX
fnp-5343	176	8	not	not	PART
fnp-5343	176	9	detected	detect	VERB
fnp-5343	176	10	viral	viral	ADJ
fnp-5343	176	11	rna	rna	NOUN
fnp-5343	176	12	or	or	CCONJ
fnp-5343	176	13	protein	protein	NOUN
fnp-5343	176	14	in	in	ADP
fnp-5343	176	15	the	the	DET
fnp-5343	176	16	brains	brain	NOUN
fnp-5343	176	17	of	of	ADP
fnp-5343	176	18	patients	patient	NOUN
fnp-5343	176	19	with	with	ADP
fnp-5343	176	20	covid-19	covid-19	PROPN
fnp-5343	176	21	using	use	VERB
fnp-5343	176	22	a	a	DET
fnp-5343	176	23	variety	variety	NOUN
fnp-5343	176	24	of	of	ADP
fnp-5343	176	25	methods	method	NOUN
fnp-5343	176	26	[	[	X
fnp-5343	176	27	145,182,186,192,195,197,198,201,216,217	145,182,186,192,195,197,198,201,216,217	NUM
fnp-5343	176	28	]	]	PUNCT
fnp-5343	176	29	,	,	PUNCT
fnp-5343	176	30	and	and	CCONJ
fnp-5343	176	31	sars	sar	NOUN
fnp-5343	176	32	-	-	PUNCT
fnp-5343	176	33	cov-2	cov-2	NUM
fnp-5343	176	34	has	have	AUX
fnp-5343	176	35	never	never	ADV
fnp-5343	176	36	been	be	AUX
fnp-5343	176	37	cultured	cultured	ADJ
fnp-5343	176	38	from	from	ADP
fnp-5343	176	39	brain	brain	NOUN
fnp-5343	176	40	[	[	X
fnp-5343	176	41	131,180	131,180	NUM
fnp-5343	176	42	]	]	PUNCT
fnp-5343	176	43	.	.	PUNCT
fnp-5343	177	1	few	few	ADJ
fnp-5343	177	2	studies	study	NOUN
fnp-5343	177	3	have	have	AUX
fnp-5343	177	4	performed	perform	VERB
fnp-5343	177	5	cellular	cellular	ADJ
fnp-5343	177	6	localization	localization	NOUN
fnp-5343	177	7	of	of	ADP
fnp-5343	177	8	viral	viral	ADJ
fnp-5343	177	9	rna	rna	NOUN
fnp-5343	177	10	using	use	VERB
fnp-5343	177	11	ish	ish	NOUN
fnp-5343	177	12	or	or	CCONJ
fnp-5343	177	13	viral	viral	ADJ
fnp-5343	177	14	protein	protein	NOUN
fnp-5343	177	15	using	use	VERB
fnp-5343	177	16	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	177	17	and	and	CCONJ
fnp-5343	177	18	most	most	ADJ
fnp-5343	177	19	have	have	AUX
fnp-5343	177	20	shown	show	VERB
fnp-5343	177	21	that	that	SCONJ
fnp-5343	177	22	they	they	PRON
fnp-5343	177	23	are	be	AUX
fnp-5343	177	24	restricted	restrict	VERB
fnp-5343	177	25	to	to	ADP
fnp-5343	177	26	vessels	vessel	NOUN
fnp-5343	177	27	/	/	SYM
fnp-5343	177	28	near	near	ADJ
fnp-5343	177	29	vessels	vessel	NOUN
fnp-5343	177	30	such	such	ADJ
fnp-5343	177	31	as	as	ADP
fnp-5343	177	32	in	in	ADP
fnp-5343	177	33	endothelium	endothelium	NOUN
fnp-5343	177	34	,	,	PUNCT
fnp-5343	177	35	within	within	ADP
fnp-5343	177	36	macrophages	macrophage	NOUN
fnp-5343	177	37	or	or	CCONJ
fnp-5343	177	38	near	near	ADJ
fnp-5343	177	39	capillaries	capillary	NOUN
fnp-5343	177	40	[	[	X
fnp-5343	177	41	148,182,225,228	148,182,225,228	NUM
fnp-5343	177	42	]	]	X
fnp-5343	177	43	.	.	PUNCT
fnp-5343	178	1	there	there	PRON
fnp-5343	178	2	are	be	VERB
fnp-5343	178	3	rare	rare	ADJ
fnp-5343	178	4	reports	report	NOUN
fnp-5343	178	5	of	of	ADP
fnp-5343	178	6	viral	viral	ADJ
fnp-5343	178	7	protein	protein	NOUN
fnp-5343	178	8	or	or	CCONJ
fnp-5343	178	9	rna	rna	NOUN
fnp-5343	178	10	in	in	ADP
fnp-5343	178	11	brain	brain	NOUN
fnp-5343	178	12	tissue	tissue	NOUN
fnp-5343	178	13	or	or	CCONJ
fnp-5343	178	14	cranial	cranial	ADJ
fnp-5343	178	15	nerves	nerve	NOUN
fnp-5343	178	16	[	[	X
fnp-5343	178	17	148,182,185,229–231	148,182,185,229–231	X
fnp-5343	178	18	]	]	X
fnp-5343	178	19	,	,	PUNCT
fnp-5343	178	20	including	include	VERB
fnp-5343	178	21	a	a	DET
fnp-5343	178	22	report	report	NOUN
fnp-5343	178	23	by	by	ADP
fnp-5343	178	24	thakur	thakur	PROPN
fnp-5343	178	25	et	et	PROPN
fnp-5343	178	26	al	al	PROPN
fnp-5343	178	27	.	.	PROPN
fnp-5343	178	28	which	which	PRON
fnp-5343	178	29	found	find	VERB
fnp-5343	178	30	low	low	ADJ
fnp-5343	178	31	levels	level	NOUN
fnp-5343	178	32	of	of	ADP
fnp-5343	178	33	viral	viral	ADJ
fnp-5343	178	34	rna	rna	NOUN
fnp-5343	178	35	by	by	ADP
fnp-5343	178	36	rt	rt	PROPN
fnp-5343	178	37	-	-	PUNCT
fnp-5343	178	38	pcr	pcr	PROPN
fnp-5343	178	39	but	but	CCONJ
fnp-5343	178	40	no	no	DET
fnp-5343	178	41	viral	viral	ADJ
fnp-5343	178	42	rna	rna	NOUN
fnp-5343	178	43	or	or	CCONJ
fnp-5343	178	44	protein	protein	NOUN
fnp-5343	178	45	by	by	ADP
fnp-5343	178	46	rnascope	rnascope	NOUN
fnp-5343	178	47	and	and	CCONJ
fnp-5343	178	48	immunohistochemistry	immunohistochemistry	NOUN
fnp-5343	178	49	[	[	X
fnp-5343	178	50	185	185	NUM
fnp-5343	178	51	]	]	PUNCT
fnp-5343	178	52	.	.	PUNCT
fnp-5343	179	1	viral	viral	ADJ
fnp-5343	179	2	rna	rna	NOUN
fnp-5343	179	3	was	be	AUX
fnp-5343	179	4	seen	see	VERB
fnp-5343	179	5	in	in	ADP
fnp-5343	179	6	the	the	DET
fnp-5343	179	7	adventitia	adventitia	NOUN
fnp-5343	179	8	of	of	ADP
fnp-5343	179	9	a	a	DET
fnp-5343	179	10	meningeal	meningeal	ADJ
fnp-5343	179	11	blood	blood	NOUN
fnp-5343	179	12	vessel	vessel	NOUN
fnp-5343	179	13	outside	outside	ADP
fnp-5343	179	14	the	the	DET
fnp-5343	179	15	medulla	medulla	NOUN
fnp-5343	179	16	in	in	ADP
fnp-5343	179	17	one	one	NUM
fnp-5343	179	18	case	case	NOUN
fnp-5343	179	19	[	[	X
fnp-5343	179	20	185	185	NUM
fnp-5343	179	21	]	]	PUNCT
fnp-5343	179	22	.	.	PUNCT
fnp-5343	180	1	because	because	SCONJ
fnp-5343	180	2	of	of	ADP
fnp-5343	180	3	frequent	frequent	ADJ
fnp-5343	180	4	anosmia	anosmia	NOUN
fnp-5343	180	5	/	/	SYM
fnp-5343	180	6	hyposmia	hyposmia	NOUN
fnp-5343	180	7	and	and	CCONJ
fnp-5343	180	8	olfactory	olfactory	ADJ
fnp-5343	180	9	dysfunction	dysfunction	NOUN
fnp-5343	180	10	in	in	ADP
fnp-5343	180	11	covid-19	covid-19	PROPN
fnp-5343	180	12	,	,	PUNCT
fnp-5343	180	13	the	the	DET
fnp-5343	180	14	suspicion	suspicion	NOUN
fnp-5343	180	15	is	be	AUX
fnp-5343	180	16	that	that	SCONJ
fnp-5343	180	17	the	the	DET
fnp-5343	180	18	virus	virus	NOUN
fnp-5343	180	19	may	may	AUX
fnp-5343	180	20	enter	enter	VERB
fnp-5343	180	21	the	the	DET
fnp-5343	180	22	brain	brain	NOUN
fnp-5343	180	23	via	via	ADP
fnp-5343	180	24	the	the	DET
fnp-5343	180	25	olfactory	olfactory	NOUN
fnp-5343	180	26	route	route	NOUN
fnp-5343	180	27	through	through	ADP
fnp-5343	180	28	the	the	DET
fnp-5343	180	29	cribriform	cribriform	NOUN
fnp-5343	180	30	plate	plate	NOUN
fnp-5343	180	31	,	,	PUNCT
fnp-5343	180	32	similar	similar	ADJ
fnp-5343	180	33	to	to	ADP
fnp-5343	180	34	neurotropic	neurotropic	ADJ
fnp-5343	180	35	viruses	virus	NOUN
fnp-5343	180	36	[	[	X
fnp-5343	180	37	232–234	232–234	NUM
fnp-5343	180	38	]	]	X
fnp-5343	180	39	.	.	PUNCT
fnp-5343	181	1	several	several	ADJ
fnp-5343	181	2	studies	study	NOUN
fnp-5343	181	3	have	have	AUX
fnp-5343	181	4	examined	examine	VERB
fnp-5343	181	5	the	the	DET
fnp-5343	181	6	olfactory	olfactory	ADJ
fnp-5343	181	7	bulbs	bulb	NOUN
fnp-5343	182	1	[	[	X
fnp-5343	182	2	185,193,201,230,231,235	185,193,201,230,231,235	NUM
fnp-5343	182	3	]	]	PUNCT
fnp-5343	182	4	.	.	PUNCT
fnp-5343	183	1	most	most	ADJ
fnp-5343	183	2	showed	show	VERB
fnp-5343	183	3	variable	variable	ADJ
fnp-5343	183	4	degrees	degree	NOUN
fnp-5343	183	5	of	of	ADP
fnp-5343	183	6	t	t	PROPN
fnp-5343	183	7	-	-	PUNCT
fnp-5343	183	8	lymphocytic	lymphocytic	ADJ
fnp-5343	183	9	infiltration	infiltration	NOUN
fnp-5343	183	10	and	and	CCONJ
fnp-5343	183	11	gliosis	gliosis	NOUN
fnp-5343	183	12	without	without	ADP
fnp-5343	183	13	presence	presence	NOUN
fnp-5343	183	14	of	of	ADP
fnp-5343	183	15	viral	viral	ADJ
fnp-5343	183	16	protein	protein	NOUN
fnp-5343	183	17	,	,	PUNCT
fnp-5343	183	18	but	but	CCONJ
fnp-5343	183	19	variability	variability	NOUN
fnp-5343	183	20	in	in	ADP
fnp-5343	183	21	presence	presence	NOUN
fnp-5343	183	22	of	of	ADP
fnp-5343	183	23	viral	viral	ADJ
fnp-5343	183	24	rna	rna	NOUN
fnp-5343	183	25	in	in	ADP
fnp-5343	183	26	human	human	ADJ
fnp-5343	183	27	tissue	tissue	NOUN
fnp-5343	184	1	[	[	X
fnp-5343	184	2	185,193,201,230,231,235	185,193,201,230,231,235	NUM
fnp-5343	184	3	]	]	PUNCT
fnp-5343	184	4	.	.	PUNCT
fnp-5343	185	1	these	these	DET
fnp-5343	185	2	discrepancies	discrepancy	NOUN
fnp-5343	185	3	may	may	AUX
fnp-5343	185	4	partly	partly	ADV
fnp-5343	185	5	be	be	AUX
fnp-5343	185	6	due	due	ADJ
fnp-5343	185	7	to	to	ADP
fnp-5343	185	8	differences	difference	NOUN
fnp-5343	185	9	in	in	ADP
fnp-5343	185	10	patient	patient	ADJ
fnp-5343	185	11	cohorts	cohort	NOUN
fnp-5343	185	12	and	and	CCONJ
fnp-5343	185	13	methods	method	NOUN
fnp-5343	185	14	employed	employ	VERB
fnp-5343	185	15	including	include	VERB
fnp-5343	185	16	the	the	DET
fnp-5343	185	17	usage	usage	NOUN
fnp-5343	185	18	of	of	ADP
fnp-5343	185	19	different	different	ADJ
fnp-5343	185	20	commercial	commercial	ADJ
fnp-5343	185	21	antibodies	antibodie	VERB
fnp-5343	185	22	.	.	PUNCT
fnp-5343	186	1	some	some	DET
fnp-5343	186	2	antibodies	antibodie	VERB
fnp-5343	186	3	,	,	PUNCT
fnp-5343	186	4	including	include	VERB
fnp-5343	186	5	a	a	DET
fnp-5343	186	6	widely	widely	ADV
fnp-5343	186	7	used	use	VERB
fnp-5343	186	8	spike	spike	ADJ
fnp-5343	186	9	antibody	antibody	NOUN
fnp-5343	186	10	(	(	PUNCT
fnp-5343	186	11	abcam	abcam	VERB
fnp-5343	186	12	3a2	3a2	NUM
fnp-5343	186	13	)	)	PUNCT
fnp-5343	186	14	,	,	PUNCT
fnp-5343	186	15	have	have	AUX
fnp-5343	186	16	subsequently	subsequently	ADV
fnp-5343	186	17	been	be	AUX
fnp-5343	186	18	shown	show	VERB
fnp-5343	186	19	to	to	PART
fnp-5343	186	20	label	label	VERB
fnp-5343	186	21	vessels	vessel	NOUN
fnp-5343	186	22	and	and	CCONJ
fnp-5343	186	23	neurons	neuron	NOUN
fnp-5343	186	24	in	in	ADP
fnp-5343	186	25	both	both	CCONJ
fnp-5343	186	26	covid-19	covid-19	PROPN
fnp-5343	186	27	and	and	CCONJ
fnp-5343	186	28	control	control	NOUN
fnp-5343	186	29	patients	patient	NOUN
fnp-5343	186	30	or	or	CCONJ
fnp-5343	186	31	have	have	VERB
fnp-5343	186	32	high	high	ADJ
fnp-5343	186	33	background	background	NOUN
fnp-5343	186	34	[	[	X
fnp-5343	186	35	145,180,197,236	145,180,197,236	NUM
fnp-5343	186	36	]	]	PUNCT
fnp-5343	186	37	.	.	PUNCT
fnp-5343	187	1	viral	viral	ADJ
fnp-5343	187	2	nucleocapsid	nucleocapsid	ADJ
fnp-5343	187	3	antigen	antigen	NOUN
fnp-5343	187	4	and	and	CCONJ
fnp-5343	187	5	rna	rna	NOUN
fnp-5343	187	6	have	have	AUX
fnp-5343	187	7	only	only	ADV
fnp-5343	187	8	rarely	rarely	ADV
fnp-5343	187	9	been	be	AUX
fnp-5343	187	10	detected	detect	VERB
fnp-5343	187	11	in	in	ADP
fnp-5343	187	12	csf	csf	NOUN
fnp-5343	187	13	in	in	ADP
fnp-5343	187	14	acute	acute	ADJ
fnp-5343	187	15	disease	disease	NOUN
fnp-5343	187	16	[	[	X
fnp-5343	187	17	237–240	237–240	NUM
fnp-5343	187	18	]	]	PUNCT
fnp-5343	187	19	.	.	PUNCT
fnp-5343	188	1	csf	csf	ADJ
fnp-5343	188	2	analysis	analysis	NOUN
fnp-5343	188	3	often	often	ADV
fnp-5343	188	4	shows	show	VERB
fnp-5343	188	5	slightly	slightly	ADV
fnp-5343	188	6	increased	increase	VERB
fnp-5343	188	7	white	white	ADJ
fnp-5343	188	8	blood	blood	NOUN
fnp-5343	188	9	cell	cell	NOUN
fnp-5343	188	10	counts	count	VERB
fnp-5343	188	11	as	as	ADV
fnp-5343	188	12	well	well	ADV
fnp-5343	188	13	as	as	ADP
fnp-5343	188	14	elevated	elevated	ADJ
fnp-5343	188	15	albumin	albumin	NOUN
fnp-5343	188	16	and	and	CCONJ
fnp-5343	188	17	protein	protein	NOUN
fnp-5343	188	18	levels	level	NOUN
fnp-5343	188	19	and	and	CCONJ
fnp-5343	188	20	an	an	DET
fnp-5343	188	21	elevated	elevated	ADJ
fnp-5343	188	22	albumin	albumin	ADJ
fnp-5343	188	23	quotient	quotient	NOUN
fnp-5343	188	24	,	,	PUNCT
fnp-5343	188	25	which	which	PRON
fnp-5343	188	26	suggests	suggest	VERB
fnp-5343	188	27	disruption	disruption	NOUN
fnp-5343	188	28	of	of	ADP
fnp-5343	188	29	the	the	DET
fnp-5343	188	30	bbb	bbb	NOUN
fnp-5343	189	1	[	[	X
fnp-5343	189	2	238	238	NUM
fnp-5343	189	3	]	]	PUNCT
fnp-5343	189	4	.	.	PUNCT
fnp-5343	190	1	similar	similar	ADJ
fnp-5343	190	2	to	to	ADP
fnp-5343	190	3	the	the	DET
fnp-5343	190	4	brain	brain	NOUN
fnp-5343	190	5	,	,	PUNCT
fnp-5343	190	6	sars	sar	NOUN
fnp-5343	190	7	-	-	PUNCT
fnp-5343	190	8	cov-2	cov-2	PART
fnp-5343	190	9	has	have	AUX
fnp-5343	190	10	never	never	ADV
fnp-5343	190	11	been	be	AUX
fnp-5343	190	12	cultured	cultured	ADJ
fnp-5343	190	13	from	from	ADP
fnp-5343	190	14	csf	csf	ADJ
fnp-5343	190	15	even	even	ADV
fnp-5343	190	16	when	when	SCONJ
fnp-5343	190	17	virus	virus	NOUN
fnp-5343	190	18	could	could	AUX
fnp-5343	190	19	be	be	AUX
fnp-5343	190	20	grown	grow	VERB
fnp-5343	190	21	from	from	ADP
fnp-5343	190	22	paired	pair	VERB
fnp-5343	190	23	nasopharyngeal	nasopharyngeal	ADJ
fnp-5343	190	24	swabs	swab	NOUN
fnp-5343	191	1	[	[	X
fnp-5343	191	2	131	131	NUM
fnp-5343	191	3	]	]	PUNCT
fnp-5343	191	4	.	.	PUNCT
fnp-5343	192	1	in	in	ADP
fnp-5343	192	2	electron	electron	NOUN
fnp-5343	192	3	microscopy	microscopy	NOUN
fnp-5343	192	4	studies	study	NOUN
fnp-5343	192	5	,	,	PUNCT
fnp-5343	192	6	virions	virion	NOUN
fnp-5343	192	7	have	have	AUX
fnp-5343	192	8	mainly	mainly	ADV
fnp-5343	192	9	been	be	AUX
fnp-5343	192	10	identified	identify	VERB
fnp-5343	192	11	in	in	ADP
fnp-5343	192	12	the	the	DET
fnp-5343	192	13	respiratory	respiratory	ADJ
fnp-5343	192	14	tract	tract	NOUN
fnp-5343	192	15	,	,	PUNCT
fnp-5343	192	16	and	and	CCONJ
fnp-5343	192	17	reports	report	NOUN
fnp-5343	192	18	of	of	ADP
fnp-5343	192	19	ultrastructural	ultrastructural	ADJ
fnp-5343	192	20	detection	detection	NOUN
fnp-5343	192	21	of	of	ADP
fnp-5343	192	22	virus	virus	NOUN
fnp-5343	192	23	outside	outside	ADP
fnp-5343	192	24	the	the	DET
fnp-5343	192	25	respiratory	respiratory	ADJ
fnp-5343	192	26	tract	tract	NOUN
fnp-5343	192	27	are	be	AUX
fnp-5343	192	28	controversial	controversial	ADJ
fnp-5343	192	29	due	due	ADJ
fnp-5343	192	30	to	to	ADP
fnp-5343	192	31	potential	potential	ADJ
fnp-5343	192	32	misinterpretation	misinterpretation	NOUN
fnp-5343	192	33	of	of	ADP
fnp-5343	192	34	virus	virus	NOUN
fnp-5343	192	35	-	-	PUNCT
fnp-5343	192	36	like	like	ADJ
fnp-5343	192	37	particles	particle	NOUN
fnp-5343	192	38	[	[	X
fnp-5343	192	39	236,241–243	236,241–243	NOUN
fnp-5343	192	40	]	]	PUNCT
fnp-5343	192	41	.	.	PUNCT
fnp-5343	193	1	thus	thus	ADV
fnp-5343	193	2	,	,	PUNCT
fnp-5343	193	3	it	it	PRON
fnp-5343	193	4	is	be	AUX
fnp-5343	193	5	unclear	unclear	ADJ
fnp-5343	193	6	whether	whether	SCONJ
fnp-5343	193	7	sars	sar	NOUN
fnp-5343	193	8	-	-	PUNCT
fnp-5343	193	9	cov-2	cov-2	NOUN
fnp-5343	193	10	is	be	AUX
fnp-5343	193	11	neurotropic	neurotropic	ADJ
fnp-5343	193	12	or	or	CCONJ
fnp-5343	193	13	neuroinvasive	neuroinvasive	NOUN
fnp-5343	193	14	,	,	PUNCT
fnp-5343	193	15	and	and	CCONJ
fnp-5343	193	16	mechanisms	mechanism	NOUN
fnp-5343	193	17	other	other	ADJ
fnp-5343	193	18	than	than	ADP
fnp-5343	193	19	direct	direct	ADJ
fnp-5343	193	20	infection	infection	NOUN
fnp-5343	193	21	likely	likely	ADV
fnp-5343	193	22	contribute	contribute	VERB
fnp-5343	193	23	to	to	ADP
fnp-5343	193	24	both	both	CCONJ
fnp-5343	193	25	acute	acute	ADJ
fnp-5343	193	26	and	and	CCONJ
fnp-5343	193	27	chronic	chronic	ADJ
fnp-5343	193	28	forms	form	NOUN
fnp-5343	193	29	of	of	ADP
fnp-5343	193	30	the	the	DET
fnp-5343	193	31	disease	disease	NOUN
fnp-5343	193	32	(	(	PUNCT
fnp-5343	193	33	figure	figure	NOUN
fnp-5343	193	34	2	2	NUM
fnp-5343	193	35	)	)	PUNCT
fnp-5343	194	1	[	[	X
fnp-5343	194	2	167,232	167,232	NUM
fnp-5343	194	3	]	]	PUNCT
fnp-5343	194	4	.	.	PUNCT
fnp-5343	195	1	conclusions	conclusion	NOUN
fnp-5343	195	2	and	and	CCONJ
fnp-5343	195	3	next	next	ADJ
fnp-5343	195	4	steps	step	NOUN
fnp-5343	195	5	hiv	hiv	PROPN
fnp-5343	195	6	and	and	CCONJ
fnp-5343	195	7	sars	sar	NOUN
fnp-5343	195	8	-	-	PUNCT
fnp-5343	195	9	cov-2	cov-2	NUM
fnp-5343	195	10	are	be	AUX
fnp-5343	195	11	associated	associate	VERB
fnp-5343	195	12	with	with	ADP
fnp-5343	195	13	significant	significant	ADJ
fnp-5343	195	14	neurologic	neurologic	ADJ
fnp-5343	195	15	morbidity	morbidity	NOUN
fnp-5343	195	16	but	but	CCONJ
fnp-5343	195	17	with	with	ADP
fnp-5343	195	18	differing	differ	VERB
fnp-5343	195	19	pathogenesis	pathogenesis	NOUN
fnp-5343	195	20	underlying	underlie	VERB
fnp-5343	195	21	acute	acute	ADJ
fnp-5343	195	22	and	and	CCONJ
fnp-5343	195	23	chronic	chronic	ADJ
fnp-5343	195	24	disease	disease	NOUN
fnp-5343	195	25	.	.	PUNCT
fnp-5343	196	1	in	in	ADP
fnp-5343	196	2	acute	acute	ADJ
fnp-5343	196	3	disease	disease	NOUN
fnp-5343	196	4	,	,	PUNCT
fnp-5343	196	5	hiv	hiv	PROPN
fnp-5343	196	6	directly	directly	ADV
fnp-5343	196	7	invades	invade	VERB
fnp-5343	196	8	the	the	DET
fnp-5343	196	9	cns	cns	NOUN
fnp-5343	196	10	while	while	SCONJ
fnp-5343	196	11	sars	sar	NOUN
fnp-5343	196	12	-	-	PUNCT
fnp-5343	196	13	cov-2	cov-2	NUM
fnp-5343	196	14	may	may	AUX
fnp-5343	196	15	exert	exert	VERB
fnp-5343	196	16	its	its	PRON
fnp-5343	196	17	effects	effect	NOUN
fnp-5343	196	18	more	more	ADV
fnp-5343	196	19	indirectly	indirectly	ADV
fnp-5343	196	20	through	through	ADP
fnp-5343	196	21	systemic	systemic	ADJ
fnp-5343	196	22	inflammation	inflammation	NOUN
fnp-5343	196	23	.	.	PUNCT
fnp-5343	197	1	in	in	ADP
fnp-5343	197	2	chronic	chronic	ADJ
fnp-5343	197	3	disease	disease	NOUN
fnp-5343	197	4	,	,	PUNCT
fnp-5343	197	5	hiv	hiv	PROPN
fnp-5343	197	6	persists	persist	VERB
fnp-5343	197	7	in	in	ADP
fnp-5343	197	8	the	the	DET
fnp-5343	197	9	brain	brain	NOUN
fnp-5343	197	10	despite	despite	SCONJ
fnp-5343	197	11	cart	cart	NOUN
fnp-5343	197	12	,	,	PUNCT
fnp-5343	197	13	and	and	CCONJ
fnp-5343	197	14	sequelae	sequelae	NOUN
fnp-5343	197	15	of	of	ADP
fnp-5343	197	16	low	low	ADJ
fnp-5343	197	17	-	-	PUNCT
fnp-5343	197	18	level	level	NOUN
fnp-5343	197	19	infection	infection	NOUN
fnp-5343	197	20	may	may	AUX
fnp-5343	197	21	contribute	contribute	VERB
fnp-5343	197	22	to	to	ADP
fnp-5343	197	23	hand	hand	NOUN
fnp-5343	197	24	[	[	X
fnp-5343	197	25	115	115	NUM
fnp-5343	197	26	]	]	PUNCT
fnp-5343	197	27	.	.	PUNCT
fnp-5343	198	1	pcc	pcc	PROPN
fnp-5343	198	2	may	may	AUX
fnp-5343	198	3	also	also	ADV
fnp-5343	198	4	be	be	AUX
fnp-5343	198	5	associated	associate	VERB
fnp-5343	198	6	with	with	ADP
fnp-5343	198	7	sequelae	sequelae	NOUN
fnp-5343	198	8	of	of	ADP
fnp-5343	198	9	inflammation	inflammation	NOUN
fnp-5343	198	10	,	,	PUNCT
fnp-5343	198	11	but	but	CCONJ
fnp-5343	198	12	in	in	ADP
fnp-5343	198	13	both	both	DET
fnp-5343	198	14	diseases	disease	NOUN
fnp-5343	198	15	,	,	PUNCT
fnp-5343	198	16	complex	complex	ADJ
fnp-5343	198	17	interactions	interaction	NOUN
fnp-5343	198	18	with	with	ADP
fnp-5343	198	19	comorbidities	comorbiditie	NOUN
fnp-5343	198	20	likely	likely	ADV
fnp-5343	198	21	underlie	underlie	VERB
fnp-5343	198	22	neurologic	neurologic	ADJ
fnp-5343	198	23	manifestations	manifestation	NOUN
fnp-5343	199	1	[	[	X
fnp-5343	199	2	48,160	48,160	NUM
fnp-5343	199	3	]	]	PUNCT
fnp-5343	199	4	.	.	PUNCT
fnp-5343	200	1	furthermore	furthermore	ADV
fnp-5343	200	2	,	,	PUNCT
fnp-5343	200	3	both	both	DET
fnp-5343	200	4	pcc	pcc	NOUN
fnp-5343	200	5	and	and	CCONJ
fnp-5343	200	6	hand	hand	NOUN
fnp-5343	200	7	have	have	VERB
fnp-5343	200	8	significant	significant	ADJ
fnp-5343	200	9	components	component	NOUN
fnp-5343	200	10	of	of	ADP
fnp-5343	200	11	psychiatric	psychiatric	ADJ
fnp-5343	200	12	disease	disease	NOUN
fnp-5343	200	13	in	in	ADP
fnp-5343	200	14	which	which	PRON
fnp-5343	200	15	functional	functional	ADJ
fnp-5343	200	16	abnormalities	abnormality	NOUN
fnp-5343	200	17	are	be	AUX
fnp-5343	200	18	thought	think	VERB
fnp-5343	200	19	to	to	PART
fnp-5343	200	20	predominate	predominate	VERB
fnp-5343	200	21	over	over	ADP
fnp-5343	200	22	structural	structural	ADJ
fnp-5343	200	23	abnormalities	abnormality	NOUN
fnp-5343	200	24	[	[	X
fnp-5343	200	25	244,245	244,245	NUM
fnp-5343	200	26	]	]	PUNCT
fnp-5343	200	27	.	.	PUNCT
fnp-5343	201	1	mechanisms	mechanism	NOUN
fnp-5343	201	2	of	of	ADP
fnp-5343	201	3	aging	age	VERB
fnp-5343	201	4	related	relate	VERB
fnp-5343	201	5	neurodegeneration	neurodegeneration	NOUN
fnp-5343	201	6	have	have	AUX
fnp-5343	201	7	also	also	ADV
fnp-5343	201	8	been	be	AUX
fnp-5343	201	9	implicated	implicate	VERB
fnp-5343	201	10	.	.	PUNCT
fnp-5343	202	1	brain	brain	NOUN
fnp-5343	202	2	lysates	lysate	NOUN
fnp-5343	202	3	from	from	ADP
fnp-5343	202	4	covid-19	covid-19	PROPN
fnp-5343	202	5	patients	patient	NOUN
fnp-5343	202	6	have	have	AUX
fnp-5343	202	7	shown	show	VERB
fnp-5343	202	8	activation	activation	NOUN
fnp-5343	202	9	of	of	ADP
fnp-5343	202	10	tgf	tgf	PROPN
fnp-5343	202	11	-	-	PUNCT
fnp-5343	202	12	β	β	PROPN
fnp-5343	202	13	signaling	signal	VERB
fnp-5343	202	14	and	and	CCONJ
fnp-5343	202	15	increased	increase	VERB
fnp-5343	202	16	oxidative	oxidative	ADJ
fnp-5343	202	17	stress	stress	NOUN
fnp-5343	202	18	as	as	ADV
fnp-5343	202	19	well	well	ADV
fnp-5343	202	20	as	as	ADP
fnp-5343	202	21	activation	activation	NOUN
fnp-5343	202	22	of	of	ADP
fnp-5343	202	23	pathways	pathway	NOUN
fnp-5343	202	24	leading	lead	VERB
fnp-5343	202	25	to	to	ADP
fnp-5343	202	26	tau	tau	PROPN
fnp-5343	202	27	hyperphosphorylation	hyperphosphorylation	NOUN
fnp-5343	202	28	associated	associate	VERB
fnp-5343	202	29	with	with	ADP
fnp-5343	202	30	alzheimer	alzheimer	PROPN
fnp-5343	202	31	disease	disease	NOUN
fnp-5343	202	32	[	[	X
fnp-5343	202	33	246	246	NUM
fnp-5343	202	34	]	]	PUNCT
fnp-5343	202	35	.	.	PUNCT
fnp-5343	203	1	one	one	NUM
fnp-5343	203	2	promising	promise	VERB
fnp-5343	203	3	avenue	avenue	NOUN
fnp-5343	203	4	of	of	ADP
fnp-5343	203	5	investigation	investigation	NOUN
fnp-5343	203	6	is	be	AUX
fnp-5343	203	7	the	the	DET
fnp-5343	203	8	cerebral	cerebral	ADJ
fnp-5343	203	9	vasculature	vasculature	NOUN
fnp-5343	203	10	,	,	PUNCT
fnp-5343	203	11	as	as	SCONJ
fnp-5343	203	12	vascular	vascular	ADJ
fnp-5343	203	13	disease	disease	NOUN
fnp-5343	203	14	and	and	CCONJ
fnp-5343	203	15	bbb	bbb	NOUN
fnp-5343	203	16	dysfunction	dysfunction	NOUN
fnp-5343	203	17	have	have	AUX
fnp-5343	203	18	been	be	AUX
fnp-5343	203	19	implicated	implicate	VERB
fnp-5343	203	20	to	to	PART
fnp-5343	203	21	play	play	VERB
fnp-5343	203	22	a	a	DET
fnp-5343	203	23	significant	significant	ADJ
fnp-5343	203	24	role	role	NOUN
fnp-5343	203	25	in	in	ADP
fnp-5343	203	26	hand	hand	NOUN
fnp-5343	203	27	and	and	CCONJ
fnp-5343	204	1	acute	acute	NOUN
fnp-5343	204	2	covid-19	covid-19	PROPN
fnp-5343	205	1	[	[	X
fnp-5343	205	2	54,64,102,198	54,64,102,198	PROPN
fnp-5343	205	3	]	]	PUNCT
fnp-5343	205	4	.	.	PUNCT
fnp-5343	206	1	furthermore	furthermore	ADV
fnp-5343	206	2	,	,	PUNCT
fnp-5343	206	3	it	it	PRON
fnp-5343	206	4	is	be	AUX
fnp-5343	206	5	well	well	ADV
fnp-5343	206	6	established	establish	VERB
fnp-5343	206	7	that	that	DET
fnp-5343	206	8	vascular	vascular	ADJ
fnp-5343	206	9	disease	disease	NOUN
fnp-5343	206	10	plays	play	VERB
fnp-5343	206	11	a	a	DET
fnp-5343	206	12	significant	significant	ADJ
fnp-5343	206	13	role	role	NOUN
fnp-5343	206	14	in	in	ADP
fnp-5343	206	15	aging	age	VERB
fnp-5343	206	16	and	and	CCONJ
fnp-5343	206	17	neurodegenerative	neurodegenerative	ADJ
fnp-5343	206	18	diseases	disease	NOUN
fnp-5343	206	19	[	[	X
fnp-5343	206	20	247	247	NUM
fnp-5343	206	21	]	]	PUNCT
fnp-5343	206	22	,	,	PUNCT
fnp-5343	206	23	pathways	pathway	NOUN
fnp-5343	206	24	which	which	PRON
fnp-5343	206	25	have	have	AUX
fnp-5343	206	26	been	be	AUX
fnp-5343	206	27	implicated	implicate	VERB
fnp-5343	206	28	in	in	ADP
fnp-5343	206	29	covid-19	covid-19	PROPN
fnp-5343	206	30	as	as	ADV
fnp-5343	206	31	well	well	ADV
fnp-5343	206	32	as	as	ADP
fnp-5343	206	33	hand	hand	NOUN
fnp-5343	206	34	[	[	X
fnp-5343	206	35	145,216,248,249	145,216,248,249	NUM
fnp-5343	206	36	]	]	X
fnp-5343	206	37	.	.	PUNCT
fnp-5343	207	1	the	the	DET
fnp-5343	207	2	following	follow	VERB
fnp-5343	207	3	are	be	AUX
fnp-5343	207	4	potential	potential	ADJ
fnp-5343	207	5	"	"	PUNCT
fnp-5343	207	6	next	next	ADJ
fnp-5343	207	7	steps	step	NOUN
fnp-5343	207	8	"	"	PUNCT
fnp-5343	207	9	to	to	PART
fnp-5343	207	10	elucidate	elucidate	VERB
fnp-5343	207	11	the	the	DET
fnp-5343	207	12	mechanisms	mechanism	NOUN
fnp-5343	207	13	underlying	underlie	VERB
fnp-5343	207	14	the	the	DET
fnp-5343	207	15	neurologic	neurologic	ADJ
fnp-5343	207	16	manifestations	manifestation	NOUN
fnp-5343	207	17	in	in	ADP
fnp-5343	207	18	hand	hand	NOUN
fnp-5343	207	19	and	and	CCONJ
fnp-5343	207	20	covid-19	covid-19	PROPN
fnp-5343	207	21	/	/	SYM
fnp-5343	207	22	pcc	pcc	NOUN
fnp-5343	207	23	discussed	discuss	VERB
fnp-5343	207	24	at	at	ADP
fnp-5343	207	25	the	the	DET
fnp-5343	207	26	two	two	NUM
fnp-5343	207	27	meetings	meeting	NOUN
fnp-5343	207	28	:	:	PUNCT
fnp-5343	207	29	longitudinal	longitudinal	ADJ
fnp-5343	207	30	studies	study	NOUN
fnp-5343	207	31	of	of	ADP
fnp-5343	207	32	patients	patient	NOUN
fnp-5343	207	33	with	with	ADP
fnp-5343	207	34	hand	hand	NOUN
fnp-5343	207	35	and	and	CCONJ
fnp-5343	207	36	pcc	pcc	NOUN
fnp-5343	207	37	incorporating	incorporate	VERB
fnp-5343	207	38	clinical	clinical	ADJ
fnp-5343	207	39	,	,	PUNCT
fnp-5343	207	40	microbiology	microbiology	NOUN
fnp-5343	207	41	and	and	CCONJ
fnp-5343	207	42	pathologic	pathologic	ADJ
fnp-5343	207	43	findings	finding	NOUN
fnp-5343	207	44	using	use	VERB
fnp-5343	207	45	a	a	DET
fnp-5343	207	46	multidisciplinary	multidisciplinary	ADJ
fnp-5343	207	47	approach	approach	NOUN
fnp-5343	207	48	are	be	AUX
fnp-5343	207	49	warranted	warrant	VERB
fnp-5343	207	50	[	[	X
fnp-5343	207	51	250	250	NUM
fnp-5343	207	52	]	]	PUNCT
fnp-5343	207	53	.	.	PUNCT
fnp-5343	208	1	consensus	consensus	NOUN
fnp-5343	208	2	on	on	ADP
fnp-5343	208	3	more	more	ADV
fnp-5343	208	4	sensitive	sensitive	ADJ
fnp-5343	208	5	and	and	CCONJ
fnp-5343	208	6	specific	specific	ADJ
fnp-5343	208	7	cognitive	cognitive	ADJ
fnp-5343	208	8	assessment	assessment	NOUN
fnp-5343	208	9	tools	tool	NOUN
fnp-5343	208	10	for	for	ADP
fnp-5343	208	11	pcc	pcc	NOUN
fnp-5343	208	12	will	will	AUX
fnp-5343	208	13	help	help	VERB
fnp-5343	208	14	in	in	ADP
fnp-5343	208	15	characterizing	characterize	VERB
fnp-5343	208	16	the	the	DET
fnp-5343	208	17	clinical	clinical	ADJ
fnp-5343	208	18	spectrum	spectrum	NOUN
fnp-5343	208	19	of	of	ADP
fnp-5343	208	20	pcc	pcc	NOUN
fnp-5343	208	21	and	and	CCONJ
fnp-5343	208	22	guiding	guide	VERB
fnp-5343	208	23	further	further	ADJ
fnp-5343	208	24	investigation	investigation	NOUN
fnp-5343	209	1	[	[	X
fnp-5343	209	2	251,252	251,252	NUM
fnp-5343	209	3	]	]	PUNCT
fnp-5343	209	4	.	.	PUNCT
fnp-5343	210	1	neuropathologic	neuropathologic	ADJ
fnp-5343	210	2	studies	study	NOUN
fnp-5343	210	3	of	of	ADP
fnp-5343	210	4	patients	patient	NOUN
fnp-5343	210	5	with	with	ADP
fnp-5343	210	6	pcc	pcc	NOUN
fnp-5343	210	7	in	in	ADP
fnp-5343	210	8	comparison	comparison	NOUN
fnp-5343	210	9	to	to	PART
fnp-5343	210	10	control	control	VERB
fnp-5343	210	11	groups	group	NOUN
fnp-5343	210	12	using	use	VERB
fnp-5343	210	13	standardized	standardized	ADJ
fnp-5343	210	14	guidelines	guideline	NOUN
fnp-5343	210	15	and	and	CCONJ
fnp-5343	210	16	quantitative	quantitative	ADJ
fnp-5343	210	17	morphometric	morphometric	ADJ
fnp-5343	210	18	approaches	approach	NOUN
fnp-5343	210	19	,	,	PUNCT
fnp-5343	210	20	as	as	SCONJ
fnp-5343	210	21	has	have	AUX
fnp-5343	210	22	been	be	AUX
fnp-5343	210	23	done	do	VERB
fnp-5343	210	24	for	for	ADP
fnp-5343	210	25	hiv	hiv	PROPN
fnp-5343	210	26	,	,	PUNCT
fnp-5343	210	27	may	may	AUX
fnp-5343	210	28	be	be	AUX
fnp-5343	210	29	helpful	helpful	ADJ
fnp-5343	210	30	[	[	X
fnp-5343	210	31	251,253,254	251,253,254	NUM
fnp-5343	210	32	]	]	X
fnp-5343	210	33	.	.	PUNCT
fnp-5343	211	1	as	as	SCONJ
fnp-5343	211	2	routine	routine	ADJ
fnp-5343	211	3	light	light	ADJ
fnp-5343	211	4	microscopy	microscopy	NOUN
fnp-5343	211	5	may	may	AUX
fnp-5343	211	6	not	not	PART
fnp-5343	211	7	be	be	AUX
fnp-5343	211	8	sensitive	sensitive	ADJ
fnp-5343	211	9	enough	enough	ADV
fnp-5343	211	10	to	to	PART
fnp-5343	211	11	detect	detect	VERB
fnp-5343	211	12	subtle	subtle	ADJ
fnp-5343	211	13	changes	change	NOUN
fnp-5343	211	14	,	,	PUNCT
fnp-5343	211	15	more	more	ADJ
fnp-5343	211	16	in	in	ADP
fnp-5343	211	17	depth	depth	NOUN
fnp-5343	211	18	molecular	molecular	ADJ
fnp-5343	211	19	investigation	investigation	NOUN
fnp-5343	211	20	in	in	ADP
fnp-5343	211	21	conjunction	conjunction	NOUN
fnp-5343	211	22	with	with	ADP
fnp-5343	211	23	histopathologic	histopathologic	ADJ
fnp-5343	211	24	examination	examination	NOUN
fnp-5343	211	25	,	,	PUNCT
fnp-5343	211	26	as	as	SCONJ
fnp-5343	211	27	has	have	AUX
fnp-5343	211	28	been	be	AUX
fnp-5343	211	29	pioneered	pioneer	VERB
fnp-5343	211	30	by	by	ADP
fnp-5343	211	31	several	several	ADJ
fnp-5343	211	32	groups	group	NOUN
fnp-5343	211	33	showing	show	VERB
fnp-5343	211	34	transcriptomic	transcriptomic	ADJ
fnp-5343	211	35	changes	change	NOUN
fnp-5343	211	36	in	in	ADP
fnp-5343	211	37	both	both	DET
fnp-5343	211	38	hiv	hiv	PROPN
fnp-5343	211	39	and	and	CCONJ
fnp-5343	211	40	covid-19	covid-19	PROPN
fnp-5343	211	41	,	,	PUNCT
fnp-5343	211	42	holds	hold	VERB
fnp-5343	211	43	promise	promise	NOUN
fnp-5343	211	44	in	in	ADP
fnp-5343	211	45	shedding	shed	VERB
fnp-5343	211	46	light	light	NOUN
fnp-5343	211	47	on	on	ADP
fnp-5343	211	48	their	their	PRON
fnp-5343	211	49	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	211	50	[	[	X
fnp-5343	211	51	56,103,145	56,103,145	NUM
fnp-5343	211	52	]	]	PUNCT
fnp-5343	211	53	.	.	PUNCT
fnp-5343	212	1	greater	great	ADJ
fnp-5343	212	2	funding	funding	NOUN
fnp-5343	212	3	is	be	AUX
fnp-5343	212	4	needed	need	VERB
fnp-5343	212	5	to	to	PART
fnp-5343	212	6	perform	perform	VERB
fnp-5343	212	7	labor	labor	NOUN
fnp-5343	212	8	and	and	CCONJ
fnp-5343	212	9	resource	resource	NOUN
fnp-5343	212	10	intensive	intensive	ADJ
fnp-5343	212	11	rapid	rapid	ADJ
fnp-5343	212	12	autopsies	autopsy	NOUN
fnp-5343	212	13	on	on	ADP
fnp-5343	212	14	patients	patient	NOUN
fnp-5343	212	15	with	with	ADP
fnp-5343	212	16	hand	hand	NOUN
fnp-5343	212	17	and	and	CCONJ
fnp-5343	212	18	pcc	pcc	NOUN
fnp-5343	212	19	as	as	ADP
fnp-5343	212	20	mrna	mrna	PROPN
fnp-5343	212	21	involved	involve	VERB
fnp-5343	212	22	in	in	ADP
fnp-5343	212	23	the	the	DET
fnp-5343	212	24	immune	immune	ADJ
fnp-5343	212	25	response	response	NOUN
fnp-5343	212	26	are	be	AUX
fnp-5343	212	27	more	more	ADV
fnp-5343	212	28	susceptible	susceptible	ADJ
fnp-5343	212	29	to	to	ADP
fnp-5343	212	30	degradation	degradation	NOUN
fnp-5343	212	31	from	from	ADP
fnp-5343	212	32	prolonged	prolonged	ADJ
fnp-5343	212	33	postmortem	postmortem	NOUN
fnp-5343	212	34	intervals	interval	NOUN
fnp-5343	212	35	[	[	X
fnp-5343	212	36	255,256	255,256	NUM
fnp-5343	212	37	]	]	PUNCT
fnp-5343	212	38	.	.	PUNCT
fnp-5343	213	1	additionally	additionally	ADV
fnp-5343	213	2	,	,	PUNCT
fnp-5343	213	3	increased	increase	VERB
fnp-5343	213	4	use	use	NOUN
fnp-5343	213	5	of	of	ADP
fnp-5343	213	6	formalin	formalin	NOUN
fnp-5343	213	7	fixed	fix	VERB
fnp-5343	213	8	paraffin	paraffin	NOUN
fnp-5343	213	9	embedded	embed	VERB
fnp-5343	213	10	tissue	tissue	NOUN
fnp-5343	213	11	for	for	ADP
fnp-5343	213	12	gene	gene	NOUN
fnp-5343	213	13	expression	expression	NOUN
fnp-5343	213	14	studies	study	NOUN
fnp-5343	213	15	made	make	VERB
fnp-5343	213	16	possible	possible	ADJ
fnp-5343	213	17	by	by	ADP
fnp-5343	213	18	recent	recent	ADJ
fnp-5343	213	19	advances	advance	NOUN
fnp-5343	213	20	in	in	ADP
fnp-5343	213	21	technology	technology	NOUN
fnp-5343	213	22	will	will	AUX
fnp-5343	213	23	markedly	markedly	ADV
fnp-5343	213	24	expand	expand	VERB
fnp-5343	213	25	human	human	ADJ
fnp-5343	213	26	tissue	tissue	NOUN
fnp-5343	213	27	available	available	ADJ
fnp-5343	213	28	for	for	ADP
fnp-5343	213	29	research	research	NOUN
fnp-5343	213	30	[	[	X
fnp-5343	213	31	198	198	NUM
fnp-5343	213	32	]	]	PUNCT
fnp-5343	213	33	.	.	PUNCT
fnp-5343	214	1	further	further	ADJ
fnp-5343	214	2	consensus	consensus	NOUN
fnp-5343	214	3	on	on	ADP
fnp-5343	214	4	more	more	ADV
fnp-5343	214	5	granular	granular	ADJ
fnp-5343	214	6	and	and	CCONJ
fnp-5343	214	7	precise	precise	ADJ
fnp-5343	214	8	neuropathologic	neuropathologic	ADJ
fnp-5343	214	9	assessment	assessment	NOUN
fnp-5343	214	10	of	of	ADP
fnp-5343	214	11	vascular	vascular	ADJ
fnp-5343	214	12	disease	disease	NOUN
fnp-5343	214	13	,	,	PUNCT
fnp-5343	214	14	which	which	PRON
fnp-5343	214	15	is	be	AUX
fnp-5343	214	16	of	of	ADP
fnp-5343	214	17	increasing	increase	VERB
fnp-5343	214	18	interest	interest	NOUN
fnp-5343	214	19	to	to	ADP
fnp-5343	214	20	the	the	DET
fnp-5343	214	21	neurodegenerative	neurodegenerative	ADJ
fnp-5343	214	22	and	and	CCONJ
fnp-5343	214	23	neuropathologic	neuropathologic	ADJ
fnp-5343	214	24	community	community	NOUN
fnp-5343	214	25	,	,	PUNCT
fnp-5343	214	26	is	be	AUX
fnp-5343	214	27	needed	need	VERB
fnp-5343	214	28	to	to	PART
fnp-5343	214	29	assess	assess	VERB
fnp-5343	214	30	vascular	vascular	ADJ
fnp-5343	214	31	dysfunction	dysfunction	NOUN
fnp-5343	214	32	in	in	ADP
fnp-5343	214	33	hiv	hiv	PROPN
fnp-5343	214	34	and	and	CCONJ
fnp-5343	214	35	covid-19	covid-19	PROPN
fnp-5343	214	36	/	/	SYM
fnp-5343	214	37	pcc	pcc	NOUN
fnp-5343	214	38	[	[	X
fnp-5343	214	39	257	257	NUM
fnp-5343	214	40	]	]	PUNCT
fnp-5343	214	41	.	.	PUNCT
fnp-5343	215	1	a	a	DET
fnp-5343	215	2	better	well	ADJ
fnp-5343	215	3	understanding	understanding	NOUN
fnp-5343	215	4	of	of	ADP
fnp-5343	215	5	the	the	DET
fnp-5343	215	6	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	215	7	of	of	ADP
fnp-5343	215	8	neurologic	neurologic	ADJ
fnp-5343	215	9	complications	complication	NOUN
fnp-5343	215	10	in	in	ADP
fnp-5343	215	11	hiv	hiv	PROPN
fnp-5343	215	12	and	and	CCONJ
fnp-5343	215	13	sars	sar	NOUN
fnp-5343	215	14	-	-	PUNCT
fnp-5343	215	15	cov-2	cov-2	PART
fnp-5343	215	16	infection	infection	NOUN
fnp-5343	215	17	will	will	AUX
fnp-5343	215	18	help	help	VERB
fnp-5343	215	19	in	in	ADP
fnp-5343	215	20	the	the	DET
fnp-5343	215	21	management	management	NOUN
fnp-5343	215	22	of	of	ADP
fnp-5343	215	23	these	these	DET
fnp-5343	215	24	patients	patient	NOUN
fnp-5343	215	25	.	.	PUNCT
fnp-5343	216	1	funding	fund	VERB
fnp-5343	216	2	brain	brain	PROPN
fnp-5343	216	3	research	research	PROPN
fnp-5343	216	4	institute	institute	PROPN
fnp-5343	216	5	,	,	PUNCT
fnp-5343	216	6	david	david	PROPN
fnp-5343	216	7	geffen	geffen	PROPN
fnp-5343	216	8	school	school	PROPN
fnp-5343	216	9	of	of	ADP
fnp-5343	216	10	medicine	medicine	NOUN
fnp-5343	216	11	,	,	PUNCT
fnp-5343	216	12	university	university	PROPN
fnp-5343	216	13	of	of	ADP
fnp-5343	216	14	california	california	PROPN
fnp-5343	216	15	los	los	PROPN
fnp-5343	216	16	angeles	angeles	PROPN
fnp-5343	216	17	,	,	PUNCT
fnp-5343	216	18	los	los	PROPN
fnp-5343	216	19	angeles	angeles	PROPN
fnp-5343	216	20	,	,	PUNCT
fnp-5343	216	21	ca	ca	PROPN
fnp-5343	216	22	,	,	PUNCT
fnp-5343	216	23	usa	usa	PROPN
fnp-5343	216	24	disclosure	disclosure	NOUN
fnp-5343	216	25	statement	statement	NOUN
fnp-5343	216	26	none	none	NOUN
fnp-5343	216	27	of	of	ADP
fnp-5343	216	28	the	the	DET
fnp-5343	216	29	authors	author	NOUN
fnp-5343	216	30	has	have	VERB
fnp-5343	216	31	any	any	DET
fnp-5343	216	32	conflict	conflict	NOUN
fnp-5343	216	33	of	of	ADP
fnp-5343	216	34	interest	interest	NOUN
fnp-5343	216	35	to	to	PART
fnp-5343	216	36	disclose	disclose	VERB
fnp-5343	216	37	.	.	PUNCT
fnp-5343	217	1	references	reference	NOUN
fnp-5343	217	2	1	1	NUM
fnp-5343	217	3	.	.	X
fnp-5343	218	1	ruelas	ruelas	PROPN
fnp-5343	218	2	ds	ds	PROPN
fnp-5343	218	3	,	,	PUNCT
fnp-5343	218	4	greene	greene	PROPN
fnp-5343	218	5	wc	wc	PROPN
fnp-5343	218	6	.	.	PUNCT
fnp-5343	219	1	an	an	DET
fnp-5343	219	2	integrated	integrated	ADJ
fnp-5343	219	3	overview	overview	NOUN
fnp-5343	219	4	of	of	ADP
fnp-5343	219	5	hiv-1	hiv-1	ADJ
fnp-5343	219	6	latency	latency	NOUN
fnp-5343	219	7	.	.	PUNCT
fnp-5343	220	1	cell	cell	NOUN
fnp-5343	220	2	2013;155:519–29	2013;155:519–29	PROPN
fnp-5343	220	3	.	.	PUNCT
fnp-5343	221	1	https://doi.org/10.1016/j.cell.2013.09.044	https://doi.org/10.1016/j.cell.2013.09.044	PROPN
fnp-5343	221	2	.	.	PROPN
fnp-5343	222	1	2	2	X
fnp-5343	222	2	.	.	X
fnp-5343	222	3	gottlieb	gottlieb	PROPN
fnp-5343	222	4	ms	ms	PROPN
fnp-5343	222	5	,	,	PUNCT
fnp-5343	222	6	schroff	schroff	NOUN
fnp-5343	222	7	r	r	PROPN
fnp-5343	222	8	,	,	PUNCT
fnp-5343	222	9	schanker	schanker	PROPN
fnp-5343	222	10	hm	hm	PROPN
fnp-5343	222	11	,	,	PUNCT
fnp-5343	222	12	weisman	weisman	PROPN
fnp-5343	222	13	jd	jd	PROPN
fnp-5343	222	14	,	,	PUNCT
fnp-5343	222	15	fan	fan	PROPN
fnp-5343	222	16	pt	pt	PROPN
fnp-5343	222	17	,	,	PUNCT
fnp-5343	222	18	wolf	wolf	PROPN
fnp-5343	222	19	ra	ra	PROPN
fnp-5343	222	20	,	,	PUNCT
fnp-5343	222	21	et	et	PROPN
fnp-5343	222	22	al	al	PROPN
fnp-5343	222	23	.	.	PUNCT
fnp-5343	223	1	pneumocystis	pneumocystis	ADJ
fnp-5343	223	2	carinii	carinii	ADJ
fnp-5343	223	3	pneumonia	pneumonia	NOUN
fnp-5343	223	4	and	and	CCONJ
fnp-5343	223	5	mucosal	mucosal	ADJ
fnp-5343	223	6	candidiasis	candidiasis	NOUN
fnp-5343	223	7	in	in	ADP
fnp-5343	223	8	previously	previously	ADV
fnp-5343	223	9	healthy	healthy	ADJ
fnp-5343	223	10	homosexual	homosexual	ADJ
fnp-5343	223	11	men	man	NOUN
fnp-5343	223	12	:	:	PUNCT
fnp-5343	223	13	evidence	evidence	NOUN
fnp-5343	223	14	of	of	ADP
fnp-5343	223	15	a	a	DET
fnp-5343	223	16	new	new	ADJ
fnp-5343	223	17	acquired	acquire	VERB
fnp-5343	223	18	cellular	cellular	ADJ
fnp-5343	223	19	immunodeficiency	immunodeficiency	NOUN
fnp-5343	223	20	.	.	PUNCT
fnp-5343	224	1	n	n	CCONJ
fnp-5343	224	2	engl	engl	PROPN
fnp-5343	224	3	j	j	PROPN
fnp-5343	224	4	med	med	PROPN
fnp-5343	224	5	1981;305:1425–31	1981;305:1425–31	PROPN
fnp-5343	224	6	.	.	PUNCT
fnp-5343	224	7	https://doi.org/10.1056/nejm198112103052401	https://doi.org/10.1056/nejm198112103052401	PROPN
fnp-5343	224	8	.	.	PUNCT
fnp-5343	225	1	3	3	X
fnp-5343	225	2	.	.	X
fnp-5343	225	3	greene	greene	PROPN
fnp-5343	225	4	wc	wc	PROPN
fnp-5343	225	5	.	.	PROPN
fnp-5343	226	1	a	a	DET
fnp-5343	226	2	history	history	NOUN
fnp-5343	226	3	of	of	ADP
fnp-5343	226	4	aids	aids	PROPN
fnp-5343	226	5	:	:	PUNCT
fnp-5343	226	6	looking	look	VERB
fnp-5343	226	7	back	back	ADV
fnp-5343	226	8	to	to	PART
fnp-5343	226	9	see	see	VERB
fnp-5343	226	10	ahead	ahead	ADV
fnp-5343	226	11	.	.	PUNCT
fnp-5343	227	1	eur	eur	PROPN
fnp-5343	227	2	j	j	PROPN
fnp-5343	227	3	immunol	immunol	PROPN
fnp-5343	227	4	2007;37:94–102	2007;37:94–102	NUM
fnp-5343	227	5	.	.	PUNCT
fnp-5343	228	1	https://doi.org/10.1002/eji.200737441	https://doi.org/10.1002/eji.200737441	NOUN
fnp-5343	228	2	.	.	PUNCT
fnp-5343	229	1	4	4	X
fnp-5343	229	2	.	.	X
fnp-5343	229	3	barré	barré	NOUN
fnp-5343	229	4	-	-	PUNCT
fnp-5343	229	5	sinoussi	sinoussi	NOUN
fnp-5343	229	6	f	f	PROPN
fnp-5343	229	7	,	,	PUNCT
fnp-5343	229	8	chermann	chermann	PROPN
fnp-5343	229	9	jc	jc	PROPN
fnp-5343	229	10	,	,	PUNCT
fnp-5343	229	11	rey	rey	PROPN
fnp-5343	229	12	f	f	PROPN
fnp-5343	229	13	,	,	PUNCT
fnp-5343	229	14	nugeyre	nugeyre	PROPN
fnp-5343	229	15	mt	mt	PROPN
fnp-5343	229	16	,	,	PUNCT
fnp-5343	229	17	chamaret	chamaret	PROPN
fnp-5343	229	18	s	s	PROPN
fnp-5343	229	19	,	,	PUNCT
fnp-5343	229	20	gruest	gru	ADJ
fnp-5343	229	21	j	j	PROPN
fnp-5343	229	22	,	,	PUNCT
fnp-5343	229	23	et	et	PROPN
fnp-5343	229	24	al	al	PROPN
fnp-5343	229	25	.	.	PUNCT
fnp-5343	229	26	isolation	isolation	NOUN
fnp-5343	229	27	of	of	ADP
fnp-5343	229	28	a	a	DET
fnp-5343	229	29	t	t	NOUN
fnp-5343	229	30	-	-	PUNCT
fnp-5343	229	31	lymphotropic	lymphotropic	NOUN
fnp-5343	229	32	retrovirus	retrovirus	NOUN
fnp-5343	229	33	from	from	ADP
fnp-5343	229	34	a	a	DET
fnp-5343	229	35	patient	patient	NOUN
fnp-5343	229	36	at	at	ADP
fnp-5343	229	37	risk	risk	NOUN
fnp-5343	229	38	for	for	ADP
fnp-5343	229	39	acquired	acquire	VERB
fnp-5343	229	40	immune	immune	ADJ
fnp-5343	229	41	deficiency	deficiency	NOUN
fnp-5343	229	42	syndrome	syndrome	NOUN
fnp-5343	229	43	(	(	PUNCT
fnp-5343	229	44	aids	aids	PROPN
fnp-5343	229	45	)	)	PUNCT
fnp-5343	229	46	.	.	PUNCT
fnp-5343	230	1	science	science	PROPN
fnp-5343	230	2	1983;220:868–71	1983;220:868–71	PROPN
fnp-5343	230	3	.	.	PUNCT
fnp-5343	231	1	https://doi.org/10.1126/science.6189183	https://doi.org/10.1126/science.6189183	ADJ
fnp-5343	231	2	.	.	PUNCT
fnp-5343	232	1	5	5	NUM
fnp-5343	232	2	.	.	X
fnp-5343	232	3	popovic	popovic	PROPN
fnp-5343	232	4	m	m	PROPN
fnp-5343	232	5	,	,	PUNCT
fnp-5343	232	6	sarngadharan	sarngadharan	VERB
fnp-5343	232	7	mg	mg	PROPN
fnp-5343	232	8	,	,	PUNCT
fnp-5343	232	9	read	read	VERB
fnp-5343	232	10	e	e	NOUN
fnp-5343	232	11	,	,	PUNCT
fnp-5343	232	12	gallo	gallo	PROPN
fnp-5343	232	13	rc	rc	PROPN
fnp-5343	232	14	.	.	PROPN
fnp-5343	232	15	detection	detection	PROPN
fnp-5343	232	16	,	,	PUNCT
fnp-5343	232	17	isolation	isolation	NOUN
fnp-5343	232	18	,	,	PUNCT
fnp-5343	232	19	and	and	CCONJ
fnp-5343	232	20	continuous	continuous	ADJ
fnp-5343	232	21	production	production	NOUN
fnp-5343	232	22	of	of	ADP
fnp-5343	232	23	cytopathic	cytopathic	ADJ
fnp-5343	232	24	retroviruses	retrovirus	NOUN
fnp-5343	232	25	(	(	PUNCT
fnp-5343	232	26	htlv	htlv	PROPN
fnp-5343	232	27	-	-	PUNCT
fnp-5343	232	28	iii	iii	PROPN
fnp-5343	232	29	)	)	PUNCT
fnp-5343	232	30	from	from	ADP
fnp-5343	232	31	patients	patient	NOUN
fnp-5343	232	32	with	with	ADP
fnp-5343	232	33	aids	aid	NOUN
fnp-5343	232	34	and	and	CCONJ
fnp-5343	232	35	pre	pre	NOUN
fnp-5343	232	36	-	-	NOUN
fnp-5343	232	37	aids	aid	NOUN
fnp-5343	232	38	.	.	PUNCT
fnp-5343	233	1	science	science	NOUN
fnp-5343	233	2	1984;224:497–500	1984;224:497–500	NUM
fnp-5343	233	3	.	.	PUNCT
fnp-5343	234	1	https://doi.org/10.1126/science.6200935	https://doi.org/10.1126/science.6200935	PROPN
fnp-5343	234	2	.	.	PUNCT
fnp-5343	235	1	6	6	X
fnp-5343	235	2	.	.	X
fnp-5343	236	1	saylor	saylor	PROPN
fnp-5343	236	2	d	d	PROPN
fnp-5343	236	3	,	,	PUNCT
fnp-5343	236	4	dickens	dickens	PROPN
fnp-5343	236	5	am	be	AUX
fnp-5343	236	6	,	,	PUNCT
fnp-5343	236	7	sacktor	sacktor	NOUN
fnp-5343	236	8	n	n	CCONJ
fnp-5343	236	9	,	,	PUNCT
fnp-5343	236	10	haughey	haughey	PROPN
fnp-5343	236	11	n	n	PROPN
fnp-5343	236	12	,	,	PUNCT
fnp-5343	236	13	slusher	slusher	PROPN
fnp-5343	236	14	b	b	PROPN
fnp-5343	236	15	,	,	PUNCT
fnp-5343	236	16	pletnikov	pletnikov	PROPN
fnp-5343	236	17	m	m	PROPN
fnp-5343	236	18	,	,	PUNCT
fnp-5343	236	19	et	et	PROPN
fnp-5343	236	20	al	al	PROPN
fnp-5343	236	21	.	.	PUNCT
fnp-5343	237	1	hiv	hiv	PROPN
fnp-5343	237	2	-	-	PUNCT
fnp-5343	237	3	associated	associate	VERB
fnp-5343	237	4	neurocognitive	neurocognitive	ADJ
fnp-5343	237	5	disorder	disorder	NOUN
fnp-5343	237	6	—	—	PUNCT
fnp-5343	237	7	pathogenesis	pathogenesis	NOUN
fnp-5343	237	8	and	and	CCONJ
fnp-5343	237	9	prospects	prospect	NOUN
fnp-5343	237	10	for	for	ADP
fnp-5343	237	11	treatment	treatment	NOUN
fnp-5343	237	12	.	.	PUNCT
fnp-5343	238	1	nat	nat	PROPN
fnp-5343	238	2	rev	rev	VERB
fnp-5343	238	3	neurol	neurol	PROPN
fnp-5343	238	4	2016;12:234–48	2016;12:234–48	NUM
fnp-5343	238	5	.	.	PUNCT
fnp-5343	239	1	https://doi.org/10.1038/nrneurol.2016.27	https://doi.org/10.1038/nrneurol.2016.27	PROPN
fnp-5343	239	2	.	.	PROPN
fnp-5343	239	3	7	7	X
fnp-5343	239	4	.	.	X
fnp-5343	239	5	scaravilli	scaravilli	PROPN
fnp-5343	239	6	f	f	PROPN
fnp-5343	239	7	,	,	PUNCT
fnp-5343	239	8	bazille	bazille	NOUN
fnp-5343	239	9	c	c	NOUN
fnp-5343	239	10	,	,	PUNCT
fnp-5343	239	11	gray	gray	ADJ
fnp-5343	239	12	f.	f.	PROPN
fnp-5343	239	13	neuropathologic	neuropathologic	PROPN
fnp-5343	239	14	contributions	contribution	NOUN
fnp-5343	239	15	to	to	ADP
fnp-5343	239	16	understanding	understand	VERB
fnp-5343	239	17	aids	aid	NOUN
fnp-5343	239	18	and	and	CCONJ
fnp-5343	239	19	the	the	DET
fnp-5343	239	20	central	central	ADJ
fnp-5343	239	21	nervous	nervous	ADJ
fnp-5343	239	22	system	system	NOUN
fnp-5343	239	23	.	.	PUNCT
fnp-5343	240	1	brain	brain	NOUN
fnp-5343	240	2	pathol	pathol	NOUN
fnp-5343	240	3	2007;17:197–208	2007;17:197–208	NUM
fnp-5343	240	4	.	.	PUNCT
fnp-5343	240	5	https://doi.org/10.1111/j.1750-3639.2007.00047.x	https://doi.org/10.1111/j.1750-3639.2007.00047.x	NOUN
fnp-5343	240	6	.	.	PUNCT
fnp-5343	241	1	8	8	X
fnp-5343	241	2	.	.	X
fnp-5343	241	3	clavel	clavel	PROPN
fnp-5343	241	4	f	f	PROPN
fnp-5343	241	5	,	,	PUNCT
fnp-5343	241	6	guétard	guétard	PROPN
fnp-5343	241	7	d	d	PROPN
fnp-5343	241	8	,	,	PUNCT
fnp-5343	241	9	brun	brun	NOUN
fnp-5343	241	10	-	-	PUNCT
fnp-5343	241	11	vézinet	vézinet	ADJ
fnp-5343	241	12	f	f	NOUN
fnp-5343	241	13	,	,	PUNCT
fnp-5343	241	14	chamaret	chamaret	PROPN
fnp-5343	241	15	s	s	PROPN
fnp-5343	241	16	,	,	PUNCT
fnp-5343	241	17	rey	rey	PROPN
fnp-5343	241	18	ma	ma	PROPN
fnp-5343	241	19	,	,	PUNCT
fnp-5343	241	20	santos	santos	PROPN
fnp-5343	241	21	-	-	PUNCT
fnp-5343	241	22	ferreira	ferreira	PROPN
fnp-5343	241	23	mo	mo	PROPN
fnp-5343	241	24	,	,	PUNCT
fnp-5343	241	25	et	et	PROPN
fnp-5343	241	26	al	al	PROPN
fnp-5343	241	27	.	.	PUNCT
fnp-5343	241	28	isolation	isolation	NOUN
fnp-5343	241	29	of	of	ADP
fnp-5343	241	30	a	a	DET
fnp-5343	241	31	new	new	ADJ
fnp-5343	241	32	human	human	ADJ
fnp-5343	241	33	retrovirus	retrovirus	NOUN
fnp-5343	241	34	from	from	ADP
fnp-5343	241	35	west	west	ADJ
fnp-5343	241	36	african	african	ADJ
fnp-5343	241	37	patients	patient	NOUN
fnp-5343	241	38	with	with	ADP
fnp-5343	241	39	aids	aids	PROPN
fnp-5343	241	40	.	.	PUNCT
fnp-5343	242	1	science	science	NOUN
fnp-5343	242	2	1986;233:343–6	1986;233:343–6	NUM
fnp-5343	242	3	.	.	PUNCT
fnp-5343	242	4	https://doi.org/10.1126/science.2425430	https://doi.org/10.1126/science.2425430	PROPN
fnp-5343	242	5	.	.	PUNCT
fnp-5343	243	1	9	9	X
fnp-5343	243	2	.	.	X
fnp-5343	243	3	clavel	clavel	PROPN
fnp-5343	243	4	f	f	PROPN
fnp-5343	243	5	,	,	PUNCT
fnp-5343	243	6	mansinho	mansinho	PROPN
fnp-5343	243	7	k	k	PROPN
fnp-5343	243	8	,	,	PUNCT
fnp-5343	243	9	chamaret	chamaret	PROPN
fnp-5343	243	10	s	s	PROPN
fnp-5343	243	11	,	,	PUNCT
fnp-5343	243	12	guetard	guetard	NOUN
fnp-5343	243	13	d	d	NOUN
fnp-5343	243	14	,	,	PUNCT
fnp-5343	243	15	favier	favi	ADJ
fnp-5343	243	16	v	v	NOUN
fnp-5343	243	17	,	,	PUNCT
fnp-5343	243	18	nina	nina	PROPN
fnp-5343	243	19	j	j	PROPN
fnp-5343	243	20	,	,	PUNCT
fnp-5343	243	21	et	et	PROPN
fnp-5343	243	22	al	al	PROPN
fnp-5343	243	23	.	.	PUNCT
fnp-5343	244	1	human	human	ADJ
fnp-5343	244	2	immunodeficiency	immunodeficiency	NOUN
fnp-5343	244	3	virus	virus	NOUN
fnp-5343	244	4	type	type	NOUN
fnp-5343	244	5	2	2	NUM
fnp-5343	244	6	infection	infection	NOUN
fnp-5343	244	7	associated	associate	VERB
fnp-5343	244	8	with	with	ADP
fnp-5343	244	9	aids	aid	NOUN
fnp-5343	244	10	in	in	ADP
fnp-5343	244	11	west	west	PROPN
fnp-5343	244	12	africa	africa	PROPN
fnp-5343	244	13	.	.	PUNCT
fnp-5343	245	1	n	n	PROPN
fnp-5343	245	2	engl	engl	PROPN
fnp-5343	245	3	j	j	PROPN
fnp-5343	245	4	med	med	PROPN
fnp-5343	245	5	1987;316:1180–5	1987;316:1180–5	NOUN
fnp-5343	245	6	.	.	PUNCT
fnp-5343	246	1	https://doi.org/10.1056/nejm198705073161903	https://doi.org/10.1056/nejm198705073161903	VERB
fnp-5343	246	2	.	.	PUNCT
fnp-5343	247	1	10	10	NUM
fnp-5343	247	2	.	.	X
fnp-5343	247	3	trickey	trickey	PROPN
fnp-5343	247	4	a	a	PRON
fnp-5343	247	5	,	,	PUNCT
fnp-5343	247	6	may	may	PROPN
fnp-5343	247	7	mt	mt	PROPN
fnp-5343	247	8	,	,	PUNCT
fnp-5343	247	9	vehreschild	vehreschild	PROPN
fnp-5343	247	10	j	j	PROPN
fnp-5343	247	11	-	-	PROPN
fnp-5343	247	12	j	j	PROPN
fnp-5343	247	13	,	,	PUNCT
fnp-5343	247	14	obel	obel	PROPN
fnp-5343	247	15	n	n	CCONJ
fnp-5343	247	16	,	,	PUNCT
fnp-5343	247	17	gill	gill	PROPN
fnp-5343	247	18	mj	mj	PROPN
fnp-5343	247	19	,	,	PUNCT
fnp-5343	247	20	crane	crane	NOUN
fnp-5343	247	21	hm	hm	INTJ
fnp-5343	247	22	,	,	PUNCT
fnp-5343	247	23	et	et	PROPN
fnp-5343	247	24	al	al	PROPN
fnp-5343	247	25	.	.	PROPN
fnp-5343	248	1	survival	survival	PROPN
fnp-5343	248	2	of	of	ADP
fnp-5343	248	3	hiv	hiv	PROPN
fnp-5343	248	4	-	-	PUNCT
fnp-5343	248	5	positive	positive	ADJ
fnp-5343	248	6	patients	patient	NOUN
fnp-5343	248	7	starting	start	VERB
fnp-5343	248	8	antiretroviral	antiretroviral	ADJ
fnp-5343	248	9	therapy	therapy	NOUN
fnp-5343	248	10	between	between	ADP
fnp-5343	248	11	1996	1996	NUM
fnp-5343	248	12	and	and	CCONJ
fnp-5343	248	13	2013	2013	NUM
fnp-5343	248	14	:	:	PUNCT
fnp-5343	248	15	a	a	DET
fnp-5343	248	16	collaborative	collaborative	ADJ
fnp-5343	248	17	analysis	analysis	NOUN
fnp-5343	248	18	of	of	ADP
fnp-5343	248	19	cohort	cohort	NOUN
fnp-5343	248	20	studies	study	NOUN
fnp-5343	248	21	.	.	PUNCT
fnp-5343	249	1	lancet	lancet	PROPN
fnp-5343	249	2	hiv	hiv	PROPN
fnp-5343	249	3	2017;4	2017;4	NUM
fnp-5343	249	4	:	:	PUNCT
fnp-5343	249	5	e349–56	e349–56	PROPN
fnp-5343	249	6	.	.	PUNCT
fnp-5343	249	7	https://doi.org/10.1016/s2352-3018(17)30066-8	https://doi.org/10.1016/s2352-3018(17)30066-8	PROPN
fnp-5343	249	8	.	.	PUNCT
fnp-5343	250	1	11	11	NUM
fnp-5343	250	2	.	.	PUNCT
fnp-5343	251	1	joint	joint	ADJ
fnp-5343	251	2	united	united	PROPN
fnp-5343	251	3	nations	nations	PROPN
fnp-5343	251	4	programme	programme	PROPN
fnp-5343	251	5	on	on	ADP
fnp-5343	251	6	hiv	hiv	PROPN
fnp-5343	251	7	/	/	SYM
fnp-5343	251	8	aids	aids	PROPN
fnp-5343	251	9	.	.	PUNCT
fnp-5343	252	1	unaids	unaid	NOUN
fnp-5343	252	2	data	data	PROPN
fnp-5343	252	3	2022	2022	NUM
fnp-5343	252	4	.	.	PUNCT
fnp-5343	253	1	https://www.unaids.org/sites/default/files/media_asset/data-book-2022_en.pdf	https://www.unaids.org/sites/default/files/media_asset/data-book-2022_en.pdf	PROPN
fnp-5343	253	2	.	.	PUNCT
fnp-5343	254	1	accessed	access	VERB
fnp-5343	254	2	:	:	PUNCT
fnp-5343	254	3	june	june	PROPN
fnp-5343	254	4	28	28	NUM
fnp-5343	254	5	,	,	PUNCT
fnp-5343	254	6	2023	2023	NUM
fnp-5343	254	7	.	.	PUNCT
fnp-5343	255	1	12	12	NUM
fnp-5343	255	2	.	.	PUNCT
fnp-5343	256	1	bissel	bissel	PROPN
fnp-5343	256	2	sj	sj	PROPN
fnp-5343	256	3	,	,	PUNCT
fnp-5343	256	4	wiley	wiley	PROPN
fnp-5343	256	5	ca	ca	PROPN
fnp-5343	256	6	.	.	PUNCT
fnp-5343	257	1	human	human	ADJ
fnp-5343	257	2	immunodeficiency	immunodeficiency	NOUN
fnp-5343	257	3	virus	virus	NOUN
fnp-5343	257	4	infection	infection	NOUN
fnp-5343	257	5	of	of	ADP
fnp-5343	257	6	the	the	DET
fnp-5343	257	7	brain	brain	NOUN
fnp-5343	257	8	:	:	PUNCT
fnp-5343	257	9	pitfalls	pitfall	NOUN
fnp-5343	257	10	in	in	ADP
fnp-5343	257	11	evaluating	evaluate	VERB
fnp-5343	257	12	infected	infect	VERB
fnp-5343	257	13	/	/	SYM
fnp-5343	257	14	affected	affect	VERB
fnp-5343	257	15	cell	cell	NOUN
fnp-5343	257	16	populations	population	NOUN
fnp-5343	257	17	.	.	PUNCT
fnp-5343	258	1	brain	brain	NOUN
fnp-5343	258	2	pathol	pathol	NOUN
fnp-5343	258	3	2004;14:97–108	2004;14:97–108	NUM
fnp-5343	258	4	.	.	PUNCT
fnp-5343	259	1	https://doi.org/10.1111/j.1750-3639.2004.tb00503.x	https://doi.org/10.1111/j.1750-3639.2004.tb00503.x	NOUN
fnp-5343	259	2	.	.	NOUN
fnp-5343	259	3	13	13	NUM
fnp-5343	259	4	.	.	PUNCT
fnp-5343	260	1	patrick	patrick	PROPN
fnp-5343	260	2	mk	mk	PROPN
fnp-5343	260	3	,	,	PUNCT
fnp-5343	260	4	johnston	johnston	PROPN
fnp-5343	260	5	jb	jb	PROPN
fnp-5343	260	6	,	,	PUNCT
fnp-5343	260	7	power	power	PROPN
fnp-5343	260	8	c.	c.	PROPN
fnp-5343	260	9	lentiviral	lentiviral	PROPN
fnp-5343	260	10	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	260	11	:	:	PUNCT
fnp-5343	260	12	comparative	comparative	ADJ
fnp-5343	260	13	neuroinvasion	neuroinvasion	NOUN
fnp-5343	260	14	,	,	PUNCT
fnp-5343	260	15	neurotropism	neurotropism	NOUN
fnp-5343	260	16	,	,	PUNCT
fnp-5343	260	17	neurovirulence	neurovirulence	NOUN
fnp-5343	260	18	,	,	PUNCT
fnp-5343	260	19	and	and	CCONJ
fnp-5343	260	20	host	host	NOUN
fnp-5343	260	21	neurosusceptibility	neurosusceptibility	NOUN
fnp-5343	260	22	.	.	PUNCT
fnp-5343	261	1	j	j	PROPN
fnp-5343	261	2	virol	virol	PROPN
fnp-5343	261	3	2002;76:7923–31	2002;76:7923–31	PROPN
fnp-5343	261	4	.	.	PUNCT
fnp-5343	262	1	https://doi.org/10.1128/jvi.76.16.7923-7931.2002	https://doi.org/10.1128/jvi.76.16.7923-7931.2002	NOUN
fnp-5343	262	2	.	.	PROPN
fnp-5343	262	3	14	14	NUM
fnp-5343	262	4	.	.	PUNCT
fnp-5343	263	1	stevenson	stevenson	PROPN
fnp-5343	263	2	m.	m.	PROPN
fnp-5343	263	3	hiv-1	hiv-1	X
fnp-5343	263	4	pathogenesis	pathogenesis	NOUN
fnp-5343	263	5	.	.	PUNCT
fnp-5343	264	1	nat	nat	PROPN
fnp-5343	264	2	med	med	PROPN
fnp-5343	264	3	2003;9:853–60	2003;9:853–60	PROPN
fnp-5343	264	4	.	.	PUNCT
fnp-5343	265	1	https://doi.org/10.1038/nm0703-853	https://doi.org/10.1038/nm0703-853	NOUN
fnp-5343	265	2	.	.	PUNCT
fnp-5343	266	1	15	15	NUM
fnp-5343	266	2	.	.	PUNCT
fnp-5343	266	3	albright	albright	PROPN
fnp-5343	266	4	a	a	DET
fnp-5343	266	5	v.	v.	PROPN
fnp-5343	266	6	,	,	PUNCT
fnp-5343	266	7	shieh	shieh	PROPN
fnp-5343	266	8	jtc	jtc	PROPN
fnp-5343	266	9	,	,	PUNCT
fnp-5343	266	10	itoh	itoh	PROPN
fnp-5343	266	11	t	t	PROPN
fnp-5343	266	12	,	,	PUNCT
fnp-5343	266	13	lee	lee	PROPN
fnp-5343	266	14	b	b	PROPN
fnp-5343	266	15	,	,	PUNCT
fnp-5343	266	16	pleasure	pleasure	NOUN
fnp-5343	266	17	d	d	NOUN
fnp-5343	266	18	,	,	PUNCT
fnp-5343	266	19	o’connor	o’connor	ADV
fnp-5343	266	20	mj	mj	PROPN
fnp-5343	266	21	,	,	PUNCT
fnp-5343	266	22	et	et	PROPN
fnp-5343	266	23	al	al	PROPN
fnp-5343	266	24	.	.	PUNCT
fnp-5343	267	1	microglia	microglia	PROPN
fnp-5343	267	2	express	express	ADJ
fnp-5343	267	3	ccr5	ccr5	NOUN
fnp-5343	267	4	,	,	PUNCT
fnp-5343	267	5	cxcr4	cxcr4	NOUN
fnp-5343	267	6	,	,	PUNCT
fnp-5343	267	7	and	and	CCONJ
fnp-5343	267	8	ccr3	ccr3	PROPN
fnp-5343	267	9	,	,	PUNCT
fnp-5343	267	10	but	but	CCONJ
fnp-5343	267	11	of	of	ADP
fnp-5343	267	12	these	these	PRON
fnp-5343	267	13	,	,	PUNCT
fnp-5343	267	14	ccr5	ccr5	PROPN
fnp-5343	267	15	is	be	AUX
fnp-5343	267	16	the	the	DET
fnp-5343	267	17	principal	principal	ADJ
fnp-5343	267	18	coreceptor	coreceptor	NOUN
fnp-5343	267	19	for	for	ADP
fnp-5343	267	20	human	human	ADJ
fnp-5343	267	21	immunodeficiency	immunodeficiency	NOUN
fnp-5343	267	22	virus	virus	NOUN
fnp-5343	267	23	type	type	NOUN
fnp-5343	267	24	1	1	NUM
fnp-5343	267	25	dementia	dementia	NOUN
fnp-5343	267	26	isolates	isolate	NOUN
fnp-5343	267	27	.	.	PUNCT
fnp-5343	268	1	j	j	PROPN
fnp-5343	268	2	virol	virol	PROPN
fnp-5343	268	3	1999;73:205–13	1999;73:205–13	PROPN
fnp-5343	268	4	.	.	PUNCT
fnp-5343	269	1	https://doi.org/10.1128/jvi.73.1.205-213.1999	https://doi.org/10.1128/jvi.73.1.205-213.1999	X
fnp-5343	269	2	.	.	PUNCT
fnp-5343	270	1	16	16	NUM
fnp-5343	270	2	.	.	PUNCT
fnp-5343	271	1	gonzález	gonzález	PROPN
fnp-5343	271	2	-	-	PUNCT
fnp-5343	271	3	scarano	scarano	PROPN
fnp-5343	271	4	f	f	PROPN
fnp-5343	271	5	,	,	PUNCT
fnp-5343	271	6	martín	martín	NOUN
fnp-5343	271	7	-	-	PUNCT
fnp-5343	271	8	garcía	garcía	ADJ
fnp-5343	271	9	j.	j.	PROPN
fnp-5343	271	10	the	the	DET
fnp-5343	271	11	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	271	12	of	of	ADP
fnp-5343	271	13	aids	aids	PROPN
fnp-5343	271	14	.	.	PUNCT
fnp-5343	272	1	nat	nat	PROPN
fnp-5343	272	2	rev	rev	VERB
fnp-5343	272	3	immunol	immunol	NOUN
fnp-5343	272	4	2005;5:69–81	2005;5:69–81	NUM
fnp-5343	272	5	.	.	PUNCT
fnp-5343	273	1	https://doi.org/10.1038/nri1527	https://doi.org/10.1038/nri1527	PROPN
fnp-5343	273	2	.	.	PROPN
fnp-5343	274	1	17	17	NUM
fnp-5343	274	2	.	.	PUNCT
fnp-5343	275	1	saito	saito	PROPN
fnp-5343	275	2	y	y	PROPN
fnp-5343	275	3	,	,	PUNCT
fnp-5343	275	4	sharer	sharer	PROPN
fnp-5343	275	5	lr	lr	PROPN
fnp-5343	275	6	,	,	PUNCT
fnp-5343	275	7	epstein	epstein	PROPN
fnp-5343	275	8	lg	lg	PROPN
fnp-5343	275	9	,	,	PUNCT
fnp-5343	275	10	michaels	michaels	PROPN
fnp-5343	275	11	j	j	PROPN
fnp-5343	275	12	,	,	PUNCT
fnp-5343	275	13	mintz	mintz	PROPN
fnp-5343	275	14	m	m	PROPN
fnp-5343	275	15	,	,	PUNCT
fnp-5343	275	16	louder	louder	ADV
fnp-5343	275	17	m	m	PROPN
fnp-5343	275	18	,	,	PUNCT
fnp-5343	275	19	et	et	PROPN
fnp-5343	275	20	al	al	PROPN
fnp-5343	275	21	.	.	PROPN
fnp-5343	275	22	overexpression	overexpression	NOUN
fnp-5343	275	23	of	of	ADP
fnp-5343	275	24	nef	nef	PROPN
fnp-5343	275	25	as	as	ADP
fnp-5343	275	26	a	a	DET
fnp-5343	275	27	marker	marker	NOUN
fnp-5343	275	28	for	for	ADP
fnp-5343	275	29	restricted	restrict	VERB
fnp-5343	275	30	hiv‐1	hiv‐1	NOUN
fnp-5343	275	31	infection	infection	NOUN
fnp-5343	275	32	of	of	ADP
fnp-5343	275	33	astrocytes	astrocyte	NOUN
fnp-5343	275	34	in	in	ADP
fnp-5343	275	35	postmortem	postmortem	NOUN
fnp-5343	275	36	pediatric	pediatric	ADJ
fnp-5343	275	37	central	central	ADJ
fnp-5343	275	38	nervous	nervous	ADJ
fnp-5343	275	39	tissues	tissue	NOUN
fnp-5343	275	40	.	.	PUNCT
fnp-5343	276	1	neurology	neurology	NOUN
fnp-5343	276	2	1994;44:474–474	1994;44:474–474	PROPN
fnp-5343	276	3	.	.	PUNCT
fnp-5343	277	1	https://doi.org/10.1212/wnl.44.3_part_1.474	https://doi.org/10.1212/wnl.44.3_part_1.474	PROPN
fnp-5343	277	2	.	.	PROPN
fnp-5343	278	1	18	18	NUM
fnp-5343	278	2	.	.	PUNCT
fnp-5343	279	1	an	an	DET
fnp-5343	279	2	sf	sf	PROPN
fnp-5343	279	3	,	,	PUNCT
fnp-5343	279	4	groves	grove	NOUN
fnp-5343	279	5	m	m	PROPN
fnp-5343	279	6	,	,	PUNCT
fnp-5343	279	7	giometto	giometto	PROPN
fnp-5343	279	8	b	b	PROPN
fnp-5343	279	9	,	,	PUNCT
fnp-5343	279	10	beckett	beckett	PROPN
fnp-5343	279	11	aaj	aaj	PROPN
fnp-5343	279	12	,	,	PUNCT
fnp-5343	279	13	scaravilli	scaravilli	PROPN
fnp-5343	279	14	f.	f.	PROPN
fnp-5343	279	15	detection	detection	PROPN
fnp-5343	279	16	and	and	CCONJ
fnp-5343	279	17	localisation	localisation	NOUN
fnp-5343	279	18	of	of	ADP
fnp-5343	279	19	hiv-1	hiv-1	PUNCT
fnp-5343	279	20	dna	dna	PROPN
fnp-5343	279	21	and	and	CCONJ
fnp-5343	279	22	rna	rna	NOUN
fnp-5343	279	23	in	in	ADP
fnp-5343	279	24	fixed	fix	VERB
fnp-5343	279	25	adult	adult	NOUN
fnp-5343	279	26	aids	aid	NOUN
fnp-5343	279	27	brain	brain	NOUN
fnp-5343	279	28	by	by	ADP
fnp-5343	279	29	polymerase	polymerase	NOUN
fnp-5343	279	30	chain	chain	NOUN
fnp-5343	279	31	reaction	reaction	NOUN
fnp-5343	279	32	/	/	SYM
fnp-5343	279	33	in	in	ADP
fnp-5343	279	34	situ	situ	ADJ
fnp-5343	279	35	hybridisation	hybridisation	NOUN
fnp-5343	279	36	technique	technique	NOUN
fnp-5343	279	37	.	.	PUNCT
fnp-5343	280	1	acta	acta	PROPN
fnp-5343	280	2	neuropathol	neuropathol	PROPN
fnp-5343	280	3	1999;98:481–7	1999;98:481–7	NUM
fnp-5343	280	4	.	.	PUNCT
fnp-5343	281	1	https://doi.org/10.1007/s004010051113	https://doi.org/10.1007/s004010051113	NUM
fnp-5343	281	2	.	.	NOUN
fnp-5343	282	1	19	19	NUM
fnp-5343	282	2	.	.	PUNCT
fnp-5343	282	3	resnick	resnick	PROPN
fnp-5343	282	4	l	l	PROPN
fnp-5343	282	5	,	,	PUNCT
fnp-5343	282	6	berger	berger	PROPN
fnp-5343	282	7	jr	jr	PROPN
fnp-5343	282	8	,	,	PUNCT
fnp-5343	282	9	shapshak	shapshak	VERB
fnp-5343	282	10	p	p	NOUN
fnp-5343	282	11	,	,	PUNCT
fnp-5343	282	12	tourtellotte	tourtellotte	PROPN
fnp-5343	282	13	ww	ww	PROPN
fnp-5343	282	14	.	.	PROPN
fnp-5343	283	1	early	early	ADJ
fnp-5343	283	2	penetration	penetration	NOUN
fnp-5343	283	3	of	of	ADP
fnp-5343	283	4	the	the	DET
fnp-5343	283	5	blood	blood	NOUN
fnp-5343	283	6	-	-	PUNCT
fnp-5343	283	7	brain	brain	NOUN
fnp-5343	283	8	-	-	PUNCT
fnp-5343	283	9	barrier	barrier	NOUN
fnp-5343	283	10	by	by	ADP
fnp-5343	283	11	hiv	hiv	PROPN
fnp-5343	283	12	.	.	PUNCT
fnp-5343	284	1	neurology	neurology	PROPN
fnp-5343	284	2	1988;38:9–14	1988;38:9–14	PROPN
fnp-5343	284	3	.	.	PUNCT
fnp-5343	284	4	https://doi.org/10.1212/wnl.38.1.9	https://doi.org/10.1212/wnl.38.1.9	PROPN
fnp-5343	284	5	.	.	PUNCT
fnp-5343	285	1	20	20	NUM
fnp-5343	285	2	.	.	PUNCT
fnp-5343	286	1	gray	gray	ADJ
fnp-5343	286	2	f	f	NOUN
fnp-5343	286	3	,	,	PUNCT
fnp-5343	286	4	scaravilli	scaravilli	PROPN
fnp-5343	286	5	f	f	PROPN
fnp-5343	286	6	,	,	PUNCT
fnp-5343	286	7	everall	everall	NOUN
fnp-5343	286	8	i	i	PROPN
fnp-5343	286	9	,	,	PUNCT
fnp-5343	286	10	chretien	chretien	PROPN
fnp-5343	286	11	f	f	PROPN
fnp-5343	286	12	,	,	PUNCT
fnp-5343	286	13	an	an	DET
fnp-5343	286	14	s	s	PROPN
fnp-5343	286	15	,	,	PUNCT
fnp-5343	286	16	boche	boche	PROPN
fnp-5343	286	17	d	d	PROPN
fnp-5343	286	18	,	,	PUNCT
fnp-5343	286	19	et	et	PROPN
fnp-5343	286	20	al	al	PROPN
fnp-5343	286	21	.	.	PROPN
fnp-5343	286	22	neuropathology	neuropathology	NOUN
fnp-5343	286	23	of	of	ADP
fnp-5343	286	24	early	early	ADJ
fnp-5343	286	25	hiv-1	hiv-1	ADJ
fnp-5343	286	26	infection	infection	NOUN
fnp-5343	286	27	.	.	PUNCT
fnp-5343	287	1	brain	brain	NOUN
fnp-5343	287	2	pathol	pathol	NOUN
fnp-5343	287	3	1996;6:1–15	1996;6:1–15	NUM
fnp-5343	287	4	.	.	PUNCT
fnp-5343	288	1	https://doi.org/10.1111/j.1750-3639.1996.tb00775.x	https://doi.org/10.1111/j.1750-3639.1996.tb00775.x	PROPN
fnp-5343	288	2	.	.	PROPN
fnp-5343	289	1	21	21	NUM
fnp-5343	289	2	.	.	PUNCT
fnp-5343	290	1	valcour	valcour	PROPN
fnp-5343	290	2	v	v	PROPN
fnp-5343	290	3	,	,	PUNCT
fnp-5343	290	4	sithinamsuwan	sithinamsuwan	X
fnp-5343	290	5	p	p	NOUN
fnp-5343	290	6	,	,	PUNCT
fnp-5343	290	7	letendre	letendre	PROPN
fnp-5343	290	8	s	s	PROPN
fnp-5343	290	9	,	,	PUNCT
fnp-5343	290	10	ances	ance	NOUN
fnp-5343	290	11	b.	b.	PROPN
fnp-5343	290	12	pathogenesis	pathogenesis	PROPN
fnp-5343	290	13	of	of	ADP
fnp-5343	290	14	hiv	hiv	PROPN
fnp-5343	290	15	in	in	ADP
fnp-5343	290	16	the	the	DET
fnp-5343	290	17	central	central	ADJ
fnp-5343	290	18	nervous	nervous	ADJ
fnp-5343	290	19	system	system	NOUN
fnp-5343	290	20	.	.	PUNCT
fnp-5343	291	1	curr	curr	PROPN
fnp-5343	291	2	hiv	hiv	PROPN
fnp-5343	291	3	/	/	SYM
fnp-5343	291	4	aids	aids	PROPN
fnp-5343	291	5	rep	rep	PROPN
fnp-5343	291	6	2011;8:54–61	2011;8:54–61	PROPN
fnp-5343	291	7	.	.	PUNCT
fnp-5343	292	1	https://doi.org/10.1007/s11904-010-0070-4	https://doi.org/10.1007/s11904-010-0070-4	NUM
fnp-5343	292	2	.	.	PUNCT
fnp-5343	293	1	22	22	NUM
fnp-5343	293	2	.	.	PUNCT
fnp-5343	294	1	clifford	clifford	PROPN
fnp-5343	294	2	db	db	PROPN
fnp-5343	294	3	.	.	PROPN
fnp-5343	294	4	hiv	hiv	PROPN
fnp-5343	294	5	-	-	PUNCT
fnp-5343	294	6	associated	associate	VERB
fnp-5343	294	7	neurocognitive	neurocognitive	ADJ
fnp-5343	294	8	disorder	disorder	NOUN
fnp-5343	294	9	.	.	PUNCT
fnp-5343	295	1	curr	curr	PROPN
fnp-5343	295	2	opin	opin	NOUN
fnp-5343	295	3	infect	infect	NOUN
fnp-5343	295	4	dis	dis	PROPN
fnp-5343	295	5	2017;30:117–22	2017;30:117–22	NUM
fnp-5343	295	6	.	.	PUNCT
fnp-5343	296	1	https://doi.org/10.1097/qco.0000000000000328	https://doi.org/10.1097/qco.0000000000000328	PROPN
fnp-5343	296	2	.	.	PROPN
fnp-5343	297	1	23	23	NUM
fnp-5343	297	2	.	.	PUNCT
fnp-5343	298	1	tan	tan	PROPN
fnp-5343	298	2	il	il	PROPN
fnp-5343	298	3	,	,	PUNCT
fnp-5343	298	4	smith	smith	PROPN
fnp-5343	298	5	br	br	PROPN
fnp-5343	298	6	,	,	PUNCT
fnp-5343	298	7	von	von	PROPN
fnp-5343	298	8	geldern	geldern	PROPN
fnp-5343	298	9	g	g	PROPN
fnp-5343	298	10	,	,	PUNCT
fnp-5343	298	11	mateen	mateen	PROPN
fnp-5343	298	12	fj	fj	PROPN
fnp-5343	298	13	,	,	PUNCT
fnp-5343	298	14	mcarthur	mcarthur	PROPN
fnp-5343	298	15	jc	jc	PROPN
fnp-5343	298	16	.	.	PROPN
fnp-5343	298	17	hiv	hiv	PROPN
fnp-5343	298	18	-	-	PUNCT
fnp-5343	298	19	associated	associate	VERB
fnp-5343	298	20	opportunistic	opportunistic	ADJ
fnp-5343	298	21	infections	infection	NOUN
fnp-5343	298	22	of	of	ADP
fnp-5343	298	23	the	the	DET
fnp-5343	298	24	cns	cns	PROPN
fnp-5343	298	25	.	.	PUNCT
fnp-5343	299	1	lancet	lancet	PROPN
fnp-5343	299	2	neurol	neurol	PROPN
fnp-5343	299	3	2012;11:605–17	2012;11:605–17	NUM
fnp-5343	299	4	.	.	PUNCT
fnp-5343	300	1	https://doi.org/10.1016/s1474-4422(12)70098-4	https://doi.org/10.1016/s1474-4422(12)70098-4	PROPN
fnp-5343	300	2	.	.	PUNCT
fnp-5343	301	1	24	24	NUM
fnp-5343	301	2	.	.	PUNCT
fnp-5343	302	1	antinori	antinori	PROPN
fnp-5343	302	2	a	a	PRON
fnp-5343	302	3	,	,	PUNCT
fnp-5343	302	4	arendt	arendt	PROPN
fnp-5343	302	5	g	g	PROPN
fnp-5343	302	6	,	,	PUNCT
fnp-5343	302	7	becker	becker	PROPN
fnp-5343	302	8	jt	jt	PROPN
fnp-5343	302	9	,	,	PUNCT
fnp-5343	302	10	brew	brew	VERB
fnp-5343	302	11	bj	bj	ADP
fnp-5343	302	12	,	,	PUNCT
fnp-5343	302	13	byrd	byrd	PROPN
fnp-5343	302	14	da	da	PROPN
fnp-5343	302	15	,	,	PUNCT
fnp-5343	302	16	cherner	cherner	NOUN
fnp-5343	302	17	m	m	PROPN
fnp-5343	302	18	,	,	PUNCT
fnp-5343	302	19	et	et	PROPN
fnp-5343	302	20	al	al	PROPN
fnp-5343	302	21	.	.	PROPN
fnp-5343	302	22	updated	update	VERB
fnp-5343	302	23	research	research	NOUN
fnp-5343	302	24	nosology	nosology	NOUN
fnp-5343	302	25	for	for	ADP
fnp-5343	302	26	hiv	hiv	PROPN
fnp-5343	302	27	-	-	PUNCT
fnp-5343	302	28	associated	associate	VERB
fnp-5343	302	29	neuro	neuro	PROPN
fnp-5343	302	30	cognitive	cognitive	ADJ
fnp-5343	302	31	disorders	disorder	NOUN
fnp-5343	302	32	.	.	PUNCT
fnp-5343	303	1	neurology	neurology	NOUN
fnp-5343	303	2	2007;69:1789–99	2007;69:1789–99	NUM
fnp-5343	303	3	.	.	PUNCT
fnp-5343	304	1	https://doi.org/10.1212/01.wnl.0000287431.88658.8b	https://doi.org/10.1212/01.wnl.0000287431.88658.8b	ADJ
fnp-5343	304	2	.	.	PUNCT
fnp-5343	305	1	25	25	NUM
fnp-5343	305	2	.	.	PUNCT
fnp-5343	306	1	janssen	janssen	PROPN
fnp-5343	306	2	rs	rs	PROPN
fnp-5343	306	3	,	,	PUNCT
fnp-5343	306	4	cornblath	cornblath	PROPN
fnp-5343	306	5	dr	dr	PROPN
fnp-5343	306	6	,	,	PUNCT
fnp-5343	306	7	epstein	epstein	PROPN
fnp-5343	306	8	lg	lg	PROPN
fnp-5343	306	9	,	,	PUNCT
fnp-5343	306	10	foa	foa	PROPN
fnp-5343	306	11	rp	rp	PROPN
fnp-5343	306	12	,	,	PUNCT
fnp-5343	306	13	mcarthur	mcarthur	PROPN
fnp-5343	306	14	jc	jc	PROPN
fnp-5343	306	15	,	,	PUNCT
fnp-5343	306	16	price	price	NOUN
fnp-5343	306	17	rw	rw	NOUN
fnp-5343	306	18	,	,	PUNCT
fnp-5343	306	19	et	et	PROPN
fnp-5343	306	20	al	al	PROPN
fnp-5343	306	21	.	.	PUNCT
fnp-5343	307	1	nomenclature	nomenclature	NOUN
fnp-5343	307	2	and	and	CCONJ
fnp-5343	307	3	research	research	NOUN
fnp-5343	307	4	case	case	NOUN
fnp-5343	307	5	definitions	definition	NOUN
fnp-5343	307	6	for	for	ADP
fnp-5343	307	7	neurologic	neurologic	ADJ
fnp-5343	307	8	manifestations	manifestation	NOUN
fnp-5343	307	9	of	of	ADP
fnp-5343	307	10	human	human	ADJ
fnp-5343	307	11	immunodeficiency	immunodeficiency	NOUN
fnp-5343	307	12	virus	virus	NOUN
fnp-5343	307	13	-	-	PUNCT
fnp-5343	307	14	type	type	NOUN
fnp-5343	307	15	1	1	NUM
fnp-5343	307	16	(	(	PUNCT
fnp-5343	307	17	hiv-1	hiv-1	NOUN
fnp-5343	307	18	)	)	PUNCT
fnp-5343	307	19	infection	infection	NOUN
fnp-5343	307	20	.	.	PUNCT
fnp-5343	308	1	report	report	NOUN
fnp-5343	308	2	of	of	ADP
fnp-5343	308	3	a	a	DET
fnp-5343	308	4	working	work	VERB
fnp-5343	308	5	group	group	NOUN
fnp-5343	308	6	of	of	ADP
fnp-5343	308	7	the	the	DET
fnp-5343	308	8	american	american	PROPN
fnp-5343	308	9	academy	academy	PROPN
fnp-5343	308	10	of	of	ADP
fnp-5343	308	11	neurology	neurology	NOUN
fnp-5343	308	12	aids	aids	PROPN
fnp-5343	308	13	task	task	PROPN
fnp-5343	308	14	force	force	NOUN
fnp-5343	308	15	.	.	PUNCT
fnp-5343	309	1	neurology	neurology	NOUN
fnp-5343	309	2	1991;41:778–85	1991;41:778–85	PROPN
fnp-5343	309	3	.	.	PUNCT
fnp-5343	310	1	https://doi.org/10.1212/wnl.41.6.778	https://doi.org/10.1212/wnl.41.6.778	PROPN
fnp-5343	310	2	.	.	PUNCT
fnp-5343	311	1	26	26	NUM
fnp-5343	311	2	.	.	PUNCT
fnp-5343	312	1	navia	navia	PROPN
fnp-5343	312	2	ba	ba	PROPN
fnp-5343	312	3	,	,	PUNCT
fnp-5343	312	4	cho	cho	PROPN
fnp-5343	312	5	bd	bd	PROPN
fnp-5343	312	6	,	,	PUNCT
fnp-5343	312	7	price	price	NOUN
fnp-5343	312	8	rw	rw	NOUN
fnp-5343	312	9	.	.	PUNCT
fnp-5343	313	1	the	the	DET
fnp-5343	313	2	aids	aids	PROPN
fnp-5343	313	3	dementia	dementia	NOUN
fnp-5343	313	4	complex	complex	NOUN
fnp-5343	313	5	:	:	PUNCT
fnp-5343	313	6	i.	i.	PROPN
fnp-5343	313	7	clinical	clinical	ADJ
fnp-5343	313	8	features	feature	NOUN
fnp-5343	313	9	.	.	PUNCT
fnp-5343	314	1	ann	ann	PROPN
fnp-5343	314	2	neurol	neurol	PROPN
fnp-5343	314	3	1986;19:517–24	1986;19:517–24	PROPN
fnp-5343	314	4	.	.	PUNCT
fnp-5343	315	1	https://doi.org/10.1002/ana.410190603	https://doi.org/10.1002/ana.410190603	PROPN
fnp-5343	315	2	.	.	PUNCT
fnp-5343	316	1	27	27	NUM
fnp-5343	316	2	.	.	PUNCT
fnp-5343	317	1	ho	ho	PROPN
fnp-5343	317	2	dd	dd	PROPN
fnp-5343	317	3	,	,	PUNCT
fnp-5343	317	4	bredesen	bredesen	ADJ
fnp-5343	317	5	de	de	NOUN
fnp-5343	317	6	,	,	PUNCT
fnp-5343	317	7	vinters	vinters	PROPN
fnp-5343	317	8	hv	hv	PROPN
fnp-5343	317	9	,	,	PUNCT
fnp-5343	317	10	daar	daar	NOUN
fnp-5343	317	11	es	es	PROPN
fnp-5343	317	12	.	.	PUNCT
fnp-5343	318	1	the	the	DET
fnp-5343	318	2	acquired	acquire	VERB
fnp-5343	318	3	immunodeficiency	immunodeficiency	NOUN
fnp-5343	318	4	syndrome	syndrome	NOUN
fnp-5343	318	5	(	(	PUNCT
fnp-5343	318	6	aids	aids	PROPN
fnp-5343	318	7	)	)	PUNCT
fnp-5343	318	8	dementia	dementia	NOUN
fnp-5343	318	9	complex	complex	NOUN
fnp-5343	318	10	.	.	PUNCT
fnp-5343	319	1	ann	ann	PROPN
fnp-5343	319	2	intern	intern	PROPN
fnp-5343	319	3	med	med	PROPN
fnp-5343	319	4	1989;111:400–10	1989;111:400–10	PROPN
fnp-5343	319	5	.	.	PUNCT
fnp-5343	320	1	https://doi.org/10.7326/0003-4819-111-5-400	https://doi.org/10.7326/0003-4819-111-5-400	PRON
fnp-5343	320	2	.	.	PUNCT
fnp-5343	321	1	28	28	NUM
fnp-5343	321	2	.	.	PUNCT
fnp-5343	322	1	budka	budka	PROPN
fnp-5343	322	2	h	h	PROPN
fnp-5343	322	3	,	,	PUNCT
fnp-5343	322	4	wiley	wiley	PROPN
fnp-5343	322	5	ca	ca	PROPN
fnp-5343	322	6	,	,	PUNCT
fnp-5343	322	7	kleihues	kleihue	NOUN
fnp-5343	322	8	p	p	NOUN
fnp-5343	322	9	,	,	PUNCT
fnp-5343	322	10	artigas	artigas	PROPN
fnp-5343	322	11	j	j	PROPN
fnp-5343	322	12	,	,	PUNCT
fnp-5343	322	13	asbury	asbury	PROPN
fnp-5343	322	14	ak	ak	PROPN
fnp-5343	322	15	,	,	PUNCT
fnp-5343	322	16	cho	cho	PROPN
fnp-5343	322	17	es	es	PROPN
fnp-5343	322	18	,	,	PUNCT
fnp-5343	322	19	et	et	PROPN
fnp-5343	322	20	al	al	PROPN
fnp-5343	322	21	.	.	PUNCT
fnp-5343	322	22	hiv	hiv	PROPN
fnp-5343	322	23	-	-	PUNCT
fnp-5343	322	24	associated	associate	VERB
fnp-5343	322	25	disease	disease	NOUN
fnp-5343	322	26	of	of	ADP
fnp-5343	322	27	the	the	DET
fnp-5343	322	28	nervous	nervous	ADJ
fnp-5343	322	29	system	system	NOUN
fnp-5343	322	30	:	:	PUNCT
fnp-5343	322	31	review	review	NOUN
fnp-5343	322	32	of	of	ADP
fnp-5343	322	33	nomenclature	nomenclature	NOUN
fnp-5343	322	34	and	and	CCONJ
fnp-5343	322	35	proposal	proposal	NOUN
fnp-5343	322	36	for	for	ADP
fnp-5343	322	37	neuropathology	neuropathology	NOUN
fnp-5343	322	38	-	-	PUNCT
fnp-5343	322	39	based	base	VERB
fnp-5343	322	40	terminology	terminology	NOUN
fnp-5343	322	41	.	.	PUNCT
fnp-5343	323	1	brain	brain	NOUN
fnp-5343	323	2	pathol	pathol	NOUN
fnp-5343	323	3	1991;1:143–52	1991;1:143–52	NUM
fnp-5343	323	4	.	.	PUNCT
fnp-5343	324	1	https://doi.org/10.1111/j.1750-3639.1991.tb00653.x	https://doi.org/10.1111/j.1750-3639.1991.tb00653.x	PROPN
fnp-5343	324	2	.	.	PROPN
fnp-5343	324	3	29	29	NUM
fnp-5343	324	4	.	.	PUNCT
fnp-5343	325	1	sacktor	sacktor	NOUN
fnp-5343	325	2	n	n	CCONJ
fnp-5343	325	3	,	,	PUNCT
fnp-5343	325	4	skolasky	skolasky	ADJ
fnp-5343	325	5	rl	rl	PROPN
fnp-5343	325	6	,	,	PUNCT
fnp-5343	325	7	seaberg	seaberg	PROPN
fnp-5343	325	8	e	e	PROPN
fnp-5343	325	9	,	,	PUNCT
fnp-5343	325	10	munro	munro	PROPN
fnp-5343	325	11	c	c	PROPN
fnp-5343	325	12	,	,	PUNCT
fnp-5343	325	13	becker	becker	PROPN
fnp-5343	325	14	jt	jt	PROPN
fnp-5343	325	15	,	,	PUNCT
fnp-5343	325	16	martin	martin	PROPN
fnp-5343	325	17	e	e	PROPN
fnp-5343	325	18	,	,	PUNCT
fnp-5343	325	19	et	et	PROPN
fnp-5343	325	20	al	al	PROPN
fnp-5343	325	21	.	.	PUNCT
fnp-5343	326	1	prevalence	prevalence	NOUN
fnp-5343	326	2	of	of	ADP
fnp-5343	326	3	hiv	hiv	PROPN
fnp-5343	326	4	-	-	PUNCT
fnp-5343	326	5	associated	associate	VERB
fnp-5343	326	6	neurocognitive	neurocognitive	ADJ
fnp-5343	326	7	disorders	disorder	NOUN
fnp-5343	326	8	in	in	ADP
fnp-5343	326	9	the	the	DET
fnp-5343	326	10	multicenter	multicenter	ADJ
fnp-5343	326	11	aids	aid	NOUN
fnp-5343	326	12	cohort	cohort	NOUN
fnp-5343	326	13	study	study	NOUN
fnp-5343	326	14	.	.	PUNCT
fnp-5343	327	1	neurology	neurology	NOUN
fnp-5343	328	1	2016;86:334–40	2016;86:334–40	X
fnp-5343	328	2	.	.	PUNCT
fnp-5343	329	1	https://doi.org/10.1212/wnl.0000000000002277	https://doi.org/10.1212/wnl.0000000000002277	NOUN
fnp-5343	329	2	.	.	PUNCT
fnp-5343	330	1	30	30	NUM
fnp-5343	330	2	.	.	PUNCT
fnp-5343	331	1	clifford	clifford	PROPN
fnp-5343	331	2	db	db	PROPN
fnp-5343	331	3	,	,	PUNCT
fnp-5343	331	4	ances	ance	VERB
fnp-5343	331	5	bm	bm	PROPN
fnp-5343	331	6	.	.	PROPN
fnp-5343	332	1	hiv	hiv	PROPN
fnp-5343	332	2	-	-	PUNCT
fnp-5343	332	3	associated	associate	VERB
fnp-5343	332	4	neurocognitive	neurocognitive	ADJ
fnp-5343	332	5	disorder	disorder	NOUN
fnp-5343	332	6	.	.	PUNCT
fnp-5343	333	1	lancet	lancet	PROPN
fnp-5343	333	2	infect	infect	PROPN
fnp-5343	333	3	dis	dis	PROPN
fnp-5343	333	4	2013;13:976–86	2013;13:976–86	NUM
fnp-5343	333	5	.	.	PUNCT
fnp-5343	334	1	https://doi.org/10.1016/s1473-3099(13)70269-x	https://doi.org/10.1016/s1473-3099(13)70269-x	PROPN
fnp-5343	334	2	.	.	PUNCT
fnp-5343	335	1	31	31	NUM
fnp-5343	335	2	.	.	PUNCT
fnp-5343	336	1	heaton	heaton	PROPN
fnp-5343	336	2	rk	rk	PROPN
fnp-5343	336	3	,	,	PUNCT
fnp-5343	336	4	clifford	clifford	PROPN
fnp-5343	336	5	db	db	PROPN
fnp-5343	336	6	,	,	PUNCT
fnp-5343	336	7	franklin	franklin	PROPN
fnp-5343	336	8	dr	dr	PROPN
fnp-5343	336	9	jr	jr	PROPN
fnp-5343	336	10	,	,	PUNCT
fnp-5343	336	11	woods	woods	PROPN
fnp-5343	336	12	sp	sp	NOUN
fnp-5343	336	13	,	,	PUNCT
fnp-5343	336	14	ake	ake	NOUN
fnp-5343	336	15	c	c	NOUN
fnp-5343	336	16	,	,	PUNCT
fnp-5343	336	17	vaida	vaida	PROPN
fnp-5343	336	18	f	f	AUX
fnp-5343	336	19	,	,	PUNCT
fnp-5343	336	20	et	et	PROPN
fnp-5343	336	21	al	al	PROPN
fnp-5343	336	22	.	.	PUNCT
fnp-5343	337	1	hiv	hiv	PROPN
fnp-5343	337	2	-	-	PUNCT
fnp-5343	337	3	associated	associate	VERB
fnp-5343	337	4	neurocognitive	neurocognitive	ADJ
fnp-5343	337	5	disorders	disorder	NOUN
fnp-5343	337	6	persist	persist	VERB
fnp-5343	337	7	in	in	ADP
fnp-5343	337	8	the	the	DET
fnp-5343	337	9	era	era	NOUN
fnp-5343	337	10	of	of	ADP
fnp-5343	337	11	potent	potent	ADJ
fnp-5343	337	12	antiretroviral	antiretroviral	ADJ
fnp-5343	337	13	therapy	therapy	NOUN
fnp-5343	337	14	.	.	PUNCT
fnp-5343	338	1	neurology	neurology	NOUN
fnp-5343	338	2	2010;75:2087–96	2010;75:2087–96	NUM
fnp-5343	338	3	.	.	PUNCT
fnp-5343	339	1	https://doi.org/10.1212/wnl.0b013e318200d727	https://doi.org/10.1212/wnl.0b013e318200d727	PROPN
fnp-5343	339	2	.	.	PUNCT
fnp-5343	340	1	32	32	NUM
fnp-5343	340	2	.	.	PUNCT
fnp-5343	341	1	sacktor	sacktor	NOUN
fnp-5343	341	2	n.	n.	NOUN
fnp-5343	341	3	changing	change	VERB
fnp-5343	341	4	clinical	clinical	ADJ
fnp-5343	341	5	phenotypes	phenotype	NOUN
fnp-5343	341	6	of	of	ADP
fnp-5343	341	7	hiv	hiv	PROPN
fnp-5343	341	8	-	-	PUNCT
fnp-5343	341	9	associated	associate	VERB
fnp-5343	341	10	neurocognitive	neurocognitive	ADJ
fnp-5343	341	11	disorders	disorder	NOUN
fnp-5343	341	12	.	.	PUNCT
fnp-5343	342	1	j	j	PROPN
fnp-5343	342	2	neurovirol	neurovirol	NOUN
fnp-5343	342	3	2018;24:141–5	2018;24:141–5	NUM
fnp-5343	342	4	.	.	PUNCT
fnp-5343	343	1	https://doi.org/10.1007/s13365-017-0556-6	https://doi.org/10.1007/s13365-017-0556-6	NUM
fnp-5343	343	2	.	.	PUNCT
fnp-5343	344	1	33	33	NUM
fnp-5343	344	2	.	.	PUNCT
fnp-5343	345	1	heaton	heaton	PROPN
fnp-5343	345	2	rk	rk	PROPN
fnp-5343	345	3	,	,	PUNCT
fnp-5343	345	4	franklin	franklin	PROPN
fnp-5343	345	5	dr	dr	PROPN
fnp-5343	345	6	,	,	PUNCT
fnp-5343	345	7	ellis	ellis	PROPN
fnp-5343	345	8	rj	rj	PROPN
fnp-5343	345	9	,	,	PUNCT
fnp-5343	345	10	mccutchan	mccutchan	PROPN
fnp-5343	345	11	ja	ja	PROPN
fnp-5343	345	12	,	,	PUNCT
fnp-5343	345	13	letendre	letendre	PROPN
fnp-5343	345	14	sl	sl	PROPN
fnp-5343	345	15	,	,	PUNCT
fnp-5343	345	16	leblanc	leblanc	PROPN
fnp-5343	345	17	s	s	PROPN
fnp-5343	345	18	,	,	PUNCT
fnp-5343	345	19	et	et	PROPN
fnp-5343	345	20	al	al	PROPN
fnp-5343	345	21	.	.	PUNCT
fnp-5343	346	1	hiv	hiv	PROPN
fnp-5343	346	2	-	-	PUNCT
fnp-5343	346	3	associated	associate	VERB
fnp-5343	346	4	neurocognitive	neurocognitive	ADJ
fnp-5343	346	5	disorders	disorder	NOUN
fnp-5343	346	6	before	before	ADP
fnp-5343	346	7	and	and	CCONJ
fnp-5343	346	8	during	during	ADP
fnp-5343	346	9	the	the	DET
fnp-5343	346	10	era	era	NOUN
fnp-5343	346	11	of	of	ADP
fnp-5343	346	12	combination	combination	NOUN
fnp-5343	346	13	antiretroviral	antiretroviral	ADJ
fnp-5343	346	14	therapy	therapy	NOUN
fnp-5343	346	15	:	:	PUNCT
fnp-5343	346	16	differences	difference	NOUN
fnp-5343	346	17	in	in	ADP
fnp-5343	346	18	rates	rate	NOUN
fnp-5343	346	19	,	,	PUNCT
fnp-5343	346	20	nature	nature	NOUN
fnp-5343	346	21	,	,	PUNCT
fnp-5343	346	22	and	and	CCONJ
fnp-5343	346	23	predictors	predictor	NOUN
fnp-5343	346	24	.	.	PUNCT
fnp-5343	347	1	j	j	PROPN
fnp-5343	347	2	neurovirol	neurovirol	NOUN
fnp-5343	347	3	2011;17:3–16	2011;17:3–16	NUM
fnp-5343	347	4	.	.	PUNCT
fnp-5343	347	5	https://doi.org/10.1007/s13365-010-0006-1	https://doi.org/10.1007/s13365-010-0006-1	NUM
fnp-5343	347	6	.	.	PUNCT
fnp-5343	348	1	34	34	NUM
fnp-5343	348	2	.	.	PUNCT
fnp-5343	349	1	sacktor	sacktor	PROPN
fnp-5343	349	2	n	n	CCONJ
fnp-5343	349	3	,	,	PUNCT
fnp-5343	349	4	robertson	robertson	PROPN
fnp-5343	349	5	k.	k.	PROPN
fnp-5343	349	6	evolving	evolve	VERB
fnp-5343	349	7	clinical	clinical	ADJ
fnp-5343	349	8	phenotypes	phenotype	NOUN
fnp-5343	349	9	in	in	ADP
fnp-5343	349	10	hiv	hiv	PROPN
fnp-5343	349	11	-	-	PUNCT
fnp-5343	349	12	associated	associate	VERB
fnp-5343	349	13	neurocognitive	neurocognitive	ADJ
fnp-5343	349	14	disorders	disorder	NOUN
fnp-5343	349	15	.	.	PUNCT
fnp-5343	350	1	curr	curr	PROPN
fnp-5343	350	2	opin	opin	PROPN
fnp-5343	350	3	hiv	hiv	PROPN
fnp-5343	350	4	aids	aids	PROPN
fnp-5343	350	5	2014;9:517–20	2014;9:517–20	NUM
fnp-5343	350	6	.	.	PUNCT
fnp-5343	351	1	https://doi.org/10.1097/coh.0000000000000102	https://doi.org/10.1097/coh.0000000000000102	PROPN
fnp-5343	351	2	.	.	PROPN
fnp-5343	351	3	35	35	NUM
fnp-5343	351	4	.	.	PUNCT
fnp-5343	351	5	smail	smail	PROPN
fnp-5343	351	6	rc	rc	PROPN
fnp-5343	351	7	,	,	PUNCT
fnp-5343	351	8	brew	brew	VERB
fnp-5343	351	9	bj	bj	NOUN
fnp-5343	351	10	.	.	PUNCT
fnp-5343	352	1	hiv	hiv	PROPN
fnp-5343	352	2	-	-	PUNCT
fnp-5343	352	3	associated	associate	VERB
fnp-5343	352	4	neurocognitive	neurocognitive	ADJ
fnp-5343	352	5	disorder	disorder	NOUN
fnp-5343	352	6	.	.	PUNCT
fnp-5343	353	1	handb	handb	PROPN
fnp-5343	353	2	clin	clin	PROPN
fnp-5343	353	3	neurol	neurol	PROPN
fnp-5343	353	4	2018;152:75	2018;152:75	NUM
fnp-5343	353	5	-	-	SYM
fnp-5343	353	6	97	97	NUM
fnp-5343	353	7	.	.	PUNCT
fnp-5343	354	1	https://doi.org/10.1016/b978-0-444-63849-6.00007-4	https://doi.org/10.1016/b978-0-444-63849-6.00007-4	VERB
fnp-5343	354	2	.	.	PROPN
fnp-5343	354	3	36	36	NUM
fnp-5343	354	4	.	.	PUNCT
fnp-5343	355	1	cysique	cysique	PROPN
fnp-5343	355	2	la	la	PROPN
fnp-5343	355	3	,	,	PUNCT
fnp-5343	355	4	maruff	maruff	NOUN
fnp-5343	355	5	p	p	NOUN
fnp-5343	355	6	,	,	PUNCT
fnp-5343	355	7	brew	brew	VERB
fnp-5343	355	8	bj	bj	NOUN
fnp-5343	355	9	.	.	PUNCT
fnp-5343	356	1	prevalence	prevalence	NOUN
fnp-5343	356	2	and	and	CCONJ
fnp-5343	356	3	pattern	pattern	NOUN
fnp-5343	356	4	of	of	ADP
fnp-5343	356	5	neuropsychological	neuropsychological	ADJ
fnp-5343	356	6	impairment	impairment	NOUN
fnp-5343	356	7	in	in	ADP
fnp-5343	356	8	human	human	ADJ
fnp-5343	356	9	immunodeficiency	immunodeficiency	NOUN
fnp-5343	356	10	virus	virus	NOUN
fnp-5343	356	11	-	-	PUNCT
fnp-5343	356	12	infected	infect	VERB
fnp-5343	356	13	/	/	SYM
fnp-5343	356	14	acquired	acquire	VERB
fnp-5343	356	15	immunodeficiency	immunodeficiency	NOUN
fnp-5343	356	16	syndrome	syndrome	NOUN
fnp-5343	356	17	(	(	PUNCT
fnp-5343	356	18	hiv	hiv	PROPN
fnp-5343	356	19	/	/	SYM
fnp-5343	356	20	aids	aids	PROPN
fnp-5343	356	21	)	)	PUNCT
fnp-5343	356	22	patients	patient	NOUN
fnp-5343	356	23	across	across	ADP
fnp-5343	356	24	preand	preand	VERB
fnp-5343	356	25	post	post	ADJ
fnp-5343	356	26	-	-	ADJ
fnp-5343	356	27	highly	highly	ADV
fnp-5343	356	28	active	active	ADJ
fnp-5343	356	29	antiretroviral	antiretroviral	ADJ
fnp-5343	356	30	therapy	therapy	NOUN
fnp-5343	356	31	eras	era	NOUN
fnp-5343	356	32	:	:	PUNCT
fnp-5343	356	33	a	a	DET
fnp-5343	356	34	combined	combined	ADJ
fnp-5343	356	35	study	study	NOUN
fnp-5343	356	36	of	of	ADP
fnp-5343	356	37	two	two	NUM
fnp-5343	356	38	cohorts	cohort	NOUN
fnp-5343	356	39	.	.	PUNCT
fnp-5343	357	1	j	j	PROPN
fnp-5343	357	2	neurovirol	neurovirol	PROPN
fnp-5343	357	3	2004;10:350–7	2004;10:350–7	NUM
fnp-5343	357	4	.	.	PUNCT
fnp-5343	358	1	https://doi.org/10.1080/13550280490521078	https://doi.org/10.1080/13550280490521078	NOUN
fnp-5343	358	2	.	.	PUNCT
fnp-5343	359	1	37	37	NUM
fnp-5343	359	2	.	.	PUNCT
fnp-5343	360	1	valcour	valcour	PROPN
fnp-5343	360	2	v	v	PROPN
fnp-5343	360	3	,	,	PUNCT
fnp-5343	360	4	shikuma	shikuma	NOUN
fnp-5343	360	5	c	c	NOUN
fnp-5343	360	6	,	,	PUNCT
fnp-5343	360	7	shiramizu	shiramizu	NOUN
fnp-5343	360	8	b	b	PROPN
fnp-5343	360	9	,	,	PUNCT
fnp-5343	360	10	watters	watters	PROPN
fnp-5343	360	11	m	m	PROPN
fnp-5343	360	12	,	,	PUNCT
fnp-5343	360	13	poff	poff	PROPN
fnp-5343	360	14	p	p	PROPN
fnp-5343	360	15	,	,	PUNCT
fnp-5343	360	16	selnes	selne	NOUN
fnp-5343	360	17	o	o	NOUN
fnp-5343	360	18	,	,	PUNCT
fnp-5343	360	19	et	et	PROPN
fnp-5343	360	20	al	al	PROPN
fnp-5343	360	21	.	.	PROPN
fnp-5343	360	22	higher	high	ADJ
fnp-5343	360	23	frequency	frequency	NOUN
fnp-5343	360	24	of	of	ADP
fnp-5343	360	25	dementia	dementia	NOUN
fnp-5343	360	26	in	in	ADP
fnp-5343	360	27	older	old	ADJ
fnp-5343	360	28	hiv-1	hiv-1	ADJ
fnp-5343	360	29	individuals	individual	NOUN
fnp-5343	360	30	:	:	PUNCT
fnp-5343	360	31	the	the	DET
fnp-5343	360	32	hawaii	hawaii	PROPN
fnp-5343	360	33	aging	age	VERB
fnp-5343	360	34	with	with	ADP
fnp-5343	360	35	hiv-1	hiv-1	ADJ
fnp-5343	360	36	cohort	cohort	NOUN
fnp-5343	360	37	.	.	PUNCT
fnp-5343	361	1	neurology	neurology	NOUN
fnp-5343	361	2	2004;63:822–7	2004;63:822–7	NUM
fnp-5343	361	3	.	.	PUNCT
fnp-5343	362	1	https://doi.org/10.1212/01.wnl.0000134665.58343.8d	https://doi.org/10.1212/01.wnl.0000134665.58343.8d	X
fnp-5343	362	2	.	.	PUNCT
fnp-5343	363	1	38	38	NUM
fnp-5343	363	2	.	.	PUNCT
fnp-5343	364	1	becker	becker	PROPN
fnp-5343	364	2	jt	jt	PROPN
fnp-5343	364	3	,	,	PUNCT
fnp-5343	364	4	kingsley	kingsley	PROPN
fnp-5343	364	5	l	l	PROPN
fnp-5343	364	6	,	,	PUNCT
fnp-5343	364	7	mullen	mullen	PROPN
fnp-5343	364	8	j	j	PROPN
fnp-5343	364	9	,	,	PUNCT
fnp-5343	364	10	cohen	cohen	PROPN
fnp-5343	364	11	b	b	PROPN
fnp-5343	364	12	,	,	PUNCT
fnp-5343	364	13	martin	martin	PROPN
fnp-5343	364	14	e	e	PROPN
fnp-5343	364	15	,	,	PUNCT
fnp-5343	364	16	miller	miller	PROPN
fnp-5343	364	17	en	en	PROPN
fnp-5343	364	18	,	,	PUNCT
fnp-5343	364	19	et	et	PROPN
fnp-5343	364	20	al	al	PROPN
fnp-5343	364	21	.	.	PUNCT
fnp-5343	364	22	vascular	vascular	ADJ
fnp-5343	364	23	risk	risk	NOUN
fnp-5343	364	24	factors	factor	NOUN
fnp-5343	364	25	,	,	PUNCT
fnp-5343	364	26	hiv	hiv	PROPN
fnp-5343	364	27	serostatus	serostatus	NOUN
fnp-5343	364	28	,	,	PUNCT
fnp-5343	364	29	and	and	CCONJ
fnp-5343	364	30	cognitive	cognitive	ADJ
fnp-5343	364	31	dysfunction	dysfunction	NOUN
fnp-5343	364	32	in	in	ADP
fnp-5343	364	33	gay	gay	ADJ
fnp-5343	364	34	and	and	CCONJ
fnp-5343	364	35	bisexual	bisexual	ADJ
fnp-5343	364	36	men	man	NOUN
fnp-5343	364	37	.	.	PUNCT
fnp-5343	365	1	neurology	neurology	PROPN
fnp-5343	365	2	2009;73:1292–9	2009;73:1292–9	PROPN
fnp-5343	365	3	.	.	PUNCT
fnp-5343	366	1	https://doi.org/10.1212/wnl.0b013e3181bd10e7	https://doi.org/10.1212/wnl.0b013e3181bd10e7	PROPN
fnp-5343	366	2	.	.	PROPN
fnp-5343	366	3	39	39	NUM
fnp-5343	366	4	.	.	PUNCT
fnp-5343	367	1	mccutchan	mccutchan	PROPN
fnp-5343	367	2	ja	ja	PROPN
fnp-5343	367	3	,	,	PUNCT
fnp-5343	367	4	marquie	marquie	NOUN
fnp-5343	367	5	-	-	PUNCT
fnp-5343	367	6	beck	beck	PROPN
fnp-5343	367	7	ja	ja	PROPN
fnp-5343	367	8	,	,	PUNCT
fnp-5343	367	9	fitzsimons	fitzsimons	PROPN
fnp-5343	367	10	ca	ca	PROPN
fnp-5343	367	11	,	,	PUNCT
fnp-5343	367	12	letendre	letendre	PROPN
fnp-5343	367	13	sl	sl	PROPN
fnp-5343	367	14	,	,	PUNCT
fnp-5343	367	15	ellis	ellis	PROPN
fnp-5343	367	16	rj	rj	PROPN
fnp-5343	367	17	,	,	PUNCT
fnp-5343	367	18	heaton	heaton	PROPN
fnp-5343	367	19	rk	rk	PROPN
fnp-5343	367	20	,	,	PUNCT
fnp-5343	367	21	et	et	PROPN
fnp-5343	367	22	al	al	PROPN
fnp-5343	367	23	.	.	PUNCT
fnp-5343	368	1	role	role	NOUN
fnp-5343	368	2	of	of	ADP
fnp-5343	368	3	obesity	obesity	NOUN
fnp-5343	368	4	,	,	PUNCT
fnp-5343	368	5	metabolic	metabolic	NOUN
fnp-5343	368	6	variables	variable	NOUN
fnp-5343	368	7	,	,	PUNCT
fnp-5343	368	8	and	and	CCONJ
fnp-5343	368	9	diabetes	diabetes	NOUN
fnp-5343	368	10	in	in	ADP
fnp-5343	368	11	hiv	hiv	PROPN
fnp-5343	368	12	-	-	PUNCT
fnp-5343	368	13	associated	associate	VERB
fnp-5343	368	14	neurocognitive	neurocognitive	ADJ
fnp-5343	368	15	disorder	disorder	NOUN
fnp-5343	368	16	.	.	PUNCT
fnp-5343	369	1	neurology	neurology	NOUN
fnp-5343	369	2	2012;78:485–92	2012;78:485–92	PROPN
fnp-5343	369	3	.	.	PUNCT
fnp-5343	370	1	https://doi.org/10.1212/wnl.0b013e3182478d64	https://doi.org/10.1212/wnl.0b013e3182478d64	X
fnp-5343	370	2	.	.	PUNCT
fnp-5343	371	1	40	40	NUM
fnp-5343	371	2	.	.	PUNCT
fnp-5343	372	1	bhaskaran	bhaskaran	PROPN
fnp-5343	372	2	k	k	PROPN
fnp-5343	372	3	,	,	PUNCT
fnp-5343	372	4	mussini	mussini	PROPN
fnp-5343	372	5	c	c	X
fnp-5343	372	6	,	,	PUNCT
fnp-5343	372	7	antinori	antinori	VERB
fnp-5343	372	8	a	a	PRON
fnp-5343	372	9	,	,	PUNCT
fnp-5343	372	10	walker	walker	NOUN
fnp-5343	372	11	as	as	ADP
fnp-5343	372	12	,	,	PUNCT
fnp-5343	372	13	dorrucci	dorrucci	PROPN
fnp-5343	372	14	m	m	PROPN
fnp-5343	372	15	,	,	PUNCT
fnp-5343	372	16	sabin	sabin	PROPN
fnp-5343	372	17	c	c	PROPN
fnp-5343	372	18	,	,	PUNCT
fnp-5343	372	19	et	et	PROPN
fnp-5343	372	20	al	al	PROPN
fnp-5343	372	21	.	.	PROPN
fnp-5343	372	22	changes	change	NOUN
fnp-5343	372	23	in	in	ADP
fnp-5343	372	24	the	the	DET
fnp-5343	372	25	incidence	incidence	NOUN
fnp-5343	372	26	and	and	CCONJ
fnp-5343	372	27	predictors	predictor	NOUN
fnp-5343	372	28	of	of	ADP
fnp-5343	372	29	human	human	ADJ
fnp-5343	372	30	immunodeficiency	immunodeficiency	NOUN
fnp-5343	372	31	virus	virus	NOUN
fnp-5343	372	32	-	-	PUNCT
fnp-5343	372	33	associated	associate	VERB
fnp-5343	372	34	dementia	dementia	NOUN
fnp-5343	372	35	in	in	ADP
fnp-5343	372	36	the	the	DET
fnp-5343	372	37	era	era	NOUN
fnp-5343	372	38	of	of	ADP
fnp-5343	372	39	highly	highly	ADV
fnp-5343	372	40	active	active	ADJ
fnp-5343	372	41	antiretroviral	antiretroviral	ADJ
fnp-5343	372	42	therapy	therapy	NOUN
fnp-5343	372	43	.	.	PUNCT
fnp-5343	373	1	ann	ann	PROPN
fnp-5343	373	2	neurol	neurol	PROPN
fnp-5343	373	3	2008;63:213–21	2008;63:213–21	PROPN
fnp-5343	373	4	.	.	PUNCT
fnp-5343	374	1	https://doi.org/10.1002/ana.21225	https://doi.org/10.1002/ana.21225	PROPN
fnp-5343	374	2	.	.	PUNCT
fnp-5343	375	1	41	41	NUM
fnp-5343	375	2	.	.	PUNCT
fnp-5343	376	1	ellis	ellis	PROPN
fnp-5343	376	2	rj	rj	PROPN
fnp-5343	376	3	,	,	PUNCT
fnp-5343	376	4	badiee	badiee	VERB
fnp-5343	376	5	j	j	PROPN
fnp-5343	376	6	,	,	PUNCT
fnp-5343	376	7	vaida	vaida	PROPN
fnp-5343	376	8	f	f	AUX
fnp-5343	376	9	,	,	PUNCT
fnp-5343	376	10	letendre	letendre	PROPN
fnp-5343	376	11	s	s	PROPN
fnp-5343	376	12	,	,	PUNCT
fnp-5343	376	13	heaton	heaton	PROPN
fnp-5343	376	14	rk	rk	PROPN
fnp-5343	376	15	,	,	PUNCT
fnp-5343	376	16	clifford	clifford	PROPN
fnp-5343	376	17	d	d	PROPN
fnp-5343	376	18	,	,	PUNCT
fnp-5343	376	19	et	et	PROPN
fnp-5343	376	20	al	al	PROPN
fnp-5343	376	21	.	.	PUNCT
fnp-5343	377	1	cd4	cd4	PROPN
fnp-5343	377	2	nadir	nadir	NOUN
fnp-5343	377	3	is	be	AUX
fnp-5343	377	4	a	a	DET
fnp-5343	377	5	predictor	predictor	NOUN
fnp-5343	377	6	of	of	ADP
fnp-5343	377	7	hiv	hiv	PROPN
fnp-5343	377	8	neurocognitive	neurocognitive	ADJ
fnp-5343	377	9	impairment	impairment	NOUN
fnp-5343	377	10	in	in	ADP
fnp-5343	377	11	the	the	DET
fnp-5343	377	12	era	era	NOUN
fnp-5343	377	13	of	of	ADP
fnp-5343	377	14	combination	combination	NOUN
fnp-5343	377	15	antiretroviral	antiretroviral	ADJ
fnp-5343	377	16	therapy	therapy	NOUN
fnp-5343	377	17	.	.	PUNCT
fnp-5343	378	1	aids	aids	PROPN
fnp-5343	378	2	2011;25:1747–51	2011;25:1747–51	NUM
fnp-5343	378	3	.	.	PUNCT
fnp-5343	379	1	https://doi.org/10.1097/qad.0b013e32834a40cd	https://doi.org/10.1097/qad.0b013e32834a40cd	PROPN
fnp-5343	379	2	.	.	PUNCT
fnp-5343	380	1	42	42	NUM
fnp-5343	380	2	.	.	PUNCT
fnp-5343	380	3	valcour	valcour	PROPN
fnp-5343	380	4	vg	vg	PROPN
fnp-5343	380	5	,	,	PUNCT
fnp-5343	380	6	ananworanich	ananworanich	PROPN
fnp-5343	380	7	j	j	PROPN
fnp-5343	380	8	,	,	PUNCT
fnp-5343	380	9	agsalda	agsalda	PROPN
fnp-5343	380	10	m	m	PROPN
fnp-5343	380	11	,	,	PUNCT
fnp-5343	380	12	sailasuta	sailasuta	ADJ
fnp-5343	380	13	n	n	CCONJ
fnp-5343	380	14	,	,	PUNCT
fnp-5343	380	15	chalermchai	chalermchai	ADJ
fnp-5343	380	16	t	t	PROPN
fnp-5343	380	17	,	,	PUNCT
fnp-5343	380	18	schuetz	schuetz	VERB
fnp-5343	380	19	a	a	PRON
fnp-5343	380	20	,	,	PUNCT
fnp-5343	380	21	et	et	PROPN
fnp-5343	380	22	al	al	PROPN
fnp-5343	380	23	.	.	PROPN
fnp-5343	381	1	hiv	hiv	PROPN
fnp-5343	381	2	dna	dna	PROPN
fnp-5343	381	3	reservoir	reservoir	PROPN
fnp-5343	381	4	increases	increase	VERB
fnp-5343	381	5	risk	risk	NOUN
fnp-5343	381	6	for	for	ADP
fnp-5343	381	7	cognitive	cognitive	ADJ
fnp-5343	381	8	disorders	disorder	NOUN
fnp-5343	381	9	in	in	ADP
fnp-5343	381	10	cart	cart	NOUN
fnp-5343	381	11	-	-	PUNCT
fnp-5343	381	12	naïve	naïve	ADJ
fnp-5343	381	13	patients	patient	NOUN
fnp-5343	381	14	.	.	PUNCT
fnp-5343	382	1	plos	plos	PROPN
fnp-5343	382	2	one	one	NUM
fnp-5343	382	3	2013;8	2013;8	NUM
fnp-5343	382	4	:	:	PUNCT
fnp-5343	382	5	e70164	e70164	NOUN
fnp-5343	382	6	.	.	PUNCT
fnp-5343	382	7	https://doi.org/10.1371/journal.pone.0070164	https://doi.org/10.1371/journal.pone.0070164	NOUN
fnp-5343	382	8	.	.	PUNCT
fnp-5343	383	1	43	43	NUM
fnp-5343	383	2	.	.	PUNCT
fnp-5343	384	1	robertson	robertson	PROPN
fnp-5343	384	2	kr	kr	PROPN
fnp-5343	384	3	,	,	PUNCT
fnp-5343	384	4	robertson	robertson	PROPN
fnp-5343	384	5	wt	wt	PROPN
fnp-5343	384	6	,	,	PUNCT
fnp-5343	384	7	ford	ford	PROPN
fnp-5343	384	8	s	s	PROPN
fnp-5343	384	9	,	,	PUNCT
fnp-5343	384	10	watson	watson	PROPN
fnp-5343	384	11	d	d	PROPN
fnp-5343	384	12	,	,	PUNCT
fnp-5343	384	13	fiscus	fiscus	NOUN
fnp-5343	384	14	s	s	PROPN
fnp-5343	384	15	,	,	PUNCT
fnp-5343	384	16	harp	harp	PROPN
fnp-5343	384	17	ag	ag	PROPN
fnp-5343	384	18	,	,	PUNCT
fnp-5343	384	19	et	et	PROPN
fnp-5343	384	20	al	al	PROPN
fnp-5343	384	21	.	.	PUNCT
fnp-5343	384	22	highly	highly	ADV
fnp-5343	384	23	active	active	ADJ
fnp-5343	384	24	antiretroviral	antiretroviral	ADJ
fnp-5343	384	25	therapy	therapy	NOUN
fnp-5343	384	26	improves	improve	VERB
fnp-5343	384	27	neurocognitive	neurocognitive	ADJ
fnp-5343	384	28	functioning	function	VERB
fnp-5343	384	29	.	.	PUNCT
fnp-5343	385	1	j	j	PROPN
fnp-5343	385	2	acquir	acquir	PROPN
fnp-5343	385	3	immune	immune	VERB
fnp-5343	385	4	defic	defic	ADJ
fnp-5343	385	5	syndr	syndr	NOUN
fnp-5343	385	6	2004;36:562–6	2004;36:562–6	NUM
fnp-5343	385	7	.	.	PUNCT
fnp-5343	385	8	https://doi.org/10.1097/00126334-200405010-00003	https://doi.org/10.1097/00126334-200405010-00003	NOUN
fnp-5343	385	9	.	.	PROPN
fnp-5343	386	1	44	44	NUM
fnp-5343	386	2	.	.	PUNCT
fnp-5343	387	1	dore	dore	PROPN
fnp-5343	387	2	gj	gj	PROPN
fnp-5343	387	3	,	,	PUNCT
fnp-5343	387	4	mcdonald	mcdonald	PROPN
fnp-5343	387	5	a	a	PROPN
fnp-5343	387	6	,	,	PUNCT
fnp-5343	387	7	li	li	PROPN
fnp-5343	387	8	y	y	PROPN
fnp-5343	387	9	,	,	PUNCT
fnp-5343	387	10	kaldor	kaldor	PROPN
fnp-5343	387	11	jm	jm	PROPN
fnp-5343	387	12	,	,	PUNCT
fnp-5343	387	13	brew	brew	VERB
fnp-5343	387	14	bj	bj	NOUN
fnp-5343	387	15	.	.	PUNCT
fnp-5343	388	1	marked	mark	VERB
fnp-5343	388	2	improvement	improvement	NOUN
fnp-5343	388	3	in	in	ADP
fnp-5343	388	4	survival	survival	NOUN
fnp-5343	388	5	following	follow	VERB
fnp-5343	388	6	aids	aids	PROPN
fnp-5343	388	7	dementia	dementia	NOUN
fnp-5343	388	8	complex	complex	NOUN
fnp-5343	388	9	in	in	ADP
fnp-5343	388	10	the	the	DET
fnp-5343	388	11	era	era	NOUN
fnp-5343	388	12	of	of	ADP
fnp-5343	388	13	highly	highly	ADV
fnp-5343	388	14	active	active	ADJ
fnp-5343	388	15	antiretroviral	antiretroviral	ADJ
fnp-5343	388	16	therapy	therapy	NOUN
fnp-5343	388	17	.	.	PUNCT
fnp-5343	389	1	aids	aids	PROPN
fnp-5343	389	2	2003;17:1539–45	2003;17:1539–45	NUM
fnp-5343	389	3	.	.	PUNCT
fnp-5343	390	1	https://doi.org/10.1097/00002030-200307040-00015	https://doi.org/10.1097/00002030-200307040-00015	PROPN
fnp-5343	390	2	.	.	PUNCT
fnp-5343	391	1	45	45	NUM
fnp-5343	391	2	.	.	PUNCT
fnp-5343	391	3	sevigny	sevigny	PROPN
fnp-5343	391	4	jj	jj	PROPN
fnp-5343	391	5	,	,	PUNCT
fnp-5343	391	6	albert	albert	PROPN
fnp-5343	391	7	sm	sm	PROPN
fnp-5343	391	8	,	,	PUNCT
fnp-5343	391	9	mcdermott	mcdermott	PROPN
fnp-5343	391	10	mp	mp	PROPN
fnp-5343	391	11	,	,	PUNCT
fnp-5343	391	12	schifitto	schifitto	NOUN
fnp-5343	391	13	g	g	PROPN
fnp-5343	391	14	,	,	PUNCT
fnp-5343	391	15	mcarthur	mcarthur	PROPN
fnp-5343	391	16	jc	jc	PROPN
fnp-5343	391	17	,	,	PUNCT
fnp-5343	391	18	sacktor	sacktor	NOUN
fnp-5343	391	19	n	n	CCONJ
fnp-5343	391	20	,	,	PUNCT
fnp-5343	391	21	et	et	PROPN
fnp-5343	391	22	al	al	PROPN
fnp-5343	391	23	.	.	PUNCT
fnp-5343	392	1	an	an	DET
fnp-5343	392	2	evaluation	evaluation	NOUN
fnp-5343	392	3	of	of	ADP
fnp-5343	392	4	neurocognitive	neurocognitive	ADJ
fnp-5343	392	5	status	status	NOUN
fnp-5343	392	6	and	and	CCONJ
fnp-5343	392	7	markers	marker	NOUN
fnp-5343	392	8	of	of	ADP
fnp-5343	392	9	immune	immune	ADJ
fnp-5343	392	10	activation	activation	NOUN
fnp-5343	392	11	as	as	ADP
fnp-5343	392	12	predictors	predictor	NOUN
fnp-5343	392	13	of	of	ADP
fnp-5343	392	14	time	time	NOUN
fnp-5343	392	15	to	to	ADP
fnp-5343	392	16	death	death	NOUN
fnp-5343	392	17	in	in	ADP
fnp-5343	392	18	advanced	advanced	ADJ
fnp-5343	392	19	hiv	hiv	PROPN
fnp-5343	392	20	infection	infection	NOUN
fnp-5343	392	21	.	.	PUNCT
fnp-5343	393	1	arch	arch	ADJ
fnp-5343	393	2	neurol	neurol	PROPN
fnp-5343	393	3	2007;64:97–102	2007;64:97–102	NUM
fnp-5343	393	4	.	.	PUNCT
fnp-5343	394	1	https://doi.org/10.1001/archneur.64.1.97	https://doi.org/10.1001/archneur.64.1.97	NOUN
fnp-5343	394	2	.	.	PUNCT
fnp-5343	395	1	46	46	NUM
fnp-5343	395	2	.	.	PUNCT
fnp-5343	396	1	vivithanaporn	vivithanaporn	PROPN
fnp-5343	396	2	p	p	X
fnp-5343	396	3	,	,	PUNCT
fnp-5343	396	4	heo	heo	PROPN
fnp-5343	396	5	g	g	PROPN
fnp-5343	396	6	,	,	PUNCT
fnp-5343	396	7	gamble	gamble	ADJ
fnp-5343	396	8	j	j	PROPN
fnp-5343	396	9	,	,	PUNCT
fnp-5343	396	10	krentz	krentz	PROPN
fnp-5343	396	11	hb	hb	PROPN
fnp-5343	396	12	,	,	PUNCT
fnp-5343	396	13	hoke	hoke	PROPN
fnp-5343	396	14	a	a	PRON
fnp-5343	396	15	,	,	PUNCT
fnp-5343	396	16	gill	gill	PROPN
fnp-5343	396	17	mj	mj	PROPN
fnp-5343	396	18	,	,	PUNCT
fnp-5343	396	19	et	et	PROPN
fnp-5343	396	20	al	al	PROPN
fnp-5343	396	21	.	.	PROPN
fnp-5343	397	1	neurologic	neurologic	ADJ
fnp-5343	397	2	disease	disease	NOUN
fnp-5343	397	3	burden	burden	NOUN
fnp-5343	397	4	in	in	ADP
fnp-5343	397	5	treated	treat	VERB
fnp-5343	397	6	hiv	hiv	PROPN
fnp-5343	397	7	/	/	SYM
fnp-5343	397	8	aids	aids	PROPN
fnp-5343	397	9	predicts	predict	VERB
fnp-5343	397	10	survival	survival	NOUN
fnp-5343	397	11	:	:	PUNCT
fnp-5343	397	12	a	a	DET
fnp-5343	397	13	population	population	NOUN
fnp-5343	397	14	-	-	PUNCT
fnp-5343	397	15	based	base	VERB
fnp-5343	397	16	study	study	NOUN
fnp-5343	397	17	.	.	PUNCT
fnp-5343	398	1	neurology	neurology	NOUN
fnp-5343	398	2	2010;75:1150–8	2010;75:1150–8	PROPN
fnp-5343	398	3	.	.	PUNCT
fnp-5343	399	1	https://doi.org/10.1212/wnl.0b013e3181f4d5bb	https://doi.org/10.1212/wnl.0b013e3181f4d5bb	NOUN
fnp-5343	399	2	.	.	PUNCT
fnp-5343	400	1	47	47	NUM
fnp-5343	400	2	.	.	PUNCT
fnp-5343	401	1	rosenthal	rosenthal	PROPN
fnp-5343	401	2	j	j	PROPN
fnp-5343	401	3	,	,	PUNCT
fnp-5343	401	4	tyor	tyor	NOUN
fnp-5343	401	5	w.	w.	PROPN
fnp-5343	401	6	aging	aging	NOUN
fnp-5343	401	7	,	,	PUNCT
fnp-5343	401	8	comorbidities	comorbiditie	NOUN
fnp-5343	401	9	,	,	PUNCT
fnp-5343	401	10	and	and	CCONJ
fnp-5343	401	11	the	the	DET
fnp-5343	401	12	importance	importance	NOUN
fnp-5343	401	13	of	of	ADP
fnp-5343	401	14	finding	find	VERB
fnp-5343	401	15	biomarkers	biomarker	NOUN
fnp-5343	401	16	for	for	ADP
fnp-5343	401	17	hiv	hiv	PROPN
fnp-5343	401	18	-	-	PUNCT
fnp-5343	401	19	associated	associate	VERB
fnp-5343	401	20	neurocognitive	neurocognitive	ADJ
fnp-5343	401	21	disorders	disorder	NOUN
fnp-5343	401	22	.	.	PUNCT
fnp-5343	402	1	j	j	PROPN
fnp-5343	402	2	neurovirol	neurovirol	NOUN
fnp-5343	402	3	2019;25:673–85	2019;25:673–85	NUM
fnp-5343	402	4	.	.	PUNCT
fnp-5343	403	1	https://doi.org/10.1007/s13365-019-00735-0	https://doi.org/10.1007/s13365-019-00735-0	X
fnp-5343	403	2	.	.	PUNCT
fnp-5343	404	1	48	48	NUM
fnp-5343	404	2	.	.	PUNCT
fnp-5343	405	1	heaton	heaton	PROPN
fnp-5343	405	2	rk	rk	PROPN
fnp-5343	405	3	,	,	PUNCT
fnp-5343	405	4	ellis	ellis	PROPN
fnp-5343	405	5	rj	rj	PROPN
fnp-5343	405	6	,	,	PUNCT
fnp-5343	405	7	tang	tang	PROPN
fnp-5343	405	8	b	b	PROPN
fnp-5343	405	9	,	,	PUNCT
fnp-5343	405	10	marra	marra	PROPN
fnp-5343	405	11	cm	cm	PROPN
fnp-5343	405	12	,	,	PUNCT
fnp-5343	405	13	rubin	rubin	PROPN
fnp-5343	405	14	lh	lh	PROPN
fnp-5343	405	15	,	,	PUNCT
fnp-5343	405	16	clifford	clifford	PROPN
fnp-5343	405	17	db	db	PROPN
fnp-5343	405	18	,	,	PUNCT
fnp-5343	405	19	et	et	PROPN
fnp-5343	405	20	al	al	PROPN
fnp-5343	405	21	.	.	PROPN
fnp-5343	405	22	twelve	twelve	NUM
fnp-5343	405	23	-	-	PUNCT
fnp-5343	405	24	year	year	NOUN
fnp-5343	405	25	neurocognitive	neurocognitive	ADJ
fnp-5343	405	26	decline	decline	NOUN
fnp-5343	405	27	in	in	ADP
fnp-5343	405	28	hiv	hiv	PROPN
fnp-5343	405	29	is	be	AUX
fnp-5343	405	30	associated	associate	VERB
fnp-5343	405	31	with	with	ADP
fnp-5343	405	32	comorbidities	comorbiditie	NOUN
fnp-5343	405	33	,	,	PUNCT
fnp-5343	405	34	not	not	PART
fnp-5343	405	35	age	age	NOUN
fnp-5343	405	36	:	:	PUNCT
fnp-5343	405	37	a	a	DET
fnp-5343	405	38	charter	charter	NOUN
fnp-5343	405	39	study	study	NOUN
fnp-5343	405	40	.	.	PUNCT
fnp-5343	406	1	brain	brain	PROPN
fnp-5343	406	2	2023;146:1121–31	2023;146:1121–31	PROPN
fnp-5343	406	3	.	.	PUNCT
fnp-5343	407	1	https://doi.org/10.1093/brain/awac465	https://doi.org/10.1093/brain/awac465	X
fnp-5343	407	2	.	.	PUNCT
fnp-5343	408	1	49	49	NUM
fnp-5343	408	2	.	.	PUNCT
fnp-5343	409	1	stout	stout	PROPN
fnp-5343	409	2	jc	jc	PROPN
fnp-5343	409	3	,	,	PUNCT
fnp-5343	409	4	ellis	ellis	PROPN
fnp-5343	409	5	rj	rj	PROPN
fnp-5343	409	6	,	,	PUNCT
fnp-5343	409	7	jernigan	jernigan	PROPN
fnp-5343	409	8	tl	tl	PROPN
fnp-5343	409	9	,	,	PUNCT
fnp-5343	409	10	archibald	archibald	PROPN
fnp-5343	409	11	sl	sl	PROPN
fnp-5343	409	12	,	,	PUNCT
fnp-5343	409	13	abramson	abramson	PROPN
fnp-5343	409	14	i	i	PROPN
fnp-5343	409	15	,	,	PUNCT
fnp-5343	409	16	wolfson	wolfson	PROPN
fnp-5343	409	17	t	t	PROPN
fnp-5343	409	18	,	,	PUNCT
fnp-5343	409	19	et	et	PROPN
fnp-5343	409	20	al	al	PROPN
fnp-5343	409	21	.	.	PROPN
fnp-5343	410	1	progressive	progressive	ADJ
fnp-5343	410	2	cerebral	cerebral	ADJ
fnp-5343	410	3	volume	volume	NOUN
fnp-5343	410	4	loss	loss	NOUN
fnp-5343	410	5	in	in	ADP
fnp-5343	410	6	human	human	ADJ
fnp-5343	410	7	immunodeficiency	immunodeficiency	NOUN
fnp-5343	410	8	virus	virus	NOUN
fnp-5343	410	9	infection	infection	NOUN
fnp-5343	410	10	:	:	PUNCT
fnp-5343	410	11	a	a	DET
fnp-5343	410	12	longitudinal	longitudinal	ADJ
fnp-5343	410	13	volumetric	volumetric	ADJ
fnp-5343	410	14	magnetic	magnetic	ADJ
fnp-5343	410	15	resonance	resonance	NOUN
fnp-5343	410	16	imaging	imaging	NOUN
fnp-5343	410	17	study	study	NOUN
fnp-5343	410	18	.	.	PUNCT
fnp-5343	411	1	arch	arch	ADJ
fnp-5343	411	2	neurol	neurol	PROPN
fnp-5343	411	3	1998;55:161–8	1998;55:161–8	NUM
fnp-5343	411	4	.	.	PUNCT
fnp-5343	412	1	https://doi.org/10.1001/archneur.55.2.161	https://doi.org/10.1001/archneur.55.2.161	VERB
fnp-5343	412	2	.	.	NOUN
fnp-5343	412	3	50	50	NUM
fnp-5343	412	4	.	.	PUNCT
fnp-5343	413	1	jernigan	jernigan	PROPN
fnp-5343	413	2	tl	tl	PROPN
fnp-5343	413	3	,	,	PUNCT
fnp-5343	413	4	grant	grant	VERB
fnp-5343	413	5	i	i	PRON
fnp-5343	413	6	,	,	PUNCT
fnp-5343	413	7	hesselink	hesselink	PROPN
fnp-5343	413	8	jr	jr	PROPN
fnp-5343	413	9	,	,	PUNCT
fnp-5343	413	10	atkinson	atkinson	PROPN
fnp-5343	413	11	jh	jh	PROPN
fnp-5343	413	12	,	,	PUNCT
fnp-5343	413	13	velin	velin	PROPN
fnp-5343	413	14	ra	ra	PROPN
fnp-5343	413	15	,	,	PUNCT
fnp-5343	413	16	mccutchan	mccutchan	PROPN
fnp-5343	413	17	ja	ja	PROPN
fnp-5343	413	18	,	,	PUNCT
fnp-5343	413	19	et	et	PROPN
fnp-5343	413	20	al	al	PROPN
fnp-5343	413	21	.	.	PUNCT
fnp-5343	413	22	magnetic	magnetic	ADJ
fnp-5343	413	23	resonance	resonance	NOUN
fnp-5343	413	24	imaging	image	VERB
fnp-5343	413	25	morphometric	morphometric	ADJ
fnp-5343	413	26	analysis	analysis	NOUN
fnp-5343	413	27	of	of	ADP
fnp-5343	413	28	cerebral	cerebral	ADJ
fnp-5343	413	29	volume	volume	NOUN
fnp-5343	413	30	loss	loss	NOUN
fnp-5343	413	31	in	in	ADP
fnp-5343	413	32	human	human	ADJ
fnp-5343	413	33	immunodeficiency	immunodeficiency	NOUN
fnp-5343	413	34	virus	virus	NOUN
fnp-5343	413	35	infection	infection	NOUN
fnp-5343	413	36	.	.	PUNCT
fnp-5343	414	1	arch	arch	ADJ
fnp-5343	414	2	neurol	neurol	PROPN
fnp-5343	414	3	1993;50:250–5	1993;50:250–5	NUM
fnp-5343	414	4	.	.	PUNCT
fnp-5343	415	1	https://doi.org/10.1001/archneur.1993.00540030016007	https://doi.org/10.1001/archneur.1993.00540030016007	PROPN
fnp-5343	415	2	.	.	PROPN
fnp-5343	415	3	51	51	NUM
fnp-5343	415	4	.	.	PUNCT
fnp-5343	416	1	heindel	heindel	PROPN
fnp-5343	416	2	wc	wc	PROPN
fnp-5343	416	3	,	,	PUNCT
fnp-5343	416	4	jernigan	jernigan	PROPN
fnp-5343	416	5	tl	tl	PROPN
fnp-5343	416	6	,	,	PUNCT
fnp-5343	416	7	archibald	archibald	PROPN
fnp-5343	416	8	sl	sl	PROPN
fnp-5343	416	9	,	,	PUNCT
fnp-5343	416	10	achim	achim	PROPN
fnp-5343	416	11	cl	cl	NOUN
fnp-5343	416	12	,	,	PUNCT
fnp-5343	416	13	masliah	masliah	PROPN
fnp-5343	416	14	e	e	PROPN
fnp-5343	416	15	,	,	PUNCT
fnp-5343	416	16	wiley	wiley	PROPN
fnp-5343	416	17	ca	ca	PROPN
fnp-5343	416	18	.	.	PUNCT
fnp-5343	417	1	the	the	DET
fnp-5343	417	2	relationship	relationship	NOUN
fnp-5343	417	3	of	of	ADP
fnp-5343	417	4	quantitative	quantitative	ADJ
fnp-5343	417	5	brain	brain	NOUN
fnp-5343	417	6	magnetic	magnetic	ADJ
fnp-5343	417	7	resonance	resonance	NOUN
fnp-5343	417	8	imaging	imaging	NOUN
fnp-5343	417	9	measures	measure	NOUN
fnp-5343	417	10	to	to	PART
fnp-5343	417	11	neuropathologic	neuropathologic	ADJ
fnp-5343	417	12	indexes	index	NOUN
fnp-5343	417	13	of	of	ADP
fnp-5343	417	14	human	human	ADJ
fnp-5343	417	15	immunodeficiency	immunodeficiency	NOUN
fnp-5343	417	16	virus	virus	NOUN
fnp-5343	417	17	infection	infection	NOUN
fnp-5343	417	18	.	.	PUNCT
fnp-5343	418	1	arch	arch	ADJ
fnp-5343	418	2	neurol	neurol	NOUN
fnp-5343	418	3	1994;51:1129–35	1994;51:1129–35	NUM
fnp-5343	418	4	.	.	PUNCT
fnp-5343	419	1	https://doi.org/10.1001/archneur.1994.00540230067015	https://doi.org/10.1001/archneur.1994.00540230067015	PROPN
fnp-5343	419	2	.	.	PROPN
fnp-5343	420	1	52	52	NUM
fnp-5343	420	2	.	.	PUNCT
fnp-5343	421	1	cardenas	cardenas	PROPN
fnp-5343	421	2	v	v	PROPN
fnp-5343	421	3	,	,	PUNCT
fnp-5343	421	4	meyerhoff	meyerhoff	NOUN
fnp-5343	421	5	d	d	NOUN
fnp-5343	421	6	,	,	PUNCT
fnp-5343	421	7	studholme	studholme	ADJ
fnp-5343	421	8	c	c	NOUN
fnp-5343	421	9	,	,	PUNCT
fnp-5343	421	10	kornak	kornak	PROPN
fnp-5343	421	11	j	j	PROPN
fnp-5343	421	12	,	,	PUNCT
fnp-5343	421	13	rothlind	rothlind	PROPN
fnp-5343	421	14	j	j	PROPN
fnp-5343	421	15	,	,	PUNCT
fnp-5343	421	16	lampiris	lampiris	ADJ
fnp-5343	421	17	h	h	NOUN
fnp-5343	421	18	,	,	PUNCT
fnp-5343	421	19	et	et	PROPN
fnp-5343	421	20	al	al	PROPN
fnp-5343	421	21	.	.	PROPN
fnp-5343	421	22	evidence	evidence	NOUN
fnp-5343	421	23	for	for	ADP
fnp-5343	421	24	ongoing	ongoing	ADJ
fnp-5343	421	25	brain	brain	NOUN
fnp-5343	421	26	injury	injury	NOUN
fnp-5343	421	27	in	in	ADP
fnp-5343	421	28	human	human	ADJ
fnp-5343	421	29	immunodeficiency	immunodeficiency	NOUN
fnp-5343	421	30	viruspositive	viruspositive	NOUN
fnp-5343	421	31	patients	patient	NOUN
fnp-5343	421	32	treated	treat	VERB
fnp-5343	421	33	with	with	ADP
fnp-5343	421	34	antiretroviral	antiretroviral	ADJ
fnp-5343	421	35	therapy	therapy	NOUN
fnp-5343	421	36	.	.	PUNCT
fnp-5343	422	1	j	j	PROPN
fnp-5343	422	2	neurovirol	neurovirol	PROPN
fnp-5343	422	3	2009;15:324–33	2009;15:324–33	PROPN
fnp-5343	422	4	.	.	PUNCT
fnp-5343	423	1	https://doi.org/10.1080/13550280902973960	https://doi.org/10.1080/13550280902973960	ADV
fnp-5343	423	2	.	.	PUNCT
fnp-5343	424	1	53	53	NUM
fnp-5343	424	2	.	.	PUNCT
fnp-5343	424	3	alakkas	alakkas	PROPN
fnp-5343	424	4	a	a	PROPN
fnp-5343	424	5	,	,	PUNCT
fnp-5343	424	6	ellis	ellis	PROPN
fnp-5343	424	7	rj	rj	PROPN
fnp-5343	424	8	,	,	PUNCT
fnp-5343	424	9	watson	watson	PROPN
fnp-5343	424	10	cw	cw	PROPN
fnp-5343	424	11	-	-	PROPN
fnp-5343	424	12	m	m	PROPN
fnp-5343	424	13	,	,	PUNCT
fnp-5343	424	14	umlauf	umlauf	PROPN
fnp-5343	424	15	a	a	PROPN
fnp-5343	424	16	,	,	PUNCT
fnp-5343	424	17	heaton	heaton	PROPN
fnp-5343	424	18	rk	rk	PROPN
fnp-5343	424	19	,	,	PUNCT
fnp-5343	424	20	letendre	letendre	PROPN
fnp-5343	424	21	s	s	PROPN
fnp-5343	424	22	,	,	PUNCT
fnp-5343	424	23	et	et	PROPN
fnp-5343	424	24	al	al	PROPN
fnp-5343	424	25	.	.	PROPN
fnp-5343	425	1	white	white	PROPN
fnp-5343	425	2	matter	matter	PROPN
fnp-5343	426	1	damage	damage	NOUN
fnp-5343	426	2	,	,	PUNCT
fnp-5343	426	3	neuroinflammation	neuroinflammation	NOUN
fnp-5343	426	4	,	,	PUNCT
fnp-5343	426	5	and	and	CCONJ
fnp-5343	426	6	neuronal	neuronal	ADJ
fnp-5343	426	7	integrity	integrity	NOUN
fnp-5343	426	8	in	in	ADP
fnp-5343	426	9	hand	hand	NOUN
fnp-5343	426	10	.	.	PUNCT
fnp-5343	427	1	j	j	PROPN
fnp-5343	427	2	neurovirol	neurovirol	NOUN
fnp-5343	427	3	2019;25:32–41	2019;25:32–41	NUM
fnp-5343	427	4	.	.	PUNCT
fnp-5343	428	1	https://doi.org/10.1007/s13365-018-0682-9	https://doi.org/10.1007/s13365-018-0682-9	NOUN
fnp-5343	428	2	.	.	PUNCT
fnp-5343	429	1	54	54	NUM
fnp-5343	429	2	.	.	PUNCT
fnp-5343	430	1	chaganti	chaganti	PROPN
fnp-5343	430	2	j	j	PROPN
fnp-5343	430	3	,	,	PUNCT
fnp-5343	430	4	marripudi	marripudi	PROPN
fnp-5343	430	5	k	k	PROPN
fnp-5343	430	6	,	,	PUNCT
fnp-5343	430	7	staub	staub	VERB
fnp-5343	430	8	lp	lp	PROPN
fnp-5343	430	9	,	,	PUNCT
fnp-5343	430	10	rae	rae	PROPN
fnp-5343	430	11	cd	cd	PROPN
fnp-5343	430	12	,	,	PUNCT
fnp-5343	430	13	gates	gates	PROPN
fnp-5343	430	14	tm	tm	PROPN
fnp-5343	430	15	,	,	PUNCT
fnp-5343	430	16	moffat	moffat	PROPN
fnp-5343	430	17	kj	kj	PROPN
fnp-5343	430	18	,	,	PUNCT
fnp-5343	431	1	et	et	PROPN
fnp-5343	431	2	al	al	PROPN
fnp-5343	431	3	.	.	PUNCT
fnp-5343	431	4	imaging	imaging	NOUN
fnp-5343	431	5	correlates	correlate	VERB
fnp-5343	431	6	of	of	ADP
fnp-5343	431	7	the	the	DET
fnp-5343	431	8	blood	blood	NOUN
fnp-5343	431	9	-	-	PUNCT
fnp-5343	431	10	brain	brain	NOUN
fnp-5343	431	11	barrier	barrier	NOUN
fnp-5343	431	12	disruption	disruption	NOUN
fnp-5343	431	13	in	in	ADP
fnp-5343	431	14	hiv	hiv	PROPN
fnp-5343	431	15	-	-	PUNCT
fnp-5343	431	16	associated	associate	VERB
fnp-5343	431	17	neurocognitive	neurocognitive	ADJ
fnp-5343	431	18	disorder	disorder	NOUN
fnp-5343	431	19	and	and	CCONJ
fnp-5343	431	20	therapeutic	therapeutic	ADJ
fnp-5343	431	21	implications	implication	NOUN
fnp-5343	431	22	.	.	PUNCT
fnp-5343	432	1	aids	aids	PROPN
fnp-5343	432	2	2019;33:1843–52	2019;33:1843–52	NUM
fnp-5343	432	3	.	.	PUNCT
fnp-5343	433	1	https://doi.org/10.1097/qad.0000000000002300	https://doi.org/10.1097/qad.0000000000002300	ADJ
fnp-5343	433	2	.	.	PUNCT
fnp-5343	434	1	55	55	NUM
fnp-5343	434	2	.	.	PUNCT
fnp-5343	435	1	bell	bell	PROPN
fnp-5343	435	2	je	je	PROPN
fnp-5343	435	3	.	.	PUNCT
fnp-5343	436	1	an	an	DET
fnp-5343	436	2	update	update	NOUN
fnp-5343	436	3	on	on	ADP
fnp-5343	436	4	the	the	DET
fnp-5343	436	5	neuropathology	neuropathology	NOUN
fnp-5343	436	6	of	of	ADP
fnp-5343	436	7	hiv	hiv	PROPN
fnp-5343	436	8	in	in	ADP
fnp-5343	436	9	the	the	DET
fnp-5343	436	10	haart	haart	PROPN
fnp-5343	436	11	era	era	NOUN
fnp-5343	436	12	.	.	PUNCT
fnp-5343	437	1	histopathology	histopathology	NOUN
fnp-5343	437	2	2004;45:549–59	2004;45:549–59	PROPN
fnp-5343	437	3	.	.	PUNCT
fnp-5343	438	1	https://doi.org/10.1111/j.1365-2559.2004.02004.x	https://doi.org/10.1111/j.1365-2559.2004.02004.x	PROPN
fnp-5343	438	2	.	.	PUNCT
fnp-5343	439	1	56	56	NUM
fnp-5343	439	2	.	.	PUNCT
fnp-5343	439	3	morgello	morgello	PROPN
fnp-5343	439	4	s.	s.	PROPN
fnp-5343	439	5	hiv	hiv	PROPN
fnp-5343	439	6	neuropathology	neuropathology	PROPN
fnp-5343	439	7	.	.	PUNCT
fnp-5343	440	1	handb	handb	PROPN
fnp-5343	440	2	clin	clin	PROPN
fnp-5343	440	3	neurol	neurol	PROPN
fnp-5343	440	4	2018;152:3–19	2018;152:3–19	PROPN
fnp-5343	440	5	.	.	PUNCT
fnp-5343	441	1	https://doi.org/10.1016/b978-0-444-63849-6.00002-5	https://doi.org/10.1016/b978-0-444-63849-6.00002-5	NOUN
fnp-5343	441	2	.	.	NOUN
fnp-5343	441	3	57	57	NUM
fnp-5343	441	4	.	.	PUNCT
fnp-5343	442	1	shaw	shaw	PROPN
fnp-5343	442	2	gm	gm	PROPN
fnp-5343	442	3	,	,	PUNCT
fnp-5343	442	4	harper	harper	NOUN
fnp-5343	442	5	me	i	PRON
fnp-5343	442	6	,	,	PUNCT
fnp-5343	442	7	hahn	hahn	PROPN
fnp-5343	442	8	bh	bh	PROPN
fnp-5343	442	9	,	,	PUNCT
fnp-5343	442	10	epstein	epstein	PROPN
fnp-5343	442	11	lg	lg	PROPN
fnp-5343	442	12	,	,	PUNCT
fnp-5343	442	13	gajdusek	gajdusek	PROPN
fnp-5343	442	14	dc	dc	PROPN
fnp-5343	442	15	,	,	PUNCT
fnp-5343	442	16	price	price	NOUN
fnp-5343	442	17	rw	rw	NOUN
fnp-5343	442	18	,	,	PUNCT
fnp-5343	442	19	et	et	PROPN
fnp-5343	442	20	al	al	PROPN
fnp-5343	442	21	.	.	PUNCT
fnp-5343	443	1	htlv	htlv	PROPN
fnp-5343	443	2	-	-	PUNCT
fnp-5343	443	3	iii	iii	PROPN
fnp-5343	443	4	infection	infection	NOUN
fnp-5343	443	5	in	in	ADP
fnp-5343	443	6	brains	brain	NOUN
fnp-5343	443	7	of	of	ADP
fnp-5343	443	8	children	child	NOUN
fnp-5343	443	9	and	and	CCONJ
fnp-5343	443	10	adults	adult	NOUN
fnp-5343	443	11	with	with	ADP
fnp-5343	443	12	aids	aid	NOUN
fnp-5343	443	13	encephalopathy	encephalopathy	NOUN
fnp-5343	443	14	.	.	PUNCT
fnp-5343	444	1	science	science	NOUN
fnp-5343	444	2	1985;227:177–82	1985;227:177–82	PROPN
fnp-5343	444	3	.	.	PUNCT
fnp-5343	445	1	https://doi.org/10.1126/science.298142	https://doi.org/10.1126/science.298142	NOUN
fnp-5343	445	2	.	.	PUNCT
fnp-5343	446	1	58	58	NUM
fnp-5343	446	2	.	.	PUNCT
fnp-5343	447	1	ho	ho	PROPN
fnp-5343	447	2	dd	dd	PROPN
fnp-5343	447	3	,	,	PUNCT
fnp-5343	447	4	sarngadharan	sarngadharan	VERB
fnp-5343	447	5	mg	mg	PROPN
fnp-5343	447	6	,	,	PUNCT
fnp-5343	447	7	resnick	resnick	PROPN
fnp-5343	447	8	l	l	PROPN
fnp-5343	447	9	,	,	PUNCT
fnp-5343	447	10	dimarzoveronese	dimarzoveronese	PROPN
fnp-5343	447	11	f	f	X
fnp-5343	447	12	,	,	PUNCT
fnp-5343	447	13	rota	rota	PROPN
fnp-5343	447	14	tr	tr	VERB
fnp-5343	447	15	,	,	PUNCT
fnp-5343	447	16	hirsch	hirsch	PROPN
fnp-5343	447	17	ms	ms	PROPN
fnp-5343	447	18	.	.	PROPN
fnp-5343	447	19	primary	primary	PROPN
fnp-5343	447	20	human	human	PROPN
fnp-5343	447	21	t	t	PROPN
fnp-5343	447	22	-	-	PUNCT
fnp-5343	447	23	lymphotropic	lymphotropic	NOUN
fnp-5343	447	24	virus	virus	NOUN
fnp-5343	447	25	type	type	NOUN
fnp-5343	447	26	iii	iii	NUM
fnp-5343	447	27	infection	infection	NOUN
fnp-5343	447	28	.	.	PUNCT
fnp-5343	448	1	ann	ann	PROPN
fnp-5343	448	2	intern	intern	PROPN
fnp-5343	448	3	med	med	PROPN
fnp-5343	448	4	1985;103:880–3	1985;103:880–3	PROPN
fnp-5343	448	5	.	.	PUNCT
fnp-5343	449	1	https://doi.org/10.7326/0003-4819-103-6-880	https://doi.org/10.7326/0003-4819-103-6-880	PROPN
fnp-5343	449	2	.	.	PUNCT
fnp-5343	450	1	59	59	NUM
fnp-5343	450	2	.	.	PUNCT
fnp-5343	450	3	levy	levy	PROPN
fnp-5343	450	4	ja	ja	PROPN
fnp-5343	450	5	,	,	PUNCT
fnp-5343	450	6	shimabukuro	shimabukuro	PROPN
fnp-5343	450	7	j	j	PROPN
fnp-5343	450	8	,	,	PUNCT
fnp-5343	450	9	hollander	hollander	PROPN
fnp-5343	450	10	h	h	PROPN
fnp-5343	450	11	,	,	PUNCT
fnp-5343	450	12	mills	mills	PROPN
fnp-5343	450	13	j	j	PROPN
fnp-5343	450	14	,	,	PUNCT
fnp-5343	450	15	kaminsky	kaminsky	PROPN
fnp-5343	450	16	l.	l.	PROPN
fnp-5343	450	17	isolation	isolation	NOUN
fnp-5343	450	18	of	of	ADP
fnp-5343	450	19	aids	aids	PROPN
fnp-5343	450	20	-	-	PUNCT
fnp-5343	450	21	associated	associate	VERB
fnp-5343	450	22	retroviruses	retrovirus	NOUN
fnp-5343	450	23	from	from	ADP
fnp-5343	450	24	cerebrospinal	cerebrospinal	ADJ
fnp-5343	450	25	fluid	fluid	NOUN
fnp-5343	450	26	and	and	CCONJ
fnp-5343	450	27	brain	brain	NOUN
fnp-5343	450	28	of	of	ADP
fnp-5343	450	29	patients	patient	NOUN
fnp-5343	450	30	with	with	ADP
fnp-5343	450	31	neurological	neurological	ADJ
fnp-5343	450	32	symptoms	symptom	NOUN
fnp-5343	450	33	.	.	PUNCT
fnp-5343	451	1	lancet	lancet	PROPN
fnp-5343	451	2	1985;2:585–8	1985;2:585–8	PROPN
fnp-5343	451	3	.	.	PUNCT
fnp-5343	451	4	60	60	NUM
fnp-5343	451	5	.	.	PUNCT
fnp-5343	452	1	gray	gray	ADJ
fnp-5343	452	2	f	f	PROPN
fnp-5343	452	3	,	,	PUNCT
fnp-5343	452	4	chrétien	chrétien	PROPN
fnp-5343	452	5	f	f	PROPN
fnp-5343	452	6	,	,	PUNCT
fnp-5343	452	7	vallat	vallat	NOUN
fnp-5343	452	8	-	-	PUNCT
fnp-5343	452	9	decouvelaere	decouvelaere	PROPN
fnp-5343	452	10	av	av	PROPN
fnp-5343	452	11	,	,	PUNCT
fnp-5343	452	12	scaravilli	scaravilli	PROPN
fnp-5343	452	13	f.	f.	PROPN
fnp-5343	453	1	the	the	DET
fnp-5343	453	2	changing	change	VERB
fnp-5343	453	3	pattern	pattern	NOUN
fnp-5343	453	4	of	of	ADP
fnp-5343	453	5	hiv	hiv	PROPN
fnp-5343	453	6	neuropathology	neuropathology	NOUN
fnp-5343	453	7	in	in	ADP
fnp-5343	453	8	the	the	DET
fnp-5343	453	9	haart	haart	PROPN
fnp-5343	453	10	era	era	NOUN
fnp-5343	453	11	.	.	PUNCT
fnp-5343	454	1	j	j	PROPN
fnp-5343	454	2	neuropathol	neuropathol	PROPN
fnp-5343	454	3	exp	exp	PROPN
fnp-5343	454	4	neurol	neurol	NOUN
fnp-5343	454	5	2003;62:429–40	2003;62:429–40	NUM
fnp-5343	454	6	.	.	PUNCT
fnp-5343	455	1	https://doi.org/10.1093/jnen/62.5.429	https://doi.org/10.1093/jnen/62.5.429	PROPN
fnp-5343	455	2	.	.	PROPN
fnp-5343	455	3	61	61	NUM
fnp-5343	455	4	.	.	PUNCT
fnp-5343	456	1	elovaara	elovaara	PROPN
fnp-5343	456	2	i	i	PRON
fnp-5343	456	3	,	,	PUNCT
fnp-5343	456	4	seppälä	seppälä	PROPN
fnp-5343	456	5	i	i	PRON
fnp-5343	456	6	,	,	PUNCT
fnp-5343	456	7	poutiainen	poutiainen	PROPN
fnp-5343	456	8	e	e	PROPN
fnp-5343	456	9	,	,	PUNCT
fnp-5343	456	10	suni	suni	PROPN
fnp-5343	456	11	j	j	PROPN
fnp-5343	456	12	,	,	PUNCT
fnp-5343	456	13	valle	valle	PROPN
fnp-5343	456	14	sl	sl	NOUN
fnp-5343	456	15	.	.	PUNCT
fnp-5343	457	1	intrathecal	intrathecal	ADJ
fnp-5343	457	2	humoral	humoral	ADJ
fnp-5343	457	3	immunologic	immunologic	ADJ
fnp-5343	457	4	response	response	NOUN
fnp-5343	457	5	in	in	ADP
fnp-5343	457	6	neurologically	neurologically	ADV
fnp-5343	457	7	symptomatic	symptomatic	ADJ
fnp-5343	457	8	and	and	CCONJ
fnp-5343	457	9	asymptomatic	asymptomatic	ADJ
fnp-5343	457	10	patients	patient	NOUN
fnp-5343	457	11	with	with	ADP
fnp-5343	457	12	human	human	ADJ
fnp-5343	457	13	immunodeficiency	immunodeficiency	NOUN
fnp-5343	457	14	virus	virus	NOUN
fnp-5343	457	15	infection	infection	NOUN
fnp-5343	457	16	.	.	PUNCT
fnp-5343	458	1	neurology	neurology	NOUN
fnp-5343	458	2	1988;38:1451–6	1988;38:1451–6	PROPN
fnp-5343	458	3	.	.	PUNCT
fnp-5343	459	1	https://doi.org/10.1212/wnl.38.9.1451	https://doi.org/10.1212/wnl.38.9.1451	PROPN
fnp-5343	459	2	.	.	PUNCT
fnp-5343	460	1	62	62	NUM
fnp-5343	460	2	.	.	PUNCT
fnp-5343	461	1	davis	davis	PROPN
fnp-5343	461	2	le	le	PROPN
fnp-5343	461	3	,	,	PUNCT
fnp-5343	461	4	hjelle	hjelle	PROPN
fnp-5343	461	5	bl	bl	PROPN
fnp-5343	461	6	,	,	PUNCT
fnp-5343	461	7	miller	miller	PROPN
fnp-5343	461	8	ve	ve	PROPN
fnp-5343	461	9	,	,	PUNCT
fnp-5343	461	10	palmer	palmer	PROPN
fnp-5343	461	11	dl	dl	PROPN
fnp-5343	461	12	,	,	PUNCT
fnp-5343	461	13	llewellyn	llewellyn	PROPN
fnp-5343	461	14	al	al	PROPN
fnp-5343	461	15	,	,	PUNCT
fnp-5343	461	16	merlin	merlin	PROPN
fnp-5343	461	17	tl	tl	PROPN
fnp-5343	461	18	,	,	PUNCT
fnp-5343	461	19	et	et	PROPN
fnp-5343	461	20	al	al	PROPN
fnp-5343	461	21	.	.	PUNCT
fnp-5343	462	1	early	early	ADJ
fnp-5343	462	2	viral	viral	ADJ
fnp-5343	462	3	brain	brain	NOUN
fnp-5343	462	4	invasion	invasion	NOUN
fnp-5343	462	5	in	in	ADP
fnp-5343	462	6	iatrogenic	iatrogenic	ADJ
fnp-5343	462	7	human	human	ADJ
fnp-5343	462	8	immunodeficiency	immunodeficiency	NOUN
fnp-5343	462	9	virus	virus	NOUN
fnp-5343	462	10	infection	infection	NOUN
fnp-5343	462	11	.	.	PUNCT
fnp-5343	463	1	neurology	neurology	NOUN
fnp-5343	463	2	1992;42:1736–9	1992;42:1736–9	PROPN
fnp-5343	463	3	.	.	PUNCT
fnp-5343	464	1	https://doi.org/10.1212/wnl.42.9.1736	https://doi.org/10.1212/wnl.42.9.1736	PROPN
fnp-5343	464	2	.	.	PROPN
fnp-5343	465	1	63	63	NUM
fnp-5343	465	2	.	.	X
fnp-5343	466	1	haase	haase	NOUN
fnp-5343	466	2	at	at	ADP
fnp-5343	466	3	.	.	PUNCT
fnp-5343	467	1	pathogenesis	pathogenesis	NOUN
fnp-5343	467	2	of	of	ADP
fnp-5343	467	3	lentivirus	lentivirus	NOUN
fnp-5343	467	4	infections	infection	NOUN
fnp-5343	467	5	.	.	PUNCT
fnp-5343	468	1	nature	nature	NOUN
fnp-5343	468	2	1986;322:130–6	1986;322:130–6	NUM
fnp-5343	468	3	.	.	PUNCT
fnp-5343	469	1	https://doi.org/10.1038/322130a0	https://doi.org/10.1038/322130a0	X
fnp-5343	469	2	.	.	PROPN
fnp-5343	469	3	64	64	NUM
fnp-5343	469	4	.	.	PUNCT
fnp-5343	470	1	petito	petito	PROPN
fnp-5343	470	2	ck	ck	PROPN
fnp-5343	470	3	,	,	PUNCT
fnp-5343	470	4	cash	cash	NOUN
fnp-5343	470	5	ks	ks	NOUN
fnp-5343	470	6	.	.	PUNCT
fnp-5343	470	7	blood	blood	NOUN
fnp-5343	470	8	-	-	PUNCT
fnp-5343	470	9	brain	brain	NOUN
fnp-5343	470	10	barrier	barrier	NOUN
fnp-5343	470	11	abnormalities	abnormality	NOUN
fnp-5343	470	12	in	in	ADP
fnp-5343	470	13	the	the	DET
fnp-5343	470	14	acquired	acquire	VERB
fnp-5343	470	15	immunodeficiency	immunodeficiency	NOUN
fnp-5343	470	16	syndrome	syndrome	NOUN
fnp-5343	470	17	:	:	PUNCT
fnp-5343	470	18	immunohistochemical	immunohistochemical	ADJ
fnp-5343	470	19	localization	localization	NOUN
fnp-5343	470	20	of	of	ADP
fnp-5343	470	21	serum	serum	NOUN
fnp-5343	470	22	proteins	protein	NOUN
fnp-5343	470	23	in	in	ADP
fnp-5343	470	24	postmortem	postmortem	NOUN
fnp-5343	470	25	brain	brain	NOUN
fnp-5343	470	26	.	.	PUNCT
fnp-5343	471	1	ann	ann	PROPN
fnp-5343	471	2	neurol	neurol	PROPN
fnp-5343	471	3	1992;32:658–66	1992;32:658–66	PROPN
fnp-5343	471	4	.	.	PUNCT
fnp-5343	472	1	https://doi.org/10.1002/ana.410320509	https://doi.org/10.1002/ana.410320509	NOUN
fnp-5343	472	2	.	.	PROPN
fnp-5343	473	1	65	65	NUM
fnp-5343	473	2	.	.	PUNCT
fnp-5343	474	1	wiley	wiley	PROPN
fnp-5343	474	2	ca	ca	PROPN
fnp-5343	474	3	,	,	PUNCT
fnp-5343	474	4	schrier	schrier	PROPN
fnp-5343	474	5	rd	rd	PROPN
fnp-5343	474	6	,	,	PUNCT
fnp-5343	474	7	nelson	nelson	PROPN
fnp-5343	474	8	ja	ja	PROPN
fnp-5343	474	9	,	,	PUNCT
fnp-5343	474	10	lampert	lampert	PROPN
fnp-5343	474	11	pw	pw	PROPN
fnp-5343	474	12	,	,	PUNCT
fnp-5343	474	13	oldstone	oldstone	PROPN
fnp-5343	474	14	mb	mb	NOUN
fnp-5343	474	15	.	.	PUNCT
fnp-5343	474	16	cellular	cellular	ADJ
fnp-5343	474	17	localization	localization	NOUN
fnp-5343	474	18	of	of	ADP
fnp-5343	474	19	human	human	ADJ
fnp-5343	474	20	immunodeficiency	immunodeficiency	NOUN
fnp-5343	474	21	virus	virus	NOUN
fnp-5343	474	22	infection	infection	NOUN
fnp-5343	474	23	within	within	ADP
fnp-5343	474	24	the	the	DET
fnp-5343	474	25	brains	brain	NOUN
fnp-5343	474	26	of	of	ADP
fnp-5343	474	27	acquired	acquire	VERB
fnp-5343	474	28	immune	immune	ADJ
fnp-5343	474	29	deficiency	deficiency	NOUN
fnp-5343	474	30	syndrome	syndrome	NOUN
fnp-5343	474	31	patients	patient	NOUN
fnp-5343	474	32	.	.	PUNCT
fnp-5343	475	1	proc	proc	PROPN
fnp-5343	475	2	natl	natl	PROPN
fnp-5343	475	3	acad	acad	PROPN
fnp-5343	475	4	sci	sci	PROPN
fnp-5343	475	5	u	u	PROPN
fnp-5343	475	6	s	s	PROPN
fnp-5343	475	7	a	a	DET
fnp-5343	475	8	1986;83:7089–93	1986;83:7089–93	NUM
fnp-5343	475	9	.	.	PUNCT
fnp-5343	476	1	https://doi.org/10.1073/pnas.83.18.7089	https://doi.org/10.1073/pnas.83.18.7089	PROPN
fnp-5343	476	2	.	.	PUNCT
fnp-5343	477	1	66	66	NUM
fnp-5343	477	2	.	.	PUNCT
fnp-5343	478	1	wiley	wiley	PROPN
fnp-5343	478	2	ca	ca	PROPN
fnp-5343	478	3	,	,	PUNCT
fnp-5343	478	4	achim	achim	PROPN
fnp-5343	478	5	cl	cl	NOUN
fnp-5343	478	6	,	,	PUNCT
fnp-5343	478	7	christopherson	christopherson	PROPN
fnp-5343	478	8	c	c	PROPN
fnp-5343	478	9	,	,	PUNCT
fnp-5343	478	10	kidane	kidane	PROPN
fnp-5343	478	11	y	y	PROPN
fnp-5343	478	12	,	,	PUNCT
fnp-5343	478	13	kwok	kwok	PROPN
fnp-5343	478	14	s	s	PROPN
fnp-5343	478	15	,	,	PUNCT
fnp-5343	478	16	masliah	masliah	PROPN
fnp-5343	478	17	e	e	PROPN
fnp-5343	478	18	,	,	PUNCT
fnp-5343	478	19	mellors	mellors	PROPN
fnp-5343	478	20	j	j	PROPN
fnp-5343	478	21	,	,	PUNCT
fnp-5343	478	22	radhakrishnan	radhakrishnan	PROPN
fnp-5343	478	23	l	l	PROPN
fnp-5343	478	24	,	,	PUNCT
fnp-5343	478	25	wang	wang	PROPN
fnp-5343	478	26	g	g	PROPN
fnp-5343	478	27	,	,	PUNCT
fnp-5343	478	28	soontornniyomkij	soontornniyomkij	PROPN
fnp-5343	478	29	v.	v.	PROPN
fnp-5343	478	30	hiv	hiv	PROPN
fnp-5343	478	31	mediates	mediate	VERB
fnp-5343	478	32	a	a	DET
fnp-5343	478	33	productive	productive	ADJ
fnp-5343	478	34	infection	infection	NOUN
fnp-5343	478	35	of	of	ADP
fnp-5343	478	36	the	the	DET
fnp-5343	478	37	brain	brain	NOUN
fnp-5343	478	38	.	.	PUNCT
fnp-5343	479	1	aids	aids	PROPN
fnp-5343	479	2	1999;13:2055–9	1999;13:2055–9	NUM
fnp-5343	479	3	.	.	PUNCT
fnp-5343	480	1	https://doi.org/10.1097/00002030-199910220-00007	https://doi.org/10.1097/00002030-199910220-00007	NOUN
fnp-5343	480	2	.	.	PUNCT
fnp-5343	481	1	67	67	NUM
fnp-5343	481	2	.	.	PUNCT
fnp-5343	482	1	koenig	koenig	PROPN
fnp-5343	482	2	s	s	PROPN
fnp-5343	482	3	,	,	PUNCT
fnp-5343	482	4	gendelman	gendelman	NOUN
fnp-5343	482	5	he	he	PRON
fnp-5343	482	6	,	,	PUNCT
fnp-5343	482	7	orenstein	orenstein	PROPN
fnp-5343	482	8	jm	jm	PROPN
fnp-5343	482	9	,	,	PUNCT
fnp-5343	482	10	canto	canto	PROPN
fnp-5343	482	11	mc	mc	PROPN
fnp-5343	482	12	,	,	PUNCT
fnp-5343	482	13	pezeshkpour	pezeshkpour	ADJ
fnp-5343	482	14	h	h	NOUN
fnp-5343	482	15	,	,	PUNCT
fnp-5343	482	16	yungbluth	yungbluth	NOUN
fnp-5343	482	17	m	m	PROPN
fnp-5343	482	18	,	,	PUNCT
fnp-5343	482	19	et	et	PROPN
fnp-5343	482	20	al	al	PROPN
fnp-5343	482	21	.	.	PUNCT
fnp-5343	482	22	detection	detection	NOUN
fnp-5343	482	23	of	of	ADP
fnp-5343	482	24	aids	aids	PROPN
fnp-5343	482	25	virus	virus	NOUN
fnp-5343	482	26	in	in	ADP
fnp-5343	482	27	macrophages	macrophage	NOUN
fnp-5343	482	28	in	in	ADP
fnp-5343	482	29	brain	brain	NOUN
fnp-5343	482	30	tissue	tissue	NOUN
fnp-5343	482	31	from	from	ADP
fnp-5343	482	32	aids	aid	NOUN
fnp-5343	482	33	patients	patient	NOUN
fnp-5343	482	34	with	with	ADP
fnp-5343	482	35	encephalopathy	encephalopathy	NOUN
fnp-5343	482	36	.	.	PUNCT
fnp-5343	483	1	science	science	NOUN
fnp-5343	483	2	1986;233:1089–98	1986;233:1089–98	NUM
fnp-5343	483	3	.	.	PUNCT
fnp-5343	484	1	https://doi.org/10.1126/science.3016903	https://doi.org/10.1126/science.3016903	VERB
fnp-5343	484	2	.	.	PUNCT
fnp-5343	485	1	68	68	NUM
fnp-5343	485	2	.	.	PUNCT
fnp-5343	486	1	navia	navia	PROPN
fnp-5343	486	2	ba	ba	PROPN
fnp-5343	486	3	,	,	PUNCT
fnp-5343	486	4	cho	cho	PROPN
fnp-5343	486	5	es	es	PROPN
fnp-5343	486	6	,	,	PUNCT
fnp-5343	486	7	petito	petito	NOUN
fnp-5343	486	8	ck	ck	PROPN
fnp-5343	486	9	pr	pr	NOUN
fnp-5343	486	10	.	.	PUNCT
fnp-5343	487	1	the	the	DET
fnp-5343	487	2	aids	aids	PROPN
fnp-5343	487	3	dementia	dementia	PROPN
fnp-5343	487	4	complex	complex	PROPN
fnp-5343	487	5	:	:	PUNCT
fnp-5343	487	6	ii	ii	PROPN
fnp-5343	487	7	.	.	PUNCT
fnp-5343	487	8	neuropathology	neuropathology	PROPN
fnp-5343	487	9	.	.	PUNCT
fnp-5343	488	1	ann	ann	PROPN
fnp-5343	488	2	neurol	neurol	PROPN
fnp-5343	488	3	1986;19:525–35	1986;19:525–35	NUM
fnp-5343	488	4	.	.	PUNCT
fnp-5343	489	1	https://doi.org/10.1002/ana.410190603	https://doi.org/10.1002/ana.410190603	PROPN
fnp-5343	489	2	.	.	PUNCT
fnp-5343	490	1	69	69	NUM
fnp-5343	490	2	.	.	PUNCT
fnp-5343	491	1	cosenza	cosenza	PROPN
fnp-5343	491	2	ma	ma	PROPN
fnp-5343	491	3	,	,	PUNCT
fnp-5343	491	4	zhao	zhao	PROPN
fnp-5343	491	5	ml	ml	PROPN
fnp-5343	491	6	,	,	PUNCT
fnp-5343	491	7	si	si	PROPN
fnp-5343	491	8	q	q	PROPN
fnp-5343	491	9	,	,	PUNCT
fnp-5343	491	10	lee	lee	PROPN
fnp-5343	491	11	sc	sc	PROPN
fnp-5343	491	12	.	.	PUNCT
fnp-5343	492	1	human	human	ADJ
fnp-5343	492	2	brain	brain	NOUN
fnp-5343	492	3	parenchymal	parenchymal	ADJ
fnp-5343	492	4	microglia	microglia	NOUN
fnp-5343	492	5	express	express	VERB
fnp-5343	492	6	cd14	cd14	PROPN
fnp-5343	492	7	and	and	CCONJ
fnp-5343	492	8	cd45	cd45	PROPN
fnp-5343	492	9	and	and	CCONJ
fnp-5343	492	10	are	be	AUX
fnp-5343	492	11	productively	productively	ADV
fnp-5343	492	12	infected	infect	VERB
fnp-5343	492	13	by	by	ADP
fnp-5343	492	14	hiv-1	hiv-1	PUNCT
fnp-5343	492	15	in	in	ADP
fnp-5343	492	16	hiv-1	hiv-1	ADJ
fnp-5343	492	17	encephalitis	encephalitis	NOUN
fnp-5343	492	18	.	.	PUNCT
fnp-5343	493	1	brain	brain	NOUN
fnp-5343	493	2	pathol	pathol	NOUN
fnp-5343	493	3	2003;12:442–55	2003;12:442–55	PRON
fnp-5343	493	4	.	.	PUNCT
fnp-5343	494	1	https://doi.org/10.1111/j.1750-3639.2002.tb00461.x	https://doi.org/10.1111/j.1750-3639.2002.tb00461.x	PROPN
fnp-5343	494	2	.	.	PROPN
fnp-5343	495	1	70	70	NUM
fnp-5343	495	2	.	.	X
fnp-5343	496	1	churchill	churchill	PROPN
fnp-5343	496	2	mj	mj	PROPN
fnp-5343	496	3	,	,	PUNCT
fnp-5343	496	4	wesselingh	wesselingh	PROPN
fnp-5343	496	5	sl	sl	NOUN
fnp-5343	496	6	,	,	PUNCT
fnp-5343	496	7	cowley	cowley	PROPN
fnp-5343	496	8	d	d	PROPN
fnp-5343	496	9	,	,	PUNCT
fnp-5343	496	10	pardo	pardo	PROPN
fnp-5343	496	11	ca	ca	PROPN
fnp-5343	496	12	,	,	PUNCT
fnp-5343	496	13	mcarthur	mcarthur	PROPN
fnp-5343	496	14	jc	jc	PROPN
fnp-5343	496	15	,	,	PUNCT
fnp-5343	496	16	brew	brew	VERB
fnp-5343	496	17	bj	bj	NOUN
fnp-5343	496	18	,	,	PUNCT
fnp-5343	496	19	et	et	PROPN
fnp-5343	496	20	al	al	PROPN
fnp-5343	496	21	.	.	PROPN
fnp-5343	496	22	extensive	extensive	ADJ
fnp-5343	496	23	astrocyte	astrocyte	NOUN
fnp-5343	496	24	infection	infection	NOUN
fnp-5343	496	25	is	be	AUX
fnp-5343	496	26	prominent	prominent	ADJ
fnp-5343	496	27	in	in	ADP
fnp-5343	496	28	human	human	ADJ
fnp-5343	496	29	immunodeficiency	immunodeficiency	NOUN
fnp-5343	496	30	virus	virus	NOUN
fnp-5343	496	31	associated	associate	VERB
fnp-5343	496	32	dementia	dementia	NOUN
fnp-5343	496	33	.	.	PUNCT
fnp-5343	497	1	ann	ann	PROPN
fnp-5343	497	2	neurol	neurol	PROPN
fnp-5343	497	3	2009;66:253–8	2009;66:253–8	NUM
fnp-5343	497	4	.	.	PUNCT
fnp-5343	498	1	https://doi.org/10.1002/ana.21697	https://doi.org/10.1002/ana.21697	PROPN
fnp-5343	498	2	.	.	PROPN
fnp-5343	499	1	71	71	NUM
fnp-5343	499	2	.	.	PUNCT
fnp-5343	500	1	thompson	thompson	PROPN
fnp-5343	500	2	ka	ka	PROPN
fnp-5343	500	3	,	,	PUNCT
fnp-5343	500	4	cherry	cherry	NOUN
fnp-5343	500	5	cl	cl	PROPN
fnp-5343	500	6	,	,	PUNCT
fnp-5343	500	7	bell	bell	PROPN
fnp-5343	500	8	je	je	PROPN
fnp-5343	500	9	,	,	PUNCT
fnp-5343	500	10	mclean	mclean	PROPN
fnp-5343	500	11	ca	ca	PROPN
fnp-5343	500	12	.	.	PUNCT
fnp-5343	501	1	brain	brain	NOUN
fnp-5343	501	2	cell	cell	NOUN
fnp-5343	501	3	reservoirs	reservoir	NOUN
fnp-5343	501	4	of	of	ADP
fnp-5343	501	5	latent	latent	NOUN
fnp-5343	501	6	virus	virus	NOUN
fnp-5343	501	7	in	in	ADP
fnp-5343	501	8	presymptomatic	presymptomatic	PROPN
fnp-5343	501	9	hiv	hiv	PROPN
fnp-5343	501	10	-	-	PUNCT
fnp-5343	501	11	infected	infect	VERB
fnp-5343	501	12	individuals	individual	NOUN
fnp-5343	501	13	.	.	PUNCT
fnp-5343	502	1	am	be	AUX
fnp-5343	502	2	j	j	PROPN
fnp-5343	502	3	pathol	pathol	NOUN
fnp-5343	502	4	2011;179:1623–9	2011;179:1623–9	NUM
fnp-5343	502	5	.	.	PUNCT
fnp-5343	503	1	https://doi.org/10.1016/j.ajpath.2011.06.039	https://doi.org/10.1016/j.ajpath.2011.06.039	NOUN
fnp-5343	503	2	.	.	PUNCT
fnp-5343	504	1	72	72	NUM
fnp-5343	504	2	.	.	PUNCT
fnp-5343	505	1	gray	gray	ADJ
fnp-5343	505	2	f	f	PROPN
fnp-5343	505	3	,	,	PUNCT
fnp-5343	505	4	lescs	lescs	PROPN
fnp-5343	505	5	mc	mc	PROPN
fnp-5343	505	6	,	,	PUNCT
fnp-5343	505	7	keohane	keohane	PROPN
fnp-5343	505	8	c	c	NOUN
fnp-5343	505	9	,	,	PUNCT
fnp-5343	505	10	paraire	paraire	NOUN
fnp-5343	505	11	f	f	X
fnp-5343	505	12	,	,	PUNCT
fnp-5343	505	13	marc	marc	PROPN
fnp-5343	505	14	b	b	PROPN
fnp-5343	505	15	,	,	PUNCT
fnp-5343	505	16	durigon	durigon	PROPN
fnp-5343	505	17	m	m	PROPN
fnp-5343	505	18	,	,	PUNCT
fnp-5343	505	19	et	et	PROPN
fnp-5343	505	20	al	al	PROPN
fnp-5343	505	21	.	.	PROPN
fnp-5343	506	1	early	early	ADJ
fnp-5343	506	2	brain	brain	NOUN
fnp-5343	506	3	changes	change	NOUN
fnp-5343	506	4	in	in	ADP
fnp-5343	506	5	hiv	hiv	PROPN
fnp-5343	506	6	infection	infection	NOUN
fnp-5343	506	7	:	:	PUNCT
fnp-5343	506	8	neuropathological	neuropathological	ADJ
fnp-5343	506	9	study	study	NOUN
fnp-5343	506	10	of	of	ADP
fnp-5343	506	11	11	11	NUM
fnp-5343	506	12	hiv	hiv	NOUN
fnp-5343	506	13	seropositive	seropositive	ADJ
fnp-5343	506	14	,	,	PUNCT
fnp-5343	506	15	non	non	ADJ
fnp-5343	506	16	-	-	ADJ
fnp-5343	506	17	aids	aids	ADJ
fnp-5343	506	18	cases	case	NOUN
fnp-5343	506	19	.	.	PUNCT
fnp-5343	507	1	j	j	PROPN
fnp-5343	507	2	neuropathol	neuropathol	PROPN
fnp-5343	507	3	exp	exp	PROPN
fnp-5343	507	4	neurol	neurol	PROPN
fnp-5343	507	5	1992;51:177–85	1992;51:177–85	PRON
fnp-5343	507	6	.	.	PUNCT
fnp-5343	508	1	https://doi.org/10.1097/00005072-199203000-00007	https://doi.org/10.1097/00005072-199203000-00007	NOUN
fnp-5343	508	2	.	.	PUNCT
fnp-5343	509	1	73	73	NUM
fnp-5343	509	2	.	.	PUNCT
fnp-5343	510	1	an	an	DET
fnp-5343	510	2	sf	sf	PROPN
fnp-5343	510	3	,	,	PUNCT
fnp-5343	510	4	ciardi	ciardi	PROPN
fnp-5343	510	5	a	a	X
fnp-5343	510	6	,	,	PUNCT
fnp-5343	510	7	giometto	giometto	PROPN
fnp-5343	510	8	b	b	PROPN
fnp-5343	510	9	,	,	PUNCT
fnp-5343	510	10	scaravilli	scaravilli	PROPN
fnp-5343	510	11	t	t	PROPN
fnp-5343	510	12	,	,	PUNCT
fnp-5343	510	13	gray	gray	ADJ
fnp-5343	510	14	f	f	NOUN
fnp-5343	510	15	,	,	PUNCT
fnp-5343	510	16	scaravilli	scaravilli	PROPN
fnp-5343	510	17	f.	f.	PROPN
fnp-5343	510	18	investigation	investigation	PROPN
fnp-5343	510	19	on	on	ADP
fnp-5343	510	20	the	the	DET
fnp-5343	510	21	expression	expression	NOUN
fnp-5343	510	22	of	of	ADP
fnp-5343	510	23	major	major	ADJ
fnp-5343	510	24	histocompatibility	histocompatibility	NOUN
fnp-5343	510	25	complex	complex	ADJ
fnp-5343	510	26	class	class	NOUN
fnp-5343	510	27	ii	ii	NOUN
fnp-5343	510	28	and	and	CCONJ
fnp-5343	510	29	cytokines	cytokine	NOUN
fnp-5343	510	30	and	and	CCONJ
fnp-5343	510	31	detection	detection	NOUN
fnp-5343	510	32	of	of	ADP
fnp-5343	510	33	hiv-1	hiv-1	PUNCT
fnp-5343	510	34	dna	dna	PROPN
fnp-5343	510	35	within	within	ADP
fnp-5343	510	36	brains	brain	NOUN
fnp-5343	510	37	of	of	ADP
fnp-5343	510	38	asymptomatic	asymptomatic	ADJ
fnp-5343	510	39	and	and	CCONJ
fnp-5343	510	40	symptomatic	symptomatic	ADJ
fnp-5343	510	41	hiv-1	hiv-1	ADJ
fnp-5343	510	42	-	-	ADJ
fnp-5343	510	43	positive	positive	ADJ
fnp-5343	510	44	patients	patient	NOUN
fnp-5343	510	45	.	.	PUNCT
fnp-5343	511	1	acta	acta	PROPN
fnp-5343	511	2	neuropathol	neuropathol	PROPN
fnp-5343	511	3	1996;91:494–503	1996;91:494–503	PROPN
fnp-5343	511	4	.	.	PUNCT
fnp-5343	512	1	https://doi.org/10.1007/s004010050457	https://doi.org/10.1007/s004010050457	NUM
fnp-5343	512	2	.	.	PUNCT
fnp-5343	513	1	74	74	NUM
fnp-5343	513	2	.	.	PUNCT
fnp-5343	514	1	anders	anders	PROPN
fnp-5343	514	2	kh	kh	PROPN
fnp-5343	514	3	,	,	PUNCT
fnp-5343	514	4	guerra	guerra	PROPN
fnp-5343	514	5	wf	wf	PROPN
fnp-5343	514	6	,	,	PUNCT
fnp-5343	514	7	tomiyasu	tomiyasu	PROPN
fnp-5343	514	8	u	u	NOUN
fnp-5343	514	9	,	,	PUNCT
fnp-5343	514	10	verity	verity	NOUN
fnp-5343	514	11	ma	ma	PROPN
fnp-5343	514	12	,	,	PUNCT
fnp-5343	514	13	vinters	vinter	NOUN
fnp-5343	514	14	hv	hv	PROPN
fnp-5343	514	15	.	.	PUNCT
fnp-5343	515	1	the	the	DET
fnp-5343	515	2	neuropathology	neuropathology	NOUN
fnp-5343	515	3	of	of	ADP
fnp-5343	515	4	aids	aids	PROPN
fnp-5343	515	5	.	.	PUNCT
fnp-5343	516	1	ucla	ucla	NOUN
fnp-5343	516	2	experience	experience	NOUN
fnp-5343	516	3	and	and	CCONJ
fnp-5343	516	4	review	review	NOUN
fnp-5343	516	5	.	.	PUNCT
fnp-5343	517	1	am	be	AUX
fnp-5343	517	2	j	j	PROPN
fnp-5343	517	3	pathol	pathol	NOUN
fnp-5343	517	4	1986;124:537–58	1986;124:537–58	PROPN
fnp-5343	517	5	.	.	PUNCT
fnp-5343	518	1	pmc1888341	pmc1888341	PROPN
fnp-5343	518	2	.	.	PUNCT
fnp-5343	519	1	75	75	NUM
fnp-5343	519	2	.	.	PUNCT
fnp-5343	520	1	vago	vago	PROPN
fnp-5343	520	2	l	l	PROPN
fnp-5343	520	3	,	,	PUNCT
fnp-5343	520	4	trabattoni	trabattoni	VERB
fnp-5343	520	5	g	g	NOUN
fnp-5343	520	6	,	,	PUNCT
fnp-5343	520	7	lechi	lechi	PROPN
fnp-5343	520	8	a	a	PROPN
fnp-5343	520	9	,	,	PUNCT
fnp-5343	520	10	cristina	cristina	PROPN
fnp-5343	520	11	s	s	PROPN
fnp-5343	520	12	,	,	PUNCT
fnp-5343	520	13	budka	budka	PROPN
fnp-5343	520	14	h.	h.	PROPN
fnp-5343	520	15	neuropathology	neuropathology	PROPN
fnp-5343	520	16	of	of	ADP
fnp-5343	520	17	aids	aids	PROPN
fnp-5343	520	18	dementia	dementia	PROPN
fnp-5343	520	19	.	.	PUNCT
fnp-5343	521	1	a	a	DET
fnp-5343	521	2	review	review	NOUN
fnp-5343	521	3	after	after	ADP
fnp-5343	521	4	205	205	NUM
fnp-5343	521	5	post	post	NOUN
fnp-5343	521	6	mortem	mortem	NOUN
fnp-5343	521	7	examinations	examination	NOUN
fnp-5343	521	8	.	.	PUNCT
fnp-5343	522	1	acta	acta	PROPN
fnp-5343	522	2	neurol	neurol	PROPN
fnp-5343	522	3	(	(	PUNCT
fnp-5343	522	4	napoli	napoli	PROPN
fnp-5343	522	5	)	)	PUNCT
fnp-5343	522	6	.	.	PUNCT
fnp-5343	523	1	1990	1990	NUM
fnp-5343	523	2	feb;12:32	feb;12:32	NOUN
fnp-5343	523	3	-	-	PUNCT
fnp-5343	523	4	5	5	NUM
fnp-5343	523	5	.	.	NUM
fnp-5343	523	6	76	76	NUM
fnp-5343	523	7	.	.	PUNCT
fnp-5343	524	1	walsh	walsh	PROPN
fnp-5343	524	2	k	k	PROPN
fnp-5343	524	3	,	,	PUNCT
fnp-5343	524	4	thompson	thompson	PROPN
fnp-5343	524	5	w	w	PROPN
fnp-5343	524	6	,	,	PUNCT
fnp-5343	524	7	megyesi	megyesi	PROPN
fnp-5343	524	8	j	j	PROPN
fnp-5343	524	9	,	,	PUNCT
fnp-5343	524	10	wiley	wiley	PROPN
fnp-5343	524	11	ca	ca	PROPN
fnp-5343	524	12	,	,	PUNCT
fnp-5343	524	13	hammond	hammond	PROPN
fnp-5343	524	14	r.	r.	PROPN
fnp-5343	524	15	hiv-1	hiv-1	X
fnp-5343	524	16	/	/	SYM
fnp-5343	524	17	aids	aids	PROPN
fnp-5343	524	18	neuropathology	neuropathology	NOUN
fnp-5343	524	19	in	in	ADP
fnp-5343	524	20	a	a	DET
fnp-5343	524	21	canadian	canadian	ADJ
fnp-5343	524	22	teaching	teaching	NOUN
fnp-5343	524	23	centre	centre	NOUN
fnp-5343	524	24	.	.	PUNCT
fnp-5343	525	1	can	can	AUX
fnp-5343	525	2	j	j	PROPN
fnp-5343	525	3	neurol	neurol	VERB
fnp-5343	525	4	sci	sci	PROPN
fnp-5343	525	5	2004;31:235–41	2004;31:235–41	PROPN
fnp-5343	525	6	.	.	PUNCT
fnp-5343	526	1	https://doi.org/10.1017/s0317167100053889	https://doi.org/10.1017/s0317167100053889	NUM
fnp-5343	526	2	.	.	PUNCT
fnp-5343	527	1	77	77	NUM
fnp-5343	527	2	.	.	PUNCT
fnp-5343	528	1	snider	snider	PROPN
fnp-5343	528	2	wd	wd	PROPN
fnp-5343	528	3	,	,	PUNCT
fnp-5343	528	4	simpson	simpson	PROPN
fnp-5343	528	5	dm	dm	PROPN
fnp-5343	528	6	,	,	PUNCT
fnp-5343	528	7	nielsen	nielsen	PROPN
fnp-5343	528	8	s	s	PROPN
fnp-5343	528	9	,	,	PUNCT
fnp-5343	528	10	gold	gold	PROPN
fnp-5343	528	11	jw	jw	PROPN
fnp-5343	528	12	,	,	PUNCT
fnp-5343	528	13	metroka	metroka	PROPN
fnp-5343	528	14	ce	ce	PROPN
fnp-5343	528	15	,	,	PUNCT
fnp-5343	529	1	posner	posner	NOUN
fnp-5343	529	2	jb	jb	PROPN
fnp-5343	529	3	.	.	PUNCT
fnp-5343	530	1	neurological	neurological	ADJ
fnp-5343	530	2	complications	complication	NOUN
fnp-5343	530	3	of	of	ADP
fnp-5343	530	4	acquired	acquire	VERB
fnp-5343	530	5	immune	immune	ADJ
fnp-5343	530	6	deficiency	deficiency	NOUN
fnp-5343	530	7	syndrome	syndrome	NOUN
fnp-5343	530	8	:	:	PUNCT
fnp-5343	530	9	analysis	analysis	NOUN
fnp-5343	530	10	of	of	ADP
fnp-5343	530	11	50	50	NUM
fnp-5343	530	12	patients	patient	NOUN
fnp-5343	530	13	.	.	PUNCT
fnp-5343	531	1	ann	ann	PROPN
fnp-5343	531	2	neurol	neurol	PROPN
fnp-5343	531	3	1983;14:403–18	1983;14:403–18	NUM
fnp-5343	531	4	.	.	PUNCT
fnp-5343	532	1	https://doi.org/10.1002/ana.410140404	https://doi.org/10.1002/ana.410140404	PROPN
fnp-5343	532	2	.	.	PUNCT
fnp-5343	533	1	78	78	NUM
fnp-5343	533	2	.	.	PUNCT
fnp-5343	534	1	budka	budka	PROPN
fnp-5343	534	2	h	h	PROPN
fnp-5343	534	3	,	,	PUNCT
fnp-5343	534	4	costanzi	costanzi	NOUN
fnp-5343	534	5	g	g	NOUN
fnp-5343	534	6	,	,	PUNCT
fnp-5343	534	7	cristina	cristina	PROPN
fnp-5343	534	8	s	s	PROPN
fnp-5343	534	9	,	,	PUNCT
fnp-5343	534	10	lechi	lechi	PROPN
fnp-5343	534	11	a	a	PRON
fnp-5343	534	12	,	,	PUNCT
fnp-5343	534	13	parravicini	parravicini	PROPN
fnp-5343	534	14	c	c	NOUN
fnp-5343	534	15	,	,	PUNCT
fnp-5343	534	16	trabattoni	trabattoni	ADJ
fnp-5343	534	17	r	r	NOUN
fnp-5343	534	18	,	,	PUNCT
fnp-5343	534	19	et	et	PROPN
fnp-5343	534	20	al	al	PROPN
fnp-5343	534	21	.	.	PROPN
fnp-5343	534	22	brain	brain	NOUN
fnp-5343	534	23	pathology	pathology	NOUN
fnp-5343	534	24	induced	induce	VERB
fnp-5343	534	25	by	by	ADP
fnp-5343	534	26	infection	infection	NOUN
fnp-5343	534	27	with	with	ADP
fnp-5343	534	28	the	the	DET
fnp-5343	534	29	human	human	ADJ
fnp-5343	534	30	immunodeficiency	immunodeficiency	NOUN
fnp-5343	534	31	virus	virus	NOUN
fnp-5343	534	32	(	(	PUNCT
fnp-5343	534	33	hiv	hiv	PROPN
fnp-5343	534	34	)	)	PUNCT
fnp-5343	534	35	.	.	PUNCT
fnp-5343	535	1	a	a	DET
fnp-5343	535	2	histological	histological	ADJ
fnp-5343	535	3	,	,	PUNCT
fnp-5343	535	4	immunocytochemical	immunocytochemical	ADJ
fnp-5343	535	5	,	,	PUNCT
fnp-5343	535	6	and	and	CCONJ
fnp-5343	535	7	electron	electron	NOUN
fnp-5343	535	8	microscopical	microscopical	ADJ
fnp-5343	535	9	study	study	NOUN
fnp-5343	535	10	of	of	ADP
fnp-5343	535	11	100	100	NUM
fnp-5343	535	12	autopsy	autopsy	ADJ
fnp-5343	535	13	cases	case	NOUN
fnp-5343	535	14	.	.	PUNCT
fnp-5343	536	1	acta	acta	PROPN
fnp-5343	536	2	neuropathol	neuropathol	PROPN
fnp-5343	536	3	1987;75:185–98	1987;75:185–98	PRON
fnp-5343	536	4	.	.	PUNCT
fnp-5343	537	1	https://doi.org/10.1007/bf00687080	https://doi.org/10.1007/bf00687080	NOUN
fnp-5343	537	2	.	.	NOUN
fnp-5343	538	1	79	79	NUM
fnp-5343	538	2	.	.	PUNCT
fnp-5343	539	1	budka	budka	PROPN
fnp-5343	539	2	h.	h.	PROPN
fnp-5343	539	3	multinucleated	multinucleate	VERB
fnp-5343	539	4	giant	giant	ADJ
fnp-5343	539	5	cells	cell	NOUN
fnp-5343	539	6	in	in	ADP
fnp-5343	539	7	brain	brain	NOUN
fnp-5343	539	8	:	:	PUNCT
fnp-5343	539	9	a	a	DET
fnp-5343	539	10	hallmark	hallmark	NOUN
fnp-5343	539	11	of	of	ADP
fnp-5343	539	12	the	the	DET
fnp-5343	539	13	acquired	acquire	VERB
fnp-5343	539	14	immune	immune	ADJ
fnp-5343	539	15	deficiency	deficiency	NOUN
fnp-5343	539	16	syndrome	syndrome	NOUN
fnp-5343	539	17	(	(	PUNCT
fnp-5343	539	18	aids	aids	PROPN
fnp-5343	539	19	)	)	PUNCT
fnp-5343	539	20	.	.	PUNCT
fnp-5343	540	1	acta	acta	PROPN
fnp-5343	540	2	neuropathol	neuropathol	PROPN
fnp-5343	540	3	1986;69:253–8	1986;69:253–8	NUM
fnp-5343	540	4	.	.	PUNCT
fnp-5343	541	1	https://doi.org/10.1007/bf00688301	https://doi.org/10.1007/bf00688301	X
fnp-5343	541	2	.	.	PROPN
fnp-5343	542	1	80	80	NUM
fnp-5343	542	2	.	.	PUNCT
fnp-5343	543	1	sharer	sharer	PROPN
fnp-5343	543	2	lr	lr	PROPN
fnp-5343	543	3	,	,	PUNCT
fnp-5343	543	4	cho	cho	PROPN
fnp-5343	543	5	es	es	PROPN
fnp-5343	543	6	,	,	PUNCT
fnp-5343	543	7	epstein	epstein	PROPN
fnp-5343	543	8	lg	lg	PROPN
fnp-5343	543	9	.	.	PROPN
fnp-5343	543	10	multinucleated	multinucleate	VERB
fnp-5343	543	11	giant	giant	ADJ
fnp-5343	543	12	cells	cell	NOUN
fnp-5343	543	13	and	and	CCONJ
fnp-5343	543	14	htlv	htlv	PROPN
fnp-5343	543	15	-	-	PUNCT
fnp-5343	543	16	iii	iii	PROPN
fnp-5343	543	17	in	in	ADP
fnp-5343	543	18	aids	aid	NOUN
fnp-5343	543	19	encephalopathy	encephalopathy	NOUN
fnp-5343	543	20	.	.	PUNCT
fnp-5343	544	1	hum	hum	PROPN
fnp-5343	544	2	pathol	pathol	VERB
fnp-5343	544	3	1985;16:760	1985;16:760	NUM
fnp-5343	544	4	.	.	PUNCT
fnp-5343	545	1	https://doi.org/10.1016/s0046-8177(85)80245-8	https://doi.org/10.1016/s0046-8177(85)80245-8	PROPN
fnp-5343	545	2	.	.	PUNCT
fnp-5343	546	1	81	81	NUM
fnp-5343	546	2	.	.	PUNCT
fnp-5343	546	3	brew	brew	VERB
fnp-5343	546	4	bj	bj	ADP
fnp-5343	546	5	,	,	PUNCT
fnp-5343	546	6	rosenblum	rosenblum	PROPN
fnp-5343	546	7	m	m	PROPN
fnp-5343	546	8	,	,	PUNCT
fnp-5343	546	9	cronin	cronin	PROPN
fnp-5343	546	10	k	k	PROPN
fnp-5343	546	11	,	,	PUNCT
fnp-5343	546	12	price	price	NOUN
fnp-5343	546	13	rw	rw	NOUN
fnp-5343	546	14	.	.	PUNCT
fnp-5343	547	1	aids	aids	PROPN
fnp-5343	547	2	dementia	dementia	PROPN
fnp-5343	547	3	complex	complex	NOUN
fnp-5343	547	4	and	and	CCONJ
fnp-5343	547	5	hiv‐1	hiv‐1	NOUN
fnp-5343	547	6	brain	brain	NOUN
fnp-5343	547	7	infection	infection	NOUN
fnp-5343	547	8	:	:	PUNCT
fnp-5343	547	9	clinical‐virological	clinical‐virological	ADJ
fnp-5343	547	10	correlations	correlation	NOUN
fnp-5343	547	11	.	.	PUNCT
fnp-5343	548	1	ann	ann	PROPN
fnp-5343	548	2	neurol	neurol	PROPN
fnp-5343	548	3	1995;38:563–70	1995;38:563–70	PROPN
fnp-5343	548	4	.	.	PUNCT
fnp-5343	549	1	https://doi.org/10.1002/ana.410380404	https://doi.org/10.1002/ana.410380404	PROPN
fnp-5343	549	2	.	.	PROPN
fnp-5343	550	1	82	82	NUM
fnp-5343	550	2	.	.	PUNCT
fnp-5343	551	1	shieh	shieh	PROPN
fnp-5343	551	2	jt	jt	PROPN
fnp-5343	551	3	,	,	PUNCT
fnp-5343	551	4	martín	martín	PROPN
fnp-5343	551	5	j	j	PROPN
fnp-5343	551	6	,	,	PUNCT
fnp-5343	551	7	baltuch	baltuch	VERB
fnp-5343	551	8	g	g	NOUN
fnp-5343	551	9	,	,	PUNCT
fnp-5343	551	10	malim	malim	PROPN
fnp-5343	551	11	mh	mh	PROPN
fnp-5343	551	12	,	,	PUNCT
fnp-5343	551	13	gonzález	gonzález	PROPN
fnp-5343	551	14	-	-	PUNCT
fnp-5343	551	15	scarano	scarano	PROPN
fnp-5343	551	16	f.	f.	PROPN
fnp-5343	551	17	determinants	determinant	NOUN
fnp-5343	551	18	of	of	ADP
fnp-5343	551	19	syncytium	syncytium	NOUN
fnp-5343	551	20	formation	formation	NOUN
fnp-5343	551	21	in	in	ADP
fnp-5343	551	22	microglia	microglia	NOUN
fnp-5343	551	23	by	by	ADP
fnp-5343	551	24	human	human	ADJ
fnp-5343	551	25	immunodeficiency	immunodeficiency	NOUN
fnp-5343	551	26	virus	virus	NOUN
fnp-5343	551	27	type	type	NOUN
fnp-5343	551	28	1	1	NUM
fnp-5343	551	29	:	:	PUNCT
fnp-5343	551	30	role	role	NOUN
fnp-5343	551	31	of	of	ADP
fnp-5343	551	32	the	the	DET
fnp-5343	551	33	v1	v1	NOUN
fnp-5343	551	34	/	/	SYM
fnp-5343	551	35	v2	v2	NOUN
fnp-5343	551	36	domains	domain	NOUN
fnp-5343	551	37	.	.	PUNCT
fnp-5343	552	1	j	j	PROPN
fnp-5343	552	2	virol	virol	PROPN
fnp-5343	552	3	2000;74:693–701	2000;74:693–701	NUM
fnp-5343	552	4	.	.	PUNCT
fnp-5343	553	1	https://doi.org/10.1128/jvi.74.2.693-701.2000	https://doi.org/10.1128/jvi.74.2.693-701.2000	PROPN
fnp-5343	553	2	.	.	PUNCT
fnp-5343	554	1	83	83	NUM
fnp-5343	554	2	.	.	PUNCT
fnp-5343	555	1	budka	budka	PROPN
fnp-5343	555	2	h.	h.	PROPN
fnp-5343	555	3	neuropathology	neuropathology	PROPN
fnp-5343	555	4	of	of	ADP
fnp-5343	555	5	human	human	ADJ
fnp-5343	555	6	immunodeficiency	immunodeficiency	NOUN
fnp-5343	555	7	virus	virus	NOUN
fnp-5343	555	8	infection	infection	NOUN
fnp-5343	555	9	.	.	PUNCT
fnp-5343	556	1	brain	brain	NOUN
fnp-5343	556	2	pathol	pathol	NOUN
fnp-5343	556	3	1991;1:163–75	1991;1:163–75	NUM
fnp-5343	556	4	.	.	PUNCT
fnp-5343	557	1	https://doi.org/10.1111/j.1750-3639.1991.tb00656.x	https://doi.org/10.1111/j.1750-3639.1991.tb00656.x	PROPN
fnp-5343	557	2	.	.	NOUN
fnp-5343	557	3	84	84	NUM
fnp-5343	557	4	.	.	PUNCT
fnp-5343	558	1	everall	everall	NOUN
fnp-5343	558	2	i	i	PROPN
fnp-5343	558	3	,	,	PUNCT
fnp-5343	558	4	vaida	vaida	PROPN
fnp-5343	558	5	f	f	PROPN
fnp-5343	558	6	,	,	PUNCT
fnp-5343	558	7	khanlou	khanlou	PROPN
fnp-5343	558	8	n	n	CCONJ
fnp-5343	558	9	,	,	PUNCT
fnp-5343	558	10	lazzaretto	lazzaretto	ADJ
fnp-5343	558	11	d	d	NOUN
fnp-5343	558	12	,	,	PUNCT
fnp-5343	558	13	achim	achim	PROPN
fnp-5343	558	14	c	c	X
fnp-5343	558	15	,	,	PUNCT
fnp-5343	558	16	letendre	letendre	PROPN
fnp-5343	558	17	s	s	PROPN
fnp-5343	558	18	,	,	PUNCT
fnp-5343	558	19	et	et	PROPN
fnp-5343	558	20	al	al	PROPN
fnp-5343	558	21	.	.	PROPN
fnp-5343	558	22	cliniconeuropathologic	cliniconeuropathologic	PROPN
fnp-5343	558	23	correlates	correlate	VERB
fnp-5343	558	24	of	of	ADP
fnp-5343	558	25	human	human	ADJ
fnp-5343	558	26	immunodeficiency	immunodeficiency	NOUN
fnp-5343	558	27	virus	virus	NOUN
fnp-5343	558	28	in	in	ADP
fnp-5343	558	29	the	the	DET
fnp-5343	558	30	era	era	NOUN
fnp-5343	558	31	of	of	ADP
fnp-5343	558	32	antiretroviral	antiretroviral	ADJ
fnp-5343	558	33	therapy	therapy	NOUN
fnp-5343	558	34	.	.	PUNCT
fnp-5343	559	1	j	j	PROPN
fnp-5343	559	2	neurovirol	neurovirol	NOUN
fnp-5343	559	3	2009;15:360–70	2009;15:360–70	PRON
fnp-5343	559	4	.	.	PUNCT
fnp-5343	560	1	https://doi.org/10.3109/13550280903131915	https://doi.org/10.3109/13550280903131915	ADJ
fnp-5343	560	2	.	.	PUNCT
fnp-5343	560	3	85	85	NUM
fnp-5343	560	4	.	.	PUNCT
fnp-5343	561	1	langford	langford	PROPN
fnp-5343	561	2	td	td	PROPN
fnp-5343	561	3	,	,	PUNCT
fnp-5343	561	4	letendre	letendre	PROPN
fnp-5343	561	5	sl	sl	PROPN
fnp-5343	561	6	,	,	PUNCT
fnp-5343	561	7	larrea	larrea	PROPN
fnp-5343	561	8	gj	gj	PROPN
fnp-5343	561	9	,	,	PUNCT
fnp-5343	561	10	masliah	masliah	PROPN
fnp-5343	561	11	e.	e.	PROPN
fnp-5343	561	12	changing	change	VERB
fnp-5343	561	13	patterns	pattern	NOUN
fnp-5343	561	14	in	in	ADP
fnp-5343	561	15	the	the	DET
fnp-5343	561	16	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	561	17	of	of	ADP
fnp-5343	561	18	hiv	hiv	PROPN
fnp-5343	561	19	during	during	ADP
fnp-5343	561	20	the	the	DET
fnp-5343	561	21	haart	haart	PROPN
fnp-5343	561	22	era	era	NOUN
fnp-5343	561	23	.	.	PUNCT
fnp-5343	562	1	brain	brain	NOUN
fnp-5343	562	2	pathol	pathol	NOUN
fnp-5343	562	3	2003;13:195–210	2003;13:195–210	NUM
fnp-5343	562	4	.	.	PUNCT
fnp-5343	563	1	https://doi.org/10.1111/j.1750-3639.2003.tb00019.x	https://doi.org/10.1111/j.1750-3639.2003.tb00019.x	X
fnp-5343	563	2	.	.	PROPN
fnp-5343	564	1	86	86	NUM
fnp-5343	564	2	.	.	PUNCT
fnp-5343	565	1	masliah	masliah	PROPN
fnp-5343	565	2	e	e	PROPN
fnp-5343	565	3	,	,	PUNCT
fnp-5343	565	4	deteresa	deteresa	PROPN
fnp-5343	565	5	rm	rm	PROPN
fnp-5343	565	6	,	,	PUNCT
fnp-5343	565	7	mallory	mallory	PROPN
fnp-5343	565	8	me	me	PROPN
fnp-5343	565	9	,	,	PUNCT
fnp-5343	565	10	hansen	hansen	PROPN
fnp-5343	565	11	la	la	PROPN
fnp-5343	565	12	.	.	PUNCT
fnp-5343	565	13	changes	change	NOUN
fnp-5343	565	14	in	in	ADP
fnp-5343	565	15	pathological	pathological	ADJ
fnp-5343	565	16	findings	finding	NOUN
fnp-5343	565	17	at	at	ADP
fnp-5343	565	18	autopsy	autopsy	ADJ
fnp-5343	565	19	in	in	ADP
fnp-5343	565	20	aids	aids	NOUN
fnp-5343	565	21	cases	case	NOUN
fnp-5343	565	22	for	for	ADP
fnp-5343	565	23	the	the	DET
fnp-5343	565	24	last	last	ADJ
fnp-5343	565	25	15	15	NUM
fnp-5343	565	26	years	year	NOUN
fnp-5343	565	27	.	.	PUNCT
fnp-5343	566	1	aids	aids	PROPN
fnp-5343	566	2	2000;14:69–74	2000;14:69–74	NUM
fnp-5343	566	3	.	.	PUNCT
fnp-5343	567	1	https://doi.org/10.1097/00002030-200001070-00008	https://doi.org/10.1097/00002030-200001070-00008	NOUN
fnp-5343	567	2	.	.	PUNCT
fnp-5343	568	1	87	87	NUM
fnp-5343	568	2	.	.	PUNCT
fnp-5343	569	1	morgello	morgello	PROPN
fnp-5343	569	2	s	s	PROPN
fnp-5343	569	3	,	,	PUNCT
fnp-5343	569	4	mahboob	mahboob	PROPN
fnp-5343	569	5	r	r	NOUN
fnp-5343	569	6	,	,	PUNCT
fnp-5343	569	7	yakoushina	yakoushina	PROPN
fnp-5343	569	8	t	t	PROPN
fnp-5343	569	9	,	,	PUNCT
fnp-5343	569	10	khan	khan	PROPN
fnp-5343	569	11	s	s	PROPN
fnp-5343	569	12	,	,	PUNCT
fnp-5343	569	13	hague	hague	PROPN
fnp-5343	569	14	k.	k.	PROPN
fnp-5343	570	1	autopsy	autopsy	PROPN
fnp-5343	570	2	findings	finding	NOUN
fnp-5343	570	3	in	in	ADP
fnp-5343	570	4	a	a	DET
fnp-5343	570	5	human	human	ADJ
fnp-5343	570	6	immunodeficiency	immunodeficiency	NOUN
fnp-5343	570	7	virus	virus	NOUN
fnp-5343	570	8	-	-	PUNCT
fnp-5343	570	9	infected	infect	VERB
fnp-5343	570	10	population	population	NOUN
fnp-5343	570	11	over	over	ADP
fnp-5343	570	12	2	2	NUM
fnp-5343	570	13	decades	decade	NOUN
fnp-5343	570	14	:	:	PUNCT
fnp-5343	570	15	influences	influence	NOUN
fnp-5343	570	16	of	of	ADP
fnp-5343	570	17	gender	gender	NOUN
fnp-5343	570	18	,	,	PUNCT
fnp-5343	570	19	ethnicity	ethnicity	NOUN
fnp-5343	570	20	,	,	PUNCT
fnp-5343	570	21	risk	risk	NOUN
fnp-5343	570	22	factors	factor	NOUN
fnp-5343	570	23	,	,	PUNCT
fnp-5343	570	24	and	and	CCONJ
fnp-5343	570	25	time	time	NOUN
fnp-5343	570	26	.	.	PUNCT
fnp-5343	571	1	arch	arch	ADJ
fnp-5343	571	2	pathol	pathol	NOUN
fnp-5343	571	3	lab	lab	NOUN
fnp-5343	571	4	med	med	PROPN
fnp-5343	571	5	2002;126:182–90	2002;126:182–90	PROPN
fnp-5343	571	6	.	.	PUNCT
fnp-5343	572	1	https://doi.org/10.5858/2002-126-0182-afiahi	https://doi.org/10.5858/2002-126-0182-afiahi	PROPN
fnp-5343	572	2	.	.	PROPN
fnp-5343	572	3	88	88	NUM
fnp-5343	572	4	.	.	PUNCT
fnp-5343	573	1	gelman	gelman	PROPN
fnp-5343	573	2	bb	bb	PROPN
fnp-5343	573	3	,	,	PUNCT
fnp-5343	573	4	lisinicchia	lisinicchia	PROPN
fnp-5343	573	5	jg	jg	PROPN
fnp-5343	573	6	,	,	PUNCT
fnp-5343	573	7	morgello	morgello	PROPN
fnp-5343	573	8	s	s	PROPN
fnp-5343	573	9	,	,	PUNCT
fnp-5343	573	10	masliah	masliah	PROPN
fnp-5343	573	11	e	e	PROPN
fnp-5343	573	12	,	,	PUNCT
fnp-5343	573	13	commins	commin	VERB
fnp-5343	573	14	d	d	PROPN
fnp-5343	573	15	,	,	PUNCT
fnp-5343	573	16	achim	achim	PROPN
fnp-5343	573	17	cl	cl	NOUN
fnp-5343	573	18	,	,	PUNCT
fnp-5343	573	19	et	et	PROPN
fnp-5343	573	20	al	al	PROPN
fnp-5343	573	21	.	.	PROPN
fnp-5343	574	1	neurovirological	neurovirological	ADJ
fnp-5343	574	2	correlation	correlation	NOUN
fnp-5343	574	3	with	with	ADP
fnp-5343	574	4	hiv	hiv	PROPN
fnp-5343	574	5	-	-	PUNCT
fnp-5343	574	6	associated	associate	VERB
fnp-5343	574	7	neurocognitive	neurocognitive	ADJ
fnp-5343	574	8	disorders	disorder	NOUN
fnp-5343	574	9	and	and	CCONJ
fnp-5343	574	10	encephalitis	encephalitis	NOUN
fnp-5343	574	11	in	in	ADP
fnp-5343	574	12	a	a	DET
fnp-5343	574	13	haart	haart	PROPN
fnp-5343	574	14	-	-	PUNCT
fnp-5343	574	15	era	era	NOUN
fnp-5343	574	16	cohort	cohort	NOUN
fnp-5343	574	17	.	.	PUNCT
fnp-5343	575	1	j	j	PROPN
fnp-5343	575	2	acquir	acquir	PROPN
fnp-5343	575	3	immune	immune	VERB
fnp-5343	575	4	defic	defic	ADJ
fnp-5343	575	5	syndr	syndr	NOUN
fnp-5343	575	6	2013;62:487–95	2013;62:487–95	X
fnp-5343	575	7	.	.	PUNCT
fnp-5343	576	1	https://doi.org/10.1097/qai.0b013e31827f1bdb	https://doi.org/10.1097/qai.0b013e31827f1bdb	PROPN
fnp-5343	576	2	.	.	PROPN
fnp-5343	576	3	89	89	NUM
fnp-5343	576	4	.	.	PUNCT
fnp-5343	577	1	jellinger	jellinger	PROPN
fnp-5343	577	2	ka	ka	PROPN
fnp-5343	577	3	,	,	PUNCT
fnp-5343	577	4	setinek	setinek	NOUN
fnp-5343	577	5	u	u	PROPN
fnp-5343	577	6	,	,	PUNCT
fnp-5343	577	7	drlicek	drlicek	PROPN
fnp-5343	577	8	m	m	PROPN
fnp-5343	577	9	,	,	PUNCT
fnp-5343	577	10	böhm	böhm	NOUN
fnp-5343	577	11	g	g	NOUN
fnp-5343	577	12	,	,	PUNCT
fnp-5343	577	13	steurer	steurer	VERB
fnp-5343	577	14	a	a	DET
fnp-5343	577	15	,	,	PUNCT
fnp-5343	577	16	lintner	lintner	PROPN
fnp-5343	577	17	f.	f.	PROPN
fnp-5343	577	18	neuropathology	neuropathology	PROPN
fnp-5343	577	19	and	and	CCONJ
fnp-5343	577	20	general	general	ADJ
fnp-5343	577	21	autopsy	autopsy	ADJ
fnp-5343	577	22	findings	finding	NOUN
fnp-5343	577	23	in	in	ADP
fnp-5343	577	24	aids	aid	NOUN
fnp-5343	577	25	during	during	ADP
fnp-5343	577	26	the	the	DET
fnp-5343	577	27	last	last	ADJ
fnp-5343	577	28	15	15	NUM
fnp-5343	577	29	years	year	NOUN
fnp-5343	577	30	.	.	PUNCT
fnp-5343	578	1	acta	acta	PROPN
fnp-5343	578	2	neuropathol	neuropathol	PROPN
fnp-5343	578	3	2000;100:213–20	2000;100:213–20	PROPN
fnp-5343	578	4	.	.	PUNCT
fnp-5343	579	1	https://doi.org/10.1007/s004010000245	https://doi.org/10.1007/s004010000245	NUM
fnp-5343	579	2	.	.	PROPN
fnp-5343	580	1	90	90	NUM
fnp-5343	580	2	.	.	PUNCT
fnp-5343	581	1	umlauf	umlauf	PROPN
fnp-5343	581	2	a	a	PROPN
fnp-5343	581	3	,	,	PUNCT
fnp-5343	581	4	soontornniyomkij	soontornniyomkij	PROPN
fnp-5343	581	5	b	b	NUM
fnp-5343	581	6	,	,	PUNCT
fnp-5343	581	7	sundermann	sundermann	PROPN
fnp-5343	581	8	ee	ee	PROPN
fnp-5343	581	9	,	,	PUNCT
fnp-5343	581	10	gouaux	gouaux	PROPN
fnp-5343	581	11	b	b	PROPN
fnp-5343	581	12	,	,	PUNCT
fnp-5343	581	13	ellis	ellis	PROPN
fnp-5343	581	14	rj	rj	PROPN
fnp-5343	581	15	,	,	PUNCT
fnp-5343	581	16	levine	levine	PROPN
fnp-5343	581	17	aj	aj	PROPN
fnp-5343	581	18	,	,	PUNCT
fnp-5343	581	19	et	et	PROPN
fnp-5343	581	20	al	al	PROPN
fnp-5343	581	21	.	.	PROPN
fnp-5343	581	22	risk	risk	NOUN
fnp-5343	581	23	of	of	ADP
fnp-5343	581	24	developing	develop	VERB
fnp-5343	581	25	cerebral	cerebral	ADJ
fnp-5343	581	26	β	β	NOUN
fnp-5343	581	27	-	-	NOUN
fnp-5343	581	28	amyloid	amyloid	ADJ
fnp-5343	581	29	plaques	plaque	NOUN
fnp-5343	581	30	with	with	ADP
fnp-5343	581	31	posttranslational	posttranslational	ADJ
fnp-5343	581	32	modification	modification	NOUN
fnp-5343	581	33	among	among	ADP
fnp-5343	581	34	hiv	hiv	PROPN
fnp-5343	581	35	-	-	PUNCT
fnp-5343	581	36	infected	infect	VERB
fnp-5343	581	37	adults	adult	NOUN
fnp-5343	581	38	.	.	PUNCT
fnp-5343	582	1	aids	aids	PROPN
fnp-5343	582	2	2019;33:2157–66	2019;33:2157–66	PROPN
fnp-5343	582	3	.	.	PUNCT
fnp-5343	583	1	https://doi.org/10.1097/qad.0000000000002336	https://doi.org/10.1097/qad.0000000000002336	PROPN
fnp-5343	583	2	.	.	PUNCT
fnp-5343	584	1	91	91	NUM
fnp-5343	584	2	.	.	PUNCT
fnp-5343	585	1	gray	gray	ADJ
fnp-5343	585	2	f	f	NOUN
fnp-5343	585	3	,	,	PUNCT
fnp-5343	585	4	keohane	keohane	PROPN
fnp-5343	585	5	c.	c.	PROPN
fnp-5343	585	6	the	the	DET
fnp-5343	585	7	neuropathology	neuropathology	NOUN
fnp-5343	585	8	of	of	ADP
fnp-5343	585	9	hiv	hiv	PROPN
fnp-5343	585	10	infection	infection	NOUN
fnp-5343	585	11	in	in	ADP
fnp-5343	585	12	the	the	DET
fnp-5343	585	13	era	era	NOUN
fnp-5343	585	14	of	of	ADP
fnp-5343	585	15	highly	highly	ADV
fnp-5343	585	16	active	active	ADJ
fnp-5343	585	17	antiretroviral	antiretroviral	ADJ
fnp-5343	585	18	therapy	therapy	NOUN
fnp-5343	585	19	(	(	PUNCT
fnp-5343	585	20	haart	haart	PROPN
fnp-5343	585	21	)	)	PUNCT
fnp-5343	585	22	.	.	PUNCT
fnp-5343	586	1	brain	brain	NOUN
fnp-5343	586	2	pathol	pathol	NOUN
fnp-5343	586	3	2003;13:79–83	2003;13:79–83	NUM
fnp-5343	586	4	.	.	PUNCT
fnp-5343	587	1	https://doi.org/10.1111/j.1750-3639.2003.tb00008.x	https://doi.org/10.1111/j.1750-3639.2003.tb00008.x	PROPN
fnp-5343	587	2	.	.	PROPN
fnp-5343	587	3	92	92	NUM
fnp-5343	587	4	.	.	PUNCT
fnp-5343	588	1	vago	vago	PROPN
fnp-5343	588	2	l	l	PROPN
fnp-5343	588	3	,	,	PUNCT
fnp-5343	588	4	bonetto	bonetto	NOUN
fnp-5343	588	5	s	s	PROPN
fnp-5343	588	6	,	,	PUNCT
fnp-5343	588	7	nebuloni	nebuloni	PROPN
fnp-5343	588	8	m	m	PROPN
fnp-5343	588	9	,	,	PUNCT
fnp-5343	588	10	duca	duca	PROPN
fnp-5343	588	11	p	p	PROPN
fnp-5343	588	12	,	,	PUNCT
fnp-5343	588	13	carsana	carsana	PROPN
fnp-5343	588	14	l	l	PROPN
fnp-5343	588	15	,	,	PUNCT
fnp-5343	588	16	zerbi	zerbi	PROPN
fnp-5343	588	17	p	p	X
fnp-5343	588	18	,	,	PUNCT
fnp-5343	588	19	et	et	PROPN
fnp-5343	588	20	al	al	PROPN
fnp-5343	588	21	.	.	PUNCT
fnp-5343	589	1	pathological	pathological	ADJ
fnp-5343	589	2	findings	finding	NOUN
fnp-5343	589	3	in	in	ADP
fnp-5343	589	4	the	the	DET
fnp-5343	589	5	central	central	ADJ
fnp-5343	589	6	nervous	nervous	ADJ
fnp-5343	589	7	system	system	NOUN
fnp-5343	589	8	of	of	ADP
fnp-5343	589	9	aids	aids	PROPN
fnp-5343	589	10	patients	patient	NOUN
fnp-5343	589	11	on	on	ADP
fnp-5343	589	12	assumed	assume	VERB
fnp-5343	589	13	antiretroviral	antiretroviral	ADJ
fnp-5343	589	14	therapeutic	therapeutic	ADJ
fnp-5343	589	15	regimens	regimen	NOUN
fnp-5343	589	16	:	:	PUNCT
fnp-5343	589	17	retrospective	retrospective	ADJ
fnp-5343	589	18	study	study	NOUN
fnp-5343	589	19	of	of	ADP
fnp-5343	589	20	1597	1597	NUM
fnp-5343	589	21	autopsies	autopsy	NOUN
fnp-5343	589	22	.	.	PUNCT
fnp-5343	590	1	aids	aids	PROPN
fnp-5343	590	2	2002;16:1925–8	2002;16:1925–8	PROPN
fnp-5343	590	3	.	.	PUNCT
fnp-5343	591	1	https://doi.org/10.1097/00002030-200209270-00009	https://doi.org/10.1097/00002030-200209270-00009	NOUN
fnp-5343	591	2	.	.	PUNCT
fnp-5343	592	1	93	93	NUM
fnp-5343	592	2	.	.	PUNCT
fnp-5343	593	1	wiley	wiley	PROPN
fnp-5343	593	2	ca	ca	PROPN
fnp-5343	593	3	,	,	PUNCT
fnp-5343	593	4	achim	achim	PROPN
fnp-5343	593	5	c.	c.	PROPN
fnp-5343	593	6	human	human	ADJ
fnp-5343	593	7	immunodeficiency	immunodeficiency	NOUN
fnp-5343	593	8	virus	virus	NOUN
fnp-5343	593	9	encephalitis	encephalitis	NOUN
fnp-5343	593	10	is	be	AUX
fnp-5343	593	11	the	the	DET
fnp-5343	593	12	pathological	pathological	ADJ
fnp-5343	593	13	correlate	correlate	NOUN
fnp-5343	593	14	of	of	ADP
fnp-5343	593	15	dementia	dementia	NOUN
fnp-5343	593	16	in	in	ADP
fnp-5343	593	17	acquired	acquire	VERB
fnp-5343	593	18	immunodeficiency	immunodeficiency	NOUN
fnp-5343	593	19	syndrome	syndrome	NOUN
fnp-5343	593	20	.	.	PUNCT
fnp-5343	594	1	ann	ann	PROPN
fnp-5343	594	2	neurol	neurol	PROPN
fnp-5343	594	3	1994;36:673–6	1994;36:673–6	NUM
fnp-5343	594	4	.	.	PUNCT
fnp-5343	595	1	https://doi.org/10.1002/ana.410360422	https://doi.org/10.1002/ana.410360422	PROPN
fnp-5343	595	2	.	.	PUNCT
fnp-5343	596	1	94	94	NUM
fnp-5343	596	2	.	.	PUNCT
fnp-5343	597	1	glass	glass	PROPN
fnp-5343	597	2	jd	jd	PROPN
fnp-5343	597	3	,	,	PUNCT
fnp-5343	597	4	fedor	fedor	PROPN
fnp-5343	597	5	h	h	NOUN
fnp-5343	597	6	,	,	PUNCT
fnp-5343	597	7	wesselingh	wesselingh	PROPN
fnp-5343	597	8	sl	sl	PROPN
fnp-5343	597	9	,	,	PUNCT
fnp-5343	597	10	mcarthur	mcarthur	PROPN
fnp-5343	597	11	jc	jc	PROPN
fnp-5343	597	12	.	.	PROPN
fnp-5343	597	13	immunocytochemical	immunocytochemical	ADJ
fnp-5343	597	14	quantitation	quantitation	NOUN
fnp-5343	597	15	of	of	ADP
fnp-5343	597	16	human	human	ADJ
fnp-5343	597	17	immunodeficiency	immunodeficiency	NOUN
fnp-5343	597	18	virus	virus	NOUN
fnp-5343	597	19	in	in	ADP
fnp-5343	597	20	the	the	DET
fnp-5343	597	21	brain	brain	NOUN
fnp-5343	597	22	:	:	PUNCT
fnp-5343	597	23	correlations	correlation	NOUN
fnp-5343	597	24	with	with	ADP
fnp-5343	597	25	dementia	dementia	NOUN
fnp-5343	597	26	.	.	PUNCT
fnp-5343	598	1	ann	ann	PROPN
fnp-5343	598	2	neurol	neurol	PROPN
fnp-5343	598	3	1995;38:755–62	1995;38:755–62	PROPN
fnp-5343	598	4	.	.	PUNCT
fnp-5343	599	1	https://doi.org/10.1002/ana.410380510	https://doi.org/10.1002/ana.410380510	PROPN
fnp-5343	599	2	.	.	PROPN
fnp-5343	599	3	95	95	NUM
fnp-5343	599	4	.	.	PUNCT
fnp-5343	600	1	gray	gray	ADJ
fnp-5343	600	2	f	f	NOUN
fnp-5343	600	3	,	,	PUNCT
fnp-5343	600	4	haug	haug	VERB
fnp-5343	600	5	h	h	PROPN
fnp-5343	600	6	,	,	PUNCT
fnp-5343	600	7	chimelli	chimelli	PROPN
fnp-5343	600	8	l	l	PROPN
fnp-5343	600	9	,	,	PUNCT
fnp-5343	600	10	geny	geny	PROPN
fnp-5343	600	11	c	c	PROPN
fnp-5343	600	12	,	,	PUNCT
fnp-5343	600	13	gaston	gaston	PROPN
fnp-5343	600	14	a	a	PROPN
fnp-5343	600	15	,	,	PUNCT
fnp-5343	600	16	scaravilli	scaravilli	PROPN
fnp-5343	600	17	f	f	PROPN
fnp-5343	600	18	,	,	PUNCT
fnp-5343	600	19	et	et	PROPN
fnp-5343	600	20	al	al	PROPN
fnp-5343	600	21	.	.	PROPN
fnp-5343	601	1	prominent	prominent	ADJ
fnp-5343	601	2	cortical	cortical	ADJ
fnp-5343	601	3	atrophy	atrophy	NOUN
fnp-5343	601	4	with	with	ADP
fnp-5343	601	5	neuronal	neuronal	ADJ
fnp-5343	601	6	loss	loss	NOUN
fnp-5343	601	7	as	as	ADP
fnp-5343	601	8	correlate	correlate	ADJ
fnp-5343	601	9	of	of	ADP
fnp-5343	601	10	human	human	ADJ
fnp-5343	601	11	immunodeficiency	immunodeficiency	NOUN
fnp-5343	601	12	virus	virus	NOUN
fnp-5343	601	13	encephalopathy	encephalopathy	NOUN
fnp-5343	601	14	.	.	PUNCT
fnp-5343	602	1	acta	acta	PROPN
fnp-5343	602	2	neuropathol	neuropathol	PROPN
fnp-5343	602	3	1991;82:229–33	1991;82:229–33	PROPN
fnp-5343	602	4	.	.	PUNCT
fnp-5343	603	1	https://doi.org/10.1007/bf00294450	https://doi.org/10.1007/bf00294450	X
fnp-5343	603	2	.	.	NOUN
fnp-5343	603	3	96	96	NUM
fnp-5343	603	4	.	.	PUNCT
fnp-5343	604	1	adle	adle	ADJ
fnp-5343	604	2	-	-	PUNCT
fnp-5343	604	3	biassette	biassette	PROPN
fnp-5343	604	4	h	h	NOUN
fnp-5343	604	5	,	,	PUNCT
fnp-5343	604	6	levy	levy	NOUN
fnp-5343	604	7	y	y	PROPN
fnp-5343	604	8	,	,	PUNCT
fnp-5343	604	9	colombel	colombel	VERB
fnp-5343	604	10	m	m	PROPN
fnp-5343	604	11	,	,	PUNCT
fnp-5343	604	12	poron	poron	PROPN
fnp-5343	604	13	f	f	PROPN
fnp-5343	604	14	,	,	PUNCT
fnp-5343	604	15	natchev	natchev	PROPN
fnp-5343	604	16	s	s	PROPN
fnp-5343	604	17	,	,	PUNCT
fnp-5343	604	18	keohane	keohane	PROPN
fnp-5343	604	19	c	c	NOUN
fnp-5343	604	20	,	,	PUNCT
fnp-5343	604	21	et	et	PROPN
fnp-5343	604	22	al	al	PROPN
fnp-5343	604	23	.	.	PUNCT
fnp-5343	605	1	neuronal	neuronal	ADJ
fnp-5343	605	2	apoptosis	apoptosis	NOUN
fnp-5343	605	3	in	in	ADP
fnp-5343	605	4	hiv	hiv	PROPN
fnp-5343	605	5	infection	infection	NOUN
fnp-5343	605	6	in	in	ADP
fnp-5343	605	7	adults	adult	NOUN
fnp-5343	605	8	.	.	PUNCT
fnp-5343	606	1	neuropathol	neuropathol	NOUN
fnp-5343	606	2	appl	appl	PROPN
fnp-5343	606	3	neurobiol	neurobiol	PROPN
fnp-5343	606	4	1995;21:218–27	1995;21:218–27	NUM
fnp-5343	606	5	.	.	PUNCT
fnp-5343	607	1	https://doi.org/10.1111/j.1365-2990.1995.tb01053.x	https://doi.org/10.1111/j.1365-2990.1995.tb01053.x	PROPN
fnp-5343	607	2	.	.	PROPN
fnp-5343	607	3	97	97	NUM
fnp-5343	607	4	.	.	PUNCT
fnp-5343	608	1	adle	adle	ADJ
fnp-5343	608	2	-	-	PUNCT
fnp-5343	608	3	biassette	biassette	PROPN
fnp-5343	608	4	h	h	PROPN
fnp-5343	608	5	,	,	PUNCT
fnp-5343	608	6	chrétien	chrétien	PROPN
fnp-5343	608	7	f	f	PROPN
fnp-5343	608	8	,	,	PUNCT
fnp-5343	608	9	wingertsmann	wingertsmann	PROPN
fnp-5343	608	10	l	l	PROPN
fnp-5343	608	11	,	,	PUNCT
fnp-5343	608	12	héry	héry	PROPN
fnp-5343	608	13	c	c	NOUN
fnp-5343	608	14	,	,	PUNCT
fnp-5343	608	15	ereau	ereau	PROPN
fnp-5343	608	16	t	t	PROPN
fnp-5343	608	17	,	,	PUNCT
fnp-5343	608	18	scaravilli	scaravilli	PROPN
fnp-5343	608	19	f	f	PROPN
fnp-5343	608	20	,	,	PUNCT
fnp-5343	608	21	et	et	PROPN
fnp-5343	608	22	al	al	PROPN
fnp-5343	608	23	.	.	PUNCT
fnp-5343	609	1	neuronal	neuronal	ADJ
fnp-5343	609	2	apoptosis	apoptosis	NOUN
fnp-5343	609	3	does	do	AUX
fnp-5343	609	4	not	not	PART
fnp-5343	609	5	correlate	correlate	VERB
fnp-5343	609	6	with	with	ADP
fnp-5343	609	7	dementia	dementia	NOUN
fnp-5343	609	8	in	in	ADP
fnp-5343	609	9	hiv	hiv	PROPN
fnp-5343	609	10	infection	infection	NOUN
fnp-5343	609	11	but	but	CCONJ
fnp-5343	609	12	is	be	AUX
fnp-5343	609	13	related	relate	VERB
fnp-5343	609	14	to	to	ADP
fnp-5343	609	15	microglial	microglial	ADJ
fnp-5343	609	16	activation	activation	NOUN
fnp-5343	609	17	and	and	CCONJ
fnp-5343	609	18	axonal	axonal	ADJ
fnp-5343	609	19	damage	damage	NOUN
fnp-5343	609	20	.	.	PUNCT
fnp-5343	610	1	neuropathol	neuropathol	NOUN
fnp-5343	610	2	appl	appl	PROPN
fnp-5343	610	3	neurobiol	neurobiol	PROPN
fnp-5343	610	4	1999;25:123–33	1999;25:123–33	PROPN
fnp-5343	610	5	.	.	PUNCT
fnp-5343	611	1	https://doi.org/10.1046/j.1365-2990.1999.00167.x	https://doi.org/10.1046/j.1365-2990.1999.00167.x	NOUN
fnp-5343	611	2	.	.	PUNCT
fnp-5343	612	1	98	98	NUM
fnp-5343	612	2	.	.	PUNCT
fnp-5343	612	3	everall	everall	NOUN
fnp-5343	612	4	ip	ip	PROPN
fnp-5343	612	5	,	,	PUNCT
fnp-5343	612	6	glass	glass	PROPN
fnp-5343	612	7	jd	jd	PROPN
fnp-5343	612	8	,	,	PUNCT
fnp-5343	612	9	mcarthur	mcarthur	PROPN
fnp-5343	612	10	j	j	PROPN
fnp-5343	612	11	,	,	PUNCT
fnp-5343	612	12	spargo	spargo	PROPN
fnp-5343	612	13	e	e	NOUN
fnp-5343	612	14	,	,	PUNCT
fnp-5343	612	15	lantos	lantos	ADJ
fnp-5343	612	16	p.	p.	NOUN
fnp-5343	612	17	neuronal	neuronal	ADJ
fnp-5343	612	18	density	density	NOUN
fnp-5343	612	19	in	in	ADP
fnp-5343	612	20	the	the	DET
fnp-5343	612	21	superior	superior	ADJ
fnp-5343	612	22	frontal	frontal	ADJ
fnp-5343	612	23	and	and	CCONJ
fnp-5343	612	24	temporal	temporal	ADJ
fnp-5343	612	25	gyri	gyri	NOUN
fnp-5343	612	26	does	do	AUX
fnp-5343	612	27	not	not	PART
fnp-5343	612	28	correlate	correlate	VERB
fnp-5343	612	29	with	with	ADP
fnp-5343	612	30	the	the	DET
fnp-5343	612	31	degree	degree	NOUN
fnp-5343	612	32	of	of	ADP
fnp-5343	612	33	human	human	ADJ
fnp-5343	612	34	immunodeficiency	immunodeficiency	NOUN
fnp-5343	612	35	virus	virus	NOUN
fnp-5343	612	36	-	-	PUNCT
fnp-5343	612	37	associated	associate	VERB
fnp-5343	612	38	dementia	dementia	NOUN
fnp-5343	612	39	.	.	PUNCT
fnp-5343	613	1	acta	acta	PROPN
fnp-5343	613	2	neuropathol	neuropathol	PROPN
fnp-5343	613	3	1994;88:538–44	1994;88:538–44	PRON
fnp-5343	613	4	.	.	PUNCT
fnp-5343	614	1	https://doi.org/10.1007/bf00296490	https://doi.org/10.1007/bf00296490	X
fnp-5343	614	2	.	.	PUNCT
fnp-5343	615	1	99	99	NUM
fnp-5343	615	2	.	.	PUNCT
fnp-5343	615	3	everall	everall	NOUN
fnp-5343	615	4	i	i	PROPN
fnp-5343	615	5	,	,	PUNCT
fnp-5343	615	6	heaton	heaton	PROPN
fnp-5343	615	7	r	r	PROPN
fnp-5343	615	8	,	,	PUNCT
fnp-5343	615	9	marcotte	marcotte	PROPN
fnp-5343	615	10	t	t	PROPN
fnp-5343	615	11	,	,	PUNCT
fnp-5343	615	12	ellis	ellis	PROPN
fnp-5343	615	13	r	r	PROPN
fnp-5343	615	14	,	,	PUNCT
fnp-5343	615	15	mccutchan	mccutchan	PROPN
fnp-5343	615	16	j	j	PROPN
fnp-5343	615	17	,	,	PUNCT
fnp-5343	615	18	atkinson	atkinson	PROPN
fnp-5343	615	19	j	j	PROPN
fnp-5343	615	20	,	,	PUNCT
fnp-5343	615	21	et	et	PROPN
fnp-5343	615	22	al	al	PROPN
fnp-5343	615	23	.	.	PUNCT
fnp-5343	616	1	cortical	cortical	ADJ
fnp-5343	616	2	synaptic	synaptic	ADJ
fnp-5343	616	3	density	density	NOUN
fnp-5343	616	4	is	be	AUX
fnp-5343	616	5	reduced	reduce	VERB
fnp-5343	616	6	in	in	ADP
fnp-5343	616	7	mild	mild	ADJ
fnp-5343	616	8	to	to	ADP
fnp-5343	616	9	moderate	moderate	ADJ
fnp-5343	616	10	human	human	ADJ
fnp-5343	616	11	immunodeficiency	immunodeficiency	NOUN
fnp-5343	616	12	virus	virus	NOUN
fnp-5343	616	13	neurocognitive	neurocognitive	ADJ
fnp-5343	616	14	disorder	disorder	NOUN
fnp-5343	616	15	.	.	PUNCT
fnp-5343	617	1	hiv	hiv	PROPN
fnp-5343	617	2	neurobehavioral	neurobehavioral	ADJ
fnp-5343	617	3	research	research	NOUN
fnp-5343	617	4	center	center	NOUN
fnp-5343	617	5	.	.	PUNCT
fnp-5343	618	1	brain	brain	NOUN
fnp-5343	618	2	pathol	pathol	NOUN
fnp-5343	618	3	1999;9:209–17	1999;9:209–17	NUM
fnp-5343	618	4	.	.	PUNCT
fnp-5343	619	1	https://doi.org/10.1111/j.1750-3639.1999.tb00219.x	https://doi.org/10.1111/j.1750-3639.1999.tb00219.x	PROPN
fnp-5343	619	2	.	.	PUNCT
fnp-5343	620	1	100	100	NUM
fnp-5343	620	2	.	.	PUNCT
fnp-5343	621	1	masliah	masliah	PROPN
fnp-5343	621	2	e	e	PROPN
fnp-5343	621	3	,	,	PUNCT
fnp-5343	621	4	heaton	heaton	PROPN
fnp-5343	621	5	rk	rk	PROPN
fnp-5343	621	6	,	,	PUNCT
fnp-5343	621	7	marcotte	marcotte	PROPN
fnp-5343	621	8	td	td	PROPN
fnp-5343	621	9	,	,	PUNCT
fnp-5343	621	10	ellis	ellis	PROPN
fnp-5343	621	11	rj	rj	PROPN
fnp-5343	621	12	,	,	PUNCT
fnp-5343	621	13	wiley	wiley	PROPN
fnp-5343	621	14	ca	ca	PROPN
fnp-5343	621	15	,	,	PUNCT
fnp-5343	621	16	mallory	mallory	PROPN
fnp-5343	621	17	m	m	PROPN
fnp-5343	621	18	,	,	PUNCT
fnp-5343	621	19	et	et	PROPN
fnp-5343	621	20	al	al	PROPN
fnp-5343	621	21	.	.	PUNCT
fnp-5343	621	22	dendritic	dendritic	ADJ
fnp-5343	621	23	injury	injury	NOUN
fnp-5343	621	24	is	be	AUX
fnp-5343	621	25	a	a	DET
fnp-5343	621	26	pathological	pathological	ADJ
fnp-5343	621	27	substrate	substrate	NOUN
fnp-5343	621	28	for	for	ADP
fnp-5343	621	29	human	human	ADJ
fnp-5343	621	30	immunodeficiency	immunodeficiency	NOUN
fnp-5343	621	31	virus	virus	NOUN
fnp-5343	621	32	-	-	PUNCT
fnp-5343	621	33	related	relate	VERB
fnp-5343	621	34	cognitive	cognitive	ADJ
fnp-5343	621	35	disorders	disorder	NOUN
fnp-5343	621	36	.	.	PUNCT
fnp-5343	622	1	ann	ann	PROPN
fnp-5343	622	2	neurol	neurol	PROPN
fnp-5343	622	3	1997;42:963–72	1997;42:963–72	PROPN
fnp-5343	622	4	.	.	PUNCT
fnp-5343	623	1	https://doi.org/10.1002/ana.410420618	https://doi.org/10.1002/ana.410420618	NOUN
fnp-5343	623	2	.	.	PUNCT
fnp-5343	624	1	101	101	NUM
fnp-5343	624	2	.	.	PUNCT
fnp-5343	625	1	masliah	masliah	PROPN
fnp-5343	625	2	e	e	PROPN
fnp-5343	625	3	,	,	PUNCT
fnp-5343	625	4	achim	achim	PROPN
fnp-5343	625	5	cl	cl	PROPN
fnp-5343	625	6	,	,	PUNCT
fnp-5343	625	7	ge	ge	PROPN
fnp-5343	625	8	n	n	AUX
fnp-5343	625	9	,	,	PUNCT
fnp-5343	625	10	deteresa	deteresa	NOUN
fnp-5343	625	11	r	r	PROPN
fnp-5343	625	12	,	,	PUNCT
fnp-5343	625	13	terry	terry	PROPN
fnp-5343	625	14	rd	rd	PROPN
fnp-5343	625	15	,	,	PUNCT
fnp-5343	625	16	wiley	wiley	PROPN
fnp-5343	625	17	ca	ca	PROPN
fnp-5343	625	18	.	.	PUNCT
fnp-5343	626	1	spectrum	spectrum	NOUN
fnp-5343	626	2	of	of	ADP
fnp-5343	626	3	human	human	ADJ
fnp-5343	626	4	immunodeficiency	immunodeficiency	NOUN
fnp-5343	626	5	virus	virus	NOUN
fnp-5343	626	6	–	–	PUNCT
fnp-5343	626	7	associated	associated	ADJ
fnp-5343	626	8	neocortical	neocortical	ADJ
fnp-5343	626	9	damage	damage	NOUN
fnp-5343	626	10	.	.	PUNCT
fnp-5343	627	1	ann	ann	PROPN
fnp-5343	627	2	neurol	neurol	PROPN
fnp-5343	627	3	1992;32:321–9	1992;32:321–9	NUM
fnp-5343	627	4	.	.	PUNCT
fnp-5343	628	1	https://doi.org/10.1002/ana.410320304	https://doi.org/10.1002/ana.410320304	PROPN
fnp-5343	628	2	.	.	PUNCT
fnp-5343	629	1	102	102	NUM
fnp-5343	629	2	.	.	PUNCT
fnp-5343	630	1	power	power	NOUN
fnp-5343	630	2	c	c	PROPN
fnp-5343	630	3	,	,	PUNCT
fnp-5343	630	4	kong	kong	PROPN
fnp-5343	630	5	pa	pa	PROPN
fnp-5343	630	6	,	,	PUNCT
fnp-5343	630	7	crawford	crawford	PROPN
fnp-5343	630	8	to	to	PART
fnp-5343	630	9	,	,	PUNCT
fnp-5343	630	10	wesselingh	wesselingh	PROPN
fnp-5343	630	11	s	s	NOUN
fnp-5343	630	12	,	,	PUNCT
fnp-5343	630	13	glass	glass	PROPN
fnp-5343	630	14	jd	jd	PROPN
fnp-5343	630	15	,	,	PUNCT
fnp-5343	630	16	mcarthur	mcarthur	PROPN
fnp-5343	630	17	jc	jc	PROPN
fnp-5343	630	18	,	,	PUNCT
fnp-5343	630	19	et	et	PROPN
fnp-5343	630	20	al	al	PROPN
fnp-5343	630	21	.	.	PROPN
fnp-5343	630	22	cerebral	cerebral	ADJ
fnp-5343	630	23	white	white	ADJ
fnp-5343	630	24	matter	matter	NOUN
fnp-5343	630	25	changes	change	NOUN
fnp-5343	630	26	in	in	ADP
fnp-5343	630	27	acquired	acquire	VERB
fnp-5343	630	28	immunodeficiency	immunodeficiency	NOUN
fnp-5343	630	29	syndrome	syndrome	NOUN
fnp-5343	630	30	dementia	dementia	NOUN
fnp-5343	630	31	:	:	PUNCT
fnp-5343	630	32	alterations	alteration	NOUN
fnp-5343	630	33	of	of	ADP
fnp-5343	630	34	the	the	DET
fnp-5343	630	35	blood	blood	NOUN
fnp-5343	630	36	-	-	PUNCT
fnp-5343	630	37	brain	brain	NOUN
fnp-5343	630	38	barrier	barrier	NOUN
fnp-5343	630	39	.	.	PUNCT
fnp-5343	631	1	ann	ann	PROPN
fnp-5343	631	2	neurol	neurol	PROPN
fnp-5343	631	3	1993;34:339–50	1993;34:339–50	NUM
fnp-5343	631	4	.	.	PUNCT
fnp-5343	632	1	https://doi.org/10.1002/ana.410340307	https://doi.org/10.1002/ana.410340307	NOUN
fnp-5343	632	2	.	.	PUNCT
fnp-5343	633	1	103	103	NUM
fnp-5343	633	2	.	.	PUNCT
fnp-5343	634	1	gelman	gelman	PROPN
fnp-5343	634	2	bb	bb	PROPN
fnp-5343	634	3	,	,	PUNCT
fnp-5343	634	4	chen	chen	PROPN
fnp-5343	634	5	t	t	PROPN
fnp-5343	634	6	,	,	PUNCT
fnp-5343	634	7	lisinicchia	lisinicchia	PROPN
fnp-5343	634	8	jg	jg	PROPN
fnp-5343	634	9	,	,	PUNCT
fnp-5343	634	10	soukup	soukup	PROPN
fnp-5343	634	11	vm	vm	PROPN
fnp-5343	634	12	,	,	PUNCT
fnp-5343	634	13	carmical	carmical	PROPN
fnp-5343	634	14	jr	jr	PROPN
fnp-5343	634	15	,	,	PUNCT
fnp-5343	634	16	starkey	starkey	PROPN
fnp-5343	634	17	jm	jm	PROPN
fnp-5343	634	18	,	,	PUNCT
fnp-5343	634	19	et	et	PROPN
fnp-5343	634	20	al	al	PROPN
fnp-5343	634	21	.	.	PUNCT
fnp-5343	635	1	the	the	DET
fnp-5343	635	2	national	national	ADJ
fnp-5343	635	3	neuroaids	neuroaid	NOUN
fnp-5343	635	4	tissue	tissue	PROPN
fnp-5343	635	5	consortium	consortium	NOUN
fnp-5343	635	6	brain	brain	NOUN
fnp-5343	635	7	gene	gene	NOUN
fnp-5343	635	8	array	array	NOUN
fnp-5343	635	9	:	:	PUNCT
fnp-5343	635	10	two	two	NUM
fnp-5343	635	11	types	type	NOUN
fnp-5343	635	12	of	of	ADP
fnp-5343	635	13	hiv	hiv	PROPN
fnp-5343	635	14	-	-	PUNCT
fnp-5343	635	15	associated	associate	VERB
fnp-5343	635	16	neurocognitive	neurocognitive	ADJ
fnp-5343	635	17	impairment	impairment	NOUN
fnp-5343	635	18	.	.	PUNCT
fnp-5343	636	1	plos	plos	PROPN
fnp-5343	636	2	one	one	NUM
fnp-5343	636	3	2012;7	2012;7	NOUN
fnp-5343	636	4	:	:	PUNCT
fnp-5343	636	5	e46178	e46178	NOUN
fnp-5343	636	6	.	.	PUNCT
fnp-5343	637	1	https://doi.org/10.1371/journal.pone.0046178	https://doi.org/10.1371/journal.pone.0046178	PROPN
fnp-5343	637	2	.	.	PUNCT
fnp-5343	638	1	104	104	NUM
fnp-5343	638	2	.	.	PUNCT
fnp-5343	639	1	ginsberg	ginsberg	PROPN
fnp-5343	639	2	sd	sd	PROPN
fnp-5343	639	3	,	,	PUNCT
fnp-5343	639	4	alldred	alldre	VERB
fnp-5343	639	5	mj	mj	PROPN
fnp-5343	639	6	,	,	PUNCT
fnp-5343	639	7	gunnam	gunnam	PROPN
fnp-5343	639	8	sm	sm	PROPN
fnp-5343	639	9	,	,	PUNCT
fnp-5343	639	10	schiroli	schiroli	VERB
fnp-5343	639	11	c	c	NOUN
fnp-5343	639	12	,	,	PUNCT
fnp-5343	639	13	lee	lee	PROPN
fnp-5343	639	14	sh	sh	PROPN
fnp-5343	639	15	,	,	PUNCT
fnp-5343	639	16	morgello	morgello	PROPN
fnp-5343	639	17	s	s	PROPN
fnp-5343	639	18	,	,	PUNCT
fnp-5343	639	19	et	et	PROPN
fnp-5343	639	20	al	al	PROPN
fnp-5343	639	21	.	.	PUNCT
fnp-5343	640	1	expression	expression	NOUN
fnp-5343	640	2	profiling	profiling	NOUN
fnp-5343	640	3	suggests	suggest	VERB
fnp-5343	640	4	microglial	microglial	ADJ
fnp-5343	640	5	impairment	impairment	NOUN
fnp-5343	640	6	in	in	ADP
fnp-5343	640	7	human	human	ADJ
fnp-5343	640	8	immunodeficiency	immunodeficiency	NOUN
fnp-5343	640	9	virus	virus	NOUN
fnp-5343	640	10	neuropathogenesis	neuropathogenesis	NOUN
fnp-5343	640	11	.	.	PUNCT
fnp-5343	641	1	ann	ann	PROPN
fnp-5343	641	2	neurol	neurol	PROPN
fnp-5343	641	3	2018;83:406–17	2018;83:406–17	PROPN
fnp-5343	641	4	.	.	PUNCT
fnp-5343	642	1	https://doi.org/10.1002/ana.25160	https://doi.org/10.1002/ana.25160	NOUN
fnp-5343	642	2	.	.	PUNCT
fnp-5343	643	1	105	105	NUM
fnp-5343	643	2	.	.	PUNCT
fnp-5343	644	1	judge	judge	PROPN
fnp-5343	644	2	m	m	PROPN
fnp-5343	644	3	,	,	PUNCT
fnp-5343	644	4	parker	parker	PROPN
fnp-5343	644	5	e	e	PROPN
fnp-5343	644	6	,	,	PUNCT
fnp-5343	644	7	naniche	naniche	NOUN
fnp-5343	644	8	d	d	NOUN
fnp-5343	644	9	,	,	PUNCT
fnp-5343	644	10	le	le	X
fnp-5343	644	11	souëf	souëf	PROPN
fnp-5343	644	12	p.	p.	NOUN
fnp-5343	644	13	gene	gene	NOUN
fnp-5343	644	14	expression	expression	NOUN
fnp-5343	644	15	:	:	PUNCT
fnp-5343	644	16	the	the	DET
fnp-5343	644	17	key	key	NOUN
fnp-5343	644	18	to	to	ADP
fnp-5343	644	19	understanding	understand	VERB
fnp-5343	644	20	hiv-1	hiv-1	X
fnp-5343	644	21	infection	infection	NOUN
fnp-5343	644	22	?	?	PUNCT
fnp-5343	645	1	microbiol	microbiol	PROPN
fnp-5343	645	2	mol	mol	ADP
fnp-5343	645	3	biol	biol	PROPN
fnp-5343	645	4	rev	rev	VERB
fnp-5343	645	5	2020;84	2020;84	NUM
fnp-5343	645	6	:	:	PUNCT
fnp-5343	645	7	e00080	e00080	PROPN
fnp-5343	645	8	-	-	PUNCT
fnp-5343	645	9	19	19	NUM
fnp-5343	645	10	.	.	PUNCT
fnp-5343	646	1	https://doi.org/10.1128/mmbr.00080-19	https://doi.org/10.1128/mmbr.00080-19	PROPN
fnp-5343	646	2	.	.	PUNCT
fnp-5343	647	1	106	106	NUM
fnp-5343	647	2	.	.	PUNCT
fnp-5343	648	1	sanna	sanna	PROPN
fnp-5343	648	2	pp	pp	PROPN
fnp-5343	648	3	,	,	PUNCT
fnp-5343	648	4	repunte	repunte	NOUN
fnp-5343	648	5	-	-	PUNCT
fnp-5343	648	6	canonigo	canonigo	ADJ
fnp-5343	648	7	v	v	NOUN
fnp-5343	648	8	,	,	PUNCT
fnp-5343	648	9	masliah	masliah	PROPN
fnp-5343	648	10	e	e	PROPN
fnp-5343	648	11	,	,	PUNCT
fnp-5343	648	12	lefebvre	lefebvre	PROPN
fnp-5343	648	13	c.	c.	PROPN
fnp-5343	648	14	gene	gene	NOUN
fnp-5343	648	15	expression	expression	NOUN
fnp-5343	648	16	patterns	pattern	NOUN
fnp-5343	648	17	associated	associate	VERB
fnp-5343	648	18	with	with	ADP
fnp-5343	648	19	neurological	neurological	ADJ
fnp-5343	648	20	disease	disease	NOUN
fnp-5343	648	21	in	in	ADP
fnp-5343	648	22	human	human	ADJ
fnp-5343	648	23	hiv	hiv	PROPN
fnp-5343	648	24	infection	infection	NOUN
fnp-5343	648	25	.	.	PUNCT
fnp-5343	649	1	plos	plos	PROPN
fnp-5343	649	2	one	one	NUM
fnp-5343	649	3	2017;12	2017;12	NOUN
fnp-5343	649	4	:	:	PUNCT
fnp-5343	649	5	e0175316	e0175316	PROPN
fnp-5343	649	6	.	.	PUNCT
fnp-5343	649	7	https://doi.org/10.1371/journal.pone.0175316	https://doi.org/10.1371/journal.pone.0175316	PROPN
fnp-5343	649	8	.	.	PROPN
fnp-5343	649	9	107	107	NUM
fnp-5343	649	10	.	.	PUNCT
fnp-5343	650	1	solomon	solomon	PROPN
fnp-5343	650	2	ih	ih	PROPN
fnp-5343	650	3	,	,	PUNCT
fnp-5343	650	4	de	de	PROPN
fnp-5343	650	5	girolami	girolami	PROPN
fnp-5343	650	6	u	u	PROPN
fnp-5343	650	7	,	,	PUNCT
fnp-5343	650	8	chettimada	chettimada	PROPN
fnp-5343	650	9	s	s	PROPN
fnp-5343	650	10	,	,	PUNCT
fnp-5343	650	11	misra	misra	NOUN
fnp-5343	650	12	v	v	NOUN
fnp-5343	650	13	,	,	PUNCT
fnp-5343	650	14	singer	singer	NOUN
fnp-5343	650	15	ej	ej	NOUN
fnp-5343	650	16	,	,	PUNCT
fnp-5343	650	17	gabuzda	gabuzda	NOUN
fnp-5343	650	18	d.	d.	PROPN
fnp-5343	650	19	brain	brain	PROPN
fnp-5343	650	20	and	and	CCONJ
fnp-5343	650	21	liver	liver	NOUN
fnp-5343	650	22	pathology	pathology	NOUN
fnp-5343	650	23	,	,	PUNCT
fnp-5343	650	24	amyloid	amyloid	NOUN
fnp-5343	650	25	deposition	deposition	NOUN
fnp-5343	650	26	,	,	PUNCT
fnp-5343	650	27	and	and	CCONJ
fnp-5343	650	28	interferon	interferon	ADJ
fnp-5343	650	29	responses	response	NOUN
fnp-5343	650	30	among	among	ADP
fnp-5343	650	31	older	old	ADJ
fnp-5343	650	32	hiv	hiv	NOUN
fnp-5343	650	33	-	-	PUNCT
fnp-5343	650	34	positive	positive	ADJ
fnp-5343	650	35	patients	patient	NOUN
fnp-5343	650	36	in	in	ADP
fnp-5343	650	37	the	the	DET
fnp-5343	650	38	late	late	ADJ
fnp-5343	650	39	haart	haart	PROPN
fnp-5343	650	40	era	era	NOUN
fnp-5343	650	41	.	.	PUNCT
fnp-5343	651	1	bmc	bmc	ADJ
fnp-5343	651	2	infect	infect	NOUN
fnp-5343	651	3	dis	dis	PROPN
fnp-5343	651	4	2017;17:151	2017;17:151	NUM
fnp-5343	651	5	.	.	PUNCT
fnp-5343	652	1	https://doi.org/10.1186/s12879-017-2246-7	https://doi.org/10.1186/s12879-017-2246-7	PROPN
fnp-5343	652	2	.	.	PUNCT
fnp-5343	653	1	108	108	NUM
fnp-5343	653	2	.	.	PUNCT
fnp-5343	654	1	achim	achim	PROPN
fnp-5343	654	2	cl	cl	PROPN
fnp-5343	654	3	,	,	PUNCT
fnp-5343	654	4	wang	wang	PROPN
fnp-5343	654	5	r	r	PROPN
fnp-5343	654	6	,	,	PUNCT
fnp-5343	654	7	miners	miner	NOUN
fnp-5343	654	8	dk	dk	PROPN
fnp-5343	654	9	,	,	PUNCT
fnp-5343	654	10	wiley	wiley	PROPN
fnp-5343	654	11	ca	ca	PROPN
fnp-5343	654	12	.	.	PUNCT
fnp-5343	655	1	brain	brain	NOUN
fnp-5343	655	2	viral	viral	ADJ
fnp-5343	655	3	burden	burden	NOUN
fnp-5343	655	4	in	in	ADP
fnp-5343	655	5	hiv	hiv	PROPN
fnp-5343	655	6	infection	infection	NOUN
fnp-5343	655	7	.	.	PUNCT
fnp-5343	656	1	j	j	PROPN
fnp-5343	656	2	neuropathol	neuropathol	PROPN
fnp-5343	656	3	exp	exp	PROPN
fnp-5343	656	4	neurol	neurol	PROPN
fnp-5343	656	5	1994;53:284–94	1994;53:284–94	X
fnp-5343	656	6	.	.	PUNCT
fnp-5343	657	1	https://doi.org/10.1097/00005072-199405000-00010	https://doi.org/10.1097/00005072-199405000-00010	PROPN
fnp-5343	657	2	.	.	PROPN
fnp-5343	658	1	109	109	NUM
fnp-5343	658	2	.	.	PUNCT
fnp-5343	658	3	wiley	wiley	PROPN
fnp-5343	658	4	ca	ca	PROPN
fnp-5343	658	5	,	,	PUNCT
fnp-5343	658	6	soontornniyomkij	soontornniyomkij	PROPN
fnp-5343	658	7	v	v	PROPN
fnp-5343	658	8	,	,	PUNCT
fnp-5343	658	9	radhakrishnan	radhakrishnan	PROPN
fnp-5343	658	10	l	l	PROPN
fnp-5343	658	11	,	,	PUNCT
fnp-5343	658	12	masliah	masliah	PROPN
fnp-5343	658	13	e	e	PROPN
fnp-5343	658	14	,	,	PUNCT
fnp-5343	658	15	mellors	mellors	PROPN
fnp-5343	658	16	j	j	PROPN
fnp-5343	658	17	,	,	PUNCT
fnp-5343	658	18	hermann	hermann	PROPN
fnp-5343	658	19	sa	sa	PROPN
fnp-5343	658	20	,	,	PUNCT
fnp-5343	658	21	et	et	PROPN
fnp-5343	658	22	al	al	PROPN
fnp-5343	658	23	.	.	PUNCT
fnp-5343	658	24	distribution	distribution	NOUN
fnp-5343	658	25	of	of	ADP
fnp-5343	658	26	brain	brain	NOUN
fnp-5343	658	27	hiv	hiv	PROPN
fnp-5343	658	28	load	load	NOUN
fnp-5343	658	29	in	in	ADP
fnp-5343	658	30	aids	aids	PROPN
fnp-5343	658	31	.	.	PUNCT
fnp-5343	659	1	brain	brain	NOUN
fnp-5343	659	2	pathol	pathol	NOUN
fnp-5343	659	3	1998;8:277–84	1998;8:277–84	NOUN
fnp-5343	659	4	.	.	PUNCT
fnp-5343	660	1	https://doi.org/10.1111/j.1750-3639.1998.tb00153.x	https://doi.org/10.1111/j.1750-3639.1998.tb00153.x	PROPN
fnp-5343	660	2	.	.	PROPN
fnp-5343	661	1	110	110	NUM
fnp-5343	661	2	.	.	PUNCT
fnp-5343	662	1	anderson	anderson	PROPN
fnp-5343	662	2	am	am	PROPN
fnp-5343	662	3	,	,	PUNCT
fnp-5343	662	4	muñoz	muñoz	PROPN
fnp-5343	662	5	-	-	PUNCT
fnp-5343	662	6	moreno	moreno	PROPN
fnp-5343	662	7	ja	ja	PROPN
fnp-5343	662	8	,	,	PUNCT
fnp-5343	662	9	mcclernon	mcclernon	PROPN
fnp-5343	662	10	dr	dr	PROPN
fnp-5343	662	11	,	,	PUNCT
fnp-5343	662	12	ellis	ellis	PROPN
fnp-5343	662	13	rj	rj	PROPN
fnp-5343	662	14	,	,	PUNCT
fnp-5343	662	15	cookson	cookson	PROPN
fnp-5343	662	16	d	d	PROPN
fnp-5343	662	17	,	,	PUNCT
fnp-5343	662	18	clifford	clifford	PROPN
fnp-5343	662	19	db	db	PROPN
fnp-5343	662	20	,	,	PUNCT
fnp-5343	662	21	et	et	PROPN
fnp-5343	662	22	al	al	PROPN
fnp-5343	662	23	.	.	PUNCT
fnp-5343	663	1	prevalence	prevalence	NOUN
fnp-5343	663	2	and	and	CCONJ
fnp-5343	663	3	correlates	correlate	VERB
fnp-5343	663	4	of	of	ADP
fnp-5343	663	5	persistent	persistent	ADJ
fnp-5343	663	6	hiv-1	hiv-1	X
fnp-5343	663	7	rna	rna	NOUN
fnp-5343	663	8	in	in	ADP
fnp-5343	663	9	cerebrospinal	cerebrospinal	ADJ
fnp-5343	663	10	fluid	fluid	NOUN
fnp-5343	663	11	during	during	ADP
fnp-5343	663	12	antiretroviral	antiretroviral	ADJ
fnp-5343	663	13	therapy	therapy	NOUN
fnp-5343	663	14	.	.	PUNCT
fnp-5343	664	1	j	j	PROPN
fnp-5343	664	2	infect	infect	VERB
fnp-5343	664	3	dis	dis	PROPN
fnp-5343	664	4	2017;215:105–13	2017;215:105–13	PROPN
fnp-5343	664	5	.	.	PUNCT
fnp-5343	665	1	https://doi.org/10.1093/infdis/jiw505	https://doi.org/10.1093/infdis/jiw505	ADJ
fnp-5343	665	2	.	.	PUNCT
fnp-5343	666	1	111	111	NUM
fnp-5343	666	2	.	.	PUNCT
fnp-5343	667	1	burbelo	burbelo	PROPN
fnp-5343	667	2	pd	pd	PROPN
fnp-5343	667	3	,	,	PUNCT
fnp-5343	667	4	price	price	NOUN
fnp-5343	667	5	rw	rw	NOUN
fnp-5343	667	6	,	,	PUNCT
fnp-5343	667	7	hagberg	hagberg	PROPN
fnp-5343	667	8	l	l	PROPN
fnp-5343	667	9	,	,	PUNCT
fnp-5343	667	10	hatano	hatano	PROPN
fnp-5343	667	11	h	h	NOUN
fnp-5343	667	12	,	,	PUNCT
fnp-5343	667	13	spudich	spudich	NOUN
fnp-5343	667	14	s	s	NOUN
fnp-5343	667	15	,	,	PUNCT
fnp-5343	667	16	deeks	deek	VERB
fnp-5343	667	17	sg	sg	PROPN
fnp-5343	667	18	,	,	PUNCT
fnp-5343	667	19	et	et	PROPN
fnp-5343	667	20	al	al	PROPN
fnp-5343	667	21	.	.	PUNCT
fnp-5343	668	1	anti	anti	ADJ
fnp-5343	668	2	-	-	ADJ
fnp-5343	668	3	human	human	ADJ
fnp-5343	668	4	immunodeficiency	immunodeficiency	NOUN
fnp-5343	668	5	virus	virus	NOUN
fnp-5343	668	6	antibodies	antibodie	VERB
fnp-5343	668	7	in	in	ADP
fnp-5343	668	8	the	the	DET
fnp-5343	668	9	cerebrospinal	cerebrospinal	ADJ
fnp-5343	668	10	fluid	fluid	NOUN
fnp-5343	668	11	:	:	PUNCT
fnp-5343	668	12	evidence	evidence	NOUN
fnp-5343	668	13	of	of	ADP
fnp-5343	668	14	early	early	ADJ
fnp-5343	668	15	treatment	treatment	NOUN
fnp-5343	668	16	impact	impact	NOUN
fnp-5343	668	17	on	on	ADP
fnp-5343	668	18	central	central	ADJ
fnp-5343	668	19	nervous	nervous	ADJ
fnp-5343	668	20	system	system	NOUN
fnp-5343	668	21	reservoir	reservoir	NOUN
fnp-5343	668	22	?	?	PUNCT
fnp-5343	669	1	j	j	PROPN
fnp-5343	669	2	infect	infect	VERB
fnp-5343	669	3	dis	dis	PROPN
fnp-5343	669	4	2018;217:1024–32	2018;217:1024–32	NUM
fnp-5343	669	5	.	.	PUNCT
fnp-5343	670	1	https://doi.org/10.1093/infdis/jix662	https://doi.org/10.1093/infdis/jix662	NOUN
fnp-5343	670	2	.	.	PUNCT
fnp-5343	671	1	112	112	NUM
fnp-5343	671	2	.	.	PUNCT
fnp-5343	672	1	ko	ko	PROPN
fnp-5343	672	2	a	a	PROPN
fnp-5343	672	3	,	,	PUNCT
fnp-5343	672	4	kang	kang	PROPN
fnp-5343	672	5	g	g	PROPN
fnp-5343	672	6	,	,	PUNCT
fnp-5343	672	7	hattler	hattler	NOUN
fnp-5343	672	8	jb	jb	PROPN
fnp-5343	672	9	,	,	PUNCT
fnp-5343	672	10	galadima	galadima	PROPN
fnp-5343	672	11	hi	hi	INTJ
fnp-5343	672	12	,	,	PUNCT
fnp-5343	672	13	zhang	zhang	PROPN
fnp-5343	672	14	j	j	PROPN
fnp-5343	672	15	,	,	PUNCT
fnp-5343	672	16	li	li	PROPN
fnp-5343	673	1	q	q	PROPN
fnp-5343	673	2	,	,	PUNCT
fnp-5343	673	3	et	et	PROPN
fnp-5343	673	4	al	al	PROPN
fnp-5343	673	5	.	.	PUNCT
fnp-5343	674	1	macrophages	macrophage	NOUN
fnp-5343	674	2	but	but	CCONJ
fnp-5343	674	3	not	not	PART
fnp-5343	674	4	astrocytes	astrocyte	NOUN
fnp-5343	674	5	harbor	harbor	VERB
fnp-5343	674	6	hiv	hiv	PROPN
fnp-5343	674	7	dna	dna	PROPN
fnp-5343	674	8	in	in	ADP
fnp-5343	674	9	the	the	DET
fnp-5343	674	10	brains	brain	NOUN
fnp-5343	674	11	of	of	ADP
fnp-5343	674	12	hiv-1	hiv-1	X
fnp-5343	674	13	-	-	PUNCT
fnp-5343	674	14	infected	infect	VERB
fnp-5343	674	15	aviremic	aviremic	ADJ
fnp-5343	674	16	individuals	individual	NOUN
fnp-5343	674	17	on	on	ADP
fnp-5343	674	18	suppressive	suppressive	ADJ
fnp-5343	674	19	antiretroviral	antiretroviral	ADJ
fnp-5343	674	20	therapy	therapy	NOUN
fnp-5343	674	21	.	.	PUNCT
fnp-5343	675	1	j	j	PROPN
fnp-5343	675	2	neuroimmune	neuroimmune	PROPN
fnp-5343	675	3	pharmacol	pharmacol	PROPN
fnp-5343	675	4	2019;14:110–9	2019;14:110–9	NUM
fnp-5343	675	5	.	.	PUNCT
fnp-5343	676	1	https://doi.org/10.1007/s11481-018-9809-2	https://doi.org/10.1007/s11481-018-9809-2	PROPN
fnp-5343	676	2	.	.	PROPN
fnp-5343	676	3	113	113	NUM
fnp-5343	676	4	.	.	PUNCT
fnp-5343	677	1	smith	smith	PROPN
fnp-5343	677	2	db	db	PROPN
fnp-5343	677	3	,	,	PUNCT
fnp-5343	677	4	simmonds	simmond	VERB
fnp-5343	677	5	p	p	NOUN
fnp-5343	677	6	,	,	PUNCT
fnp-5343	677	7	bell	bell	PROPN
fnp-5343	677	8	je	je	PROPN
fnp-5343	677	9	.	.	PUNCT
fnp-5343	678	1	brain	brain	NOUN
fnp-5343	678	2	viral	viral	ADJ
fnp-5343	678	3	burden	burden	NOUN
fnp-5343	678	4	,	,	PUNCT
fnp-5343	678	5	neuroinflammation	neuroinflammation	NOUN
fnp-5343	678	6	and	and	CCONJ
fnp-5343	678	7	neurodegeneration	neurodegeneration	NOUN
fnp-5343	678	8	in	in	ADP
fnp-5343	678	9	haart	haart	PROPN
fnp-5343	678	10	-	-	PUNCT
fnp-5343	678	11	treated	treat	VERB
fnp-5343	678	12	hiv	hiv	PROPN
fnp-5343	678	13	positive	positive	ADJ
fnp-5343	678	14	injecting	inject	VERB
fnp-5343	678	15	drug	drug	NOUN
fnp-5343	678	16	users	user	NOUN
fnp-5343	678	17	.	.	PUNCT
fnp-5343	679	1	j	j	PROPN
fnp-5343	679	2	neurovirol	neurovirol	NOUN
fnp-5343	679	3	2014;20:28–38	2014;20:28–38	NUM
fnp-5343	679	4	.	.	PUNCT
fnp-5343	680	1	https://doi.org/10.1007/s13365-013-0225-3	https://doi.org/10.1007/s13365-013-0225-3	PROPN
fnp-5343	680	2	.	.	PUNCT
fnp-5343	681	1	114	114	NUM
fnp-5343	681	2	.	.	PUNCT
fnp-5343	682	1	cochrane	cochrane	PROPN
fnp-5343	682	2	cr	cr	PROPN
fnp-5343	682	3	,	,	PUNCT
fnp-5343	682	4	angelovich	angelovich	PROPN
fnp-5343	682	5	ta	ta	PROPN
fnp-5343	682	6	,	,	PUNCT
fnp-5343	682	7	byrnes	byrnes	PROPN
fnp-5343	682	8	sj	sj	PROPN
fnp-5343	682	9	,	,	PUNCT
fnp-5343	682	10	waring	ware	VERB
fnp-5343	682	11	e	e	NOUN
fnp-5343	682	12	,	,	PUNCT
fnp-5343	682	13	guanizo	guanizo	PROPN
fnp-5343	682	14	ac	ac	PROPN
fnp-5343	682	15	,	,	PUNCT
fnp-5343	682	16	trollope	trollope	PROPN
fnp-5343	682	17	gs	gs	PROPN
fnp-5343	682	18	,	,	PUNCT
fnp-5343	682	19	et	et	PROPN
fnp-5343	682	20	al	al	PROPN
fnp-5343	682	21	.	.	PROPN
fnp-5343	683	1	intact	intact	ADJ
fnp-5343	683	2	hiv	hiv	PROPN
fnp-5343	683	3	proviruses	provirus	NOUN
fnp-5343	683	4	persist	persist	VERB
fnp-5343	683	5	in	in	ADP
fnp-5343	683	6	the	the	DET
fnp-5343	683	7	brain	brain	NOUN
fnp-5343	683	8	despite	despite	SCONJ
fnp-5343	683	9	viral	viral	ADJ
fnp-5343	683	10	suppression	suppression	NOUN
fnp-5343	683	11	with	with	ADP
fnp-5343	683	12	art	art	NOUN
fnp-5343	683	13	.	.	PUNCT
fnp-5343	684	1	ann	ann	PROPN
fnp-5343	684	2	neurol	neurol	PROPN
fnp-5343	684	3	2022;92:532–44	2022;92:532–44	PROPN
fnp-5343	684	4	.	.	PUNCT
fnp-5343	685	1	https://doi.org/10.1002/ana.26456	https://doi.org/10.1002/ana.26456	PROPN
fnp-5343	685	2	.	.	PUNCT
fnp-5343	686	1	115	115	NUM
fnp-5343	686	2	.	.	PUNCT
fnp-5343	687	1	desplats	desplat	NOUN
fnp-5343	687	2	p	p	PROPN
fnp-5343	687	3	,	,	PUNCT
fnp-5343	687	4	dumaop	dumaop	PROPN
fnp-5343	687	5	w	w	PROPN
fnp-5343	687	6	,	,	PUNCT
fnp-5343	687	7	smith	smith	PROPN
fnp-5343	687	8	d	d	PROPN
fnp-5343	687	9	,	,	PUNCT
fnp-5343	687	10	adame	adame	PROPN
fnp-5343	687	11	a	a	PRON
fnp-5343	687	12	,	,	PUNCT
fnp-5343	687	13	everall	everall	NOUN
fnp-5343	688	1	i	i	PRON
fnp-5343	688	2	,	,	PUNCT
fnp-5343	688	3	letendre	letendre	PROPN
fnp-5343	688	4	s	s	PROPN
fnp-5343	688	5	,	,	PUNCT
fnp-5343	688	6	et	et	PROPN
fnp-5343	688	7	al	al	PROPN
fnp-5343	688	8	.	.	PROPN
fnp-5343	689	1	molecular	molecular	ADJ
fnp-5343	689	2	and	and	CCONJ
fnp-5343	689	3	pathologic	pathologic	ADJ
fnp-5343	689	4	insights	insight	NOUN
fnp-5343	689	5	from	from	ADP
fnp-5343	689	6	latent	latent	NOUN
fnp-5343	689	7	hiv-1	hiv-1	X
fnp-5343	689	8	infection	infection	NOUN
fnp-5343	689	9	in	in	ADP
fnp-5343	689	10	the	the	DET
fnp-5343	689	11	human	human	ADJ
fnp-5343	689	12	brain	brain	NOUN
fnp-5343	689	13	.	.	PUNCT
fnp-5343	690	1	neurology	neurology	NOUN
fnp-5343	690	2	2013;80:1415–23	2013;80:1415–23	PROPN
fnp-5343	690	3	.	.	PUNCT
fnp-5343	691	1	https://doi.org/10.1212/wnl.0b013e31828c2e9e	https://doi.org/10.1212/wnl.0b013e31828c2e9e	X
fnp-5343	691	2	.	.	NOUN
fnp-5343	692	1	116	116	NUM
fnp-5343	692	2	.	.	PUNCT
fnp-5343	693	1	glass	glass	PROPN
fnp-5343	693	2	jd	jd	PROPN
fnp-5343	693	3	,	,	PUNCT
fnp-5343	693	4	wesselingh	wesselingh	PROPN
fnp-5343	693	5	sl	sl	NOUN
fnp-5343	693	6	,	,	PUNCT
fnp-5343	693	7	selnes	selne	NOUN
fnp-5343	693	8	oa	oa	PROPN
fnp-5343	693	9	,	,	PUNCT
fnp-5343	693	10	mcarthur	mcarthur	PROPN
fnp-5343	693	11	jc	jc	PROPN
fnp-5343	693	12	.	.	PROPN
fnp-5343	693	13	clinical	clinical	ADJ
fnp-5343	693	14	-	-	PUNCT
fnp-5343	693	15	neuropathologic	neuropathologic	NOUN
fnp-5343	693	16	correlation	correlation	NOUN
fnp-5343	693	17	in	in	ADP
fnp-5343	693	18	hiv	hiv	PROPN
fnp-5343	693	19	-	-	PUNCT
fnp-5343	693	20	associated	associate	VERB
fnp-5343	693	21	dementia	dementia	NOUN
fnp-5343	693	22	.	.	PUNCT
fnp-5343	694	1	neurology	neurology	NOUN
fnp-5343	694	2	1993;43:2230–7	1993;43:2230–7	PROPN
fnp-5343	694	3	.	.	PUNCT
fnp-5343	695	1	https://doi.org/10.1212/wnl.43.11.2230	https://doi.org/10.1212/wnl.43.11.2230	PROPN
fnp-5343	695	2	.	.	PROPN
fnp-5343	696	1	117	117	NUM
fnp-5343	696	2	.	.	PUNCT
fnp-5343	697	1	an	an	DET
fnp-5343	697	2	sf	sf	PROPN
fnp-5343	697	3	,	,	PUNCT
fnp-5343	697	4	giometto	giometto	PROPN
fnp-5343	697	5	b	b	PROPN
fnp-5343	697	6	,	,	PUNCT
fnp-5343	697	7	scaravilli	scaravilli	PROPN
fnp-5343	697	8	f.	f.	PROPN
fnp-5343	697	9	hiv-1	hiv-1	PROPN
fnp-5343	697	10	dna	dna	PROPN
fnp-5343	697	11	in	in	ADP
fnp-5343	697	12	brains	brain	NOUN
fnp-5343	697	13	in	in	ADP
fnp-5343	697	14	aids	aid	NOUN
fnp-5343	697	15	and	and	CCONJ
fnp-5343	697	16	pre	pre	NOUN
fnp-5343	697	17	-	-	ADJ
fnp-5343	697	18	aids	aids	ADJ
fnp-5343	697	19	:	:	PUNCT
fnp-5343	697	20	correlation	correlation	NOUN
fnp-5343	697	21	with	with	ADP
fnp-5343	697	22	the	the	DET
fnp-5343	697	23	stage	stage	NOUN
fnp-5343	697	24	of	of	ADP
fnp-5343	697	25	disease	disease	NOUN
fnp-5343	697	26	.	.	PUNCT
fnp-5343	698	1	ann	ann	PROPN
fnp-5343	698	2	neurol	neurol	PROPN
fnp-5343	698	3	1996;40:611–7	1996;40:611–7	NUM
fnp-5343	698	4	.	.	PUNCT
fnp-5343	699	1	https://doi.org/10.1002/ana.410400411	https://doi.org/10.1002/ana.410400411	PROPN
fnp-5343	699	2	.	.	PUNCT
fnp-5343	700	1	118	118	NUM
fnp-5343	700	2	.	.	PUNCT
fnp-5343	701	1	achim	achim	PROPN
fnp-5343	701	2	cl	cl	PROPN
fnp-5343	701	3	,	,	PUNCT
fnp-5343	701	4	morey	morey	PROPN
fnp-5343	701	5	mk	mk	PROPN
fnp-5343	701	6	,	,	PUNCT
fnp-5343	701	7	wiley	wiley	PROPN
fnp-5343	701	8	ca	ca	PROPN
fnp-5343	701	9	.	.	PUNCT
fnp-5343	702	1	expression	expression	NOUN
fnp-5343	702	2	of	of	ADP
fnp-5343	702	3	major	major	ADJ
fnp-5343	702	4	histocompatibility	histocompatibility	NOUN
fnp-5343	702	5	complex	complex	NOUN
fnp-5343	702	6	and	and	CCONJ
fnp-5343	702	7	hiv	hiv	PROPN
fnp-5343	702	8	antigens	antigen	NOUN
fnp-5343	702	9	within	within	ADP
fnp-5343	702	10	the	the	DET
fnp-5343	702	11	brains	brain	NOUN
fnp-5343	702	12	of	of	ADP
fnp-5343	702	13	aids	aid	NOUN
fnp-5343	702	14	patients	patient	NOUN
fnp-5343	702	15	.	.	PUNCT
fnp-5343	703	1	aids	aids	PROPN
fnp-5343	703	2	1991;5:535–41	1991;5:535–41	NUM
fnp-5343	703	3	.	.	PUNCT
fnp-5343	704	1	https://doi.org/10.1097/00002030-199105000-00009	https://doi.org/10.1097/00002030-199105000-00009	PROPN
fnp-5343	704	2	.	.	PROPN
fnp-5343	705	1	119	119	NUM
fnp-5343	705	2	.	.	PUNCT
fnp-5343	706	1	tyor	tyor	PROPN
fnp-5343	706	2	wr	wr	PROPN
fnp-5343	706	3	,	,	PUNCT
fnp-5343	706	4	glass	glass	PROPN
fnp-5343	706	5	jd	jd	PROPN
fnp-5343	706	6	,	,	PUNCT
fnp-5343	706	7	griffin	griffin	PROPN
fnp-5343	706	8	jw	jw	PROPN
fnp-5343	706	9	,	,	PUNCT
fnp-5343	706	10	becker	becker	PROPN
fnp-5343	706	11	ps	ps	PROPN
fnp-5343	706	12	,	,	PUNCT
fnp-5343	706	13	mcarthur	mcarthur	PROPN
fnp-5343	706	14	jc	jc	PROPN
fnp-5343	706	15	,	,	PUNCT
fnp-5343	706	16	bezman	bezman	PROPN
fnp-5343	706	17	l	l	PROPN
fnp-5343	706	18	,	,	PUNCT
fnp-5343	706	19	et	et	PROPN
fnp-5343	706	20	al	al	PROPN
fnp-5343	706	21	.	.	PROPN
fnp-5343	706	22	cytokine	cytokine	ADJ
fnp-5343	706	23	expression	expression	NOUN
fnp-5343	706	24	in	in	ADP
fnp-5343	706	25	the	the	DET
fnp-5343	706	26	brain	brain	NOUN
fnp-5343	706	27	during	during	ADP
fnp-5343	706	28	the	the	DET
fnp-5343	706	29	acquired	acquire	VERB
fnp-5343	706	30	immunodeficiency	immunodeficiency	NOUN
fnp-5343	706	31	syndrome	syndrome	NOUN
fnp-5343	706	32	.	.	PUNCT
fnp-5343	707	1	ann	ann	PROPN
fnp-5343	707	2	neurol	neurol	PROPN
fnp-5343	707	3	1992;31:349–60	1992;31:349–60	PROPN
fnp-5343	707	4	.	.	PUNCT
fnp-5343	708	1	https://doi.org/10.1002/ana.410310402	https://doi.org/10.1002/ana.410310402	NOUN
fnp-5343	708	2	.	.	PUNCT
fnp-5343	709	1	120	120	NUM
fnp-5343	709	2	.	.	PUNCT
fnp-5343	710	1	ellis	ellis	PROPN
fnp-5343	710	2	r	r	PROPN
fnp-5343	710	3	,	,	PUNCT
fnp-5343	710	4	langford	langford	NOUN
fnp-5343	710	5	d	d	PROPN
fnp-5343	710	6	,	,	PUNCT
fnp-5343	710	7	masliah	masliah	PROPN
fnp-5343	710	8	e.	e.	PROPN
fnp-5343	710	9	hiv	hiv	PROPN
fnp-5343	710	10	and	and	CCONJ
fnp-5343	710	11	antiretroviral	antiretroviral	ADJ
fnp-5343	710	12	therapy	therapy	NOUN
fnp-5343	710	13	in	in	ADP
fnp-5343	710	14	the	the	DET
fnp-5343	710	15	brain	brain	NOUN
fnp-5343	710	16	:	:	PUNCT
fnp-5343	710	17	neuronal	neuronal	ADJ
fnp-5343	710	18	injury	injury	NOUN
fnp-5343	710	19	and	and	CCONJ
fnp-5343	710	20	repair	repair	NOUN
fnp-5343	710	21	.	.	PUNCT
fnp-5343	711	1	nat	nat	PROPN
fnp-5343	711	2	rev	rev	PROPN
fnp-5343	711	3	neurosci	neurosci	PROPN
fnp-5343	711	4	2007;8:33–44	2007;8:33–44	PROPN
fnp-5343	711	5	.	.	PUNCT
fnp-5343	712	1	https://doi.org/10.1038/nrn2040	https://doi.org/10.1038/nrn2040	PROPN
fnp-5343	712	2	.	.	PUNCT
fnp-5343	713	1	121	121	NUM
fnp-5343	713	2	.	.	PUNCT
fnp-5343	713	3	magaki	magaki	PROPN
fnp-5343	713	4	sd	sd	PROPN
fnp-5343	713	5	,	,	PUNCT
fnp-5343	713	6	vinters	vinters	PROPN
fnp-5343	713	7	hv	hv	PROPN
fnp-5343	713	8	,	,	PUNCT
fnp-5343	713	9	williams	williams	PROPN
fnp-5343	713	10	ck	ck	PROPN
fnp-5343	713	11	,	,	PUNCT
fnp-5343	713	12	mareninov	mareninov	NOUN
fnp-5343	713	13	s	s	PROPN
fnp-5343	713	14	,	,	PUNCT
fnp-5343	713	15	khanlou	khanlou	PROPN
fnp-5343	713	16	n	n	CCONJ
fnp-5343	713	17	,	,	PUNCT
fnp-5343	713	18	said	say	VERB
fnp-5343	713	19	j	j	PROPN
fnp-5343	713	20	,	,	PUNCT
fnp-5343	713	21	et	et	PROPN
fnp-5343	713	22	al	al	PROPN
fnp-5343	713	23	.	.	PUNCT
fnp-5343	713	24	neuropathologic	neuropathologic	PROPN
fnp-5343	713	25	findings	finding	NOUN
fnp-5343	713	26	in	in	ADP
fnp-5343	713	27	elderly	elderly	ADJ
fnp-5343	713	28	hiv	hiv	PROPN
fnp-5343	713	29	-	-	PUNCT
fnp-5343	713	30	positive	positive	ADJ
fnp-5343	713	31	individuals	individual	NOUN
fnp-5343	713	32	.	.	PUNCT
fnp-5343	714	1	2022;81:565	2022;81:565	X
fnp-5343	714	2	-	-	SYM
fnp-5343	714	3	76	76	NUM
fnp-5343	714	4	.	.	PUNCT
fnp-5343	715	1	https://doi.org/10.1093/jnen/nlac040	https://doi.org/10.1093/jnen/nlac040	NOUN
fnp-5343	715	2	.	.	PUNCT
fnp-5343	716	1	122	122	NUM
fnp-5343	716	2	.	.	PUNCT
fnp-5343	716	3	carvalho	carvalho	PROPN
fnp-5343	716	4	t	t	PROPN
fnp-5343	716	5	,	,	PUNCT
fnp-5343	716	6	krammer	krammer	PROPN
fnp-5343	716	7	f	f	PROPN
fnp-5343	716	8	,	,	PUNCT
fnp-5343	716	9	iwasaki	iwasaki	PROPN
fnp-5343	716	10	a.	a.	PROPN
fnp-5343	716	11	the	the	DET
fnp-5343	716	12	first	first	ADJ
fnp-5343	716	13	12	12	NUM
fnp-5343	716	14	months	month	NOUN
fnp-5343	716	15	of	of	ADP
fnp-5343	716	16	covid-19	covid-19	PROPN
fnp-5343	716	17	:	:	PUNCT
fnp-5343	716	18	a	a	DET
fnp-5343	716	19	timeline	timeline	NOUN
fnp-5343	716	20	of	of	ADP
fnp-5343	716	21	immunological	immunological	ADJ
fnp-5343	716	22	insights	insight	NOUN
fnp-5343	716	23	.	.	PUNCT
fnp-5343	717	1	nat	nat	PROPN
fnp-5343	717	2	rev	rev	VERB
fnp-5343	717	3	immunol	immunol	PROPN
fnp-5343	717	4	2021;21:245–56	2021;21:245–56	PROPN
fnp-5343	717	5	.	.	PUNCT
fnp-5343	718	1	https://doi.org/10.1038/s41577-021-00522-1	https://doi.org/10.1038/s41577-021-00522-1	NUM
fnp-5343	718	2	.	.	PUNCT
fnp-5343	719	1	123	123	NUM
fnp-5343	719	2	.	.	PUNCT
fnp-5343	720	1	zhu	zhu	PROPN
fnp-5343	720	2	n	n	CCONJ
fnp-5343	720	3	,	,	PUNCT
fnp-5343	720	4	zhang	zhang	PROPN
fnp-5343	720	5	d	d	PROPN
fnp-5343	720	6	,	,	PUNCT
fnp-5343	720	7	wang	wang	PROPN
fnp-5343	720	8	w	w	PROPN
fnp-5343	720	9	,	,	PUNCT
fnp-5343	720	10	li	li	PROPN
fnp-5343	720	11	x	x	PROPN
fnp-5343	720	12	,	,	PUNCT
fnp-5343	720	13	yang	yang	PROPN
fnp-5343	720	14	b	b	PROPN
fnp-5343	720	15	,	,	PUNCT
fnp-5343	720	16	song	song	PROPN
fnp-5343	720	17	j	j	PROPN
fnp-5343	720	18	,	,	PUNCT
fnp-5343	720	19	et	et	PROPN
fnp-5343	720	20	al	al	PROPN
fnp-5343	720	21	.	.	PUNCT
fnp-5343	721	1	a	a	DET
fnp-5343	721	2	novel	novel	ADJ
fnp-5343	721	3	coronavirus	coronavirus	NOUN
fnp-5343	721	4	from	from	ADP
fnp-5343	721	5	patients	patient	NOUN
fnp-5343	721	6	with	with	ADP
fnp-5343	721	7	pneumonia	pneumonia	NOUN
fnp-5343	721	8	in	in	ADP
fnp-5343	721	9	china	china	PROPN
fnp-5343	721	10	,	,	PUNCT
fnp-5343	721	11	2019	2019	NUM
fnp-5343	721	12	.	.	PUNCT
fnp-5343	722	1	n	n	X
fnp-5343	722	2	engl	engl	PROPN
fnp-5343	722	3	j	j	PROPN
fnp-5343	722	4	med	med	PROPN
fnp-5343	722	5	2020;382:727–33	2020;382:727–33	PROPN
fnp-5343	722	6	.	.	PUNCT
fnp-5343	723	1	https://doi.org/10.1056/nejmoa2001017	https://doi.org/10.1056/nejmoa2001017	NOUN
fnp-5343	723	2	.	.	PUNCT
fnp-5343	724	1	124	124	NUM
fnp-5343	724	2	.	.	PUNCT
fnp-5343	725	1	huang	huang	PROPN
fnp-5343	725	2	c	c	PROPN
fnp-5343	725	3	,	,	PUNCT
fnp-5343	725	4	wang	wang	PROPN
fnp-5343	725	5	y	y	PROPN
fnp-5343	725	6	,	,	PUNCT
fnp-5343	725	7	li	li	PROPN
fnp-5343	725	8	x	x	PROPN
fnp-5343	725	9	,	,	PUNCT
fnp-5343	725	10	ren	ren	PROPN
fnp-5343	725	11	l	l	PROPN
fnp-5343	725	12	,	,	PUNCT
fnp-5343	725	13	zhao	zhao	PROPN
fnp-5343	725	14	j	j	PROPN
fnp-5343	725	15	,	,	PUNCT
fnp-5343	725	16	hu	hu	PROPN
fnp-5343	725	17	y	y	PROPN
fnp-5343	725	18	,	,	PUNCT
fnp-5343	725	19	et	et	PROPN
fnp-5343	725	20	al	al	PROPN
fnp-5343	725	21	.	.	PUNCT
fnp-5343	726	1	clinical	clinical	ADJ
fnp-5343	726	2	features	feature	NOUN
fnp-5343	726	3	of	of	ADP
fnp-5343	726	4	patients	patient	NOUN
fnp-5343	726	5	infected	infect	VERB
fnp-5343	726	6	with	with	ADP
fnp-5343	726	7	2019	2019	NUM
fnp-5343	726	8	novel	novel	ADJ
fnp-5343	726	9	coronavirus	coronavirus	NOUN
fnp-5343	726	10	in	in	ADP
fnp-5343	726	11	wuhan	wuhan	PROPN
fnp-5343	726	12	,	,	PUNCT
fnp-5343	726	13	china	china	PROPN
fnp-5343	726	14	.	.	PUNCT
fnp-5343	727	1	lancet	lancet	PROPN
fnp-5343	727	2	2020;395:497–506	2020;395:497–506	NUM
fnp-5343	727	3	.	.	PUNCT
fnp-5343	728	1	https://doi.org/10.1016/s0140-6736(20)30183-5	https://doi.org/10.1016/s0140-6736(20)30183-5	PROPN
fnp-5343	728	2	.	.	PUNCT
fnp-5343	729	1	125	125	NUM
fnp-5343	729	2	.	.	PUNCT
fnp-5343	730	1	mathieu	mathieu	PROPN
fnp-5343	730	2	e	e	PROPN
fnp-5343	730	3	,	,	PUNCT
fnp-5343	730	4	ritchie	ritchie	PROPN
fnp-5343	730	5	h	h	PROPN
fnp-5343	730	6	,	,	PUNCT
fnp-5343	730	7	ortiz	ortiz	PROPN
fnp-5343	730	8	-	-	PUNCT
fnp-5343	730	9	ospina	ospina	PROPN
fnp-5343	730	10	e	e	PROPN
fnp-5343	730	11	,	,	PUNCT
fnp-5343	730	12	roser	roser	PROPN
fnp-5343	730	13	m	m	PROPN
fnp-5343	730	14	,	,	PUNCT
fnp-5343	730	15	hasell	hasell	PROPN
fnp-5343	730	16	j	j	PROPN
fnp-5343	730	17	,	,	PUNCT
fnp-5343	730	18	appel	appel	PROPN
fnp-5343	730	19	c	c	PROPN
fnp-5343	730	20	,	,	PUNCT
fnp-5343	730	21	et	et	PROPN
fnp-5343	730	22	al	al	PROPN
fnp-5343	730	23	.	.	PUNCT
fnp-5343	731	1	a	a	DET
fnp-5343	731	2	global	global	ADJ
fnp-5343	731	3	database	database	NOUN
fnp-5343	731	4	of	of	ADP
fnp-5343	731	5	covid-19	covid-19	PROPN
fnp-5343	731	6	vaccinations	vaccination	NOUN
fnp-5343	731	7	.	.	PUNCT
fnp-5343	732	1	nat	nat	PROPN
fnp-5343	732	2	hum	hum	PROPN
fnp-5343	732	3	behav	behav	PROPN
fnp-5343	732	4	2021;5:947–53	2021;5:947–53	PROPN
fnp-5343	732	5	.	.	PUNCT
fnp-5343	733	1	https://doi.org/10.1038/s41562-021-01122-8	https://doi.org/10.1038/s41562-021-01122-8	X
fnp-5343	733	2	.	.	PUNCT
fnp-5343	734	1	126	126	NUM
fnp-5343	734	2	.	.	PUNCT
fnp-5343	735	1	bilinski	bilinski	PROPN
fnp-5343	735	2	a	a	PRON
fnp-5343	735	3	,	,	PUNCT
fnp-5343	735	4	thompson	thompson	PROPN
fnp-5343	735	5	k	k	PROPN
fnp-5343	735	6	,	,	PUNCT
fnp-5343	735	7	emanuel	emanuel	PROPN
fnp-5343	735	8	e.	e.	PROPN
fnp-5343	735	9	covid-19	covid-19	PROPN
fnp-5343	735	10	and	and	CCONJ
fnp-5343	735	11	excess	excess	ADJ
fnp-5343	735	12	all	all	ADJ
fnp-5343	735	13	-	-	PUNCT
fnp-5343	735	14	cause	cause	NOUN
fnp-5343	735	15	mortality	mortality	NOUN
fnp-5343	735	16	in	in	ADP
fnp-5343	735	17	the	the	DET
fnp-5343	735	18	us	us	PROPN
fnp-5343	735	19	and	and	CCONJ
fnp-5343	735	20	20	20	NUM
fnp-5343	735	21	comparison	comparison	NOUN
fnp-5343	735	22	countries	country	NOUN
fnp-5343	735	23	,	,	PUNCT
fnp-5343	735	24	june	june	PROPN
fnp-5343	735	25	2021	2021	NUM
fnp-5343	735	26	-	-	PUNCT
fnp-5343	735	27	march	march	PROPN
fnp-5343	735	28	2022	2022	NUM
fnp-5343	735	29	.	.	PUNCT
fnp-5343	736	1	jama	jama	PROPN
fnp-5343	736	2	2023;329:92–4	2023;329:92–4	NUM
fnp-5343	736	3	.	.	PUNCT
fnp-5343	737	1	https://doi.org/10.1001/jama.2022.21795	https://doi.org/10.1001/jama.2022.21795	PROPN
fnp-5343	737	2	.	.	PUNCT
fnp-5343	738	1	127	127	NUM
fnp-5343	738	2	.	.	PUNCT
fnp-5343	739	1	world	world	PROPN
fnp-5343	739	2	health	health	PROPN
fnp-5343	739	3	organization	organization	PROPN
fnp-5343	739	4	.	.	PUNCT
fnp-5343	740	1	who	who	PRON
fnp-5343	740	2	coronavirus	coronavirus	VERB
fnp-5343	740	3	(	(	PUNCT
fnp-5343	740	4	covid-19	covid-19	PROPN
fnp-5343	740	5	)	)	PUNCT
fnp-5343	740	6	dashboard	dashboard	NOUN
fnp-5343	740	7	.	.	PUNCT
fnp-5343	741	1	https://covid19.who.int/.	https://covid19.who.int/.	ADJ
fnp-5343	741	2	accessed	access	VERB
fnp-5343	741	3	:	:	PUNCT
fnp-5343	741	4	july	july	PROPN
fnp-5343	741	5	26	26	NUM
fnp-5343	741	6	,	,	PUNCT
fnp-5343	741	7	2023	2023	NUM
fnp-5343	741	8	.	.	PUNCT
fnp-5343	742	1	128	128	NUM
fnp-5343	742	2	.	.	PUNCT
fnp-5343	743	1	telenti	telenti	PROPN
fnp-5343	743	2	a	a	PROPN
fnp-5343	743	3	,	,	PUNCT
fnp-5343	743	4	hodcroft	hodcroft	PROPN
fnp-5343	743	5	eb	eb	PROPN
fnp-5343	743	6	,	,	PUNCT
fnp-5343	743	7	robertson	robertson	PROPN
fnp-5343	743	8	dl	dl	PROPN
fnp-5343	743	9	.	.	PROPN
fnp-5343	744	1	the	the	DET
fnp-5343	744	2	evolution	evolution	NOUN
fnp-5343	744	3	and	and	CCONJ
fnp-5343	744	4	biology	biology	NOUN
fnp-5343	744	5	of	of	ADP
fnp-5343	744	6	sars	sar	NOUN
fnp-5343	744	7	-	-	PUNCT
fnp-5343	744	8	cov-2	cov-2	NOUN
fnp-5343	744	9	variants	variant	NOUN
fnp-5343	744	10	.	.	PUNCT
fnp-5343	745	1	cold	cold	ADJ
fnp-5343	745	2	spring	spring	NOUN
fnp-5343	745	3	harb	harb	PROPN
fnp-5343	745	4	perspect	perspect	VERB
fnp-5343	745	5	med	med	ADJ
fnp-5343	745	6	2022;12	2022;12	NOUN
fnp-5343	745	7	:	:	PUNCT
fnp-5343	745	8	a041390	a041390	NOUN
fnp-5343	745	9	.	.	PUNCT
fnp-5343	746	1	https://doi.org/10.1101/cshperspect.a041390	https://doi.org/10.1101/cshperspect.a041390	ADJ
fnp-5343	746	2	.	.	PROPN
fnp-5343	746	3	129	129	NUM
fnp-5343	746	4	.	.	PUNCT
fnp-5343	747	1	jackson	jackson	PROPN
fnp-5343	747	2	cb	cb	PROPN
fnp-5343	747	3	,	,	PUNCT
fnp-5343	747	4	farzan	farzan	PROPN
fnp-5343	747	5	m	m	PROPN
fnp-5343	747	6	,	,	PUNCT
fnp-5343	747	7	chen	chen	PROPN
fnp-5343	747	8	b	b	PROPN
fnp-5343	747	9	,	,	PUNCT
fnp-5343	747	10	choe	choe	PROPN
fnp-5343	747	11	h.	h.	PROPN
fnp-5343	747	12	mechanisms	mechanism	NOUN
fnp-5343	747	13	of	of	ADP
fnp-5343	747	14	sars	sar	NOUN
fnp-5343	747	15	-	-	PUNCT
fnp-5343	747	16	cov-2	cov-2	PART
fnp-5343	747	17	entry	entry	NOUN
fnp-5343	747	18	into	into	ADP
fnp-5343	747	19	cells	cell	NOUN
fnp-5343	747	20	.	.	PUNCT
fnp-5343	748	1	nat	nat	PROPN
fnp-5343	748	2	rev	rev	VERB
fnp-5343	748	3	mol	mol	ADP
fnp-5343	748	4	cell	cell	NOUN
fnp-5343	748	5	biol	biol	NOUN
fnp-5343	748	6	2022;23:3–20	2022;23:3–20	NUM
fnp-5343	748	7	.	.	PUNCT
fnp-5343	749	1	https://doi.org/10.1038/s41580-021-00418-x	https://doi.org/10.1038/s41580-021-00418-x	PROPN
fnp-5343	749	2	.	.	PROPN
fnp-5343	749	3	130	130	NUM
fnp-5343	749	4	.	.	PUNCT
fnp-5343	750	1	esper	esper	PROPN
fnp-5343	750	2	fp	fp	PROPN
fnp-5343	750	3	,	,	PUNCT
fnp-5343	750	4	adhikari	adhikari	PROPN
fnp-5343	750	5	tm	tm	PROPN
fnp-5343	750	6	,	,	PUNCT
fnp-5343	750	7	tu	tu	PROPN
fnp-5343	750	8	zj	zj	PROPN
fnp-5343	750	9	,	,	PUNCT
fnp-5343	750	10	cheng	cheng	PROPN
fnp-5343	750	11	yw	yw	PROPN
fnp-5343	750	12	,	,	PUNCT
fnp-5343	750	13	el	el	PROPN
fnp-5343	750	14	-	-	PROPN
fnp-5343	750	15	haddad	haddad	PROPN
fnp-5343	750	16	k	k	PROPN
fnp-5343	750	17	,	,	PUNCT
fnp-5343	750	18	farkas	farkas	PROPN
fnp-5343	750	19	dh	dh	PROPN
fnp-5343	750	20	,	,	PUNCT
fnp-5343	750	21	et	et	PROPN
fnp-5343	750	22	al	al	PROPN
fnp-5343	750	23	.	.	PROPN
fnp-5343	750	24	alpha	alpha	PROPN
fnp-5343	750	25	to	to	ADP
fnp-5343	750	26	omicron	omicron	PROPN
fnp-5343	750	27	:	:	PUNCT
fnp-5343	750	28	disease	disease	NOUN
fnp-5343	750	29	severity	severity	NOUN
fnp-5343	750	30	and	and	CCONJ
fnp-5343	750	31	clinical	clinical	ADJ
fnp-5343	750	32	outcomes	outcome	NOUN
fnp-5343	750	33	of	of	ADP
fnp-5343	750	34	major	major	ADJ
fnp-5343	750	35	sars	sar	NOUN
fnp-5343	750	36	-	-	PUNCT
fnp-5343	750	37	cov-2	cov-2	NOUN
fnp-5343	750	38	variants	variant	NOUN
fnp-5343	750	39	.	.	PUNCT
fnp-5343	751	1	j	j	PROPN
fnp-5343	751	2	infect	infect	VERB
fnp-5343	751	3	dis	dis	PROPN
fnp-5343	751	4	2023;227:344–52	2023;227:344–52	NUM
fnp-5343	751	5	.	.	PUNCT
fnp-5343	751	6	https://doi.org/10.1093/infdis/jiac411	https://doi.org/10.1093/infdis/jiac411	PROPN
fnp-5343	751	7	.	.	PUNCT
fnp-5343	752	1	131	131	X
fnp-5343	752	2	.	.	PUNCT
fnp-5343	753	1	khan	khan	PROPN
fnp-5343	753	2	m	m	PROPN
fnp-5343	753	3	,	,	PUNCT
fnp-5343	753	4	clijsters	clijsters	PROPN
fnp-5343	753	5	m	m	PROPN
fnp-5343	753	6	,	,	PUNCT
fnp-5343	753	7	choi	choi	PROPN
fnp-5343	753	8	s	s	PART
fnp-5343	753	9	,	,	PUNCT
fnp-5343	753	10	backaert	backaert	PROPN
fnp-5343	753	11	w	w	PROPN
fnp-5343	753	12	,	,	PUNCT
fnp-5343	753	13	claerhout	claerhout	PROPN
fnp-5343	753	14	m	m	PROPN
fnp-5343	753	15	,	,	PUNCT
fnp-5343	753	16	couvreur	couvreur	PROPN
fnp-5343	753	17	f	f	PROPN
fnp-5343	753	18	,	,	PUNCT
fnp-5343	753	19	et	et	PROPN
fnp-5343	753	20	al	al	PROPN
fnp-5343	753	21	.	.	PUNCT
fnp-5343	753	22	anatomical	anatomical	ADJ
fnp-5343	753	23	barriers	barrier	NOUN
fnp-5343	753	24	against	against	ADP
fnp-5343	753	25	sars	sar	NOUN
fnp-5343	753	26	-	-	PUNCT
fnp-5343	753	27	cov-2	cov-2	NOUN
fnp-5343	753	28	neuroinvasion	neuroinvasion	NOUN
fnp-5343	753	29	at	at	ADP
fnp-5343	753	30	vulnerable	vulnerable	ADJ
fnp-5343	753	31	interfaces	interface	NOUN
fnp-5343	753	32	visualized	visualize	VERB
fnp-5343	753	33	in	in	ADP
fnp-5343	753	34	deceased	deceased	ADJ
fnp-5343	753	35	covid-19	covid-19	PROPN
fnp-5343	753	36	patients	patient	NOUN
fnp-5343	753	37	.	.	PUNCT
fnp-5343	754	1	neuron	neuron	VERB
fnp-5343	754	2	2022;110:3919	2022;110:3919	NUM
fnp-5343	754	3	-	-	SYM
fnp-5343	754	4	35	35	NUM
fnp-5343	754	5	.	.	PUNCT
fnp-5343	755	1	https://doi.org/10.1016/j.neuron.2022.11.007	https://doi.org/10.1016/j.neuron.2022.11.007	PROPN
fnp-5343	755	2	.	.	PUNCT
fnp-5343	756	1	132	132	NUM
fnp-5343	756	2	.	.	PUNCT
fnp-5343	757	1	khan	khan	PROPN
fnp-5343	757	2	m	m	PROPN
fnp-5343	757	3	,	,	PUNCT
fnp-5343	757	4	yoo	yoo	PROPN
fnp-5343	757	5	sj	sj	PROPN
fnp-5343	757	6	,	,	PUNCT
fnp-5343	757	7	clijsters	clijsters	PROPN
fnp-5343	757	8	m	m	PROPN
fnp-5343	757	9	,	,	PUNCT
fnp-5343	757	10	backaert	backaert	PROPN
fnp-5343	757	11	w	w	PROPN
fnp-5343	757	12	,	,	PUNCT
fnp-5343	757	13	vanstapel	vanstapel	NOUN
fnp-5343	757	14	a	a	PRON
fnp-5343	757	15	,	,	PUNCT
fnp-5343	757	16	speleman	speleman	NOUN
fnp-5343	757	17	k	k	PROPN
fnp-5343	757	18	,	,	PUNCT
fnp-5343	757	19	et	et	PROPN
fnp-5343	757	20	al	al	PROPN
fnp-5343	757	21	.	.	PUNCT
fnp-5343	758	1	visualizing	visualize	VERB
fnp-5343	758	2	in	in	ADP
fnp-5343	758	3	deceased	deceased	ADJ
fnp-5343	758	4	covid-19	covid-19	PROPN
fnp-5343	758	5	patients	patient	NOUN
fnp-5343	758	6	how	how	SCONJ
fnp-5343	758	7	sars	sar	NOUN
fnp-5343	758	8	-	-	PUNCT
fnp-5343	758	9	cov-2	cov-2	NOUN
fnp-5343	758	10	attacks	attack	VERB
fnp-5343	758	11	the	the	DET
fnp-5343	758	12	respiratory	respiratory	ADJ
fnp-5343	758	13	and	and	CCONJ
fnp-5343	758	14	olfactory	olfactory	NOUN
fnp-5343	758	15	mucosae	mucosa	NOUN
fnp-5343	758	16	but	but	CCONJ
fnp-5343	758	17	spares	spare	VERB
fnp-5343	758	18	the	the	DET
fnp-5343	758	19	olfactory	olfactory	NOUN
fnp-5343	758	20	bulb	bulb	NOUN
fnp-5343	758	21	.	.	PUNCT
fnp-5343	759	1	cell	cell	NOUN
fnp-5343	759	2	2021;184:5932	2021;184:5932	NUM
fnp-5343	759	3	-	-	SYM
fnp-5343	759	4	49	49	NUM
fnp-5343	759	5	.	.	PUNCT
fnp-5343	760	1	https://doi.org/10.1016/j.cell.2021.10.027	https://doi.org/10.1016/j.cell.2021.10.027	PROPN
fnp-5343	760	2	.	.	PUNCT
fnp-5343	761	1	133	133	NUM
fnp-5343	761	2	.	.	PUNCT
fnp-5343	762	1	lamers	lamers	PROPN
fnp-5343	762	2	mm	mm	PROPN
fnp-5343	762	3	,	,	PUNCT
fnp-5343	762	4	haagmans	haagmans	PROPN
fnp-5343	762	5	bl	bl	PROPN
fnp-5343	762	6	.	.	PUNCT
fnp-5343	762	7	sars	sars	PROPN
fnp-5343	762	8	-	-	PUNCT
fnp-5343	762	9	cov-2	cov-2	NOUN
fnp-5343	762	10	pathogenesis	pathogenesis	NOUN
fnp-5343	762	11	.	.	PUNCT
fnp-5343	763	1	nat	nat	PROPN
fnp-5343	763	2	rev	rev	VERB
fnp-5343	763	3	microbiol	microbiol	PROPN
fnp-5343	763	4	2022;20:270–84	2022;20:270–84	PRON
fnp-5343	763	5	.	.	PUNCT
fnp-5343	763	6	https://doi.org/10.1038/s41579-022-00713-0	https://doi.org/10.1038/s41579-022-00713-0	PROPN
fnp-5343	763	7	.	.	PUNCT
fnp-5343	764	1	134	134	NUM
fnp-5343	764	2	.	.	PUNCT
fnp-5343	765	1	ahn	ahn	PROPN
fnp-5343	765	2	jh	jh	PROPN
fnp-5343	765	3	,	,	PUNCT
fnp-5343	765	4	kim	kim	PROPN
fnp-5343	765	5	jm	jm	PROPN
fnp-5343	765	6	,	,	PUNCT
fnp-5343	765	7	hong	hong	PROPN
fnp-5343	765	8	sp	sp	PROPN
fnp-5343	765	9	,	,	PUNCT
fnp-5343	765	10	choi	choi	NOUN
fnp-5343	765	11	sy	sy	PROPN
fnp-5343	765	12	,	,	PUNCT
fnp-5343	765	13	yang	yang	PROPN
fnp-5343	765	14	mj	mj	PROPN
fnp-5343	765	15	,	,	PUNCT
fnp-5343	765	16	ju	ju	PROPN
fnp-5343	765	17	ys	ys	PROPN
fnp-5343	765	18	,	,	PUNCT
fnp-5343	765	19	et	et	PROPN
fnp-5343	765	20	al	al	PROPN
fnp-5343	765	21	.	.	PROPN
fnp-5343	766	1	nasal	nasal	PROPN
fnp-5343	766	2	ciliated	ciliated	ADJ
fnp-5343	766	3	cells	cell	NOUN
fnp-5343	766	4	are	be	AUX
fnp-5343	766	5	primary	primary	ADJ
fnp-5343	766	6	targets	target	NOUN
fnp-5343	766	7	for	for	ADP
fnp-5343	766	8	sars	sar	NOUN
fnp-5343	766	9	-	-	PUNCT
fnp-5343	766	10	cov-2	cov-2	NOUN
fnp-5343	766	11	replication	replication	NOUN
fnp-5343	766	12	in	in	ADP
fnp-5343	766	13	the	the	DET
fnp-5343	766	14	early	early	ADJ
fnp-5343	766	15	stage	stage	NOUN
fnp-5343	766	16	of	of	ADP
fnp-5343	766	17	covid-19	covid-19	PROPN
fnp-5343	766	18	.	.	PUNCT
fnp-5343	767	1	j	j	PROPN
fnp-5343	767	2	clin	clin	PROPN
fnp-5343	767	3	invest	invest	VERB
fnp-5343	767	4	2021;131	2021;131	NUM
fnp-5343	767	5	:	:	PUNCT
fnp-5343	767	6	e148517	e148517	PROPN
fnp-5343	767	7	.	.	PUNCT
fnp-5343	767	8	https://doi.org/10.1172/jci148517	https://doi.org/10.1172/jci148517	PROPN
fnp-5343	767	9	.	.	PUNCT
fnp-5343	768	1	135	135	NUM
fnp-5343	768	2	.	.	PUNCT
fnp-5343	769	1	hou	hou	PROPN
fnp-5343	769	2	yj	yj	PROPN
fnp-5343	769	3	,	,	PUNCT
fnp-5343	769	4	okuda	okuda	PROPN
fnp-5343	769	5	k	k	PROPN
fnp-5343	769	6	,	,	PUNCT
fnp-5343	769	7	edwards	edwards	PROPN
fnp-5343	769	8	ce	ce	PROPN
fnp-5343	769	9	,	,	PUNCT
fnp-5343	769	10	martinez	martinez	PROPN
fnp-5343	769	11	dr	dr	PROPN
fnp-5343	769	12	,	,	PUNCT
fnp-5343	769	13	asakura	asakura	PROPN
fnp-5343	769	14	t	t	PROPN
fnp-5343	769	15	,	,	PUNCT
fnp-5343	769	16	dinnon	dinnon	PROPN
fnp-5343	769	17	kh	kh	PROPN
fnp-5343	769	18	,	,	PUNCT
fnp-5343	769	19	et	et	PROPN
fnp-5343	769	20	al	al	PROPN
fnp-5343	769	21	.	.	PUNCT
fnp-5343	770	1	sars	sars	PROPN
fnp-5343	770	2	-	-	PUNCT
fnp-5343	770	3	cov-2	cov-2	PART
fnp-5343	770	4	reverse	reverse	ADJ
fnp-5343	770	5	genetics	genetic	NOUN
fnp-5343	770	6	reveals	reveal	VERB
fnp-5343	770	7	a	a	DET
fnp-5343	770	8	variable	variable	ADJ
fnp-5343	770	9	infection	infection	NOUN
fnp-5343	770	10	gradient	gradient	NOUN
fnp-5343	770	11	in	in	ADP
fnp-5343	770	12	the	the	DET
fnp-5343	770	13	respiratory	respiratory	ADJ
fnp-5343	770	14	tract	tract	NOUN
fnp-5343	770	15	.	.	PUNCT
fnp-5343	771	1	cell	cell	NOUN
fnp-5343	771	2	2020;182:429	2020;182:429	NUM
fnp-5343	771	3	-	-	SYM
fnp-5343	771	4	46	46	NUM
fnp-5343	771	5	.	.	PUNCT
fnp-5343	772	1	https://doi.org/10.1016/j.cell.2020.05.042	https://doi.org/10.1016/j.cell.2020.05.042	NOUN
fnp-5343	772	2	.	.	PUNCT
fnp-5343	773	1	136	136	NUM
fnp-5343	773	2	.	.	PUNCT
fnp-5343	774	1	li	li	PROPN
fnp-5343	774	2	w	w	PROPN
fnp-5343	774	3	,	,	PUNCT
fnp-5343	774	4	moore	moore	PROPN
fnp-5343	774	5	mj	mj	PROPN
fnp-5343	774	6	,	,	PUNCT
fnp-5343	774	7	vasilieva	vasilieva	PROPN
fnp-5343	774	8	n	n	CCONJ
fnp-5343	774	9	,	,	PUNCT
fnp-5343	774	10	sui	sui	PROPN
fnp-5343	774	11	j	j	PROPN
fnp-5343	774	12	,	,	PUNCT
fnp-5343	774	13	wong	wong	PROPN
fnp-5343	774	14	sk	sk	PROPN
fnp-5343	774	15	,	,	PUNCT
fnp-5343	774	16	berne	berne	PROPN
fnp-5343	774	17	ma	ma	PROPN
fnp-5343	774	18	,	,	PUNCT
fnp-5343	774	19	et	et	PROPN
fnp-5343	774	20	al	al	PROPN
fnp-5343	774	21	.	.	PUNCT
fnp-5343	774	22	angiotensin	angiotensin	NOUN
fnp-5343	774	23	-	-	PUNCT
fnp-5343	774	24	converting	convert	VERB
fnp-5343	774	25	enzyme	enzyme	NOUN
fnp-5343	774	26	2	2	NUM
fnp-5343	774	27	is	be	AUX
fnp-5343	774	28	a	a	DET
fnp-5343	774	29	functional	functional	ADJ
fnp-5343	774	30	receptor	receptor	NOUN
fnp-5343	774	31	for	for	ADP
fnp-5343	774	32	the	the	DET
fnp-5343	774	33	sars	sars	PROPN
fnp-5343	774	34	coronavirus	coronavirus	PROPN
fnp-5343	774	35	.	.	PUNCT
fnp-5343	775	1	nature	nature	NOUN
fnp-5343	775	2	2003;426:450–4	2003;426:450–4	NUM
fnp-5343	775	3	.	.	PUNCT
fnp-5343	776	1	https://doi.org/10.1038/nature02145	https://doi.org/10.1038/nature02145	NOUN
fnp-5343	776	2	.	.	PUNCT
fnp-5343	777	1	137	137	NUM
fnp-5343	777	2	.	.	PUNCT
fnp-5343	778	1	zhou	zhou	PROPN
fnp-5343	778	2	p	p	PROPN
fnp-5343	778	3	,	,	PUNCT
fnp-5343	778	4	yang	yang	PROPN
fnp-5343	778	5	xl	xl	PROPN
fnp-5343	778	6	,	,	PUNCT
fnp-5343	778	7	wang	wang	PROPN
fnp-5343	778	8	xg	xg	PROPN
fnp-5343	778	9	,	,	PUNCT
fnp-5343	778	10	hu	hu	PROPN
fnp-5343	778	11	b	b	PROPN
fnp-5343	778	12	,	,	PUNCT
fnp-5343	778	13	zhang	zhang	PROPN
fnp-5343	778	14	l	l	PROPN
fnp-5343	778	15	,	,	PUNCT
fnp-5343	778	16	zhang	zhang	PROPN
fnp-5343	778	17	w	w	PROPN
fnp-5343	778	18	,	,	PUNCT
fnp-5343	778	19	et	et	PROPN
fnp-5343	778	20	al	al	PROPN
fnp-5343	778	21	.	.	PUNCT
fnp-5343	779	1	a	a	DET
fnp-5343	779	2	pneumonia	pneumonia	NOUN
fnp-5343	779	3	outbreak	outbreak	NOUN
fnp-5343	779	4	associated	associate	VERB
fnp-5343	779	5	with	with	ADP
fnp-5343	779	6	a	a	DET
fnp-5343	779	7	new	new	ADJ
fnp-5343	779	8	coronavirus	coronavirus	NOUN
fnp-5343	779	9	of	of	ADP
fnp-5343	779	10	probable	probable	ADJ
fnp-5343	779	11	bat	bat	NOUN
fnp-5343	779	12	origin	origin	NOUN
fnp-5343	779	13	.	.	PUNCT
fnp-5343	780	1	nature	nature	NOUN
fnp-5343	780	2	2020;579:270–3	2020;579:270–3	NUM
fnp-5343	780	3	.	.	PUNCT
fnp-5343	781	1	https://doi.org/10.1038/s41586-020-2012-7	https://doi.org/10.1038/s41586-020-2012-7	PROPN
fnp-5343	781	2	.	.	PUNCT
fnp-5343	782	1	138	138	NUM
fnp-5343	782	2	.	.	PUNCT
fnp-5343	783	1	millet	millet	PROPN
fnp-5343	783	2	jk	jk	PROPN
fnp-5343	783	3	,	,	PUNCT
fnp-5343	783	4	jaimes	jaimes	PROPN
fnp-5343	783	5	ja	ja	PROPN
fnp-5343	783	6	,	,	PUNCT
fnp-5343	783	7	whittaker	whittaker	PROPN
fnp-5343	783	8	gr	gr	PROPN
fnp-5343	783	9	.	.	PUNCT
fnp-5343	784	1	molecular	molecular	ADJ
fnp-5343	784	2	diversity	diversity	NOUN
fnp-5343	784	3	of	of	ADP
fnp-5343	784	4	coronavirus	coronavirus	NOUN
fnp-5343	784	5	host	host	NOUN
fnp-5343	784	6	cell	cell	NOUN
fnp-5343	784	7	entry	entry	NOUN
fnp-5343	784	8	receptors	receptor	NOUN
fnp-5343	784	9	.	.	PUNCT
fnp-5343	785	1	fems	fems	PROPN
fnp-5343	785	2	microbiol	microbiol	PROPN
fnp-5343	785	3	rev	rev	VERB
fnp-5343	785	4	2021;45	2021;45	NUM
fnp-5343	785	5	:	:	PUNCT
fnp-5343	785	6	fuaa057	fuaa057	PROPN
fnp-5343	785	7	.	.	PUNCT
fnp-5343	786	1	https://doi.org/10.1093/femsre/fuaa057	https://doi.org/10.1093/femsre/fuaa057	PROPN
fnp-5343	786	2	.	.	PROPN
fnp-5343	787	1	139	139	NUM
fnp-5343	787	2	.	.	PUNCT
fnp-5343	788	1	hoffmann	hoffmann	PROPN
fnp-5343	788	2	m	m	PROPN
fnp-5343	788	3	,	,	PUNCT
fnp-5343	788	4	kleine	kleine	PROPN
fnp-5343	788	5	-	-	PUNCT
fnp-5343	788	6	weber	weber	PROPN
fnp-5343	788	7	h	h	PROPN
fnp-5343	788	8	,	,	PUNCT
fnp-5343	788	9	schroeder	schroeder	PROPN
fnp-5343	788	10	s	s	PROPN
fnp-5343	788	11	,	,	PUNCT
fnp-5343	788	12	krüger	krüger	NOUN
fnp-5343	788	13	n	n	NOUN
fnp-5343	788	14	,	,	PUNCT
fnp-5343	788	15	herrler	herrler	PROPN
fnp-5343	788	16	t	t	PROPN
fnp-5343	788	17	,	,	PUNCT
fnp-5343	788	18	erichsen	erichsen	ADJ
fnp-5343	788	19	s	s	PROPN
fnp-5343	788	20	,	,	PUNCT
fnp-5343	788	21	et	et	PROPN
fnp-5343	788	22	al	al	PROPN
fnp-5343	788	23	.	.	PUNCT
fnp-5343	788	24	sars	sars	PROPN
fnp-5343	788	25	-	-	PUNCT
fnp-5343	788	26	cov-2	cov-2	PART
fnp-5343	788	27	cell	cell	NOUN
fnp-5343	788	28	entry	entry	NOUN
fnp-5343	788	29	depends	depend	VERB
fnp-5343	788	30	on	on	ADP
fnp-5343	788	31	ace2	ace2	NOUN
fnp-5343	788	32	and	and	CCONJ
fnp-5343	788	33	tmprss2	tmprss2	ADV
fnp-5343	788	34	and	and	CCONJ
fnp-5343	788	35	is	be	AUX
fnp-5343	788	36	blocked	block	VERB
fnp-5343	788	37	by	by	ADP
fnp-5343	788	38	a	a	DET
fnp-5343	788	39	clinically	clinically	ADV
fnp-5343	788	40	proven	prove	VERB
fnp-5343	788	41	protease	protease	NOUN
fnp-5343	788	42	inhibitor	inhibitor	NOUN
fnp-5343	788	43	.	.	PUNCT
fnp-5343	789	1	cell	cell	NOUN
fnp-5343	789	2	2020;181:271	2020;181:271	NUM
fnp-5343	789	3	-	-	SYM
fnp-5343	789	4	80	80	NUM
fnp-5343	789	5	.	.	PUNCT
fnp-5343	790	1	https://doi.org/10.1016/j.cell.2020.02.052	https://doi.org/10.1016/j.cell.2020.02.052	PROPN
fnp-5343	790	2	.	.	PROPN
fnp-5343	791	1	140	140	NUM
fnp-5343	791	2	.	.	PUNCT
fnp-5343	791	3	letko	letko	PROPN
fnp-5343	791	4	m	m	PROPN
fnp-5343	791	5	,	,	PUNCT
fnp-5343	791	6	marzi	marzi	NOUN
fnp-5343	791	7	a	a	X
fnp-5343	791	8	,	,	PUNCT
fnp-5343	791	9	munster	munster	PROPN
fnp-5343	791	10	v.	v.	ADP
fnp-5343	791	11	functional	functional	ADJ
fnp-5343	791	12	assessment	assessment	NOUN
fnp-5343	791	13	of	of	ADP
fnp-5343	791	14	cell	cell	NOUN
fnp-5343	791	15	entry	entry	NOUN
fnp-5343	791	16	and	and	CCONJ
fnp-5343	791	17	receptor	receptor	NOUN
fnp-5343	791	18	usage	usage	NOUN
fnp-5343	791	19	for	for	ADP
fnp-5343	791	20	sars	sar	NOUN
fnp-5343	791	21	-	-	PUNCT
fnp-5343	791	22	cov-2	cov-2	PUNCT
fnp-5343	791	23	and	and	CCONJ
fnp-5343	791	24	other	other	ADJ
fnp-5343	791	25	lineage	lineage	NOUN
fnp-5343	791	26	b	b	PROPN
fnp-5343	791	27	betacoronaviruses	betacoronaviruse	NOUN
fnp-5343	791	28	.	.	PUNCT
fnp-5343	792	1	nat	nat	PROPN
fnp-5343	792	2	microbiol	microbiol	PROPN
fnp-5343	792	3	2020;5:562–9	2020;5:562–9	PROPN
fnp-5343	792	4	.	.	PUNCT
fnp-5343	793	1	https://doi.org/10.1038/s41564-020-0688-y	https://doi.org/10.1038/s41564-020-0688-y	PROPN
fnp-5343	793	2	.	.	PROPN
fnp-5343	794	1	141	141	NUM
fnp-5343	794	2	.	.	PUNCT
fnp-5343	795	1	donoghue	donoghue	PROPN
fnp-5343	795	2	m	m	PROPN
fnp-5343	795	3	,	,	PUNCT
fnp-5343	795	4	hsieh	hsieh	PROPN
fnp-5343	795	5	f	f	PROPN
fnp-5343	795	6	,	,	PUNCT
fnp-5343	795	7	baronas	baronas	X
fnp-5343	795	8	e	e	NOUN
fnp-5343	795	9	,	,	PUNCT
fnp-5343	795	10	godbout	godbout	PROPN
fnp-5343	795	11	k	k	PROPN
fnp-5343	795	12	,	,	PUNCT
fnp-5343	795	13	gosselin	gosselin	PROPN
fnp-5343	795	14	m	m	PROPN
fnp-5343	795	15	,	,	PUNCT
fnp-5343	795	16	stagliano	stagliano	PROPN
fnp-5343	795	17	n	n	CCONJ
fnp-5343	795	18	,	,	PUNCT
fnp-5343	795	19	et	et	PROPN
fnp-5343	795	20	al	al	PROPN
fnp-5343	795	21	.	.	PUNCT
fnp-5343	796	1	a	a	DET
fnp-5343	796	2	novel	novel	ADJ
fnp-5343	796	3	angiotensin	angiotensin	NOUN
fnp-5343	796	4	-	-	PUNCT
fnp-5343	796	5	converting	convert	VERB
fnp-5343	796	6	enzyme	enzyme	NOUN
fnp-5343	796	7	-	-	PUNCT
fnp-5343	796	8	related	relate	VERB
fnp-5343	796	9	carboxypeptidase	carboxypeptidase	NOUN
fnp-5343	796	10	(	(	PUNCT
fnp-5343	796	11	ace2	ace2	PROPN
fnp-5343	796	12	)	)	PUNCT
fnp-5343	796	13	converts	convert	VERB
fnp-5343	796	14	angiotensin	angiotensin	NOUN
fnp-5343	796	15	i	i	PRON
fnp-5343	796	16	to	to	PART
fnp-5343	796	17	angiotensin	angiotensin	VERB
fnp-5343	796	18	1	1	NUM
fnp-5343	796	19	-	-	SYM
fnp-5343	796	20	9	9	NUM
fnp-5343	796	21	.	.	PUNCT
fnp-5343	797	1	circ	circ	PROPN
fnp-5343	797	2	res	res	PROPN
fnp-5343	797	3	2000;87	2000;87	NUM
fnp-5343	797	4	:	:	PUNCT
fnp-5343	797	5	e1	e1	NOUN
fnp-5343	797	6	-	-	SYM
fnp-5343	797	7	9	9	NUM
fnp-5343	797	8	.	.	PUNCT
fnp-5343	798	1	https://doi.org/10.1161/01.res.87.5.e1	https://doi.org/10.1161/01.res.87.5.e1	NOUN
fnp-5343	798	2	.	.	NOUN
fnp-5343	798	3	142	142	NUM
fnp-5343	798	4	.	.	PUNCT
fnp-5343	799	1	harmer	harmer	PROPN
fnp-5343	799	2	d	d	PROPN
fnp-5343	799	3	,	,	PUNCT
fnp-5343	799	4	gilbert	gilbert	PROPN
fnp-5343	799	5	m	m	PROPN
fnp-5343	799	6	,	,	PUNCT
fnp-5343	799	7	borman	borman	NOUN
fnp-5343	799	8	r	r	NOUN
fnp-5343	799	9	,	,	PUNCT
fnp-5343	799	10	clark	clark	PROPN
fnp-5343	799	11	kl	kl	PROPN
fnp-5343	799	12	.	.	PROPN
fnp-5343	799	13	quantitative	quantitative	ADJ
fnp-5343	799	14	mrna	mrna	PROPN
fnp-5343	799	15	expression	expression	NOUN
fnp-5343	799	16	profiling	profiling	NOUN
fnp-5343	799	17	of	of	ADP
fnp-5343	799	18	ace	ace	NOUN
fnp-5343	799	19	2	2	NUM
fnp-5343	799	20	,	,	PUNCT
fnp-5343	799	21	a	a	DET
fnp-5343	799	22	novel	novel	ADJ
fnp-5343	799	23	homologue	homologue	NOUN
fnp-5343	799	24	of	of	ADP
fnp-5343	799	25	angiotensin	angiotensin	NOUN
fnp-5343	799	26	converting	convert	VERB
fnp-5343	799	27	enzyme	enzyme	NOUN
fnp-5343	799	28	.	.	PUNCT
fnp-5343	800	1	febs	febs	NOUN
fnp-5343	800	2	lett	lett	PROPN
fnp-5343	800	3	2002;532:107–10	2002;532:107–10	PROPN
fnp-5343	800	4	.	.	PUNCT
fnp-5343	801	1	https://doi.org/10.1016/s0014-5793(02)03640-2	https://doi.org/10.1016/s0014-5793(02)03640-2	PROPN
fnp-5343	801	2	.	.	PUNCT
fnp-5343	802	1	143	143	NUM
fnp-5343	802	2	.	.	PUNCT
fnp-5343	803	1	hikmet	hikmet	PROPN
fnp-5343	803	2	f	f	PROPN
fnp-5343	803	3	,	,	PUNCT
fnp-5343	803	4	méar	méar	PROPN
fnp-5343	803	5	l	l	PROPN
fnp-5343	803	6	,	,	PUNCT
fnp-5343	803	7	edvinsson	edvinsson	PROPN
fnp-5343	803	8	å	å	PROPN
fnp-5343	803	9	,	,	PUNCT
fnp-5343	803	10	micke	micke	PROPN
fnp-5343	803	11	p	p	PROPN
fnp-5343	803	12	,	,	PUNCT
fnp-5343	803	13	uhlén	uhlén	PROPN
fnp-5343	803	14	m	m	PROPN
fnp-5343	803	15	,	,	PUNCT
fnp-5343	803	16	lindskog	lindskog	PROPN
fnp-5343	803	17	c.	c.	PROPN
fnp-5343	803	18	the	the	DET
fnp-5343	803	19	protein	protein	NOUN
fnp-5343	803	20	expression	expression	NOUN
fnp-5343	803	21	profile	profile	NOUN
fnp-5343	803	22	of	of	ADP
fnp-5343	803	23	ace2	ace2	PROPN
fnp-5343	803	24	in	in	ADP
fnp-5343	803	25	human	human	ADJ
fnp-5343	803	26	tissues	tissue	NOUN
fnp-5343	803	27	.	.	PUNCT
fnp-5343	804	1	mol	mol	ADP
fnp-5343	804	2	syst	syst	PROPN
fnp-5343	804	3	biol	biol	PROPN
fnp-5343	804	4	2020;16	2020;16	PROPN
fnp-5343	804	5	:	:	PUNCT
fnp-5343	804	6	e9610	e9610	PROPN
fnp-5343	804	7	.	.	PUNCT
fnp-5343	804	8	https://doi.org/10.15252/msb.20209610	https://doi.org/10.15252/msb.20209610	PROPN
fnp-5343	804	9	.	.	PUNCT
fnp-5343	805	1	144	144	NUM
fnp-5343	805	2	.	.	PUNCT
fnp-5343	806	1	chen	chen	PROPN
fnp-5343	806	2	r	r	PROPN
fnp-5343	806	3	,	,	PUNCT
fnp-5343	806	4	wang	wang	PROPN
fnp-5343	806	5	k	k	PROPN
fnp-5343	806	6	,	,	PUNCT
fnp-5343	806	7	yu	yu	PROPN
fnp-5343	806	8	j	j	PROPN
fnp-5343	806	9	,	,	PUNCT
fnp-5343	806	10	howard	howard	PROPN
fnp-5343	806	11	d	d	PROPN
fnp-5343	806	12	,	,	PUNCT
fnp-5343	806	13	french	french	ADJ
fnp-5343	806	14	l	l	NOUN
fnp-5343	806	15	,	,	PUNCT
fnp-5343	807	1	chen	chen	PROPN
fnp-5343	807	2	z	z	PROPN
fnp-5343	807	3	,	,	PUNCT
fnp-5343	807	4	et	et	PROPN
fnp-5343	807	5	al	al	PROPN
fnp-5343	807	6	.	.	PUNCT
fnp-5343	808	1	the	the	DET
fnp-5343	808	2	spatial	spatial	ADJ
fnp-5343	808	3	and	and	CCONJ
fnp-5343	808	4	cell	cell	NOUN
fnp-5343	808	5	-	-	PUNCT
fnp-5343	808	6	type	type	NOUN
fnp-5343	808	7	distribution	distribution	NOUN
fnp-5343	808	8	of	of	ADP
fnp-5343	808	9	sars	sar	NOUN
fnp-5343	808	10	-	-	PUNCT
fnp-5343	808	11	cov-2	cov-2	NOUN
fnp-5343	808	12	receptor	receptor	NOUN
fnp-5343	808	13	ace2	ace2	NOUN
fnp-5343	808	14	in	in	ADP
fnp-5343	808	15	the	the	DET
fnp-5343	808	16	human	human	ADJ
fnp-5343	808	17	and	and	CCONJ
fnp-5343	808	18	mouse	mouse	NOUN
fnp-5343	808	19	brains	brain	NOUN
fnp-5343	808	20	.	.	PUNCT
fnp-5343	809	1	front	front	ADJ
fnp-5343	809	2	neurol	neurol	NOUN
fnp-5343	809	3	2021;11:573095	2021;11:573095	NUM
fnp-5343	809	4	.	.	PUNCT
fnp-5343	810	1	https://doi.org/10.3389/fneur.2020.573095	https://doi.org/10.3389/fneur.2020.573095	PROPN
fnp-5343	810	2	.	.	PROPN
fnp-5343	810	3	145	145	NUM
fnp-5343	810	4	.	.	PUNCT
fnp-5343	811	1	yang	yang	PROPN
fnp-5343	811	2	ac	ac	PROPN
fnp-5343	811	3	,	,	PUNCT
fnp-5343	811	4	kern	kern	PROPN
fnp-5343	811	5	f	f	PROPN
fnp-5343	811	6	,	,	PUNCT
fnp-5343	811	7	losada	losada	PROPN
fnp-5343	811	8	pm	pm	PROPN
fnp-5343	811	9	,	,	PUNCT
fnp-5343	811	10	agam	agam	PROPN
fnp-5343	811	11	mr	mr	PROPN
fnp-5343	811	12	,	,	PUNCT
fnp-5343	811	13	maat	maat	PROPN
fnp-5343	811	14	ca	can	AUX
fnp-5343	811	15	,	,	PUNCT
fnp-5343	811	16	schmartz	schmartz	VERB
fnp-5343	811	17	gp	gp	NOUN
fnp-5343	811	18	,	,	PUNCT
fnp-5343	811	19	et	et	PROPN
fnp-5343	811	20	al	al	PROPN
fnp-5343	811	21	.	.	PROPN
fnp-5343	811	22	dysregulation	dysregulation	NOUN
fnp-5343	811	23	of	of	ADP
fnp-5343	811	24	brain	brain	NOUN
fnp-5343	811	25	and	and	CCONJ
fnp-5343	811	26	choroid	choroid	NOUN
fnp-5343	811	27	plexus	plexus	NOUN
fnp-5343	811	28	cell	cell	NOUN
fnp-5343	811	29	types	type	NOUN
fnp-5343	811	30	in	in	ADP
fnp-5343	811	31	severe	severe	ADJ
fnp-5343	811	32	covid-19	covid-19	PROPN
fnp-5343	811	33	.	.	PUNCT
fnp-5343	811	34	nature	nature	PROPN
fnp-5343	811	35	2021;595:565–71	2021;595:565–71	PROPN
fnp-5343	811	36	.	.	PUNCT
fnp-5343	812	1	https://doi.org/10.1038/s41586-021-03710-0	https://doi.org/10.1038/s41586-021-03710-0	NUM
fnp-5343	812	2	.	.	PUNCT
fnp-5343	813	1	146	146	NUM
fnp-5343	813	2	.	.	PUNCT
fnp-5343	814	1	wang	wang	PROPN
fnp-5343	814	2	y	y	PROPN
fnp-5343	814	3	,	,	PUNCT
fnp-5343	814	4	wang	wang	PROPN
fnp-5343	814	5	y	y	PROPN
fnp-5343	814	6	,	,	PUNCT
fnp-5343	814	7	luo	luo	PROPN
fnp-5343	814	8	w	w	PROPN
fnp-5343	814	9	,	,	PUNCT
fnp-5343	814	10	huang	huang	PROPN
fnp-5343	814	11	l	l	PROPN
fnp-5343	814	12	,	,	PUNCT
fnp-5343	814	13	xiao	xiao	PROPN
fnp-5343	814	14	j	j	PROPN
fnp-5343	814	15	,	,	PUNCT
fnp-5343	814	16	li	li	PROPN
fnp-5343	814	17	f	f	PROPN
fnp-5343	814	18	,	,	PUNCT
fnp-5343	814	19	et	et	PROPN
fnp-5343	814	20	al	al	PROPN
fnp-5343	814	21	.	.	PUNCT
fnp-5343	815	1	a	a	DET
fnp-5343	815	2	comprehensive	comprehensive	ADJ
fnp-5343	815	3	investigation	investigation	NOUN
fnp-5343	815	4	of	of	ADP
fnp-5343	815	5	the	the	DET
fnp-5343	815	6	mrna	mrna	NOUN
fnp-5343	815	7	and	and	CCONJ
fnp-5343	815	8	protein	protein	NOUN
fnp-5343	815	9	level	level	NOUN
fnp-5343	815	10	of	of	ADP
fnp-5343	815	11	ace2	ace2	NOUN
fnp-5343	815	12	,	,	PUNCT
fnp-5343	815	13	the	the	DET
fnp-5343	815	14	putative	putative	ADJ
fnp-5343	815	15	receptor	receptor	NOUN
fnp-5343	815	16	of	of	ADP
fnp-5343	815	17	sars	sar	NOUN
fnp-5343	815	18	-	-	PUNCT
fnp-5343	815	19	cov-2	cov-2	NOUN
fnp-5343	815	20	,	,	PUNCT
fnp-5343	815	21	in	in	ADP
fnp-5343	815	22	human	human	ADJ
fnp-5343	815	23	tissues	tissue	NOUN
fnp-5343	815	24	and	and	CCONJ
fnp-5343	815	25	blood	blood	NOUN
fnp-5343	815	26	cells	cell	NOUN
fnp-5343	815	27	.	.	PUNCT
fnp-5343	816	1	int	int	PROPN
fnp-5343	816	2	j	j	PROPN
fnp-5343	816	3	med	med	PROPN
fnp-5343	816	4	sci	sci	PROPN
fnp-5343	816	5	2020;17:1522–31	2020;17:1522–31	NUM
fnp-5343	816	6	.	.	PUNCT
fnp-5343	817	1	https://doi.org/10.7150/ijms.46695	https://doi.org/10.7150/ijms.46695	X
fnp-5343	817	2	.	.	PUNCT
fnp-5343	818	1	147	147	NUM
fnp-5343	818	2	.	.	PUNCT
fnp-5343	819	1	hamming	ham	VERB
fnp-5343	819	2	i	i	PRON
fnp-5343	819	3	,	,	PUNCT
fnp-5343	819	4	timens	timens	PROPN
fnp-5343	819	5	w	w	PROPN
fnp-5343	819	6	,	,	PUNCT
fnp-5343	819	7	bulthuis	bulthuis	PROPN
fnp-5343	819	8	mlc	mlc	PROPN
fnp-5343	819	9	,	,	PUNCT
fnp-5343	819	10	lely	lely	ADV
fnp-5343	819	11	at	at	ADP
fnp-5343	819	12	,	,	PUNCT
fnp-5343	819	13	navis	navis	PROPN
fnp-5343	819	14	gj	gj	PROPN
fnp-5343	819	15	,	,	PUNCT
fnp-5343	819	16	van	van	PROPN
fnp-5343	819	17	goor	goor	PROPN
fnp-5343	819	18	h.	h.	PROPN
fnp-5343	819	19	tissue	tissue	NOUN
fnp-5343	819	20	distribution	distribution	NOUN
fnp-5343	819	21	of	of	ADP
fnp-5343	819	22	ace2	ace2	NOUN
fnp-5343	819	23	protein	protein	NOUN
fnp-5343	819	24	,	,	PUNCT
fnp-5343	819	25	the	the	DET
fnp-5343	819	26	functional	functional	ADJ
fnp-5343	819	27	receptor	receptor	NOUN
fnp-5343	819	28	for	for	ADP
fnp-5343	819	29	sars	sars	PROPN
fnp-5343	819	30	coronavirus	coronavirus	PROPN
fnp-5343	819	31	.	.	PUNCT
fnp-5343	820	1	a	a	DET
fnp-5343	820	2	first	first	ADJ
fnp-5343	820	3	step	step	NOUN
fnp-5343	820	4	in	in	ADP
fnp-5343	820	5	understanding	understand	VERB
fnp-5343	820	6	sars	sar	NOUN
fnp-5343	820	7	pathogenesis	pathogenesis	NOUN
fnp-5343	820	8	.	.	PUNCT
fnp-5343	821	1	j	j	PROPN
fnp-5343	821	2	pathol	pathol	PROPN
fnp-5343	821	3	2004;203:631–7	2004;203:631–7	NUM
fnp-5343	821	4	.	.	PUNCT
fnp-5343	822	1	https://doi.org/10.1002/path.1570	https://doi.org/10.1002/path.1570	NOUN
fnp-5343	822	2	.	.	PUNCT
fnp-5343	823	1	148	148	NUM
fnp-5343	823	2	.	.	PUNCT
fnp-5343	824	1	nuovo	nuovo	PROPN
fnp-5343	824	2	gj	gj	PROPN
fnp-5343	824	3	,	,	PUNCT
fnp-5343	824	4	magro	magro	VERB
fnp-5343	824	5	c	c	PROPN
fnp-5343	824	6	,	,	PUNCT
fnp-5343	824	7	shaffer	shaffer	PROPN
fnp-5343	824	8	t	t	PROPN
fnp-5343	824	9	,	,	PUNCT
fnp-5343	824	10	awad	awad	PROPN
fnp-5343	824	11	h	h	PROPN
fnp-5343	824	12	,	,	PUNCT
fnp-5343	824	13	suster	suster	NOUN
fnp-5343	824	14	d	d	PROPN
fnp-5343	824	15	,	,	PUNCT
fnp-5343	824	16	mikhail	mikhail	PROPN
fnp-5343	824	17	s	s	PART
fnp-5343	824	18	,	,	PUNCT
fnp-5343	824	19	et	et	PROPN
fnp-5343	824	20	al	al	PROPN
fnp-5343	824	21	.	.	PUNCT
fnp-5343	824	22	endothelial	endothelial	ADJ
fnp-5343	824	23	cell	cell	NOUN
fnp-5343	824	24	damage	damage	NOUN
fnp-5343	824	25	is	be	AUX
fnp-5343	824	26	the	the	DET
fnp-5343	824	27	central	central	ADJ
fnp-5343	824	28	part	part	NOUN
fnp-5343	824	29	of	of	ADP
fnp-5343	824	30	covid-19	covid-19	PROPN
fnp-5343	824	31	and	and	CCONJ
fnp-5343	824	32	a	a	DET
fnp-5343	824	33	mouse	mouse	NOUN
fnp-5343	824	34	model	model	NOUN
fnp-5343	824	35	induced	induce	VERB
fnp-5343	824	36	by	by	ADP
fnp-5343	824	37	injection	injection	NOUN
fnp-5343	824	38	of	of	ADP
fnp-5343	824	39	the	the	DET
fnp-5343	824	40	s1	s1	NOUN
fnp-5343	824	41	subunit	subunit	NOUN
fnp-5343	824	42	of	of	ADP
fnp-5343	824	43	the	the	DET
fnp-5343	824	44	spike	spike	ADJ
fnp-5343	824	45	protein	protein	NOUN
fnp-5343	824	46	.	.	PUNCT
fnp-5343	825	1	ann	ann	PROPN
fnp-5343	825	2	diagn	diagn	PROPN
fnp-5343	825	3	pathol	pathol	PROPN
fnp-5343	825	4	2021;51:151682	2021;51:151682	NUM
fnp-5343	825	5	.	.	PUNCT
fnp-5343	826	1	https://doi.org/10.1016/j.anndiagpath.2020.151682	https://doi.org/10.1016/j.anndiagpath.2020.151682	NOUN
fnp-5343	826	2	.	.	PUNCT
fnp-5343	827	1	149	149	NUM
fnp-5343	827	2	.	.	PUNCT
fnp-5343	828	1	bryce	bryce	PROPN
fnp-5343	828	2	c	c	PROPN
fnp-5343	828	3	,	,	PUNCT
fnp-5343	828	4	grimes	grimes	PROPN
fnp-5343	828	5	z	z	PROPN
fnp-5343	828	6	,	,	PUNCT
fnp-5343	828	7	pujadas	pujadas	PROPN
fnp-5343	828	8	e	e	NOUN
fnp-5343	828	9	,	,	PUNCT
fnp-5343	828	10	ahuja	ahuja	PROPN
fnp-5343	828	11	s	s	PROPN
fnp-5343	828	12	,	,	PUNCT
fnp-5343	828	13	beasley	beasley	PROPN
fnp-5343	828	14	mb	mb	PROPN
fnp-5343	828	15	,	,	PUNCT
fnp-5343	828	16	albrecht	albrecht	PROPN
fnp-5343	828	17	r	r	NOUN
fnp-5343	828	18	,	,	PUNCT
fnp-5343	828	19	et	et	PROPN
fnp-5343	828	20	al	al	PROPN
fnp-5343	828	21	.	.	PROPN
fnp-5343	828	22	pathophysiology	pathophysiology	PROPN
fnp-5343	828	23	of	of	ADP
fnp-5343	828	24	sars	sar	NOUN
fnp-5343	828	25	-	-	PUNCT
fnp-5343	828	26	cov-2	cov-2	NUM
fnp-5343	828	27	:	:	PUNCT
fnp-5343	828	28	the	the	DET
fnp-5343	828	29	mount	mount	PROPN
fnp-5343	828	30	sinai	sinai	PROPN
fnp-5343	828	31	covid-19	covid-19	PROPN
fnp-5343	828	32	autopsy	autopsy	ADJ
fnp-5343	828	33	experience	experience	NOUN
fnp-5343	828	34	.	.	PUNCT
fnp-5343	829	1	mod	mod	PROPN
fnp-5343	829	2	pathol	pathol	PROPN
fnp-5343	829	3	2021;34:1456–67	2021;34:1456–67	NUM
fnp-5343	829	4	.	.	PUNCT
fnp-5343	830	1	https://doi.org/10.1038/s41379-021-00793-y	https://doi.org/10.1038/s41379-021-00793-y	PROPN
fnp-5343	830	2	.	.	PROPN
fnp-5343	830	3	150	150	NUM
fnp-5343	830	4	.	.	PUNCT
fnp-5343	831	1	bocci	bocci	PROPN
fnp-5343	831	2	m	m	PROPN
fnp-5343	831	3	,	,	PUNCT
fnp-5343	831	4	oudenaarden	oudenaarden	ADJ
fnp-5343	831	5	c	c	NOUN
fnp-5343	831	6	,	,	PUNCT
fnp-5343	831	7	sàenz‐sardà	sàenz‐sardà	PROPN
fnp-5343	831	8	x	x	AUX
fnp-5343	831	9	,	,	PUNCT
fnp-5343	831	10	simrén	simrén	PROPN
fnp-5343	831	11	j	j	PROPN
fnp-5343	831	12	,	,	PUNCT
fnp-5343	831	13	edén	edén	PROPN
fnp-5343	831	14	a	a	PRON
fnp-5343	831	15	,	,	PUNCT
fnp-5343	831	16	sjölund	sjölund	PROPN
fnp-5343	831	17	j	j	PROPN
fnp-5343	831	18	,	,	PUNCT
fnp-5343	831	19	et	et	PROPN
fnp-5343	831	20	al	al	PROPN
fnp-5343	831	21	.	.	PUNCT
fnp-5343	832	1	infection	infection	NOUN
fnp-5343	832	2	of	of	ADP
fnp-5343	832	3	brain	brain	NOUN
fnp-5343	832	4	pericytes	pericyte	NOUN
fnp-5343	832	5	underlying	underlie	VERB
fnp-5343	832	6	neuropathology	neuropathology	NOUN
fnp-5343	832	7	of	of	ADP
fnp-5343	832	8	covid‐19	covid‐19	PROPN
fnp-5343	832	9	patients	patient	NOUN
fnp-5343	832	10	.	.	PUNCT
fnp-5343	833	1	int	int	PROPN
fnp-5343	833	2	j	j	PROPN
fnp-5343	833	3	mol	mol	ADP
fnp-5343	833	4	sci	sci	PROPN
fnp-5343	833	5	2021;22:11622	2021;22:11622	PROPN
fnp-5343	833	6	.	.	PUNCT
fnp-5343	834	1	https://doi.org/10.3390/ijms222111622	https://doi.org/10.3390/ijms222111622	PROPN
fnp-5343	834	2	.	.	PUNCT
fnp-5343	835	1	151	151	NUM
fnp-5343	835	2	.	.	PUNCT
fnp-5343	836	1	lindskog	lindskog	PROPN
fnp-5343	836	2	c	c	PROPN
fnp-5343	836	3	,	,	PUNCT
fnp-5343	836	4	méar	méar	PROPN
fnp-5343	836	5	l	l	PROPN
fnp-5343	836	6	,	,	PUNCT
fnp-5343	836	7	virhammar	virhammar	PROPN
fnp-5343	836	8	j	j	PROPN
fnp-5343	836	9	,	,	PUNCT
fnp-5343	836	10	fällmar	fällmar	PROPN
fnp-5343	836	11	d	d	PROPN
fnp-5343	836	12	,	,	PUNCT
fnp-5343	836	13	kumlien	kumlien	PROPN
fnp-5343	836	14	e	e	PROPN
fnp-5343	836	15	,	,	PUNCT
fnp-5343	836	16	hesselager	hesselager	NOUN
fnp-5343	836	17	g	g	PROPN
fnp-5343	836	18	,	,	PUNCT
fnp-5343	836	19	et	et	PROPN
fnp-5343	836	20	al	al	PROPN
fnp-5343	836	21	.	.	PUNCT
fnp-5343	837	1	protein	protein	NOUN
fnp-5343	837	2	expression	expression	NOUN
fnp-5343	837	3	profile	profile	NOUN
fnp-5343	837	4	of	of	ADP
fnp-5343	837	5	ace2	ace2	NOUN
fnp-5343	837	6	in	in	ADP
fnp-5343	837	7	the	the	DET
fnp-5343	837	8	normal	normal	ADJ
fnp-5343	837	9	and	and	CCONJ
fnp-5343	837	10	covid-19	covid-19	PROPN
fnp-5343	837	11	-	-	PUNCT
fnp-5343	837	12	affected	affect	VERB
fnp-5343	837	13	human	human	ADJ
fnp-5343	837	14	brain	brain	NOUN
fnp-5343	837	15	.	.	PUNCT
fnp-5343	838	1	j	j	PROPN
fnp-5343	838	2	proteome	proteome	PROPN
fnp-5343	838	3	res	res	PROPN
fnp-5343	838	4	2022;21:2137–45	2022;21:2137–45	PROPN
fnp-5343	838	5	.	.	PUNCT
fnp-5343	839	1	https://doi.org/10.1021/acs.jproteome.2c00184	https://doi.org/10.1021/acs.jproteome.2c00184	PROPN
fnp-5343	839	2	.	.	PROPN
fnp-5343	839	3	152	152	NUM
fnp-5343	839	4	.	.	PUNCT
fnp-5343	840	1	deigendesch	deigendesch	PROPN
fnp-5343	840	2	n	n	CCONJ
fnp-5343	840	3	,	,	PUNCT
fnp-5343	840	4	sironi	sironi	PROPN
fnp-5343	840	5	l	l	NOUN
fnp-5343	840	6	,	,	PUNCT
fnp-5343	840	7	kutza	kutza	PROPN
fnp-5343	840	8	m	m	PROPN
fnp-5343	840	9	,	,	PUNCT
fnp-5343	840	10	wischnewski	wischnewski	PROPN
fnp-5343	840	11	s	s	NOUN
fnp-5343	840	12	,	,	PUNCT
fnp-5343	840	13	fuchs	fuchs	PROPN
fnp-5343	840	14	v	v	ADP
fnp-5343	840	15	,	,	PUNCT
fnp-5343	840	16	hench	hench	NOUN
fnp-5343	840	17	j	j	PROPN
fnp-5343	840	18	,	,	PUNCT
fnp-5343	840	19	et	et	PROPN
fnp-5343	840	20	al	al	PROPN
fnp-5343	840	21	.	.	PROPN
fnp-5343	840	22	correlates	correlate	VERB
fnp-5343	840	23	of	of	ADP
fnp-5343	840	24	critical	critical	ADJ
fnp-5343	840	25	illness	illness	NOUN
fnp-5343	840	26	-	-	PUNCT
fnp-5343	840	27	related	relate	VERB
fnp-5343	840	28	encephalopathy	encephalopathy	NOUN
fnp-5343	840	29	predominate	predominate	ADJ
fnp-5343	840	30	postmortem	postmortem	NOUN
fnp-5343	840	31	covid-19	covid-19	PROPN
fnp-5343	840	32	neuropathology	neuropathology	NOUN
fnp-5343	840	33	.	.	PUNCT
fnp-5343	841	1	acta	acta	PROPN
fnp-5343	841	2	neuropathol	neuropathol	PROPN
fnp-5343	842	1	2020;140:583–6	2020;140:583–6	NUM
fnp-5343	842	2	.	.	PUNCT
fnp-5343	843	1	https://doi.org/10.1007/s00401-020-02213-y	https://doi.org/10.1007/s00401-020-02213-y	PROPN
fnp-5343	843	2	.	.	PROPN
fnp-5343	843	3	153	153	NUM
fnp-5343	843	4	.	.	PUNCT
fnp-5343	843	5	mao	mao	PROPN
fnp-5343	844	1	l	l	NOUN
fnp-5343	844	2	,	,	PUNCT
fnp-5343	844	3	jin	jin	PROPN
fnp-5343	844	4	h	h	PROPN
fnp-5343	844	5	,	,	PUNCT
fnp-5343	844	6	wang	wang	PROPN
fnp-5343	844	7	m	m	PROPN
fnp-5343	844	8	,	,	PUNCT
fnp-5343	844	9	hu	hu	PROPN
fnp-5343	844	10	y	y	PROPN
fnp-5343	844	11	,	,	PUNCT
fnp-5343	844	12	chen	chen	PROPN
fnp-5343	844	13	s	s	PROPN
fnp-5343	844	14	,	,	PUNCT
fnp-5343	844	15	he	he	PRON
fnp-5343	844	16	q	q	AUX
fnp-5343	844	17	,	,	PUNCT
fnp-5343	844	18	et	et	PROPN
fnp-5343	844	19	al	al	PROPN
fnp-5343	844	20	.	.	PUNCT
fnp-5343	845	1	neurologic	neurologic	ADJ
fnp-5343	845	2	manifestations	manifestation	NOUN
fnp-5343	845	3	of	of	ADP
fnp-5343	845	4	hospitalized	hospitalize	VERB
fnp-5343	845	5	patients	patient	NOUN
fnp-5343	845	6	with	with	ADP
fnp-5343	845	7	coronavirus	coronavirus	NOUN
fnp-5343	845	8	disease	disease	NOUN
fnp-5343	845	9	2019	2019	NUM
fnp-5343	845	10	in	in	ADP
fnp-5343	845	11	wuhan	wuhan	PROPN
fnp-5343	845	12	,	,	PUNCT
fnp-5343	845	13	china	china	PROPN
fnp-5343	845	14	.	.	PUNCT
fnp-5343	846	1	jama	jama	PROPN
fnp-5343	846	2	neurol	neurol	PROPN
fnp-5343	846	3	2020;77:683–90	2020;77:683–90	PROPN
fnp-5343	846	4	.	.	PUNCT
fnp-5343	847	1	https://doi.org/10.1001/jamaneurol.2020.1127	https://doi.org/10.1001/jamaneurol.2020.1127	PROPN
fnp-5343	847	2	.	.	PROPN
fnp-5343	847	3	154	154	NUM
fnp-5343	847	4	.	.	PUNCT
fnp-5343	848	1	misra	misra	PROPN
fnp-5343	848	2	s	s	PROPN
fnp-5343	848	3	,	,	PUNCT
fnp-5343	848	4	kolappa	kolappa	PROPN
fnp-5343	848	5	k	k	PROPN
fnp-5343	848	6	,	,	PUNCT
fnp-5343	848	7	prasad	prasad	PROPN
fnp-5343	848	8	m	m	PROPN
fnp-5343	848	9	,	,	PUNCT
fnp-5343	848	10	radhakrishnan	radhakrishnan	PROPN
fnp-5343	848	11	d	d	PROPN
fnp-5343	848	12	,	,	PUNCT
fnp-5343	848	13	thakur	thakur	PROPN
fnp-5343	848	14	kt	kt	PROPN
fnp-5343	848	15	,	,	PUNCT
fnp-5343	848	16	solomon	solomon	PROPN
fnp-5343	848	17	t	t	PROPN
fnp-5343	848	18	,	,	PUNCT
fnp-5343	848	19	et	et	PROPN
fnp-5343	848	20	al	al	PROPN
fnp-5343	848	21	.	.	PROPN
fnp-5343	848	22	frequency	frequency	PROPN
fnp-5343	848	23	of	of	ADP
fnp-5343	848	24	neurologic	neurologic	ADJ
fnp-5343	848	25	manifestations	manifestation	NOUN
fnp-5343	848	26	in	in	ADP
fnp-5343	848	27	covid-19	covid-19	PROPN
fnp-5343	848	28	:	:	PUNCT
fnp-5343	848	29	a	a	DET
fnp-5343	848	30	systematic	systematic	ADJ
fnp-5343	848	31	review	review	NOUN
fnp-5343	848	32	and	and	CCONJ
fnp-5343	848	33	meta	meta	ADJ
fnp-5343	848	34	-	-	PUNCT
fnp-5343	848	35	analysis	analysis	NOUN
fnp-5343	848	36	.	.	PUNCT
fnp-5343	849	1	neurology	neurology	NOUN
fnp-5343	849	2	2021;97	2021;97	NOUN
fnp-5343	849	3	:	:	PUNCT
fnp-5343	849	4	e2269–81	e2269–81	X
fnp-5343	849	5	.	.	PUNCT
fnp-5343	850	1	https://doi.org/10.1212/wnl.0000000000012930	https://doi.org/10.1212/wnl.0000000000012930	NOUN
fnp-5343	850	2	.	.	PUNCT
fnp-5343	851	1	155	155	NUM
fnp-5343	851	2	.	.	PUNCT
fnp-5343	851	3	taquet	taquet	PROPN
fnp-5343	851	4	m	m	PROPN
fnp-5343	851	5	,	,	PUNCT
fnp-5343	851	6	geddes	geddes	PROPN
fnp-5343	851	7	jr	jr	PROPN
fnp-5343	851	8	,	,	PUNCT
fnp-5343	851	9	husain	husain	PROPN
fnp-5343	851	10	m	m	PROPN
fnp-5343	851	11	,	,	PUNCT
fnp-5343	851	12	luciano	luciano	PROPN
fnp-5343	851	13	s	s	PROPN
fnp-5343	851	14	,	,	PUNCT
fnp-5343	851	15	harrison	harrison	PROPN
fnp-5343	851	16	pj	pj	PROPN
fnp-5343	851	17	.	.	PROPN
fnp-5343	852	1	6	6	NUM
fnp-5343	852	2	-	-	PUNCT
fnp-5343	852	3	month	month	NOUN
fnp-5343	852	4	neurological	neurological	ADJ
fnp-5343	852	5	and	and	CCONJ
fnp-5343	852	6	psychiatric	psychiatric	ADJ
fnp-5343	852	7	outcomes	outcome	NOUN
fnp-5343	852	8	in	in	ADP
fnp-5343	852	9	236	236	NUM
fnp-5343	852	10	379	379	NUM
fnp-5343	852	11	survivors	survivor	NOUN
fnp-5343	852	12	of	of	ADP
fnp-5343	852	13	covid-19	covid-19	PROPN
fnp-5343	852	14	:	:	PUNCT
fnp-5343	852	15	a	a	DET
fnp-5343	852	16	retrospective	retrospective	ADJ
fnp-5343	852	17	cohort	cohort	NOUN
fnp-5343	852	18	study	study	NOUN
fnp-5343	852	19	using	use	VERB
fnp-5343	852	20	electronic	electronic	ADJ
fnp-5343	852	21	health	health	NOUN
fnp-5343	852	22	records	record	NOUN
fnp-5343	852	23	.	.	PUNCT
fnp-5343	853	1	lancet	lancet	PROPN
fnp-5343	853	2	psychiatry	psychiatry	PROPN
fnp-5343	854	1	2021;8:416–27	2021;8:416–27	PROPN
fnp-5343	854	2	.	.	PUNCT
fnp-5343	854	3	https://doi.org/10.1016/s2215-0366(21)00084-5	https://doi.org/10.1016/s2215-0366(21)00084-5	PROPN
fnp-5343	854	4	.	.	PUNCT
fnp-5343	855	1	156	156	NUM
fnp-5343	855	2	.	.	PUNCT
fnp-5343	856	1	cho	cho	PROPN
fnp-5343	856	2	sm	sm	PROPN
fnp-5343	856	3	,	,	PUNCT
fnp-5343	856	4	white	white	PROPN
fnp-5343	856	5	n	n	CCONJ
fnp-5343	856	6	,	,	PUNCT
fnp-5343	856	7	premraj	premraj	ADJ
fnp-5343	856	8	l	l	NOUN
fnp-5343	856	9	,	,	PUNCT
fnp-5343	856	10	battaglini	battaglini	PROPN
fnp-5343	856	11	d	d	PROPN
fnp-5343	856	12	,	,	PUNCT
fnp-5343	856	13	fanning	fan	VERB
fnp-5343	856	14	j	j	PROPN
fnp-5343	856	15	,	,	PUNCT
fnp-5343	856	16	suen	suen	PROPN
fnp-5343	856	17	j	j	PROPN
fnp-5343	856	18	,	,	PUNCT
fnp-5343	856	19	et	et	PROPN
fnp-5343	856	20	al	al	PROPN
fnp-5343	856	21	.	.	PROPN
fnp-5343	857	1	neurological	neurological	ADJ
fnp-5343	857	2	manifestations	manifestation	NOUN
fnp-5343	857	3	of	of	ADP
fnp-5343	857	4	covid-19	covid-19	PROPN
fnp-5343	857	5	in	in	ADP
fnp-5343	857	6	adults	adult	NOUN
fnp-5343	857	7	and	and	CCONJ
fnp-5343	857	8	children	child	NOUN
fnp-5343	857	9	.	.	PUNCT
fnp-5343	858	1	brain	brain	NOUN
fnp-5343	858	2	2023;146:1648–61	2023;146:1648–61	NUM
fnp-5343	858	3	.	.	PUNCT
fnp-5343	859	1	https://doi.org/10.1093/brain/awac332	https://doi.org/10.1093/brain/awac332	X
fnp-5343	859	2	.	.	PUNCT
fnp-5343	860	1	157	157	NUM
fnp-5343	860	2	.	.	PUNCT
fnp-5343	861	1	shahjouei	shahjouei	PROPN
fnp-5343	861	2	s	s	PROPN
fnp-5343	861	3	,	,	PUNCT
fnp-5343	861	4	tsivgoulis	tsivgouli	NOUN
fnp-5343	861	5	g	g	PROPN
fnp-5343	861	6	,	,	PUNCT
fnp-5343	861	7	farahmand	farahmand	NOUN
fnp-5343	861	8	g	g	PROPN
fnp-5343	861	9	,	,	PUNCT
fnp-5343	861	10	koza	koza	PROPN
fnp-5343	861	11	e	e	PROPN
fnp-5343	861	12	,	,	PUNCT
fnp-5343	861	13	mowla	mowla	PROPN
fnp-5343	861	14	a	a	PRON
fnp-5343	861	15	,	,	PUNCT
fnp-5343	861	16	sadr	sadr	PROPN
fnp-5343	861	17	av	av	PROPN
fnp-5343	861	18	,	,	PUNCT
fnp-5343	861	19	et	et	PROPN
fnp-5343	861	20	al	al	PROPN
fnp-5343	861	21	.	.	PUNCT
fnp-5343	862	1	sars	sars	PROPN
fnp-5343	862	2	-	-	PUNCT
fnp-5343	862	3	cov-2	cov-2	X
fnp-5343	862	4	and	and	CCONJ
fnp-5343	862	5	stroke	stroke	NOUN
fnp-5343	862	6	characteristics	characteristic	NOUN
fnp-5343	862	7	:	:	PUNCT
fnp-5343	862	8	a	a	DET
fnp-5343	862	9	report	report	NOUN
fnp-5343	862	10	from	from	ADP
fnp-5343	862	11	the	the	DET
fnp-5343	862	12	multinational	multinational	ADJ
fnp-5343	862	13	covid-19	covid-19	PROPN
fnp-5343	862	14	stroke	stroke	NOUN
fnp-5343	862	15	study	study	PROPN
fnp-5343	862	16	group	group	NOUN
fnp-5343	862	17	.	.	PUNCT
fnp-5343	863	1	stroke	stroke	NOUN
fnp-5343	863	2	2021;52	2021;52	NUM
fnp-5343	863	3	:	:	PUNCT
fnp-5343	863	4	e117–30	e117–30	PROPN
fnp-5343	863	5	.	.	PUNCT
fnp-5343	864	1	https://doi.org/10.1161/strokeaha.120.032927	https://doi.org/10.1161/strokeaha.120.032927	ADJ
fnp-5343	864	2	.	.	NOUN
fnp-5343	865	1	158	158	X
fnp-5343	865	2	.	.	PUNCT
fnp-5343	866	1	merkler	merkler	PROPN
fnp-5343	866	2	ae	ae	PROPN
fnp-5343	866	3	,	,	PUNCT
fnp-5343	866	4	parikh	parikh	PROPN
fnp-5343	866	5	ns	ns	PROPN
fnp-5343	866	6	,	,	PUNCT
fnp-5343	866	7	mir	mir	PROPN
fnp-5343	866	8	s	s	X
fnp-5343	866	9	,	,	PUNCT
fnp-5343	866	10	gupta	gupta	PROPN
fnp-5343	866	11	a	a	PRON
fnp-5343	866	12	,	,	PUNCT
fnp-5343	866	13	kamel	kamel	PROPN
fnp-5343	866	14	h	h	PROPN
fnp-5343	866	15	,	,	PUNCT
fnp-5343	866	16	lin	lin	PROPN
fnp-5343	866	17	e	e	PROPN
fnp-5343	866	18	,	,	PUNCT
fnp-5343	866	19	et	et	PROPN
fnp-5343	866	20	al	al	PROPN
fnp-5343	866	21	.	.	PROPN
fnp-5343	866	22	risk	risk	NOUN
fnp-5343	866	23	of	of	ADP
fnp-5343	866	24	ischemic	ischemic	ADJ
fnp-5343	866	25	stroke	stroke	NOUN
fnp-5343	866	26	in	in	ADP
fnp-5343	866	27	patients	patient	NOUN
fnp-5343	866	28	with	with	ADP
fnp-5343	866	29	coronavirus	coronavirus	NOUN
fnp-5343	866	30	disease	disease	NOUN
fnp-5343	866	31	2019	2019	NUM
fnp-5343	866	32	(	(	PUNCT
fnp-5343	866	33	covid-19	covid-19	PROPN
fnp-5343	866	34	)	)	PUNCT
fnp-5343	866	35	vs	vs	ADP
fnp-5343	866	36	patients	patient	NOUN
fnp-5343	866	37	with	with	ADP
fnp-5343	866	38	influenza	influenza	NOUN
fnp-5343	866	39	.	.	PUNCT
fnp-5343	867	1	jama	jama	PROPN
fnp-5343	867	2	neurol	neurol	PROPN
fnp-5343	867	3	2020;77:1366–72	2020;77:1366–72	NUM
fnp-5343	867	4	.	.	PUNCT
fnp-5343	868	1	https://doi.org/10.1001/jamaneurol.2020.2730	https://doi.org/10.1001/jamaneurol.2020.2730	PROPN
fnp-5343	868	2	.	.	PROPN
fnp-5343	868	3	159	159	NUM
fnp-5343	868	4	.	.	PUNCT
fnp-5343	869	1	katsoularis	katsoularis	PROPN
fnp-5343	869	2	i	i	PROPN
fnp-5343	869	3	,	,	PUNCT
fnp-5343	869	4	fonseca	fonseca	NOUN
fnp-5343	869	5	-	-	PUNCT
fnp-5343	869	6	rodríguez	rodríguez	NOUN
fnp-5343	869	7	o	o	PROPN
fnp-5343	869	8	,	,	PUNCT
fnp-5343	869	9	farrington	farrington	PROPN
fnp-5343	869	10	p	p	X
fnp-5343	869	11	,	,	PUNCT
fnp-5343	869	12	lindmark	lindmark	PROPN
fnp-5343	869	13	k	k	PROPN
fnp-5343	869	14	,	,	PUNCT
fnp-5343	869	15	connolly	connolly	PROPN
fnp-5343	869	16	amf	amf	PROPN
fnp-5343	869	17	.	.	PROPN
fnp-5343	869	18	risk	risk	NOUN
fnp-5343	869	19	of	of	ADP
fnp-5343	869	20	acute	acute	ADJ
fnp-5343	869	21	myocardial	myocardial	ADJ
fnp-5343	869	22	infarction	infarction	NOUN
fnp-5343	869	23	and	and	CCONJ
fnp-5343	869	24	ischaemic	ischaemic	ADJ
fnp-5343	869	25	stroke	stroke	NOUN
fnp-5343	869	26	following	follow	VERB
fnp-5343	869	27	covid-19	covid-19	PROPN
fnp-5343	869	28	in	in	ADP
fnp-5343	869	29	sweden	sweden	PROPN
fnp-5343	869	30	:	:	PUNCT
fnp-5343	869	31	a	a	DET
fnp-5343	869	32	self	self	NOUN
fnp-5343	869	33	-	-	PUNCT
fnp-5343	869	34	controlled	control	VERB
fnp-5343	869	35	case	case	NOUN
fnp-5343	869	36	series	series	NOUN
fnp-5343	869	37	and	and	CCONJ
fnp-5343	869	38	matched	match	VERB
fnp-5343	869	39	cohort	cohort	NOUN
fnp-5343	869	40	study	study	NOUN
fnp-5343	869	41	.	.	PUNCT
fnp-5343	870	1	lancet	lancet	PROPN
fnp-5343	870	2	2021;398:599–607	2021;398:599–607	NUM
fnp-5343	870	3	.	.	PUNCT
fnp-5343	871	1	https://doi.org/10.1016/s0140-6736(21)00896-5	https://doi.org/10.1016/s0140-6736(21)00896-5	PROPN
fnp-5343	871	2	.	.	PROPN
fnp-5343	872	1	160	160	NUM
fnp-5343	872	2	.	.	PUNCT
fnp-5343	873	1	russell	russell	PROPN
fnp-5343	873	2	cd	cd	PROPN
fnp-5343	873	3	,	,	PUNCT
fnp-5343	873	4	lone	lone	PROPN
fnp-5343	873	5	ni	ni	PROPN
fnp-5343	873	6	,	,	PUNCT
fnp-5343	873	7	baillie	baillie	PROPN
fnp-5343	873	8	jk	jk	PROPN
fnp-5343	873	9	.	.	PROPN
fnp-5343	873	10	comorbidities	comorbiditie	NOUN
fnp-5343	873	11	,	,	PUNCT
fnp-5343	873	12	multimorbidity	multimorbidity	NOUN
fnp-5343	873	13	and	and	CCONJ
fnp-5343	873	14	covid-19	covid-19	PROPN
fnp-5343	873	15	.	.	PUNCT
fnp-5343	874	1	nat	nat	PROPN
fnp-5343	874	2	med	med	PROPN
fnp-5343	874	3	2023;29:334–43	2023;29:334–43	PROPN
fnp-5343	874	4	.	.	PUNCT
fnp-5343	875	1	https://doi.org/10.1038/s41591-022-02156-9	https://doi.org/10.1038/s41591-022-02156-9	NUM
fnp-5343	875	2	.	.	PUNCT
fnp-5343	876	1	161	161	NUM
fnp-5343	876	2	.	.	PUNCT
fnp-5343	877	1	world	world	PROPN
fnp-5343	877	2	health	health	PROPN
fnp-5343	877	3	organization	organization	PROPN
fnp-5343	877	4	.	.	PUNCT
fnp-5343	878	1	a	a	DET
fnp-5343	878	2	clinical	clinical	ADJ
fnp-5343	878	3	case	case	NOUN
fnp-5343	878	4	definition	definition	NOUN
fnp-5343	878	5	of	of	ADP
fnp-5343	878	6	post	post	NOUN
fnp-5343	878	7	covid-19	covid-19	PROPN
fnp-5343	878	8	condition	condition	NOUN
fnp-5343	878	9	by	by	ADP
fnp-5343	878	10	a	a	DET
fnp-5343	878	11	delphi	delphi	ADJ
fnp-5343	878	12	consensus	consensus	NOUN
fnp-5343	878	13	2021	2021	NUM
fnp-5343	878	14	.	.	PUNCT
fnp-5343	879	1	https://www.who.int/publications/i/item/who-2019-ncov-post_covid-19_condition-clinical_case_definition-2021.1	https://www.who.int/publications/i/item/who-2019-ncov-post_covid-19_condition-clinical_case_definition-2021.1	PROPN
fnp-5343	879	2	.	.	PROPN
fnp-5343	880	1	accessed	access	VERB
fnp-5343	880	2	:	:	PUNCT
fnp-5343	880	3	november	november	PROPN
fnp-5343	880	4	26	26	NUM
fnp-5343	880	5	,	,	PUNCT
fnp-5343	880	6	2023	2023	NUM
fnp-5343	880	7	.	.	PUNCT
fnp-5343	881	1	162	162	NUM
fnp-5343	881	2	.	.	PUNCT
fnp-5343	881	3	xu	xu	PROPN
fnp-5343	882	1	e	e	PROPN
fnp-5343	882	2	,	,	PUNCT
fnp-5343	882	3	xie	xie	PROPN
fnp-5343	882	4	y	y	PROPN
fnp-5343	882	5	,	,	PUNCT
fnp-5343	882	6	al	al	PROPN
fnp-5343	882	7	-	-	PUNCT
fnp-5343	882	8	aly	aly	PROPN
fnp-5343	882	9	z.	z.	PROPN
fnp-5343	882	10	long	long	ADJ
fnp-5343	882	11	-	-	PUNCT
fnp-5343	882	12	term	term	NOUN
fnp-5343	882	13	neurologic	neurologic	ADJ
fnp-5343	882	14	outcomes	outcome	NOUN
fnp-5343	882	15	of	of	ADP
fnp-5343	882	16	covid-19	covid-19	PROPN
fnp-5343	882	17	.	.	PUNCT
fnp-5343	883	1	nat	nat	PROPN
fnp-5343	883	2	med	med	PROPN
fnp-5343	883	3	2022;28:2406–15	2022;28:2406–15	PROPN
fnp-5343	883	4	.	.	PUNCT
fnp-5343	884	1	https://doi.org/10.1038/s41591-022-02001-z	https://doi.org/10.1038/s41591-022-02001-z	PROPN
fnp-5343	884	2	.	.	PUNCT
fnp-5343	885	1	163	163	NUM
fnp-5343	885	2	.	.	PUNCT
fnp-5343	886	1	chang	chang	PROPN
fnp-5343	886	2	l	l	PROPN
fnp-5343	886	3	,	,	PUNCT
fnp-5343	886	4	ryan	ryan	PROPN
fnp-5343	886	5	mc	mc	PROPN
fnp-5343	886	6	,	,	PUNCT
fnp-5343	886	7	liang	liang	PROPN
fnp-5343	886	8	h	h	PROPN
fnp-5343	886	9	,	,	PUNCT
fnp-5343	886	10	zhang	zhang	PROPN
fnp-5343	886	11	x	x	PROPN
fnp-5343	886	12	,	,	PUNCT
fnp-5343	886	13	cunningham	cunningham	PROPN
fnp-5343	886	14	e	e	PROPN
fnp-5343	886	15	,	,	PUNCT
fnp-5343	886	16	wang	wang	PROPN
fnp-5343	886	17	j	j	PROPN
fnp-5343	886	18	,	,	PUNCT
fnp-5343	886	19	et	et	PROPN
fnp-5343	886	20	al	al	PROPN
fnp-5343	886	21	.	.	PROPN
fnp-5343	886	22	changes	change	NOUN
fnp-5343	886	23	in	in	ADP
fnp-5343	886	24	brain	brain	NOUN
fnp-5343	886	25	activation	activation	NOUN
fnp-5343	886	26	patterns	pattern	NOUN
fnp-5343	886	27	during	during	ADP
fnp-5343	886	28	working	work	VERB
fnp-5343	886	29	memory	memory	NOUN
fnp-5343	886	30	tasks	task	NOUN
fnp-5343	886	31	in	in	ADP
fnp-5343	886	32	people	people	NOUN
fnp-5343	886	33	with	with	ADP
fnp-5343	886	34	post	post	ADJ
fnp-5343	886	35	-	-	ADJ
fnp-5343	886	36	covid	covid	ADJ
fnp-5343	886	37	condition	condition	NOUN
fnp-5343	886	38	and	and	CCONJ
fnp-5343	886	39	persistent	persistent	ADJ
fnp-5343	886	40	neuropsychiatric	neuropsychiatric	ADJ
fnp-5343	886	41	symptoms	symptom	NOUN
fnp-5343	886	42	.	.	PUNCT
fnp-5343	887	1	neurology	neurology	PROPN
fnp-5343	887	2	2023;100	2023;100	PROPN
fnp-5343	887	3	:	:	PUNCT
fnp-5343	887	4	e2409–23	e2409–23	X
fnp-5343	887	5	.	.	PUNCT
fnp-5343	888	1	https://doi.org/10.1212/wnl.0000000000207309	https://doi.org/10.1212/wnl.0000000000207309	PROPN
fnp-5343	888	2	.	.	PROPN
fnp-5343	888	3	164	164	NUM
fnp-5343	888	4	.	.	PUNCT
fnp-5343	889	1	mina	mina	PROPN
fnp-5343	889	2	y	y	PROPN
fnp-5343	889	3	,	,	PUNCT
fnp-5343	889	4	enose	enose	NOUN
fnp-5343	889	5	-	-	PUNCT
fnp-5343	889	6	akahata	akahata	NOUN
fnp-5343	889	7	y	y	PROPN
fnp-5343	889	8	,	,	PUNCT
fnp-5343	889	9	hammoud	hammoud	PROPN
fnp-5343	889	10	da	da	PROPN
fnp-5343	889	11	,	,	PUNCT
fnp-5343	889	12	videckis	videckis	PROPN
fnp-5343	889	13	aj	aj	PROPN
fnp-5343	889	14	,	,	PUNCT
fnp-5343	889	15	narpala	narpala	PROPN
fnp-5343	889	16	sr	sr	PROPN
fnp-5343	889	17	,	,	PUNCT
fnp-5343	889	18	o’connell	o’connell	PROPN
fnp-5343	889	19	se	se	PROPN
fnp-5343	889	20	,	,	PUNCT
fnp-5343	889	21	et	et	PROPN
fnp-5343	889	22	al	al	PROPN
fnp-5343	889	23	.	.	PUNCT
fnp-5343	890	1	deep	deep	ADJ
fnp-5343	890	2	phenotyping	phenotyping	NOUN
fnp-5343	890	3	of	of	ADP
fnp-5343	890	4	neurologic	neurologic	ADJ
fnp-5343	890	5	postacute	postacute	NOUN
fnp-5343	890	6	sequelae	sequelae	NOUN
fnp-5343	890	7	of	of	ADP
fnp-5343	890	8	sars	sar	NOUN
fnp-5343	890	9	-	-	PUNCT
fnp-5343	890	10	cov-2	cov-2	PART
fnp-5343	890	11	infection	infection	NOUN
fnp-5343	890	12	.	.	PUNCT
fnp-5343	891	1	neurol	neurol	PROPN
fnp-5343	891	2	neuroimmunol	neuroimmunol	PROPN
fnp-5343	891	3	neuroinflamm	neuroinflamm	PROPN
fnp-5343	891	4	2023;10	2023;10	NOUN
fnp-5343	891	5	:	:	PUNCT
fnp-5343	891	6	e200097	e200097	NOUN
fnp-5343	891	7	.	.	PUNCT
fnp-5343	892	1	https://doi.org/10.1212/nxi.0000000000200097	https://doi.org/10.1212/nxi.0000000000200097	PROPN
fnp-5343	892	2	.	.	PUNCT
fnp-5343	893	1	165	165	NUM
fnp-5343	893	2	.	.	PUNCT
fnp-5343	894	1	nalbandian	nalbandian	PROPN
fnp-5343	894	2	a	a	X
fnp-5343	894	3	,	,	PUNCT
fnp-5343	894	4	sehgal	sehgal	PROPN
fnp-5343	894	5	k	k	PROPN
fnp-5343	894	6	,	,	PUNCT
fnp-5343	894	7	gupta	gupta	PROPN
fnp-5343	894	8	a	a	PROPN
fnp-5343	894	9	,	,	PUNCT
fnp-5343	894	10	madhavan	madhavan	PROPN
fnp-5343	894	11	mv	mv	PROPN
fnp-5343	894	12	,	,	PUNCT
fnp-5343	894	13	mcgroder	mcgroder	NOUN
fnp-5343	894	14	c	c	PROPN
fnp-5343	894	15	,	,	PUNCT
fnp-5343	894	16	stevens	stevens	PROPN
fnp-5343	894	17	js	js	PROPN
fnp-5343	894	18	,	,	PUNCT
fnp-5343	894	19	et	et	PROPN
fnp-5343	894	20	al	al	PROPN
fnp-5343	894	21	.	.	PUNCT
fnp-5343	895	1	post	post	ADJ
fnp-5343	895	2	-	-	ADJ
fnp-5343	895	3	acute	acute	ADJ
fnp-5343	895	4	covid-19	covid-19	PROPN
fnp-5343	895	5	syndrome	syndrome	NOUN
fnp-5343	895	6	.	.	PUNCT
fnp-5343	896	1	nat	nat	PROPN
fnp-5343	896	2	med	med	PROPN
fnp-5343	896	3	2021;27:601–15	2021;27:601–15	PROPN
fnp-5343	896	4	.	.	PUNCT
fnp-5343	897	1	https://doi.org/10.1038/s41591-021-01283-z	https://doi.org/10.1038/s41591-021-01283-z	PROPN
fnp-5343	897	2	.	.	PROPN
fnp-5343	898	1	166	166	NUM
fnp-5343	898	2	.	.	PUNCT
fnp-5343	899	1	lam	lam	PROPN
fnp-5343	899	2	mhb	mhb	PROPN
fnp-5343	899	3	,	,	PUNCT
fnp-5343	899	4	wing	wing	NOUN
fnp-5343	899	5	yk	yk	PROPN
fnp-5343	899	6	,	,	PUNCT
fnp-5343	899	7	yu	yu	PROPN
fnp-5343	899	8	mwm	mwm	PROPN
fnp-5343	899	9	,	,	PUNCT
fnp-5343	899	10	leung	leung	PROPN
fnp-5343	899	11	cm	cm	PROPN
fnp-5343	899	12	,	,	PUNCT
fnp-5343	899	13	ma	ma	PROPN
fnp-5343	899	14	rcw	rcw	PROPN
fnp-5343	899	15	,	,	PUNCT
fnp-5343	899	16	kong	kong	PROPN
fnp-5343	899	17	aps	aps	PROPN
fnp-5343	899	18	,	,	PUNCT
fnp-5343	899	19	et	et	PROPN
fnp-5343	899	20	al	al	PROPN
fnp-5343	899	21	.	.	PROPN
fnp-5343	900	1	mental	mental	ADJ
fnp-5343	900	2	morbidities	morbidity	NOUN
fnp-5343	900	3	and	and	CCONJ
fnp-5343	900	4	chronic	chronic	ADJ
fnp-5343	900	5	fatigue	fatigue	NOUN
fnp-5343	900	6	in	in	ADP
fnp-5343	900	7	severe	severe	ADJ
fnp-5343	900	8	acute	acute	ADJ
fnp-5343	900	9	respiratory	respiratory	ADJ
fnp-5343	900	10	syndrome	syndrome	NOUN
fnp-5343	900	11	survivors	survivor	NOUN
fnp-5343	900	12	:	:	PUNCT
fnp-5343	900	13	long	long	ADJ
fnp-5343	900	14	-	-	PUNCT
fnp-5343	900	15	term	term	NOUN
fnp-5343	900	16	follow	follow	NOUN
fnp-5343	900	17	-	-	PUNCT
fnp-5343	900	18	up	up	NOUN
fnp-5343	900	19	.	.	PUNCT
fnp-5343	901	1	arch	arch	ADJ
fnp-5343	901	2	intern	intern	NOUN
fnp-5343	901	3	med	med	PROPN
fnp-5343	901	4	2009;169:2142–7	2009;169:2142–7	PROPN
fnp-5343	901	5	.	.	PUNCT
fnp-5343	902	1	https://doi.org/10.1001/archinternmed.2009.384	https://doi.org/10.1001/archinternmed.2009.384	PROPN
fnp-5343	902	2	.	.	PUNCT
fnp-5343	903	1	167	167	NUM
fnp-5343	903	2	.	.	PUNCT
fnp-5343	903	3	aschman	aschman	PROPN
fnp-5343	903	4	t	t	PROPN
fnp-5343	903	5	,	,	PUNCT
fnp-5343	903	6	mothes	mothe	VERB
fnp-5343	903	7	r	r	PROPN
fnp-5343	903	8	,	,	PUNCT
fnp-5343	903	9	heppner	heppner	PROPN
fnp-5343	903	10	fl	fl	PROPN
fnp-5343	903	11	,	,	PUNCT
fnp-5343	903	12	radbruch	radbruch	PROPN
fnp-5343	903	13	h.	h.	PROPN
fnp-5343	903	14	what	what	PRON
fnp-5343	903	15	sars	sar	NOUN
fnp-5343	903	16	-	-	PUNCT
fnp-5343	903	17	cov-2	cov-2	NOUN
fnp-5343	903	18	does	do	VERB
fnp-5343	903	19	to	to	ADP
fnp-5343	903	20	our	our	PRON
fnp-5343	903	21	brains	brain	NOUN
fnp-5343	903	22	.	.	PUNCT
fnp-5343	904	1	immunity	immunity	NOUN
fnp-5343	904	2	2022;55:1159–72	2022;55:1159–72	NUM
fnp-5343	904	3	.	.	PUNCT
fnp-5343	905	1	https://doi.org/10.1016/j.immuni.2022.06.013	https://doi.org/10.1016/j.immuni.2022.06.013	PROPN
fnp-5343	905	2	.	.	PUNCT
fnp-5343	906	1	168	168	NUM
fnp-5343	906	2	.	.	PUNCT
fnp-5343	907	1	annane	annane	PROPN
fnp-5343	907	2	d	d	PROPN
fnp-5343	907	3	,	,	PUNCT
fnp-5343	907	4	sharshar	sharshar	ADJ
fnp-5343	907	5	t.	t.	NOUN
fnp-5343	907	6	cognitive	cognitive	ADJ
fnp-5343	907	7	decline	decline	NOUN
fnp-5343	907	8	after	after	ADP
fnp-5343	907	9	sepsis	sepsis	NOUN
fnp-5343	907	10	.	.	PUNCT
fnp-5343	908	1	lancet	lancet	PROPN
fnp-5343	908	2	respir	respir	VERB
fnp-5343	908	3	med	med	ADJ
fnp-5343	908	4	2015;3:61–9	2015;3:61–9	PROPN
fnp-5343	908	5	.	.	PUNCT
fnp-5343	909	1	https://doi.org/10.1016/s2213-2600(14)70246-2	https://doi.org/10.1016/s2213-2600(14)70246-2	PROPN
fnp-5343	909	2	.	.	PUNCT
fnp-5343	910	1	169	169	NUM
fnp-5343	910	2	.	.	PUNCT
fnp-5343	911	1	lamar	lamar	PROPN
fnp-5343	911	2	cd	cd	PROPN
fnp-5343	911	3	,	,	PUNCT
fnp-5343	911	4	hurley	hurley	PROPN
fnp-5343	911	5	ra	ra	PROPN
fnp-5343	911	6	,	,	PUNCT
fnp-5343	911	7	taber	taber	PROPN
fnp-5343	911	8	kh	kh	PROPN
fnp-5343	911	9	.	.	PROPN
fnp-5343	911	10	sepsis	sepsis	NOUN
fnp-5343	911	11	-	-	PUNCT
fnp-5343	911	12	associated	associate	VERB
fnp-5343	911	13	encephalopathy	encephalopathy	NOUN
fnp-5343	911	14	:	:	PUNCT
fnp-5343	911	15	review	review	NOUN
fnp-5343	911	16	of	of	ADP
fnp-5343	911	17	the	the	DET
fnp-5343	911	18	neuropsychiatric	neuropsychiatric	ADJ
fnp-5343	911	19	manifestations	manifestation	NOUN
fnp-5343	911	20	and	and	CCONJ
fnp-5343	911	21	cognitive	cognitive	ADJ
fnp-5343	911	22	outcome	outcome	NOUN
fnp-5343	911	23	.	.	PUNCT
fnp-5343	912	1	j	j	PROPN
fnp-5343	912	2	neuropsychiatry	neuropsychiatry	PROPN
fnp-5343	912	3	clin	clin	PROPN
fnp-5343	912	4	neurosci	neurosci	PROPN
fnp-5343	912	5	2011;23:237–41	2011;23:237–41	X
fnp-5343	912	6	.	.	PUNCT
fnp-5343	913	1	https://doi.org/10.1176/jnp.23.3.jnp237	https://doi.org/10.1176/jnp.23.3.jnp237	PROPN
fnp-5343	913	2	.	.	PROPN
fnp-5343	914	1	170	170	NUM
fnp-5343	914	2	.	.	PUNCT
fnp-5343	915	1	al	al	PROPN
fnp-5343	915	2	-	-	PUNCT
fnp-5343	915	3	aly	aly	PROPN
fnp-5343	915	4	z	z	PROPN
fnp-5343	915	5	,	,	PUNCT
fnp-5343	915	6	xie	xie	PROPN
fnp-5343	915	7	y	y	PROPN
fnp-5343	915	8	,	,	PUNCT
fnp-5343	915	9	bowe	bowe	PROPN
fnp-5343	915	10	b.	b.	PROPN
fnp-5343	915	11	high	high	ADV
fnp-5343	915	12	-	-	PUNCT
fnp-5343	915	13	dimensional	dimensional	ADJ
fnp-5343	915	14	characterization	characterization	NOUN
fnp-5343	915	15	of	of	ADP
fnp-5343	915	16	post	post	ADJ
fnp-5343	915	17	-	-	ADJ
fnp-5343	915	18	acute	acute	ADJ
fnp-5343	915	19	sequelae	sequelae	NOUN
fnp-5343	915	20	of	of	ADP
fnp-5343	915	21	covid-19	covid-19	PROPN
fnp-5343	915	22	.	.	PUNCT
fnp-5343	915	23	nature	nature	PROPN
fnp-5343	915	24	2021;594:259–64	2021;594:259–64	PROPN
fnp-5343	915	25	.	.	PROPN
fnp-5343	915	26	https://doi.org/10.1038/s41586-021-03553-9	https://doi.org/10.1038/s41586-021-03553-9	NUM
fnp-5343	915	27	.	.	PUNCT
fnp-5343	916	1	171	171	NUM
fnp-5343	916	2	.	.	PUNCT
fnp-5343	917	1	perez	perez	PROPN
fnp-5343	917	2	giraldo	giraldo	PROPN
fnp-5343	917	3	gs	gs	PROPN
fnp-5343	917	4	,	,	PUNCT
fnp-5343	917	5	ali	ali	PROPN
fnp-5343	917	6	st	st	PROPN
fnp-5343	917	7	,	,	PUNCT
fnp-5343	917	8	kang	kang	PROPN
fnp-5343	917	9	ak	ak	PROPN
fnp-5343	917	10	,	,	PUNCT
fnp-5343	917	11	patel	patel	NOUN
fnp-5343	917	12	tr	tr	VERB
fnp-5343	917	13	,	,	PUNCT
fnp-5343	917	14	budhiraja	budhiraja	PROPN
fnp-5343	917	15	s	s	PROPN
fnp-5343	917	16	,	,	PUNCT
fnp-5343	917	17	gaelen	gaelen	PROPN
fnp-5343	917	18	ji	ji	PROPN
fnp-5343	917	19	,	,	PUNCT
fnp-5343	917	20	et	et	PROPN
fnp-5343	917	21	al	al	PROPN
fnp-5343	917	22	.	.	PUNCT
fnp-5343	918	1	neurologic	neurologic	ADJ
fnp-5343	918	2	manifestations	manifestation	NOUN
fnp-5343	918	3	of	of	ADP
fnp-5343	918	4	long	long	ADJ
fnp-5343	918	5	covid	covid	NOUN
fnp-5343	918	6	differ	differ	VERB
fnp-5343	918	7	based	base	VERB
fnp-5343	918	8	on	on	ADP
fnp-5343	918	9	acute	acute	ADJ
fnp-5343	918	10	covid-19	covid-19	PROPN
fnp-5343	918	11	severity	severity	NOUN
fnp-5343	918	12	.	.	PUNCT
fnp-5343	919	1	ann	ann	PROPN
fnp-5343	919	2	neurol	neurol	PROPN
fnp-5343	919	3	2023;94:146	2023;94:146	PROPN
fnp-5343	919	4	-	-	SYM
fnp-5343	919	5	59	59	NUM
fnp-5343	919	6	.	.	PUNCT
fnp-5343	920	1	https://doi.org/10.1002/ana.26649	https://doi.org/10.1002/ana.26649	NOUN
fnp-5343	920	2	.	.	PUNCT
fnp-5343	921	1	172	172	NUM
fnp-5343	921	2	.	.	PUNCT
fnp-5343	922	1	al	al	PROPN
fnp-5343	922	2	-	-	PUNCT
fnp-5343	922	3	aly	aly	PROPN
fnp-5343	922	4	z	z	PROPN
fnp-5343	922	5	,	,	PUNCT
fnp-5343	922	6	bowe	bowe	PROPN
fnp-5343	922	7	b	b	PROPN
fnp-5343	922	8	,	,	PUNCT
fnp-5343	922	9	xie	xie	PROPN
fnp-5343	922	10	y.	y.	PROPN
fnp-5343	922	11	long	long	PROPN
fnp-5343	922	12	covid	covid	PROPN
fnp-5343	922	13	after	after	ADP
fnp-5343	922	14	breakthrough	breakthrough	NOUN
fnp-5343	922	15	sars	sar	NOUN
fnp-5343	922	16	-	-	PUNCT
fnp-5343	922	17	cov-2	cov-2	PART
fnp-5343	922	18	infection	infection	NOUN
fnp-5343	922	19	.	.	PUNCT
fnp-5343	923	1	nat	nat	PROPN
fnp-5343	923	2	med	med	PROPN
fnp-5343	923	3	2022;28:1461–7	2022;28:1461–7	PROPN
fnp-5343	923	4	.	.	PUNCT
fnp-5343	923	5	https://doi.org/10.1038/s41591-022-01840-0	https://doi.org/10.1038/s41591-022-01840-0	NUM
fnp-5343	923	6	.	.	PUNCT
fnp-5343	924	1	173	173	NUM
fnp-5343	924	2	.	.	PUNCT
fnp-5343	925	1	afsahi	afsahi	NOUN
fnp-5343	925	2	am	be	AUX
fnp-5343	925	3	,	,	PUNCT
fnp-5343	925	4	norbash	norbash	NOUN
fnp-5343	925	5	am	be	AUX
fnp-5343	925	6	,	,	PUNCT
fnp-5343	925	7	syed	syed	ADJ
fnp-5343	925	8	sf	sf	PROPN
fnp-5343	925	9	,	,	PUNCT
fnp-5343	925	10	sedaghat	sedaghat	PRON
fnp-5343	925	11	m	m	ADV
fnp-5343	925	12	,	,	PUNCT
fnp-5343	925	13	afsahi	afsahi	NOUN
fnp-5343	925	14	g	g	NOUN
fnp-5343	925	15	,	,	PUNCT
fnp-5343	925	16	shahidi	shahidi	NOUN
fnp-5343	925	17	r	r	NOUN
fnp-5343	925	18	,	,	PUNCT
fnp-5343	925	19	et	et	PROPN
fnp-5343	925	20	al	al	PROPN
fnp-5343	925	21	.	.	PROPN
fnp-5343	925	22	brain	brain	PROPN
fnp-5343	925	23	mri	mri	NOUN
fnp-5343	925	24	findings	finding	NOUN
fnp-5343	925	25	in	in	ADP
fnp-5343	925	26	neurologically	neurologically	ADV
fnp-5343	925	27	symptomatic	symptomatic	ADJ
fnp-5343	925	28	covid-19	covid-19	PROPN
fnp-5343	925	29	patients	patient	NOUN
fnp-5343	925	30	:	:	PUNCT
fnp-5343	925	31	a	a	DET
fnp-5343	925	32	systematic	systematic	ADJ
fnp-5343	925	33	review	review	NOUN
fnp-5343	925	34	and	and	CCONJ
fnp-5343	925	35	meta	meta	ADJ
fnp-5343	925	36	-	-	PUNCT
fnp-5343	925	37	analysis	analysis	NOUN
fnp-5343	925	38	.	.	PUNCT
fnp-5343	926	1	j	j	PROPN
fnp-5343	926	2	neurol	neurol	PROPN
fnp-5343	926	3	2023;270:5131–54	2023;270:5131–54	NUM
fnp-5343	926	4	.	.	PUNCT
fnp-5343	927	1	https://doi.org/10.1007/s00415-023-11914-9	https://doi.org/10.1007/s00415-023-11914-9	NUM
fnp-5343	927	2	.	.	PUNCT
fnp-5343	928	1	174	174	NUM
fnp-5343	928	2	.	.	PUNCT
fnp-5343	929	1	chakravarty	chakravarty	PROPN
fnp-5343	929	2	n	n	CCONJ
fnp-5343	929	3	,	,	PUNCT
fnp-5343	929	4	senthilnathan	senthilnathan	PROPN
fnp-5343	929	5	t	t	PROPN
fnp-5343	929	6	,	,	PUNCT
fnp-5343	929	7	paiola	paiola	PROPN
fnp-5343	929	8	s	s	PROPN
fnp-5343	929	9	,	,	PUNCT
fnp-5343	929	10	gyani	gyani	X
fnp-5343	929	11	p	p	NOUN
fnp-5343	929	12	,	,	PUNCT
fnp-5343	929	13	castillo	castillo	PROPN
fnp-5343	929	14	cario	cario	PROPN
fnp-5343	929	15	s	s	PROPN
fnp-5343	929	16	,	,	PUNCT
fnp-5343	929	17	urena	urena	NOUN
fnp-5343	929	18	e	e	NOUN
fnp-5343	929	19	,	,	PUNCT
fnp-5343	929	20	et	et	PROPN
fnp-5343	929	21	al	al	PROPN
fnp-5343	929	22	.	.	PROPN
fnp-5343	930	1	neurological	neurological	ADJ
fnp-5343	930	2	pathophysiology	pathophysiology	NOUN
fnp-5343	930	3	of	of	ADP
fnp-5343	930	4	sars	sar	NOUN
fnp-5343	930	5	-	-	PUNCT
fnp-5343	930	6	cov-2	cov-2	PUNCT
fnp-5343	930	7	and	and	CCONJ
fnp-5343	930	8	pandemic	pandemic	ADJ
fnp-5343	930	9	potential	potential	ADJ
fnp-5343	930	10	rna	rna	NOUN
fnp-5343	930	11	viruses	virus	NOUN
fnp-5343	930	12	:	:	PUNCT
fnp-5343	930	13	a	a	DET
fnp-5343	930	14	comparative	comparative	ADJ
fnp-5343	930	15	analysis	analysis	NOUN
fnp-5343	930	16	.	.	PUNCT
fnp-5343	931	1	febs	febs	NOUN
fnp-5343	931	2	lett	lett	PROPN
fnp-5343	931	3	2021;595:2854–71	2021;595:2854–71	NUM
fnp-5343	931	4	.	.	PUNCT
fnp-5343	932	1	https://doi.org/10.1002/1873-3468.14227	https://doi.org/10.1002/1873-3468.14227	PROPN
fnp-5343	932	2	.	.	PUNCT
fnp-5343	933	1	175	175	NUM
fnp-5343	933	2	.	.	PUNCT
fnp-5343	934	1	hosp	hosp	PROPN
fnp-5343	934	2	ja	ja	PROPN
fnp-5343	934	3	,	,	PUNCT
fnp-5343	934	4	dressing	dress	VERB
fnp-5343	934	5	a	a	PRON
fnp-5343	934	6	,	,	PUNCT
fnp-5343	934	7	blazhenets	blazhenet	NOUN
fnp-5343	934	8	g	g	PROPN
fnp-5343	934	9	,	,	PUNCT
fnp-5343	934	10	bormann	bormann	PROPN
fnp-5343	934	11	t	t	PROPN
fnp-5343	934	12	,	,	PUNCT
fnp-5343	934	13	rau	rau	PROPN
fnp-5343	934	14	a	a	PROPN
fnp-5343	934	15	,	,	PUNCT
fnp-5343	934	16	schwabenland	schwabenland	NOUN
fnp-5343	934	17	m	m	PROPN
fnp-5343	934	18	,	,	PUNCT
fnp-5343	934	19	et	et	PROPN
fnp-5343	934	20	al	al	PROPN
fnp-5343	934	21	.	.	PROPN
fnp-5343	934	22	cognitive	cognitive	ADJ
fnp-5343	934	23	impairment	impairment	NOUN
fnp-5343	934	24	and	and	CCONJ
fnp-5343	934	25	altered	alter	VERB
fnp-5343	934	26	cerebral	cerebral	ADJ
fnp-5343	934	27	glucose	glucose	NOUN
fnp-5343	934	28	metabolism	metabolism	NOUN
fnp-5343	934	29	in	in	ADP
fnp-5343	934	30	the	the	DET
fnp-5343	934	31	subacute	subacute	ADJ
fnp-5343	934	32	stage	stage	NOUN
fnp-5343	934	33	of	of	ADP
fnp-5343	934	34	covid-19	covid-19	PROPN
fnp-5343	934	35	.	.	PUNCT
fnp-5343	935	1	brain	brain	PROPN
fnp-5343	935	2	2021;144:1263–76	2021;144:1263–76	NUM
fnp-5343	935	3	.	.	PUNCT
fnp-5343	936	1	https://doi.org/10.1093/brain/awab009	https://doi.org/10.1093/brain/awab009	X
fnp-5343	936	2	.	.	PROPN
fnp-5343	937	1	176	176	NUM
fnp-5343	937	2	.	.	PUNCT
fnp-5343	938	1	blazhenets	blazhenet	NOUN
fnp-5343	938	2	g	g	PROPN
fnp-5343	938	3	,	,	PUNCT
fnp-5343	938	4	schroeter	schroeter	NOUN
fnp-5343	938	5	n	n	NOUN
fnp-5343	938	6	,	,	PUNCT
fnp-5343	938	7	bormann	bormann	PROPN
fnp-5343	938	8	t	t	PROPN
fnp-5343	938	9	,	,	PUNCT
fnp-5343	938	10	thurow	thurow	PROPN
fnp-5343	938	11	j	j	PROPN
fnp-5343	938	12	,	,	PUNCT
fnp-5343	938	13	wagner	wagner	PROPN
fnp-5343	938	14	d	d	PROPN
fnp-5343	938	15	,	,	PUNCT
fnp-5343	938	16	frings	frings	PROPN
fnp-5343	938	17	l	l	PROPN
fnp-5343	938	18	,	,	PUNCT
fnp-5343	938	19	et	et	PROPN
fnp-5343	938	20	al	al	PROPN
fnp-5343	938	21	.	.	PROPN
fnp-5343	939	1	slow	slow	ADJ
fnp-5343	939	2	but	but	CCONJ
fnp-5343	939	3	evident	evident	ADJ
fnp-5343	939	4	recovery	recovery	NOUN
fnp-5343	939	5	from	from	ADP
fnp-5343	939	6	neocortical	neocortical	ADJ
fnp-5343	939	7	dysfunction	dysfunction	NOUN
fnp-5343	939	8	and	and	CCONJ
fnp-5343	939	9	cognitive	cognitive	ADJ
fnp-5343	939	10	impairment	impairment	NOUN
fnp-5343	939	11	in	in	ADP
fnp-5343	939	12	a	a	DET
fnp-5343	939	13	series	series	NOUN
fnp-5343	939	14	of	of	ADP
fnp-5343	939	15	chronic	chronic	ADJ
fnp-5343	939	16	covid-19	covid-19	PROPN
fnp-5343	939	17	patients	patient	NOUN
fnp-5343	939	18	.	.	PUNCT
fnp-5343	940	1	j	j	PROPN
fnp-5343	940	2	nucl	nucl	PROPN
fnp-5343	940	3	med	me	VERB
fnp-5343	940	4	2021;62:910–5	2021;62:910–5	NUM
fnp-5343	940	5	.	.	PUNCT
fnp-5343	941	1	https://doi.org/10.2967/jnumed.121.262128	https://doi.org/10.2967/jnumed.121.262128	NOUN
fnp-5343	941	2	.	.	PUNCT
fnp-5343	942	1	177	177	NUM
fnp-5343	942	2	.	.	PUNCT
fnp-5343	942	3	douaud	douaud	VERB
fnp-5343	942	4	g	g	PROPN
fnp-5343	942	5	,	,	PUNCT
fnp-5343	942	6	lee	lee	PROPN
fnp-5343	942	7	s	s	PROPN
fnp-5343	942	8	,	,	PUNCT
fnp-5343	942	9	alfaro	alfaro	PROPN
fnp-5343	942	10	-	-	PUNCT
fnp-5343	942	11	almagro	almagro	PROPN
fnp-5343	942	12	f	f	PROPN
fnp-5343	942	13	,	,	PUNCT
fnp-5343	942	14	arthofer	arthofer	NOUN
fnp-5343	942	15	c	c	PROPN
fnp-5343	942	16	,	,	PUNCT
fnp-5343	942	17	wang	wang	PROPN
fnp-5343	942	18	c	c	PROPN
fnp-5343	942	19	,	,	PUNCT
fnp-5343	942	20	mccarthy	mccarthy	PROPN
fnp-5343	942	21	p	p	X
fnp-5343	942	22	,	,	PUNCT
fnp-5343	942	23	et	et	PROPN
fnp-5343	942	24	al	al	PROPN
fnp-5343	942	25	.	.	PUNCT
fnp-5343	943	1	sars	sars	PROPN
fnp-5343	943	2	-	-	PUNCT
fnp-5343	943	3	cov-2	cov-2	NUM
fnp-5343	943	4	is	be	AUX
fnp-5343	943	5	associated	associate	VERB
fnp-5343	943	6	with	with	ADP
fnp-5343	943	7	changes	change	NOUN
fnp-5343	943	8	in	in	ADP
fnp-5343	943	9	brain	brain	NOUN
fnp-5343	943	10	structure	structure	NOUN
fnp-5343	943	11	in	in	ADP
fnp-5343	943	12	uk	uk	PROPN
fnp-5343	943	13	biobank	biobank	PROPN
fnp-5343	943	14	.	.	PUNCT
fnp-5343	944	1	nature	nature	NOUN
fnp-5343	944	2	2022;604:697–707	2022;604:697–707	NOUN
fnp-5343	944	3	.	.	PUNCT
fnp-5343	945	1	https://doi.org/10.1038/s41586-022-04569-5	https://doi.org/10.1038/s41586-022-04569-5	NUM
fnp-5343	945	2	.	.	PUNCT
fnp-5343	946	1	178	178	NUM
fnp-5343	946	2	.	.	PUNCT
fnp-5343	946	3	du	du	PROPN
fnp-5343	946	4	y	y	PROPN
fnp-5343	946	5	,	,	PUNCT
fnp-5343	946	6	zhao	zhao	PROPN
fnp-5343	946	7	w	w	PROPN
fnp-5343	946	8	,	,	PUNCT
fnp-5343	946	9	huang	huang	PROPN
fnp-5343	946	10	s	s	PROPN
fnp-5343	946	11	,	,	PUNCT
fnp-5343	946	12	huang	huang	PROPN
fnp-5343	946	13	c	c	PROPN
fnp-5343	946	14	,	,	PUNCT
fnp-5343	946	15	li	li	PROPN
fnp-5343	946	16	c	c	PROPN
fnp-5343	946	17	,	,	PUNCT
fnp-5343	946	18	chen	chen	PROPN
fnp-5343	946	19	y	y	PROPN
fnp-5343	946	20	,	,	PUNCT
fnp-5343	946	21	et	et	PROPN
fnp-5343	946	22	al	al	PROPN
fnp-5343	946	23	.	.	PROPN
fnp-5343	946	24	gray	gray	ADJ
fnp-5343	946	25	matter	matter	NOUN
fnp-5343	946	26	thickness	thickness	NOUN
fnp-5343	946	27	and	and	CCONJ
fnp-5343	946	28	subcortical	subcortical	ADJ
fnp-5343	946	29	nuclear	nuclear	ADJ
fnp-5343	946	30	volume	volume	NOUN
fnp-5343	946	31	in	in	ADP
fnp-5343	946	32	men	man	NOUN
fnp-5343	946	33	after	after	ADP
fnp-5343	946	34	sars	sar	NOUN
fnp-5343	946	35	-	-	PUNCT
fnp-5343	946	36	cov-2	cov-2	NOUN
fnp-5343	946	37	omicron	omicron	PROPN
fnp-5343	946	38	infection	infection	NOUN
fnp-5343	946	39	.	.	PUNCT
fnp-5343	947	1	jama	jama	PROPN
fnp-5343	947	2	netw	netw	PROPN
fnp-5343	947	3	open	open	ADJ
fnp-5343	947	4	2023;6	2023;6	PRON
fnp-5343	947	5	:	:	PUNCT
fnp-5343	947	6	e2345626	e2345626	PROPN
fnp-5343	947	7	.	.	PUNCT
fnp-5343	948	1	https://doi.org/10.1001/jamanetworkopen.2023.45626	https://doi.org/10.1001/jamanetworkopen.2023.45626	PROPN
fnp-5343	948	2	.	.	PUNCT
fnp-5343	948	3	179	179	NUM
fnp-5343	948	4	.	.	PUNCT
fnp-5343	949	1	díez	díez	PROPN
fnp-5343	949	2	-	-	PUNCT
fnp-5343	949	3	cirarda	cirarda	PROPN
fnp-5343	949	4	m	m	PROPN
fnp-5343	949	5	,	,	PUNCT
fnp-5343	949	6	yus	yus	PROPN
fnp-5343	949	7	m	m	PROPN
fnp-5343	949	8	,	,	PUNCT
fnp-5343	949	9	gómez	gómez	NOUN
fnp-5343	949	10	-	-	PUNCT
fnp-5343	949	11	ruiz	ruiz	NOUN
fnp-5343	949	12	n	n	NOUN
fnp-5343	949	13	,	,	PUNCT
fnp-5343	949	14	polidura	polidura	NOUN
fnp-5343	949	15	c	c	PROPN
fnp-5343	949	16	,	,	PUNCT
fnp-5343	949	17	gil	gil	PROPN
fnp-5343	949	18	-	-	PUNCT
fnp-5343	949	19	martínez	martínez	PROPN
fnp-5343	949	20	l	l	NOUN
fnp-5343	949	21	,	,	PUNCT
fnp-5343	949	22	delgado	delgado	NOUN
fnp-5343	949	23	-	-	PUNCT
fnp-5343	949	24	alonso	alonso	PROPN
fnp-5343	949	25	c	c	NOUN
fnp-5343	949	26	,	,	PUNCT
fnp-5343	949	27	et	et	PROPN
fnp-5343	949	28	al	al	PROPN
fnp-5343	949	29	.	.	PUNCT
fnp-5343	949	30	multimodal	multimodal	NOUN
fnp-5343	949	31	neuroimaging	neuroimaging	NOUN
fnp-5343	949	32	in	in	ADP
fnp-5343	949	33	post	post	ADJ
fnp-5343	949	34	-	-	ADJ
fnp-5343	949	35	covid	covid	ADJ
fnp-5343	949	36	syndrome	syndrome	NOUN
fnp-5343	949	37	and	and	CCONJ
fnp-5343	949	38	correlation	correlation	NOUN
fnp-5343	949	39	with	with	ADP
fnp-5343	949	40	cognition	cognition	NOUN
fnp-5343	949	41	.	.	PUNCT
fnp-5343	950	1	brain	brain	PROPN
fnp-5343	950	2	2023;146:2142–52	2023;146:2142–52	PROPN
fnp-5343	950	3	.	.	PUNCT
fnp-5343	951	1	https://doi.org/10.1093/brain/awac384	https://doi.org/10.1093/brain/awac384	X
fnp-5343	951	2	.	.	PUNCT
fnp-5343	952	1	180	180	NUM
fnp-5343	952	2	.	.	PUNCT
fnp-5343	953	1	solomon	solomon	PROPN
fnp-5343	953	2	ih	ih	PROPN
fnp-5343	953	3	,	,	PUNCT
fnp-5343	953	4	singh	singh	PROPN
fnp-5343	953	5	a	a	PRON
fnp-5343	953	6	,	,	PUNCT
fnp-5343	953	7	folkerth	folkerth	PROPN
fnp-5343	953	8	rd	rd	PROPN
fnp-5343	953	9	,	,	PUNCT
fnp-5343	953	10	mukerji	mukerji	PROPN
fnp-5343	953	11	ss	ss	PROPN
fnp-5343	953	12	.	.	PUNCT
fnp-5343	954	1	what	what	PRON
fnp-5343	954	2	can	can	AUX
fnp-5343	954	3	we	we	PRON
fnp-5343	954	4	still	still	ADV
fnp-5343	954	5	learn	learn	VERB
fnp-5343	954	6	from	from	ADP
fnp-5343	954	7	brain	brain	NOUN
fnp-5343	954	8	autopsies	autopsy	NOUN
fnp-5343	954	9	in	in	ADP
fnp-5343	954	10	covid-19	covid-19	PROPN
fnp-5343	954	11	?	?	PUNCT
fnp-5343	955	1	semin	semin	PROPN
fnp-5343	955	2	neurol	neurol	PROPN
fnp-5343	955	3	2023;43:195	2023;43:195	PROPN
fnp-5343	955	4	-	-	SYM
fnp-5343	955	5	204	204	NUM
fnp-5343	955	6	.	.	PUNCT
fnp-5343	956	1	https://doi.org/10.1055/s-0043-1767716	https://doi.org/10.1055/s-0043-1767716	NOUN
fnp-5343	956	2	.	.	PUNCT
fnp-5343	957	1	181	181	NUM
fnp-5343	957	2	.	.	PUNCT
fnp-5343	958	1	al	al	PROPN
fnp-5343	958	2	-	-	PUNCT
fnp-5343	958	3	sarraj	sarraj	VERB
fnp-5343	958	4	s	s	PROPN
fnp-5343	958	5	,	,	PUNCT
fnp-5343	958	6	troakes	troake	VERB
fnp-5343	958	7	c	c	PROPN
fnp-5343	958	8	,	,	PUNCT
fnp-5343	958	9	hanley	hanley	PROPN
fnp-5343	958	10	b	b	PROPN
fnp-5343	958	11	,	,	PUNCT
fnp-5343	958	12	osborn	osborn	PROPN
fnp-5343	958	13	m	m	PROPN
fnp-5343	958	14	,	,	PUNCT
fnp-5343	958	15	richardson	richardson	PROPN
fnp-5343	958	16	mp	mp	PROPN
fnp-5343	958	17	,	,	PUNCT
fnp-5343	958	18	hotopf	hotopf	PROPN
fnp-5343	958	19	m	m	PROPN
fnp-5343	958	20	,	,	PUNCT
fnp-5343	958	21	et	et	PROPN
fnp-5343	958	22	al	al	PROPN
fnp-5343	958	23	.	.	PROPN
fnp-5343	958	24	invited	invite	VERB
fnp-5343	958	25	review	review	NOUN
fnp-5343	958	26	:	:	PUNCT
fnp-5343	958	27	the	the	DET
fnp-5343	958	28	spectrum	spectrum	NOUN
fnp-5343	958	29	of	of	ADP
fnp-5343	958	30	neuropathology	neuropathology	NOUN
fnp-5343	958	31	in	in	ADP
fnp-5343	958	32	covid-19	covid-19	PROPN
fnp-5343	958	33	.	.	PUNCT
fnp-5343	958	34	neuropathol	neuropathol	PROPN
fnp-5343	958	35	appl	appl	PROPN
fnp-5343	958	36	neurobiol	neurobiol	PROPN
fnp-5343	958	37	2021;47:3–16	2021;47:3–16	NUM
fnp-5343	958	38	.	.	PUNCT
fnp-5343	959	1	https://doi.org/10.1111/nan.12667	https://doi.org/10.1111/nan.12667	INTJ
fnp-5343	959	2	.	.	PUNCT
fnp-5343	960	1	182	182	NUM
fnp-5343	960	2	.	.	PUNCT
fnp-5343	961	1	lebrun	lebrun	NOUN
fnp-5343	961	2	l	l	PROPN
fnp-5343	961	3	,	,	PUNCT
fnp-5343	961	4	absil	absil	NOUN
fnp-5343	961	5	l	l	NOUN
fnp-5343	961	6	,	,	PUNCT
fnp-5343	961	7	remmelink	remmelink	PROPN
fnp-5343	961	8	m	m	NOUN
fnp-5343	961	9	,	,	PUNCT
fnp-5343	961	10	de	de	X
fnp-5343	961	11	mendonça	mendonça	X
fnp-5343	961	12	r	r	NOUN
fnp-5343	961	13	,	,	PUNCT
fnp-5343	961	14	d’haene	d’haene	PROPN
fnp-5343	961	15	n	n	CCONJ
fnp-5343	961	16	,	,	PUNCT
fnp-5343	961	17	gaspard	gaspard	PROPN
fnp-5343	961	18	n	n	CCONJ
fnp-5343	961	19	,	,	PUNCT
fnp-5343	961	20	et	et	PROPN
fnp-5343	961	21	al	al	PROPN
fnp-5343	961	22	.	.	PUNCT
fnp-5343	962	1	sars	sars	PROPN
fnp-5343	962	2	-	-	PUNCT
fnp-5343	962	3	cov-2	cov-2	PART
fnp-5343	962	4	infection	infection	NOUN
fnp-5343	962	5	and	and	CCONJ
fnp-5343	962	6	neuropathological	neuropathological	ADJ
fnp-5343	962	7	findings	finding	NOUN
fnp-5343	962	8	:	:	PUNCT
fnp-5343	962	9	a	a	DET
fnp-5343	962	10	report	report	NOUN
fnp-5343	962	11	of	of	ADP
fnp-5343	962	12	18	18	NUM
fnp-5343	962	13	cases	case	NOUN
fnp-5343	962	14	and	and	CCONJ
fnp-5343	962	15	review	review	NOUN
fnp-5343	962	16	of	of	ADP
fnp-5343	962	17	the	the	DET
fnp-5343	962	18	literature	literature	NOUN
fnp-5343	962	19	.	.	PUNCT
fnp-5343	963	1	acta	acta	PROPN
fnp-5343	963	2	neuropathol	neuropathol	PROPN
fnp-5343	963	3	commun	commun	PROPN
fnp-5343	963	4	2023;11:78	2023;11:78	NUM
fnp-5343	963	5	.	.	PUNCT
fnp-5343	964	1	https://doi.org/10.1186/s40478-023-01566-1	https://doi.org/10.1186/s40478-023-01566-1	PROPN
fnp-5343	964	2	.	.	PUNCT
fnp-5343	965	1	183	183	NUM
fnp-5343	965	2	.	.	PUNCT
fnp-5343	966	1	maiese	maiese	PROPN
fnp-5343	966	2	a	a	PRON
fnp-5343	966	3	,	,	PUNCT
fnp-5343	966	4	manetti	manetti	ADJ
fnp-5343	966	5	ac	ac	PROPN
fnp-5343	966	6	,	,	PUNCT
fnp-5343	966	7	bosetti	bosetti	ADJ
fnp-5343	966	8	c	c	PROPN
fnp-5343	966	9	,	,	PUNCT
fnp-5343	966	10	del	del	PROPN
fnp-5343	966	11	duca	duca	PROPN
fnp-5343	966	12	f	f	PROPN
fnp-5343	966	13	,	,	PUNCT
fnp-5343	966	14	la	la	PRON
fnp-5343	966	15	russa	russa	NOUN
fnp-5343	966	16	r	r	NOUN
fnp-5343	966	17	,	,	PUNCT
fnp-5343	966	18	frati	frati	NOUN
fnp-5343	966	19	p	p	X
fnp-5343	966	20	,	,	PUNCT
fnp-5343	966	21	et	et	PROPN
fnp-5343	966	22	al	al	PROPN
fnp-5343	966	23	.	.	PUNCT
fnp-5343	967	1	sars	sars	PROPN
fnp-5343	967	2	-	-	PUNCT
fnp-5343	967	3	cov-2	cov-2	PUNCT
fnp-5343	967	4	and	and	CCONJ
fnp-5343	967	5	the	the	DET
fnp-5343	967	6	brain	brain	NOUN
fnp-5343	967	7	:	:	PUNCT
fnp-5343	967	8	a	a	DET
fnp-5343	967	9	review	review	NOUN
fnp-5343	967	10	of	of	ADP
fnp-5343	967	11	the	the	DET
fnp-5343	967	12	current	current	ADJ
fnp-5343	967	13	knowledge	knowledge	NOUN
fnp-5343	967	14	on	on	ADP
fnp-5343	967	15	neuropathology	neuropathology	NOUN
fnp-5343	967	16	in	in	ADP
fnp-5343	967	17	covid-19	covid-19	PROPN
fnp-5343	967	18	.	.	PUNCT
fnp-5343	967	19	brain	brain	NOUN
fnp-5343	967	20	pathol	pathol	NOUN
fnp-5343	967	21	2021;31	2021;31	NUM
fnp-5343	967	22	:	:	PUNCT
fnp-5343	967	23	e13013	e13013	PROPN
fnp-5343	967	24	.	.	PROPN
fnp-5343	968	1	https://doi.org/10.1111/bpa.13013	https://doi.org/10.1111/bpa.13013	PROPN
fnp-5343	968	2	.	.	PUNCT
fnp-5343	969	1	184	184	NUM
fnp-5343	969	2	.	.	PUNCT
fnp-5343	970	1	cosentino	cosentino	PROPN
fnp-5343	970	2	g	g	PROPN
fnp-5343	970	3	,	,	PUNCT
fnp-5343	970	4	todisco	todisco	VERB
fnp-5343	970	5	m	m	PROPN
fnp-5343	970	6	,	,	PUNCT
fnp-5343	970	7	hota	hota	NOUN
fnp-5343	970	8	n	n	CCONJ
fnp-5343	970	9	,	,	PUNCT
fnp-5343	970	10	della	della	PROPN
fnp-5343	970	11	porta	porta	NOUN
fnp-5343	970	12	g	g	PROPN
fnp-5343	970	13	,	,	PUNCT
fnp-5343	970	14	morbini	morbini	PROPN
fnp-5343	970	15	p	p	NOUN
fnp-5343	970	16	,	,	PUNCT
fnp-5343	970	17	tassorelli	tassorelli	VERB
fnp-5343	970	18	c	c	NOUN
fnp-5343	970	19	,	,	PUNCT
fnp-5343	970	20	et	et	PROPN
fnp-5343	970	21	al	al	PROPN
fnp-5343	970	22	.	.	PUNCT
fnp-5343	971	1	neuropathological	neuropathological	PROPN
fnp-5343	971	2	findings	finding	NOUN
fnp-5343	971	3	from	from	ADP
fnp-5343	971	4	covid-19	covid-19	PROPN
fnp-5343	971	5	patients	patient	NOUN
fnp-5343	971	6	with	with	ADP
fnp-5343	971	7	neurological	neurological	ADJ
fnp-5343	971	8	symptoms	symptom	NOUN
fnp-5343	971	9	argue	argue	VERB
fnp-5343	971	10	against	against	ADP
fnp-5343	971	11	a	a	DET
fnp-5343	971	12	direct	direct	ADJ
fnp-5343	971	13	brain	brain	NOUN
fnp-5343	971	14	invasion	invasion	NOUN
fnp-5343	971	15	of	of	ADP
fnp-5343	971	16	sars	sar	NOUN
fnp-5343	971	17	-	-	PUNCT
fnp-5343	971	18	cov-2	cov-2	NOUN
fnp-5343	971	19	:	:	PUNCT
fnp-5343	971	20	a	a	DET
fnp-5343	971	21	critical	critical	ADJ
fnp-5343	971	22	systematic	systematic	ADJ
fnp-5343	971	23	review	review	NOUN
fnp-5343	971	24	.	.	PUNCT
fnp-5343	972	1	eur	eur	PROPN
fnp-5343	972	2	j	j	PROPN
fnp-5343	972	3	neurol	neurol	PROPN
fnp-5343	972	4	2021;28:3856–65	2021;28:3856–65	PROPN
fnp-5343	972	5	.	.	PUNCT
fnp-5343	973	1	https://doi.org/10.1111/ene.15045	https://doi.org/10.1111/ene.15045	PROPN
fnp-5343	973	2	.	.	PROPN
fnp-5343	973	3	185	185	NUM
fnp-5343	973	4	.	.	PUNCT
fnp-5343	974	1	thakur	thakur	PROPN
fnp-5343	974	2	kt	kt	PROPN
fnp-5343	974	3	,	,	PUNCT
fnp-5343	974	4	miller	miller	PROPN
fnp-5343	974	5	eh	eh	INTJ
fnp-5343	974	6	,	,	PUNCT
fnp-5343	974	7	glendinning	glendinne	VERB
fnp-5343	974	8	md	md	PROPN
fnp-5343	974	9	,	,	PUNCT
fnp-5343	974	10	al	al	PROPN
fnp-5343	974	11	-	-	PUNCT
fnp-5343	974	12	dalahmah	dalahmah	PROPN
fnp-5343	974	13	o	o	NOUN
fnp-5343	974	14	,	,	PUNCT
fnp-5343	974	15	banu	banu	PROPN
fnp-5343	974	16	ma	ma	PROPN
fnp-5343	974	17	,	,	PUNCT
fnp-5343	974	18	boehme	boehme	PROPN
fnp-5343	974	19	ak	ak	PROPN
fnp-5343	974	20	,	,	PUNCT
fnp-5343	974	21	et	et	PROPN
fnp-5343	974	22	al	al	PROPN
fnp-5343	974	23	.	.	PUNCT
fnp-5343	975	1	covid-19	covid-19	PROPN
fnp-5343	975	2	neuropathology	neuropathology	NOUN
fnp-5343	975	3	at	at	ADP
fnp-5343	975	4	columbia	columbia	PROPN
fnp-5343	975	5	university	university	PROPN
fnp-5343	975	6	irving	irving	PROPN
fnp-5343	975	7	medical	medical	ADJ
fnp-5343	975	8	center	center	PROPN
fnp-5343	975	9	/	/	SYM
fnp-5343	975	10	new	new	PROPN
fnp-5343	975	11	york	york	PROPN
fnp-5343	975	12	presbyterian	presbyterian	PROPN
fnp-5343	975	13	hospital	hospital	PROPN
fnp-5343	975	14	.	.	PUNCT
fnp-5343	976	1	brain	brain	NOUN
fnp-5343	976	2	2021;144:2696	2021;144:2696	NUM
fnp-5343	976	3	-	-	SYM
fnp-5343	976	4	708	708	NUM
fnp-5343	976	5	.	.	PUNCT
fnp-5343	977	1	https://doi.org/10.1093/brain/awab148	https://doi.org/10.1093/brain/awab148	NOUN
fnp-5343	977	2	.	.	PUNCT
fnp-5343	978	1	186	186	NUM
fnp-5343	978	2	.	.	PUNCT
fnp-5343	979	1	solomon	solomon	PROPN
fnp-5343	979	2	ih	ih	PROPN
fnp-5343	979	3	,	,	PUNCT
fnp-5343	979	4	normandin	normandin	NOUN
fnp-5343	979	5	e	e	NOUN
fnp-5343	979	6	,	,	PUNCT
fnp-5343	979	7	bhattacharyya	bhattacharyya	PROPN
fnp-5343	979	8	s	s	PROPN
fnp-5343	979	9	,	,	PUNCT
fnp-5343	979	10	mukerji	mukerji	PROPN
fnp-5343	979	11	ss	ss	PROPN
fnp-5343	979	12	,	,	PUNCT
fnp-5343	979	13	keller	keller	PROPN
fnp-5343	979	14	k	k	PROPN
fnp-5343	979	15	,	,	PUNCT
fnp-5343	979	16	ali	ali	PROPN
fnp-5343	979	17	as	as	ADP
fnp-5343	979	18	,	,	PUNCT
fnp-5343	979	19	et	et	PROPN
fnp-5343	979	20	al	al	PROPN
fnp-5343	979	21	.	.	PUNCT
fnp-5343	979	22	neuropathological	neuropathological	ADJ
fnp-5343	979	23	features	feature	NOUN
fnp-5343	979	24	of	of	ADP
fnp-5343	979	25	covid-19	covid-19	PROPN
fnp-5343	979	26	.	.	PUNCT
fnp-5343	980	1	n	n	PROPN
fnp-5343	980	2	engl	engl	PROPN
fnp-5343	980	3	j	j	PROPN
fnp-5343	980	4	med	med	PROPN
fnp-5343	980	5	2020;383:989	2020;383:989	NUM
fnp-5343	980	6	-	-	SYM
fnp-5343	980	7	92	92	NUM
fnp-5343	980	8	.	.	PUNCT
fnp-5343	981	1	https://doi.org/10.1056/nejmc2019373	https://doi.org/10.1056/nejmc2019373	NOUN
fnp-5343	981	2	.	.	PUNCT
fnp-5343	982	1	187	187	NUM
fnp-5343	982	2	.	.	PUNCT
fnp-5343	983	1	lou	lou	PROPN
fnp-5343	983	2	jj	jj	PROPN
fnp-5343	983	3	,	,	PUNCT
fnp-5343	983	4	movassaghi	movassaghi	PROPN
fnp-5343	983	5	m	m	PROPN
fnp-5343	983	6	,	,	PUNCT
fnp-5343	983	7	gordy	gordy	PROPN
fnp-5343	983	8	d	d	PROPN
fnp-5343	983	9	,	,	PUNCT
fnp-5343	983	10	olson	olson	NOUN
fnp-5343	983	11	mg	mg	PROPN
fnp-5343	983	12	,	,	PUNCT
fnp-5343	983	13	zhang	zhang	PROPN
fnp-5343	983	14	t	t	PROPN
fnp-5343	983	15	,	,	PUNCT
fnp-5343	983	16	khurana	khurana	PROPN
fnp-5343	983	17	ms	ms	PROPN
fnp-5343	983	18	,	,	PUNCT
fnp-5343	983	19	et	et	PROPN
fnp-5343	983	20	al	al	PROPN
fnp-5343	983	21	.	.	PROPN
fnp-5343	983	22	neuropathology	neuropathology	NOUN
fnp-5343	983	23	of	of	ADP
fnp-5343	983	24	covid-19	covid-19	PROPN
fnp-5343	983	25	(	(	PUNCT
fnp-5343	983	26	neuro	neuro	NOUN
fnp-5343	983	27	-	-	PUNCT
fnp-5343	983	28	covid	covid	PROPN
fnp-5343	983	29	):	):	PUNCT
fnp-5343	983	30	clinicopathological	clinicopathological	ADJ
fnp-5343	983	31	update	update	NOUN
fnp-5343	983	32	.	.	PUNCT
fnp-5343	984	1	free	free	ADJ
fnp-5343	984	2	neuropathol	neuropathol	NOUN
fnp-5343	984	3	2021;2:2	2021;2:2	NOUN
fnp-5343	984	4	.	.	PUNCT
fnp-5343	985	1	https://doi.org/10.17879/freeneuropathology-2021-2993	https://doi.org/10.17879/freeneuropathology-2021-2993	NOUN
fnp-5343	985	2	.	.	PUNCT
fnp-5343	986	1	188	188	NUM
fnp-5343	986	2	.	.	PUNCT
fnp-5343	987	1	santana	santana	PROPN
fnp-5343	987	2	mf	mf	PROPN
fnp-5343	987	3	,	,	PUNCT
fnp-5343	987	4	frank	frank	PROPN
fnp-5343	987	5	chm	chm	PROPN
fnp-5343	987	6	,	,	PUNCT
fnp-5343	987	7	almeida	almeida	PROPN
fnp-5343	987	8	tvr	tvr	PROPN
fnp-5343	987	9	,	,	PUNCT
fnp-5343	987	10	jeronimo	jeronimo	PROPN
fnp-5343	987	11	cmp	cmp	PROPN
fnp-5343	987	12	,	,	PUNCT
fnp-5343	987	13	de	de	X
fnp-5343	987	14	araújo	araújo	PROPN
fnp-5343	987	15	pinto	pinto	PROPN
fnp-5343	987	16	ra	ra	PROPN
fnp-5343	987	17	,	,	PUNCT
fnp-5343	987	18	martins	martin	NOUN
fnp-5343	987	19	yf	yf	NOUN
fnp-5343	987	20	,	,	PUNCT
fnp-5343	987	21	et	et	PROPN
fnp-5343	987	22	al	al	PROPN
fnp-5343	987	23	.	.	PROPN
fnp-5343	987	24	hemorrhagic	hemorrhagic	PROPN
fnp-5343	987	25	and	and	CCONJ
fnp-5343	987	26	thrombotic	thrombotic	ADJ
fnp-5343	987	27	manifestations	manifestation	NOUN
fnp-5343	987	28	in	in	ADP
fnp-5343	987	29	the	the	DET
fnp-5343	987	30	central	central	ADJ
fnp-5343	987	31	nervous	nervous	ADJ
fnp-5343	987	32	system	system	NOUN
fnp-5343	987	33	in	in	ADP
fnp-5343	987	34	covid-19	covid-19	PROPN
fnp-5343	987	35	:	:	PUNCT
fnp-5343	987	36	a	a	DET
fnp-5343	987	37	large	large	ADJ
fnp-5343	987	38	observational	observational	ADJ
fnp-5343	987	39	study	study	NOUN
fnp-5343	987	40	in	in	ADP
fnp-5343	987	41	the	the	DET
fnp-5343	987	42	brazilian	brazilian	ADJ
fnp-5343	987	43	amazon	amazon	NOUN
fnp-5343	987	44	with	with	ADP
fnp-5343	987	45	a	a	DET
fnp-5343	987	46	complete	complete	ADJ
fnp-5343	987	47	autopsy	autopsy	ADJ
fnp-5343	987	48	series	series	NOUN
fnp-5343	987	49	.	.	PUNCT
fnp-5343	988	1	plos	plos	PROPN
fnp-5343	988	2	one	one	NUM
fnp-5343	988	3	2021;16	2021;16	NUM
fnp-5343	988	4	:	:	PUNCT
fnp-5343	988	5	e0255950	e0255950	PROPN
fnp-5343	988	6	.	.	PROPN
fnp-5343	988	7	https://doi.org/10.1371/journal.pone.0255950	https://doi.org/10.1371/journal.pone.0255950	PROPN
fnp-5343	988	8	.	.	PROPN
fnp-5343	988	9	189	189	NUM
fnp-5343	988	10	.	.	PUNCT
fnp-5343	989	1	hanley	hanley	PROPN
fnp-5343	989	2	b	b	PROPN
fnp-5343	989	3	,	,	PUNCT
fnp-5343	989	4	naresh	naresh	PROPN
fnp-5343	989	5	kn	kn	PROPN
fnp-5343	989	6	,	,	PUNCT
fnp-5343	989	7	roufosse	roufosse	NOUN
fnp-5343	989	8	c	c	PROPN
fnp-5343	989	9	,	,	PUNCT
fnp-5343	989	10	nicholson	nicholson	PROPN
fnp-5343	989	11	ag	ag	PROPN
fnp-5343	989	12	,	,	PUNCT
fnp-5343	989	13	weir	weir	PROPN
fnp-5343	989	14	j	j	PROPN
fnp-5343	989	15	,	,	PUNCT
fnp-5343	989	16	cooke	cooke	PROPN
fnp-5343	989	17	gs	gs	PROPN
fnp-5343	989	18	,	,	PUNCT
fnp-5343	989	19	et	et	PROPN
fnp-5343	989	20	al	al	PROPN
fnp-5343	989	21	.	.	PUNCT
fnp-5343	990	1	histopathological	histopathological	ADJ
fnp-5343	990	2	findings	finding	NOUN
fnp-5343	990	3	and	and	CCONJ
fnp-5343	990	4	viral	viral	ADJ
fnp-5343	990	5	tropism	tropism	NOUN
fnp-5343	990	6	in	in	ADP
fnp-5343	990	7	uk	uk	PROPN
fnp-5343	990	8	patients	patient	NOUN
fnp-5343	990	9	with	with	ADP
fnp-5343	990	10	severe	severe	ADJ
fnp-5343	990	11	fatal	fatal	ADJ
fnp-5343	990	12	covid-19	covid-19	PROPN
fnp-5343	990	13	:	:	PUNCT
fnp-5343	990	14	a	a	DET
fnp-5343	990	15	post	post	ADJ
fnp-5343	990	16	-	-	ADJ
fnp-5343	990	17	mortem	mortem	ADJ
fnp-5343	990	18	study	study	NOUN
fnp-5343	990	19	.	.	PUNCT
fnp-5343	991	1	lancet	lancet	PROPN
fnp-5343	991	2	microbe	microbe	PROPN
fnp-5343	991	3	2020;1	2020;1	PROPN
fnp-5343	991	4	:	:	PUNCT
fnp-5343	991	5	e245–53	e245–53	ADJ
fnp-5343	991	6	.	.	PUNCT
fnp-5343	992	1	https://doi.org/10.1016/s2666-5247(20)30115-4	https://doi.org/10.1016/s2666-5247(20)30115-4	PROPN
fnp-5343	992	2	.	.	PUNCT
fnp-5343	993	1	190	190	NUM
fnp-5343	993	2	.	.	PUNCT
fnp-5343	994	1	jaunmuktane	jaunmuktane	PROPN
fnp-5343	994	2	z	z	PROPN
fnp-5343	994	3	,	,	PUNCT
fnp-5343	994	4	mahadeva	mahadeva	PROPN
fnp-5343	994	5	u	u	PROPN
fnp-5343	994	6	,	,	PUNCT
fnp-5343	994	7	green	green	PROPN
fnp-5343	994	8	a	a	PROPN
fnp-5343	994	9	,	,	PUNCT
fnp-5343	994	10	sekhawat	sekhawat	NOUN
fnp-5343	994	11	v	v	NOUN
fnp-5343	994	12	,	,	PUNCT
fnp-5343	994	13	barrett	barrett	PROPN
fnp-5343	994	14	na	na	PROPN
fnp-5343	994	15	,	,	PUNCT
fnp-5343	994	16	childs	child	VERB
fnp-5343	994	17	l	l	PROPN
fnp-5343	994	18	,	,	PUNCT
fnp-5343	994	19	et	et	PROPN
fnp-5343	994	20	al	al	PROPN
fnp-5343	994	21	.	.	PUNCT
fnp-5343	994	22	microvascular	microvascular	ADJ
fnp-5343	994	23	injury	injury	NOUN
fnp-5343	994	24	and	and	CCONJ
fnp-5343	994	25	hypoxic	hypoxic	ADJ
fnp-5343	994	26	damage	damage	NOUN
fnp-5343	994	27	:	:	PUNCT
fnp-5343	994	28	emerging	emerge	VERB
fnp-5343	994	29	neuropathological	neuropathological	ADJ
fnp-5343	994	30	signatures	signature	NOUN
fnp-5343	994	31	in	in	ADP
fnp-5343	994	32	covid-19	covid-19	PROPN
fnp-5343	994	33	.	.	PUNCT
fnp-5343	995	1	acta	acta	PROPN
fnp-5343	995	2	neuropathol	neuropathol	PROPN
fnp-5343	995	3	2020;140:397–400	2020;140:397–400	PROPN
fnp-5343	995	4	.	.	PUNCT
fnp-5343	996	1	https://doi.org/10.1007/s00401-020-02190-2	https://doi.org/10.1007/s00401-020-02190-2	PROPN
fnp-5343	996	2	.	.	PUNCT
fnp-5343	997	1	191	191	NUM
fnp-5343	997	2	.	.	PUNCT
fnp-5343	998	1	levine	levine	PROPN
fnp-5343	998	2	a	a	PROPN
fnp-5343	998	3	,	,	PUNCT
fnp-5343	998	4	lee	lee	PROPN
fnp-5343	998	5	c	c	X
fnp-5343	998	6	,	,	PUNCT
fnp-5343	998	7	fava	fava	NOUN
fnp-5343	998	8	c	c	PROPN
fnp-5343	998	9	,	,	PUNCT
fnp-5343	998	10	tsang	tsang	PROPN
fnp-5343	998	11	f	f	PROPN
fnp-5343	998	12	,	,	PUNCT
fnp-5343	998	13	macneil	macneil	PROPN
fnp-5343	998	14	k	k	PROPN
fnp-5343	998	15	,	,	PUNCT
fnp-5343	998	16	yip	yip	PROPN
fnp-5343	998	17	st	st	PROPN
fnp-5343	998	18	,	,	PUNCT
fnp-5343	998	19	et	et	PROPN
fnp-5343	998	20	al	al	PROPN
fnp-5343	998	21	.	.	PUNCT
fnp-5343	999	1	detailed	detailed	ADJ
fnp-5343	999	2	neuropathologic	neuropathologic	ADJ
fnp-5343	999	3	report	report	NOUN
fnp-5343	999	4	of	of	ADP
fnp-5343	999	5	covid-19	covid-19	PROPN
fnp-5343	999	6	complicated	complicate	VERB
fnp-5343	999	7	by	by	ADP
fnp-5343	999	8	large	large	ADJ
fnp-5343	999	9	intracerebral	intracerebral	ADJ
fnp-5343	999	10	hemorrhage	hemorrhage	NOUN
fnp-5343	999	11	and	and	CCONJ
fnp-5343	999	12	periventricular	periventricular	ADJ
fnp-5343	999	13	lesions	lesion	NOUN
fnp-5343	999	14	with	with	ADP
fnp-5343	999	15	macrophagic	macrophagic	NOUN
fnp-5343	999	16	infiltrates	infiltrate	NOUN
fnp-5343	999	17	.	.	PUNCT
fnp-5343	1000	1	free	free	ADJ
fnp-5343	1000	2	neuropathol	neuropathol	NOUN
fnp-5343	1000	3	2021;2:7	2021;2:7	PROPN
fnp-5343	1000	4	.	.	PUNCT
fnp-5343	1001	1	https://doi.org/10.17879/freeneuropathology-2021-3266	https://doi.org/10.17879/freeneuropathology-2021-3266	NOUN
fnp-5343	1001	2	.	.	PUNCT
fnp-5343	1001	3	192	192	NUM
fnp-5343	1001	4	.	.	PUNCT
fnp-5343	1002	1	el	el	PROPN
fnp-5343	1002	2	jamal	jamal	PROPN
fnp-5343	1002	3	sm	sm	PROPN
fnp-5343	1002	4	,	,	PUNCT
fnp-5343	1002	5	pujadas	pujadas	PROPN
fnp-5343	1002	6	e	e	PROPN
fnp-5343	1002	7	,	,	PUNCT
fnp-5343	1002	8	ramos	ramos	PROPN
fnp-5343	1002	9	i	i	PROPN
fnp-5343	1002	10	,	,	PUNCT
fnp-5343	1002	11	bryce	bryce	PROPN
fnp-5343	1002	12	c	c	PROPN
fnp-5343	1002	13	,	,	PUNCT
fnp-5343	1002	14	grimes	grimes	PROPN
fnp-5343	1002	15	zm	zm	PROPN
fnp-5343	1002	16	,	,	PUNCT
fnp-5343	1002	17	amanat	amanat	PROPN
fnp-5343	1003	1	f	f	PROPN
fnp-5343	1003	2	,	,	PUNCT
fnp-5343	1003	3	et	et	PROPN
fnp-5343	1003	4	al	al	PROPN
fnp-5343	1003	5	.	.	PUNCT
fnp-5343	1003	6	tissue	tissue	NOUN
fnp-5343	1003	7	-	-	PUNCT
fnp-5343	1003	8	based	base	VERB
fnp-5343	1003	9	sars	sar	NOUN
fnp-5343	1003	10	-	-	PUNCT
fnp-5343	1003	11	cov-2	cov-2	NOUN
fnp-5343	1003	12	detection	detection	NOUN
fnp-5343	1003	13	in	in	ADP
fnp-5343	1003	14	fatal	fatal	ADJ
fnp-5343	1003	15	covid-19	covid-19	PROPN
fnp-5343	1003	16	infections	infection	NOUN
fnp-5343	1003	17	:	:	PUNCT
fnp-5343	1003	18	sustained	sustain	VERB
fnp-5343	1003	19	direct	direct	ADJ
fnp-5343	1003	20	viral	viral	ADJ
fnp-5343	1003	21	-	-	PUNCT
fnp-5343	1003	22	induced	induce	VERB
fnp-5343	1003	23	damage	damage	NOUN
fnp-5343	1003	24	is	be	AUX
fnp-5343	1003	25	not	not	PART
fnp-5343	1003	26	necessary	necessary	ADJ
fnp-5343	1003	27	to	to	PART
fnp-5343	1003	28	drive	drive	VERB
fnp-5343	1003	29	disease	disease	NOUN
fnp-5343	1003	30	progression	progression	NOUN
fnp-5343	1003	31	.	.	PUNCT
fnp-5343	1004	1	hum	hum	PROPN
fnp-5343	1004	2	pathol	pathol	NOUN
fnp-5343	1004	3	2021;114:110–9	2021;114:110–9	NUM
fnp-5343	1004	4	.	.	PUNCT
fnp-5343	1005	1	https://doi.org/10.1016/j.humpath.2021.04.012	https://doi.org/10.1016/j.humpath.2021.04.012	PROPN
fnp-5343	1005	2	.	.	PUNCT
fnp-5343	1006	1	193	193	NUM
fnp-5343	1006	2	.	.	PUNCT
fnp-5343	1007	1	fabbri	fabbri	NOUN
fnp-5343	1007	2	vp	vp	PROPN
fnp-5343	1007	3	,	,	PUNCT
fnp-5343	1007	4	foschini	foschini	PROPN
fnp-5343	1007	5	mp	mp	PROPN
fnp-5343	1007	6	,	,	PUNCT
fnp-5343	1007	7	lazzarotto	lazzarotto	ADJ
fnp-5343	1007	8	t	t	PROPN
fnp-5343	1007	9	,	,	PUNCT
fnp-5343	1007	10	gabrielli	gabrielli	PROPN
fnp-5343	1007	11	l	l	PROPN
fnp-5343	1007	12	,	,	PUNCT
fnp-5343	1007	13	cenacchi	cenacchi	PROPN
fnp-5343	1007	14	g	g	PROPN
fnp-5343	1007	15	,	,	PUNCT
fnp-5343	1007	16	gallo	gallo	PROPN
fnp-5343	1007	17	c	c	PROPN
fnp-5343	1007	18	,	,	PUNCT
fnp-5343	1007	19	et	et	PROPN
fnp-5343	1007	20	al	al	PROPN
fnp-5343	1007	21	.	.	PROPN
fnp-5343	1008	1	brain	brain	PROPN
fnp-5343	1008	2	ischemic	ischemic	ADJ
fnp-5343	1008	3	injury	injury	NOUN
fnp-5343	1008	4	in	in	ADP
fnp-5343	1008	5	covid-19	covid-19	PROPN
fnp-5343	1008	6	-	-	PUNCT
fnp-5343	1008	7	infected	infect	VERB
fnp-5343	1008	8	patients	patient	NOUN
fnp-5343	1008	9	:	:	PUNCT
fnp-5343	1008	10	a	a	DET
fnp-5343	1008	11	series	series	NOUN
fnp-5343	1008	12	of	of	ADP
fnp-5343	1008	13	10	10	NUM
fnp-5343	1008	14	post	post	ADJ
fnp-5343	1008	15	-	-	ADJ
fnp-5343	1008	16	mortem	mortem	ADJ
fnp-5343	1008	17	cases	case	NOUN
fnp-5343	1008	18	.	.	PUNCT
fnp-5343	1009	1	brain	brain	NOUN
fnp-5343	1009	2	pathol	pathol	NOUN
fnp-5343	1009	3	2021;31:205–10	2021;31:205–10	NOUN
fnp-5343	1009	4	.	.	PUNCT
fnp-5343	1010	1	https://doi.org/10.1111/bpa.12901	https://doi.org/10.1111/bpa.12901	NOUN
fnp-5343	1010	2	.	.	PUNCT
fnp-5343	1011	1	194	194	NUM
fnp-5343	1011	2	.	.	PUNCT
fnp-5343	1012	1	kirschenbaum	kirschenbaum	PROPN
fnp-5343	1012	2	d	d	PROPN
fnp-5343	1012	3	,	,	PUNCT
fnp-5343	1012	4	imbach	imbach	NOUN
fnp-5343	1012	5	ll	ll	NOUN
fnp-5343	1012	6	,	,	PUNCT
fnp-5343	1012	7	ulrich	ulrich	PROPN
fnp-5343	1012	8	s	s	PROPN
fnp-5343	1012	9	,	,	PUNCT
fnp-5343	1012	10	rushing	rush	VERB
fnp-5343	1012	11	ej	ej	PROPN
fnp-5343	1012	12	,	,	PUNCT
fnp-5343	1012	13	keller	keller	PROPN
fnp-5343	1012	14	e	e	PROPN
fnp-5343	1012	15	,	,	PUNCT
fnp-5343	1012	16	reimann	reimann	PROPN
fnp-5343	1012	17	rr	rr	PROPN
fnp-5343	1012	18	,	,	PUNCT
fnp-5343	1012	19	et	et	PROPN
fnp-5343	1012	20	al	al	PROPN
fnp-5343	1012	21	.	.	PUNCT
fnp-5343	1012	22	inflammatory	inflammatory	ADJ
fnp-5343	1012	23	olfactory	olfactory	NOUN
fnp-5343	1012	24	neuropathy	neuropathy	ADJ
fnp-5343	1012	25	in	in	ADP
fnp-5343	1012	26	two	two	NUM
fnp-5343	1012	27	patients	patient	NOUN
fnp-5343	1012	28	with	with	ADP
fnp-5343	1012	29	covid-19	covid-19	PROPN
fnp-5343	1012	30	.	.	PUNCT
fnp-5343	1013	1	lancet	lancet	PROPN
fnp-5343	1013	2	2020;396:166	2020;396:166	NUM
fnp-5343	1013	3	.	.	PUNCT
fnp-5343	1014	1	https://doi.org/10.1016/s0140-6736(20)31525-7	https://doi.org/10.1016/s0140-6736(20)31525-7	NOUN
fnp-5343	1014	2	.	.	PUNCT
fnp-5343	1015	1	195	195	NUM
fnp-5343	1015	2	.	.	PUNCT
fnp-5343	1015	3	eschbacher	eschbacher	PROPN
fnp-5343	1015	4	kl	kl	PROPN
fnp-5343	1015	5	,	,	PUNCT
fnp-5343	1015	6	larsen	larsen	PROPN
fnp-5343	1015	7	ra	ra	PROPN
fnp-5343	1015	8	,	,	PUNCT
fnp-5343	1015	9	moyer	moyer	PROPN
fnp-5343	1015	10	am	am	PROPN
fnp-5343	1015	11	,	,	PUNCT
fnp-5343	1015	12	majumdar	majumdar	PROPN
fnp-5343	1015	13	r	r	PROPN
fnp-5343	1015	14	,	,	PUNCT
fnp-5343	1015	15	reichard	reichard	PROPN
fnp-5343	1015	16	rr	rr	PROPN
fnp-5343	1015	17	.	.	PUNCT
fnp-5343	1016	1	neuropathological	neuropathological	ADJ
fnp-5343	1016	2	findings	finding	NOUN
fnp-5343	1016	3	in	in	ADP
fnp-5343	1016	4	covid-19	covid-19	PROPN
fnp-5343	1016	5	:	:	PUNCT
fnp-5343	1016	6	an	an	DET
fnp-5343	1016	7	autopsy	autopsy	ADJ
fnp-5343	1016	8	cohort	cohort	NOUN
fnp-5343	1016	9	.	.	PUNCT
fnp-5343	1017	1	j	j	PROPN
fnp-5343	1017	2	neuropathol	neuropathol	PROPN
fnp-5343	1017	3	exp	exp	PROPN
fnp-5343	1017	4	neurol	neurol	PROPN
fnp-5343	1017	5	2022;82:21–8	2022;82:21–8	PROPN
fnp-5343	1017	6	.	.	PUNCT
fnp-5343	1018	1	https://doi.org/10.1093/jnen/nlac101	https://doi.org/10.1093/jnen/nlac101	PROPN
fnp-5343	1018	2	.	.	PUNCT
fnp-5343	1019	1	196	196	NUM
fnp-5343	1019	2	.	.	PUNCT
fnp-5343	1020	1	al	al	PROPN
fnp-5343	1020	2	-	-	PUNCT
fnp-5343	1020	3	dalahmah	dalahmah	PROPN
fnp-5343	1020	4	o	o	NOUN
fnp-5343	1020	5	,	,	PUNCT
fnp-5343	1020	6	thakur	thakur	PROPN
fnp-5343	1020	7	kt	kt	PROPN
fnp-5343	1020	8	,	,	PUNCT
fnp-5343	1020	9	nordvig	nordvig	ADP
fnp-5343	1020	10	as	as	ADP
fnp-5343	1020	11	,	,	PUNCT
fnp-5343	1020	12	prust	prust	PROPN
fnp-5343	1020	13	ml	ml	PROPN
fnp-5343	1020	14	,	,	PUNCT
fnp-5343	1020	15	roth	roth	PROPN
fnp-5343	1020	16	w	w	PROPN
fnp-5343	1020	17	,	,	PUNCT
fnp-5343	1020	18	lignelli	lignelli	NOUN
fnp-5343	1020	19	a	a	NOUN
fnp-5343	1020	20	,	,	PUNCT
fnp-5343	1020	21	et	et	PROPN
fnp-5343	1020	22	al	al	PROPN
fnp-5343	1020	23	.	.	PROPN
fnp-5343	1020	24	neuronophagia	neuronophagia	PROPN
fnp-5343	1020	25	and	and	CCONJ
fnp-5343	1020	26	microglial	microglial	ADJ
fnp-5343	1020	27	nodules	nodule	NOUN
fnp-5343	1020	28	in	in	ADP
fnp-5343	1020	29	a	a	DET
fnp-5343	1020	30	sars	sar	NOUN
fnp-5343	1020	31	-	-	PUNCT
fnp-5343	1020	32	cov-2	cov-2	NOUN
fnp-5343	1020	33	patient	patient	NOUN
fnp-5343	1020	34	with	with	ADP
fnp-5343	1020	35	cerebellar	cerebellar	ADJ
fnp-5343	1020	36	hemorrhage	hemorrhage	NOUN
fnp-5343	1020	37	.	.	PUNCT
fnp-5343	1021	1	acta	acta	PROPN
fnp-5343	1021	2	neuropathol	neuropathol	PROPN
fnp-5343	1021	3	commun	commun	PROPN
fnp-5343	1021	4	2020;8:147	2020;8:147	NUM
fnp-5343	1021	5	.	.	PUNCT
fnp-5343	1022	1	https://doi.org/10.1186/s40478-020-01024-2	https://doi.org/10.1186/s40478-020-01024-2	NUM
fnp-5343	1022	2	.	.	PUNCT
fnp-5343	1023	1	197	197	NUM
fnp-5343	1023	2	.	.	PUNCT
fnp-5343	1024	1	stein	stein	PROPN
fnp-5343	1024	2	ja	ja	PROPN
fnp-5343	1024	3	,	,	PUNCT
fnp-5343	1024	4	kaes	kaes	PROPN
fnp-5343	1024	5	m	m	PROPN
fnp-5343	1024	6	,	,	PUNCT
fnp-5343	1024	7	smola	smola	PROPN
fnp-5343	1024	8	s	s	PROPN
fnp-5343	1024	9	,	,	PUNCT
fnp-5343	1024	10	schulz	schulz	PROPN
fnp-5343	1024	11	-	-	PUNCT
fnp-5343	1024	12	schaeffer	schaeffer	PROPN
fnp-5343	1024	13	wj	wj	PROPN
fnp-5343	1024	14	.	.	PUNCT
fnp-5343	1024	15	neuropathology	neuropathology	NOUN
fnp-5343	1024	16	in	in	ADP
fnp-5343	1024	17	covid-19	covid-19	PROPN
fnp-5343	1024	18	autopsies	autopsy	NOUN
fnp-5343	1024	19	is	be	AUX
fnp-5343	1024	20	defined	define	VERB
fnp-5343	1024	21	by	by	ADP
fnp-5343	1024	22	microglial	microglial	ADJ
fnp-5343	1024	23	activation	activation	NOUN
fnp-5343	1024	24	and	and	CCONJ
fnp-5343	1024	25	lesions	lesion	NOUN
fnp-5343	1024	26	of	of	ADP
fnp-5343	1024	27	the	the	DET
fnp-5343	1024	28	white	white	ADJ
fnp-5343	1024	29	matter	matter	NOUN
fnp-5343	1024	30	with	with	ADP
fnp-5343	1024	31	emphasis	emphasis	NOUN
fnp-5343	1024	32	in	in	ADP
fnp-5343	1024	33	cerebellar	cerebellar	ADJ
fnp-5343	1024	34	and	and	CCONJ
fnp-5343	1024	35	brain	brain	NOUN
fnp-5343	1024	36	stem	stem	NOUN
fnp-5343	1024	37	areas	area	NOUN
fnp-5343	1024	38	.	.	PUNCT
fnp-5343	1025	1	front	front	ADJ
fnp-5343	1025	2	neurol	neurol	NOUN
fnp-5343	1025	3	2023;14:1229641	2023;14:1229641	NUM
fnp-5343	1025	4	.	.	PUNCT
fnp-5343	1026	1	https://doi.org/10.3389/fneur.2023.1229641	https://doi.org/10.3389/fneur.2023.1229641	PROPN
fnp-5343	1026	2	.	.	PUNCT
fnp-5343	1027	1	198	198	NUM
fnp-5343	1027	2	.	.	PUNCT
fnp-5343	1028	1	lee	lee	PROPN
fnp-5343	1028	2	mh	mh	PROPN
fnp-5343	1028	3	,	,	PUNCT
fnp-5343	1028	4	perl	perl	PROPN
fnp-5343	1028	5	dp	dp	PROPN
fnp-5343	1028	6	,	,	PUNCT
fnp-5343	1028	7	steiner	steiner	PROPN
fnp-5343	1028	8	j	j	PROPN
fnp-5343	1028	9	,	,	PUNCT
fnp-5343	1028	10	pasternack	pasternack	NOUN
fnp-5343	1028	11	n	n	CCONJ
fnp-5343	1028	12	,	,	PUNCT
fnp-5343	1028	13	li	li	PROPN
fnp-5343	1028	14	w	w	PROPN
fnp-5343	1028	15	,	,	PUNCT
fnp-5343	1028	16	maric	maric	PROPN
fnp-5343	1028	17	d	d	PROPN
fnp-5343	1028	18	,	,	PUNCT
fnp-5343	1028	19	et	et	PROPN
fnp-5343	1028	20	al	al	PROPN
fnp-5343	1028	21	.	.	PUNCT
fnp-5343	1028	22	neurovascular	neurovascular	PROPN
fnp-5343	1028	23	injury	injury	NOUN
fnp-5343	1028	24	with	with	ADP
fnp-5343	1028	25	complement	complement	NOUN
fnp-5343	1028	26	activation	activation	NOUN
fnp-5343	1028	27	and	and	CCONJ
fnp-5343	1028	28	inflammation	inflammation	NOUN
fnp-5343	1028	29	in	in	ADP
fnp-5343	1028	30	covid-19	covid-19	PROPN
fnp-5343	1028	31	.	.	PUNCT
fnp-5343	1029	1	brain	brain	PROPN
fnp-5343	1029	2	2022;145:2555–68	2022;145:2555–68	PROPN
fnp-5343	1029	3	.	.	PUNCT
fnp-5343	1030	1	https://doi.org/10.1093/brain/awac151	https://doi.org/10.1093/brain/awac151	PROPN
fnp-5343	1030	2	.	.	PUNCT
fnp-5343	1031	1	199	199	NUM
fnp-5343	1031	2	.	.	PUNCT
fnp-5343	1032	1	stram	stram	PROPN
fnp-5343	1032	2	mn	mn	PROPN
fnp-5343	1032	3	,	,	PUNCT
fnp-5343	1032	4	seifert	seifert	PROPN
fnp-5343	1032	5	ac	ac	PROPN
fnp-5343	1032	6	,	,	PUNCT
fnp-5343	1032	7	cortes	corte	VERB
fnp-5343	1032	8	e	e	NOUN
fnp-5343	1032	9	,	,	PUNCT
fnp-5343	1032	10	akyatan	akyatan	ADJ
fnp-5343	1032	11	a	a	DET
fnp-5343	1032	12	,	,	PUNCT
fnp-5343	1032	13	woodoff	woodoff	NOUN
fnp-5343	1032	14	-	-	PUNCT
fnp-5343	1032	15	leith	leith	NOUN
fnp-5343	1032	16	e	e	PROPN
fnp-5343	1032	17	,	,	PUNCT
fnp-5343	1032	18	borukhov	borukhov	ADJ
fnp-5343	1032	19	v	v	NOUN
fnp-5343	1032	20	,	,	PUNCT
fnp-5343	1032	21	et	et	PROPN
fnp-5343	1032	22	al	al	PROPN
fnp-5343	1032	23	.	.	PROPN
fnp-5343	1032	24	neuropathology	neuropathology	NOUN
fnp-5343	1032	25	of	of	ADP
fnp-5343	1032	26	pediatric	pediatric	ADJ
fnp-5343	1032	27	sars	sar	NOUN
fnp-5343	1032	28	-	-	PUNCT
fnp-5343	1032	29	cov-2	cov-2	NOUN
fnp-5343	1032	30	infection	infection	NOUN
fnp-5343	1032	31	in	in	ADP
fnp-5343	1032	32	the	the	DET
fnp-5343	1032	33	forensic	forensic	ADJ
fnp-5343	1032	34	setting	setting	NOUN
fnp-5343	1032	35	:	:	PUNCT
fnp-5343	1032	36	novel	novel	ADJ
fnp-5343	1032	37	application	application	NOUN
fnp-5343	1032	38	of	of	ADP
fnp-5343	1032	39	ex	ex	X
fnp-5343	1032	40	vivo	vivo	NOUN
fnp-5343	1032	41	imaging	imaging	NOUN
fnp-5343	1032	42	in	in	ADP
fnp-5343	1032	43	analysis	analysis	NOUN
fnp-5343	1032	44	of	of	ADP
fnp-5343	1032	45	brain	brain	NOUN
fnp-5343	1032	46	microvasculature	microvasculature	NOUN
fnp-5343	1032	47	.	.	PUNCT
fnp-5343	1033	1	front	front	ADJ
fnp-5343	1033	2	neurol	neurol	NOUN
fnp-5343	1033	3	2022;13:894565	2022;13:894565	NUM
fnp-5343	1033	4	.	.	PUNCT
fnp-5343	1034	1	https://doi.org/10.3389/fneur.2022.894565	https://doi.org/10.3389/fneur.2022.894565	PROPN
fnp-5343	1034	2	.	.	PROPN
fnp-5343	1034	3	200	200	NUM
fnp-5343	1034	4	.	.	PUNCT
fnp-5343	1034	5	serrano	serrano	PROPN
fnp-5343	1034	6	ge	ge	PROPN
fnp-5343	1034	7	,	,	PUNCT
fnp-5343	1034	8	walker	walker	PROPN
fnp-5343	1034	9	je	je	PROPN
fnp-5343	1034	10	,	,	PUNCT
fnp-5343	1034	11	tremblay	tremblay	VERB
fnp-5343	1034	12	c	c	PRON
fnp-5343	1034	13	,	,	PUNCT
fnp-5343	1034	14	piras	piras	PROPN
fnp-5343	1034	15	is	be	AUX
fnp-5343	1034	16	,	,	PUNCT
fnp-5343	1034	17	huentelman	huentelman	PROPN
fnp-5343	1034	18	mj	mj	PROPN
fnp-5343	1034	19	,	,	PUNCT
fnp-5343	1034	20	belden	belden	PROPN
fnp-5343	1034	21	cm	cm	PROPN
fnp-5343	1034	22	,	,	PUNCT
fnp-5343	1034	23	et	et	PROPN
fnp-5343	1034	24	al	al	PROPN
fnp-5343	1034	25	.	.	PUNCT
fnp-5343	1035	1	sars	sars	PROPN
fnp-5343	1035	2	-	-	PUNCT
fnp-5343	1035	3	cov-2	cov-2	PART
fnp-5343	1035	4	brain	brain	NOUN
fnp-5343	1035	5	regional	regional	ADJ
fnp-5343	1035	6	detection	detection	NOUN
fnp-5343	1035	7	,	,	PUNCT
fnp-5343	1035	8	histopathology	histopathology	NOUN
fnp-5343	1035	9	,	,	PUNCT
fnp-5343	1035	10	gene	gene	NOUN
fnp-5343	1035	11	expression	expression	NOUN
fnp-5343	1035	12	,	,	PUNCT
fnp-5343	1035	13	and	and	CCONJ
fnp-5343	1035	14	immunomodulatory	immunomodulatory	ADJ
fnp-5343	1035	15	changes	change	NOUN
fnp-5343	1035	16	in	in	ADP
fnp-5343	1035	17	decedents	decedent	NOUN
fnp-5343	1035	18	with	with	ADP
fnp-5343	1035	19	covid-19	covid-19	PROPN
fnp-5343	1035	20	.	.	PUNCT
fnp-5343	1036	1	j	j	PROPN
fnp-5343	1036	2	neuropathol	neuropathol	PROPN
fnp-5343	1036	3	exp	exp	PROPN
fnp-5343	1036	4	neurol	neurol	PROPN
fnp-5343	1036	5	2022;81:666–95	2022;81:666–95	PROPN
fnp-5343	1036	6	.	.	PUNCT
fnp-5343	1037	1	https://doi.org/10.1093/jnen/nlac056	https://doi.org/10.1093/jnen/nlac056	PROPN
fnp-5343	1037	2	.	.	PROPN
fnp-5343	1037	3	201	201	NUM
fnp-5343	1037	4	.	.	PUNCT
fnp-5343	1038	1	schurink	schurink	PROPN
fnp-5343	1038	2	b	b	PROPN
fnp-5343	1038	3	,	,	PUNCT
fnp-5343	1038	4	roos	roo	NOUN
fnp-5343	1038	5	e	e	NOUN
fnp-5343	1038	6	,	,	PUNCT
fnp-5343	1038	7	radonic	radonic	ADJ
fnp-5343	1038	8	t	t	PROPN
fnp-5343	1038	9	,	,	PUNCT
fnp-5343	1038	10	barbe	barbe	PROPN
fnp-5343	1038	11	e	e	PROPN
fnp-5343	1038	12	,	,	PUNCT
fnp-5343	1038	13	bouman	bouman	PROPN
fnp-5343	1038	14	csc	csc	PROPN
fnp-5343	1038	15	,	,	PUNCT
fnp-5343	1038	16	de	de	PROPN
fnp-5343	1038	17	boer	boer	PROPN
fnp-5343	1038	18	hh	hh	PROPN
fnp-5343	1038	19	,	,	PUNCT
fnp-5343	1038	20	et	et	PROPN
fnp-5343	1038	21	al	al	PROPN
fnp-5343	1038	22	.	.	PROPN
fnp-5343	1039	1	viral	viral	ADJ
fnp-5343	1039	2	presence	presence	NOUN
fnp-5343	1039	3	and	and	CCONJ
fnp-5343	1039	4	immunopathology	immunopathology	NOUN
fnp-5343	1039	5	in	in	ADP
fnp-5343	1039	6	patients	patient	NOUN
fnp-5343	1039	7	with	with	ADP
fnp-5343	1039	8	lethal	lethal	ADJ
fnp-5343	1039	9	covid-19	covid-19	PROPN
fnp-5343	1039	10	:	:	PUNCT
fnp-5343	1039	11	a	a	DET
fnp-5343	1039	12	prospective	prospective	ADJ
fnp-5343	1039	13	autopsy	autopsy	ADJ
fnp-5343	1039	14	cohort	cohort	NOUN
fnp-5343	1039	15	study	study	NOUN
fnp-5343	1039	16	.	.	PUNCT
fnp-5343	1040	1	lancet	lancet	PROPN
fnp-5343	1040	2	microbe	microbe	PROPN
fnp-5343	1040	3	2020;1	2020;1	PROPN
fnp-5343	1040	4	:	:	PUNCT
fnp-5343	1040	5	e290–9	e290–9	NOUN
fnp-5343	1040	6	.	.	PUNCT
fnp-5343	1041	1	https://doi.org/10.1016/s2666-5247(20)30144-0	https://doi.org/10.1016/s2666-5247(20)30144-0	PROPN
fnp-5343	1041	2	.	.	PUNCT
fnp-5343	1042	1	202	202	NUM
fnp-5343	1042	2	.	.	PUNCT
fnp-5343	1043	1	normandin	normandin	NOUN
fnp-5343	1043	2	e	e	PROPN
fnp-5343	1043	3	,	,	PUNCT
fnp-5343	1043	4	valizadeh	valizadeh	NOUN
fnp-5343	1043	5	n	n	CCONJ
fnp-5343	1043	6	,	,	PUNCT
fnp-5343	1043	7	rudmann	rudmann	PROPN
fnp-5343	1043	8	ea	ea	NOUN
fnp-5343	1043	9	,	,	PUNCT
fnp-5343	1043	10	uddin	uddin	NOUN
fnp-5343	1043	11	r	r	NOUN
fnp-5343	1043	12	,	,	PUNCT
fnp-5343	1043	13	dobbins	dobbins	PROPN
fnp-5343	1043	14	st	st	PROPN
fnp-5343	1043	15	,	,	PUNCT
fnp-5343	1043	16	macinnis	macinnis	PROPN
fnp-5343	1043	17	bl	bl	PROPN
fnp-5343	1043	18	,	,	PUNCT
fnp-5343	1043	19	et	et	PROPN
fnp-5343	1043	20	al	al	PROPN
fnp-5343	1043	21	.	.	PUNCT
fnp-5343	1043	22	neuropathological	neuropathological	ADJ
fnp-5343	1043	23	features	feature	NOUN
fnp-5343	1043	24	of	of	ADP
fnp-5343	1043	25	sars	sar	NOUN
fnp-5343	1043	26	-	-	PUNCT
fnp-5343	1043	27	cov-2	cov-2	NOUN
fnp-5343	1043	28	delta	delta	NOUN
fnp-5343	1043	29	and	and	CCONJ
fnp-5343	1043	30	omicron	omicron	PROPN
fnp-5343	1043	31	variants	variant	NOUN
fnp-5343	1043	32	.	.	PUNCT
fnp-5343	1044	1	j	j	PROPN
fnp-5343	1044	2	neuropathol	neuropathol	PROPN
fnp-5343	1044	3	exp	exp	PROPN
fnp-5343	1044	4	neurol	neurol	NOUN
fnp-5343	1044	5	2023;82:283–95	2023;82:283–95	NUM
fnp-5343	1044	6	.	.	PUNCT
fnp-5343	1045	1	https://doi.org/10.1093/jnen/nlad015	https://doi.org/10.1093/jnen/nlad015	X
fnp-5343	1045	2	.	.	PUNCT
fnp-5343	1046	1	203	203	NUM
fnp-5343	1046	2	.	.	PUNCT
fnp-5343	1046	3	wierzba	wierzba	NOUN
fnp-5343	1046	4	-	-	PUNCT
fnp-5343	1046	5	bobrowicz	bobrowicz	PROPN
fnp-5343	1046	6	t	t	PROPN
fnp-5343	1046	7	,	,	PUNCT
fnp-5343	1046	8	krajewski	krajewski	PROPN
fnp-5343	1046	9	p	p	PROPN
fnp-5343	1046	10	,	,	PUNCT
fnp-5343	1046	11	tarka	tarka	PROPN
fnp-5343	1046	12	s	s	PROPN
fnp-5343	1046	13	,	,	PUNCT
fnp-5343	1046	14	acewicz	acewicz	VERB
fnp-5343	1046	15	a	a	PRON
fnp-5343	1046	16	,	,	PUNCT
fnp-5343	1046	17	felczak	felczak	NOUN
fnp-5343	1046	18	p	p	NOUN
fnp-5343	1046	19	,	,	PUNCT
fnp-5343	1046	20	stepien	stepien	NOUN
fnp-5343	1046	21	t	t	PROPN
fnp-5343	1046	22	,	,	PUNCT
fnp-5343	1046	23	et	et	PROPN
fnp-5343	1046	24	al	al	PROPN
fnp-5343	1046	25	.	.	PUNCT
fnp-5343	1047	1	neuropathological	neuropathological	ADJ
fnp-5343	1047	2	analysis	analysis	NOUN
fnp-5343	1047	3	of	of	ADP
fnp-5343	1047	4	the	the	DET
fnp-5343	1047	5	brains	brain	NOUN
fnp-5343	1047	6	of	of	ADP
fnp-5343	1047	7	fifty	fifty	NUM
fnp-5343	1047	8	-	-	PUNCT
fnp-5343	1047	9	two	two	NUM
fnp-5343	1047	10	patients	patient	NOUN
fnp-5343	1047	11	with	with	ADP
fnp-5343	1047	12	covid-19	covid-19	PROPN
fnp-5343	1047	13	.	.	PUNCT
fnp-5343	1047	14	folia	folia	PROPN
fnp-5343	1047	15	neuropathol	neuropathol	PROPN
fnp-5343	1047	16	2021;59:219–31	2021;59:219–31	PROPN
fnp-5343	1047	17	.	.	PUNCT
fnp-5343	1048	1	https://doi.org/10.5114/fn.2021.108829	https://doi.org/10.5114/fn.2021.108829	NOUN
fnp-5343	1048	2	.	.	PUNCT
fnp-5343	1049	1	204	204	NUM
fnp-5343	1049	2	.	.	PUNCT
fnp-5343	1050	1	magaki	magaki	PROPN
fnp-5343	1050	2	s	s	PROPN
fnp-5343	1050	3	,	,	PUNCT
fnp-5343	1050	4	chen	chen	PROPN
fnp-5343	1050	5	z	z	PROPN
fnp-5343	1050	6	,	,	PUNCT
fnp-5343	1050	7	severance	severance	NOUN
fnp-5343	1050	8	a	a	PRON
fnp-5343	1050	9	,	,	PUNCT
fnp-5343	1050	10	williams	williams	PROPN
fnp-5343	1050	11	ck	ck	PROPN
fnp-5343	1050	12	,	,	PUNCT
fnp-5343	1050	13	diaz	diaz	PROPN
fnp-5343	1050	14	r	r	PROPN
fnp-5343	1050	15	,	,	PUNCT
fnp-5343	1050	16	fang	fang	PROPN
fnp-5343	1050	17	c	c	X
fnp-5343	1050	18	,	,	PUNCT
fnp-5343	1050	19	et	et	PROPN
fnp-5343	1050	20	al	al	PROPN
fnp-5343	1050	21	.	.	PROPN
fnp-5343	1050	22	neuropathology	neuropathology	NOUN
fnp-5343	1050	23	of	of	ADP
fnp-5343	1050	24	microbleeds	microbleed	NOUN
fnp-5343	1050	25	in	in	ADP
fnp-5343	1050	26	cerebral	cerebral	ADJ
fnp-5343	1050	27	autosomal	autosomal	ADJ
fnp-5343	1050	28	dominant	dominant	ADJ
fnp-5343	1050	29	arteriopathy	arteriopathy	NOUN
fnp-5343	1050	30	with	with	ADP
fnp-5343	1050	31	subcortical	subcortical	ADJ
fnp-5343	1050	32	infarcts	infarct	NOUN
fnp-5343	1050	33	and	and	CCONJ
fnp-5343	1050	34	leukoencephalopathy	leukoencephalopathy	ADV
fnp-5343	1050	35	(	(	PUNCT
fnp-5343	1050	36	cadasil	cadasil	PROPN
fnp-5343	1050	37	)	)	PUNCT
fnp-5343	1050	38	.	.	PUNCT
fnp-5343	1051	1	j	j	PROPN
fnp-5343	1051	2	neuropathol	neuropathol	PROPN
fnp-5343	1051	3	exp	exp	PROPN
fnp-5343	1051	4	neurol	neurol	PROPN
fnp-5343	1051	5	2023;82:333	2023;82:333	NOUN
fnp-5343	1051	6	-	-	SYM
fnp-5343	1051	7	44	44	NUM
fnp-5343	1051	8	.	.	PUNCT
fnp-5343	1051	9	https://doi.org/10.1093/jnen/nlad004	https://doi.org/10.1093/jnen/nlad004	PROPN
fnp-5343	1051	10	.	.	PUNCT
fnp-5343	1052	1	205	205	NUM
fnp-5343	1052	2	.	.	PUNCT
fnp-5343	1052	3	janaway	janaway	PROPN
fnp-5343	1052	4	bm	bm	PROPN
fnp-5343	1052	5	,	,	PUNCT
fnp-5343	1052	6	simpson	simpson	PROPN
fnp-5343	1052	7	je	je	PROPN
fnp-5343	1052	8	,	,	PUNCT
fnp-5343	1052	9	hoggard	hoggard	PROPN
fnp-5343	1052	10	n	n	CCONJ
fnp-5343	1052	11	,	,	PUNCT
fnp-5343	1052	12	highley	highley	PROPN
fnp-5343	1052	13	jr	jr	PROPN
fnp-5343	1052	14	,	,	PUNCT
fnp-5343	1052	15	forster	forster	PROPN
fnp-5343	1052	16	g	g	PROPN
fnp-5343	1052	17	,	,	PUNCT
fnp-5343	1052	18	drew	draw	VERB
fnp-5343	1052	19	d	d	PROPN
fnp-5343	1052	20	,	,	PUNCT
fnp-5343	1052	21	et	et	PROPN
fnp-5343	1052	22	al	al	PROPN
fnp-5343	1052	23	.	.	PROPN
fnp-5343	1052	24	brain	brain	PROPN
fnp-5343	1052	25	haemosiderin	haemosiderin	NOUN
fnp-5343	1052	26	in	in	ADP
fnp-5343	1052	27	older	old	ADJ
fnp-5343	1052	28	people	people	NOUN
fnp-5343	1052	29	:	:	PUNCT
fnp-5343	1052	30	pathological	pathological	ADJ
fnp-5343	1052	31	evidence	evidence	NOUN
fnp-5343	1052	32	for	for	ADP
fnp-5343	1052	33	an	an	DET
fnp-5343	1052	34	ischaemic	ischaemic	ADJ
fnp-5343	1052	35	origin	origin	NOUN
fnp-5343	1052	36	of	of	ADP
fnp-5343	1052	37	magnetic	magnetic	ADJ
fnp-5343	1052	38	resonance	resonance	NOUN
fnp-5343	1052	39	imaging	imaging	NOUN
fnp-5343	1052	40	(	(	PUNCT
fnp-5343	1052	41	mri	mri	NOUN
fnp-5343	1052	42	)	)	PUNCT
fnp-5343	1052	43	microbleeds	microbleed	NOUN
fnp-5343	1052	44	.	.	PUNCT
fnp-5343	1053	1	neuropathol	neuropathol	NOUN
fnp-5343	1053	2	appl	appl	PROPN
fnp-5343	1053	3	neurobiol	neurobiol	PROPN
fnp-5343	1053	4	2014;40:258–69	2014;40:258–69	NUM
fnp-5343	1053	5	.	.	PUNCT
fnp-5343	1054	1	https://doi.org/10.1111/nan.12062	https://doi.org/10.1111/nan.12062	PROPN
fnp-5343	1054	2	.	.	PROPN
fnp-5343	1054	3	206	206	NUM
fnp-5343	1054	4	.	.	PUNCT
fnp-5343	1055	1	dallaire	dallaire	NOUN
fnp-5343	1055	2	-	-	PUNCT
fnp-5343	1055	3	théroux	théroux	NOUN
fnp-5343	1055	4	c	c	NOUN
fnp-5343	1055	5	,	,	PUNCT
fnp-5343	1055	6	saikali	saikali	PROPN
fnp-5343	1055	7	s	s	PROPN
fnp-5343	1055	8	,	,	PUNCT
fnp-5343	1055	9	richer	rich	ADJ
fnp-5343	1055	10	m	m	PROPN
fnp-5343	1055	11	,	,	PUNCT
fnp-5343	1055	12	potvin	potvin	PROPN
fnp-5343	1055	13	o	o	PROPN
fnp-5343	1055	14	,	,	PUNCT
fnp-5343	1055	15	duchesne	duchesne	PROPN
fnp-5343	1055	16	s.	s.	PROPN
fnp-5343	1056	1	histopathological	histopathological	ADJ
fnp-5343	1056	2	analysis	analysis	NOUN
fnp-5343	1056	3	of	of	ADP
fnp-5343	1056	4	cerebrovascular	cerebrovascular	ADJ
fnp-5343	1056	5	lesions	lesion	NOUN
fnp-5343	1056	6	associated	associate	VERB
fnp-5343	1056	7	with	with	ADP
fnp-5343	1056	8	aging	aging	NOUN
fnp-5343	1056	9	.	.	PUNCT
fnp-5343	1057	1	j	j	PROPN
fnp-5343	1057	2	neuropathol	neuropathol	PROPN
fnp-5343	1057	3	exp	exp	PROPN
fnp-5343	1057	4	neurol	neurol	PROPN
fnp-5343	1057	5	2022;81:97–105	2022;81:97–105	PROPN
fnp-5343	1057	6	.	.	PUNCT
fnp-5343	1058	1	https://doi.org/10.1093/jnen/nlab125	https://doi.org/10.1093/jnen/nlab125	X
fnp-5343	1058	2	.	.	PUNCT
fnp-5343	1059	1	207	207	NUM
fnp-5343	1059	2	.	.	PUNCT
fnp-5343	1060	1	van	van	PROPN
fnp-5343	1060	2	veluw	veluw	NOUN
fnp-5343	1060	3	sj	sj	PROPN
fnp-5343	1060	4	,	,	PUNCT
fnp-5343	1060	5	biessels	biessels	PROPN
fnp-5343	1060	6	gj	gj	PROPN
fnp-5343	1060	7	,	,	PUNCT
fnp-5343	1060	8	klijn	klijn	PROPN
fnp-5343	1060	9	cjm	cjm	PROPN
fnp-5343	1060	10	,	,	PUNCT
fnp-5343	1060	11	rozemuller	rozemuller	NOUN
fnp-5343	1060	12	ajm	ajm	PROPN
fnp-5343	1060	13	.	.	PROPN
fnp-5343	1060	14	heterogeneous	heterogeneous	ADJ
fnp-5343	1060	15	histopathology	histopathology	NOUN
fnp-5343	1060	16	of	of	ADP
fnp-5343	1060	17	cortical	cortical	ADJ
fnp-5343	1060	18	microbleeds	microbleed	NOUN
fnp-5343	1060	19	in	in	ADP
fnp-5343	1060	20	cerebral	cerebral	ADJ
fnp-5343	1060	21	amyloid	amyloid	NOUN
fnp-5343	1060	22	angiopathy	angiopathy	NOUN
fnp-5343	1060	23	.	.	PUNCT
fnp-5343	1061	1	neurology	neurology	NOUN
fnp-5343	1061	2	2016;86:867–71	2016;86:867–71	PROPN
fnp-5343	1061	3	.	.	PUNCT
fnp-5343	1062	1	https://doi.org/10.1212/wnl.0000000000002419	https://doi.org/10.1212/wnl.0000000000002419	PROPN
fnp-5343	1062	2	.	.	PUNCT
fnp-5343	1063	1	208	208	NUM
fnp-5343	1063	2	.	.	PUNCT
fnp-5343	1064	1	mcmullen	mcmullen	PROPN
fnp-5343	1064	2	p	p	PROPN
fnp-5343	1064	3	,	,	PUNCT
fnp-5343	1064	4	smith	smith	PROPN
fnp-5343	1064	5	h	h	PROPN
fnp-5343	1064	6	,	,	PUNCT
fnp-5343	1064	7	pytel	pytel	PROPN
fnp-5343	1064	8	p.	p.	PROPN
fnp-5343	1064	9	entrapped	entrap	VERB
fnp-5343	1064	10	megakaryocytes	megakaryocyte	NOUN
fnp-5343	1064	11	in	in	ADP
fnp-5343	1064	12	the	the	DET
fnp-5343	1064	13	microvasculature	microvasculature	NOUN
fnp-5343	1064	14	of	of	ADP
fnp-5343	1064	15	brain	brain	NOUN
fnp-5343	1064	16	tissues	tissue	NOUN
fnp-5343	1064	17	are	be	AUX
fnp-5343	1064	18	not	not	PART
fnp-5343	1064	19	specific	specific	ADJ
fnp-5343	1064	20	to	to	ADP
fnp-5343	1064	21	covid-19	covid-19	PROPN
fnp-5343	1064	22	but	but	CCONJ
fnp-5343	1064	23	can	can	AUX
fnp-5343	1064	24	be	be	AUX
fnp-5343	1064	25	seen	see	VERB
fnp-5343	1064	26	scross	scross	VERB
fnp-5343	1064	27	a	a	DET
fnp-5343	1064	28	spectrum	spectrum	NOUN
fnp-5343	1064	29	of	of	ADP
fnp-5343	1064	30	acute	acute	ADJ
fnp-5343	1064	31	lung	lung	NOUN
fnp-5343	1064	32	injuries	injury	NOUN
fnp-5343	1064	33	.	.	PUNCT
fnp-5343	1065	1	j	j	PROPN
fnp-5343	1065	2	neuropathol	neuropathol	PROPN
fnp-5343	1065	3	exp	exp	PROPN
fnp-5343	1065	4	neurol	neurol	PROPN
fnp-5343	1065	5	2021;80:1078–80	2021;80:1078–80	PROPN
fnp-5343	1065	6	.	.	PUNCT
fnp-5343	1065	7	https://doi.org/10.1093/jnen/nlab048	https://doi.org/10.1093/jnen/nlab048	PROPN
fnp-5343	1065	8	.	.	PUNCT
fnp-5343	1066	1	209	209	NUM
fnp-5343	1066	2	.	.	PUNCT
fnp-5343	1067	1	nauen	nauen	PROPN
fnp-5343	1067	2	dw	dw	PROPN
fnp-5343	1067	3	,	,	PUNCT
fnp-5343	1067	4	hooper	hooper	PROPN
fnp-5343	1067	5	je	je	PROPN
fnp-5343	1067	6	,	,	PUNCT
fnp-5343	1067	7	stewart	stewart	PROPN
fnp-5343	1067	8	cm	cm	PROPN
fnp-5343	1067	9	,	,	PUNCT
fnp-5343	1067	10	solomon	solomon	PROPN
fnp-5343	1067	11	ih	ih	PROPN
fnp-5343	1067	12	.	.	PUNCT
fnp-5343	1068	1	assessing	assess	VERB
fnp-5343	1068	2	brain	brain	NOUN
fnp-5343	1068	3	capillaries	capillary	NOUN
fnp-5343	1068	4	in	in	ADP
fnp-5343	1068	5	coronavirus	coronavirus	NOUN
fnp-5343	1068	6	disease	disease	NOUN
fnp-5343	1068	7	2019	2019	NUM
fnp-5343	1068	8	.	.	PUNCT
fnp-5343	1069	1	jama	jama	PROPN
fnp-5343	1069	2	neurol	neurol	PROPN
fnp-5343	1069	3	2021;78:760	2021;78:760	NUM
fnp-5343	1069	4	-	-	SYM
fnp-5343	1069	5	62	62	NUM
fnp-5343	1069	6	.	.	PUNCT
fnp-5343	1070	1	https://doi.org/10.1001/jamaneurol.2021.0225	https://doi.org/10.1001/jamaneurol.2021.0225	NOUN
fnp-5343	1070	2	.	.	NOUN
fnp-5343	1070	3	210	210	NUM
fnp-5343	1070	4	.	.	PUNCT
fnp-5343	1071	1	jensen	jensen	PROPN
fnp-5343	1071	2	mp	mp	PROPN
fnp-5343	1071	3	,	,	PUNCT
fnp-5343	1071	4	le	le	X
fnp-5343	1071	5	quesne	quesne	PROPN
fnp-5343	1071	6	j	j	PROPN
fnp-5343	1071	7	,	,	PUNCT
fnp-5343	1071	8	officer	officer	NOUN
fnp-5343	1071	9	-	-	PUNCT
fnp-5343	1071	10	jones	jones	PROPN
fnp-5343	1071	11	l	l	PROPN
fnp-5343	1071	12	,	,	PUNCT
fnp-5343	1071	13	teodòsio	teodòsio	ADV
fnp-5343	1071	14	a	a	PRON
fnp-5343	1071	15	,	,	PUNCT
fnp-5343	1071	16	thaventhiran	thaventhiran	ADJ
fnp-5343	1071	17	j	j	PROPN
fnp-5343	1071	18	,	,	PUNCT
fnp-5343	1071	19	ficken	ficken	VERB
fnp-5343	1071	20	c	c	PROPN
fnp-5343	1071	21	,	,	PUNCT
fnp-5343	1071	22	et	et	PROPN
fnp-5343	1071	23	al	al	PROPN
fnp-5343	1071	24	.	.	PUNCT
fnp-5343	1071	25	neuropathological	neuropathological	ADJ
fnp-5343	1071	26	findings	finding	NOUN
fnp-5343	1071	27	in	in	ADP
fnp-5343	1071	28	two	two	NUM
fnp-5343	1071	29	patients	patient	NOUN
fnp-5343	1071	30	with	with	ADP
fnp-5343	1071	31	fatal	fatal	ADJ
fnp-5343	1071	32	covid-19	covid-19	PROPN
fnp-5343	1071	33	.	.	PUNCT
fnp-5343	1071	34	neuropathol	neuropathol	PROPN
fnp-5343	1071	35	appl	appl	PROPN
fnp-5343	1071	36	neurobiol	neurobiol	PROPN
fnp-5343	1071	37	2021;47:17	2021;47:17	NUM
fnp-5343	1071	38	-	-	SYM
fnp-5343	1071	39	25	25	NUM
fnp-5343	1071	40	.	.	PUNCT
fnp-5343	1072	1	https://doi.org/10.1111/nan.12662	https://doi.org/10.1111/nan.12662	PROPN
fnp-5343	1072	2	.	.	PUNCT
fnp-5343	1072	3	211	211	NUM
fnp-5343	1072	4	.	.	PUNCT
fnp-5343	1073	1	reichard	reichard	PROPN
fnp-5343	1073	2	rr	rr	PROPN
fnp-5343	1073	3	,	,	PUNCT
fnp-5343	1073	4	kashani	kashani	PROPN
fnp-5343	1073	5	kb	kb	PROPN
fnp-5343	1073	6	,	,	PUNCT
fnp-5343	1073	7	boire	boire	X
fnp-5343	1073	8	na	na	PROPN
fnp-5343	1073	9	,	,	PUNCT
fnp-5343	1073	10	constantopoulos	constantopoulos	PROPN
fnp-5343	1073	11	e	e	PROPN
fnp-5343	1073	12	,	,	PUNCT
fnp-5343	1073	13	guo	guo	PROPN
fnp-5343	1073	14	y	y	PROPN
fnp-5343	1073	15	,	,	PUNCT
fnp-5343	1073	16	lucchinetti	lucchinetti	PROPN
fnp-5343	1073	17	cf	cf	NOUN
fnp-5343	1073	18	.	.	PUNCT
fnp-5343	1074	1	neuropathology	neuropathology	NOUN
fnp-5343	1074	2	of	of	ADP
fnp-5343	1074	3	covid-19	covid-19	PROPN
fnp-5343	1074	4	:	:	PUNCT
fnp-5343	1074	5	a	a	DET
fnp-5343	1074	6	spectrum	spectrum	NOUN
fnp-5343	1074	7	of	of	ADP
fnp-5343	1074	8	vascular	vascular	NOUN
fnp-5343	1074	9	and	and	CCONJ
fnp-5343	1074	10	acute	acute	ADJ
fnp-5343	1074	11	disseminated	disseminate	VERB
fnp-5343	1074	12	encephalomyelitis	encephalomyelitis	NOUN
fnp-5343	1074	13	(	(	PUNCT
fnp-5343	1074	14	adem)-like	adem)-like	ADP
fnp-5343	1074	15	pathology	pathology	NOUN
fnp-5343	1074	16	.	.	PUNCT
fnp-5343	1075	1	acta	acta	PROPN
fnp-5343	1075	2	neuropathol	neuropathol	PROPN
fnp-5343	1075	3	2020;140:1–6	2020;140:1–6	NUM
fnp-5343	1075	4	.	.	PUNCT
fnp-5343	1076	1	https://doi.org/10.1007/s00401-020-02166-2	https://doi.org/10.1007/s00401-020-02166-2	X
fnp-5343	1076	2	.	.	PUNCT
fnp-5343	1077	1	212	212	NUM
fnp-5343	1077	2	.	.	PUNCT
fnp-5343	1078	1	walker	walker	PROPN
fnp-5343	1078	2	jm	jm	PROPN
fnp-5343	1078	3	,	,	PUNCT
fnp-5343	1078	4	gilbert	gilbert	PROPN
fnp-5343	1078	5	ar	ar	PROPN
fnp-5343	1078	6	,	,	PUNCT
fnp-5343	1078	7	bieniek	bieniek	PROPN
fnp-5343	1078	8	kf	kf	PROPN
fnp-5343	1078	9	,	,	PUNCT
fnp-5343	1078	10	richardson	richardson	PROPN
fnp-5343	1078	11	te	te	PROPN
fnp-5343	1078	12	.	.	PUNCT
fnp-5343	1079	1	covid-19	covid-19	PROPN
fnp-5343	1079	2	patients	patient	NOUN
fnp-5343	1079	3	with	with	ADP
fnp-5343	1079	4	cns	cns	PROPN
fnp-5343	1079	5	complications	complication	NOUN
fnp-5343	1079	6	and	and	CCONJ
fnp-5343	1079	7	neuropathologic	neuropathologic	ADJ
fnp-5343	1079	8	features	feature	NOUN
fnp-5343	1079	9	of	of	ADP
fnp-5343	1079	10	acute	acute	NOUN
fnp-5343	1079	11	disseminated	disseminate	VERB
fnp-5343	1079	12	encephalomyelitis	encephalomyelitis	NOUN
fnp-5343	1079	13	and	and	CCONJ
fnp-5343	1079	14	acute	acute	ADJ
fnp-5343	1079	15	hemorrhagic	hemorrhagic	NOUN
fnp-5343	1079	16	leukoencephalopathy	leukoencephalopathy	NOUN
fnp-5343	1079	17	.	.	PUNCT
fnp-5343	1080	1	j	j	PROPN
fnp-5343	1080	2	neuropathol	neuropathol	PROPN
fnp-5343	1080	3	exp	exp	PROPN
fnp-5343	1080	4	neurol	neurol	PROPN
fnp-5343	1080	5	2021;80:628–31	2021;80:628–31	PROPN
fnp-5343	1080	6	.	.	PUNCT
fnp-5343	1080	7	https://doi.org/10.1093/jnen/nlab036	https://doi.org/10.1093/jnen/nlab036	PROPN
fnp-5343	1080	8	.	.	PUNCT
fnp-5343	1080	9	213	213	NUM
fnp-5343	1080	10	.	.	PUNCT
fnp-5343	1081	1	manzano	manzano	PROPN
fnp-5343	1081	2	gs	gs	PROPN
fnp-5343	1081	3	,	,	PUNCT
fnp-5343	1081	4	mcentire	mcentire	PROPN
fnp-5343	1081	5	crs	crs	PROPN
fnp-5343	1081	6	,	,	PUNCT
fnp-5343	1081	7	martinez	martinez	PROPN
fnp-5343	1081	8	-	-	PUNCT
fnp-5343	1081	9	lage	lage	PROPN
fnp-5343	1081	10	m	m	PROPN
fnp-5343	1081	11	,	,	PUNCT
fnp-5343	1081	12	mateen	mateen	PROPN
fnp-5343	1081	13	fj	fj	PROPN
fnp-5343	1081	14	,	,	PUNCT
fnp-5343	1081	15	hutto	hutto	PROPN
fnp-5343	1081	16	sk	sk	PROPN
fnp-5343	1081	17	.	.	PROPN
fnp-5343	1081	18	acute	acute	PROPN
fnp-5343	1081	19	disseminated	disseminate	VERB
fnp-5343	1081	20	encephalomyelitis	encephalomyelitis	NOUN
fnp-5343	1081	21	and	and	CCONJ
fnp-5343	1081	22	acute	acute	ADJ
fnp-5343	1081	23	hemorrhagic	hemorrhagic	NOUN
fnp-5343	1081	24	leukoencephalitis	leukoencephalitis	NOUN
fnp-5343	1081	25	following	follow	VERB
fnp-5343	1081	26	covid-19	covid-19	PROPN
fnp-5343	1081	27	:	:	PUNCT
fnp-5343	1081	28	systematic	systematic	ADJ
fnp-5343	1081	29	review	review	NOUN
fnp-5343	1081	30	and	and	CCONJ
fnp-5343	1081	31	meta	meta	ADJ
fnp-5343	1081	32	-	-	PUNCT
fnp-5343	1081	33	synthesis	synthesis	NOUN
fnp-5343	1081	34	.	.	PUNCT
fnp-5343	1082	1	neurol	neurol	PROPN
fnp-5343	1082	2	neuroimmunol	neuroimmunol	PROPN
fnp-5343	1082	3	neuroinflammation	neuroinflammation	NOUN
fnp-5343	1082	4	2021;8	2021;8	NUM
fnp-5343	1082	5	:	:	PUNCT
fnp-5343	1082	6	e1080	e1080	NOUN
fnp-5343	1082	7	.	.	PUNCT
fnp-5343	1083	1	https://doi.org/10.1212/nxi.0000000000001080	https://doi.org/10.1212/nxi.0000000000001080	PROPN
fnp-5343	1083	2	.	.	PROPN
fnp-5343	1084	1	214	214	NUM
fnp-5343	1084	2	.	.	PUNCT
fnp-5343	1085	1	kantonen	kantonen	PROPN
fnp-5343	1085	2	j	j	PROPN
fnp-5343	1085	3	,	,	PUNCT
fnp-5343	1085	4	mahzabin	mahzabin	PROPN
fnp-5343	1085	5	s	s	PROPN
fnp-5343	1085	6	,	,	PUNCT
fnp-5343	1085	7	mäyränpää	mäyränpää	PROPN
fnp-5343	1085	8	mi	mi	PROPN
fnp-5343	1085	9	,	,	PUNCT
fnp-5343	1085	10	tynninen	tynninen	NOUN
fnp-5343	1085	11	o	o	NOUN
fnp-5343	1085	12	,	,	PUNCT
fnp-5343	1085	13	paetau	paetau	VERB
fnp-5343	1085	14	a	a	PRON
fnp-5343	1085	15	,	,	PUNCT
fnp-5343	1085	16	andersson	andersson	PROPN
fnp-5343	1085	17	n	n	CCONJ
fnp-5343	1085	18	,	,	PUNCT
fnp-5343	1085	19	et	et	PROPN
fnp-5343	1085	20	al	al	PROPN
fnp-5343	1085	21	.	.	PROPN
fnp-5343	1085	22	neuropathologic	neuropathologic	PROPN
fnp-5343	1085	23	features	feature	NOUN
fnp-5343	1085	24	of	of	ADP
fnp-5343	1085	25	four	four	NUM
fnp-5343	1085	26	autopsied	autopsie	VERB
fnp-5343	1085	27	covid-19	covid-19	PROPN
fnp-5343	1085	28	patients	patient	NOUN
fnp-5343	1085	29	.	.	PUNCT
fnp-5343	1086	1	brain	brain	NOUN
fnp-5343	1086	2	pathol	pathol	PROPN
fnp-5343	1086	3	2020;30:1012–6	2020;30:1012–6	PROPN
fnp-5343	1086	4	.	.	PUNCT
fnp-5343	1087	1	https://doi.org/10.1111/bpa.12889	https://doi.org/10.1111/bpa.12889	PROPN
fnp-5343	1087	2	.	.	PUNCT
fnp-5343	1088	1	215	215	NUM
fnp-5343	1088	2	.	.	PUNCT
fnp-5343	1089	1	lee	lee	PROPN
fnp-5343	1089	2	mh	mh	PROPN
fnp-5343	1089	3	,	,	PUNCT
fnp-5343	1089	4	perl	perl	PROPN
fnp-5343	1089	5	dp	dp	PROPN
fnp-5343	1089	6	,	,	PUNCT
fnp-5343	1089	7	nair	nair	NOUN
fnp-5343	1089	8	g	g	PROPN
fnp-5343	1089	9	,	,	PUNCT
fnp-5343	1089	10	li	li	PROPN
fnp-5343	1089	11	w	w	PROPN
fnp-5343	1089	12	,	,	PUNCT
fnp-5343	1089	13	maric	maric	PROPN
fnp-5343	1089	14	d	d	PROPN
fnp-5343	1089	15	,	,	PUNCT
fnp-5343	1089	16	murray	murray	PROPN
fnp-5343	1089	17	h	h	PROPN
fnp-5343	1089	18	,	,	PUNCT
fnp-5343	1089	19	et	et	PROPN
fnp-5343	1089	20	al	al	PROPN
fnp-5343	1089	21	.	.	PUNCT
fnp-5343	1089	22	microvascular	microvascular	ADJ
fnp-5343	1089	23	injury	injury	NOUN
fnp-5343	1089	24	in	in	ADP
fnp-5343	1089	25	the	the	DET
fnp-5343	1089	26	brains	brain	NOUN
fnp-5343	1089	27	of	of	ADP
fnp-5343	1089	28	patients	patient	NOUN
fnp-5343	1089	29	with	with	ADP
fnp-5343	1089	30	covid-19	covid-19	PROPN
fnp-5343	1089	31	.	.	PUNCT
fnp-5343	1090	1	n	n	PROPN
fnp-5343	1090	2	engl	engl	PROPN
fnp-5343	1090	3	j	j	PROPN
fnp-5343	1090	4	med	med	PROPN
fnp-5343	1090	5	2021;384:481–3	2021;384:481–3	PROPN
fnp-5343	1090	6	.	.	PUNCT
fnp-5343	1091	1	https://doi.org/10.1056/nejmc2033369	https://doi.org/10.1056/nejmc2033369	PROPN
fnp-5343	1091	2	.	.	PUNCT
fnp-5343	1092	1	216	216	NUM
fnp-5343	1092	2	.	.	PUNCT
fnp-5343	1092	3	mavrikaki	mavrikaki	PROPN
fnp-5343	1092	4	m	m	PROPN
fnp-5343	1092	5	,	,	PUNCT
fnp-5343	1092	6	lee	lee	PROPN
fnp-5343	1092	7	jd	jd	PROPN
fnp-5343	1092	8	,	,	PUNCT
fnp-5343	1092	9	solomon	solomon	PROPN
fnp-5343	1092	10	ih	ih	PROPN
fnp-5343	1092	11	,	,	PUNCT
fnp-5343	1092	12	slack	slack	VERB
fnp-5343	1092	13	fj	fj	INTJ
fnp-5343	1092	14	.	.	PUNCT
fnp-5343	1093	1	severe	severe	PROPN
fnp-5343	1093	2	covid-19	covid-19	PROPN
fnp-5343	1093	3	is	be	AUX
fnp-5343	1093	4	associated	associate	VERB
fnp-5343	1093	5	with	with	ADP
fnp-5343	1093	6	molecular	molecular	ADJ
fnp-5343	1093	7	signatures	signature	NOUN
fnp-5343	1093	8	of	of	ADP
fnp-5343	1093	9	aging	aging	NOUN
fnp-5343	1093	10	in	in	ADP
fnp-5343	1093	11	the	the	DET
fnp-5343	1093	12	human	human	ADJ
fnp-5343	1093	13	brain	brain	NOUN
fnp-5343	1093	14	.	.	PUNCT
fnp-5343	1094	1	nat	nat	NOUN
fnp-5343	1094	2	aging	age	VERB
fnp-5343	1094	3	2022;2:1130–7	2022;2:1130–7	PROPN
fnp-5343	1094	4	.	.	PUNCT
fnp-5343	1095	1	https://doi.org/10.1038/s43587-022-00321-w	https://doi.org/10.1038/s43587-022-00321-w	NOUN
fnp-5343	1095	2	.	.	PUNCT
fnp-5343	1096	1	217	217	NUM
fnp-5343	1096	2	.	.	PUNCT
fnp-5343	1097	1	fullard	fullard	PROPN
fnp-5343	1097	2	jf	jf	PROPN
fnp-5343	1097	3	,	,	PUNCT
fnp-5343	1097	4	lee	lee	PROPN
fnp-5343	1097	5	hc	hc	PROPN
fnp-5343	1097	6	,	,	PUNCT
fnp-5343	1097	7	voloudakis	voloudakis	PROPN
fnp-5343	1097	8	g	g	PROPN
fnp-5343	1097	9	,	,	PUNCT
fnp-5343	1097	10	suo	suo	PROPN
fnp-5343	1097	11	s	s	PROPN
fnp-5343	1097	12	,	,	PUNCT
fnp-5343	1097	13	javidfar	javidfar	PROPN
fnp-5343	1097	14	b	b	PROPN
fnp-5343	1097	15	,	,	PUNCT
fnp-5343	1097	16	shao	shao	PROPN
fnp-5343	1097	17	z	z	PROPN
fnp-5343	1097	18	,	,	PUNCT
fnp-5343	1097	19	et	et	PROPN
fnp-5343	1097	20	al	al	PROPN
fnp-5343	1097	21	.	.	PUNCT
fnp-5343	1097	22	single	single	ADJ
fnp-5343	1097	23	-	-	PUNCT
fnp-5343	1097	24	nucleus	nucleus	ADJ
fnp-5343	1097	25	transcriptome	transcriptome	ADJ
fnp-5343	1097	26	analysis	analysis	NOUN
fnp-5343	1097	27	of	of	ADP
fnp-5343	1097	28	human	human	ADJ
fnp-5343	1097	29	brain	brain	NOUN
fnp-5343	1097	30	immune	immune	ADJ
fnp-5343	1097	31	response	response	NOUN
fnp-5343	1097	32	in	in	ADP
fnp-5343	1097	33	patients	patient	NOUN
fnp-5343	1097	34	with	with	ADP
fnp-5343	1097	35	severe	severe	ADJ
fnp-5343	1097	36	covid-19	covid-19	PROPN
fnp-5343	1097	37	.	.	PUNCT
fnp-5343	1097	38	genome	genome	NOUN
fnp-5343	1097	39	med	me	VERB
fnp-5343	1097	40	2021;13:118	2021;13:118	NUM
fnp-5343	1097	41	.	.	PUNCT
fnp-5343	1098	1	https://doi.org/10.1186/s13073-021-00933-8	https://doi.org/10.1186/s13073-021-00933-8	PROPN
fnp-5343	1098	2	.	.	PUNCT
fnp-5343	1099	1	218	218	NUM
fnp-5343	1099	2	.	.	PUNCT
fnp-5343	1100	1	mukherjee	mukherjee	PROPN
fnp-5343	1100	2	a	a	PROPN
fnp-5343	1100	3	,	,	PUNCT
fnp-5343	1100	4	peterson	peterson	PROPN
fnp-5343	1100	5	jeg	jeg	PROPN
fnp-5343	1100	6	,	,	PUNCT
fnp-5343	1100	7	sandberg	sandberg	PROPN
fnp-5343	1100	8	g	g	PROPN
fnp-5343	1100	9	,	,	PUNCT
fnp-5343	1100	10	takei	takei	PROPN
fnp-5343	1100	11	h	h	PROPN
fnp-5343	1100	12	,	,	PUNCT
fnp-5343	1100	13	adesina	adesina	PROPN
fnp-5343	1100	14	a	a	PROPN
fnp-5343	1100	15	,	,	PUNCT
fnp-5343	1100	16	goodman	goodman	PROPN
fnp-5343	1100	17	jc	jc	PROPN
fnp-5343	1100	18	,	,	PUNCT
fnp-5343	1100	19	et	et	PROPN
fnp-5343	1100	20	al	al	PROPN
fnp-5343	1100	21	.	.	PUNCT
fnp-5343	1101	1	central	central	ADJ
fnp-5343	1101	2	nervous	nervous	ADJ
fnp-5343	1101	3	system	system	NOUN
fnp-5343	1101	4	pathology	pathology	NOUN
fnp-5343	1101	5	in	in	ADP
fnp-5343	1101	6	fatal	fatal	ADJ
fnp-5343	1101	7	swine	swine	NOUN
fnp-5343	1101	8	-	-	PUNCT
fnp-5343	1101	9	origin	origin	NOUN
fnp-5343	1101	10	influenza	influenza	NOUN
fnp-5343	1101	11	a	a	DET
fnp-5343	1101	12	h1n1	h1n1	NOUN
fnp-5343	1101	13	virus	virus	NOUN
fnp-5343	1101	14	infection	infection	NOUN
fnp-5343	1101	15	in	in	ADP
fnp-5343	1101	16	patients	patient	NOUN
fnp-5343	1101	17	with	with	ADP
fnp-5343	1101	18	and	and	CCONJ
fnp-5343	1101	19	without	without	ADP
fnp-5343	1101	20	neurological	neurological	ADJ
fnp-5343	1101	21	symptoms	symptom	NOUN
fnp-5343	1101	22	:	:	PUNCT
fnp-5343	1101	23	an	an	DET
fnp-5343	1101	24	autopsy	autopsy	ADJ
fnp-5343	1101	25	study	study	NOUN
fnp-5343	1101	26	of	of	ADP
fnp-5343	1101	27	15	15	NUM
fnp-5343	1101	28	cases	case	NOUN
fnp-5343	1101	29	.	.	PUNCT
fnp-5343	1102	1	acta	acta	PROPN
fnp-5343	1102	2	neuropathol	neuropathol	PROPN
fnp-5343	1102	3	2011;122:371–3	2011;122:371–3	PROPN
fnp-5343	1102	4	.	.	PUNCT
fnp-5343	1103	1	https://doi.org/10.1007/s00401-011-0854-7	https://doi.org/10.1007/s00401-011-0854-7	PROPN
fnp-5343	1103	2	.	.	PUNCT
fnp-5343	1104	1	219	219	NUM
fnp-5343	1104	2	.	.	PUNCT
fnp-5343	1105	1	gu	gu	PROPN
fnp-5343	1105	2	j	j	PROPN
fnp-5343	1105	3	,	,	PUNCT
fnp-5343	1105	4	korteweg	korteweg	PROPN
fnp-5343	1105	5	c.	c.	PROPN
fnp-5343	1105	6	pathology	pathology	PROPN
fnp-5343	1105	7	and	and	CCONJ
fnp-5343	1105	8	pathogenesis	pathogenesis	NOUN
fnp-5343	1105	9	of	of	ADP
fnp-5343	1105	10	severe	severe	ADJ
fnp-5343	1105	11	acute	acute	ADJ
fnp-5343	1105	12	respiratory	respiratory	ADJ
fnp-5343	1105	13	syndrome	syndrome	NOUN
fnp-5343	1105	14	.	.	PUNCT
fnp-5343	1106	1	am	be	AUX
fnp-5343	1106	2	j	j	PROPN
fnp-5343	1106	3	pathol	pathol	NOUN
fnp-5343	1106	4	2007;170:1136–47	2007;170:1136–47	NUM
fnp-5343	1106	5	.	.	PUNCT
fnp-5343	1107	1	https://doi.org/10.2353/ajpath.2007.061088	https://doi.org/10.2353/ajpath.2007.061088	PROPN
fnp-5343	1107	2	.	.	PROPN
fnp-5343	1107	3	220	220	NUM
fnp-5343	1107	4	.	.	PUNCT
fnp-5343	1107	5	gu	gu	PROPN
fnp-5343	1107	6	j	j	PROPN
fnp-5343	1107	7	,	,	PUNCT
fnp-5343	1107	8	gong	gong	PROPN
fnp-5343	1107	9	e	e	PROPN
fnp-5343	1107	10	,	,	PUNCT
fnp-5343	1107	11	zhang	zhang	PROPN
fnp-5343	1107	12	b	b	PROPN
fnp-5343	1107	13	,	,	PUNCT
fnp-5343	1107	14	zheng	zheng	PROPN
fnp-5343	1107	15	j	j	PROPN
fnp-5343	1107	16	,	,	PUNCT
fnp-5343	1107	17	gao	gao	PROPN
fnp-5343	1107	18	z	z	PROPN
fnp-5343	1107	19	,	,	PUNCT
fnp-5343	1107	20	zhong	zhong	PROPN
fnp-5343	1107	21	y	y	PROPN
fnp-5343	1107	22	,	,	PUNCT
fnp-5343	1107	23	et	et	PROPN
fnp-5343	1107	24	al	al	PROPN
fnp-5343	1107	25	.	.	PUNCT
fnp-5343	1107	26	multiple	multiple	ADJ
fnp-5343	1107	27	organ	organ	NOUN
fnp-5343	1107	28	infection	infection	NOUN
fnp-5343	1107	29	and	and	CCONJ
fnp-5343	1107	30	the	the	DET
fnp-5343	1107	31	pathogenesis	pathogenesis	NOUN
fnp-5343	1107	32	of	of	ADP
fnp-5343	1107	33	sars	sars	PROPN
fnp-5343	1107	34	.	.	PUNCT
fnp-5343	1108	1	j	j	PROPN
fnp-5343	1108	2	exp	exp	NOUN
fnp-5343	1108	3	med	med	PROPN
fnp-5343	1108	4	2005;202:415–24	2005;202:415–24	PROPN
fnp-5343	1108	5	.	.	PUNCT
fnp-5343	1109	1	https://doi.org/10.1084/jem.20050828	https://doi.org/10.1084/jem.20050828	NOUN
fnp-5343	1109	2	.	.	PUNCT
fnp-5343	1110	1	221	221	NUM
fnp-5343	1110	2	.	.	PUNCT
fnp-5343	1111	1	xu	xu	PROPN
fnp-5343	1111	2	j	j	PROPN
fnp-5343	1111	3	,	,	PUNCT
fnp-5343	1111	4	zhong	zhong	PROPN
fnp-5343	1111	5	s	s	PROPN
fnp-5343	1111	6	,	,	PUNCT
fnp-5343	1111	7	liu	liu	PROPN
fnp-5343	1111	8	j	j	PROPN
fnp-5343	1111	9	,	,	PUNCT
fnp-5343	1111	10	li	li	PROPN
fnp-5343	1111	11	l	l	PROPN
fnp-5343	1111	12	,	,	PUNCT
fnp-5343	1111	13	li	li	PROPN
fnp-5343	1111	14	y	y	PROPN
fnp-5343	1111	15	,	,	PUNCT
fnp-5343	1111	16	wu	wu	PROPN
fnp-5343	1111	17	x	x	PROPN
fnp-5343	1111	18	,	,	PUNCT
fnp-5343	1111	19	et	et	PROPN
fnp-5343	1111	20	al	al	PROPN
fnp-5343	1111	21	.	.	PUNCT
fnp-5343	1111	22	detection	detection	NOUN
fnp-5343	1111	23	of	of	ADP
fnp-5343	1111	24	severe	severe	ADJ
fnp-5343	1111	25	acute	acute	ADJ
fnp-5343	1111	26	respiratory	respiratory	ADJ
fnp-5343	1111	27	syndrome	syndrome	NOUN
fnp-5343	1111	28	coronavirus	coronavirus	NOUN
fnp-5343	1111	29	in	in	ADP
fnp-5343	1111	30	the	the	DET
fnp-5343	1111	31	brain	brain	NOUN
fnp-5343	1111	32	:	:	PUNCT
fnp-5343	1111	33	potential	potential	ADJ
fnp-5343	1111	34	role	role	NOUN
fnp-5343	1111	35	of	of	ADP
fnp-5343	1111	36	the	the	DET
fnp-5343	1111	37	chemokine	chemokine	ADJ
fnp-5343	1111	38	mig	mig	NOUN
fnp-5343	1111	39	in	in	ADP
fnp-5343	1111	40	pathogenesis	pathogenesis	NOUN
fnp-5343	1111	41	.	.	PUNCT
fnp-5343	1112	1	clin	clin	PROPN
fnp-5343	1112	2	infect	infect	PROPN
fnp-5343	1112	3	dis	dis	PROPN
fnp-5343	1112	4	2005;41:1089–96	2005;41:1089–96	NUM
fnp-5343	1112	5	.	.	PUNCT
fnp-5343	1113	1	https://doi.org/10.1086/444461	https://doi.org/10.1086/444461	X
fnp-5343	1113	2	.	.	PUNCT
fnp-5343	1114	1	222	222	NUM
fnp-5343	1114	2	.	.	PUNCT
fnp-5343	1115	1	lau	lau	PROPN
fnp-5343	1115	2	kk	kk	PROPN
fnp-5343	1115	3	,	,	PUNCT
fnp-5343	1115	4	yu	yu	PROPN
fnp-5343	1115	5	wc	wc	PROPN
fnp-5343	1115	6	,	,	PUNCT
fnp-5343	1115	7	chu	chu	PROPN
fnp-5343	1115	8	cm	cm	PROPN
fnp-5343	1115	9	,	,	PUNCT
fnp-5343	1115	10	lau	lau	PROPN
fnp-5343	1115	11	st	st	PROPN
fnp-5343	1115	12	,	,	PUNCT
fnp-5343	1115	13	sheng	sheng	PROPN
fnp-5343	1115	14	b	b	PROPN
fnp-5343	1115	15	,	,	PUNCT
fnp-5343	1115	16	yuen	yuen	PROPN
fnp-5343	1115	17	ky	ky	PROPN
fnp-5343	1115	18	.	.	PUNCT
fnp-5343	1116	1	possible	possible	ADJ
fnp-5343	1116	2	central	central	ADJ
fnp-5343	1116	3	nervous	nervous	ADJ
fnp-5343	1116	4	system	system	NOUN
fnp-5343	1116	5	infection	infection	NOUN
fnp-5343	1116	6	by	by	ADP
fnp-5343	1116	7	sars	sars	PROPN
fnp-5343	1116	8	coronavirus	coronavirus	PROPN
fnp-5343	1116	9	.	.	PUNCT
fnp-5343	1117	1	emerg	emerg	PROPN
fnp-5343	1117	2	infect	infect	NOUN
fnp-5343	1117	3	dis	dis	PROPN
fnp-5343	1117	4	2004;10:342–4	2004;10:342–4	NUM
fnp-5343	1117	5	.	.	PUNCT
fnp-5343	1118	1	https://doi.org/10.3201/eid1002.030638	https://doi.org/10.3201/eid1002.030638	NOUN
fnp-5343	1118	2	.	.	PUNCT
fnp-5343	1118	3	223	223	NUM
fnp-5343	1118	4	.	.	PUNCT
fnp-5343	1119	1	hung	hung	PROPN
fnp-5343	1119	2	ec	ec	PROPN
fnp-5343	1119	3	,	,	PUNCT
fnp-5343	1119	4	chim	chim	PROPN
fnp-5343	1119	5	ss	ss	PROPN
fnp-5343	1119	6	,	,	PUNCT
fnp-5343	1119	7	chan	chan	PROPN
fnp-5343	1119	8	pk	pk	PROPN
fnp-5343	1119	9	,	,	PUNCT
fnp-5343	1119	10	tong	tong	PROPN
fnp-5343	1119	11	yk	yk	PROPN
fnp-5343	1119	12	,	,	PUNCT
fnp-5343	1119	13	ng	ng	PROPN
fnp-5343	1119	14	ek	ek	PROPN
fnp-5343	1119	15	,	,	PUNCT
fnp-5343	1119	16	chiu	chiu	PROPN
fnp-5343	1119	17	rw	rw	PROPN
fnp-5343	1119	18	,	,	PUNCT
fnp-5343	1119	19	et	et	PROPN
fnp-5343	1119	20	al	al	PROPN
fnp-5343	1119	21	.	.	PUNCT
fnp-5343	1119	22	detection	detection	NOUN
fnp-5343	1119	23	of	of	ADP
fnp-5343	1119	24	sars	sars	PROPN
fnp-5343	1119	25	coronavirus	coronavirus	PROPN
fnp-5343	1119	26	rna	rna	PROPN
fnp-5343	1119	27	in	in	ADP
fnp-5343	1119	28	the	the	DET
fnp-5343	1119	29	cerebrospinal	cerebrospinal	ADJ
fnp-5343	1119	30	fluid	fluid	NOUN
fnp-5343	1119	31	of	of	ADP
fnp-5343	1119	32	a	a	DET
fnp-5343	1119	33	patient	patient	NOUN
fnp-5343	1119	34	with	with	ADP
fnp-5343	1119	35	severe	severe	ADJ
fnp-5343	1119	36	acute	acute	ADJ
fnp-5343	1119	37	respiratory	respiratory	ADJ
fnp-5343	1119	38	syndrome	syndrome	NOUN
fnp-5343	1119	39	.	.	PUNCT
fnp-5343	1120	1	clin	clin	PROPN
fnp-5343	1120	2	chem	chem	NOUN
fnp-5343	1120	3	2003;49:2108–9	2003;49:2108–9	NOUN
fnp-5343	1120	4	.	.	PUNCT
fnp-5343	1121	1	https://doi.org/10.1373/clinchem.2003.025437	https://doi.org/10.1373/clinchem.2003.025437	PROPN
fnp-5343	1121	2	.	.	PROPN
fnp-5343	1121	3	224	224	NUM
fnp-5343	1121	4	.	.	PUNCT
fnp-5343	1122	1	ding	ding	PROPN
fnp-5343	1122	2	y	y	PROPN
fnp-5343	1122	3	,	,	PUNCT
fnp-5343	1122	4	he	he	PRON
fnp-5343	1122	5	l	l	NOUN
fnp-5343	1122	6	,	,	PUNCT
fnp-5343	1123	1	zhang	zhang	PROPN
fnp-5343	1123	2	q	q	PROPN
fnp-5343	1123	3	,	,	PUNCT
fnp-5343	1123	4	huang	huang	PROPN
fnp-5343	1123	5	z	z	PROPN
fnp-5343	1123	6	,	,	PUNCT
fnp-5343	1123	7	che	che	PROPN
fnp-5343	1123	8	x	x	PROPN
fnp-5343	1123	9	,	,	PUNCT
fnp-5343	1123	10	hou	hou	PROPN
fnp-5343	1123	11	j	j	PROPN
fnp-5343	1123	12	,	,	PUNCT
fnp-5343	1123	13	et	et	PROPN
fnp-5343	1123	14	al	al	PROPN
fnp-5343	1123	15	.	.	PROPN
fnp-5343	1123	16	organ	organ	NOUN
fnp-5343	1123	17	distribution	distribution	NOUN
fnp-5343	1123	18	of	of	ADP
fnp-5343	1123	19	severe	severe	ADJ
fnp-5343	1123	20	acute	acute	ADJ
fnp-5343	1123	21	respiratory	respiratory	ADJ
fnp-5343	1123	22	syndrome	syndrome	NOUN
fnp-5343	1123	23	(	(	PUNCT
fnp-5343	1123	24	sars	sars	PROPN
fnp-5343	1123	25	)	)	PUNCT
fnp-5343	1123	26	associated	associate	VERB
fnp-5343	1123	27	coronavirus	coronavirus	NOUN
fnp-5343	1123	28	(	(	PUNCT
fnp-5343	1123	29	sars	sars	NOUN
fnp-5343	1123	30	-	-	PUNCT
fnp-5343	1123	31	cov	cov	NOUN
fnp-5343	1123	32	)	)	PUNCT
fnp-5343	1123	33	in	in	ADP
fnp-5343	1123	34	sars	sars	PROPN
fnp-5343	1123	35	patients	patient	NOUN
fnp-5343	1123	36	:	:	PUNCT
fnp-5343	1123	37	implications	implication	NOUN
fnp-5343	1123	38	for	for	ADP
fnp-5343	1123	39	pathogenesis	pathogenesis	NOUN
fnp-5343	1123	40	virus	virus	NOUN
fnp-5343	1123	41	transmission	transmission	NOUN
fnp-5343	1123	42	pathways	pathway	NOUN
fnp-5343	1123	43	.	.	PUNCT
fnp-5343	1124	1	j	j	PROPN
fnp-5343	1124	2	pathol	pathol	PROPN
fnp-5343	1124	3	2004;203:622–30	2004;203:622–30	PROPN
fnp-5343	1124	4	.	.	PUNCT
fnp-5343	1125	1	https://doi.org/10.1002/path.1560	https://doi.org/10.1002/path.1560	PROPN
fnp-5343	1125	2	.	.	PUNCT
fnp-5343	1126	1	225	225	NUM
fnp-5343	1126	2	.	.	PUNCT
fnp-5343	1126	3	bhatnagar	bhatnagar	PROPN
fnp-5343	1126	4	j	j	PROPN
fnp-5343	1126	5	,	,	PUNCT
fnp-5343	1126	6	gary	gary	PROPN
fnp-5343	1126	7	j	j	PROPN
fnp-5343	1126	8	,	,	PUNCT
fnp-5343	1126	9	reagan	reagan	PROPN
fnp-5343	1126	10	-	-	PUNCT
fnp-5343	1126	11	steiner	steiner	PROPN
fnp-5343	1126	12	s	s	PROPN
fnp-5343	1126	13	,	,	PUNCT
fnp-5343	1126	14	estetter	estett	ADJ
fnp-5343	1126	15	lb	lb	NOUN
fnp-5343	1126	16	,	,	PUNCT
fnp-5343	1126	17	tong	tong	PROPN
fnp-5343	1126	18	s	s	PROPN
fnp-5343	1126	19	,	,	PUNCT
fnp-5343	1126	20	tao	tao	PROPN
fnp-5343	1126	21	y	y	PROPN
fnp-5343	1126	22	,	,	PUNCT
fnp-5343	1126	23	et	et	PROPN
fnp-5343	1126	24	al	al	PROPN
fnp-5343	1126	25	.	.	PROPN
fnp-5343	1127	1	evidence	evidence	NOUN
fnp-5343	1127	2	of	of	ADP
fnp-5343	1127	3	severe	severe	ADJ
fnp-5343	1127	4	acute	acute	ADJ
fnp-5343	1127	5	respiratory	respiratory	ADJ
fnp-5343	1127	6	syndrome	syndrome	NOUN
fnp-5343	1127	7	coronavirus	coronavirus	NOUN
fnp-5343	1127	8	2	2	NUM
fnp-5343	1127	9	replication	replication	NOUN
fnp-5343	1127	10	and	and	CCONJ
fnp-5343	1127	11	tropism	tropism	NOUN
fnp-5343	1127	12	in	in	ADP
fnp-5343	1127	13	the	the	DET
fnp-5343	1127	14	lungs	lung	NOUN
fnp-5343	1127	15	,	,	PUNCT
fnp-5343	1127	16	airways	airway	NOUN
fnp-5343	1127	17	,	,	PUNCT
fnp-5343	1127	18	and	and	CCONJ
fnp-5343	1127	19	vascular	vascular	ADJ
fnp-5343	1127	20	endothelium	endothelium	NOUN
fnp-5343	1127	21	of	of	ADP
fnp-5343	1127	22	patients	patient	NOUN
fnp-5343	1127	23	with	with	ADP
fnp-5343	1127	24	fatal	fatal	ADJ
fnp-5343	1127	25	coronavirus	coronavirus	NOUN
fnp-5343	1127	26	disease	disease	NOUN
fnp-5343	1127	27	2019	2019	NUM
fnp-5343	1127	28	:	:	PUNCT
fnp-5343	1127	29	an	an	DET
fnp-5343	1127	30	autopsy	autopsy	ADJ
fnp-5343	1127	31	case	case	NOUN
fnp-5343	1127	32	series	series	NOUN
fnp-5343	1127	33	.	.	PUNCT
fnp-5343	1128	1	j	j	PROPN
fnp-5343	1128	2	infect	infect	VERB
fnp-5343	1128	3	dis	dis	PROPN
fnp-5343	1128	4	2021;223:752–64	2021;223:752–64	PROPN
fnp-5343	1128	5	.	.	PUNCT
fnp-5343	1129	1	https://doi.org/10.1093/infdis/jiab039	https://doi.org/10.1093/infdis/jiab039	PROPN
fnp-5343	1129	2	.	.	PUNCT
fnp-5343	1130	1	226	226	NUM
fnp-5343	1130	2	.	.	PUNCT
fnp-5343	1131	1	remmelink	remmelink	PROPN
fnp-5343	1131	2	m	m	NOUN
fnp-5343	1131	3	,	,	PUNCT
fnp-5343	1131	4	de	de	X
fnp-5343	1131	5	mendonça	mendonça	X
fnp-5343	1131	6	r	r	NOUN
fnp-5343	1131	7	,	,	PUNCT
fnp-5343	1131	8	d’haene	d’haene	PROPN
fnp-5343	1131	9	n	n	CCONJ
fnp-5343	1131	10	,	,	PUNCT
fnp-5343	1131	11	de	de	PROPN
fnp-5343	1131	12	clercq	clercq	PROPN
fnp-5343	1131	13	s	s	PART
fnp-5343	1131	14	,	,	PUNCT
fnp-5343	1131	15	verocq	verocq	NOUN
fnp-5343	1131	16	c	c	NOUN
fnp-5343	1131	17	,	,	PUNCT
fnp-5343	1131	18	lebrun	lebrun	NOUN
fnp-5343	1131	19	l	l	NOUN
fnp-5343	1131	20	,	,	PUNCT
fnp-5343	1131	21	et	et	PROPN
fnp-5343	1131	22	al	al	PROPN
fnp-5343	1131	23	.	.	PROPN
fnp-5343	1132	1	unspecific	unspecific	ADJ
fnp-5343	1132	2	post	post	ADJ
fnp-5343	1132	3	-	-	ADJ
fnp-5343	1132	4	mortem	mortem	ADJ
fnp-5343	1132	5	findings	finding	NOUN
fnp-5343	1132	6	despite	despite	SCONJ
fnp-5343	1132	7	multiorgan	multiorgan	PROPN
fnp-5343	1132	8	viral	viral	ADJ
fnp-5343	1132	9	spread	spread	NOUN
fnp-5343	1132	10	in	in	ADP
fnp-5343	1132	11	covid-19	covid-19	PROPN
fnp-5343	1132	12	patients	patient	NOUN
fnp-5343	1132	13	.	.	PUNCT
fnp-5343	1133	1	crit	crit	PROPN
fnp-5343	1133	2	care	care	NOUN
fnp-5343	1133	3	2020;24:495	2020;24:495	PROPN
fnp-5343	1133	4	.	.	PUNCT
fnp-5343	1134	1	https://doi.org/10.1186/s13054-020-03218-5	https://doi.org/10.1186/s13054-020-03218-5	PROPN
fnp-5343	1134	2	.	.	PUNCT
fnp-5343	1135	1	227	227	NUM
fnp-5343	1135	2	.	.	PUNCT
fnp-5343	1135	3	fabbri	fabbri	NOUN
fnp-5343	1135	4	vp	vp	PROPN
fnp-5343	1135	5	,	,	PUNCT
fnp-5343	1135	6	riefolo	riefolo	PROPN
fnp-5343	1135	7	m	m	PROPN
fnp-5343	1135	8	,	,	PUNCT
fnp-5343	1135	9	lazzarotto	lazzarotto	ADJ
fnp-5343	1135	10	t	t	PROPN
fnp-5343	1135	11	,	,	PUNCT
fnp-5343	1135	12	gabrielli	gabrielli	PROPN
fnp-5343	1135	13	l	l	PROPN
fnp-5343	1135	14	,	,	PUNCT
fnp-5343	1135	15	cenacchi	cenacchi	PROPN
fnp-5343	1135	16	g	g	PROPN
fnp-5343	1135	17	,	,	PUNCT
fnp-5343	1135	18	gallo	gallo	PROPN
fnp-5343	1135	19	c	c	PROPN
fnp-5343	1135	20	,	,	PUNCT
fnp-5343	1135	21	et	et	PROPN
fnp-5343	1135	22	al	al	PROPN
fnp-5343	1135	23	.	.	PUNCT
fnp-5343	1136	1	covid-19	covid-19	PROPN
fnp-5343	1136	2	and	and	CCONJ
fnp-5343	1136	3	the	the	DET
fnp-5343	1136	4	brain	brain	NOUN
fnp-5343	1136	5	:	:	PUNCT
fnp-5343	1136	6	the	the	DET
fnp-5343	1136	7	neuropathological	neuropathological	ADJ
fnp-5343	1136	8	italian	italian	ADJ
fnp-5343	1136	9	experience	experience	NOUN
fnp-5343	1136	10	on	on	ADP
fnp-5343	1136	11	33	33	NUM
fnp-5343	1136	12	adult	adult	NOUN
fnp-5343	1136	13	autopsies	autopsy	NOUN
fnp-5343	1136	14	.	.	PUNCT
fnp-5343	1137	1	biomolecules	biomolecule	NOUN
fnp-5343	1137	2	2022;12:629	2022;12:629	PROPN
fnp-5343	1137	3	.	.	PUNCT
fnp-5343	1138	1	https://doi.org/10.3390/biom12050629	https://doi.org/10.3390/biom12050629	PROPN
fnp-5343	1138	2	.	.	PUNCT
fnp-5343	1139	1	228	228	NUM
fnp-5343	1139	2	.	.	PUNCT
fnp-5343	1140	1	boluda	boluda	PROPN
fnp-5343	1140	2	s	s	PROPN
fnp-5343	1140	3	,	,	PUNCT
fnp-5343	1140	4	mokhtari	mokhtari	PROPN
fnp-5343	1140	5	k	k	PROPN
fnp-5343	1140	6	,	,	PUNCT
fnp-5343	1140	7	mégarbane	mégarbane	PROPN
fnp-5343	1140	8	b	b	PROPN
fnp-5343	1140	9	,	,	PUNCT
fnp-5343	1140	10	annane	annane	NOUN
fnp-5343	1140	11	d	d	PROPN
fnp-5343	1140	12	,	,	PUNCT
fnp-5343	1140	13	mathon	mathon	PROPN
fnp-5343	1140	14	b	b	NUM
fnp-5343	1140	15	,	,	PUNCT
fnp-5343	1140	16	cao	cao	PROPN
fnp-5343	1140	17	a	a	X
fnp-5343	1140	18	,	,	PUNCT
fnp-5343	1140	19	et	et	PROPN
fnp-5343	1140	20	al	al	PROPN
fnp-5343	1140	21	.	.	PUNCT
fnp-5343	1140	22	golgi	golgi	PROPN
fnp-5343	1140	23	localization	localization	NOUN
fnp-5343	1140	24	of	of	ADP
fnp-5343	1140	25	sars	sar	NOUN
fnp-5343	1140	26	-	-	PUNCT
fnp-5343	1140	27	cov-2	cov-2	NOUN
fnp-5343	1140	28	spike	spike	ADJ
fnp-5343	1140	29	protein	protein	NOUN
fnp-5343	1140	30	and	and	CCONJ
fnp-5343	1140	31	interaction	interaction	NOUN
fnp-5343	1140	32	with	with	ADP
fnp-5343	1140	33	furin	furin	NOUN
fnp-5343	1140	34	in	in	ADP
fnp-5343	1140	35	cerebral	cerebral	ADJ
fnp-5343	1140	36	covid-19	covid-19	PROPN
fnp-5343	1140	37	microangiopathy	microangiopathy	PROPN
fnp-5343	1140	38	:	:	PUNCT
fnp-5343	1140	39	a	a	DET
fnp-5343	1140	40	clue	clue	NOUN
fnp-5343	1140	41	to	to	ADP
fnp-5343	1140	42	the	the	DET
fnp-5343	1140	43	central	central	ADJ
fnp-5343	1140	44	nervous	nervous	ADJ
fnp-5343	1140	45	system	system	NOUN
fnp-5343	1140	46	involvement	involvement	NOUN
fnp-5343	1140	47	?	?	PUNCT
fnp-5343	1141	1	free	free	ADJ
fnp-5343	1141	2	neuropathol	neuropathol	NOUN
fnp-5343	1141	3	2023;4:4	2023;4:4	NUM
fnp-5343	1141	4	-	-	SYM
fnp-5343	1141	5	1	1	NUM
fnp-5343	1141	6	.	.	PUNCT
fnp-5343	1141	7	https://doi.org/10.17879/freeneuropathology-2023-4584	https://doi.org/10.17879/freeneuropathology-2023-4584	NOUN
fnp-5343	1141	8	.	.	PROPN
fnp-5343	1141	9	229	229	NUM
fnp-5343	1141	10	.	.	PUNCT
fnp-5343	1142	1	song	song	PROPN
fnp-5343	1142	2	e	e	PROPN
fnp-5343	1142	3	,	,	PUNCT
fnp-5343	1142	4	zhang	zhang	PROPN
fnp-5343	1142	5	c	c	X
fnp-5343	1142	6	,	,	PUNCT
fnp-5343	1142	7	israelow	israelow	NOUN
fnp-5343	1142	8	b	b	PROPN
fnp-5343	1142	9	,	,	PUNCT
fnp-5343	1142	10	lu	lu	NOUN
fnp-5343	1142	11	-	-	PUNCT
fnp-5343	1142	12	culligan	culligan	PROPN
fnp-5343	1142	13	a	a	PRON
fnp-5343	1142	14	,	,	PUNCT
fnp-5343	1142	15	prado	prado	PROPN
fnp-5343	1142	16	av	av	PROPN
fnp-5343	1142	17	,	,	PUNCT
fnp-5343	1142	18	skriabine	skriabine	PROPN
fnp-5343	1142	19	s	s	PROPN
fnp-5343	1142	20	,	,	PUNCT
fnp-5343	1142	21	et	et	PROPN
fnp-5343	1142	22	al	al	PROPN
fnp-5343	1142	23	.	.	PROPN
fnp-5343	1142	24	neuroinvasion	neuroinvasion	PROPN
fnp-5343	1142	25	of	of	ADP
fnp-5343	1142	26	sars	sar	NOUN
fnp-5343	1142	27	-	-	PUNCT
fnp-5343	1142	28	cov-2	cov-2	NOUN
fnp-5343	1142	29	in	in	ADP
fnp-5343	1142	30	human	human	ADJ
fnp-5343	1142	31	and	and	CCONJ
fnp-5343	1142	32	mouse	mouse	NOUN
fnp-5343	1142	33	brain	brain	NOUN
fnp-5343	1142	34	.	.	PUNCT
fnp-5343	1143	1	j	j	PROPN
fnp-5343	1143	2	exp	exp	NOUN
fnp-5343	1143	3	med	med	PROPN
fnp-5343	1143	4	2021;218	2021;218	NOUN
fnp-5343	1143	5	:	:	PUNCT
fnp-5343	1143	6	e20202135	e20202135	NOUN
fnp-5343	1143	7	.	.	PUNCT
fnp-5343	1144	1	https://doi.org/10.1084/jem.20202135	https://doi.org/10.1084/jem.20202135	NOUN
fnp-5343	1144	2	.	.	PUNCT
fnp-5343	1145	1	230	230	NUM
fnp-5343	1145	2	.	.	PUNCT
fnp-5343	1146	1	matschke	matschke	PROPN
fnp-5343	1146	2	j	j	PROPN
fnp-5343	1146	3	,	,	PUNCT
fnp-5343	1146	4	lütgehetmann	lütgehetmann	PROPN
fnp-5343	1146	5	m	m	PROPN
fnp-5343	1146	6	,	,	PUNCT
fnp-5343	1146	7	hagel	hagel	PROPN
fnp-5343	1146	8	c	c	NOUN
fnp-5343	1146	9	,	,	PUNCT
fnp-5343	1146	10	sperhake	sperhake	NOUN
fnp-5343	1146	11	jp	jp	PROPN
fnp-5343	1146	12	,	,	PUNCT
fnp-5343	1146	13	schröder	schröder	NOUN
fnp-5343	1146	14	as	as	ADP
fnp-5343	1146	15	,	,	PUNCT
fnp-5343	1146	16	edler	edler	PROPN
fnp-5343	1146	17	c	c	PROPN
fnp-5343	1146	18	,	,	PUNCT
fnp-5343	1146	19	et	et	PROPN
fnp-5343	1146	20	al	al	PROPN
fnp-5343	1146	21	.	.	PROPN
fnp-5343	1146	22	neuropathology	neuropathology	NOUN
fnp-5343	1146	23	of	of	ADP
fnp-5343	1146	24	patients	patient	NOUN
fnp-5343	1146	25	with	with	ADP
fnp-5343	1146	26	covid-19	covid-19	PROPN
fnp-5343	1146	27	in	in	ADP
fnp-5343	1146	28	germany	germany	PROPN
fnp-5343	1146	29	:	:	PUNCT
fnp-5343	1146	30	a	a	DET
fnp-5343	1146	31	post	post	ADJ
fnp-5343	1146	32	-	-	ADJ
fnp-5343	1146	33	mortem	mortem	ADJ
fnp-5343	1146	34	case	case	NOUN
fnp-5343	1146	35	series	series	NOUN
fnp-5343	1146	36	.	.	PUNCT
fnp-5343	1147	1	lancet	lancet	PROPN
fnp-5343	1147	2	neurol	neurol	PROPN
fnp-5343	1147	3	2020;19:919–29	2020;19:919–29	NUM
fnp-5343	1147	4	.	.	PUNCT
fnp-5343	1147	5	https://doi.org/10.1016/s1474-4422(20)30308-2	https://doi.org/10.1016/s1474-4422(20)30308-2	NOUN
fnp-5343	1147	6	.	.	PUNCT
fnp-5343	1148	1	231	231	NUM
fnp-5343	1148	2	.	.	X
fnp-5343	1149	1	meinhardt	meinhardt	PROPN
fnp-5343	1149	2	j	j	PROPN
fnp-5343	1149	3	,	,	PUNCT
fnp-5343	1149	4	radke	radke	PROPN
fnp-5343	1149	5	j	j	PROPN
fnp-5343	1149	6	,	,	PUNCT
fnp-5343	1149	7	dittmayer	dittmayer	PROPN
fnp-5343	1149	8	c	c	X
fnp-5343	1149	9	,	,	PUNCT
fnp-5343	1149	10	franz	franz	PROPN
fnp-5343	1149	11	j	j	PROPN
fnp-5343	1149	12	,	,	PUNCT
fnp-5343	1149	13	thomas	thomas	PROPN
fnp-5343	1149	14	c	c	PROPN
fnp-5343	1149	15	,	,	PUNCT
fnp-5343	1149	16	mothes	mothe	VERB
fnp-5343	1149	17	r	r	NOUN
fnp-5343	1149	18	,	,	PUNCT
fnp-5343	1149	19	et	et	PROPN
fnp-5343	1149	20	al	al	PROPN
fnp-5343	1149	21	.	.	PROPN
fnp-5343	1149	22	olfactory	olfactory	PROPN
fnp-5343	1149	23	transmucosal	transmucosal	PROPN
fnp-5343	1149	24	sars	sars	PROPN
fnp-5343	1149	25	-	-	PUNCT
fnp-5343	1149	26	cov-2	cov-2	PART
fnp-5343	1149	27	invasion	invasion	NOUN
fnp-5343	1149	28	as	as	ADP
fnp-5343	1149	29	a	a	DET
fnp-5343	1149	30	port	port	NOUN
fnp-5343	1149	31	of	of	ADP
fnp-5343	1149	32	central	central	ADJ
fnp-5343	1149	33	nervous	nervous	ADJ
fnp-5343	1149	34	system	system	NOUN
fnp-5343	1149	35	entry	entry	NOUN
fnp-5343	1149	36	in	in	ADP
fnp-5343	1149	37	individuals	individual	NOUN
fnp-5343	1149	38	with	with	ADP
fnp-5343	1149	39	covid-19	covid-19	PROPN
fnp-5343	1149	40	.	.	PUNCT
fnp-5343	1150	1	nat	nat	PROPN
fnp-5343	1150	2	neurosci	neurosci	PROPN
fnp-5343	1150	3	2021;24:168–75	2021;24:168–75	PROPN
fnp-5343	1150	4	.	.	PUNCT
fnp-5343	1150	5	https://doi.org/10.1038/s41593-020-00758-5	https://doi.org/10.1038/s41593-020-00758-5	NUM
fnp-5343	1150	6	.	.	PUNCT
fnp-5343	1151	1	232	232	NUM
fnp-5343	1151	2	.	.	PUNCT
fnp-5343	1152	1	bauer	bauer	PROPN
fnp-5343	1152	2	l	l	PROPN
fnp-5343	1152	3	,	,	PUNCT
fnp-5343	1152	4	laksono	laksono	PROPN
fnp-5343	1152	5	bm	bm	PROPN
fnp-5343	1152	6	,	,	PUNCT
fnp-5343	1152	7	de	de	PROPN
fnp-5343	1152	8	vrij	vrij	PROPN
fnp-5343	1152	9	fms	fms	PROPN
fnp-5343	1152	10	,	,	PUNCT
fnp-5343	1152	11	kushner	kushner	PROPN
fnp-5343	1152	12	sa	sa	PROPN
fnp-5343	1152	13	,	,	PUNCT
fnp-5343	1152	14	harschnitz	harschnitz	PROPN
fnp-5343	1152	15	o	o	PROPN
fnp-5343	1152	16	,	,	PUNCT
fnp-5343	1152	17	van	van	PROPN
fnp-5343	1152	18	riel	riel	PROPN
fnp-5343	1152	19	d.	d.	PROPN
fnp-5343	1152	20	the	the	DET
fnp-5343	1152	21	neuroinvasiveness	neuroinvasiveness	PROPN
fnp-5343	1152	22	,	,	PUNCT
fnp-5343	1152	23	neurotropism	neurotropism	NOUN
fnp-5343	1152	24	,	,	PUNCT
fnp-5343	1152	25	and	and	CCONJ
fnp-5343	1152	26	neurovirulence	neurovirulence	NOUN
fnp-5343	1152	27	of	of	ADP
fnp-5343	1152	28	sars	sar	NOUN
fnp-5343	1152	29	-	-	PUNCT
fnp-5343	1152	30	cov-2	cov-2	NOUN
fnp-5343	1152	31	.	.	PUNCT
fnp-5343	1153	1	trends	trend	NOUN
fnp-5343	1153	2	neurosci	neurosci	VERB
fnp-5343	1153	3	2022;45:358–68	2022;45:358–68	X
fnp-5343	1153	4	.	.	PUNCT
fnp-5343	1153	5	https://doi.org/10.1016/j.tins.2022.02.006	https://doi.org/10.1016/j.tins.2022.02.006	PROPN
fnp-5343	1153	6	.	.	PUNCT
fnp-5343	1154	1	233	233	NUM
fnp-5343	1154	2	.	.	PUNCT
fnp-5343	1154	3	de	de	PROPN
fnp-5343	1154	4	melo	melo	PROPN
fnp-5343	1154	5	gd	gd	PROPN
fnp-5343	1154	6	,	,	PUNCT
fnp-5343	1154	7	lazarini	lazarini	NOUN
fnp-5343	1154	8	f	f	PROPN
fnp-5343	1154	9	,	,	PUNCT
fnp-5343	1154	10	levallois	levallois	PROPN
fnp-5343	1154	11	s	s	PROPN
fnp-5343	1154	12	,	,	PUNCT
fnp-5343	1154	13	hautefort	hautefort	NOUN
fnp-5343	1154	14	c	c	PROPN
fnp-5343	1154	15	,	,	PUNCT
fnp-5343	1154	16	michel	michel	PROPN
fnp-5343	1154	17	v	v	PROPN
fnp-5343	1154	18	,	,	PUNCT
fnp-5343	1154	19	larrous	larrous	ADJ
fnp-5343	1154	20	f	f	X
fnp-5343	1154	21	,	,	PUNCT
fnp-5343	1154	22	et	et	PROPN
fnp-5343	1154	23	al	al	PROPN
fnp-5343	1154	24	.	.	PUNCT
fnp-5343	1154	25	covid-19	covid-19	PROPN
fnp-5343	1154	26	-	-	PUNCT
fnp-5343	1154	27	related	relate	VERB
fnp-5343	1154	28	anosmia	anosmia	NOUN
fnp-5343	1154	29	is	be	AUX
fnp-5343	1154	30	associated	associate	VERB
fnp-5343	1154	31	with	with	ADP
fnp-5343	1154	32	viral	viral	ADJ
fnp-5343	1154	33	persistence	persistence	NOUN
fnp-5343	1154	34	and	and	CCONJ
fnp-5343	1154	35	inflammation	inflammation	NOUN
fnp-5343	1154	36	in	in	ADP
fnp-5343	1154	37	human	human	ADJ
fnp-5343	1154	38	olfactory	olfactory	NOUN
fnp-5343	1154	39	epithelium	epithelium	NOUN
fnp-5343	1154	40	and	and	CCONJ
fnp-5343	1154	41	brain	brain	NOUN
fnp-5343	1154	42	infection	infection	NOUN
fnp-5343	1154	43	in	in	ADP
fnp-5343	1154	44	hamsters	hamster	NOUN
fnp-5343	1154	45	.	.	PUNCT
fnp-5343	1155	1	sci	sci	PROPN
fnp-5343	1155	2	transl	transl	PROPN
fnp-5343	1155	3	med	me	VERB
fnp-5343	1155	4	2021;13	2021;13	NUM
fnp-5343	1155	5	:	:	PUNCT
fnp-5343	1156	1	eabf8396	eabf8396	PROPN
fnp-5343	1156	2	.	.	PUNCT
fnp-5343	1157	1	https://doi.org/10.1126/scitranslmed.abf8396	https://doi.org/10.1126/scitranslmed.abf8396	PROPN
fnp-5343	1157	2	.	.	PUNCT
fnp-5343	1158	1	234	234	NUM
fnp-5343	1158	2	.	.	PUNCT
fnp-5343	1159	1	durrant	durrant	PROPN
fnp-5343	1159	2	dm	dm	PROPN
fnp-5343	1159	3	,	,	PUNCT
fnp-5343	1159	4	ghosh	ghosh	PROPN
fnp-5343	1159	5	s	s	PROPN
fnp-5343	1159	6	,	,	PUNCT
fnp-5343	1159	7	klein	klein	PROPN
fnp-5343	1159	8	rs	rs	PROPN
fnp-5343	1159	9	.	.	PUNCT
fnp-5343	1160	1	the	the	DET
fnp-5343	1160	2	olfactory	olfactory	NOUN
fnp-5343	1160	3	bulb	bulb	NOUN
fnp-5343	1160	4	:	:	PUNCT
fnp-5343	1160	5	an	an	DET
fnp-5343	1160	6	immunosensory	immunosensory	NOUN
fnp-5343	1160	7	effector	effector	NOUN
fnp-5343	1160	8	organ	organ	VERB
fnp-5343	1160	9	during	during	ADP
fnp-5343	1160	10	neurotropic	neurotropic	ADJ
fnp-5343	1160	11	viral	viral	ADJ
fnp-5343	1160	12	infections	infection	NOUN
fnp-5343	1160	13	.	.	PUNCT
fnp-5343	1161	1	acs	acs	PROPN
fnp-5343	1161	2	chem	chem	NOUN
fnp-5343	1161	3	neurosci	neurosci	PROPN
fnp-5343	1161	4	2016;7:464–9	2016;7:464–9	NOUN
fnp-5343	1161	5	.	.	PUNCT
fnp-5343	1162	1	https://doi.org/10.1021/acschemneuro.6b00043	https://doi.org/10.1021/acschemneuro.6b00043	NOUN
fnp-5343	1162	2	.	.	PUNCT
fnp-5343	1162	3	235	235	NUM
fnp-5343	1162	4	.	.	PUNCT
fnp-5343	1163	1	lopez	lopez	PROPN
fnp-5343	1163	2	g	g	PROPN
fnp-5343	1163	3	,	,	PUNCT
fnp-5343	1163	4	tonello	tonello	PROPN
fnp-5343	1163	5	c	c	NOUN
fnp-5343	1163	6	,	,	PUNCT
fnp-5343	1163	7	osipova	osipova	X
fnp-5343	1163	8	g	g	PROPN
fnp-5343	1163	9	,	,	PUNCT
fnp-5343	1163	10	carsana	carsana	PROPN
fnp-5343	1163	11	l	l	NOUN
fnp-5343	1163	12	,	,	PUNCT
fnp-5343	1163	13	biasin	biasin	VERB
fnp-5343	1163	14	m	m	PROPN
fnp-5343	1163	15	,	,	PUNCT
fnp-5343	1163	16	cappelletti	cappelletti	PROPN
fnp-5343	1163	17	g	g	NOUN
fnp-5343	1163	18	,	,	PUNCT
fnp-5343	1163	19	et	et	PROPN
fnp-5343	1163	20	al	al	PROPN
fnp-5343	1163	21	.	.	PUNCT
fnp-5343	1163	22	olfactory	olfactory	PROPN
fnp-5343	1163	23	bulb	bulb	PROPN
fnp-5343	1163	24	sars	sar	NOUN
fnp-5343	1163	25	-	-	PUNCT
fnp-5343	1163	26	cov-2	cov-2	PART
fnp-5343	1163	27	infection	infection	NOUN
fnp-5343	1163	28	is	be	AUX
fnp-5343	1163	29	not	not	PART
fnp-5343	1163	30	paralleled	parallel	VERB
fnp-5343	1163	31	by	by	ADP
fnp-5343	1163	32	the	the	DET
fnp-5343	1163	33	presence	presence	NOUN
fnp-5343	1163	34	of	of	ADP
fnp-5343	1163	35	virus	virus	NOUN
fnp-5343	1163	36	in	in	ADP
fnp-5343	1163	37	other	other	ADJ
fnp-5343	1163	38	central	central	ADJ
fnp-5343	1163	39	nervous	nervous	ADJ
fnp-5343	1163	40	system	system	NOUN
fnp-5343	1163	41	areas	area	NOUN
fnp-5343	1163	42	.	.	PUNCT
fnp-5343	1164	1	neuropathol	neuropathol	NOUN
fnp-5343	1164	2	appl	appl	PROPN
fnp-5343	1164	3	neurobiol	neurobiol	PROPN
fnp-5343	1164	4	2022;48	2022;48	NUM
fnp-5343	1164	5	:	:	PUNCT
fnp-5343	1164	6	e12752	e12752	PROPN
fnp-5343	1164	7	.	.	PUNCT
fnp-5343	1165	1	https://doi.org/10.1111/nan.12752	https://doi.org/10.1111/nan.12752	PROPN
fnp-5343	1165	2	.	.	PUNCT
fnp-5343	1166	1	236	236	NUM
fnp-5343	1166	2	.	.	PUNCT
fnp-5343	1167	1	krasemann	krasemann	PROPN
fnp-5343	1167	2	s	s	PROPN
fnp-5343	1167	3	,	,	PUNCT
fnp-5343	1167	4	dittmayer	dittmayer	PROPN
fnp-5343	1167	5	c	c	PROPN
fnp-5343	1167	6	,	,	PUNCT
fnp-5343	1167	7	von	von	PROPN
fnp-5343	1167	8	stillfried	stillfrie	VERB
fnp-5343	1167	9	s	s	PROPN
fnp-5343	1167	10	,	,	PUNCT
fnp-5343	1167	11	meinhardt	meinhardt	PROPN
fnp-5343	1167	12	j	j	PROPN
fnp-5343	1167	13	,	,	PUNCT
fnp-5343	1167	14	heinrich	heinrich	NOUN
fnp-5343	1167	15	f	f	PROPN
fnp-5343	1167	16	,	,	PUNCT
fnp-5343	1167	17	hartmann	hartmann	PROPN
fnp-5343	1167	18	k	k	PROPN
fnp-5343	1167	19	,	,	PUNCT
fnp-5343	1167	20	et	et	PROPN
fnp-5343	1167	21	al	al	PROPN
fnp-5343	1167	22	.	.	PUNCT
fnp-5343	1167	23	assessing	assess	VERB
fnp-5343	1167	24	and	and	CCONJ
fnp-5343	1167	25	improving	improve	VERB
fnp-5343	1167	26	the	the	DET
fnp-5343	1167	27	validity	validity	NOUN
fnp-5343	1167	28	of	of	ADP
fnp-5343	1167	29	covid-19	covid-19	PROPN
fnp-5343	1167	30	autopsy	autopsy	ADJ
fnp-5343	1167	31	studies	study	NOUN
fnp-5343	1167	32	a	a	DET
fnp-5343	1167	33	multicentre	multicentre	NOUN
fnp-5343	1167	34	approach	approach	NOUN
fnp-5343	1167	35	to	to	PART
fnp-5343	1167	36	establish	establish	VERB
fnp-5343	1167	37	essential	essential	ADJ
fnp-5343	1167	38	standards	standard	NOUN
fnp-5343	1167	39	for	for	ADP
fnp-5343	1167	40	immunohistochemical	immunohistochemical	ADJ
fnp-5343	1167	41	and	and	CCONJ
fnp-5343	1167	42	ultrastructural	ultrastructural	ADJ
fnp-5343	1167	43	analyses	analysis	NOUN
fnp-5343	1167	44	.	.	PUNCT
fnp-5343	1168	1	ebiomedicine	ebiomedicine	PROPN
fnp-5343	1168	2	2022;83:104193	2022;83:104193	NUM
fnp-5343	1168	3	.	.	PUNCT
fnp-5343	1169	1	https://doi.org/10.1016/j.ebiom.2022.104193	https://doi.org/10.1016/j.ebiom.2022.104193	NOUN
fnp-5343	1169	2	.	.	PUNCT
fnp-5343	1170	1	237	237	NUM
fnp-5343	1170	2	.	.	PUNCT
fnp-5343	1171	1	jarius	jarius	PROPN
fnp-5343	1171	2	s	s	PROPN
fnp-5343	1171	3	,	,	PUNCT
fnp-5343	1171	4	pache	pache	NOUN
fnp-5343	1171	5	f	f	X
fnp-5343	1171	6	,	,	PUNCT
fnp-5343	1171	7	körtvelyessy	körtvelyessy	ADJ
fnp-5343	1171	8	p	p	X
fnp-5343	1171	9	,	,	PUNCT
fnp-5343	1171	10	jelčić	jelčić	PROPN
fnp-5343	1171	11	i	i	PRON
fnp-5343	1171	12	,	,	PUNCT
fnp-5343	1171	13	stettner	stettner	NOUN
fnp-5343	1171	14	m	m	PROPN
fnp-5343	1171	15	,	,	PUNCT
fnp-5343	1171	16	franciotta	franciotta	NOUN
fnp-5343	1171	17	d	d	PROPN
fnp-5343	1171	18	,	,	PUNCT
fnp-5343	1171	19	et	et	PROPN
fnp-5343	1171	20	al	al	PROPN
fnp-5343	1171	21	.	.	PUNCT
fnp-5343	1171	22	cerebrospinal	cerebrospinal	ADJ
fnp-5343	1171	23	fluid	fluid	ADJ
fnp-5343	1171	24	findings	finding	NOUN
fnp-5343	1171	25	in	in	ADP
fnp-5343	1171	26	covid-19	covid-19	PROPN
fnp-5343	1171	27	:	:	PUNCT
fnp-5343	1171	28	a	a	DET
fnp-5343	1171	29	multicenter	multicenter	ADJ
fnp-5343	1171	30	study	study	NOUN
fnp-5343	1171	31	of	of	ADP
fnp-5343	1171	32	150	150	NUM
fnp-5343	1171	33	lumbar	lumbar	NOUN
fnp-5343	1171	34	punctures	puncture	NOUN
fnp-5343	1171	35	in	in	ADP
fnp-5343	1171	36	127	127	NUM
fnp-5343	1171	37	patients	patient	NOUN
fnp-5343	1171	38	.	.	PUNCT
fnp-5343	1172	1	j	j	PROPN
fnp-5343	1172	2	neuroinflammation	neuroinflammation	NOUN
fnp-5343	1172	3	2022;19:19	2022;19:19	NUM
fnp-5343	1172	4	.	.	PUNCT
fnp-5343	1173	1	https://doi.org/10.1186/s12974-021-02339-0	https://doi.org/10.1186/s12974-021-02339-0	NUM
fnp-5343	1173	2	.	.	PUNCT
fnp-5343	1174	1	238	238	NUM
fnp-5343	1174	2	.	.	PUNCT
fnp-5343	1175	1	lersy	lersy	PROPN
fnp-5343	1175	2	f	f	PROPN
fnp-5343	1175	3	,	,	PUNCT
fnp-5343	1175	4	benotmane	benotmane	PROPN
fnp-5343	1175	5	i	i	PRON
fnp-5343	1175	6	,	,	PUNCT
fnp-5343	1175	7	helms	helms	PROPN
fnp-5343	1175	8	j	j	PROPN
fnp-5343	1175	9	,	,	PUNCT
fnp-5343	1175	10	collange	collange	ADJ
fnp-5343	1175	11	o	o	NOUN
fnp-5343	1175	12	,	,	PUNCT
fnp-5343	1175	13	schenck	schenck	PROPN
fnp-5343	1175	14	m	m	PROPN
fnp-5343	1175	15	,	,	PUNCT
fnp-5343	1175	16	brisset	brisset	VERB
fnp-5343	1175	17	jc	jc	PROPN
fnp-5343	1175	18	,	,	PUNCT
fnp-5343	1175	19	et	et	PROPN
fnp-5343	1175	20	al	al	PROPN
fnp-5343	1175	21	.	.	PUNCT
fnp-5343	1175	22	cerebrospinal	cerebrospinal	ADJ
fnp-5343	1175	23	fluid	fluid	NOUN
fnp-5343	1175	24	features	feature	NOUN
fnp-5343	1175	25	in	in	ADP
fnp-5343	1175	26	patients	patient	NOUN
fnp-5343	1175	27	with	with	ADP
fnp-5343	1175	28	coronavirus	coronavirus	NOUN
fnp-5343	1175	29	disease	disease	NOUN
fnp-5343	1175	30	2019	2019	NUM
fnp-5343	1175	31	and	and	CCONJ
fnp-5343	1175	32	neurological	neurological	ADJ
fnp-5343	1175	33	manifestations	manifestation	NOUN
fnp-5343	1175	34	:	:	PUNCT
fnp-5343	1175	35	correlation	correlation	NOUN
fnp-5343	1175	36	with	with	ADP
fnp-5343	1175	37	brain	brain	NOUN
fnp-5343	1175	38	magnetic	magnetic	ADJ
fnp-5343	1175	39	resonance	resonance	NOUN
fnp-5343	1175	40	imaging	imaging	NOUN
fnp-5343	1175	41	findings	finding	NOUN
fnp-5343	1175	42	in	in	ADP
fnp-5343	1175	43	58	58	NUM
fnp-5343	1175	44	patients	patient	NOUN
fnp-5343	1175	45	.	.	PUNCT
fnp-5343	1176	1	j	j	PROPN
fnp-5343	1176	2	infect	infect	VERB
fnp-5343	1176	3	dis	dis	PROPN
fnp-5343	1176	4	2021;223:600–9	2021;223:600–9	NUM
fnp-5343	1176	5	.	.	PUNCT
fnp-5343	1176	6	https://doi.org/10.1093/infdis/jiaa745	https://doi.org/10.1093/infdis/jiaa745	PROPN
fnp-5343	1176	7	.	.	PUNCT
fnp-5343	1177	1	239	239	NUM
fnp-5343	1177	2	.	.	PUNCT
fnp-5343	1177	3	destras	destras	PROPN
fnp-5343	1177	4	g	g	NOUN
fnp-5343	1177	5	,	,	PUNCT
fnp-5343	1177	6	bal	bal	PROPN
fnp-5343	1177	7	a	a	PRON
fnp-5343	1177	8	,	,	PUNCT
fnp-5343	1177	9	escuret	escuret	NOUN
fnp-5343	1177	10	v	v	NOUN
fnp-5343	1177	11	,	,	PUNCT
fnp-5343	1177	12	morfin	morfin	NOUN
fnp-5343	1177	13	f	f	PROPN
fnp-5343	1177	14	,	,	PUNCT
fnp-5343	1177	15	lina	lina	PROPN
fnp-5343	1177	16	b	b	PROPN
fnp-5343	1177	17	,	,	PUNCT
fnp-5343	1178	1	josset	josset	PROPN
fnp-5343	1178	2	l.	l.	PROPN
fnp-5343	1178	3	systematic	systematic	PROPN
fnp-5343	1178	4	sars	sars	PROPN
fnp-5343	1178	5	-	-	PUNCT
fnp-5343	1178	6	cov-2	cov-2	PART
fnp-5343	1178	7	screening	screening	NOUN
fnp-5343	1178	8	in	in	ADP
fnp-5343	1178	9	cerebrospinal	cerebrospinal	ADJ
fnp-5343	1178	10	fluid	fluid	NOUN
fnp-5343	1178	11	during	during	ADP
fnp-5343	1178	12	the	the	DET
fnp-5343	1178	13	covid-19	covid-19	PROPN
fnp-5343	1178	14	pandemic	pandemic	NOUN
fnp-5343	1178	15	.	.	PUNCT
fnp-5343	1179	1	lancet	lancet	PROPN
fnp-5343	1179	2	microbe	microbe	PROPN
fnp-5343	1179	3	2020;1	2020;1	NUM
fnp-5343	1179	4	:	:	PUNCT
fnp-5343	1179	5	e149	e149	NUM
fnp-5343	1179	6	.	.	PUNCT
fnp-5343	1180	1	https://doi.org/10.1016/s2666-5247(20)30066-5	https://doi.org/10.1016/s2666-5247(20)30066-5	PROPN
fnp-5343	1180	2	.	.	PROPN
fnp-5343	1181	1	240	240	NUM
fnp-5343	1181	2	.	.	PUNCT
fnp-5343	1181	3	edén	edén	PROPN
fnp-5343	1181	4	a	a	PRON
fnp-5343	1181	5	,	,	PUNCT
fnp-5343	1181	6	grahn	grahn	VERB
fnp-5343	1181	7	a	a	PRON
fnp-5343	1181	8	,	,	PUNCT
fnp-5343	1181	9	bremell	bremell	NOUN
fnp-5343	1181	10	d	d	PROPN
fnp-5343	1181	11	,	,	PUNCT
fnp-5343	1181	12	aghvanyan	aghvanyan	ADJ
fnp-5343	1181	13	a	a	PRON
fnp-5343	1181	14	,	,	PUNCT
fnp-5343	1181	15	bathala	bathala	PROPN
fnp-5343	1181	16	p	p	X
fnp-5343	1181	17	,	,	PUNCT
fnp-5343	1181	18	fuchs	fuchs	PROPN
fnp-5343	1181	19	d	d	PROPN
fnp-5343	1181	20	,	,	PUNCT
fnp-5343	1181	21	et	et	PROPN
fnp-5343	1181	22	al	al	PROPN
fnp-5343	1181	23	.	.	PROPN
fnp-5343	1181	24	viral	viral	ADJ
fnp-5343	1181	25	antigen	antigen	NOUN
fnp-5343	1181	26	and	and	CCONJ
fnp-5343	1181	27	inflammatory	inflammatory	ADJ
fnp-5343	1181	28	biomarkers	biomarker	NOUN
fnp-5343	1181	29	in	in	ADP
fnp-5343	1181	30	cerebrospinal	cerebrospinal	ADJ
fnp-5343	1181	31	fluid	fluid	NOUN
fnp-5343	1181	32	in	in	ADP
fnp-5343	1181	33	patients	patient	NOUN
fnp-5343	1181	34	with	with	ADP
fnp-5343	1181	35	covid-19	covid-19	PROPN
fnp-5343	1181	36	infection	infection	NOUN
fnp-5343	1181	37	and	and	CCONJ
fnp-5343	1181	38	neurologic	neurologic	ADJ
fnp-5343	1181	39	symptoms	symptom	NOUN
fnp-5343	1181	40	compared	compare	VERB
fnp-5343	1181	41	with	with	ADP
fnp-5343	1181	42	control	control	NOUN
fnp-5343	1181	43	participants	participant	NOUN
fnp-5343	1181	44	without	without	ADP
fnp-5343	1181	45	infection	infection	NOUN
fnp-5343	1181	46	or	or	CCONJ
fnp-5343	1181	47	neurologic	neurologic	ADJ
fnp-5343	1181	48	symptoms	symptom	NOUN
fnp-5343	1181	49	.	.	PUNCT
fnp-5343	1182	1	jama	jama	PROPN
fnp-5343	1182	2	netw	netw	PROPN
fnp-5343	1182	3	open	open	PROPN
fnp-5343	1182	4	2022;5	2022;5	NUM
fnp-5343	1182	5	:	:	PUNCT
fnp-5343	1182	6	e2213253	e2213253	NUM
fnp-5343	1182	7	.	.	PUNCT
fnp-5343	1183	1	https://doi.org/10.1001/jamanetworkopen.2022.13253	https://doi.org/10.1001/jamanetworkopen.2022.13253	PROPN
fnp-5343	1183	2	.	.	PUNCT
fnp-5343	1184	1	241	241	NUM
fnp-5343	1184	2	.	.	PUNCT
fnp-5343	1184	3	hopfer	hopfer	PROPN
fnp-5343	1184	4	h	h	PROPN
fnp-5343	1184	5	,	,	PUNCT
fnp-5343	1184	6	herzig	herzig	PROPN
fnp-5343	1184	7	mc	mc	PROPN
fnp-5343	1184	8	,	,	PUNCT
fnp-5343	1184	9	gosert	gosert	PROPN
fnp-5343	1184	10	r	r	PROPN
fnp-5343	1184	11	,	,	PUNCT
fnp-5343	1184	12	menter	menter	PROPN
fnp-5343	1184	13	t	t	PROPN
fnp-5343	1184	14	,	,	PUNCT
fnp-5343	1184	15	hench	hench	NOUN
fnp-5343	1184	16	j	j	PROPN
fnp-5343	1184	17	,	,	PUNCT
fnp-5343	1184	18	tzankov	tzankov	VERB
fnp-5343	1184	19	a	a	X
fnp-5343	1184	20	,	,	PUNCT
fnp-5343	1184	21	et	et	PROPN
fnp-5343	1184	22	al	al	PROPN
fnp-5343	1184	23	.	.	PUNCT
fnp-5343	1185	1	hunting	hunt	VERB
fnp-5343	1185	2	coronavirus	coronavirus	NOUN
fnp-5343	1185	3	by	by	ADP
fnp-5343	1185	4	transmission	transmission	NOUN
fnp-5343	1185	5	electron	electron	NOUN
fnp-5343	1185	6	microscopy	microscopy	NOUN
fnp-5343	1185	7	–	–	PUNCT
fnp-5343	1185	8	a	a	DET
fnp-5343	1185	9	guide	guide	NOUN
fnp-5343	1185	10	to	to	ADP
fnp-5343	1185	11	sars	sar	NOUN
fnp-5343	1185	12	-	-	PUNCT
fnp-5343	1185	13	cov-2	cov-2	ADV
fnp-5343	1185	14	-	-	PUNCT
fnp-5343	1185	15	associated	associate	VERB
fnp-5343	1185	16	ultrastructural	ultrastructural	ADJ
fnp-5343	1185	17	pathology	pathology	NOUN
fnp-5343	1185	18	in	in	ADP
fnp-5343	1185	19	covid-19	covid-19	PROPN
fnp-5343	1185	20	tissues	tissue	NOUN
fnp-5343	1185	21	.	.	PUNCT
fnp-5343	1186	1	histopathology	histopathology	PROPN
fnp-5343	1186	2	2021;78:358–70	2021;78:358–70	PROPN
fnp-5343	1186	3	.	.	PUNCT
fnp-5343	1187	1	https://doi.org/10.1111/his.14264	https://doi.org/10.1111/his.14264	NOUN
fnp-5343	1187	2	.	.	PUNCT
fnp-5343	1188	1	242	242	NUM
fnp-5343	1188	2	.	.	PUNCT
fnp-5343	1189	1	goldsmith	goldsmith	PROPN
fnp-5343	1189	2	cs	cs	PROPN
fnp-5343	1189	3	,	,	PUNCT
fnp-5343	1189	4	miller	miller	PROPN
fnp-5343	1189	5	se	se	PROPN
fnp-5343	1189	6	,	,	PUNCT
fnp-5343	1189	7	martines	martine	NOUN
fnp-5343	1189	8	rb	rb	VERB
fnp-5343	1189	9	,	,	PUNCT
fnp-5343	1189	10	bullock	bullock	NOUN
fnp-5343	1189	11	ha	ha	INTJ
fnp-5343	1189	12	,	,	PUNCT
fnp-5343	1189	13	zaki	zaki	PROPN
fnp-5343	1189	14	sr	sr	PROPN
fnp-5343	1189	15	.	.	PUNCT
fnp-5343	1190	1	electron	electron	PROPN
fnp-5343	1190	2	microscopy	microscopy	NOUN
fnp-5343	1190	3	of	of	ADP
fnp-5343	1190	4	sars	sar	NOUN
fnp-5343	1190	5	-	-	PUNCT
fnp-5343	1190	6	cov-2	cov-2	NOUN
fnp-5343	1190	7	:	:	PUNCT
fnp-5343	1190	8	a	a	DET
fnp-5343	1190	9	challenging	challenging	ADJ
fnp-5343	1190	10	task	task	NOUN
fnp-5343	1190	11	.	.	PUNCT
fnp-5343	1191	1	lancet	lancet	PROPN
fnp-5343	1191	2	2020;395	2020;395	NUM
fnp-5343	1191	3	:	:	PUNCT
fnp-5343	1191	4	e99	e99	NUM
fnp-5343	1191	5	.	.	PUNCT
fnp-5343	1192	1	https://doi.org/10.1016/s0140-6736(20)31188-0	https://doi.org/10.1016/s0140-6736(20)31188-0	PROPN
fnp-5343	1192	2	243	243	NUM
fnp-5343	1192	3	.	.	PUNCT
fnp-5343	1193	1	bullock	bullock	PROPN
fnp-5343	1193	2	ha	ha	INTJ
fnp-5343	1193	3	,	,	PUNCT
fnp-5343	1193	4	goldsmith	goldsmith	PROPN
fnp-5343	1193	5	cs	cs	PROPN
fnp-5343	1193	6	,	,	PUNCT
fnp-5343	1193	7	zaki	zaki	PROPN
fnp-5343	1193	8	sr	sr	PROPN
fnp-5343	1193	9	,	,	PUNCT
fnp-5343	1193	10	martines	martine	NOUN
fnp-5343	1193	11	rb	rb	PROPN
fnp-5343	1193	12	,	,	PUNCT
fnp-5343	1193	13	miller	miller	PROPN
fnp-5343	1193	14	se	se	PROPN
fnp-5343	1193	15	.	.	PUNCT
fnp-5343	1194	1	difficulties	difficulty	NOUN
fnp-5343	1194	2	in	in	ADP
fnp-5343	1194	3	differentiating	differentiate	VERB
fnp-5343	1194	4	coronaviruses	coronaviruse	NOUN
fnp-5343	1194	5	from	from	ADP
fnp-5343	1194	6	subcellular	subcellular	ADJ
fnp-5343	1194	7	structures	structure	NOUN
fnp-5343	1194	8	in	in	ADP
fnp-5343	1194	9	human	human	ADJ
fnp-5343	1194	10	tissues	tissue	NOUN
fnp-5343	1194	11	by	by	ADP
fnp-5343	1194	12	electron	electron	NOUN
fnp-5343	1194	13	microscopy	microscopy	NOUN
fnp-5343	1194	14	.	.	PUNCT
fnp-5343	1195	1	emerg	emerg	PROPN
fnp-5343	1195	2	infect	infect	NOUN
fnp-5343	1195	3	dis	dis	PROPN
fnp-5343	1195	4	2021;27:1023–31	2021;27:1023–31	NUM
fnp-5343	1195	5	.	.	PUNCT
fnp-5343	1196	1	https://doi.org/10.3201/eid2704.204337	https://doi.org/10.3201/eid2704.204337	NOUN
fnp-5343	1196	2	.	.	PUNCT
fnp-5343	1197	1	244	244	NUM
fnp-5343	1197	2	.	.	PUNCT
fnp-5343	1198	1	xekardaki	xekardaki	PROPN
fnp-5343	1198	2	a	a	PRON
fnp-5343	1198	3	,	,	PUNCT
fnp-5343	1198	4	santos	santos	PROPN
fnp-5343	1198	5	m	m	PROPN
fnp-5343	1198	6	,	,	PUNCT
fnp-5343	1198	7	hof	hof	PROPN
fnp-5343	1199	1	p	p	NOUN
fnp-5343	1199	2	,	,	PUNCT
fnp-5343	1199	3	kövari	kövari	ADJ
fnp-5343	1199	4	e	e	NOUN
fnp-5343	1199	5	,	,	PUNCT
fnp-5343	1199	6	bouras	boura	NOUN
fnp-5343	1199	7	c	c	NOUN
fnp-5343	1199	8	,	,	PUNCT
fnp-5343	1199	9	giannakopoulos	giannakopoulos	PROPN
fnp-5343	1199	10	p.	p.	PROPN
fnp-5343	1200	1	neuropathological	neuropathological	ADJ
fnp-5343	1200	2	substrates	substrate	NOUN
fnp-5343	1200	3	and	and	CCONJ
fnp-5343	1200	4	structural	structural	ADJ
fnp-5343	1200	5	changes	change	NOUN
fnp-5343	1200	6	in	in	ADP
fnp-5343	1200	7	late	late	ADJ
fnp-5343	1200	8	-	-	PUNCT
fnp-5343	1200	9	life	life	NOUN
fnp-5343	1200	10	depression	depression	NOUN
fnp-5343	1200	11	:	:	PUNCT
fnp-5343	1200	12	the	the	DET
fnp-5343	1200	13	impact	impact	NOUN
fnp-5343	1200	14	of	of	ADP
fnp-5343	1200	15	vascular	vascular	ADJ
fnp-5343	1200	16	burden	burden	NOUN
fnp-5343	1200	17	.	.	PUNCT
fnp-5343	1201	1	acta	acta	PROPN
fnp-5343	1201	2	neuropathol	neuropathol	PROPN
fnp-5343	1202	1	2012;124:453–64	2012;124:453–64	PROPN
fnp-5343	1202	2	.	.	PUNCT
fnp-5343	1203	1	https://doi.org/10.1007/s00401-012-1021-5	https://doi.org/10.1007/s00401-012-1021-5	PROPN
fnp-5343	1203	2	.	.	PUNCT
fnp-5343	1204	1	245	245	NUM
fnp-5343	1204	2	.	.	PUNCT
fnp-5343	1205	1	jellinger	jellinger	PROPN
fnp-5343	1205	2	ka	ka	PROPN
fnp-5343	1205	3	.	.	PUNCT
fnp-5343	1206	1	the	the	DET
fnp-5343	1206	2	heterogeneity	heterogeneity	NOUN
fnp-5343	1206	3	of	of	ADP
fnp-5343	1206	4	late	late	ADJ
fnp-5343	1206	5	-	-	PUNCT
fnp-5343	1206	6	life	life	NOUN
fnp-5343	1206	7	depression	depression	NOUN
fnp-5343	1206	8	and	and	CCONJ
fnp-5343	1206	9	its	its	PRON
fnp-5343	1206	10	pathobiology	pathobiology	NOUN
fnp-5343	1206	11	:	:	PUNCT
fnp-5343	1206	12	a	a	DET
fnp-5343	1206	13	brain	brain	NOUN
fnp-5343	1206	14	network	network	NOUN
fnp-5343	1206	15	dysfunction	dysfunction	NOUN
fnp-5343	1206	16	disorder	disorder	NOUN
fnp-5343	1206	17	.	.	PUNCT
fnp-5343	1207	1	j	j	PROPN
fnp-5343	1207	2	neural	neural	PROPN
fnp-5343	1207	3	transm	transm	PROPN
fnp-5343	1207	4	2023;130:1057–76	2023;130:1057–76	NUM
fnp-5343	1207	5	.	.	PUNCT
fnp-5343	1208	1	https://doi.org/10.1007/s00702-023-02648-z	https://doi.org/10.1007/s00702-023-02648-z	PROPN
fnp-5343	1208	2	.	.	PROPN
fnp-5343	1209	1	246	246	NUM
fnp-5343	1209	2	.	.	PUNCT
fnp-5343	1210	1	reiken	reiken	VERB
fnp-5343	1210	2	s	s	PROPN
fnp-5343	1210	3	,	,	PUNCT
fnp-5343	1210	4	sittenfeld	sittenfeld	ADJ
fnp-5343	1210	5	l	l	NOUN
fnp-5343	1210	6	,	,	PUNCT
fnp-5343	1210	7	dridi	dridi	ADJ
fnp-5343	1210	8	h	h	NOUN
fnp-5343	1210	9	,	,	PUNCT
fnp-5343	1210	10	liu	liu	PROPN
fnp-5343	1210	11	y	y	PROPN
fnp-5343	1210	12	,	,	PUNCT
fnp-5343	1210	13	liu	liu	PROPN
fnp-5343	1210	14	x	x	PROPN
fnp-5343	1210	15	,	,	PUNCT
fnp-5343	1210	16	marks	marks	PROPN
fnp-5343	1210	17	ar	ar	PROPN
fnp-5343	1210	18	.	.	PROPN
fnp-5343	1210	19	alzheimer’s	alzheimer’s	PROPN
fnp-5343	1210	20	-	-	PUNCT
fnp-5343	1210	21	like	like	ADJ
fnp-5343	1210	22	signaling	signal	VERB
fnp-5343	1210	23	in	in	ADP
fnp-5343	1210	24	brains	brain	NOUN
fnp-5343	1210	25	of	of	ADP
fnp-5343	1210	26	covid-19	covid-19	PROPN
fnp-5343	1210	27	patients	patient	NOUN
fnp-5343	1210	28	.	.	PUNCT
fnp-5343	1211	1	alzheimer	alzheimer	PROPN
fnp-5343	1211	2	’s	’s	PART
fnp-5343	1211	3	dement	dement	PROPN
fnp-5343	1211	4	2022;18:955–65	2022;18:955–65	PROPN
fnp-5343	1211	5	.	.	PUNCT
fnp-5343	1212	1	https://doi.org/10.1002/alz.12558	https://doi.org/10.1002/alz.12558	PROPN
fnp-5343	1212	2	.	.	PUNCT
fnp-5343	1213	1	247	247	NUM
fnp-5343	1213	2	.	.	PUNCT
fnp-5343	1214	1	nelson	nelson	PROPN
fnp-5343	1214	2	pt	pt	PROPN
fnp-5343	1214	3	,	,	PUNCT
fnp-5343	1214	4	head	head	NOUN
fnp-5343	1214	5	e	e	NOUN
fnp-5343	1214	6	,	,	PUNCT
fnp-5343	1214	7	schmitt	schmitt	PROPN
fnp-5343	1214	8	fa	fa	PROPN
fnp-5343	1214	9	,	,	PUNCT
fnp-5343	1214	10	davis	davis	PROPN
fnp-5343	1214	11	pr	pr	PROPN
fnp-5343	1214	12	,	,	PUNCT
fnp-5343	1214	13	neltner	neltner	PROPN
fnp-5343	1214	14	jh	jh	PROPN
fnp-5343	1214	15	,	,	PUNCT
fnp-5343	1214	16	jicha	jicha	PROPN
fnp-5343	1214	17	ga	ga	PROPN
fnp-5343	1214	18	,	,	PUNCT
fnp-5343	1214	19	et	et	PROPN
fnp-5343	1214	20	al	al	PROPN
fnp-5343	1214	21	.	.	PROPN
fnp-5343	1214	22	alzheimer	alzheimer	PROPN
fnp-5343	1214	23	’s	’s	PART
fnp-5343	1214	24	disease	disease	NOUN
fnp-5343	1214	25	is	be	AUX
fnp-5343	1214	26	not	not	PART
fnp-5343	1214	27	"	"	PUNCT
fnp-5343	1214	28	brain	brain	NOUN
fnp-5343	1214	29	aging	aging	NOUN
fnp-5343	1214	30	"	"	PUNCT
fnp-5343	1214	31	:	:	PUNCT
fnp-5343	1214	32	neuropathological	neuropathological	ADJ
fnp-5343	1214	33	,	,	PUNCT
fnp-5343	1214	34	genetic	genetic	ADJ
fnp-5343	1214	35	,	,	PUNCT
fnp-5343	1214	36	and	and	CCONJ
fnp-5343	1214	37	epidemiological	epidemiological	ADJ
fnp-5343	1214	38	human	human	ADJ
fnp-5343	1214	39	studies	study	NOUN
fnp-5343	1214	40	.	.	PUNCT
fnp-5343	1215	1	acta	acta	PROPN
fnp-5343	1215	2	neuropathol	neuropathol	PROPN
fnp-5343	1215	3	2011;121:571–87	2011;121:571–87	PROPN
fnp-5343	1215	4	.	.	PUNCT
fnp-5343	1216	1	https://doi.org/10.1007/s00401-011-0826-y	https://doi.org/10.1007/s00401-011-0826-y	NOUN
fnp-5343	1216	2	.	.	PROPN
fnp-5343	1216	3	248	248	NUM
fnp-5343	1216	4	.	.	PUNCT
fnp-5343	1217	1	horvath	horvath	PROPN
fnp-5343	1217	2	s	s	PROPN
fnp-5343	1217	3	,	,	PUNCT
fnp-5343	1217	4	levine	levine	PROPN
fnp-5343	1217	5	aj	aj	PROPN
fnp-5343	1217	6	.	.	PROPN
fnp-5343	1217	7	hiv-1	hiv-1	PUNCT
fnp-5343	1217	8	infection	infection	NOUN
fnp-5343	1217	9	accelerates	accelerate	VERB
fnp-5343	1217	10	age	age	NOUN
fnp-5343	1217	11	according	accord	VERB
fnp-5343	1217	12	to	to	ADP
fnp-5343	1217	13	the	the	DET
fnp-5343	1217	14	epigenetic	epigenetic	ADJ
fnp-5343	1217	15	clock	clock	NOUN
fnp-5343	1217	16	.	.	PUNCT
fnp-5343	1218	1	j	j	PROPN
fnp-5343	1218	2	infect	infect	VERB
fnp-5343	1218	3	dis	dis	PROPN
fnp-5343	1218	4	2015;212:1563–73	2015;212:1563–73	NUM
fnp-5343	1218	5	.	.	PUNCT
fnp-5343	1219	1	https://doi.org/10.1093/infdis/jiv277	https://doi.org/10.1093/infdis/jiv277	NOUN
fnp-5343	1219	2	.	.	PUNCT
fnp-5343	1220	1	249	249	NUM
fnp-5343	1220	2	.	.	PUNCT
fnp-5343	1221	1	khanlou	khanlou	PROPN
fnp-5343	1221	2	n	n	PROPN
fnp-5343	1221	3	,	,	PUNCT
fnp-5343	1221	4	moore	moore	PROPN
fnp-5343	1221	5	dj	dj	PROPN
fnp-5343	1221	6	,	,	PUNCT
fnp-5343	1221	7	chana	chana	NOUN
fnp-5343	1221	8	g	g	NOUN
fnp-5343	1221	9	,	,	PUNCT
fnp-5343	1221	10	cherner	cherner	PROPN
fnp-5343	1221	11	m	m	PROPN
fnp-5343	1221	12	,	,	PUNCT
fnp-5343	1221	13	lazzaretto	lazzaretto	ADJ
fnp-5343	1221	14	d	d	NOUN
fnp-5343	1221	15	,	,	PUNCT
fnp-5343	1221	16	dawes	dawes	PROPN
fnp-5343	1221	17	s	s	PART
fnp-5343	1221	18	,	,	PUNCT
fnp-5343	1221	19	et	et	PROPN
fnp-5343	1221	20	al	al	PROPN
fnp-5343	1221	21	.	.	PROPN
fnp-5343	1221	22	increased	increase	VERB
fnp-5343	1221	23	frequency	frequency	NOUN
fnp-5343	1221	24	of	of	ADP
fnp-5343	1221	25	alpha	alpha	NOUN
fnp-5343	1221	26	-	-	PUNCT
fnp-5343	1221	27	synuclein	synuclein	NOUN
fnp-5343	1221	28	in	in	ADP
fnp-5343	1221	29	the	the	DET
fnp-5343	1221	30	substantia	substantia	NOUN
fnp-5343	1221	31	nigra	nigra	NOUN
fnp-5343	1221	32	in	in	ADP
fnp-5343	1221	33	human	human	ADJ
fnp-5343	1221	34	immunodeficiency	immunodeficiency	NOUN
fnp-5343	1221	35	virus	virus	NOUN
fnp-5343	1221	36	infection	infection	NOUN
fnp-5343	1221	37	.	.	PUNCT
fnp-5343	1222	1	j	j	PROPN
fnp-5343	1222	2	neurovirol	neurovirol	PROPN
fnp-5343	1222	3	2009;15:131–8	2009;15:131–8	NUM
fnp-5343	1222	4	.	.	PUNCT
fnp-5343	1223	1	https://doi.org/10.1080/13550280802578075	https://doi.org/10.1080/13550280802578075	X
fnp-5343	1223	2	.	.	PUNCT
fnp-5343	1224	1	250	250	NUM
fnp-5343	1224	2	.	.	PUNCT
fnp-5343	1225	1	levine	levine	PROPN
fnp-5343	1225	2	a	a	PRON
fnp-5343	1225	3	,	,	PUNCT
fnp-5343	1225	4	sacktor	sacktor	NOUN
fnp-5343	1225	5	n	n	CCONJ
fnp-5343	1225	6	,	,	PUNCT
fnp-5343	1225	7	becker	becker	PROPN
fnp-5343	1225	8	jt	jt	PROPN
fnp-5343	1225	9	.	.	PUNCT
fnp-5343	1226	1	studying	study	VERB
fnp-5343	1226	2	the	the	DET
fnp-5343	1226	3	neuropsychological	neuropsychological	ADJ
fnp-5343	1226	4	sequelae	sequelae	NOUN
fnp-5343	1226	5	of	of	ADP
fnp-5343	1226	6	sars	sar	NOUN
fnp-5343	1226	7	-	-	PUNCT
fnp-5343	1226	8	cov-2	cov-2	NOUN
fnp-5343	1226	9	:	:	PUNCT
fnp-5343	1226	10	lessons	lesson	NOUN
fnp-5343	1226	11	learned	learn	VERB
fnp-5343	1226	12	from	from	ADP
fnp-5343	1226	13	35	35	NUM
fnp-5343	1226	14	years	year	NOUN
fnp-5343	1226	15	of	of	ADP
fnp-5343	1226	16	neurohiv	neurohiv	PROPN
fnp-5343	1226	17	research	research	NOUN
fnp-5343	1226	18	.	.	PUNCT
fnp-5343	1227	1	j	j	PROPN
fnp-5343	1227	2	neurovirol	neurovirol	NOUN
fnp-5343	1227	3	2020;26:809–23	2020;26:809–23	PRON
fnp-5343	1227	4	.	.	PUNCT
fnp-5343	1228	1	https://doi.org/10.1007/s13365-020-00897-2	https://doi.org/10.1007/s13365-020-00897-2	NUM
fnp-5343	1228	2	.	.	PUNCT
fnp-5343	1229	1	251	251	NUM
fnp-5343	1229	2	.	.	PUNCT
fnp-5343	1230	1	voruz	voruz	PROPN
fnp-5343	1230	2	p	p	PROPN
fnp-5343	1230	3	,	,	PUNCT
fnp-5343	1230	4	jacot	jacot	X
fnp-5343	1230	5	de	de	X
fnp-5343	1230	6	alcântara	alcântara	PROPN
fnp-5343	1230	7	i	i	PROPN
fnp-5343	1230	8	,	,	PUNCT
fnp-5343	1230	9	nuber	nuber	PROPN
fnp-5343	1230	10	-	-	PUNCT
fnp-5343	1230	11	champier	champier	PROPN
fnp-5343	1230	12	a	a	PRON
fnp-5343	1230	13	,	,	PUNCT
fnp-5343	1230	14	cionca	cionca	NOUN
fnp-5343	1230	15	a	a	PRON
fnp-5343	1230	16	,	,	PUNCT
fnp-5343	1230	17	allali	allali	NOUN
fnp-5343	1230	18	g	g	NOUN
fnp-5343	1230	19	,	,	PUNCT
fnp-5343	1230	20	benzakour	benzakour	PROPN
fnp-5343	1230	21	l	l	NOUN
fnp-5343	1230	22	,	,	PUNCT
fnp-5343	1230	23	et	et	PROPN
fnp-5343	1230	24	al	al	PROPN
fnp-5343	1230	25	.	.	PROPN
fnp-5343	1230	26	frequency	frequency	PROPN
fnp-5343	1230	27	of	of	ADP
fnp-5343	1230	28	abnormally	abnormally	ADV
fnp-5343	1230	29	low	low	ADJ
fnp-5343	1230	30	neuropsychological	neuropsychological	ADJ
fnp-5343	1230	31	scores	score	NOUN
fnp-5343	1230	32	in	in	ADP
fnp-5343	1230	33	post	post	ADJ
fnp-5343	1230	34	-	-	ADJ
fnp-5343	1230	35	covid-19	covid-19	ADJ
fnp-5343	1230	36	syndrome	syndrome	NOUN
fnp-5343	1230	37	:	:	PUNCT
fnp-5343	1230	38	the	the	DET
fnp-5343	1230	39	geneva	geneva	PROPN
fnp-5343	1230	40	covid	covid	PROPN
fnp-5343	1230	41	-	-	PUNCT
fnp-5343	1230	42	cog	cog	PROPN
fnp-5343	1230	43	cohort	cohort	NOUN
fnp-5343	1230	44	.	.	PUNCT
fnp-5343	1231	1	arch	arch	ADJ
fnp-5343	1231	2	clin	clin	PROPN
fnp-5343	1231	3	neuropsychol	neuropsychol	PROPN
fnp-5343	1231	4	2023;38:1–11	2023;38:1–11	AUX
fnp-5343	1231	5	.	.	PUNCT
fnp-5343	1232	1	https://doi.org/10.1093/arclin/acac068	https://doi.org/10.1093/arclin/acac068	X
fnp-5343	1232	2	.	.	PUNCT
fnp-5343	1233	1	252	252	NUM
fnp-5343	1233	2	.	.	PUNCT
fnp-5343	1234	1	lynch	lynch	PROPN
fnp-5343	1234	2	s	s	PART
fnp-5343	1234	3	,	,	PUNCT
fnp-5343	1234	4	ferrando	ferrando	PROPN
fnp-5343	1234	5	sj	sj	NOUN
fnp-5343	1234	6	,	,	PUNCT
fnp-5343	1234	7	dornbush	dornbush	NOUN
fnp-5343	1234	8	r	r	NOUN
fnp-5343	1234	9	,	,	PUNCT
fnp-5343	1234	10	shahar	shahar	PROPN
fnp-5343	1234	11	s	s	PROPN
fnp-5343	1234	12	,	,	PUNCT
fnp-5343	1234	13	smiley	smiley	VERB
fnp-5343	1234	14	a	a	PRON
fnp-5343	1234	15	,	,	PUNCT
fnp-5343	1234	16	klepacz	klepacz	NOUN
fnp-5343	1234	17	l.	l.	NOUN
fnp-5343	1234	18	screening	screen	VERB
fnp-5343	1234	19	for	for	ADP
fnp-5343	1234	20	brain	brain	NOUN
fnp-5343	1234	21	fog	fog	PROPN
fnp-5343	1234	22	:	:	PUNCT
fnp-5343	1234	23	is	be	AUX
fnp-5343	1234	24	the	the	DET
fnp-5343	1234	25	montreal	montreal	PROPN
fnp-5343	1234	26	cognitive	cognitive	ADJ
fnp-5343	1234	27	assessment	assessment	NOUN
fnp-5343	1234	28	an	an	DET
fnp-5343	1234	29	effective	effective	ADJ
fnp-5343	1234	30	screening	screening	NOUN
fnp-5343	1234	31	tool	tool	NOUN
fnp-5343	1234	32	for	for	ADP
fnp-5343	1234	33	neurocognitive	neurocognitive	ADJ
fnp-5343	1234	34	complaints	complaint	NOUN
fnp-5343	1234	35	post	post	ADJ
fnp-5343	1234	36	-	-	ADJ
fnp-5343	1234	37	covid-19	covid-19	PROPN
fnp-5343	1234	38	?	?	PUNCT
fnp-5343	1235	1	gen	gen	PROPN
fnp-5343	1235	2	hosp	hosp	PROPN
fnp-5343	1235	3	psychiatry	psychiatry	PROPN
fnp-5343	1235	4	2022;78:80–6	2022;78:80–6	PROPN
fnp-5343	1235	5	.	.	PUNCT
fnp-5343	1236	1	https://doi.org/10.1016/j.genhosppsych.2022.07.013	https://doi.org/10.1016/j.genhosppsych.2022.07.013	PROPN
fnp-5343	1236	2	.	.	PROPN
fnp-5343	1237	1	253	253	NUM
fnp-5343	1237	2	.	.	PUNCT
fnp-5343	1238	1	lou	lou	PROPN
fnp-5343	1238	2	j	j	PROPN
fnp-5343	1238	3	,	,	PUNCT
fnp-5343	1238	4	movassaghi	movassaghi	PROPN
fnp-5343	1238	5	m	m	PROPN
fnp-5343	1238	6	,	,	PUNCT
fnp-5343	1238	7	gordy	gordy	PROPN
fnp-5343	1238	8	d	d	PROPN
fnp-5343	1238	9	,	,	PUNCT
fnp-5343	1238	10	olson	olson	PROPN
fnp-5343	1238	11	m	m	PROPN
fnp-5343	1238	12	,	,	PUNCT
fnp-5343	1238	13	singer	singer	NOUN
fnp-5343	1238	14	e	e	NOUN
fnp-5343	1238	15	,	,	PUNCT
fnp-5343	1238	16	magaki	magaki	PROPN
fnp-5343	1238	17	s	s	PROPN
fnp-5343	1238	18	,	,	PUNCT
fnp-5343	1238	19	et	et	PROPN
fnp-5343	1238	20	al	al	PROPN
fnp-5343	1238	21	.	.	PROPN
fnp-5343	1238	22	data	datum	NOUN
fnp-5343	1238	23	elements	element	NOUN
fnp-5343	1238	24	and	and	CCONJ
fnp-5343	1238	25	tissue	tissue	NOUN
fnp-5343	1238	26	procurement	procurement	NOUN
fnp-5343	1238	27	for	for	ADP
fnp-5343	1238	28	covid-19	covid-19	PROPN
fnp-5343	1238	29	brain	brain	NOUN
fnp-5343	1238	30	banking	banking	NOUN
fnp-5343	1238	31	.	.	PUNCT
fnp-5343	1239	1	j	j	PROPN
fnp-5343	1239	2	neuropathol	neuropathol	PROPN
fnp-5343	1239	3	exp	exp	PROPN
fnp-5343	1239	4	neurol	neurol	PROPN
fnp-5343	1239	5	2021;80:579–80	2021;80:579–80	PROPN
fnp-5343	1239	6	.	.	PROPN
fnp-5343	1240	1	254	254	NUM
fnp-5343	1240	2	.	.	PUNCT
fnp-5343	1241	1	morgello	morgello	PROPN
fnp-5343	1241	2	s	s	PROPN
fnp-5343	1241	3	,	,	PUNCT
fnp-5343	1241	4	gelman	gelman	PROPN
fnp-5343	1241	5	bb	bb	PROPN
fnp-5343	1241	6	,	,	PUNCT
fnp-5343	1241	7	kozlowski	kozlowski	PROPN
fnp-5343	1241	8	pb	pb	PROPN
fnp-5343	1241	9	,	,	PUNCT
fnp-5343	1241	10	vinters	vinters	PROPN
fnp-5343	1241	11	hv	hv	PROPN
fnp-5343	1241	12	,	,	PUNCT
fnp-5343	1241	13	masliah	masliah	PROPN
fnp-5343	1241	14	e	e	PROPN
fnp-5343	1241	15	,	,	PUNCT
fnp-5343	1241	16	cornford	cornford	PROPN
fnp-5343	1241	17	m	m	PROPN
fnp-5343	1241	18	,	,	PUNCT
fnp-5343	1241	19	et	et	PROPN
fnp-5343	1241	20	al	al	PROPN
fnp-5343	1241	21	.	.	PUNCT
fnp-5343	1242	1	the	the	DET
fnp-5343	1242	2	national	national	ADJ
fnp-5343	1242	3	neuroaids	neuroaid	NOUN
fnp-5343	1242	4	tissue	tissue	NOUN
fnp-5343	1242	5	consortium	consortium	NOUN
fnp-5343	1242	6	:	:	PUNCT
fnp-5343	1242	7	a	a	DET
fnp-5343	1242	8	new	new	ADJ
fnp-5343	1242	9	paradigm	paradigm	NOUN
fnp-5343	1242	10	in	in	ADP
fnp-5343	1242	11	brain	brain	NOUN
fnp-5343	1242	12	banking	banking	NOUN
fnp-5343	1242	13	with	with	ADP
fnp-5343	1242	14	an	an	DET
fnp-5343	1242	15	emphasis	emphasis	NOUN
fnp-5343	1242	16	on	on	ADP
fnp-5343	1242	17	infectious	infectious	ADJ
fnp-5343	1242	18	disease	disease	NOUN
fnp-5343	1242	19	.	.	PUNCT
fnp-5343	1243	1	2001;27:326	2001;27:326	NUM
fnp-5343	1243	2	-	-	SYM
fnp-5343	1243	3	35	35	NUM
fnp-5343	1243	4	.	.	PUNCT
fnp-5343	1244	1	https://doi.org/10.1046/j.0305-1846.2001.00334.x	https://doi.org/10.1046/j.0305-1846.2001.00334.x	NOUN
fnp-5343	1244	2	.	.	PUNCT
fnp-5343	1245	1	255	255	NUM
fnp-5343	1245	2	.	.	PUNCT
fnp-5343	1246	1	hooper	hooper	PROPN
fnp-5343	1246	2	je	je	PROPN
fnp-5343	1246	3	.	.	PROPN
fnp-5343	1247	1	rapid	rapid	ADJ
fnp-5343	1247	2	autopsy	autopsy	ADJ
fnp-5343	1247	3	programs	program	NOUN
fnp-5343	1247	4	and	and	CCONJ
fnp-5343	1247	5	research	research	NOUN
fnp-5343	1247	6	support	support	NOUN
fnp-5343	1247	7	:	:	PUNCT
fnp-5343	1247	8	the	the	DET
fnp-5343	1247	9	preand	preand	NOUN
fnp-5343	1247	10	post	post	ADJ
fnp-5343	1247	11	-	-	ADJ
fnp-5343	1247	12	covid-19	covid-19	ADJ
fnp-5343	1247	13	environments	environment	NOUN
fnp-5343	1247	14	.	.	PUNCT
fnp-5343	1248	1	ajsp	ajsp	PROPN
fnp-5343	1248	2	rev	rev	PROPN
fnp-5343	1248	3	rep	rep	PROPN
fnp-5343	1248	4	2021;26:100–7	2021;26:100–7	PROPN
fnp-5343	1248	5	.	.	PUNCT
fnp-5343	1249	1	pmc7954201	pmc7954201	ADJ
fnp-5343	1249	2	.	.	PUNCT
fnp-5343	1250	1	256	256	NUM
fnp-5343	1250	2	.	.	PUNCT
fnp-5343	1251	1	zhu	zhu	PROPN
fnp-5343	1251	2	y	y	PROPN
fnp-5343	1251	3	,	,	PUNCT
fnp-5343	1251	4	wang	wang	PROPN
fnp-5343	1251	5	l	l	PROPN
fnp-5343	1251	6	,	,	PUNCT
fnp-5343	1251	7	yin	yin	PROPN
fnp-5343	1251	8	y	y	PROPN
fnp-5343	1251	9	,	,	PUNCT
fnp-5343	1252	1	yang	yang	PROPN
fnp-5343	1252	2	e.	e.	PROPN
fnp-5343	1252	3	systematic	systematic	PROPN
fnp-5343	1252	4	analysis	analysis	NOUN
fnp-5343	1252	5	of	of	ADP
fnp-5343	1252	6	gene	gene	NOUN
fnp-5343	1252	7	expression	expression	NOUN
fnp-5343	1252	8	patterns	pattern	NOUN
fnp-5343	1252	9	associated	associate	VERB
fnp-5343	1252	10	with	with	ADP
fnp-5343	1252	11	postmortem	postmortem	NOUN
fnp-5343	1252	12	interval	interval	NOUN
fnp-5343	1252	13	in	in	ADP
fnp-5343	1252	14	human	human	ADJ
fnp-5343	1252	15	tissues	tissue	NOUN
fnp-5343	1252	16	.	.	PUNCT
fnp-5343	1253	1	sci	sci	PROPN
fnp-5343	1253	2	rep	rep	PROPN
fnp-5343	1253	3	2017;7:5435	2017;7:5435	PROPN
fnp-5343	1253	4	.	.	PUNCT
fnp-5343	1254	1	https://doi.org/10.1038/s41598-017-05882-0	https://doi.org/10.1038/s41598-017-05882-0	NUM
fnp-5343	1254	2	.	.	PUNCT
fnp-5343	1255	1	257	257	X
fnp-5343	1255	2	.	.	PUNCT
fnp-5343	1256	1	skrobot	skrobot	PROPN
fnp-5343	1256	2	oa	oa	PROPN
fnp-5343	1256	3	,	,	PUNCT
fnp-5343	1256	4	attems	attem	VERB
fnp-5343	1256	5	j	j	PROPN
fnp-5343	1256	6	,	,	PUNCT
fnp-5343	1256	7	esiri	esiri	PROPN
fnp-5343	1256	8	m	m	PROPN
fnp-5343	1256	9	,	,	PUNCT
fnp-5343	1256	10	hortobágyi	hortobágyi	PROPN
fnp-5343	1256	11	t	t	PROPN
fnp-5343	1256	12	,	,	PUNCT
fnp-5343	1256	13	ironside	ironside	PROPN
fnp-5343	1256	14	jw	jw	PROPN
fnp-5343	1256	15	,	,	PUNCT
fnp-5343	1256	16	kalaria	kalaria	PROPN
fnp-5343	1256	17	rn	rn	PROPN
fnp-5343	1256	18	,	,	PUNCT
fnp-5343	1256	19	et	et	PROPN
fnp-5343	1256	20	al	al	PROPN
fnp-5343	1256	21	.	.	PUNCT
fnp-5343	1257	1	vascular	vascular	ADJ
fnp-5343	1257	2	cognitive	cognitive	ADJ
fnp-5343	1257	3	impairment	impairment	NOUN
fnp-5343	1257	4	neuropathology	neuropathology	NOUN
fnp-5343	1257	5	guidelines	guideline	NOUN
fnp-5343	1257	6	(	(	PUNCT
fnp-5343	1257	7	vcing	vcing	NOUN
fnp-5343	1257	8	):	):	PUNCT
fnp-5343	1257	9	the	the	DET
fnp-5343	1257	10	contribution	contribution	NOUN
fnp-5343	1257	11	of	of	ADP
fnp-5343	1257	12	cerebrovascular	cerebrovascular	ADJ
fnp-5343	1257	13	pathology	pathology	NOUN
fnp-5343	1257	14	to	to	PART
fnp-5343	1257	15	cognitive	cognitive	ADJ
fnp-5343	1257	16	impairment	impairment	NOUN
fnp-5343	1257	17	.	.	PUNCT
fnp-5343	1258	1	brain	brain	NOUN
fnp-5343	1258	2	2016;139:2957	2016;139:2957	NUM
fnp-5343	1258	3	-	-	SYM
fnp-5343	1258	4	69	69	NUM
fnp-5343	1258	5	.	.	PUNCT
fnp-5343	1259	1	https://doi.org/10.1093/brain/aww214	https://doi.org/10.1093/brain/aww214	NOUN
fnp-5343	1259	2	.	.	PUNCT
fnp-5343	1260	1	copyright	copyright	NOUN
fnp-5343	1260	2	:	:	PUNCT
fnp-5343	1260	3	©	©	PROPN
fnp-5343	1260	4	2024	2024	NUM
fnp-5343	1260	5	the	the	DET
fnp-5343	1260	6	author(s	author(s	NOUN
fnp-5343	1260	7	)	)	PUNCT
fnp-5343	1260	8	.	.	PUNCT
fnp-5343	1261	1	this	this	PRON
fnp-5343	1261	2	is	be	AUX
fnp-5343	1261	3	an	an	DET
fnp-5343	1261	4	open	open	ADJ
fnp-5343	1261	5	access	access	NOUN
fnp-5343	1261	6	article	article	NOUN
fnp-5343	1261	7	distributed	distribute	VERB
fnp-5343	1261	8	under	under	ADP
fnp-5343	1261	9	the	the	DET
fnp-5343	1261	10	terms	term	NOUN
fnp-5343	1261	11	of	of	ADP
fnp-5343	1261	12	the	the	DET
fnp-5343	1261	13	creative	creative	ADJ
fnp-5343	1261	14	commons	common	NOUN
fnp-5343	1261	15	attribution	attribution	NOUN
fnp-5343	1261	16	4.0	4.0	NUM
fnp-5343	1261	17	international	international	ADJ
fnp-5343	1261	18	license	license	NOUN
fnp-5343	1261	19	(	(	PUNCT
fnp-5343	1261	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-5343	1261	21	)	)	PUNCT
fnp-5343	1261	22	,	,	PUNCT
fnp-5343	1261	23	which	which	PRON
fnp-5343	1261	24	permits	permit	VERB
fnp-5343	1261	25	unrestricted	unrestricted	ADJ
fnp-5343	1261	26	use	use	NOUN
fnp-5343	1261	27	,	,	PUNCT
fnp-5343	1261	28	distribution	distribution	NOUN
fnp-5343	1261	29	,	,	PUNCT
fnp-5343	1261	30	and	and	CCONJ
fnp-5343	1261	31	reproduction	reproduction	NOUN
fnp-5343	1261	32	in	in	ADP
fnp-5343	1261	33	any	any	DET
fnp-5343	1261	34	medium	medium	NOUN
fnp-5343	1261	35	,	,	PUNCT
fnp-5343	1261	36	provided	provide	VERB
fnp-5343	1261	37	the	the	DET
fnp-5343	1261	38	original	original	ADJ
fnp-5343	1261	39	author	author	NOUN
fnp-5343	1261	40	and	and	CCONJ
fnp-5343	1261	41	source	source	NOUN
fnp-5343	1261	42	are	be	AUX
fnp-5343	1261	43	credited	credit	VERB
fnp-5343	1261	44	,	,	PUNCT
fnp-5343	1261	45	a	a	DET
fnp-5343	1261	46	link	link	NOUN
fnp-5343	1261	47	to	to	ADP
fnp-5343	1261	48	the	the	DET
fnp-5343	1261	49	creative	creative	ADJ
fnp-5343	1261	50	commons	common	NOUN
fnp-5343	1261	51	license	license	NOUN
fnp-5343	1261	52	is	be	AUX
fnp-5343	1261	53	provided	provide	VERB
fnp-5343	1261	54	,	,	PUNCT
fnp-5343	1261	55	and	and	CCONJ
fnp-5343	1261	56	any	any	DET
fnp-5343	1261	57	changes	change	NOUN
fnp-5343	1261	58	are	be	AUX
fnp-5343	1261	59	indicated	indicate	VERB
fnp-5343	1261	60	.	.	PUNCT
fnp-5343	1262	1	the	the	DET
fnp-5343	1262	2	creative	creative	ADJ
fnp-5343	1262	3	commons	common	NOUN
fnp-5343	1262	4	public	public	ADJ
fnp-5343	1262	5	domain	domain	NOUN
fnp-5343	1262	6	dedication	dedication	NOUN
fnp-5343	1262	7	waiver	waiver	NOUN
fnp-5343	1262	8	(	(	PUNCT
fnp-5343	1262	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-5343	1262	10	)	)	PUNCT
fnp-5343	1262	11	applies	apply	VERB
fnp-5343	1262	12	to	to	ADP
fnp-5343	1262	13	the	the	DET
fnp-5343	1262	14	data	datum	NOUN
fnp-5343	1262	15	made	make	VERB
fnp-5343	1262	16	available	available	ADJ
fnp-5343	1262	17	in	in	ADP
fnp-5343	1262	18	this	this	DET
fnp-5343	1262	19	article	article	NOUN
fnp-5343	1262	20	,	,	PUNCT
fnp-5343	1262	21	unless	unless	SCONJ
fnp-5343	1262	22	otherwise	otherwise	ADV
fnp-5343	1262	23	stated	state	VERB
fnp-5343	1262	24	.	.	PUNCT